TOC


Please note: A selected table may take a few minutes to load.

Results from the 2025 National Survey on Drug Use and Health: Detailed Tables

Prevalence Estimates, Standard Errors, P Values, and Sample Sizes

Section 1: Illicit Drug Use/Misuse Tables – 1.1 to 1.145

Section 2: Nicotine Product and Alcohol Use Tables – 2.1 to 2.53

Section 3: Risk and Protective Factor Tables – 3.1 to 3.16

Section 4: Incidence Tables – 4.1 to 4.11

Section 5: Substance Use Disorder and Treatment Tables – 5.1 to 5.37

Section 6: Adult Mental Health Tables – 6.1 to 6.99

Section 7: Youth Mental Health Tables – 7.1 to 7.49

Section 8: Miscellaneous Tables – 8.1 to 8.44

Section 9: Trend Tables – 9.1 to 9.102

Section 10: Sample Size and Population Tables – 10.1 to 10.24

The Results from the 2025 National Survey on Drug Use and Health: Detailed Tables was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) under contract number 75S20322C00001 with SAMHSA, U.S. Department of Health and Human Services (HHS). Elizabeth Crane served as Contracting Officer’s Representative, and Carlos Graham served as Alternate Contracting Officer’s Representative.

Recommended Citation

Center for Behavioral Health Statistics and Quality. (2026). Results from the 2025 National Survey on Drug Use and Health: Detailed tables. https://www.samhsa.gov/data/data‐we‐collect/nsduh‐national‐survey‐drug‐use‐and‐health/national‐releases

Originating Office

Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Released 2026.

Electronic Access

Products may be downloaded at https://library.samhsa.gov/.

Disclaimer

Nothing in this document constitutes a direct or indirect endorsement by SAMHSA or HHS of any nonfederal entity’s products, services, or policies.

Public Domain Notice

This publication is in the public domain and may be reproduced or copied without permission from SAMHSA. Citation of the source is appreciated. However, this publication may not be reproduced or distributed for a fee without the specific, written authorization of the Office of Communications, SAMHSA, HHS.

U.S. Department of Health and Human Services

Substance Abuse and Mental Health Services Administration

Center for Behavioral Health Statistics and Quality

Office of Population Surveys

Released 2026

Introduction

The Results from the 2025 National Survey on Drug Use and Health: Detailed Tables is a collection of tables presenting national estimates from the National Survey on Drug Use and Health (NSDUH). These tables present combined information for youths aged 12 to 17 and adults aged 18 or older on drug, alcohol, and tobacco use (including nicotine vaping), as well as substance use disorder (SUD), availability of substance use, and substance use treatment topics. Specific to youths, these tables present separate information on youth experiences, risk of substance use, mental health treatment, nonsuicidal self‐harm, suicidality, major depressive episode (MDE), co‑occurrence of MDE with substance use or with SUDs, and severity of symptoms of generalized anxiety disorder (GAD). Specific to adults, these tables present separate information on any mental illness (AMI), serious mental illness (SMI), mental health treatment, suicidality, MDE, GAD, symptoms of sleep disturbance, chronic pain, serious psychological distress (SPD), and co‑occurrence of mental disorders with substance use or with SUDs. Estimates are presented by a variety of demographic, geographic, and other variables. The tables include prevalence rates of the behaviors, numbers of people engaging in these behaviors, and other statistics.

The reference tools section summarizes the tools provided to help navigate the detailed tables and to define the topics presented within them. These tools include the Table of Contents; glossary; List of Tables, including titles, numbers, and types; and a search feature. A glossary of topics and terms used in these detailed tables can be found in Appendix A. Where relevant, the glossary provides cross‐references to refer data users to the correct entry in the glossary or to aid data users in understanding the meaning of the current definition. The 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions report provides further analytic details on the survey topics, design, and methodology.1 Additional 2025 national reports and products can be found on the NSDUH Data Collection web page.

Survey Background

NSDUH is an annual multimode survey sponsored by the Substance Abuse and Mental Health Services Administration within the U.S. Department of Health and Human Services. The target population for NSDUH is the civilian, noninstitutionalized population aged 12 years or older residing within the United States. The survey covers residents of households (e.g., individuals living in houses or townhouses, apartments, and condominiums; civilians living in housing on military bases) and individuals in noninstitutional group quarters (e.g., shelters, rooming or boarding houses, college dormitories, halfway houses). The survey does not cover individuals with no fixed household address (e.g., homeless and/or transient people not in shelters), active‐duty military personnel, and residents of institutional group quarters, such as jails or hospitals. Those who are unable to take the survey in either English or Spanish are part of the eligible population but are also excluded. For more information, see the 2025 Methodological Summary and Definitions report.

Analysis Weights

NSDUH person‐level weights are calibrated to population estimates for the state and demographic domains provided by the U.S. Census Bureau and American Community Survey. Starting with the 2021 NSDUH, population estimates based on the 2020 decennial census were used in developing the person‐level analysis weights.

The use of multimode data collection starting in 2021 increased nonresponse rates due to web respondents discontinuing the survey prior to completion (i.e., breaking off). To reduce the potential bias that would arise from handling missing data due to break‐offs the same way that other missing data (i.e., responses of “don’t know” or “refused”) were handled in analyses (i.e., excluding missing data), break‐off analysis weights were created. These break‐off analysis weights were used for a subset of unimputed measures that were derived from questions asked later in the survey.

Relatively few youths aged 12 to 17 broke off the interview after the youth experiences section. Therefore, a break‐off adjustment was not performed for youths aged 12 to 17. Nevertheless, a break‐off weight was created for youths for use in analyses for people aged 12 or older that required the break‐off analysis weight. For these analyses, the break‐off weight that was created for youths was the same as the main weight. For more information on the analysis weights, see the 2025 Methodological Summary and Definitions report.

Analyses conducted for the 2021 NSDUH indicated that key substance use and mental health estimates differed between data collection modes (i.e., web or in person); these differences are known as “mode effects.” Specifically, web respondents tended to be less likely than in‑person respondents to report most substance use or mental health issues. Weighting reduced the mode effects somewhat but not enough to eliminate statistically significant differences.

As long as the proportion of interviews completed via these two different modes is stable across years, then mode effects would have little effect on differences in estimates over time. However, the proportions of interviews completed via the web or in person had not stabilized in 2021 and 2022. Specifically, more than half of interviews in 2021 (54.6 percent) were completed via the web, but less than half in 2022 (42.4 percent) were completed via the web. Moreover, less than 40 percent of interviews in Quarter 2 (April to June) and Quarter 4 (October to December) of 2022 were completed via the web. Consequently, mode effects could distort differences in estimates between 2021 and 2022, unless the analysis weights are adjusted to take these different mode proportions into account.

The analysis weights used for tables for the 2021 NSDUH included two‑way interactions of quarter with other demographic characteristics in the adjustment models as a means of partially accounting for quarterly variations in interview mode proportions. However, including these interaction terms did not adjust the proportions of interviews that were completed via the web or in person to a set of fixed proportions. Without further adjustment to the weights, apparent increases in estimates between 2021 and 2022 could be due to a greater proportion of in‑person interviews in 2022 rather than real changes in the population. Stated another way, apparent increases in estimates for 2022 could be partially due to the greater proportion of in‑person respondents in 2022, and not just to true changes in prevalence in the population. Similarly, decreases in prevalence may be partially obscured by the changes in proportions.

For this reason, the 2025 Detailed Tables include revised estimates for 2021 that were created using the updated person‐level weights. These updated weights for 2021 were adjusted so that 2021 and 2022 estimates were based on consistent annual mode proportions for comparison. Consequently, NSDUH estimates for 2021 that are presented in the 2025 Detailed Tables may differ from the previously published estimates in national reports and tables for the 2021 NSDUH. For more information on the creation of the revised weights, investigations to update the 2021 weights, and the effects of the recalibrated 2021 weights on the 2021 estimates, see the 2022 Methodological Summary and Definitions report.2

Disruptions to in‑person data collection in the second and fourth quarters of 2025 reduced the number of completed interviews in 2025. Therefore, the 2025 weighting procedures for multimode data collection included new two‑way interactions between mode and key characteristics including state, age group, sex, race, and Hispanic origin in the person‐level poststratification adjustment of the weight procedures. This approach aimed to stabilize domain‐specific mode proportions relative to historical benchmarks. See Section 2.3.4.2 of the 2025 Methodological Summary and Definitions report for more details.

Changes and Impact

NSDUH has undergone changes over the years to improve the quality of its data and to address the changing needs of policymakers and researchers with regard to substance use and mental health issues. Information pertaining to some of the major changes to the 2025 NSDUH are summarized in Table 1. For more information on the revisions summarized below as well as other revisions to the survey including imputed measures, see the 2025 Methodological Summary and Definitions report.

Table 1. Summary of Changes and Impact
Topic Description of Change Presentation in 2025 Detailed Tables
Changes from Current NSDUH
Hallucinogen Use Questionnaire was expanded to ask most recent use and age and date of first use for additional specific hallucinogens. Only 2025 estimates are presented for all peyote and mescaline outcomes.
Inhalant Use Questionnaire wording was changed in the introductory and individual question text to say “to get high” instead of “for fun or to get high.” Only 2025 estimates are presented for the following outcomes: lifetime, past year, and past month use of any inhalants; lifetime, past year, and past month use of illicit drugs other than marijuana; lifetime use of all specific inhalants (e.g., amyl nitrite, poppers, locker room odorizers, or Rush; correction fluid, degreaser, or cleaning fluid; gasoline or lighter fluid); past year initiation of inhalant use, including risk for initiation, age at first use, and the date of first use; past year and past month frequency of use (i.e., number of days used).

Only 2025 estimates are presented for the 12‑17 and 12‑20 age groups for the following outcomes: lifetime and past year use of illicit drugs.
Nicotine Vaping Nicotine vaping and related variables were revised for 2022‑2024 to correctly handle missing values for interview date and time. Estimates for 2022‑2024 nicotine vaping measures including any aggregate outcomes such as nicotine products may differ from previously published 2022‑2024 estimates.
Risk and Availability Questionnaire was revised to ask only adolescent respondents aged 12 to 17 questions about perceived risk of harm from use of selected substances.

Handling of missing data was revised for perceived risk and availability variables to consider responses of “don’t know” as valid rather than missing data. Variables were revised for 2024 as appropriate.
Only estimates for adolescents aged 12 to 17 are presented for perceived risk of harm outcomes.

Only 2025 estimates presented for perceived availability of drugs among the 12 or older, 18 or older, 12 to 20, 18 to 25, and 26 or older age groups.

Separate estimates for “don’t know” are presented in select perceived risk and availability tables.

Estimates for 2024 perceived risk and availability outcomes may differ from previously published 2024 estimates.
Risk and Protective Factors Question asking whether adolescent respondents discussed the dangers of tobacco, alcohol, or drug use with at least one parent was added to the questionnaire at the end of January 2025 but after the start of data collection.

Handling of missing data was revised for feelings about peers’ substance use variables to consider responses of “don’t know” as valid rather than missing data. Variables were revised for 2024 as appropriate.
Only 2025 percentage estimates are presented for discussing the dangers of tobacco, alcohol, or drug use with at least one parent. No estimates for numbers in thousands are presented.

Separate estimates for “don’t know” are presented in select perceived risk and availability tables.

Estimates for 2024 feelings about peers’ substance use outcomes may differ from previously published 2024 estimates.
Substance Use Treatment Questionnaire wording was changed for individual inpatient and outpatient treatment questions for the 2024 NSDUH after the start of data collection. Only 2025 estimates are presented for the following measures: treatment for substance use at any location (including treatment for specific substances), inpatient treatment for substance use (including treatment for specific substances and specific inpatient locations), outpatient treatment for substance use (including treatment for specific substances and specific outpatient locations), classified as needing substance use treatment, perceived unmet need for substance use, sought treatment for substance use, and reasons for not receiving substance use treatment.

Estimates for treatment for unspecified substances are no longer presented.
Mental Health Treatment Questionnaire wording was changed for individual inpatient and outpatient treatment questions for the 2024 NSDUH after the start of data collection. Only 2025 estimates are presented for the following measures: mental health treatment at any location, inpatient mental health treatment (including specific inpatient locations), outpatient mental health treatment (including specific outpatient locations), perceived unmet need for mental health treatment, sought mental health treatment, and reasons for not receiving mental health treatment.
Mental Illness Methods for estimating mental illness levels were revised to recalibrate the prediction model using data from the Mental Illness Calibration Study. Variables were revised for 2021‑2024. Estimates for 2021‑2024 mental illness measures including any co‑occurring outcomes such as any mental illness or substance us disorder may differ from previously published 2021‑2024 estimates.
County Type County type measures were revised to use 2023 Rural‐Urban Continuum codes. Variables were revised for 2021‑2024. The 2021‑2024 estimates by county type may differ from previously published 2021‑2024 estimates.
Changes from Prior NSDUHs
Opioid Use Definition for opioid use was revised to refer to heroin or prescription opioids. The 2021‑2023 estimates for opioid use measures may differ from previously published 2021‑2023 estimates.
Suppression Suppression criteria was simplified. Suppression for 2021‑2023 estimates may differ from suppression for previously published 2021‑2023 estimates.

Table Presentation

The 2025 Detailed Tables present estimates from the 2021‑2025 NSDUHs. The following sections provide information on how the tables are organized, the types and purpose of tables that are available, information about specific indicators used for the tables, information on missingness, information on the impact of rounding on estimates presented in the tables, and how totals are to be interpreted within the tables.

Table Numbering

The detailed tables are numbered using a three‐part numbering scheme (e.g., 1.15A). The first part of the table number (1.15A) is the subject matter section to which a particular table belongs. The second part (1.15A) is the number of the table within a particular section. The third part (1.15A) is a table type indicator, an alphabetic letter appended to the table number. Each table number, as explained below, has multiple table types. Tables are numbered sequentially within each subject matter section. Identical tables across years may not be assigned the same table number each year.

The 10 subject matter sections and the number of tables per section in 2025 are as follows:

Table Types and Purpose

The table type indicators are primarily defined as follows:

Table Type Purpose of the Table
A Presents estimates of the numbers of people exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings.
B Presents estimates of the percentages of people exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings.
C Presents the standard error associated with each of the estimates in the “A” tables.
D Presents the standard error associated with each of the percentages in the “B” tables.
N Presents the number of cases in the specified NSDUH sample with the characteristics defined by the column and row headings.
P Presents the p values from tests of the statistical significance of differences between columns in the “B” tables.

Most tables within the detailed tables consist of five table types (A, B, C, D, and P) as defined above. Table type N is used exclusively within Section 10 to display the sample size counts. Exceptions to this organization are noted as follows:

Exceptions Applicable Table Numbers
Table type A contains both numbers and percentages where the percentages are repeated in the B tables. Section 1: Tables 1.121 to 1.145
Section 5: Table 5.32 and 5.33
Section 8: Table 8.2
Only table types B, D, and P are produced. Section 4: Tables 4.1 to 4.9, and 4.11
Section 9: Tables 9.29, 9.30, and 9.50
Only table types A and C are produced. Section 4: Table 4.10
Only table types A, C, and N are produced. Section 10: Tables 10.1 to 10.24
Table type P is not produced because all 2024 estimates are unavailable. Section 1: Tables 1.11, 1.21, 1.38 to 1.40, 1.67, 1.68, 1.85 to 1.87, 1.114, and 1.115
Section 5: Tables 5.14 to 5.20 and 5.28 to 5.37
Section 6: Tables 6.21 to 6.23, 6.26 to 6.28, 6.31 to 6.40, and 6.47 to 6.49
Section 7: Tables 7.8 to 7.10, 7.13 to 7.15, 7.18 to 7.26, and 7.35 to 7.37
Section 8: Tables 8.38 to 8.44

Table Indicators

Each 2025 detailed table, excluding those in Section 10, contains the following definitional footnote, regardless of whether any or all of the indicators were used in the table:

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

The “* = low precision” portion of the footnote indicates an estimate is being suppressed (i.e., not shown) due to low precision. For more information on how low precision is defined, see Section 3.2.2 of the 2025 Methodological Summary and Definitions report. Section 10 tables include a similar version of the definitional footnote; however, the low precision portion is not included because suppression is not applied to Section 10 tables.

The “‑‑ = not available or not shown due to methodological or questionnaire changes” portion of the footnote indicates that for the given year, either the questions used to produce the estimates were not available or the measures exist for prior years but are not shown for prior years due to comparability concerns. For example, information about past year use of pipe tobacco is not collected. Thus, estimates for past year pipe tobacco use are shown with the “‑‑” notation.

The “da = does not apply” portion of the footnote indicates that the question or estimate does not apply to a certain group. For example, in the incidence tables that show numbers in thousands and percentages in the same table, the p values for the numbers in thousands are replaced with “da” because the detailed tables show only p values of tests of differences of percentages.

The “nr = not reported due to measurement issues” portion of the footnote indicates that the estimate could be calculated based on available data but is not calculated due to potential measurement issues. For example, lifetime use of prescription pain relievers is shown as “nr” because the questionnaire was changed to focus on past year misuse of pain relievers rather than lifetime use of pain relievers, and there appears to be an underestimate of lifetime pain reliever use compared with prior years.

Rounding and Estimate Presentation

Rounding and presentation of unsuppressed prevalence estimates and totals are as follows:

Table Type Rounding and Estimate Presentation
A and C Total estimates are rounded to the nearest thousand people.
Estimated numbers less than 500 people are shown as “<1” in tables to indicate that the number rounds to less than 1,000 people.
Estimated numbers greater than or equal to 500 but less than 1,000 people are shown as “1” in tables because they round to 1,000 people.
B Estimated percentages are rounded to the nearest tenth of a percent.
Estimated percentages less than 0.05 are shown as “<0.1” in tables.
Estimated percentages greater than or equal to 0.05 but less than 0.1 are shown as “0.1” in tables because they round to 0.1 percent.
D Estimated standard errors of percentages are rounded to the nearest hundredth of a percent.
Estimated standard errors of percentages less than 0.005 are shown as “<0.01” in tables.
Estimated standard errors of percentages greater than or equal to 0.005 but less than 0.01 are shown as “0.01” in tables because they round to 0.01.
N Unweighted sample sizes are rounded to the nearest 10 people.
Unweighted sample sizes less than 100 people are shown as “<100” in tables.
P P values for the test of differences between prevalence estimates are rounded to the nearest ten thousandth.

Definitions of Totals

Totals are defined in different ways within the detailed tables. Totals can refer to the estimated number of people with a specific characteristic, as shown in table type A and displayed in numbers of thousands. For example, in Table 2.1, the total estimated population of youths aged 12 to 17 who used cigarettes in the past year in 2025 was approximately 877,000 and was shown as 877 in table type A. Totals can also be presented in the table rows or columns, either as a total of a subgroup category or listed as the “Total Population.” If the estimate is a total of a subgroup category (e.g., total of sex), the estimate is the total number of both males and females combined. Instances where measures have missing data may cause the subcategories to not add up to a total and are noted in the tables. If the estimate is shown as the “Total Population” on the row, then that estimate is usually included as a reference. This total population estimate is normally the number being used in the denominator to allow users to easily see that estimate without having to switch tables. For example, in Table 6.17, the total population row for table type A shows the estimated number of people who fit the criteria in the columns, which are the column denominators (i.e., there was an estimated 54,631,000 adults with past year any mental illness for 2025), and this number is used as the denominator in all the 2025 substance use disorder severity estimates.

Reference Tools

Reference tools are provided to help users navigate the Results from the 2025 National Survey on Drug Use and Health: Detailed Tables and to define the topics presented in the tables. These tools can be used independently or in conjunction with one another for table navigation. The tools provided with the 2025 Detailed Tables are described in Table 1. As shown in Table 1, select tools include hyperlinks that lead directly to the detailed tables for easy reference. This document summarizes the organization of the detailed tables and provides information on the measures and terms used in them, followed by table navigation examples.

Table 1. Reference Tool Summary
Reference Tool Description Hyperlinks to the Detailed Tables
Table of Contents (TOC) Provides an overview of the contents and organization of the detailed tables with links to tables (by subject matter and table type) and to the introduction and reference tools. Yes
Search Feature Allows users to enter a keyword or short phrase in a search box to return a list of specific detailed tables that contain that term, including links to those tables (by table type). Yes
Appendix A: Glossary Defines and cross‐references commonly used measures and terms in the 2025 Detailed Tables. For some key terms, specific question wording is provided for clarity. Not all measures and terms listed in the glossary are specifically mentioned in the TOC. No
Appendix B: List of Tables (LOT) Lists a condensed version of each table title by subject matter section with links to tables (by table type). Yes

Table Organization Summary

The detailed tables are organized by table type:

The table types are grouped into two categories:

Both categories of tables include 10 subject matter sections:

Refer to the Table Presentation section of the Introduction for more details about the table types, including some exceptions to the primary table types.

Measures and Terms Used in the Tables

A glossary is included with the detailed tables to provide more information about the measures and terms used in the tables. The glossary (Appendix A) can be used to determine how commonly used measures and terms are defined in the 2025 Detailed Tables and what other related topics are available. Where relevant, cross‐references to additional details in the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions report are provided (Center for Behavioral Health Statistics and Quality, 2026).1 The glossary may also be helpful when used in conjunction with the Table of Contents (TOC), the List of Tables (LOT), and the search feature in identifying tables that contain information for a topic of interest.

For example, a user who has identified tables of interest (e.g., Tables 1.23 to 1.69) and would like more information about a topic included in those tables (e.g., race) can look up that topic (e.g., race) or the categories displayed for that topic (e.g., NHPI, Two or More Races, Hispanic or Latino) in the glossary to obtain more information. Alternatively, a user interested in tables that present information about the prevalence of alcohol use measures can first review the “Alcohol Use” entry in the glossary. By looking up “Alcohol Use” in the glossary, a user will find information about how alcohol use is defined, the alcohol use questions, and related measures (i.e., Binge Use of Alcohol, Current Use or Misuse, Heavy Use of Alcohol, Lifetime Use or Misuse, Past Month Use or Misuse, Past Year Use or Misuse, Recency of Use or Misuse, and Underage Alcohol Use). The related measures provide the time periods shown for the “Alcohol Use” measure, as well as other types of alcohol use measures. After reviewing the definitions for the various available measures, the user can determine measures of interest and use the TOC, LOT, or search feature to identify tables that contain the selected measures.

Table Navigation Examples

Using the TOC

The TOC can be used to identify groups of tables in each of the 10 subject matter sections in the 2025 Detailed Tables. A user can click on the links and be taken directly to the first table in the specified group.

For example, a user interested in information about the prevalence of illicit drug use by age can first review the TOC and see that tables pertaining to illicit drug use can be found in Section 1: Illicit Drug Use/Misuse Tables. Scanning through Section 1 of the TOC, the user can see that data on the prevalence of illicit drug use by standard age categories are provided in Tables 1.1 to 1.5. To access the detailed tables of interest, the user can click on the table number in the TOC to open Table 1.1A, which is the first prevalence estimate table available for this table number. Clicking on “SE” will open Table 1.1C, which is the first standard error table available for this table number.

Using the Search Feature

For the 2025 Detailed Tables, a robust search feature is available to help users navigate particular tables. When a keyword or short phrase is entered in the search box, the search returns a list of the tables that contain that term, including links to those tables (by table type). This search is operational from within the TOC, the combined HTML file of the detailed tables, and individual HTML tables or table sections.

Using the LOT

The LOT can be used to identify a specific table in the subject matter sections listed previously. For each table in a section, the LOT provides the table number, table type indicators, and a condensed version of the table title. To reduce redundancy, the portion of the actual table title that describes the table type is omitted. At the top of the LOT, the five table types are defined for easy reference. An example of a condensed table title is shown as follows.

Table 1.1 (A, B, C, D, P) Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older (2024 and 2025)

For the LOT, a user can click on any of the table type indicators included in the parentheses to go to the specified table part (A, B, C, D, N, or P) for that table number.

For example, a user interested in information about the prevalence of past month alcohol use among people aged 12 to 20 can review the LOT in Section 2: Nicotine Product and Alcohol Use Tables and identify Table 2.50 and Table 2.52 as the tables of interest. A user can click on the “A” in the parentheses after either of these table numbers to go to the numbers in thousands tables and click on the “B” to go to the percentage tables.

Footnote

1 See the NSDUH Methodology Resources web page.

260501
Table 1.1A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 149,927 145,476 73,637a 69,791 48,224 47,546
Marijuana 137,055 136,335 64,194 61,590 44,266 43,776
Cocaine 42,408 40,833 4,257 4,937 1,671 1,993
Crack 10,634 10,086 749 986 392 457
Heroin 6,515 6,436 556 581 259 412
Hallucinogens 51,559 50,765 10,423a 9,139 2,783 2,722
LSD 30,935 29,162 1,619 1,400 259 289
Psilocybin 35,347 34,154 7,890b 6,518 1,749 1,617
Ecstasy 22,060 22,359 2,013 1,957 532 480
Inhalants3 ‑‑ 21,884 ‑‑ 2,385 ‑‑ 992
Methamphetamine 15,294 15,279 2,384 2,653 1,418 1,753
Misuse of Prescription Psychotherapeutics nr nr 13,797 12,804 4,279 3,781
Pain Relievers nr nr 8,000 7,178 2,113 1,953
Prescription Opioids ‑‑ ‑‑ 7,570 6,881 1,951 1,816
Stimulants nr nr 3,899 3,940 1,239 1,262
Tranquilizers or Sedatives nr nr 4,575 4,237 1,480 1,187
Tranquilizers nr nr 3,829 3,665 1,259 974
Sedatives nr nr 920 977 254 306
Benzodiazepines ‑‑ ‑‑ 3,360 3,293 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 7,795 7,080 2,117 2,051
Misuse of Central Nervous System Stimulants nr nr 9,031 9,486 3,934 4,465
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 23,691 ‑‑ 9,104
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 8,011 7,311 2,291 2,132
Illegally Made Fentanyl 1,911 1,615 668 768 418 403

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.1B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 52.0b 50.1 25.5b 24.0 16.7 16.4
Marijuana 47.5 46.9 22.3a 21.2 15.4 15.1
Cocaine 14.7 14.1 1.5 1.7 0.6 0.7
Crack 3.7 3.5 0.3 0.3 0.1 0.2
Heroin 2.3 2.2 0.2 0.2 0.1 0.1
Hallucinogens 17.9 17.5 3.6a 3.1 1.0 0.9
LSD 10.7 10.0 0.6 0.5 0.1 0.1
Psilocybin 12.3 11.8 2.7b 2.2 0.6 0.6
Ecstasy 7.7 7.7 0.7 0.7 0.2 0.2
Inhalants3 ‑‑ 7.5 ‑‑ 0.8 ‑‑ 0.3
Methamphetamine 5.3 5.3 0.8 0.9 0.5 0.6
Misuse of Prescription Psychotherapeutics nr nr 4.8 4.4 1.5 1.3
Pain Relievers nr nr 2.8 2.5 0.7 0.7
Prescription Opioids ‑‑ ‑‑ 2.6 2.4 0.7 0.6
Stimulants nr nr 1.4 1.4 0.4 0.4
Tranquilizers or Sedatives nr nr 1.6 1.5 0.5 0.4
Tranquilizers nr nr 1.3 1.3 0.4 0.3
Sedatives nr nr 0.3 0.3 0.1 0.1
Benzodiazepines ‑‑ ‑‑ 1.2 1.1 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 2.7 2.4 0.7 0.7
Misuse of Central Nervous System Stimulants nr nr 3.1 3.3 1.4 1.5
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 8.2 ‑‑ 3.1
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 2.8 2.5 0.8 0.7
Illegally Made Fentanyl 0.7 0.6 0.2 0.3 0.1 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.2A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 ‑‑ 4,149 ‑‑ 2,851 1,950b 1,482
Marijuana 3,363a 2,915 2,694b 2,223 1,554a 1,279
Cocaine 109 106 72 57 13 7
Crack 25 17 8 9 <1 *
Heroin 22 6 10 <1 1 <1
Hallucinogens 591 570 405 360 123 101
LSD 222 188 112 96 15 17
Psilocybin 458 428 311 265 63 73
Ecstasy 127 148 57 70 8 16
Inhalants3 ‑‑ 1,008 ‑‑ 360 ‑‑ 113
Methamphetamine 87 53 57 32 35 16
Misuse of Prescription Psychotherapeutics nr nr 647 598 176 152
Pain Relievers nr nr 425 420 113 112
Prescription Opioids ‑‑ ‑‑ 395 402 106 105
Stimulants nr nr 203 216 33 50
Tranquilizers or Sedatives nr nr 172 141 38 29
Tranquilizers nr nr 126 119 28 24
Sedatives nr nr 64 31 11 8
Benzodiazepines ‑‑ ‑‑ 107 122 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 400 403 107 105
Misuse of Central Nervous System Stimulants nr nr 293 241 80 54
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 1,131 ‑‑ 329
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 432 431 129 117
Illegally Made Fentanyl 56 41 38 34 23 17

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.2B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 ‑‑ 16.3 ‑‑ 11.2 7.5b 5.8
Marijuana 13.0a 11.5 10.4b 8.7 6.0a 5.0
Cocaine 0.4 0.4 0.3 0.2 <0.1 <0.1
Crack 0.1 0.1 <0.1 <0.1 <0.1 *
Heroin 0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Hallucinogens 2.3 2.2 1.6 1.4 0.5 0.4
LSD 0.9 0.7 0.4 0.4 0.1 0.1
Psilocybin 1.8 1.7 1.2 1.0 0.2 0.3
Ecstasy 0.5 0.6 0.2 0.3 <0.1 0.1
Inhalants3 ‑‑ 4.0 ‑‑ 1.4 ‑‑ 0.4
Methamphetamine 0.3 0.2 0.2 0.1 0.1 0.1
Misuse of Prescription Psychotherapeutics nr nr 2.5 2.4 0.7 0.6
Pain Relievers nr nr 1.6 1.7 0.4 0.4
Prescription Opioids ‑‑ ‑‑ 1.5 1.6 0.4 0.4
Stimulants nr nr 0.8 0.8 0.1 0.2
Tranquilizers or Sedatives nr nr 0.7 0.6 0.1 0.1
Tranquilizers nr nr 0.5 0.5 0.1 0.1
Sedatives nr nr 0.2 0.1 <0.1 <0.1
Benzodiazepines ‑‑ ‑‑ 0.4 0.5 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 1.5 1.6 0.4 0.4
Misuse of Central Nervous System Stimulants nr nr 1.1 0.9 0.3 0.2
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 4.4 ‑‑ 1.3
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 1.7 1.7 0.5 0.5
Illegally Made Fentanyl 0.2 0.2 0.1 0.1 0.1 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.3A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 143,653 141,327 69,720 66,940 46,273 46,064
Marijuana 133,692 133,420 61,500 59,367 42,712 42,497
Cocaine 42,299 40,727 4,185 4,881 1,658 1,985
Crack 10,609 10,070 741 977 392 457
Heroin 6,493 6,430 546 580 258 412
Hallucinogens 50,968 50,194 10,018a 8,779 2,660 2,621
LSD 30,713 28,974 1,507 1,304 244 271
Psilocybin 34,889 33,725 7,579b 6,253 1,686 1,544
Ecstasy 21,933 22,211 1,956 1,887 524 464
Inhalants3 ‑‑ 20,876 ‑‑ 2,026 ‑‑ 879
Methamphetamine 15,206 15,226 2,327 2,621 1,383 1,737
Misuse of Prescription Psychotherapeutics nr nr 13,150 12,206 4,103 3,629
Pain Relievers nr nr 7,575 6,758 2,000 1,841
Prescription Opioids ‑‑ ‑‑ 7,176 6,479 1,845 1,711
Stimulants nr nr 3,696 3,724 1,206 1,212
Tranquilizers or Sedatives nr nr 4,403 4,095 1,442 1,158
Tranquilizers nr nr 3,703 3,546 1,231 950
Sedatives nr nr 857 946 243 298
Benzodiazepines ‑‑ ‑‑ 3,253 3,172 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 7,396 6,678 2,010 1,946
Misuse of Central Nervous System Stimulants nr nr 8,738 9,245 3,854 4,411
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 22,559 ‑‑ 8,775
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 7,580 6,880 2,163 2,015
Illegally Made Fentanyl 1,855 1,574 630 734 395 385

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.3B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 54.8a 53.3 26.6a 25.3 17.6 17.4
Marijuana 51.0 50.3 23.4a 22.4 16.3 16.0
Cocaine 16.1 15.4 1.6 1.8 0.6 0.7
Crack 4.0 3.8 0.3 0.4 0.1 0.2
Heroin 2.5 2.4 0.2 0.2 0.1 0.2
Hallucinogens 19.4 18.9 3.8a 3.3 1.0 1.0
LSD 11.7 10.9 0.6 0.5 0.1 0.1
Psilocybin 13.3 12.7 2.9b 2.4 0.6 0.6
Ecstasy 8.4 8.4 0.7 0.7 0.2 0.2
Inhalants3 ‑‑ 7.9 ‑‑ 0.8 ‑‑ 0.3
Methamphetamine 5.8 5.7 0.9 1.0 0.5 0.7
Misuse of Prescription Psychotherapeutics nr nr 5.0 4.6 1.6 1.4
Pain Relievers nr nr 2.9 2.5 0.8 0.7
Prescription Opioids ‑‑ ‑‑ 2.7 2.4 0.7 0.6
Stimulants nr nr 1.4 1.4 0.5 0.5
Tranquilizers or Sedatives nr nr 1.7 1.5 0.5 0.4
Tranquilizers nr nr 1.4 1.3 0.5 0.4
Sedatives nr nr 0.3 0.4 0.1 0.1
Benzodiazepines ‑‑ ‑‑ 1.2 1.2 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 2.8 2.5 0.8 0.7
Misuse of Central Nervous System Stimulants nr nr 3.3 3.5 1.5 1.7
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 8.5 ‑‑ 3.3
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 2.9 2.6 0.8 0.8
Illegally Made Fentanyl 0.7 0.6 0.2 0.3 0.2 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.4A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 18,697 18,125 13,299 13,094 8,884 8,808
Marijuana 17,068 17,221 12,226 12,167 8,439 8,405
Cocaine 2,226 2,179 811 950 221a 353
Crack 153 182 46 23 13 8
Heroin 180 179 51b 6 14 3
Hallucinogens 5,661 5,245 2,364 2,165 489 634
LSD 2,817 2,591 369 413 60 70
Psilocybin 4,468 4,378 1,898 1,621 307 401
Ecstasy 1,920 1,828 405 505 94 76
Inhalants3 ‑‑ 2,243 ‑‑ 636 ‑‑ 179
Methamphetamine 464 468 161 145 77 82
Misuse of Prescription Psychotherapeutics nr nr 2,019 1,909 512 507
Pain Relievers nr nr 955 775 242 199
Prescription Opioids ‑‑ ‑‑ 897 733 214 176
Stimulants nr nr 973 978 210 260
Tranquilizers or Sedatives nr nr 571 582 160 150
Tranquilizers nr nr 522 515 131 140
Sedatives nr nr 76 118 35 13
Benzodiazepines ‑‑ ‑‑ 488 470 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 925 736 221 179
Misuse of Central Nervous System Stimulants nr nr 1,646 1,681 466 623
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 4,015 ‑‑ 1,373
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 976a 750 265 185
Illegally Made Fentanyl 176 138 99 57 63a 7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.4B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 53.5b 50.2 38.1 36.3 25.4 24.4
Marijuana 48.8 47.7 35.0 33.7 24.1 23.3
Cocaine 6.4 6.0 2.3 2.6 0.6 1.0
Crack 0.4 0.5 0.1 0.1 <0.1 <0.1
Heroin 0.5 0.5 0.1b <0.1 <0.1 <0.1
Hallucinogens 16.2a 14.5 6.8 6.0 1.4 1.8
LSD 8.1 7.2 1.1 1.1 0.2 0.2
Psilocybin 12.8 12.1 5.4a 4.5 0.9 1.1
Ecstasy 5.5 5.1 1.2 1.4 0.3 0.2
Inhalants3 ‑‑ 6.2 ‑‑ 1.8 ‑‑ 0.5
Methamphetamine 1.3 1.3 0.5 0.4 0.2 0.2
Misuse of Prescription Psychotherapeutics nr nr 5.8 5.3 1.5 1.4
Pain Relievers nr nr 2.7 2.1 0.7 0.6
Prescription Opioids ‑‑ ‑‑ 2.6 2.0 0.6 0.5
Stimulants nr nr 2.8 2.7 0.6 0.7
Tranquilizers or Sedatives nr nr 1.6 1.6 0.5 0.4
Tranquilizers nr nr 1.5 1.4 0.4 0.4
Sedatives nr nr 0.2 0.3 0.1 <0.1
Benzodiazepines ‑‑ ‑‑ 1.4 1.3 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 2.6a 2.0 0.6 0.5
Misuse of Central Nervous System Stimulants nr nr 4.7 4.7 1.3 1.7
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 11.1 ‑‑ 3.8
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 2.8a 2.1 0.8 0.5
Illegally Made Fentanyl 0.5 0.4 0.3 0.2 0.2a <0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.5A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 124,955 123,202 56,421 53,846 37,390 37,257
Marijuana 116,624 116,199 49,274 47,199 34,273 34,092
Cocaine 40,074 38,548 3,374 3,930 1,437 1,633
Crack 10,455 9,888 695 954 378 449
Heroin 6,313 6,251 495 574 244 409
Hallucinogens 45,307 44,949 7,653a 6,614 2,171 1,987
LSD 27,896 26,383 1,137 891 184 202
Psilocybin 30,421 29,348 5,681a 4,632 1,379 1,143
Ecstasy 20,013 20,383 1,551 1,382 429 388
Inhalants3 ‑‑ 18,634 ‑‑ 1,390 ‑‑ 700
Methamphetamine 14,742 14,758 2,166 2,475 1,306 1,655
Misuse of Prescription Psychotherapeutics nr nr 11,131 10,297 3,591 3,122
Pain Relievers nr nr 6,620 5,983 1,758 1,642
Prescription Opioids ‑‑ ‑‑ 6,279 5,746 1,631 1,535
Stimulants nr nr 2,723 2,746 995 953
Tranquilizers or Sedatives nr nr 3,832 3,513 1,282 1,008
Tranquilizers nr nr 3,181 3,031 1,099 810
Sedatives nr nr 781 828 208 285
Benzodiazepines ‑‑ ‑‑ 2,766 2,702 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 6,471 5,941 1,788 1,767
Misuse of Central Nervous System Stimulants nr nr 7,092 7,564 3,388 3,789
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 18,544 ‑‑ 7,402
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 6,604 6,130 1,898 1,830
Illegally Made Fentanyl 1,680 1,436 531 676 332 379

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.5B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 55.0 53.8 24.8a 23.5 16.4 16.3
Marijuana 51.3 50.7 21.7 20.6 15.1 14.9
Cocaine 17.6 16.8 1.5 1.7 0.6 0.7
Crack 4.6 4.3 0.3 0.4 0.2 0.2
Heroin 2.8 2.7 0.2 0.3 0.1 0.2
Hallucinogens 19.9 19.6 3.4a 2.9 1.0 0.9
LSD 12.3 11.5 0.5 0.4 0.1 0.1
Psilocybin 13.4 12.8 2.5a 2.0 0.6 0.5
Ecstasy 8.8 8.9 0.7 0.6 0.2 0.2
Inhalants3 ‑‑ 8.1 ‑‑ 0.6 ‑‑ 0.3
Methamphetamine 6.5 6.4 1.0 1.1 0.6 0.7
Misuse of Prescription Psychotherapeutics nr nr 4.9 4.5 1.6 1.4
Pain Relievers nr nr 2.9 2.6 0.8 0.7
Prescription Opioids ‑‑ ‑‑ 2.8 2.5 0.7 0.7
Stimulants nr nr 1.2 1.2 0.4 0.4
Tranquilizers or Sedatives nr nr 1.7 1.5 0.6 0.4
Tranquilizers nr nr 1.4 1.3 0.5 0.4
Sedatives nr nr 0.3 0.4 0.1 0.1
Benzodiazepines ‑‑ ‑‑ 1.2 1.2 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 2.8 2.6 0.8 0.8
Misuse of Central Nervous System Stimulants nr nr 3.1 3.3 1.5 1.7
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 8.1 ‑‑ 3.2
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 2.9 2.7 0.8 0.8
Illegally Made Fentanyl 0.7 0.6 0.2 0.3 0.1 0.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.6A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 149,927 145,476 73,637a 69,791 48,224 47,546
12‑20 ‑‑ 9,696 ‑‑ 7,248 4,580 4,291
21 or Older 138,012 135,780 65,580 62,544 43,644 43,255
12‑17 ‑‑ 4,149 ‑‑ 2,851 1,950b 1,482
12‑13 ‑‑ 717 ‑‑ 387 221 172
14‑15 ‑‑ 1,284 ‑‑ 940 549 453
16‑17 ‑‑ 2,149 ‑‑ 1,524 1,180b 856
18 or Older 143,653 141,327 69,720 66,940 46,273 46,064
18‑25 18,697 18,125 13,299 13,094 8,884 8,808
18‑20 5,641 5,547 4,140 4,397 2,630 2,809
21‑25 13,057 12,579 9,159 8,697 6,254 5,998
26 or Older 124,955 123,202 56,421 53,846 37,390 37,257
26‑49 63,218 62,225 34,889 33,395 23,521 23,141
26‑29 10,819 10,652 7,155a 6,262 4,854 4,408
30‑34 14,233 14,397 8,255 8,413 5,402 5,768
35‑39 13,852 12,952 7,647 6,982 5,386 4,674
40‑44 13,083 12,979 6,587 6,482 4,437 4,492
45‑49 11,231 11,246 5,246 5,257 3,443 3,800
50 or Older 61,738 60,976 21,532 20,451 13,868 14,116
50‑54 10,299 9,540 4,654 4,847 2,976 3,567
55‑59 11,233 10,407 4,548 3,831 3,182 2,801
60‑64 13,273 12,568 4,553 4,169 3,109 3,037
65 or Older 26,932 28,462 7,777 7,603 4,600 4,712

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.6B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 52.0b 50.1 25.5b 24.0 16.7 16.4
12‑20 ‑‑ 24.7 ‑‑ 18.5 11.9 10.9
21 or Older 55.3 54.0 26.3a 24.9 17.5 17.2
12‑17 ‑‑ 16.3 ‑‑ 11.2 7.5b 5.8
12‑13 ‑‑ 9.1 ‑‑ 4.9 2.7 2.2
14‑15 ‑‑ 14.7 ‑‑ 10.8 6.2 5.2
16‑17 ‑‑ 24.2 ‑‑ 17.1 13.1b 9.6
18 or Older 54.8a 53.3 26.6a 25.3 17.6 17.4
18‑25 53.5b 50.2 38.1 36.3 25.4 24.4
18‑20 44.9b 40.2 33.0 31.9 20.9 20.4
21‑25 58.3 56.4 40.9 39.0 27.9 26.9
26 or Older 55.0 53.8 24.8a 23.5 16.4 16.3
26‑49 59.7 59.1 33.0 31.7 22.2 22.0
26‑29 61.9 61.8 41.0b 36.3 27.8 25.6
30‑34 60.5 61.4 35.1 35.9 23.0 24.6
35‑39 59.8 57.5 33.0 31.0 23.2 20.7
40‑44 58.4 59.2 29.4 29.6 19.8 20.5
45‑49 58.4 55.7 27.3 26.0 17.9 18.8
50 or Older 50.8 49.3 17.7 16.5 11.4 11.4
50‑54 52.3 52.8 23.6 26.8 15.1a 19.7
55‑59 57.7 53.0 23.4 19.5 16.3 14.3
60‑64 59.0 55.4 20.2 18.4 13.8 13.4
65 or Older 45.0 45.0 13.0 12.0 7.7 7.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.7A – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 137,055 136,335 64,194 61,590 44,266 43,776
12‑20 8,235 8,097 6,436 6,271 4,046 3,974
21 or Older 128,819 128,238 57,758 55,320 40,220 39,802
12‑17 3,363a 2,915 2,694b 2,223 1,554a 1,279
12‑13 229 255 190 178 91 101
14‑15 950 890 739 701 405 379
16‑17 2,183b 1,770 1,765b 1,344 1,058b 799
18 or Older 133,692 133,420 61,500 59,367 42,712 42,497
18‑25 17,068 17,221 12,226 12,167 8,439 8,405
18‑20 4,873 5,182 3,742 4,047 2,491 2,695
21‑25 12,195 12,039 8,484 8,120 5,947 5,710
26 or Older 116,624 116,199 49,274 47,199 34,273 34,092
26‑49 59,055 59,118 31,043 30,025 21,706 21,369
26‑29 10,249 10,282 6,583 5,845 4,663 4,268
30‑34 13,278 13,757 7,442 7,620 4,996 5,295
35‑39 13,013 12,183 6,776 6,053 5,002a 4,269
40‑44 12,275 12,331 5,674 5,830 3,949 4,062
45‑49 10,240 10,564 4,568 4,676 3,095 3,474
50 or Older 57,569 57,081 18,231 17,175 12,567 12,724
50‑54 9,607 8,908 4,089 4,136 2,778 3,126
55‑59 10,343 9,704 3,915 3,059 2,852 2,434
60‑64 12,423 11,770 3,926 3,720 2,786 2,792
65 or Older 25,196 26,699 6,301 6,261 4,151 4,372

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.7B – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 47.5 46.9 22.3a 21.2 15.4 15.1
12‑20 21.4 20.6 16.7 16.0 10.5 10.1
21 or Older 51.6 51.0 23.1a 22.0 16.1 15.8
12‑17 13.0a 11.5 10.4b 8.7 6.0a 5.0
12‑13 2.8 3.2 2.3 2.3 1.1 1.3
14‑15 10.7 10.2 8.3 8.0 4.6 4.3
16‑17 24.3b 19.9 19.6b 15.1 11.8b 9.0
18 or Older 51.0 50.3 23.4a 22.4 16.3 16.0
18‑25 48.8 47.7 35.0 33.7 24.1 23.3
18‑20 38.8 37.6 29.8 29.4 19.8 19.5
21‑25 54.5 54.0 37.9 36.4 26.6 25.6
26 or Older 51.3 50.7 21.7 20.6 15.1 14.9
26‑49 55.8 56.1 29.3 28.5 20.5 20.3
26‑29 58.7 59.6 37.7a 33.9 26.7 24.8
30‑34 56.5 58.7 31.7 32.5 21.2 22.6
35‑39 56.2 54.1 29.2 26.9 21.6 19.0
40‑44 54.8 56.2 25.3 26.6 17.6 18.5
45‑49 53.2 52.3 23.7 23.1 16.1 17.2
50 or Older 47.4 46.2 15.0 13.9 10.3 10.3
50‑54 48.8 49.3 20.8 22.9 14.1 17.3
55‑59 53.1 49.4 20.1a 15.6 14.7 12.4
60‑64 55.2 51.9 17.4 16.4 12.4 12.3
65 or Older 42.1 42.2 10.5 9.9 6.9 6.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.8A – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 42,408 40,833 4,257 4,937 1,671 1,993
12‑20 399 412 242 219 53 69
21 or Older 42,009 40,421 4,015 4,719 1,618 1,923
12‑17 109 106 72 57 13 7
12‑13 9 11 6 9 1 <1
14‑15 33 20 24 7 1 1
16‑17 66 75 42 40 11 6
18 or Older 42,299 40,727 4,185 4,881 1,658 1,985
18‑25 2,226 2,179 811 950 221a 353
18‑20 291 306 170 162 40 62
21‑25 1,935 1,873 641 789 181 291
26 or Older 40,074 38,548 3,374 3,930 1,437 1,633
26‑49 18,614 17,972 2,678 3,011 964 1,178
26‑29 2,762 2,536 672 579 215 189
30‑34 3,803 4,164 639 867 212 333
35‑39 4,519 4,068 629 704 242 236
40‑44 4,123 3,659 376 500 134 231
45‑49 3,407 3,546 362 362 160 188
50 or Older 21,459 20,576 696 919 473 455
50‑54 2,982 3,130 250 180 151 44
55‑59 4,203 3,425 217 277 185 203
60‑64 6,079 5,086 91 267 49 146
65 or Older 8,195 8,933 137 195 87 61

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.8B – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 14.7 14.1 1.5 1.7 0.6 0.7
12‑20 1.0 1.1 0.6 0.6 0.1 0.2
21 or Older 16.8 16.1 1.6 1.9 0.6 0.8
12‑17 0.4 0.4 0.3 0.2 <0.1 <0.1
12‑13 0.1 0.1 0.1 0.1 <0.1 <0.1
14‑15 0.4 0.2 0.3 0.1 <0.1 <0.1
16‑17 0.7 0.8 0.5 0.5 0.1 0.1
18 or Older 16.1 15.4 1.6 1.8 0.6 0.7
18‑25 6.4 6.0 2.3 2.6 0.6 1.0
18‑20 2.3 2.2 1.4 1.2 0.3 0.5
21‑25 8.6 8.4 2.9 3.5 0.8 1.3
26 or Older 17.6 16.8 1.5 1.7 0.6 0.7
26‑49 17.6 17.1 2.5 2.9 0.9 1.1
26‑29 15.8 14.7 3.8 3.4 1.2 1.1
30‑34 16.2 17.8 2.7 3.7 0.9 1.4
35‑39 19.5 18.1 2.7 3.1 1.0 1.0
40‑44 18.4 16.7 1.7 2.3 0.6 1.1
45‑49 17.7 17.5 1.9 1.8 0.8 0.9
50 or Older 17.7 16.6 0.6 0.7 0.4 0.4
50‑54 15.1 17.3 1.3 1.0 0.8 0.2
55‑59 21.6a 17.5 1.1 1.4 1.0 1.0
60‑64 27.0a 22.4 0.4 1.2 0.2 0.6
65 or Older 13.7 14.1 0.2 0.3 0.1 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.9A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 10,634 10,086 749 986 392 457
12‑20 55 38 21 16 1 1
21 or Older 10,579 10,048 728 970 391 457
12‑17 25 17 8 9 <1 *
12‑13 1 9 1 9 <1 *
14‑15 17 1 7 * * *
16‑17 7 7 <1 <1 * *
18 or Older 10,609 10,070 741 977 392 457
18‑25 153 182 46 23 13 8
18‑20 30 21 13 6 1 1
21‑25 123 160 34 16 12 8
26 or Older 10,455 9,888 695 954 378 449
26‑49 4,474 4,091 361a 587 149 286
26‑29 332 242 20 24 4 14
30‑34 656 628 58 154 12 70
35‑39 1,096 970 74 143 24 67
40‑44 1,141 1,109 74 118 23 33
45‑49 1,249 1,141 135 148 86 102
50 or Older 5,981 5,797 334 366 229 163
50‑54 1,140 1,307 77 79 63 26
55‑59 1,597 1,188 126 68 106 54
60‑64 1,784 1,547 87 152 47 77
65 or Older 1,460 1,755 44 68 13 6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.9B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 3.7 3.5 0.3 0.3 0.1 0.2
12‑20 0.1 0.1 0.1 <0.1 <0.1 <0.1
21 or Older 4.2 4.0 0.3 0.4 0.2 0.2
12‑17 0.1 0.1 <0.1 <0.1 <0.1 *
12‑13 <0.1 0.1 <0.1 0.1 <0.1 *
14‑15 0.2 <0.1 0.1 * * *
16‑17 0.1 0.1 <0.1 <0.1 * *
18 or Older 4.0 3.8 0.3 0.4 0.1 0.2
18‑25 0.4 0.5 0.1 0.1 <0.1 <0.1
18‑20 0.2 0.2 0.1 <0.1 <0.1 <0.1
21‑25 0.5 0.7 0.2 0.1 0.1 <0.1
26 or Older 4.6 4.3 0.3 0.4 0.2 0.2
26‑49 4.2 3.9 0.3a 0.6 0.1 0.3
26‑29 1.9 1.4 0.1 0.1 <0.1 0.1
30‑34 2.8 2.7 0.2a 0.7 0.1 0.3
35‑39 4.7 4.3 0.3 0.6 0.1 0.3
40‑44 5.1 5.1 0.3 0.5 0.1 0.1
45‑49 6.5 5.6 0.7 0.7 0.4 0.5
50 or Older 4.9 4.7 0.3 0.3 0.2 0.1
50‑54 5.8 7.2 0.4 0.4 0.3 0.1
55‑59 8.2 6.1 0.6 0.3 0.5 0.3
60‑64 7.9 6.8 0.4 0.7 0.2 0.3
65 or Older 2.4 2.8 0.1 0.1 <0.1 <0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.10A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 51,559 50,765 10,423a 9,139 2,783 2,722
12‑20 1,918 1,855 1,074 1,040 249 371
21 or Older 49,641 48,910 9,349a 8,099 2,534 2,351
12‑17 591 570 405 360 123 101
12‑13 48 62 24 25 6 9
14‑15 170 130 104 77 29 33
16‑17 373 379 277 258 87 59
18 or Older 50,968 50,194 10,018a 8,779 2,660 2,621
18‑25 5,661 5,245 2,364 2,165 489 634
18‑20 1,327 1,285 669 681 127a 270
21‑25 4,334 3,960 1,695 1,485 362 364
26 or Older 45,307 44,949 7,653a 6,614 2,171 1,987
26‑49 25,426 25,322 6,402a 5,299 1,797 1,652
26‑29 4,327 3,886 1,678a 1,176 418a 238
30‑34 5,582 6,000 1,451 1,305 421 463
35‑39 5,682 5,302 1,458a 1,094 440 368
40‑44 5,301 5,222 1,110 940 340 312
45‑49 4,534 4,913 705 784 178 271
50 or Older 19,881 19,627 1,251 1,315 374 335
50‑54 3,602 3,693 579 533 163 86
55‑59 3,864 3,294 208 275 94 70
60‑64 4,805 4,178 289 253 79 92
65 or Older 7,611 8,461 176 253 37 87

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.10B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 17.9 17.5 3.6a 3.1 1.0 0.9
12‑20 5.0 4.7 2.8 2.7 0.6 0.9
21 or Older 19.9 19.5 3.7a 3.2 1.0 0.9
12‑17 2.3 2.2 1.6 1.4 0.5 0.4
12‑13 0.6 0.8 0.3 0.3 0.1 0.1
14‑15 1.9 1.5 1.2 0.9 0.3 0.4
16‑17 4.2 4.3 3.1 2.9 1.0 0.7
18 or Older 19.4 18.9 3.8a 3.3 1.0 1.0
18‑25 16.2a 14.5 6.8 6.0 1.4 1.8
18‑20 10.6 9.3 5.3 4.9 1.0a 2.0
21‑25 19.4 17.8 7.6 6.7 1.6 1.6
26 or Older 19.9 19.6 3.4a 2.9 1.0 0.9
26‑49 24.0 24.0 6.1b 5.0 1.7 1.6
26‑29 24.8 22.5 9.6b 6.8 2.4a 1.4
30‑34 23.7 25.6 6.2 5.6 1.8 2.0
35‑39 24.5 23.5 6.3 4.9 1.9 1.6
40‑44 23.7 23.8 5.0 4.3 1.5 1.4
45‑49 23.6 24.3 3.7 3.9 0.9 1.3
50 or Older 16.4 15.9 1.0 1.1 0.3 0.3
50‑54 18.3 20.4 2.9 2.9 0.8 0.5
55‑59 19.8 16.8 1.1 1.4 0.5 0.4
60‑64 21.3 18.4 1.3 1.1 0.4 0.4
65 or Older 12.7 13.4 0.3 0.4 0.1 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.11A – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 21,884 ‑‑ 2,385 ‑‑ 992
12‑20 ‑‑ 1,543 ‑‑ 584 ‑‑ 169
21 or Older ‑‑ 20,341 ‑‑ 1,801 ‑‑ 823
12‑17 ‑‑ 1,008 ‑‑ 360 ‑‑ 113
12‑13 ‑‑ 345 ‑‑ 128 ‑‑ 47
14‑15 ‑‑ 331 ‑‑ 151 ‑‑ 39
16‑17 ‑‑ 332 ‑‑ 80 ‑‑ 27
18 or Older ‑‑ 20,876 ‑‑ 2,026 ‑‑ 879
18‑25 ‑‑ 2,243 ‑‑ 636 ‑‑ 179
18‑20 ‑‑ 535 ‑‑ 224 ‑‑ 56
21‑25 ‑‑ 1,707 ‑‑ 412 ‑‑ 123
26 or Older ‑‑ 18,634 ‑‑ 1,390 ‑‑ 700
26‑49 ‑‑ 9,616 ‑‑ 1,084 ‑‑ 435
26‑29 ‑‑ 1,349 ‑‑ 299 ‑‑ 111
30‑34 ‑‑ 1,945 ‑‑ 341 ‑‑ 144
35‑39 ‑‑ 2,175 ‑‑ 207 ‑‑ 76
40‑44 ‑‑ 2,095 ‑‑ 175 ‑‑ 80
45‑49 ‑‑ 2,052 ‑‑ 61 ‑‑ 24
50 or Older ‑‑ 9,018 ‑‑ 305 ‑‑ 265
50‑54 ‑‑ 1,751 ‑‑ 123 ‑‑ 123
55‑59 ‑‑ 1,772 ‑‑ 57 ‑‑ 34
60‑64 ‑‑ 2,106 ‑‑ 20 ‑‑ 17
65 or Older ‑‑ 3,389 ‑‑ 106 ‑‑ 91

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.11B – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 7.5 ‑‑ 0.8 ‑‑ 0.3
12‑20 ‑‑ 3.9 ‑‑ 1.5 ‑‑ 0.4
21 or Older ‑‑ 8.1 ‑‑ 0.7 ‑‑ 0.3
12‑17 ‑‑ 4.0 ‑‑ 1.4 ‑‑ 0.4
12‑13 ‑‑ 4.4 ‑‑ 1.6 ‑‑ 0.6
14‑15 ‑‑ 3.8 ‑‑ 1.7 ‑‑ 0.5
16‑17 ‑‑ 3.7 ‑‑ 0.9 ‑‑ 0.3
18 or Older ‑‑ 7.9 ‑‑ 0.8 ‑‑ 0.3
18‑25 ‑‑ 6.2 ‑‑ 1.8 ‑‑ 0.5
18‑20 ‑‑ 3.9 ‑‑ 1.6 ‑‑ 0.4
21‑25 ‑‑ 7.7 ‑‑ 1.8 ‑‑ 0.6
26 or Older ‑‑ 8.1 ‑‑ 0.6 ‑‑ 0.3
26‑49 ‑‑ 9.1 ‑‑ 1.0 ‑‑ 0.4
26‑29 ‑‑ 7.8 ‑‑ 1.7 ‑‑ 0.6
30‑34 ‑‑ 8.3 ‑‑ 1.5 ‑‑ 0.6
35‑39 ‑‑ 9.7 ‑‑ 0.9 ‑‑ 0.3
40‑44 ‑‑ 9.6 ‑‑ 0.8 ‑‑ 0.4
45‑49 ‑‑ 10.2 ‑‑ 0.3 ‑‑ 0.1
50 or Older ‑‑ 7.3 ‑‑ 0.2 ‑‑ 0.2
50‑54 ‑‑ 9.7 ‑‑ 0.7 ‑‑ 0.7
55‑59 ‑‑ 9.0 ‑‑ 0.3 ‑‑ 0.2
60‑64 ‑‑ 9.3 ‑‑ 0.1 ‑‑ 0.1
65 or Older ‑‑ 5.4 ‑‑ 0.2 ‑‑ 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.12A – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 15,294 15,279 2,384 2,653 1,418 1,753
12‑20 178 128 86 59 47 33
21 or Older 15,116 15,151 2,298 2,594 1,372 1,720
12‑17 87 53 57 32 35 16
12‑13 15 11 15 10 7 1
14‑15 27 21 16 4 6 *
16‑17 45 21 26 19 23 15
18 or Older 15,206 15,226 2,327 2,621 1,383 1,737
18‑25 464 468 161 145 77 82
18‑20 91 75 29 26 11 17
21‑25 373 394 132 119 65 65
26 or Older 14,742 14,758 2,166 2,475 1,306 1,655
26‑49 7,707 7,456 1,431 1,391 839 900
26‑29 744 562 193a 71 84 24
30‑34 1,225 1,175 288 320 135 236
35‑39 1,855 1,802 343 420 203 216
40‑44 2,162 1,910 316 257 234 163
45‑49 1,720 2,008 291 324 184 261
50 or Older 7,035 7,302 735 1,084 467 755
50‑54 1,173 1,606 272 403 166 247
55‑59 1,675 1,711 226 221 188 173
60‑64 1,840 1,683 123 269 60a 217
65 or Older 2,347 2,302 115 192 53 118

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.12B – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 5.3 5.3 0.8 0.9 0.5 0.6
12‑20 0.5 0.3 0.2 0.1 0.1 0.1
21 or Older 6.1 6.0 0.9 1.0 0.5 0.7
12‑17 0.3 0.2 0.2 0.1 0.1 0.1
12‑13 0.2 0.1 0.2 0.1 0.1 <0.1
14‑15 0.3 0.2 0.2 <0.1 0.1 *
16‑17 0.5 0.2 0.3 0.2 0.3 0.2
18 or Older 5.8 5.7 0.9 1.0 0.5 0.7
18‑25 1.3 1.3 0.5 0.4 0.2 0.2
18‑20 0.7 0.5 0.2 0.2 0.1 0.1
21‑25 1.7 1.8 0.6 0.5 0.3 0.3
26 or Older 6.5 6.4 1.0 1.1 0.6 0.7
26‑49 7.3 7.1 1.4 1.3 0.8 0.9
26‑29 4.3 3.3 1.1a 0.4 0.5 0.1
30‑34 5.2 5.0 1.2 1.4 0.6 1.0
35‑39 8.0 8.0 1.5 1.9 0.9 1.0
40‑44 9.6 8.7 1.4 1.2 1.0 0.7
45‑49 8.9 9.9 1.5 1.6 1.0 1.3
50 or Older 5.8 5.9 0.6 0.9 0.4 0.6
50‑54 6.0a 8.9 1.4 2.2 0.8 1.4
55‑59 8.6 8.7 1.2 1.1 1.0 0.9
60‑64 8.2 7.4 0.5 1.2 0.3a 1.0
65 or Older 3.9 3.6 0.2 0.3 0.1 0.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.13A – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 63,149 60,619 7,570 6,881 1,951 1,816
12‑20 4,784 4,442 674 662 163 191
21 or Older 58,365 56,177 6,896 6,219 1,788 1,625
12‑17 2,998 2,670 395 402 106 105
12‑13 710 575 91 62 23 16
14‑15 1,073 899 150 134 49 38
16‑17 1,215 1,196 153 206 33 51
18 or Older 60,151 57,949 7,176 6,479 1,845 1,711
18‑25 4,731 4,676 897 733 214 176
18‑20 1,786 1,772 279 260 57 86
21‑25 2,945 2,904 618 473 157 90
26 or Older 55,420 53,272 6,279 5,746 1,631 1,535
26‑49 22,117b 19,726 3,468 2,984 873 860
26‑29 2,908a 2,416 535a 341 135 79
30‑34 4,330 3,856 594 600 121 151
35‑39 4,937a 4,196 814 778 227 252
40‑44 5,244 4,702 861 621 237 207
45‑49 4,697 4,557 664 644 154 172
50 or Older 33,303 33,547 2,811 2,762 758 675
50‑54 5,093 4,955 584 589 257 248
55‑59 4,973 5,311 588 665 137 156
60‑64 6,530 6,629 535 405 183 75
65 or Older 16,708 16,652 1,104 1,103 181 197

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.13B – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 21.9a 20.9 2.6 2.4 0.7 0.6
12‑20 12.4a 11.3 1.7 1.7 0.4 0.5
21 or Older 23.4 22.4 2.8 2.5 0.7 0.6
12‑17 11.6 10.5 1.5 1.6 0.4 0.4
12‑13 8.8 7.3 1.1 0.8 0.3 0.2
14‑15 12.1 10.3 1.7 1.5 0.6 0.4
16‑17 13.5 13.5 1.7 2.3 0.4 0.6
18 or Older 22.9a 21.9 2.7 2.4 0.7 0.6
18‑25 13.5 13.0 2.6 2.0 0.6 0.5
18‑20 14.2 12.9 2.2 1.9 0.5 0.6
21‑25 13.2 13.0 2.8 2.1 0.7 0.4
26 or Older 24.4 23.3 2.8 2.5 0.7 0.7
26‑49 20.9b 18.7 3.3 2.8 0.8 0.8
26‑29 16.6a 14.0 3.1a 2.0 0.8 0.5
30‑34 18.4 16.5 2.5 2.6 0.5 0.6
35‑39 21.3a 18.6 3.5 3.5 1.0 1.1
40‑44 23.4 21.4 3.8 2.8 1.1 0.9
45‑49 24.4 22.5 3.4 3.2 0.8 0.9
50 or Older 27.4 27.1 2.3 2.2 0.6 0.5
50‑54 25.8 27.4 3.0 3.3 1.3 1.4
55‑59 25.5 27.1 3.0 3.4 0.7 0.8
60‑64 29.0 29.2 2.4 1.8 0.8 0.3
65 or Older 27.9 26.3 1.8 1.7 0.3 0.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.14A – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 20,507 21,237 3,899 3,940 1,239 1,262
12‑20 3,148 3,018 489 500 109 119
21 or Older 17,359 18,219 3,410 3,440 1,130 1,143
12‑17 1,830 1,889 203 216 33 50
12‑13 370 453 12 31 3 5
14‑15 674 575 42 47 8 3
16‑17 786 860 149 139 22 41
18 or Older 18,677 19,348 3,696 3,724 1,206 1,212
18‑25 3,639 3,769 973 978 210 260
18‑20 1,318 1,129 286 283 76 69
21‑25 2,321 2,640 687 694 134 191
26 or Older 15,038 15,579 2,723 2,746 995 953
26‑49 10,320 10,719 2,296 2,391 838 879
26‑29 1,920 2,003 576 478 147 155
30‑34 2,516 2,777 575 711 237 202
35‑39 2,242 2,083 501 449 156 186
40‑44 2,091 2,196 364 440 170 216
45‑49 1,551 1,661 279 312 128 120
50 or Older 4,718 4,860 427 355 158 74
50‑54 1,349 1,053 147 90 52 12
55‑59 1,071 991 123 108 9 47
60‑64 948 1,069 100 88 50 5
65 or Older 1,351 1,746 56 70 47 10

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.14B – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 7.1 7.3 1.4 1.4 0.4 0.4
12‑20 8.2 7.7 1.3 1.3 0.3 0.3
21 or Older 7.0 7.3 1.4 1.4 0.5 0.5
12‑17 7.1 7.4 0.8 0.8 0.1 0.2
12‑13 4.6 5.8 0.1 0.4 <0.1 0.1
14‑15 7.6 6.6 0.5 0.5 0.1 <0.1
16‑17 8.7 9.7 1.7 1.6 0.2 0.5
18 or Older 7.1 7.3 1.4 1.4 0.5 0.5
18‑25 10.4 10.4 2.8 2.7 0.6 0.7
18‑20 10.5a 8.2 2.3 2.1 0.6 0.5
21‑25 10.4 11.8 3.1 3.1 0.6 0.9
26 or Older 6.6 6.8 1.2 1.2 0.4 0.4
26‑49 9.8 10.2 2.2 2.3 0.8 0.8
26‑29 11.0 11.6 3.3 2.8 0.8 0.9
30‑34 10.7 11.8 2.4 3.0 1.0 0.9
35‑39 9.7 9.2 2.2 2.0 0.7 0.8
40‑44 9.3 10.0 1.6 2.0 0.8 1.0
45‑49 8.1 8.2 1.5 1.5 0.7 0.6
50 or Older 3.9 3.9 0.4 0.3 0.1 0.1
50‑54 6.8 5.8 0.7 0.5 0.3 0.1
55‑59 5.5 5.0 0.6 0.5 <0.1 0.2
60‑64 4.2 4.7 0.4 0.4 0.2 <0.1
65 or Older 2.3 2.8 0.1 0.1 0.1 <0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.15A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 39,709a 36,756 4,575 4,237 1,480 1,187
12‑20 1,711 1,482 342 300 83 55
21 or Older 37,998a 35,274 4,233 3,937 1,397 1,132
12‑17 945 821 172 141 38 29
12‑13 224 192 21a 5 11 *
14‑15 337 263 63 49 4 8
16‑17 384 366 88 88 23 21
18 or Older 38,765a 35,935 4,403 4,095 1,442 1,158
18‑25 2,477 2,461 571 582 160 150
18‑20 767 661 170 159 45 26
21‑25 1,710 1,800 401 424 115 124
26 or Older 36,288a 33,474 3,832 3,513 1,282 1,008
26‑49 14,242 13,338 2,144 2,108 696 574
26‑29 1,783 1,603 400 311 118 57
30‑34 2,526 2,449 421 466 135 121
35‑39 3,193 2,755 500 445 161 145
40‑44 3,436 3,423 489 468 195 174
45‑49 3,304 3,107 333 418 87 78
50 or Older 22,046 20,136 1,688 1,405 586 434
50‑54 3,817 3,140 246 238 111a 12
55‑59 3,616 3,189 414 243 110 140
60‑64 4,184a 3,277 370 206 141 40
65 or Older 10,430 10,530 659 718 225 242

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.15B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 13.8b 12.7 1.6 1.5 0.5 0.4
12‑20 4.4a 3.8 0.9 0.8 0.2 0.1
21 or Older 15.2b 14.0 1.7 1.6 0.6 0.5
12‑17 3.6 3.2 0.7 0.6 0.1 0.1
12‑13 2.8 2.4 0.3a 0.1 0.1 *
14‑15 3.8 3.0 0.7 0.6 <0.1 0.1
16‑17 4.3 4.1 1.0 1.0 0.3 0.2
18 or Older 14.8b 13.6 1.7 1.5 0.5 0.4
18‑25 7.1 6.8 1.6 1.6 0.5 0.4
18‑20 6.1a 4.8 1.4 1.2 0.4 0.2
21‑25 7.6 8.1 1.8 1.9 0.5 0.6
26 or Older 16.0b 14.6 1.7 1.5 0.6 0.4
26‑49 13.5 12.7 2.0 2.0 0.7 0.5
26‑29 10.2 9.3 2.3 1.8 0.7 0.3
30‑34 10.7 10.5 1.8 2.0 0.6 0.5
35‑39 13.8 12.2 2.2 2.0 0.7 0.6
40‑44 15.3 15.6 2.2 2.1 0.9 0.8
45‑49 17.2 15.4 1.7 2.1 0.5 0.4
50 or Older 18.1a 16.3 1.4 1.1 0.5 0.4
50‑54 19.4 17.4 1.2 1.3 0.6 0.1
55‑59 18.6 16.2 2.1 1.2 0.6 0.7
60‑64 18.6a 14.4 1.6 0.9 0.6 0.2
65 or Older 17.4 16.7 1.1 1.1 0.4 0.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.16A – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 31,451a 28,826 3,829 3,665 1,259 974
12‑20 1,069 972 278 270 57 49
21 or Older 30,382a 27,854 3,551 3,395 1,202 925
12‑17 500 508 126 119 28 24
12‑13 94 78 8 2 6 *
14‑15 174 181 42 36 3 4
16‑17 232 248 75 81 20 20
18 or Older 30,951a 28,318 3,703 3,546 1,231 950
18‑25 1,944 1,811 522 515 131 140
18‑20 569 465 152 151 29 25
21‑25 1,375 1,346 370 364 102 115
26 or Older 29,007a 26,507 3,181 3,031 1,099 810
26‑49 11,988 11,162 1,921 1,918 602 496
26‑29 1,539 1,294 362 264 92a 27
30‑34 2,140 2,086 378 433 113 117
35‑39 2,734a 2,236 448 354 136 136
40‑44 2,871 2,946 422 450 181 162
45‑49 2,705 2,601 310 416 79 55
50 or Older 17,018 15,345 1,260 1,113 498 314
50‑54 3,129 2,546 179 238 95 12
55‑59 2,796 2,505 340 243 58 117
60‑64 3,172 2,557 239 163 138a 17
65 or Older 7,921 7,737 501 469 207 169

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.16B – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 10.9b 9.9 1.3 1.3 0.4 0.3
12‑20 2.8 2.5 0.7 0.7 0.1 0.1
21 or Older 12.2b 11.1 1.4 1.4 0.5 0.4
12‑17 1.9 2.0 0.5 0.5 0.1 0.1
12‑13 1.2 1.0 0.1 <0.1 0.1 *
14‑15 2.0 2.1 0.5 0.4 <0.1 <0.1
16‑17 2.6 2.8 0.8 0.9 0.2 0.2
18 or Older 11.8b 10.7 1.4 1.3 0.5 0.4
18‑25 5.6 5.0 1.5 1.4 0.4 0.4
18‑20 4.5a 3.4 1.2 1.1 0.2 0.2
21‑25 6.1 6.0 1.7 1.6 0.5 0.5
26 or Older 12.8b 11.6 1.4 1.3 0.5 0.4
26‑49 11.3 10.6 1.8 1.8 0.6 0.5
26‑29 8.8 7.5 2.1 1.5 0.5a 0.2
30‑34 9.1 8.9 1.6 1.8 0.5 0.5
35‑39 11.8a 9.9 1.9 1.6 0.6 0.6
40‑44 12.8 13.4 1.9 2.1 0.8 0.7
45‑49 14.1 12.9 1.6 2.1 0.4 0.3
50 or Older 14.0a 12.4 1.0 0.9 0.4 0.3
50‑54 15.9 14.1 0.9 1.3 0.5 0.1
55‑59 14.4 12.8 1.7 1.2 0.3 0.6
60‑64 14.1 11.3 1.1 0.7 0.6a 0.1
65 or Older 13.2 12.2 0.8 0.7 0.3 0.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.17A – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 13,762 13,659 920 977 254 306
12‑20 844a 666 87 48 27 10
21 or Older 12,918 12,993 833 929 226 297
12‑17 545a 395 64 31 11 8
12‑13 144 121 13a 2 6 *
14‑15 202a 112 32 16 1 7
16‑17 199 162 18 13 4 1
18 or Older 13,217 13,264 857 946 243 298
18‑25 830 930 76 118 35 13
18‑20 299 271 24 17 17 1
21‑25 531 659 52 102 18 11
26 or Older 12,387 12,334 781 828 208 285
26‑49 4,038 3,859 341 404 120 140
26‑29 437 553 42 48 26 30
30‑34 672 648 77 56 32 10
35‑39 868 841 108 107 32 11
40‑44 1,049 880 77 120 18 62
45‑49 1,013 936 36 73 12 27
50 or Older 8,349 8,475 440 424 88 146
50‑54 1,405 1,320 72 58 15 11
55‑59 1,275 1,346 73 43 52 38
60‑64 1,532 1,305 135 60 3 23
65 or Older 4,137 4,504 160 263 18 74

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.17B – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 4.8 4.7 0.3 0.3 0.1 0.1
12‑20 2.2a 1.7 0.2 0.1 0.1 <0.1
21 or Older 5.2 5.2 0.3 0.4 0.1 0.1
12‑17 2.1a 1.6 0.2 0.1 <0.1 <0.1
12‑13 1.8 1.5 0.2a <0.1 0.1 *
14‑15 2.3a 1.3 0.4 0.2 <0.1 0.1
16‑17 2.2 1.8 0.2 0.2 <0.1 <0.1
18 or Older 5.0 5.0 0.3 0.4 0.1 0.1
18‑25 2.4 2.6 0.2 0.3 0.1 <0.1
18‑20 2.4 2.0 0.2 0.1 0.1 <0.1
21‑25 2.4 3.0 0.2 0.5 0.1 0.1
26 or Older 5.4 5.4 0.3 0.4 0.1 0.1
26‑49 3.8 3.7 0.3 0.4 0.1 0.1
26‑29 2.5 3.2 0.2 0.3 0.1 0.2
30‑34 2.9 2.8 0.3 0.2 0.1 <0.1
35‑39 3.7 3.7 0.5 0.5 0.1 <0.1
40‑44 4.7 4.0 0.3 0.5 0.1 0.3
45‑49 5.3 4.6 0.2 0.4 0.1 0.1
50 or Older 6.9 6.9 0.4 0.3 0.1 0.1
50‑54 7.1 7.3 0.4 0.3 0.1 0.1
55‑59 6.6 6.9 0.4 0.2 0.3 0.2
60‑64 6.8 5.8 0.6 0.3 <0.1 0.1
65 or Older 6.9 7.1 0.3 0.4 <0.1 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.18A – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
TOTAL 24,207a 22,280 3,360 3,293
12‑20 832 806 235 260
21 or Older 23,375a 21,474 3,125 3,033
12‑17 371 398 107 122
12‑13 77 73 15 2
14‑15 119 97 36 40
16‑17 175 227 56 79
18 or Older 23,835a 21,883 3,253 3,172
18‑25 1,628 1,536 488 470
18‑20 461 408 129 139
21‑25 1,167 1,128 359 331
26 or Older 22,208a 20,346 2,766 2,702
26‑49 9,356 8,730 1,695 1,671
26‑29 1,340 1,058 353 263
30‑34 1,652 1,631 337 382
35‑39 2,212a 1,748 376 318
40‑44 2,145 2,285 397 362
45‑49 2,007 2,008 231 346
50 or Older 12,852 11,617 1,071 1,031
50‑54 2,210 2,033 163 206
55‑59 2,023 1,759 312 217
60‑64 2,431 1,914 190 163
65 or Older 6,188 5,910 407 444

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.18B – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
TOTAL 8.4a 7.7 1.2 1.1
12‑20 2.2 2.1 0.6 0.7
21 or Older 9.4a 8.5 1.3 1.2
12‑17 1.4 1.6 0.4 0.5
12‑13 1.0 0.9 0.2 <0.1
14‑15 1.3 1.1 0.4 0.5
16‑17 1.9 2.6 0.6 0.9
18 or Older 9.1b 8.3 1.2 1.2
18‑25 4.7 4.3 1.4 1.3
18‑20 3.7 3.0 1.0 1.0
21‑25 5.2 5.1 1.6 1.5
26 or Older 9.8a 8.9 1.2 1.2
26‑49 8.8 8.3 1.6 1.6
26‑29 7.7 6.1 2.0 1.5
30‑34 7.0 7.0 1.4 1.6
35‑39 9.5a 7.8 1.6 1.4
40‑44 9.6 10.4 1.8 1.7
45‑49 10.4 9.9 1.2 1.7
50 or Older 10.6a 9.4 0.9 0.8
50‑54 11.2 11.2 0.8 1.1
55‑59 10.4 9.0 1.6 1.1
60‑64 10.8 8.4 0.8 0.7
65 or Older 10.3 9.3 0.7 0.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.19A – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 63,203 60,669 7,795 7,080 2,117 2,051
12‑20 4,789 4,443 683 663 165 192
21 or Older 58,414 56,226 7,112 6,417 1,952 1,860
12‑17 2,998 2,670 400 403 107 105
12‑13 710 575 91 62 24 16
14‑15 1,074 899 155 134 49 38
16‑17 1,215 1,196 153 206 34 51
18 or Older 60,204 57,998 7,396 6,678 2,010 1,946
18‑25 4,741 4,679 925 736 221 179
18‑20 1,790 1,773 283 260 58 86
21‑25 2,951 2,907 642 476 163 93
26 or Older 55,464 53,319 6,471 5,941 1,788 1,767
26‑49 22,160b 19,771 3,588 3,115 999 1,063
26‑29 2,910a 2,416 540a 352 139 88
30‑34 4,351 3,879 622 646 126 204
35‑39 4,939a 4,200 846 797 283 309
40‑44 5,257 4,712 888 637 266 264
45‑49 4,703 4,564 693 683 186 198
50 or Older 33,303 33,548 2,883 2,826 789 704
50‑54 5,093 4,955 595 601 285 251
55‑59 4,973 5,311 623 665 140 156
60‑64 6,530 6,629 561 440 183 99
65 or Older 16,708 16,653 1,104 1,120 181 198

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Any use of opioids includes the use of heroin or any use of prescription opioids.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.19B – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 21.9a 20.9 2.7 2.4 0.7 0.7
12‑20 12.4a 11.3 1.8 1.7 0.4 0.5
21 or Older 23.4 22.4 2.8 2.6 0.8 0.7
12‑17 11.6 10.5 1.5 1.6 0.4 0.4
12‑13 8.8 7.3 1.1 0.8 0.3 0.2
14‑15 12.1 10.3 1.7 1.5 0.6 0.4
16‑17 13.5 13.5 1.7 2.3 0.4 0.6
18 or Older 23.0a 21.9 2.8 2.5 0.8 0.7
18‑25 13.6 13.0 2.6a 2.0 0.6 0.5
18‑20 14.3 12.9 2.3 1.9 0.5 0.6
21‑25 13.2 13.0 2.9 2.1 0.7 0.4
26 or Older 24.4 23.3 2.8 2.6 0.8 0.8
26‑49 20.9b 18.8 3.4 3.0 0.9 1.0
26‑29 16.7a 14.0 3.1a 2.0 0.8 0.5
30‑34 18.5 16.6 2.6 2.8 0.5 0.9
35‑39 21.3a 18.6 3.7 3.5 1.2 1.4
40‑44 23.5 21.5 4.0 2.9 1.2 1.2
45‑49 24.4 22.6 3.6 3.4 1.0 1.0
50 or Older 27.4 27.1 2.4 2.3 0.6 0.6
50‑54 25.8 27.4 3.0 3.3 1.4 1.4
55‑59 25.5 27.1 3.2 3.4 0.7 0.8
60‑64 29.0 29.2 2.5 1.9 0.8 0.4
65 or Older 27.9 26.3 1.8 1.8 0.3 0.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Any use of opioids includes the use of heroin or any use of prescription opioids.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.20A – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 24,907 25,821 9,031 9,486 3,934 4,465
12‑20 3,296 3,155 697 644 201 189
21 or Older 21,611 22,667 8,334 8,842 3,733 4,276
12‑17 1,890 1,909 293 241 80 54
12‑13 385 463 32 41 10 6
14‑15 692 577 61 53 15 4
16‑17 813 869 200 147 55 43
18 or Older 23,017 23,912 8,738 9,245 3,854 4,411
18‑25 4,191 4,292 1,646 1,681 466 623
18‑20 1,406 1,246 404 403 121 135
21‑25 2,785 3,046 1,242 1,278 345 488
26 or Older 18,827 19,620 7,092 7,564 3,388 3,789
26‑49 12,967 13,234 5,409 5,465 2,413 2,563
26‑29 2,519 2,319 1,256a 933 417 341
30‑34 3,017 3,409 1,218 1,547 501 691
35‑39 2,921 2,834 1,301 1,247 564 559
40‑44 2,529 2,605 876 986 494 502
45‑49 1,981 2,067 759 752 438 471
50 or Older 5,859 6,387 1,682 2,099 974 1,225
50‑54 1,751 1,481 612 619 338 298
55‑59 1,440 1,339 494 522 316 407
60‑64 1,140 1,485 307 532 158 336
65 or Older 1,529a 2,081 269 425 163 185

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.20B – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 8.6 8.9 3.1 3.3 1.4 1.5
12‑20 8.6 8.0 1.8 1.6 0.5 0.5
21 or Older 8.7 9.0 3.3 3.5 1.5 1.7
12‑17 7.3 7.5 1.1 0.9 0.3 0.2
12‑13 4.8 5.9 0.4 0.5 0.1 0.1
14‑15 7.8 6.6 0.7 0.6 0.2 <0.1
16‑17 9.0 9.8 2.2 1.7 0.6 0.5
18 or Older 8.8 9.0 3.3 3.5 1.5 1.7
18‑25 12.0 11.9 4.7 4.7 1.3 1.7
18‑20 11.2a 9.0 3.2 2.9 1.0 1.0
21‑25 12.4 13.7 5.5 5.7 1.5 2.2
26 or Older 8.3 8.6 3.1 3.3 1.5 1.7
26‑49 12.3 12.6 5.1 5.2 2.3 2.4
26‑29 14.4 13.4 7.2a 5.4 2.4 2.0
30‑34 12.8 14.5 5.2a 6.6 2.1 2.9
35‑39 12.6 12.6 5.6 5.5 2.4 2.5
40‑44 11.3 11.9 3.9 4.5 2.2 2.3
45‑49 10.3 10.2 3.9 3.7 2.3 2.3
50 or Older 4.8 5.2 1.4 1.7 0.8 1.0
50‑54 8.9 8.2 3.1 3.4 1.7 1.6
55‑59 7.4 6.8 2.5 2.7 1.6 2.1
60‑64 5.1 6.5 1.4 2.3 0.7 1.5
65 or Older 2.6 3.3 0.4 0.7 0.3 0.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.21A – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 23,691 ‑‑ 9,104
12‑20 ‑‑ 2,408 ‑‑ 797
21 or Older ‑‑ 21,282 ‑‑ 8,306
12‑17 ‑‑ 1,131 ‑‑ 329
12‑13 ‑‑ 240 ‑‑ 77
14‑15 ‑‑ 377 ‑‑ 110
16‑17 ‑‑ 514 ‑‑ 142
18 or Older ‑‑ 22,559 ‑‑ 8,775
18‑25 ‑‑ 4,015 ‑‑ 1,373
18‑20 ‑‑ 1,277 ‑‑ 469
21‑25 ‑‑ 2,738 ‑‑ 905
26 or Older ‑‑ 18,544 ‑‑ 7,402
26‑49 ‑‑ 11,995 ‑‑ 4,794
26‑29 ‑‑ 2,095 ‑‑ 643
30‑34 ‑‑ 3,048 ‑‑ 1,250
35‑39 ‑‑ 2,589 ‑‑ 1,059
40‑44 ‑‑ 2,326 ‑‑ 1,029
45‑49 ‑‑ 1,935 ‑‑ 813
50 or Older ‑‑ 6,550 ‑‑ 2,608
50‑54 ‑‑ 1,585 ‑‑ 725
55‑59 ‑‑ 1,343 ‑‑ 644
60‑64 ‑‑ 1,242 ‑‑ 545
65 or Older ‑‑ 2,379 ‑‑ 694

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.21B – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 8.2 ‑‑ 3.1
12‑20 ‑‑ 6.1 ‑‑ 2.0
21 or Older ‑‑ 8.5 ‑‑ 3.3
12‑17 ‑‑ 4.4 ‑‑ 1.3
12‑13 ‑‑ 3.1 ‑‑ 1.0
14‑15 ‑‑ 4.3 ‑‑ 1.3
16‑17 ‑‑ 5.8 ‑‑ 1.6
18 or Older ‑‑ 8.5 ‑‑ 3.3
18‑25 ‑‑ 11.1 ‑‑ 3.8
18‑20 ‑‑ 9.3 ‑‑ 3.4
21‑25 ‑‑ 12.3 ‑‑ 4.1
26 or Older ‑‑ 8.1 ‑‑ 3.2
26‑49 ‑‑ 11.4 ‑‑ 4.6
26‑29 ‑‑ 12.2 ‑‑ 3.7
30‑34 ‑‑ 13.0 ‑‑ 5.3
35‑39 ‑‑ 11.5 ‑‑ 4.7
40‑44 ‑‑ 10.6 ‑‑ 4.7
45‑49 ‑‑ 9.6 ‑‑ 4.0
50 or Older ‑‑ 5.3 ‑‑ 2.1
50‑54 ‑‑ 8.8 ‑‑ 4.0
55‑59 ‑‑ 6.8 ‑‑ 3.3
60‑64 ‑‑ 5.5 ‑‑ 2.4
65 or Older ‑‑ 3.8 ‑‑ 1.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.22A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Prescription Drug/Age Group Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Misuse in Past Year among Past Year Any Users
(2024)
Misuse in Past Year among Past Year Any Users
(2025)
PRESCRIPTION PSYCHOTHERAPEUTICS 98,945 95,175 13,797 12,804 13,797 12,804
12‑17 5,048 4,613 647 598 647 598
18 or Older 93,897 90,562 13,150 12,206 13,150 12,206
18‑25 8,960 9,146 2,019 1,909 2,019 1,909
26 or Older 84,937 81,417 11,131 10,297 11,131 10,297
PAIN RELIEVERS 69,909 67,215 8,000 7,178 8,000 7,178
12‑17 3,259 2,939 425 420 425 420
18 or Older 66,650 64,275 7,575 6,758 7,575 6,758
18‑25 5,314 5,270 955 775 955 775
26 or Older 61,336 59,005 6,620 5,983 6,620 5,983
PRESCRIPTION OPIOIDS 63,149 60,619 7,570 6,881 7,570 6,881
12‑17 2,998 2,670 395 402 395 402
18 or Older 60,151 57,949 7,176 6,479 7,176 6,479
18‑25 4,731 4,676 897 733 897 733
26 or Older 55,420 53,272 6,279 5,746 6,279 5,746
STIMULANTS 20,507 21,237 3,899 3,940 3,899 3,940
12‑17 1,830 1,889 203 216 203 216
18 or Older 18,677 19,348 3,696 3,724 3,696 3,724
18‑25 3,639 3,769 973 978 973 978
26 or Older 15,038 15,579 2,723 2,746 2,723 2,746
TRANQUILIZERS OR SEDATIVES 39,709a 36,756 4,575 4,237 4,575 4,237
12‑17 945 821 172 141 172 141
18 or Older 38,765a 35,935 4,403 4,095 4,403 4,095
18‑25 2,477 2,461 571 582 571 582
26 or Older 36,288a 33,474 3,832 3,513 3,832 3,513
TRANQUILIZERS 31,451a 28,826 3,829 3,665 3,829 3,665
12‑17 500 508 126 119 126 119
18 or Older 30,951a 28,318 3,703 3,546 3,703 3,546
18‑25 1,944 1,811 522 515 522 515
26 or Older 29,007a 26,507 3,181 3,031 3,181 3,031
SEDATIVES 13,762 13,659 920 977 920 977
12‑17 545a 395 64 31 64 31
18 or Older 13,217 13,264 857 946 857 946
18‑25 830 930 76 118 76 118
26 or Older 12,387 12,334 781 828 781 828
BENZODIAZEPINES 24,207a 22,280 3,360 3,293 3,360 3,293
12‑17 371 398 107 122 107 122
18 or Older 23,835a 21,883 3,253 3,172 3,253 3,172
18‑25 1,628 1,536 488 470 488 470
26 or Older 22,208a 20,346 2,766 2,702 2,766 2,702

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.22B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Prescription Drug/Age Group Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Misuse in Past Year among Past Year Any Users
(2024)
Misuse in Past Year among Past Year Any Users
(2025)
PRESCRIPTION PSYCHOTHERAPEUTICS 34.3b 32.8 4.8 4.4 13.9 13.5
12‑17 19.5 18.1 2.5 2.4 12.8 13.0
18 or Older 35.8b 34.2 5.0 4.6 14.0 13.5
18‑25 25.6 25.3 5.8 5.3 22.5 20.9
26 or Older 37.4b 35.6 4.9 4.5 13.1 12.6
PAIN RELIEVERS 24.3a 23.1 2.8 2.5 11.4 10.7
12‑17 12.6 11.5 1.6 1.7 13.0 14.3
18 or Older 25.4a 24.2 2.9 2.5 11.4 10.5
18‑25 15.2 14.6 2.7 2.1 18.0 14.7
26 or Older 27.0a 25.8 2.9 2.6 10.8 10.1
PRESCRIPTION OPIOIDS 21.9a 20.9 2.6 2.4 12.0 11.4
12‑17 11.6 10.5 1.5 1.6 13.2 15.1
18 or Older 22.9a 21.9 2.7 2.4 11.9 11.2
18‑25 13.5 13.0 2.6 2.0 19.0 15.7
26 or Older 24.4 23.3 2.8 2.5 11.3 10.8
STIMULANTS 7.1 7.3 1.4 1.4 19.0 18.6
12‑17 7.1 7.4 0.8 0.8 11.1 11.4
18 or Older 7.1 7.3 1.4 1.4 19.8 19.2
18‑25 10.4 10.4 2.8 2.7 26.7 25.9
26 or Older 6.6 6.8 1.2 1.2 18.1 17.6
TRANQUILIZERS OR SEDATIVES 13.8b 12.7 1.6 1.5 11.5 11.5
12‑17 3.6 3.2 0.7 0.6 18.2 17.2
18 or Older 14.8b 13.6 1.7 1.5 11.4 11.4
18‑25 7.1 6.8 1.6 1.6 23.1 23.7
26 or Older 16.0b 14.6 1.7 1.5 10.6 10.5
TRANQUILIZERS 10.9b 9.9 1.3 1.3 12.2 12.7
12‑17 1.9 2.0 0.5 0.5 25.2 23.5
18 or Older 11.8b 10.7 1.4 1.3 12.0 12.5
18‑25 5.6 5.0 1.5 1.4 26.8 28.4
26 or Older 12.8b 11.6 1.4 1.3 11.0 11.4
SEDATIVES 4.8 4.7 0.3 0.3 6.7 7.2
12‑17 2.1a 1.6 0.2 0.1 11.7 7.9
18 or Older 5.0 5.0 0.3 0.4 6.5 7.1
18‑25 2.4 2.6 0.2 0.3 9.1 12.7
26 or Older 5.4 5.4 0.3 0.4 6.3 6.7
BENZODIAZEPINES 8.4a 7.7 1.2 1.1 13.9 14.8
12‑17 1.4 1.6 0.4 0.5 28.7 30.6
18 or Older 9.1b 8.3 1.2 1.2 13.6 14.5
18‑25 4.7 4.3 1.4 1.3 30.0 30.6
26 or Older 9.8a 8.9 1.2 1.2 12.5 13.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.23A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 149,927 145,476 ‑‑ 4,149 143,653 141,327 18,697 18,125 124,955 123,202
SEX                    
Male 76,888 74,727 ‑‑ 2,029 73,834 72,698 9,203 8,941 64,631 63,756
Female 73,039 70,749 ‑‑ 2,120 69,819 68,630 9,495 9,184 60,324 59,445
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 126,718 122,273 ‑‑ 2,952 122,101 119,320 14,487 13,770 107,614 105,550
AIAN 744a 1,017 ‑‑ 46 693a 970 87 109 606 861
Asian 5,098 4,242 ‑‑ 76 4,832 4,166 833 893 3,999 3,273
Black or African American 17,203 16,215 ‑‑ 746 16,192 15,470 2,453 2,195 13,739 13,274
NHPI * * ‑‑ * * * * * * *
White 98,942 94,559 ‑‑ 1,825 95,994 92,734 10,316 9,554 85,678 83,180
Two or More Races 4,163b 5,664 ‑‑ 247 3,841b 5,416 755a 975 3,085b 4,442
Hispanic or Latino 23,209 23,204 ‑‑ 1,197 21,551 22,007 4,210 4,355 17,341 17,652
EDUCATION LEVEL                    
< High School da da da da 10,214 10,437 1,655 1,697 8,558 8,740
High School Graduate da da da da 35,949 35,966 6,173 6,101 29,776 29,864
Some College/Associate’s Degree da da da da 46,518 44,768 7,290 6,751 39,228 38,018
College Graduate da da da da 50,972 50,156 3,579 3,577 47,393 46,579
EMPLOYMENT STATUS                    
Full‑Time da da da da 70,897 67,315 8,326 7,833 62,571 59,482
Part‑Time da da da da 18,666 19,652 4,618 4,716 14,049 14,936
Unemployed da da da da 7,590 7,912 2,013 2,063 5,577 5,849
Other1 da da da da 46,499 46,447 3,741 3,513 42,758 42,934

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.23B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 52.0b 50.1 ‑‑ 16.3 54.8a 53.3 53.5b 50.2 55.0 53.8
SEX                    
Male 54.5 53.1 ‑‑ 15.6 57.8 56.9 52.4a 49.1 58.7 58.2
Female 49.6b 47.2 ‑‑ 17.0 51.9a 50.0 54.6a 51.3 51.5 49.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 54.2b 52.3 ‑‑ 15.8 56.9a 55.4 55.3b 51.8 57.1 55.9
AIAN 54.6 55.0 ‑‑ 17.2 60.0 61.5 56.2 52.9 60.6 62.8
Asian 27.4b 22.1 ‑‑ 5.0 28.2a 23.6 34.7 35.2 27.2a 21.6
Black or African American 48.8 47.0 ‑‑ 21.9 51.1 49.8 53.4a 47.2 50.7 50.2
NHPI * * ‑‑ * * * * * * *
White 58.0a 56.3 ‑‑ 15.2 60.8 59.5 58.2a 55.0 61.1 60.0
Two or More Races 64.2 59.9 ‑‑ 18.6 70.6 66.6 65.9a 57.2 71.8 69.1
Hispanic or Latino 42.5 41.1 ‑‑ 17.5 45.1 44.3 48.0 45.8 44.5 43.9
EDUCATION LEVEL                    
< High School da da da da 42.5 42.7 46.8 45.6 41.7 42.2
High School Graduate da da da da 51.1 50.7 50.7a 47.5 51.2 51.4
Some College/Associate’s Degree da da da da 59.7 57.9 55.0b 50.6 60.7 59.4
College Graduate da da da da 56.6a 54.3 59.8 57.8 56.4a 54.0
EMPLOYMENT STATUS                    
Full‑Time da da da da 58.5 57.1 59.3 57.2 58.4 57.1
Part‑Time da da da da 57.6 56.3 52.4 48.9 59.5 59.1
Unemployed da da da da 58.9 57.8 54.8 50.5 60.5 60.9
Other1 da da da da 48.5 47.1 44.3a 40.5 49.0 47.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.24A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 73,637a 69,791 ‑‑ 2,851 69,720 66,940 13,299 13,094 56,421 53,846
SEX                    
Male 39,437a 36,840 ‑‑ 1,406 37,597 35,435 6,648 6,743 30,950 28,692
Female 34,199 32,951 ‑‑ 1,445 32,123 31,505 6,652 6,351 25,471 25,154
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 61,644a 57,859 ‑‑ 2,054 58,694 55,806 10,350 10,065 48,344 45,741
AIAN 403 549 ‑‑ 39 371 509 66 71 305 439
Asian 2,245 1,860 ‑‑ 48 2,128 1,812 533 594 1,595 1,217
Black or African American 9,547 8,866 ‑‑ 489 8,881 8,377 1,824 1,656 7,057 6,721
NHPI 233 223 ‑‑ * 218 212 * * 189 *
White 46,866b 42,976 ‑‑ 1,280 44,940a 41,696 7,317 6,956 37,623a 34,740
Two or More Races 2,350b 3,386 ‑‑ 186 2,157b 3,200 581a 762 1,576b 2,438
Hispanic or Latino 11,993 11,932 ‑‑ 797 11,026 11,135 2,949 3,029 8,077 8,106
EDUCATION LEVEL                    
< High School da da da da 5,264 5,969 1,243 1,303 4,021 4,666
High School Graduate da da da da 19,111 18,149 4,528 4,432 14,583 13,718
Some College/Associate’s Degree da da da da 23,520a 21,600 5,166 4,961 18,354a 16,639
College Graduate da da da da 21,825 21,223 2,363 2,398 19,463 18,825
EMPLOYMENT STATUS                    
Full‑Time da da da da 35,234a 32,550 5,899 5,404 29,335 27,146
Part‑Time da da da da 9,570 10,056 3,330 3,567 6,240 6,490
Unemployed da da da da 4,948 5,087 1,427 1,674 3,521 3,413
Other1 da da da da 19,969 19,247 2,643 2,449 17,326 16,798

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.24B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 25.5b 24.0 ‑‑ 11.2 26.6a 25.3 38.1 36.3 24.8a 23.5
SEX                    
Male 28.0a 26.2 ‑‑ 10.8 29.4a 27.8 37.9 37.1 28.1a 26.2
Female 23.2a 22.0 ‑‑ 11.6 23.9 22.9 38.3a 35.5 21.7 21.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 26.4b 24.7 ‑‑ 11.0 27.4a 25.9 39.5 37.9 25.7a 24.2
AIAN 29.6 29.7 ‑‑ 14.5 32.1 32.3 42.5 34.1 30.5 32.0
Asian 12.0 9.7 ‑‑ 3.1 12.4 10.3 22.2 23.4 10.8 8.1
Black or African American 27.1 25.7 ‑‑ 14.3 28.0 26.9 39.7 35.6 26.1 25.4
NHPI 18.8 20.9 ‑‑ * 18.8 21.3 * * 18.7 *
White 27.5b 25.6 ‑‑ 10.7 28.4a 26.7 41.3 40.0 26.8a 25.1
Two or More Races 36.2 35.8 ‑‑ 14.0 39.6 39.4 50.7 44.7 36.7 38.0
Hispanic or Latino 22.0 21.1 ‑‑ 11.7 23.1 22.4 33.6 31.8 20.7 20.2
EDUCATION LEVEL                    
< High School da da da da 21.9 24.4 35.2 35.0 19.6 22.5
High School Graduate da da da da 27.2 25.6 37.2 34.5 25.1 23.6
Some College/Associate’s Degree da da da da 30.2a 27.9 39.0 37.2 28.4a 26.0
College Graduate da da da da 24.2 23.0 39.5 38.7 23.2 21.8
EMPLOYMENT STATUS                    
Full‑Time da da da da 29.1 27.6 42.0 39.4 27.4 26.0
Part‑Time da da da da 29.5 28.8 37.8 37.0 26.4 25.7
Unemployed da da da da 38.4 37.1 38.9 41.0 38.2 35.5
Other1 da da da da 20.8 19.5 31.3 28.3 19.8 18.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.25A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 48,224 47,546 1,950b 1,482 46,273 46,064 8,884 8,808 37,390 37,257
SEX                    
Male 26,972 26,072 883 776 26,089 25,296 4,530 4,652 21,559 20,644
Female 21,251 21,475 1,067b 706 20,185 20,769 4,354 4,156 15,830 16,613
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 41,195 39,561 1,442b 1,039 39,753 38,522 7,018 6,765 32,735 31,757
AIAN 280 403 20 14 260 389 50 52 210 337
Asian 1,294 1,018 33 17 1,262 1,000 286 316 976 684
Black or African American 6,462 6,290 333 252 6,129 6,038 1,333 1,122 4,796 4,915
NHPI 122 146 2 * 121 146 * * 94 *
White 31,307 29,316 975b 674 30,332 28,641 4,895 4,734 25,437 23,907
Two or More Races 1,729b 2,390 80 81 1,649b 2,309 427 514 1,222a 1,795
Hispanic or Latino 7,029 7,985 508 443 6,521a 7,542 1,866 2,043 4,655 5,500
EDUCATION LEVEL                    
< High School da da da da 3,688a 4,548 891 948 2,797a 3,600
High School Graduate da da da da 13,500 13,100 3,116 3,146 10,384 9,953
Some College/Associate’s Degree da da da da 16,329 15,137 3,396 3,240 12,933 11,898
College Graduate da da da da 12,756 13,280 1,481 1,474 11,275 11,806
EMPLOYMENT STATUS                    
Full‑Time da da da da 23,107 22,345 4,049 3,808 19,058 18,536
Part‑Time da da da da 6,233 6,929 2,084 2,258 4,149 4,671
Unemployed da da da da 3,502 3,585 1,001 1,121 2,502 2,464
Other1 da da da da 13,431 13,206 1,750 1,621 11,681 11,585

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.25B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 16.7 16.4 7.5b 5.8 17.6 17.4 25.4 24.4 16.4 16.3
SEX                    
Male 19.1 18.5 6.7 6.0 20.4 19.8 25.8 25.6 19.6 18.9
Female 14.4 14.3 8.4b 5.7 15.0 15.1 25.0 23.2 13.5 13.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 17.6 16.9 7.6b 5.6 18.5 17.9 26.8 25.5 17.4 16.8
AIAN 20.6 21.8 9.5 5.0 22.6 24.7 32.5 25.2 21.0 24.6
Asian 6.9 5.3 2.2 1.1 7.4 5.7 11.9 12.5 6.6 4.5
Black or African American 18.3 18.2 9.3 7.4 19.3 19.4 29.0a 24.1 17.7 18.6
NHPI 9.9 13.7 2.0 * 10.4 14.6 * * 9.3 *
White 18.3 17.5 7.7b 5.6 19.2 18.4 27.6 27.2 18.1 17.3
Two or More Races 26.7 25.3 7.7 6.1 30.3 28.4 37.2 30.1 28.4 27.9
Hispanic or Latino 12.9 14.1 7.4 6.5 13.7 15.2 21.3 21.5 11.9 13.7
EDUCATION LEVEL                    
< High School da da da da 15.3a 18.6 25.2 25.5 13.6a 17.4
High School Graduate da da da da 19.2 18.5 25.6 24.5 17.9 17.1
Some College/Associate’s Degree da da da da 21.0 19.6 25.6 24.3 20.0 18.6
College Graduate da da da da 14.2 14.4 24.8 23.8 13.4 13.7
EMPLOYMENT STATUS                    
Full‑Time da da da da 19.1 18.9 28.9 27.8 17.8 17.8
Part‑Time da da da da 19.2 19.9 23.7 23.4 17.6 18.5
Unemployed da da da da 27.2 26.2 27.3 27.4 27.1 25.6
Other1 da da da da 14.0 13.4 20.7 18.7 13.4 12.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.26A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 137,055 136,335 3,363a 2,915 133,692 133,420 17,068 17,221 116,624 116,199
SEX                    
Male 70,404 69,897 1,566 1,395 68,838 68,502 8,352 8,431 60,486 60,071
Female 66,651 66,438 1,797a 1,520 64,854 64,918 8,716 8,790 56,138 56,127
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 116,715 115,446 2,496b 2,058 114,220 113,388 13,250 13,128 100,969 100,260
AIAN 625b 968 25 38 599a 930 78 100 521a 830
Asian 4,053 3,758 54 22 3,999 3,736 611 762 3,388 2,974
Black or African American 15,807 15,097 540 499 15,267 14,598 2,260 2,086 13,006 12,512
NHPI 504 * 3 * * * * * * *
White 91,894 89,620 1,699b 1,287 90,195 88,333 9,539 9,189 80,657 79,144
Two or More Races 3,832b 5,476 174 202 3,658b 5,274 722a 949 2,937b 4,325
Hispanic or Latino 20,339 20,889 867 857 19,472 20,032 3,818 4,093 15,655 15,939
EDUCATION LEVEL                    
< High School da da da da 8,940 9,543 1,434 1,571 7,506 7,973
High School Graduate da da da da 33,658 34,042 5,666 5,804 27,991 28,237
Some College/Associate’s Degree da da da da 43,644 42,439 6,606 6,429 37,039 36,010
College Graduate da da da da 47,450 47,396 3,362 3,417 44,088 43,979
EMPLOYMENT STATUS                    
Full‑Time da da da da 66,496 64,430 7,746 7,580 58,750 56,849
Part‑Time da da da da 17,316 18,344 4,145 4,501 13,172 13,843
Unemployed da da da da 7,014 7,440 1,902 1,939 5,113 5,501
Other1 da da da da 42,865 43,206 3,275 3,201 39,590 40,005

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.26B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 47.5 46.9 13.0a 11.5 51.0 50.3 48.8 47.7 51.3 50.7
SEX                    
Male 49.9 49.7 11.8 10.7 53.9 53.7 47.6 46.3 54.9 54.9
Female 45.3 44.3 14.2a 12.2 48.2 47.3 50.1 49.1 47.9 47.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 50.0 49.3 13.1b 11.0 53.2 52.6 50.6 49.4 53.6 53.1
AIAN 45.8 52.4 12.1 14.1 51.9 59.0 50.5 48.5 52.1 60.6
Asian 21.7 19.6 3.5 1.5 23.4 21.2 25.4 30.0 23.0 19.7
Black or African American 44.8 43.8 15.1 14.6 48.2 47.0 49.2 44.8 48.0 47.3
NHPI 40.7 * 3.8 * * * * * * *
White 53.9 53.4 13.5b 10.7 57.1 56.7 53.8 52.9 57.5 57.1
Two or More Races 59.1 57.9 16.7 15.1 67.2 64.9 63.0 55.7 68.3 67.3
Hispanic or Latino 37.2 37.0 12.6 12.6 40.8 40.3 43.5 43.0 40.2 39.7
EDUCATION LEVEL                    
< High School da da da da 37.2 39.1 40.6 42.2 36.6 38.5
High School Graduate da da da da 47.9 48.0 46.6 45.2 48.1 48.6
Some College/Associate’s Degree da da da da 56.0 54.9 49.8 48.2 57.3 56.3
College Graduate da da da da 52.7 51.3 56.2 55.2 52.4 51.0
EMPLOYMENT STATUS                    
Full‑Time da da da da 54.9 54.6 55.2 55.3 54.8 54.5
Part‑Time da da da da 53.4 52.6 47.1 46.7 55.8 54.8
Unemployed da da da da 54.4 54.3 51.8 47.5 55.4 57.2
Other1 da da da da 44.8 43.8 38.8 36.9 45.3 44.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.27A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 64,194 61,590 2,694b 2,223 61,500 59,367 12,226 12,167 49,274 47,199
SEX                    
Male 34,598 32,572 1,239 1,127 33,359 31,445 6,186 6,297 27,173 25,148
Female 29,595 29,018 1,454b 1,096 28,141 27,922 6,040 5,870 22,101 22,052
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 54,208 51,451 2,040b 1,607 52,167 49,844 9,528 9,422 42,639 40,422
AIAN 332 441 22 32 310 409 63 62 246 347
Asian 1,765 1,610 46 17 1,719 1,593 416 507 1,304 1,086
Black or African American 8,420 8,106 434 385 7,986 7,721 1,744 1,595 6,241 6,126
NHPI 179 180 3 * 176 171 * * 148 *
White 41,442a 37,966 1,400b 1,011 40,042a 36,955 6,716 6,510 33,327a 30,445
Two or More Races 2,069b 3,148 135 153 1,934b 2,995 561 722 1,373b 2,274
Hispanic or Latino 9,986 10,139 653 616 9,333 9,523 2,698 2,746 6,634 6,778
EDUCATION LEVEL                    
< High School da da da da 4,352 4,997 1,133 1,185 3,218 3,812
High School Graduate da da da da 17,003 16,304 4,178 4,105 12,826 12,199
Some College/Associate’s Degree da da da da 20,909 19,347 4,706 4,657 16,202a 14,690
College Graduate da da da da 19,236 18,719 2,209 2,221 17,027 16,499
EMPLOYMENT STATUS                    
Full‑Time da da da da 31,738 29,590 5,498 5,115 26,239 24,476
Part‑Time da da da da 8,448 9,066 3,044 3,372 5,404 5,694
Unemployed da da da da 4,392 4,517 1,342 1,544 3,050 2,973
Other1 da da da da 16,922 16,194 2,342 2,137 14,580 14,057

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.27B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 22.3a 21.2 10.4b 8.7 23.4a 22.4 35.0 33.7 21.7 20.6
SEX                    
Male 24.5a 23.2 9.3 8.7 26.1a 24.6 35.2 34.6 24.7a 23.0
Female 20.1 19.4 11.5b 8.8 20.9 20.3 34.7 32.8 18.9 18.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 23.2a 22.0 10.7b 8.6 24.3a 23.1 36.4 35.4 22.6a 21.4
AIAN 24.3 23.9 10.4 11.8 26.8 25.9 40.9 30.1 24.7 25.3
Asian 9.5 8.4 3.0 1.1 10.0 9.0 17.3 20.0 8.9 7.2
Black or African American 23.9 23.5 12.2 11.3 25.2 24.8 38.0 34.3 23.0 23.2
NHPI 14.4 16.9 3.5 * 15.2 17.1 * * 14.7 *
White 24.3b 22.6 11.1b 8.4 25.3a 23.7 37.9 37.4 23.8a 22.0
Two or More Races 31.9 33.3 13.0 11.4 35.5 36.9 48.9 42.3 31.9 35.4
Hispanic or Latino 18.3 17.9 9.5 9.0 19.6 19.2 30.8 28.9 17.0 16.9
EDUCATION LEVEL                    
< High School da da da da 18.1 20.5 32.0 31.9 15.7 18.4
High School Graduate da da da da 24.2 23.0 34.3 32.0 22.1 21.0
Some College/Associate’s Degree da da da da 26.9a 25.0 35.5 34.9 25.1a 23.0
College Graduate da da da da 21.4 20.3 36.9 35.9 20.3 19.1
EMPLOYMENT STATUS                    
Full‑Time da da da da 26.2 25.1 39.2 37.3 24.5 23.5
Part‑Time da da da da 26.1 26.0 34.6 35.0 22.9 22.5
Unemployed da da da da 34.1 33.0 36.6 37.8 33.1 30.9
Other1 da da da da 17.7 16.4 27.7 24.7 16.7 15.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.28A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 44,266 43,776 1,554a 1,279 42,712 42,497 8,439 8,405 34,273 34,092
SEX                    
Male 24,833 23,964 714 673 24,119 23,291 4,346 4,478 19,773 18,813
Female 19,433 19,812 841b 606 18,592 19,206 4,093 3,926 14,499 15,279
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 37,938 36,574 1,143a 913 36,795 35,661 6,675 6,496 30,120 29,165
AIAN 263 334 12 12 250 322 50 51 200 271
Asian 1,116 883 22 9 1,093 874 260 292 833 583
Black or African American 6,001 5,979 253 229 5,748 5,750 1,288 1,097 4,460 4,653
NHPI 115 139 2 * 114 139 * * 87 *
White 28,903 26,994 796a 588 28,107 26,406 4,633 4,538 23,474 21,868
Two or More Races 1,540b 2,245 57 74 1,483b 2,171 417 493 1,066b 1,678
Hispanic or Latino 6,328 7,202 411 366 5,917a 6,836 1,764 1,908 4,153 4,927
EDUCATION LEVEL                    
< High School da da da da 3,311a 3,965 839 892 2,472 3,073
High School Graduate da da da da 12,628 12,343 2,964 3,035 9,664 9,308
Some College/Associate’s Degree da da da da 15,068 14,038 3,219 3,085 11,849 10,952
College Graduate da da da da 11,705 12,152 1,418 1,393 10,287 10,760
EMPLOYMENT STATUS                    
Full‑Time da da da da 21,606 20,741 3,893 3,655 17,713 17,086
Part‑Time da da da da 5,704 6,330 1,947 2,136 3,757 4,194
Unemployed da da da da 3,198 3,336 973 1,060 2,225 2,276
Other1 da da da da 12,205 12,090 1,626 1,554 10,578 10,536

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.28B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 15.4 15.1 6.0a 5.0 16.3 16.0 24.1 23.3 15.1 14.9
SEX                    
Male 17.6 17.0 5.4 5.2 18.9 18.2 24.8 24.6 17.9 17.2
Female 13.2 13.2 6.6b 4.9 13.8 14.0 23.5 21.9 12.4 12.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 16.2 15.6 6.0a 4.9 17.1 16.6 25.5 24.4 16.0 15.4
AIAN 19.3 18.1 5.9 4.5 21.7 20.4 32.2 24.5 20.0 19.8
Asian 6.0 4.6 1.5 0.6 6.4 5.0 10.8 11.5 5.7 3.9
Black or African American 17.0 17.3 7.1 6.7 18.1 18.5 28.0a 23.6 16.5 17.6
NHPI 9.3 13.1 2.0 * 9.8 13.9 * * 8.6 *
White 16.9 16.1 6.3a 4.9 17.8 16.9 26.1 26.1 16.7 15.8
Two or More Races 23.7 23.7 5.5 5.6 27.2 26.7 36.4 28.9 24.8 26.1
Hispanic or Latino 11.6 12.7 6.0 5.4 12.4 13.8 20.1 20.1 10.7 12.3
EDUCATION LEVEL                    
< High School da da da da 13.8 16.2 23.7 24.0 12.1a 14.8
High School Graduate da da da da 18.0 17.4 24.4 23.6 16.6 16.0
Some College/Associate’s Degree da da da da 19.3 18.2 24.3 23.1 18.3 17.1
College Graduate da da da da 13.0 13.1 23.7 22.5 12.2 12.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 17.8 17.6 27.7 26.7 16.5 16.4
Part‑Time da da da da 17.6 18.1 22.1 22.2 15.9 16.6
Unemployed da da da da 24.8 24.4 26.5 25.9 24.1 23.7
Other1 da da da da 12.7 12.3 19.3 17.9 12.1 11.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.29A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 42,408 40,833 109 106 42,299 40,727 2,226 2,179 40,074 38,548
SEX                    
Male 25,032 23,289 54 55 24,978 23,235 1,186 1,078 23,792 22,157
Female 17,376 17,544 55 51 17,321 17,492 1,040 1,101 16,282 16,391
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 36,345 35,036 70 46 36,274 34,990 1,796 1,606 34,478 33,383
AIAN 194b 400 1 <1 194b 400 23 12 170b 388
Asian 775 691 * * 775 691 64 71 711 620
Black or African American 3,299 2,962 7 4 3,293 2,958 82 89 3,211 2,869
NHPI 93 100 <1 * 93 100 * * 91 92
White 30,904 29,109 61 36 30,843 29,073 1,544 1,313 29,299 27,761
Two or More Races 1,079b 1,775 2 6 1,077b 1,768 81 115 995b 1,654
Hispanic or Latino 6,063 5,797 38 60 6,025 5,737 429 572 5,596 5,165
EDUCATION LEVEL                    
< High School da da da da 3,597 3,518 206 160 3,391 3,357
High School Graduate da da da da 10,905 11,032 715 703 10,190 10,329
Some College/Associate’s Degree da da da da 14,265 13,551 762 769 13,503 12,781
College Graduate da da da da 13,531 12,627 542 547 12,989 12,080
EMPLOYMENT STATUS                    
Full‑Time da da da da 20,682 19,131 1,151 1,080 19,531 18,051
Part‑Time da da da da 5,300 5,312 406 516 4,894 4,795
Unemployed da da da da 2,101 2,321 262 240 1,839 2,082
Other1 da da da da 14,216 13,963 406 343 13,810 13,620

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.29B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 14.7 14.1 0.4 0.4 16.1 15.4 6.4 6.0 17.6 16.8
SEX                    
Male 17.8 16.6 0.4 0.4 19.6 18.2 6.8 5.9 21.6 20.2
Female 11.8 11.7 0.4 0.4 12.9 12.7 6.0 6.2 13.9 13.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15.6 15.0 0.4 0.2 16.9 16.2 6.9 6.0 18.3 17.7
AIAN 14.2 21.7 0.3 0.2 16.8 25.3 15.1 5.7 17.0a 28.3
Asian 4.2 3.6 * * 4.5 3.9 2.7 2.8 4.8 4.1
Black or African American 9.4 8.6 0.2 0.1 10.4 9.5 1.8 1.9 11.9 10.9
NHPI 7.5 9.3 0.2 * 8.0 10.0 * * 9.0 10.1
White 18.1 17.3 0.5 0.3 19.5 18.6 8.7 7.6 20.9 20.0
Two or More Races 16.6 18.8 0.2 0.5 19.8 21.8 7.1 6.7 23.2 25.7
Hispanic or Latino 11.1 10.3 0.6 0.9 12.6 11.5 4.9 6.0 14.4 12.9
EDUCATION LEVEL                    
< High School da da da da 15.0 14.4 5.8 4.3 16.5 16.2
High School Graduate da da da da 15.5 15.6 5.9 5.5 17.5 17.8
Some College/Associate’s Degree da da da da 18.3 17.5 5.7 5.8 20.9 20.0
College Graduate da da da da 15.0 13.7 9.1 8.8 15.5a 14.0
EMPLOYMENT STATUS                    
Full‑Time da da da da 17.1 16.2 8.2 7.9 18.2 17.3
Part‑Time da da da da 16.4 15.2 4.6 5.4 20.7 19.0
Unemployed da da da da 16.3 16.9 7.1 5.9 19.9 21.7
Other1 da da da da 14.8 14.2 4.8 4.0 15.8 15.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.30A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 4,257 4,937 72 57 4,185 4,881 811 950 3,374 3,930
SEX                    
Male 2,903 3,182 31 23 2,871 3,159 421 533 2,450 2,627
Female 1,354a 1,755 41 34 1,314a 1,721 390 418 924a 1,304
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,451 3,684 47 33 3,403 3,650 645 681 2,758 2,969
AIAN 15 24 * <1 15 24 6 2 9 22
Asian 161 160 * * 161 160 26 23 135 137
Black or African American 466 556 4 4 462 552 37 61 425 490
NHPI 3 * <1 * 3 * * * 2 *
White 2,638 2,702 43 29 2,595 2,673 556 541 2,040 2,132
Two or More Races 168 222 1 * 167 222 19 54 148 168
Hispanic or Latino 806a 1,254 24 23 782a 1,230 166 269 616a 961
EDUCATION LEVEL                    
< High School da da da da 385 548 66 64 318 484
High School Graduate da da da da 1,348 1,189 264 258 1,084 931
Some College/Associate’s Degree da da da da 1,252a 1,618 284 351 968 1,267
College Graduate da da da da 1,200 1,526 196 277 1,004 1,248
EMPLOYMENT STATUS                    
Full‑Time da da da da 2,230 2,336 427 459 1,803 1,877
Part‑Time da da da da 512 807 119a 233 393 574
Unemployed da da da da 438 524 98 104 340 420
Other1 da da da da 1,005 1,214 166 155 838 1,059

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.30B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.5 1.7 0.3 0.2 1.6 1.8 2.3 2.6 1.5 1.7
SEX                    
Male 2.1 2.3 0.2 0.2 2.2 2.5 2.4 2.9 2.2 2.4
Female 0.9a 1.2 0.3 0.3 1.0a 1.3 2.2 2.3 0.8a 1.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.5 1.6 0.2 0.2 1.6 1.7 2.5 2.6 1.5 1.6
AIAN 1.1 1.3 * 0.2 1.3 1.5 3.8 0.9 0.9 1.6
Asian 0.9 0.8 * * 0.9 0.9 1.1 0.9 0.9 0.9
Black or African American 1.3 1.6 0.1 0.1 1.5 1.8 0.8 1.3 1.6 1.9
NHPI 0.3 * 0.2 * 0.3 * * * 0.2 *
White 1.5 1.6 0.3 0.2 1.6 1.7 3.1 3.1 1.5 1.5
Two or More Races 2.6 2.3 0.1 * 3.1 2.7 1.6 3.2 3.4 2.6
Hispanic or Latino 1.5a 2.2 0.4 0.3 1.6a 2.5 1.9 2.8 1.6a 2.4
EDUCATION LEVEL                    
< High School da da da da 1.6 2.2 1.9 1.7 1.6 2.3
High School Graduate da da da da 1.9 1.7 2.2 2.0 1.9 1.6
Some College/Associate’s Degree da da da da 1.6a 2.1 2.1 2.6 1.5 2.0
College Graduate da da da da 1.3 1.7 3.3 4.5 1.2 1.4
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.8 2.0 3.0 3.4 1.7 1.8
Part‑Time da da da da 1.6 2.3 1.4a 2.4 1.7 2.3
Unemployed da da da da 3.4 3.8 2.7 2.5 3.7 4.4
Other1 da da da da 1.0 1.2 2.0 1.8 1.0 1.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.31A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,671 1,993 13 7 1,658 1,985 221a 353 1,437 1,633
SEX                    
Male 1,166 1,287 10a <1 1,157 1,287 130 220 1,027 1,067
Female 504 705 3 7 501 698 91 133 410 566
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,362 1,456 6 6 1,356 1,450 156 257 1,200 1,193
AIAN 1a 15 * * 1a 15 * 1 1a 14
Asian 102 70 * * 102 70 3 10 99 60
Black or African American 235 277 * <1 235 277 12 26 223 251
NHPI 2 1 <1 * 2 1 <1 * 2 <1
White 916 1,018 5 6 910 1,012 131 207 779 805
Two or More Races 107 76 1 * 106 76 10 13 96 63
Hispanic or Latino 308 536 6 1 302 535 65 96 237 440
EDUCATION LEVEL                    
< High School da da da da 212 384 31 21 181 363
High School Graduate da da da da 596 399 76 101 520 298
Some College/Associate’s Degree da da da da 489 659 66a 142 424 517
College Graduate da da da da 361 543 49 89 312 454
EMPLOYMENT STATUS                    
Full‑Time da da da da 715 820 115 162 600 658
Part‑Time da da da da 238 393 26a 103 212 290
Unemployed da da da da 165 208 19 28 146 180
Other1 da da da da 540 565 62 60 478 505

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.31B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.6 0.7 <0.1 <0.1 0.6 0.7 0.6 1.0 0.6 0.7
SEX                    
Male 0.8 0.9 0.1a <0.1 0.9 1.0 0.7 1.2 0.9 1.0
Female 0.3 0.5 <0.1 0.1 0.4 0.5 0.5 0.7 0.3 0.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6 0.6 <0.1 <0.1 0.6 0.7 0.6 1.0 0.6 0.6
AIAN 0.1a 0.8 * * 0.1a 0.9 * 0.3 0.1a 1.0
Asian 0.5 0.4 * * 0.6 0.4 0.1 0.4 0.7 0.4
Black or African American 0.7 0.8 * <0.1 0.7 0.9 0.3 0.6 0.8 1.0
NHPI 0.1 0.1 0.2 * 0.1 0.1 <0.1 * 0.2 <0.1
White 0.5 0.6 <0.1 <0.1 0.6 0.6 0.7 1.2 0.6 0.6
Two or More Races 1.6 0.8 0.1 * 1.9 0.9 0.9 0.7 2.2 1.0
Hispanic or Latino 0.6 0.9 0.1 <0.1 0.6 1.1 0.7 1.0 0.6 1.1
EDUCATION LEVEL                    
< High School da da da da 0.9 1.6 0.9 0.6 0.9 1.8
High School Graduate da da da da 0.8 0.6 0.6 0.8 0.9 0.5
Some College/Associate’s Degree da da da da 0.6 0.9 0.5a 1.1 0.7 0.8
College Graduate da da da da 0.4 0.6 0.8 1.4 0.4 0.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.6 0.7 0.8 1.2 0.6 0.6
Part‑Time da da da da 0.7 1.1 0.3a 1.1 0.9 1.1
Unemployed da da da da 1.3 1.5 0.5 0.7 1.6 1.9
Other1 da da da da 0.6 0.6 0.7 0.7 0.5 0.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.32A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 10,634 10,086 25 17 10,609 10,070 153 182 10,455 9,888
SEX                    
Male 6,980 6,063 7 6 6,973 6,057 78 94 6,895 5,963
Female 3,653 4,023 18 10 3,635 4,013 75 88 3,560 3,925
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 9,498 9,011 17 2 9,481 9,010 125 162 9,356 8,848
AIAN 83 150 * <1 83 149 3 3 80 147
Asian 89 110 * * 89 110 7 1 82 110
Black or African American 1,533a 1,005 * * 1,533a 1,005 6 8 1,527a 997
NHPI 40 * * * 40 * * * 40 *
White 7,446 7,132 17 1 7,429 7,130 104 134 7,325 6,996
Two or More Races 306a 598 * * 306a 598 4 15 302a 582
Hispanic or Latino 1,136 1,075 8 15 1,128 1,060 29 20 1,099 1,040
EDUCATION LEVEL                    
< High School da da da da 1,575 1,579 33 25 1,542 1,553
High School Graduate da da da da 3,641 3,541 90 107 3,550 3,434
Some College/Associate’s Degree da da da da 3,812 3,714 30 47 3,782 3,667
College Graduate da da da da 1,582 1,236 1 3 1,581 1,233
EMPLOYMENT STATUS                    
Full‑Time da da da da 4,401 3,890 57 87 4,345 3,802
Part‑Time da da da da 1,241 1,291 14 43 1,228 1,248
Unemployed da da da da 654 696 26 19 628 677
Other1 da da da da 4,312 4,193 57 33 4,255 4,160

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.32B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3.7 3.5 0.1 0.1 4.0 3.8 0.4 0.5 4.6 4.3
SEX                    
Male 5.0 4.3 0.1 <0.1 5.5 4.7 0.4 0.5 6.3 5.4
Female 2.5 2.7 0.1 0.1 2.7 2.9 0.4 0.5 3.0 3.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4.1 3.9 0.1 <0.1 4.4 4.2 0.5 0.6 5.0 4.7
AIAN 6.1 8.1 * 0.2 7.2 9.5 1.9 1.2 8.0 10.7
Asian 0.5 0.6 * * 0.5 0.6 0.3 <0.1 0.6 0.7
Black or African American 4.3a 2.9 * * 4.8a 3.2 0.1 0.2 5.6a 3.8
NHPI 3.2 * * * 3.5 * * * 4.0 *
White 4.4 4.2 0.1 <0.1 4.7 4.6 0.6 0.8 5.2 5.1
Two or More Races 4.7 6.3 * * 5.6 7.4 0.4 0.9 7.0 9.1
Hispanic or Latino 2.1 1.9 0.1 0.2 2.4 2.1 0.3 0.2 2.8 2.6
EDUCATION LEVEL                    
< High School da da da da 6.6 6.5 0.9 0.7 7.5 7.5
High School Graduate da da da da 5.2 5.0 0.7 0.8 6.1 5.9
Some College/Associate’s Degree da da da da 4.9 4.8 0.2 0.4 5.9 5.7
College Graduate da da da da 1.8 1.3 <0.1 <0.1 1.9 1.4
EMPLOYMENT STATUS                    
Full‑Time da da da da 3.6 3.3 0.4 0.6 4.1 3.6
Part‑Time da da da da 3.8 3.7 0.2 0.4 5.2 4.9
Unemployed da da da da 5.1 5.1 0.7 0.5 6.8 7.1
Other1 da da da da 4.5 4.3 0.7 0.4 4.9 4.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.33A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 749 986 8 9 741 977 46 23 695 954
SEX                    
Male 518 609 * * 518 609 26 16 492 593
Female 231 377 8 9 223 368 21 7 203 360
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 637 780 <1 <1 637 779 24 21 612 758
AIAN 1 11 * <1 1 11 <1 <1 1 10
Asian 16 51 * * 16 51 * * 16 51
Black or African American 149 174 * * 149 174 3 * 146 174
NHPI 2 * * * 2 * * * 2 *
White 458 469 <1 * 457 469 21 15 436 454
Two or More Races 12 75 * * 12 75 * 5 12 69
Hispanic or Latino 112 206 8 9 105 197 22 2 83 195
EDUCATION LEVEL                    
< High School da da da da 139 216 17 7 122 208
High School Graduate da da da da 392 309 23 10 369 299
Some College/Associate’s Degree da da da da 162a 340 7 5 155a 335
College Graduate da da da da 48 111 * <1 48 111
EMPLOYMENT STATUS                    
Full‑Time da da da da 92a 194 2 13 90a 181
Part‑Time da da da da 93 112 6 2 86 110
Unemployed da da da da 93 172 9 2 84 169
Other1 da da da da 463 499 29 6 434 493

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.33B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3 0.3 <0.1 <0.1 0.3 0.4 0.1 0.1 0.3 0.4
SEX                    
Male 0.4 0.4 * * 0.4 0.5 0.1 0.1 0.4 0.5
Female 0.2 0.3 0.1 0.1 0.2 0.3 0.1 <0.1 0.2 0.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3 0.3 <0.1 <0.1 0.3 0.4 0.1 0.1 0.3 0.4
AIAN 0.1 0.6 * 0.2 0.1 0.7 0.1 0.2 0.1 0.7
Asian 0.1 0.3 * * 0.1 0.3 * * 0.1 0.3
Black or African American 0.4 0.5 * * 0.5 0.6 0.1 * 0.5 0.7
NHPI 0.1 * * * 0.1 * * * 0.2 *
White 0.3 0.3 <0.1 * 0.3 0.3 0.1 0.1 0.3 0.3
Two or More Races 0.2 0.8 * * 0.2 0.9 * 0.3 0.3 1.1
Hispanic or Latino 0.2 0.4 0.1 0.1 0.2 0.4 0.3 <0.1 0.2 0.5
EDUCATION LEVEL                    
< High School da da da da 0.6 0.9 0.5 0.2 0.6 1.0
High School Graduate da da da da 0.6 0.4 0.2 0.1 0.6 0.5
Some College/Associate’s Degree da da da da 0.2a 0.4 0.1 <0.1 0.2a 0.5
College Graduate da da da da 0.1 0.1 * <0.1 0.1 0.1
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.1a 0.2 <0.1 0.1 0.1a 0.2
Part‑Time da da da da 0.3 0.3 0.1 <0.1 0.4 0.4
Unemployed da da da da 0.7 1.3 0.2 0.1 0.9 1.8
Other1 da da da da 0.5 0.5 0.3 0.1 0.5 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.34A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 392 457 <1 * 392 457 13 8 378 449
SEX                    
Male 288 248 * * 288 248 12 2 276 245
Female 103 209 <1 * 103 209 1 6 102 204
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 362 343 * * 362 343 6 6 356 336
AIAN * 9 * * * 9 * * * 9
Asian 16 27 * * 16 27 * * 16 27
Black or African American 106 107 * * 106 107 * * 106 107
NHPI 2 * * * 2 * * * 2 *
White 230 194 * * 230 194 6 6 225 188
Two or More Races 8 5 * * 8 5 * 1 8 4
Hispanic or Latino 30 114 <1 * 30 114 8 2 22 112
EDUCATION LEVEL                    
< High School da da da da 84 156 2 7 82 149
High School Graduate da da da da 205 71 8 1 197 69
Some College/Associate’s Degree da da da da 82 174 3 * 79 174
College Graduate da da da da 21 57 * * 21 57
EMPLOYMENT STATUS                    
Full‑Time da da da da 33a 93 * 2 33 91
Part‑Time da da da da 63 55 4 2 59 53
Unemployed da da da da 48 60 3 1 45 59
Other1 da da da da 247 250 6 4 241 246

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.34B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1 0.2 <0.1 * 0.1 0.2 <0.1 <0.1 0.2 0.2
SEX                    
Male 0.2 0.2 * * 0.2 0.2 0.1 <0.1 0.3 0.2
Female 0.1 0.1 <0.1 * 0.1 0.2 <0.1 <0.1 0.1 0.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2 0.1 * * 0.2 0.2 <0.1 <0.1 0.2 0.2
AIAN * 0.5 * * * 0.6 * * * 0.7
Asian 0.1 0.1 * * 0.1 0.2 * * 0.1 0.2
Black or African American 0.3 0.3 * * 0.3 0.3 * * 0.4 0.4
NHPI 0.1 * * * 0.1 * * * 0.2 *
White 0.1 0.1 * * 0.1 0.1 <0.1 <0.1 0.2 0.1
Two or More Races 0.1 <0.1 * * 0.2 0.1 * <0.1 0.2 0.1
Hispanic or Latino 0.1 0.2 <0.1 * 0.1 0.2 0.1 <0.1 0.1 0.3
EDUCATION LEVEL                    
< High School da da da da 0.4 0.6 0.1 0.2 0.4 0.7
High School Graduate da da da da 0.3 0.1 0.1 <0.1 0.3 0.1
Some College/Associate’s Degree da da da da 0.1 0.2 <0.1 * 0.1 0.3
College Graduate da da da da <0.1 0.1 * * <0.1 0.1
EMPLOYMENT STATUS                    
Full‑Time da da da da <0.1a 0.1 * <0.1 <0.1a 0.1
Part‑Time da da da da 0.2 0.2 <0.1 <0.1 0.3 0.2
Unemployed da da da da 0.4 0.4 0.1 <0.1 0.5 0.6
Other1 da da da da 0.3 0.3 0.1 <0.1 0.3 0.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.35A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 51,559 50,765 591 570 50,968 50,194 5,661 5,245 45,307 44,949
SEX                    
Male 30,297 28,684 286 365 30,011 28,319 3,169 2,848 26,842 25,472
Female 21,262 22,080 305 205 20,957 21,875 2,492 2,397 18,465 19,478
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 44,591 43,855 427 395 44,164 43,460 4,499a 3,925 39,665 39,535
AIAN 280 456 4 8 275 448 42 27 234 421
Asian 1,104 1,442 7 14 1,098 1,428 207 155 891 1,273
Black or African American 3,467 3,582 34 47 3,433 3,534 487 376 2,946 3,159
NHPI 196 205 1 * 195 205 * * 184 *
White 37,940 35,655 362 258 37,578 35,397 3,449 3,075 34,129 32,322
Two or More Races 1,603b 2,516 19b 69 1,584b 2,447 302 288 1,283b 2,160
Hispanic or Latino 6,968 6,910 164 176 6,804 6,734 1,163 1,320 5,642 5,414
EDUCATION LEVEL                    
< High School da da da da 3,155 3,085 542 454 2,612 2,631
High School Graduate da da da da 11,820 12,532 1,749 1,789 10,072 10,743
Some College/Associate’s Degree da da da da 17,430 16,692 2,186 1,886 15,245 14,807
College Graduate da da da da 18,563 17,886 1,185 1,117 17,378 16,769
EMPLOYMENT STATUS                    
Full‑Time da da da da 26,867 25,308 2,683 2,567 24,184 22,741
Part‑Time da da da da 6,353 7,097 1,230 1,315 5,122 5,783
Unemployed da da da da 3,121 3,088 698 551 2,423 2,538
Other1 da da da da 14,627 14,701 1,050a 813 13,577 13,888

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.35B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 17.9 17.5 2.3 2.2 19.4 18.9 16.2a 14.5 19.9 19.6
SEX                    
Male 21.5 20.4 2.2 2.8 23.5 22.2 18.0a 15.7 24.4 23.3
Female 14.4 14.7 2.4 1.6 15.6 15.9 14.3 13.4 15.8 16.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 19.1 18.7 2.2 2.1 20.6 20.2 17.2b 14.8 21.1 20.9
AIAN 20.5 24.7 2.1 2.9 23.8 28.4 26.8a 13.0 23.4 30.8
Asian 5.9 7.5 0.4 0.9 6.4 8.1 8.6 6.1 6.0 8.4
Black or African American 9.8 10.4 1.0 1.4 10.8 11.4 10.6 8.1 10.9 11.9
NHPI 15.8 19.3 1.2 * 16.9 20.6 * * 18.2 *
White 22.2 21.2 2.9 2.1 23.8 22.7 19.5 17.7 24.3 23.3
Two or More Races 24.7 26.6 1.8a 5.1 29.1 30.1 26.3b 16.9 29.8 33.6
Hispanic or Latino 12.8 12.2 2.4 2.6 14.3 13.6 13.3 13.9 14.5 13.5
EDUCATION LEVEL                    
< High School da da da da 13.1 12.6 15.3 12.2 12.7 12.7
High School Graduate da da da da 16.8 17.7 14.4 13.9 17.3 18.5
Some College/Associate’s Degree da da da da 22.4 21.6 16.5a 14.1 23.6 23.1
College Graduate da da da da 20.6 19.3 19.8 18.0 20.7 19.4
EMPLOYMENT STATUS                    
Full‑Time da da da da 22.2 21.5 19.1 18.7 22.6 21.8
Part‑Time da da da da 19.6 20.3 14.0 13.6 21.7 22.9
Unemployed da da da da 24.2 22.6 19.0b 13.5 26.3 26.4
Other1 da da da da 15.3 14.9 12.4b 9.4 15.5 15.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.36A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 10,423a 9,139 405 360 10,018a 8,779 2,364 2,165 7,653a 6,614
SEX                    
Male 6,516b 5,415 207 243 6,309b 5,172 1,381 1,243 4,928a 3,930
Female 3,907 3,724 198a 117 3,709 3,607 984 923 2,725 2,684
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 8,793b 7,313 288 248 8,506b 7,065 1,887 1,601 6,618a 5,464
AIAN 49 100 3 * 46 97 * 11 * 86
Asian 383 343 * 6 383 337 80 80 302 257
Black or African American 809 636 27 33 782 603 207 139 575 464
NHPI 22 * 1 * 21 * 4 * 17 *
White 7,043b 5,690 249 171 6,794b 5,519 1,449 1,244 5,345b 4,275
Two or More Races 488 505 7a 36 481 469 141 125 340 344
Hispanic or Latino 1,630 1,826 118 112 1,512 1,715 477 565 1,035 1,150
EDUCATION LEVEL                    
< High School da da da da 524 550 201 168 323 381
High School Graduate da da da da 2,036 1,787 708 697 1,327 1,090
Some College/Associate’s Degree da da da da 3,355 2,783 959 841 2,397 1,941
College Graduate da da da da 4,103 3,660 497 458 3,606 3,202
EMPLOYMENT STATUS                    
Full‑Time da da da da 5,812b 4,709 1,065 878 4,747a 3,831
Part‑Time da da da da 1,534 1,584 560 675 975 909
Unemployed da da da da 930 788 300 261 630 528
Other1 da da da da 1,742 1,698 440 352 1,302 1,346

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.36B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3.6a 3.1 1.6 1.4 3.8a 3.3 6.8 6.0 3.4a 2.9
SEX                    
Male 4.6b 3.8 1.6 1.9 4.9b 4.1 7.9 6.8 4.5a 3.6
Female 2.7 2.5 1.6a 0.9 2.8 2.6 5.7 5.2 2.3 2.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.8b 3.1 1.5 1.3 4.0b 3.3 7.2a 6.0 3.5b 2.9
AIAN 3.6 5.4 1.4 * 4.0 6.2 * 5.4 * 6.3
Asian 2.1 1.8 * 0.4 2.2 1.9 3.3 3.2 2.1 1.7
Black or African American 2.3 1.8 0.8 1.0 2.5 1.9 4.5 3.0 2.1 1.8
NHPI 1.8 * 1.2 * 1.8 * 2.5 * 1.7 *
White 4.1b 3.4 2.0 1.4 4.3b 3.5 8.2 7.2 3.8b 3.1
Two or More Races 7.5 5.3 0.7a 2.7 8.8 5.8 12.3 7.3 7.9 5.4
Hispanic or Latino 3.0 3.2 1.7 1.6 3.2 3.5 5.4 5.9 2.7 2.9
EDUCATION LEVEL                    
< High School da da da da 2.2 2.3 5.7 4.5 1.6 1.8
High School Graduate da da da da 2.9 2.5 5.8 5.4 2.3 1.9
Some College/Associate’s Degree da da da da 4.3 3.6 7.2 6.3 3.7 3.0
College Graduate da da da da 4.6 4.0 8.3 7.4 4.3 3.7
EMPLOYMENT STATUS                    
Full‑Time da da da da 4.8a 4.0 7.6 6.4 4.4a 3.7
Part‑Time da da da da 4.7 4.5 6.4 7.0 4.1 3.6
Unemployed da da da da 7.2 5.8 8.2 6.4 6.8 5.5
Other1 da da da da 1.8 1.7 5.2 4.1 1.5 1.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.37A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,783 2,722 123 101 2,660 2,621 489 634 2,171 1,987
SEX                    
Male 1,779 1,632 60 71 1,719 1,560 288 399 1,430 1,161
Female 1,004 1,091 62 30 942 1,061 201 235 741 826
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2,390 2,184 89 70 2,301 2,113 385 430 1,916 1,684
AIAN 9 29 <1 * 9 27 * 1 4 25
Asian 106 87 * * 106 87 5 19 100 68
Black or African American 306a 183 <1 11 305a 172 75 43 230 129
NHPI 8 2 * * 8 2 1 * * 2
White 1,816 1,769 83 56 1,733 1,713 280 327 1,453 1,387
Two or More Races 146 112 5 <1 140 112 18 39 122 73
Hispanic or Latino 393 539 34 31 359 508 104 204 255 303
EDUCATION LEVEL                    
< High School da da da da 156 237 47 74 108 163
High School Graduate da da da da 590 526 164 209 425 317
Some College/Associate’s Degree da da da da 691 757 160 229 532 528
College Graduate da da da da 1,224 1,102 118 123 1,106 979
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,637 1,433 224 232 1,413 1,201
Part‑Time da da da da 374 483 110 177 264 307
Unemployed da da da da 166 142 60 83 106 59
Other1 da da da da 482 563 95 143 388 421

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.37B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.0 0.9 0.5 0.4 1.0 1.0 1.4 1.8 1.0 0.9
SEX                    
Male 1.3 1.2 0.5 0.5 1.3 1.2 1.6 2.2 1.3 1.1
Female 0.7 0.7 0.5 0.2 0.7 0.8 1.2 1.3 0.6 0.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.0 0.9 0.5 0.4 1.1 1.0 1.5 1.6 1.0 0.9
AIAN 0.7 1.6 0.2 * 0.8 1.7 * 0.7 0.4 1.8
Asian 0.6 0.5 * * 0.6 0.5 0.2 0.8 0.7 0.4
Black or African American 0.9a 0.5 <0.1 0.3 1.0a 0.6 1.6 0.9 0.9 0.5
NHPI 0.7 0.2 * * 0.7 0.2 0.9 * * 0.2
White 1.1 1.1 0.7 0.5 1.1 1.1 1.6 1.9 1.0 1.0
Two or More Races 2.2 1.2 0.5 <0.1 2.6 1.4 1.6 2.3 2.8 1.1
Hispanic or Latino 0.7 1.0 0.5 0.5 0.8 1.0 1.2 2.1 0.7 0.8
EDUCATION LEVEL                    
< High School da da da da 0.6 1.0 1.3 2.0 0.5 0.8
High School Graduate da da da da 0.8 0.7 1.4 1.6 0.7 0.5
Some College/Associate’s Degree da da da da 0.9 1.0 1.2 1.7 0.8 0.8
College Graduate da da da da 1.4 1.2 2.0 2.0 1.3 1.1
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.4 1.2 1.6 1.7 1.3 1.2
Part‑Time da da da da 1.2 1.4 1.3 1.8 1.1 1.2
Unemployed da da da da 1.3 1.0 1.6 2.0 1.2 0.6
Other1 da da da da 0.5 0.6 1.1 1.6 0.4 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.38A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 21,884 ‑‑ 1,008 ‑‑ 20,876 ‑‑ 2,243 ‑‑ 18,634
SEX                    
Male ‑‑ 13,406 ‑‑ 455 ‑‑ 12,951 ‑‑ 1,121 ‑‑ 11,830
Female ‑‑ 8,478 ‑‑ 553 ‑‑ 7,925 ‑‑ 1,121 ‑‑ 6,804
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 18,833 ‑‑ 749 ‑‑ 18,085 ‑‑ 1,727 ‑‑ 16,358
AIAN ‑‑ 154 ‑‑ 9 ‑‑ 145 ‑‑ 14 ‑‑ 131
Asian ‑‑ 624 ‑‑ 46 ‑‑ 579 ‑‑ 177 ‑‑ 402
Black or African American ‑‑ 957 ‑‑ 182 ‑‑ 775 ‑‑ 153 ‑‑ 622
NHPI ‑‑ 16 ‑‑ * ‑‑ 15 ‑‑ * ‑‑ 12
White ‑‑ 15,879 ‑‑ 460 ‑‑ 15,419 ‑‑ 1,255 ‑‑ 14,164
Two or More Races ‑‑ 1,203 ‑‑ 52 ‑‑ 1,151 ‑‑ 124 ‑‑ 1,028
Hispanic or Latino ‑‑ 3,051 ‑‑ 260 ‑‑ 2,791 ‑‑ 516 ‑‑ 2,275
EDUCATION LEVEL                    
< High School da da da da ‑‑ 1,393 ‑‑ 164 ‑‑ 1,229
High School Graduate da da da da ‑‑ 4,772 ‑‑ 627 ‑‑ 4,146
Some College/Associate’s Degree da da da da ‑‑ 7,351 ‑‑ 899 ‑‑ 6,453
College Graduate da da da da ‑‑ 7,360 ‑‑ 553 ‑‑ 6,806
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 10,071 ‑‑ 942 ‑‑ 9,129
Part‑Time da da da da ‑‑ 3,214 ‑‑ 637 ‑‑ 2,577
Unemployed da da da da ‑‑ 1,236 ‑‑ 190 ‑‑ 1,046
Other1 da da da da ‑‑ 6,355 ‑‑ 473 ‑‑ 5,882

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.38B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 7.5 ‑‑ 4.0 ‑‑ 7.9 ‑‑ 6.2 ‑‑ 8.1
SEX                    
Male ‑‑ 9.5 ‑‑ 3.5 ‑‑ 10.1 ‑‑ 6.2 ‑‑ 10.8
Female ‑‑ 5.7 ‑‑ 4.4 ‑‑ 5.8 ‑‑ 6.3 ‑‑ 5.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 8.0 ‑‑ 4.0 ‑‑ 8.4 ‑‑ 6.5 ‑‑ 8.7
AIAN ‑‑ 8.4 ‑‑ 3.3 ‑‑ 9.2 ‑‑ 6.7 ‑‑ 9.6
Asian ‑‑ 3.3 ‑‑ 3.0 ‑‑ 3.3 ‑‑ 7.0 ‑‑ 2.7
Black or African American ‑‑ 2.8 ‑‑ 5.3 ‑‑ 2.5 ‑‑ 3.3 ‑‑ 2.4
NHPI ‑‑ 1.5 ‑‑ * ‑‑ 1.5 ‑‑ * ‑‑ 1.3
White ‑‑ 9.5 ‑‑ 3.8 ‑‑ 9.9 ‑‑ 7.2 ‑‑ 10.2
Two or More Races ‑‑ 12.7 ‑‑ 3.9 ‑‑ 14.2 ‑‑ 7.3 ‑‑ 16.0
Hispanic or Latino ‑‑ 5.4 ‑‑ 3.8 ‑‑ 5.6 ‑‑ 5.4 ‑‑ 5.7
EDUCATION LEVEL                    
< High School da da da da ‑‑ 5.7 ‑‑ 4.4 ‑‑ 5.9
High School Graduate da da da da ‑‑ 6.7 ‑‑ 4.9 ‑‑ 7.1
Some College/Associate’s Degree da da da da ‑‑ 9.5 ‑‑ 6.7 ‑‑ 10.1
College Graduate da da da da ‑‑ 8.0 ‑‑ 8.9 ‑‑ 7.9
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 8.5 ‑‑ 6.9 ‑‑ 8.8
Part‑Time da da da da ‑‑ 9.2 ‑‑ 6.6 ‑‑ 10.2
Unemployed da da da da ‑‑ 9.0 ‑‑ 4.7 ‑‑ 10.9
Other1 da da da da ‑‑ 6.4 ‑‑ 5.5 ‑‑ 6.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.39A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 2,385 ‑‑ 360 ‑‑ 2,026 ‑‑ 636 ‑‑ 1,390
SEX                    
Male ‑‑ 1,541 ‑‑ 168 ‑‑ 1,373 ‑‑ 302 ‑‑ 1,071
Female ‑‑ 844 ‑‑ 192 ‑‑ 652 ‑‑ 334 ‑‑ 319
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 1,685 ‑‑ 257 ‑‑ 1,428 ‑‑ 452 ‑‑ 976
AIAN ‑‑ 5 ‑‑ 2 ‑‑ 3 ‑‑ 2 ‑‑ 2
Asian ‑‑ 110 ‑‑ 25 ‑‑ 86 ‑‑ 50 ‑‑ 36
Black or African American ‑‑ 219 ‑‑ 53 ‑‑ 166 ‑‑ 50 ‑‑ 116
NHPI ‑‑ 2 ‑‑ * ‑‑ 2 ‑‑ * ‑‑ 2
White ‑‑ 1,176 ‑‑ 151 ‑‑ 1,025 ‑‑ 309 ‑‑ 716
Two or More Races ‑‑ 172 ‑‑ 25 ‑‑ 146 ‑‑ 41 ‑‑ 105
Hispanic or Latino ‑‑ 700 ‑‑ 103 ‑‑ 598 ‑‑ 184 ‑‑ 414
EDUCATION LEVEL                    
< High School da da da da ‑‑ 148 ‑‑ 27 ‑‑ 120
High School Graduate da da da da ‑‑ 320 ‑‑ 143 ‑‑ 177
Some College/Associate’s Degree da da da da ‑‑ 751 ‑‑ 318 ‑‑ 433
College Graduate da da da da ‑‑ 806 ‑‑ 147 ‑‑ 659
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 978 ‑‑ 213 ‑‑ 765
Part‑Time da da da da ‑‑ 499 ‑‑ 219 ‑‑ 280
Unemployed da da da da ‑‑ 205 ‑‑ 69 ‑‑ 136
Other1 da da da da ‑‑ 343 ‑‑ 134 ‑‑ 209

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.39B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.8 ‑‑ 1.4 ‑‑ 0.8 ‑‑ 1.8 ‑‑ 0.6
SEX                    
Male ‑‑ 1.1 ‑‑ 1.3 ‑‑ 1.1 ‑‑ 1.7 ‑‑ 1.0
Female ‑‑ 0.6 ‑‑ 1.5 ‑‑ 0.5 ‑‑ 1.9 ‑‑ 0.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 0.7 ‑‑ 1.4 ‑‑ 0.7 ‑‑ 1.7 ‑‑ 0.5
AIAN ‑‑ 0.3 ‑‑ 0.7 ‑‑ 0.2 ‑‑ 0.9 ‑‑ 0.1
Asian ‑‑ 0.6 ‑‑ 1.6 ‑‑ 0.5 ‑‑ 2.0 ‑‑ 0.2
Black or African American ‑‑ 0.6 ‑‑ 1.6 ‑‑ 0.5 ‑‑ 1.1 ‑‑ 0.4
NHPI ‑‑ 0.2 ‑‑ * ‑‑ 0.2 ‑‑ * ‑‑ 0.2
White ‑‑ 0.7 ‑‑ 1.3 ‑‑ 0.7 ‑‑ 1.8 ‑‑ 0.5
Two or More Races ‑‑ 1.8 ‑‑ 1.9 ‑‑ 1.8 ‑‑ 2.4 ‑‑ 1.6
Hispanic or Latino ‑‑ 1.2 ‑‑ 1.5 ‑‑ 1.2 ‑‑ 1.9 ‑‑ 1.0
EDUCATION LEVEL                    
< High School da da da da ‑‑ 0.6 ‑‑ 0.7 ‑‑ 0.6
High School Graduate da da da da ‑‑ 0.5 ‑‑ 1.1 ‑‑ 0.3
Some College/Associate’s Degree da da da da ‑‑ 1.0 ‑‑ 2.4 ‑‑ 0.7
College Graduate da da da da ‑‑ 0.9 ‑‑ 2.4 ‑‑ 0.8
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 0.8 ‑‑ 1.6 ‑‑ 0.7
Part‑Time da da da da ‑‑ 1.4 ‑‑ 2.3 ‑‑ 1.1
Unemployed da da da da ‑‑ 1.5 ‑‑ 1.7 ‑‑ 1.4
Other1 da da da da ‑‑ 0.3 ‑‑ 1.6 ‑‑ 0.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.40A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 992 ‑‑ 113 ‑‑ 879 ‑‑ 179 ‑‑ 700
SEX                    
Male ‑‑ 754 ‑‑ 62 ‑‑ 693 ‑‑ 109 ‑‑ 584
Female ‑‑ 238 ‑‑ 51 ‑‑ 186 ‑‑ 70 ‑‑ 116
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 695 ‑‑ 64 ‑‑ 631 ‑‑ 144 ‑‑ 487
AIAN ‑‑ 3 ‑‑ <1 ‑‑ 3 ‑‑ 2 ‑‑ 1
Asian ‑‑ 52 ‑‑ 9 ‑‑ 43 ‑‑ 19 ‑‑ 25
Black or African American ‑‑ 61 ‑‑ 22 ‑‑ 39 ‑‑ 20 ‑‑ 19
NHPI ‑‑ <1 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 471 ‑‑ 31 ‑‑ 440 ‑‑ 82 ‑‑ 358
Two or More Races ‑‑ 107 ‑‑ 1 ‑‑ 106 ‑‑ 22 ‑‑ 84
Hispanic or Latino ‑‑ 297 ‑‑ 49 ‑‑ 248 ‑‑ 35 ‑‑ 213
EDUCATION LEVEL                    
< High School da da da da ‑‑ 105 ‑‑ 13 ‑‑ 92
High School Graduate da da da da ‑‑ 115 ‑‑ 32 ‑‑ 84
Some College/Associate’s Degree da da da da ‑‑ 338 ‑‑ 91 ‑‑ 247
College Graduate da da da da ‑‑ 321 ‑‑ 44 ‑‑ 277
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 409 ‑‑ 57 ‑‑ 352
Part‑Time da da da da ‑‑ 260 ‑‑ 58 ‑‑ 202
Unemployed da da da da ‑‑ 46 ‑‑ 8 ‑‑ 38
Other1 da da da da ‑‑ 163 ‑‑ 56 ‑‑ 108

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.40B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.3 ‑‑ 0.4 ‑‑ 0.3 ‑‑ 0.5 ‑‑ 0.3
SEX                    
Male ‑‑ 0.5 ‑‑ 0.5 ‑‑ 0.5 ‑‑ 0.6 ‑‑ 0.5
Female ‑‑ 0.2 ‑‑ 0.4 ‑‑ 0.1 ‑‑ 0.4 ‑‑ 0.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.5 ‑‑ 0.3
AIAN ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.7 ‑‑ 0.1
Asian ‑‑ 0.3 ‑‑ 0.6 ‑‑ 0.2 ‑‑ 0.7 ‑‑ 0.2
Black or African American ‑‑ 0.2 ‑‑ 0.6 ‑‑ 0.1 ‑‑ 0.4 ‑‑ 0.1
NHPI ‑‑ <0.1 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.5 ‑‑ 0.3
Two or More Races ‑‑ 1.1 ‑‑ 0.1 ‑‑ 1.3 ‑‑ 1.3 ‑‑ 1.3
Hispanic or Latino ‑‑ 0.5 ‑‑ 0.7 ‑‑ 0.5 ‑‑ 0.4 ‑‑ 0.5
EDUCATION LEVEL                    
< High School da da da da ‑‑ 0.4 ‑‑ 0.3 ‑‑ 0.4
High School Graduate da da da da ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.1
Some College/Associate’s Degree da da da da ‑‑ 0.4 ‑‑ 0.7 ‑‑ 0.4
College Graduate da da da da ‑‑ 0.3 ‑‑ 0.7 ‑‑ 0.3
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 0.3 ‑‑ 0.4 ‑‑ 0.3
Part‑Time da da da da ‑‑ 0.7 ‑‑ 0.6 ‑‑ 0.8
Unemployed da da da da ‑‑ 0.3 ‑‑ 0.2 ‑‑ 0.4
Other1 da da da da ‑‑ 0.2 ‑‑ 0.6 ‑‑ 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.41A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 15,294 15,279 87 53 15,206 15,226 464 468 14,742 14,758
SEX                    
Male 9,450 8,554 35 16 9,415 8,538 257 225 9,159 8,314
Female 5,844 6,725 53 37 5,791a 6,688 207 244 5,584 6,444
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 12,952 13,182 73 44 12,879 13,137 323 390 12,556 12,747
AIAN 133 244 * * 133 244 * * 126 236
Asian 254 175 * * 246 175 7 * 239 175
Black or African American 448 437 4 3 443 433 12 36 431 397
NHPI 31 64 * * 31 * * * 31 *
White 11,576 11,233 54 39 11,522 11,194 284 324 11,237 10,870
Two or More Races 511b 1,029 6 2 505b 1,027 13 18 492b 1,009
Hispanic or Latino 2,341 2,098 14 9 2,327 2,089 141 78 2,186 2,011
EDUCATION LEVEL                    
< High School da da da da 1,674 1,838 87 83 1,588 1,755
High School Graduate da da da da 4,904 5,205 254 224 4,650 4,981
Some College/Associate’s Degree da da da da 5,893 5,708 106 143 5,787 5,566
College Graduate da da da da 2,735 2,475 17 19 2,718 2,456
EMPLOYMENT STATUS                    
Full‑Time da da da da 6,557 6,070 143 192 6,414 5,879
Part‑Time da da da da 1,682 2,121 49 78 1,633 2,043
Unemployed da da da da 1,134 1,157 104 90 1,031 1,067
Other1 da da da da 5,834 5,878 168 109 5,665 5,769

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.41B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 5.3 5.3 0.3 0.2 5.8 5.7 1.3 1.3 6.5 6.4
SEX                    
Male 6.7 6.1 0.3 0.1 7.4 6.7 1.5 1.2 8.3 7.6
Female 4.0 4.5 0.4 0.3 4.3 4.9 1.2 1.4 4.8 5.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5.5 5.6 0.4 0.2 6.0 6.1 1.2 1.5 6.7 6.8
AIAN 9.8 13.2 * * 11.5 15.5 * * 12.6 17.2
Asian 1.4 0.9 * * 1.4 1.0 0.3 * 1.6 1.2
Black or African American 1.3 1.3 0.1 0.1 1.4 1.4 0.3 0.8 1.6 1.5
NHPI 2.5 6.0 * * 2.7 * * * 3.0 *
White 6.8 6.7 0.4 0.3 7.3 7.2 1.6 1.9 8.0 7.8
Two or More Races 7.9 10.9 0.6 0.1 9.3 12.6 1.1 1.1 11.4 15.7
Hispanic or Latino 4.3 3.7 0.2 0.1 4.9 4.2 1.6 0.8 5.6 5.0
EDUCATION LEVEL                    
< High School da da da da 7.0 7.5 2.4 2.2 7.7 8.5
High School Graduate da da da da 7.0 7.3 2.1 1.7 8.0 8.6
Some College/Associate’s Degree da da da da 7.6 7.4 0.8 1.1 9.0 8.7
College Graduate da da da da 3.0 2.7 0.3 0.3 3.2 2.8
EMPLOYMENT STATUS                    
Full‑Time da da da da 5.4 5.1 1.0 1.4 6.0 5.6
Part‑Time da da da da 5.2 6.1 0.6 0.8 6.9 8.1
Unemployed da da da da 8.8 8.4 2.8 2.2 11.2 11.1
Other1 da da da da 6.1 6.0 2.0 1.3 6.5 6.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.42A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,384 2,653 57 32 2,327 2,621 161 145 2,166 2,475
SEX                    
Male 1,580 1,524 15 12 1,565 1,512 106 53 1,459 1,459
Female 804 1,129 42 20 763a 1,109 56 92 707 1,017
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,965 2,243 50 23 1,915 2,219 115 127 1,800 2,093
AIAN 19 77 * * 19 * 1 1 19 *
Asian 49 69 * * 41 69 * * 41 69
Black or African American 131 94 4 3 127 90 6 8 121 82
NHPI 8 2 * * 8 2 * * 8 2
White 1,648 1,811 32 20 1,616 1,791 100 115 1,517 1,676
Two or More Races 110 189 6 * 104 189 9 2 95 187
Hispanic or Latino 419 410 7 9 412 401 46 18 366 383
EDUCATION LEVEL                    
< High School da da da da 421 389 37 23 384 366
High School Graduate da da da da 1,008 895 88 60 920 836
Some College/Associate’s Degree da da da da 733 1,040 35 52 697 988
College Graduate da da da da 166 296 1 11 165 286
EMPLOYMENT STATUS                    
Full‑Time da da da da 578 776 38 58 540 718
Part‑Time da da da da 231 401 6 42 225 359
Unemployed da da da da 384 345 39 28 345 317
Other1 da da da da 1,134 1,098 78b 17 1,055 1,082

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.42B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.8 0.9 0.2 0.1 0.9 1.0 0.5 0.4 1.0 1.1
SEX                    
Male 1.1 1.1 0.1 0.1 1.2 1.2 0.6 0.3 1.3 1.3
Female 0.5 0.8 0.3 0.2 0.6a 0.8 0.3 0.5 0.6 0.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8 1.0 0.3 0.1 0.9 1.0 0.4 0.5 1.0 1.1
AIAN 1.4 4.2 * * 1.7 * 0.3 0.4 1.9 *
Asian 0.3 0.4 * * 0.2 0.4 * * 0.3 0.5
Black or African American 0.4 0.3 0.1 0.1 0.4 0.3 0.1 0.2 0.4 0.3
NHPI 0.6 0.2 * * 0.7 0.2 * * 0.8 0.2
White 1.0 1.1 0.3 0.2 1.0 1.1 0.6 0.7 1.1 1.2
Two or More Races 1.7 2.0 0.6 * 1.9 2.3 0.8 0.1 2.2 2.9
Hispanic or Latino 0.8 0.7 0.1 0.1 0.9 0.8 0.5 0.2 0.9 1.0
EDUCATION LEVEL                    
< High School da da da da 1.8 1.6 1.1 0.6 1.9 1.8
High School Graduate da da da da 1.4 1.3 0.7 0.5 1.6 1.4
Some College/Associate’s Degree da da da da 0.9 1.3 0.3 0.4 1.1 1.5
College Graduate da da da da 0.2 0.3 <0.1 0.2 0.2 0.3
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.5 0.7 0.3 0.4 0.5 0.7
Part‑Time da da da da 0.7 1.1 0.1 0.4 1.0 1.4
Unemployed da da da da 3.0 2.5 1.1 0.7 3.7 3.3
Other1 da da da da 1.2 1.1 0.9b 0.2 1.2 1.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.43A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,418 1,753 35 16 1,383 1,737 77 82 1,306 1,655
SEX                    
Male 958 1,123 8 12 949 1,111 57 21 892 1,090
Female 461 630 27 4 434 626 19 61 414 565
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,193 1,433 34 16 1,158 1,417 60 66 1,098 1,351
AIAN 7 * * * 7 * <1 1 7 *
Asian 27 63 * * 27 63 * * 27 63
Black or African American 69 63 4 3 64 60 6 6 59 53
NHPI 2 2 * * 2 2 * * 2 2
White 998 1,165 27 12 971 1,152 49 59 922 1,094
Two or More Races 91 78 3 * 88 78 5 * 83 78
Hispanic or Latino 225 320 1 * 225 320 17 17 208 303
EDUCATION LEVEL                    
< High School da da da da 236 287 11 16 225 271
High School Graduate da da da da 620 507 39 33 581 474
Some College/Associate’s Degree da da da da 402a 733 26 25 376a 708
College Graduate da da da da 124 211 * 9 124 202
EMPLOYMENT STATUS                    
Full‑Time da da da da 320 507 16 46 305 461
Part‑Time da da da da 66b 322 <1 17 66a 305
Unemployed da da da da 239 236 8 15 230 221
Other1 da da da da 758 672 52b 4 706 668

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.43B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5 0.6 0.1 0.1 0.5 0.7 0.2 0.2 0.6 0.7
SEX                    
Male 0.7 0.8 0.1 0.1 0.7 0.9 0.3 0.1 0.8 1.0
Female 0.3 0.4 0.2 <0.1 0.3 0.5 0.1 0.3 0.4 0.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.5 0.6 0.2 0.1 0.5 0.7 0.2 0.2 0.6 0.7
AIAN 0.5 * * * 0.6 * 0.1 0.4 0.7 *
Asian 0.1 0.3 * * 0.2 0.4 * * 0.2 0.4
Black or African American 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.2
NHPI 0.1 0.2 * * 0.1 0.2 * * 0.2 0.2
White 0.6 0.7 0.2 0.1 0.6 0.7 0.3 0.3 0.7 0.8
Two or More Races 1.4 0.8 0.3 * 1.6 1.0 0.4 * 1.9 1.2
Hispanic or Latino 0.4 0.6 <0.1 * 0.5 0.6 0.2 0.2 0.5 0.8
EDUCATION LEVEL                    
< High School da da da da 1.0 1.2 0.3 0.4 1.1 1.3
High School Graduate da da da da 0.9 0.7 0.3 0.3 1.0 0.8
Some College/Associate’s Degree da da da da 0.5a 0.9 0.2 0.2 0.6a 1.1
College Graduate da da da da 0.1 0.2 * 0.1 0.1 0.2
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.3 0.4 0.1 0.3 0.3 0.4
Part‑Time da da da da 0.2b 0.9 <0.1 0.2 0.3a 1.2
Unemployed da da da da 1.9 1.7 0.2 0.4 2.5 2.3
Other1 da da da da 0.8 0.7 0.6b <0.1 0.8 0.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.44A – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 63,149 60,619 2,998 2,670 60,151 57,949 4,731 4,676 55,420 53,272
SEX                    
Male 29,377 27,543 1,502 1,362 27,875 26,181 2,093 2,038 25,781 24,143
Female 33,772 33,076 1,496 1,308 32,277 31,768 2,638 2,639 29,639 29,129
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 52,953 51,411 2,105 1,981 50,848 49,430 3,594 3,509 47,254 45,921
AIAN 333 415 24 43 309 371 39 40 271 332
Asian 2,397 1,849 119 125 2,278 1,724 226 259 2,053 1,465
Black or African American 7,676 8,102 424 359 7,253 7,743 667 681 6,586 7,062
NHPI 207 205 * * 194 195 * 2 175 *
White 40,871 38,589 1,386 1,280 39,485 37,309 2,454 2,313 37,031 34,996
Two or More Races 1,468b 2,251 140 164 1,329b 2,087 190 214 1,138b 1,873
Hispanic or Latino 10,196 9,208 893a 689 9,303 8,519 1,137 1,168 8,166 7,351
EDUCATION LEVEL                    
< High School da da da da 5,633 6,178 542 549 5,090 5,629
High School Graduate da da da da 16,694 16,506 1,835 1,604 14,858 14,902
Some College/Associate’s Degree da da da da 20,638 19,025 1,793 1,900 18,846a 17,125
College Graduate da da da da 17,187 16,240 561 623 16,625 15,617
EMPLOYMENT STATUS                    
Full‑Time da da da da 23,750a 21,828 1,847 1,759 21,902 20,070
Part‑Time da da da da 6,714 6,310 1,212 1,251 5,503 5,059
Unemployed da da da da 2,523 2,872 508 519 2,014 2,353
Other1 da da da da 27,165 26,938 1,164 1,148 26,000 25,790

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.44B – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 21.9a 20.9 11.6 10.5 22.9a 21.9 13.5 13.0 24.4 23.3
SEX                    
Male 20.8 19.6 11.3 10.5 21.8 20.5 11.9 11.2 23.4 22.1
Female 22.9 22.1 11.8 10.5 24.0 23.1 15.2 14.7 25.3 24.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 22.7 22.0 11.1 10.6 23.7 23.0 13.7 13.2 25.1 24.3
AIAN 24.4 22.4 11.3 15.9 26.8 23.6 24.9 19.2 27.1 24.2
Asian 12.9a 9.6 7.8 8.1 13.3a 9.8 9.4 10.2 13.9a 9.7
Black or African American 21.8 23.5 11.9 10.5 22.9 24.9 14.5 14.6 24.3 26.7
NHPI 16.7 19.3 * * 16.7 19.5 * 2.4 17.3 *
White 24.0 23.0 11.0 10.7 25.0 23.9 13.8 13.3 26.4 25.3
Two or More Races 22.6 23.8 13.4 12.3 24.4 25.7 16.6 12.5 26.5 29.2
Hispanic or Latino 18.7a 16.3 12.9a 10.1 19.5a 17.1 13.0 12.3 21.0a 18.3
EDUCATION LEVEL                    
< High School da da da da 23.4 25.3 15.3 14.8 24.8 27.2
High School Graduate da da da da 23.7 23.3 15.1b 12.5 25.5 25.7
Some College/Associate’s Degree da da da da 26.5a 24.6 13.5 14.2 29.2a 26.8
College Graduate da da da da 19.1a 17.6 9.4 10.1 19.8a 18.1
EMPLOYMENT STATUS                    
Full‑Time da da da da 19.6 18.5 13.2 12.8 20.4 19.3
Part‑Time da da da da 20.7a 18.1 13.8 13.0 23.3a 20.0
Unemployed da da da da 19.6 21.0 13.8 12.7 21.8 24.5
Other1 da da da da 28.4 27.3 13.8 13.2 29.8 28.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.45A – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 7,570 6,881 395 402 7,176 6,479 897 733 6,279 5,746
SEX                    
Male 3,940 3,687 161 200 3,779 3,487 385 375 3,394 3,113
Female 3,630 3,194 234 203 3,397 2,992 512a 358 2,885 2,634
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6,143 5,358 253 263 5,890 5,094 685 569 5,205 4,525
AIAN 45 65 8 10 38 56 * 3 31 53
Asian 258 151 13 14 244 137 28 19 217 118
Black or African American 1,037 794 32 45 1,005 749 139 82 866 667
NHPI 34 11 * * 34 10 * * 32 10
White 4,504 4,051 182 177 4,321 3,874 489 441 3,833 3,434
Two or More Races 266 285 18 17 248 268 21 25 227 243
Hispanic or Latino 1,427 1,524 142 139 1,286 1,385 212 164 1,074 1,221
EDUCATION LEVEL                    
< High School da da da da 910 904 108 110 801 794
High School Graduate da da da da 2,400 2,042 358 270 2,042 1,773
Some College/Associate’s Degree da da da da 2,435 2,167 339 279 2,096 1,889
College Graduate da da da da 1,430 1,366 91 75 1,339 1,291
EMPLOYMENT STATUS                    
Full‑Time da da da da 2,927 2,501 342 321 2,585 2,180
Part‑Time da da da da 864 684 226 132 638 552
Unemployed da da da da 563 563 120 113 443 450
Other1 da da da da 2,822 2,731 209 167 2,613 2,565

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.45B – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2.6 2.4 1.5 1.6 2.7 2.4 2.6 2.0 2.8 2.5
SEX                    
Male 2.8 2.6 1.2 1.5 3.0 2.7 2.2 2.1 3.1 2.8
Female 2.5 2.1 1.8 1.6 2.5 2.2 2.9a 2.0 2.5 2.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.6a 2.3 1.3 1.4 2.7a 2.4 2.6 2.1 2.8 2.4
AIAN 3.3 3.5 3.6 3.7 3.3 3.5 * 1.3 3.1 3.9
Asian 1.4 0.8 0.9 0.9 1.4 0.8 1.1 0.7 1.5 0.8
Black or African American 2.9 2.3 0.9 1.3 3.2 2.4 3.0 1.8 3.2 2.5
NHPI 2.7 1.1 * * 2.9 1.0 * * 3.1 1.1
White 2.6 2.4 1.4 1.5 2.7 2.5 2.8 2.5 2.7 2.5
Two or More Races 4.1 3.0 1.7 1.2 4.6 3.3 1.8 1.5 5.3 3.8
Hispanic or Latino 2.6 2.7 2.1 2.0 2.7 2.8 2.4 1.7 2.8 3.0
EDUCATION LEVEL                    
< High School da da da da 3.8 3.7 3.1 2.9 3.9 3.8
High School Graduate da da da da 3.4 2.9 2.9 2.1 3.5 3.1
Some College/Associate’s Degree da da da da 3.1 2.8 2.6 2.1 3.2 3.0
College Graduate da da da da 1.6 1.5 1.5 1.2 1.6 1.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 2.4 2.1 2.4 2.3 2.4 2.1
Part‑Time da da da da 2.7 2.0 2.6a 1.4 2.7 2.2
Unemployed da da da da 4.4 4.1 3.3 2.8 4.8 4.7
Other1 da da da da 2.9 2.8 2.5 1.9 3.0 2.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.46A – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,951 1,816 106 105 1,845 1,711 214 176 1,631 1,535
SEX                    
Male 958 978 28 55 930 923 79 125 851 797
Female 993 838 78 50 915 788 135a 50 780 738
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,533 1,397 59 72 1,474 1,325 133 150 1,342 1,174
AIAN 8 6 1 1 7 5 * * 2 5
Asian 21 17 10 1 12 16 2 * 10 16
Black or African American 234 181 7 9 227 172 32a 8 195 164
NHPI 2 1 * * 2 1 * * * 1
White 1,172 1,015 37 59 1,135 956 90 139 1,045 817
Two or More Races 95 177 4 2 92 175 3 3 89 171
Hispanic or Latino 418 419 47 33 371 386 82a 25 289 361
EDUCATION LEVEL                    
< High School da da da da 268 297 33 47 235 250
High School Graduate da da da da 611 478 107 67 505 412
Some College/Associate’s Degree da da da da 673 688 46 40 626 647
College Graduate da da da da 293 248 28 22 265 226
EMPLOYMENT STATUS                    
Full‑Time da da da da 586 736 46 87 539 650
Part‑Time da da da da 242 134 72a 15 170 119
Unemployed da da da da 180 196 39 36 142 160
Other1 da da da da 837 644 57 38 780 606

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.46B – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7 0.6 0.4 0.4 0.7 0.6 0.6 0.5 0.7 0.7
SEX                    
Male 0.7 0.7 0.2 0.4 0.7 0.7 0.4 0.7 0.8 0.7
Female 0.7 0.6 0.6 0.4 0.7 0.6 0.8a 0.3 0.7 0.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.6 0.3 0.4 0.7 0.6 0.5 0.6 0.7 0.6
AIAN 0.6 0.4 0.6 0.5 0.6 0.3 * * 0.2 0.4
Asian 0.1 0.1 0.6 0.1 0.1 0.1 0.1 * 0.1 0.1
Black or African American 0.7 0.5 0.2 0.3 0.7 0.6 0.7a 0.2 0.7 0.6
NHPI 0.1 0.1 * * 0.1 0.1 * * * 0.1
White 0.7 0.6 0.3 0.5 0.7 0.6 0.5 0.8 0.7 0.6
Two or More Races 1.5 1.9 0.3 0.2 1.7 2.1 0.2 0.2 2.1 2.7
Hispanic or Latino 0.8 0.7 0.7 0.5 0.8 0.8 0.9a 0.3 0.7 0.9
EDUCATION LEVEL                    
< High School da da da da 1.1 1.2 0.9 1.3 1.1 1.2
High School Graduate da da da da 0.9 0.7 0.9 0.5 0.9 0.7
Some College/Associate’s Degree da da da da 0.9 0.9 0.3 0.3 1.0 1.0
College Graduate da da da da 0.3 0.3 0.5 0.4 0.3 0.3
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.5 0.6 0.3 0.6 0.5 0.6
Part‑Time da da da da 0.7a 0.4 0.8a 0.2 0.7 0.5
Unemployed da da da da 1.4 1.4 1.0 0.9 1.5 1.7
Other1 da da da da 0.9 0.7 0.7 0.4 0.9 0.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.47A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 20,507 21,237 1,830 1,889 18,677 19,348 3,639 3,769 15,038 15,579
SEX                    
Male 9,487 9,970 973 1,115 8,514 8,855 1,927 1,935 6,587 6,920
Female 11,021 11,266 858 774 10,163 10,492 1,712 1,834 8,451 8,659
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 17,755 18,045 1,536 1,514 16,219 16,530 2,921 2,994 13,298 13,536
AIAN 57b 167 10 9 47b 158 3a 19 44b 139
Asian 676 476 49 32 628 445 172 141 456 303
Black or African American 1,331 1,414 126 144 1,205 1,269 213 233 992 1,036
NHPI * 40 * * * * * * * *
White 14,981 15,031 1,286 1,220 13,695 13,811 2,400 2,399 11,294 11,413
Two or More Races 636a 916 65 107 571 809 130 200 441 609
Hispanic or Latino 2,752 3,192 294 374 2,458 2,817 719 775 1,740 2,043
EDUCATION LEVEL                    
< High School da da da da 847 1,181 326 283 521a 898
High School Graduate da da da da 4,096 3,802 1,090 966 3,007 2,836
Some College/Associate’s Degree da da da da 6,511 6,673 1,571 1,644 4,939 5,029
College Graduate da da da da 7,222 7,692 652a 876 6,570 6,816
EMPLOYMENT STATUS                    
Full‑Time da da da da 10,113 10,175 1,396 1,378 8,717 8,797
Part‑Time da da da da 2,633 2,953 992 1,092 1,641 1,861
Unemployed da da da da 1,115 1,035 363 361 752 674
Other1 da da da da 4,815 5,185 888 938 3,927 4,247

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.47B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 7.1 7.3 7.1 7.4 7.1 7.3 10.4 10.4 6.6 6.8
SEX                    
Male 6.7 7.1 7.3 8.6 6.7 6.9 11.0 10.6 6.0 6.3
Female 7.5 7.5 6.8 6.2 7.6 7.6 9.8 10.2 7.2 7.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7.6 7.7 8.1 8.1 7.6 7.7 11.2 11.3 7.1 7.2
AIAN 4.2a 9.1 4.7 3.5 4.1a 10.0 2.2a 9.0 4.4a 10.2
Asian 3.6 2.5 3.2 2.1 3.7 2.5 7.2 5.6 3.1 2.0
Black or African American 3.8 4.1 3.5 4.2 3.8 4.1 4.6 5.0 3.7 3.9
NHPI * 3.8 * * * * * * * *
White 8.8 9.0 10.2 10.2 8.7 8.9 13.5 13.8 8.1 8.2
Two or More Races 9.8 9.7 6.2 8.0 10.5 10.0 11.3 11.7 10.3 9.5
Hispanic or Latino 5.0 5.6 4.3 5.5 5.2 5.7 8.2 8.1 4.5 5.1
EDUCATION LEVEL                    
< High School da da da da 3.5 4.8 9.2 7.6 2.5a 4.3
High School Graduate da da da da 5.8 5.4 9.0 7.5 5.2 4.9
Some College/Associate’s Degree da da da da 8.4 8.6 11.9 12.3 7.6 7.9
College Graduate da da da da 8.0 8.3 10.9a 14.1 7.8 7.9
EMPLOYMENT STATUS                    
Full‑Time da da da da 8.3 8.6 10.0 10.1 8.1 8.4
Part‑Time da da da da 8.1 8.5 11.3 11.3 7.0 7.4
Unemployed da da da da 8.7 7.6 9.9 8.8 8.2 7.0
Other1 da da da da 5.0 5.3 10.5 10.8 4.5 4.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.48A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,899 3,940 203 216 3,696 3,724 973 978 2,723 2,746
SEX                    
Male 2,122 2,088 101 92 2,021 1,996 492 508 1,529 1,488
Female 1,777 1,852 102 124 1,675 1,728 481 470 1,194 1,258
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,402 3,348 160 164 3,242 3,184 752 773 2,490 2,410
AIAN 7 39 2 1 5 39 * 3 4 35
Asian 173 114 15 2 157 112 42 69 115 44
Black or African American 226 170 19 31 206 139 37 51 170 88
NHPI 9 10 * * 9 8 * * 7 8
White 2,878 2,859 115 107 2,763 2,752 643 632 2,120 2,121
Two or More Races 110 155 8 22 102 133 26 18 75 115
Hispanic or Latino 497 592 43 52 454 540 221 204 233 336
EDUCATION LEVEL                    
< High School da da da da 151 210 84 63 67 147
High School Graduate da da da da 769 624 239 191 530 433
Some College/Associate’s Degree da da da da 1,320 1,350 444 444 876 906
College Graduate da da da da 1,457 1,540 206 279 1,250 1,261
EMPLOYMENT STATUS                    
Full‑Time da da da da 2,214 2,071 414 400 1,800 1,671
Part‑Time da da da da 502 555 231 265 271 290
Unemployed da da da da 259 290 115 70 145 221
Other1 da da da da 721 807 213 242 507 565

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.48B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.4 1.4 0.8 0.8 1.4 1.4 2.8 2.7 1.2 1.2
SEX                    
Male 1.5 1.5 0.8 0.7 1.6 1.6 2.8 2.8 1.4 1.4
Female 1.2 1.2 0.8 1.0 1.2 1.3 2.8 2.6 1.0 1.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.5 1.4 0.8 0.9 1.5 1.5 2.9 2.9 1.3 1.3
AIAN 0.5 2.1 1.0 0.3 0.4 2.5 * 1.6 0.4 2.6
Asian 0.9 0.6 1.0 0.1 0.9 0.6 1.8 2.7 0.8 0.3
Black or African American 0.6 0.5 0.5 0.9 0.7 0.4 0.8 1.1 0.6 0.3
NHPI 0.7 0.9 * * 0.8 0.8 * * 0.7 0.9
White 1.7 1.7 0.9 0.9 1.7 1.8 3.6 3.6 1.5 1.5
Two or More Races 1.7 1.6 0.8 1.7 1.9 1.6 2.3 1.0 1.8 1.8
Hispanic or Latino 0.9 1.0 0.6 0.8 1.0 1.1 2.5 2.1 0.6 0.8
EDUCATION LEVEL                    
< High School da da da da 0.6 0.9 2.4 1.7 0.3 0.7
High School Graduate da da da da 1.1 0.9 2.0 1.5 0.9 0.7
Some College/Associate’s Degree da da da da 1.7 1.7 3.3 3.3 1.4 1.4
College Graduate da da da da 1.6 1.7 3.5 4.5 1.5 1.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.8 1.8 2.9 2.9 1.7 1.6
Part‑Time da da da da 1.6 1.6 2.6 2.7 1.1 1.1
Unemployed da da da da 2.0 2.1 3.1 1.7 1.6 2.3
Other1 da da da da 0.8 0.8 2.5 2.8 0.6 0.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.49A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,239 1,262 33 50 1,206 1,212 210 260 995 953
SEX                    
Male 656 598 23 24 633 574 90 139 543 436
Female 584 664 11 26 573 638 121 121 453 517
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,129 1,024 26 37 1,104 987 162 196 942 791
AIAN 2 <1 * <1 1 <1 <1 <1 1 *
Asian 99 38 * 2 99 37 * 5 89 32
Black or African American 67 26 * 3 67a 22 8 5 59 17
NHPI * * * * * * * * * *
White 904 893 23 29 881 864 140 182 741 681
Two or More Races 57 61 2 3 55 58 4 3 52 55
Hispanic or Latino 110 238 8 13 102 226 49 64 54 161
EDUCATION LEVEL                    
< High School da da da da 39 80 24 14 15a 65
High School Graduate da da da da 245 253 79 62 166 190
Some College/Associate’s Degree da da da da 481 390 78 134 403 256
College Graduate da da da da 442 491 30 50 412 441
EMPLOYMENT STATUS                    
Full‑Time da da da da 841 686 96 117 744 569
Part‑Time da da da da 134 215 57 78 78 137
Unemployed da da da da 34 104 18 15 16 90
Other1 da da da da 197 207 40 50 158 157

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.49B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4 0.4 0.1 0.2 0.5 0.5 0.6 0.7 0.4 0.4
SEX                    
Male 0.5 0.4 0.2 0.2 0.5 0.4 0.5 0.8 0.5 0.4
Female 0.4 0.4 0.1 0.2 0.4 0.5 0.7 0.7 0.4 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.5 0.4 0.1 0.2 0.5 0.5 0.6 0.7 0.5 0.4
AIAN 0.2 <0.1 * 0.1 0.1 <0.1 <0.1 0.1 0.1 *
Asian 0.5 0.2 * 0.1 0.6 0.2 * 0.2 0.6 0.2
Black or African American 0.2 0.1 * 0.1 0.2a 0.1 0.2 0.1 0.2 0.1
NHPI * * * * * * * * * *
White 0.5 0.5 0.2 0.2 0.6 0.6 0.8 1.0 0.5 0.5
Two or More Races 0.9 0.6 0.2 0.2 1.0 0.7 0.3 0.2 1.2 0.9
Hispanic or Latino 0.2 0.4 0.1 0.2 0.2 0.5 0.6 0.7 0.1 0.4
EDUCATION LEVEL                    
< High School da da da da 0.2 0.3 0.7 0.4 0.1a 0.3
High School Graduate da da da da 0.3 0.4 0.6 0.5 0.3 0.3
Some College/Associate’s Degree da da da da 0.6 0.5 0.6 1.0 0.6 0.4
College Graduate da da da da 0.5 0.5 0.5 0.8 0.5 0.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.7 0.6 0.7 0.9 0.7 0.5
Part‑Time da da da da 0.4 0.6 0.6 0.8 0.3 0.5
Unemployed da da da da 0.3 0.8 0.5 0.4 0.2 0.9
Other1 da da da da 0.2 0.2 0.5 0.6 0.2 0.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.50A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 39,709a 36,756 945 821 38,765a 35,935 2,477 2,461 36,288a 33,474
SEX                    
Male 15,351 14,477 492 363 14,859 14,114 958 1,008 13,901 13,106
Female 24,358a 22,279 452 458 23,906a 21,820 1,519 1,453 22,387a 20,367
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 34,472 32,587 723 658 33,749 31,929 1,982 1,912 31,767 30,017
AIAN 172 185 9 14 164 171 16 10 147 161
Asian 961 968 49 41 912 927 96 79 816 848
Black or African American 3,004 2,755 109 119 2,895 2,636 178 270 2,716 2,366
NHPI 131 98 * * 130 96 * * 121 92
White 29,184 27,217 520 425 28,663 26,793 1,550 1,434 27,113 25,359
Two or More Races 1,021 1,363 35 57 986 1,306 133 116 854 1,190
Hispanic or Latino 5,237a 4,169 222 163 5,015a 4,006 494 549 4,521a 3,457
EDUCATION LEVEL                    
< High School da da da da 2,299 2,480 189 257 2,110 2,223
High School Graduate da da da da 9,312a 7,936 832 740 8,480a 7,196
Some College/Associate’s Degree da da da da 13,387b 11,457 1,069 992 12,319b 10,465
College Graduate da da da da 13,767 14,062 387 472 13,380 13,590
EMPLOYMENT STATUS                    
Full‑Time da da da da 14,942 14,184 940 872 14,002 13,312
Part‑Time da da da da 5,249 4,596 643 730 4,607 3,865
Unemployed da da da da 1,506 1,382 225 307 1,282 1,075
Other1 da da da da 17,067 15,773 669 551 16,397 15,221

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.50B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 13.8b 12.7 3.6 3.2 14.8b 13.6 7.1 6.8 16.0b 14.6
SEX                    
Male 10.9 10.3 3.7 2.8 11.6 11.1 5.5 5.5 12.6 12.0
Female 16.5b 14.9 3.6 3.7 17.8b 15.9 8.7 8.1 19.1b 17.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 14.8a 13.9 3.8 3.5 15.7a 14.8 7.6 7.2 16.9a 15.9
AIAN 12.6 10.0 4.2 5.3 14.2 10.8 10.6 4.7 14.7 11.8
Asian 5.2 5.0 3.3 2.7 5.3 5.3 4.0 3.1 5.5 5.6
Black or African American 8.5 8.0 3.1 3.5 9.1 8.5 3.9 5.8 10.0 8.9
NHPI 10.6 9.2 * * 11.3 9.7 * * 12.0 10.2
White 17.1 16.2 4.1 3.5 18.1 17.2 8.7 8.2 19.3 18.3
Two or More Races 15.7 14.4 3.4 4.3 18.1 16.1 11.6a 6.8 19.9 18.5
Hispanic or Latino 9.6b 7.4 3.2 2.4 10.5b 8.1 5.6 5.8 11.6b 8.6
EDUCATION LEVEL                    
< High School da da da da 9.6 10.2 5.3 6.9 10.3 10.7
High School Graduate da da da da 13.2b 11.2 6.8 5.8 14.6a 12.4
Some College/Associate’s Degree da da da da 17.2b 14.8 8.1 7.4 19.1b 16.4
College Graduate da da da da 15.3 15.2 6.5 7.6 15.9 15.8
EMPLOYMENT STATUS                    
Full‑Time da da da da 12.3 12.0 6.7 6.4 13.1 12.8
Part‑Time da da da da 16.2b 13.2 7.3 7.6 19.5b 15.3
Unemployed da da da da 11.7 10.1 6.1 7.5 13.9 11.2
Other1 da da da da 17.8a 16.0 7.9 6.4 18.8a 16.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.51A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 4,575 4,237 172 141 4,403 4,095 571 582 3,832 3,513
SEX                    
Male 2,293 1,792 57 53 2,236 1,739 217 215 2,019 1,524
Female 2,282 2,445 115 89 2,167 2,357 354 367 1,813 1,989
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,830 3,555 127 114 3,704 3,441 433 416 3,271 3,025
AIAN 47 30 * <1 46 * * 1 38 *
Asian 96 73 * * 96 73 18 12 78 62
Black or African American 283 211 8 15 274 197 27 34 248 163
NHPI 9 1 * * 9 * * * 9 *
White 3,193 3,074 111 83 3,081 2,990 353 342 2,728 2,648
Two or More Races 203 166 6 15 197 151 28 27 169 124
Hispanic or Latino 744 681 45 27 699 654 138 166 561 488
EDUCATION LEVEL                    
< High School da da da da 337 359 47 63 289 296
High School Graduate da da da da 1,224 980 233 206 991 774
Some College/Associate’s Degree da da da da 1,452 1,418 235 199 1,217 1,219
College Graduate da da da da 1,390 1,339 56 114 1,334 1,224
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,671 1,528 192 188 1,480 1,340
Part‑Time da da da da 733 574 162 180 572 394
Unemployed da da da da 332 288 55 80 278 209
Other1 da da da da 1,666 1,705 163 135 1,503 1,570

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.51B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.6 1.5 0.7 0.6 1.7 1.5 1.6 1.6 1.7 1.5
SEX                    
Male 1.6 1.3 0.4 0.4 1.8 1.4 1.2 1.2 1.8 1.4
Female 1.5 1.6 0.9 0.7 1.6 1.7 2.0 2.1 1.5 1.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.6 1.5 0.7 0.6 1.7 1.6 1.7 1.6 1.7 1.6
AIAN 3.4 1.6 * 0.1 4.0 * * 0.5 3.8 *
Asian 0.5 0.4 * * 0.6 0.4 0.7 0.5 0.5 0.4
Black or African American 0.8 0.6 0.2 0.4 0.9 0.6 0.6 0.7 0.9 0.6
NHPI 0.8 0.1 * * 0.8 * * * 0.9 *
White 1.9 1.8 0.9 0.7 2.0 1.9 2.0 2.0 1.9 1.9
Two or More Races 3.1 1.8 0.6 1.1 3.6 1.9 2.4 1.6 3.9 1.9
Hispanic or Latino 1.4 1.2 0.7 0.4 1.5 1.3 1.6 1.7 1.4 1.2
EDUCATION LEVEL                    
< High School da da da da 1.4 1.5 1.3 1.7 1.4 1.4
High School Graduate da da da da 1.7 1.4 1.9 1.6 1.7 1.3
Some College/Associate’s Degree da da da da 1.9 1.8 1.8 1.5 1.9 1.9
College Graduate da da da da 1.5 1.4 0.9 1.8 1.6 1.4
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.4 1.3 1.4 1.4 1.4 1.3
Part‑Time da da da da 2.3 1.6 1.8 1.9 2.4 1.6
Unemployed da da da da 2.6 2.1 1.5 2.0 3.0 2.2
Other1 da da da da 1.7 1.7 1.9 1.6 1.7 1.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.52A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,480 1,187 38 29 1,442 1,158 160 150 1,282 1,008
SEX                    
Male 792a 436 10 13 783a 423 44 74 739b 349
Female 688 751 28 16 660 735 116 76 543 659
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,325a 921 36 29 1,288a 892 124 102 1,164a 790
AIAN 14 * * <1 13 * * 1 12 *
Asian 35 20 * * 35 20 2 <1 34 19
Black or African American 71 42 3 3 68 38 7 11 61 27
NHPI * * * * * * * * * *
White 1,111a 762 28 24 1,083a 737 108 86 975 651
Two or More Races 94 74 5 1 89 73 6 4 83 69
Hispanic or Latino 155 266 1 * 154 266 36 49 118 217
EDUCATION LEVEL                    
< High School da da da da 66 133 6 27 59 106
High School Graduate da da da da 430a 228 73 41 356 186
Some College/Associate’s Degree da da da da 447 536 62 73 385 462
College Graduate da da da da 500a 262 18 9 481a 253
EMPLOYMENT STATUS                    
Full‑Time da da da da 508 405 43 38 465 366
Part‑Time da da da da 362b 107 50 54 312b 53
Unemployed da da da da 121 119 10 35 111 84
Other1 da da da da 451 527 57 23 394 505

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.52B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5 0.4 0.1 0.1 0.5 0.4 0.5 0.4 0.6 0.4
SEX                    
Male 0.6a 0.3 0.1 0.1 0.6a 0.3 0.3 0.4 0.7b 0.3
Female 0.5 0.5 0.2 0.1 0.5 0.5 0.7 0.4 0.5 0.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6a 0.4 0.2 0.2 0.6a 0.4 0.5 0.4 0.6a 0.4
AIAN 1.0 * * 0.1 1.1 * * 0.4 1.2 *
Asian 0.2 0.1 * * 0.2 0.1 0.1 <0.1 0.2 0.1
Black or African American 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1
NHPI * * * * * * * * * *
White 0.7a 0.5 0.2 0.2 0.7a 0.5 0.6 0.5 0.7 0.5
Two or More Races 1.4 0.8 0.4 0.1 1.6 0.9 0.5 0.2 1.9 1.1
Hispanic or Latino 0.3 0.5 <0.1 * 0.3 0.5 0.4 0.5 0.3 0.5
EDUCATION LEVEL                    
< High School da da da da 0.3 0.5 0.2 0.7 0.3 0.5
High School Graduate da da da da 0.6a 0.3 0.6 0.3 0.6 0.3
Some College/Associate’s Degree da da da da 0.6 0.7 0.5 0.5 0.6 0.7
College Graduate da da da da 0.6a 0.3 0.3 0.1 0.6a 0.3
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.4 0.3 0.3 0.3 0.4 0.4
Part‑Time da da da da 1.1b 0.3 0.6 0.6 1.3b 0.2
Unemployed da da da da 0.9 0.9 0.3 0.9 1.2 0.9
Other1 da da da da 0.5 0.5 0.7 0.3 0.5 0.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.53A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 31,451a 28,826 500 508 30,951a 28,318 1,944 1,811 29,007a 26,507
SEX                    
Male 11,502 10,687 240 201 11,262 10,486 717 710 10,545 9,777
Female 19,949a 18,138 260 306 19,689a 17,832 1,227 1,101 18,462a 16,730
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 27,318a 25,362 401 399 26,917a 24,963 1,544 1,408 25,373 23,554
AIAN 123 138 6 6 117 132 * 7 103 124
Asian 799 677 24 26 775 651 48 49 726 602
Black or African American 2,291 2,098 40 59 2,251 2,038 123 144 2,128 1,895
NHPI 122 81 <1 * 122 80 * * * 79
White 23,132a 21,166 301 267 22,831a 20,898 1,235 1,107 21,595a 19,791
Two or More Races 851 1,204 29 39 821 1,165 120 101 701 1,064
Hispanic or Latino 4,133 3,464 99 108 4,034 3,355 400 403 3,634 2,953
EDUCATION LEVEL                    
< High School da da da da 1,878 2,005 142 217 1,735 1,788
High School Graduate da da da da 7,537a 6,386 671 565 6,866a 5,821
Some College/Associate’s Degree da da da da 10,656b 8,990 818 667 9,838a 8,323
College Graduate da da da da 10,880 10,938 313 362 10,567 10,575
EMPLOYMENT STATUS                    
Full‑Time da da da da 11,943 11,338 738 655 11,205 10,683
Part‑Time da da da da 4,414a 3,549 522 550 3,892b 2,999
Unemployed da da da da 1,193 1,139 163 228 1,030 911
Other1 da da da da 13,400 12,292 520a 378 12,880 11,914

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.53B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 10.9b 9.9 1.9 2.0 11.8b 10.7 5.6 5.0 12.8b 11.6
SEX                    
Male 8.2 7.6 1.8 1.5 8.8 8.2 4.1 3.9 9.6 8.9
Female 13.5b 12.1 2.1 2.5 14.6b 13.0 7.1 6.2 15.8b 14.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 11.7a 10.8 2.1 2.1 12.5a 11.6 5.9 5.3 13.5a 12.5
AIAN 9.1 7.5 3.1 2.3 10.1 8.3 * 3.5 10.3 9.1
Asian 4.3 3.5 1.6 1.7 4.5 3.7 2.0 1.9 4.9 4.0
Black or African American 6.5 6.1 1.1 1.7 7.1 6.6 2.7 3.1 7.9 7.2
NHPI 9.8 7.6 <0.1 * 10.5 8.0 * * * 8.7
White 13.6a 12.6 2.4 2.2 14.5a 13.4 7.0 6.4 15.4a 14.3
Two or More Races 13.1 12.7 2.8 3.0 15.1 14.3 10.5 5.9 16.3 16.6
Hispanic or Latino 7.6a 6.1 1.4 1.6 8.5a 6.8 4.6 4.2 9.3a 7.3
EDUCATION LEVEL                    
< High School da da da da 7.8 8.2 4.0 5.8 8.5 8.6
High School Graduate da da da da 10.7a 9.0 5.5 4.4 11.8a 10.0
Some College/Associate’s Degree da da da da 13.7b 11.6 6.2 5.0 15.2b 13.0
College Graduate da da da da 12.1 11.8 5.2 5.9 12.6 12.3
EMPLOYMENT STATUS                    
Full‑Time da da da da 9.9 9.6 5.3 4.8 10.5 10.3
Part‑Time da da da da 13.6b 10.2 5.9 5.7 16.5b 11.9
Unemployed da da da da 9.3 8.3 4.5 5.6 11.2 9.5
Other1 da da da da 14.0a 12.5 6.2a 4.4 14.7a 13.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.54A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,829 3,665 126 119 3,703 3,546 522 515 3,181 3,031
SEX                    
Male 1,925 1,523 41 46 1,884 1,476 183 193 1,701 1,283
Female 1,903 2,142 85 73 1,819 2,070 339 322 1,480 1,747
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,146 3,079 95 93 3,051 2,986 394 366 2,658 2,620
AIAN 34 30 * <1 33 * * 1 * *
Asian 83 73 * * 83 73 5 12 78 62
Black or African American 251 183 6 8 245 175 23 30 222 146
NHPI 9 1 * * 9 * * * 9 *
White 2,626 2,675 87 69 2,538 2,606 331 296 2,208 2,310
Two or More Races 143 116 <1 15 142 102 28 27 115 75
Hispanic or Latino 683 586 31 26 652 560 128 149 524 411
EDUCATION LEVEL                    
< High School da da da da 320 358 37 61 283 296
High School Graduate da da da da 1,083 779 227 181 855 598
Some College/Associate’s Degree da da da da 1,221 1,245 203 176 1,018 1,069
College Graduate da da da da 1,080 1,164 55 96 1,024 1,068
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,458 1,374 188 165 1,270 1,210
Part‑Time da da da da 679 511 140 165 539 345
Unemployed da da da da 307 260 51 71 256 189
Other1 da da da da 1,259 1,401 142 114 1,117 1,287

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.54B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.3 1.3 0.5 0.5 1.4 1.3 1.5 1.4 1.4 1.3
SEX                    
Male 1.4 1.1 0.3 0.4 1.5 1.2 1.0 1.1 1.5 1.2
Female 1.3 1.4 0.7 0.6 1.4 1.5 1.9 1.8 1.3 1.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.3 1.3 0.5 0.5 1.4 1.4 1.5 1.4 1.4 1.4
AIAN 2.5 1.6 * 0.1 2.9 * * 0.5 * *
Asian 0.4 0.4 * * 0.5 0.4 0.2 0.5 0.5 0.4
Black or African American 0.7 0.5 0.2 0.2 0.8 0.6 0.5 0.6 0.8 0.6
NHPI 0.8 0.1 * * 0.8 * * * 0.9 *
White 1.5 1.6 0.7 0.6 1.6 1.7 1.9 1.7 1.6 1.7
Two or More Races 2.2 1.2 <0.1 1.1 2.6 1.3 2.4 1.6 2.7 1.2
Hispanic or Latino 1.2 1.0 0.5 0.4 1.4 1.1 1.5 1.6 1.3 1.0
EDUCATION LEVEL                    
< High School da da da da 1.3 1.5 1.0 1.6 1.4 1.4
High School Graduate da da da da 1.5 1.1 1.9 1.4 1.5 1.0
Some College/Associate’s Degree da da da da 1.6 1.6 1.5 1.3 1.6 1.7
College Graduate da da da da 1.2 1.3 0.9 1.6 1.2 1.2
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.2 1.2 1.3 1.2 1.2 1.2
Part‑Time da da da da 2.1 1.5 1.6 1.7 2.3 1.4
Unemployed da da da da 2.4 1.9 1.4 1.7 2.8 2.0
Other1 da da da da 1.3 1.4 1.7 1.3 1.3 1.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.55A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,259 974 28 24 1,231 950 131 140 1,099 810
SEX                    
Male 692a 414 8 13 684a 401 35 70 649a 331
Female 566 559 20 11 546 549 96 70 450 479
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,107a 742 27 24 1,081a 718 99 96 982a 622
AIAN 5 * * <1 5 * * <1 4 *
Asian 34 20 * * 34 20 * <1 34 19
Black or African American 46 39 2 3 44 36 5 11 39 25
NHPI * * * * * * * * * *
White 935 633 24 19 911 614 87 81 824 533
Two or More Races 88 27 * 1 88 25 6 4 82 22
Hispanic or Latino 151 231 1 * 150 231 32 44 118 188
EDUCATION LEVEL                    
< High School da da da da 62 132 3 26 59 106
High School Graduate da da da da 373a 185 64 33 309 153
Some College/Associate’s Degree da da da da 392 422 48 72 344 349
College Graduate da da da da 404a 210 16 9 388a 202
EMPLOYMENT STATUS                    
Full‑Time da da da da 415 331 38 36 376 295
Part‑Time da da da da 336b 106 40 53 296b 53
Unemployed da da da da 95 110 8 31 87 80
Other1 da da da da 385 402 45 20 341 383

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.55B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4 0.3 0.1 0.1 0.5 0.4 0.4 0.4 0.5 0.4
SEX                    
Male 0.5a 0.3 0.1 0.1 0.5a 0.3 0.2 0.4 0.6a 0.3
Female 0.4 0.4 0.2 0.1 0.4 0.4 0.6 0.4 0.4 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.5a 0.3 0.1 0.1 0.5a 0.3 0.4 0.4 0.5a 0.3
AIAN 0.3 * * 0.1 0.4 * * 0.2 0.4 *
Asian 0.2 0.1 * * 0.2 0.1 * <0.1 0.2 0.1
Black or African American 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1
NHPI * * * * * * * * * *
White 0.5 0.4 0.2 0.2 0.6 0.4 0.5 0.5 0.6 0.4
Two or More Races 1.4 0.3 * 0.1 1.6 0.3 0.5 0.2 1.9 0.3
Hispanic or Latino 0.3 0.4 <0.1 * 0.3 0.5 0.4 0.5 0.3 0.5
EDUCATION LEVEL                    
< High School da da da da 0.3 0.5 0.1 0.7 0.3 0.5
High School Graduate da da da da 0.5a 0.3 0.5 0.3 0.5 0.3
Some College/Associate’s Degree da da da da 0.5 0.5 0.4 0.5 0.5 0.5
College Graduate da da da da 0.4a 0.2 0.3 0.1 0.5a 0.2
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.3 0.3 0.3 0.3 0.4 0.3
Part‑Time da da da da 1.0b 0.3 0.5 0.5 1.3b 0.2
Unemployed da da da da 0.7 0.8 0.2 0.7 0.9 0.8
Other1 da da da da 0.4 0.4 0.5 0.2 0.4 0.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.56A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 13,762 13,659 545a 395 13,217 13,264 830 930 12,387 12,334
SEX                    
Male 5,649 5,828 290a 175 5,359 5,653 344 422 5,015 5,231
Female 8,113 7,832 254 220 7,858 7,611 487 508 7,372 7,103
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 12,010 12,346 396 307 11,614 12,039 675 739 10,938 11,300
AIAN 75 84 4 9 71 75 4 6 67 68
Asian 279 381 29 17 250 364 62 37 188 327
Black or African American 1,123 1,083 71 63 1,052 1,020 81a 155 971 865
NHPI 15 21 * * 14 * * * 8 *
White 10,255 10,213 282 197 9,973 10,016 505 498 9,468 9,518
Two or More Races 264a 564 10 19 254a 545 17 39 237a 506
Hispanic or Latino 1,753 1,313 149 88 1,604 1,225 155 191 1,448 1,034
EDUCATION LEVEL                    
< High School da da da da 648 1,068 78 71 570 996
High School Graduate da da da da 2,952 2,670 285 284 2,666 2,386
Some College/Associate’s Degree da da da da 4,884 4,298 358 422 4,526 3,876
College Graduate da da da da 4,733 5,228 109 153 4,624 5,075
EMPLOYMENT STATUS                    
Full‑Time da da da da 4,672 4,765 289 315 4,383 4,450
Part‑Time da da da da 1,600 1,583 192 244 1,408 1,339
Unemployed da da da da 513 425 84 115 429 309
Other1 da da da da 6,432 6,491 265 256 6,167 6,235

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.56B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 4.8 4.7 2.1a 1.6 5.0 5.0 2.4 2.6 5.4 5.4
SEX                    
Male 4.0 4.1 2.2a 1.3 4.2 4.4 2.0 2.3 4.6 4.8
Female 5.5 5.2 2.0 1.8 5.8 5.5 2.8 2.8 6.3 5.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5.1 5.3 2.1 1.7 5.4 5.6 2.6 2.8 5.8 6.0
AIAN 5.5 4.6 1.8 3.5 6.2 4.7 2.6 3.1 6.7 5.0
Asian 1.5 2.0 1.9 1.1 1.5 2.1 2.6 1.5 1.3 2.2
Black or African American 3.2 3.1 2.0 1.9 3.3 3.3 1.8a 3.3 3.6 3.3
NHPI 1.2 2.0 * * 1.2 * * * 0.8 *
White 6.0 6.1 2.2 1.6 6.3 6.4 2.8 2.9 6.8 6.9
Two or More Races 4.1 6.0 1.0 1.4 4.7 6.7 1.5 2.3 5.5 7.9
Hispanic or Latino 3.2a 2.3 2.2 1.3 3.4 2.5 1.8 2.0 3.7a 2.6
EDUCATION LEVEL                    
< High School da da da da 2.7 4.4 2.2 1.9 2.8a 4.8
High School Graduate da da da da 4.2 3.8 2.3 2.2 4.6 4.1
Some College/Associate’s Degree da da da da 6.3 5.6 2.7 3.2 7.0 6.1
College Graduate da da da da 5.3 5.7 1.8 2.5 5.5 5.9
EMPLOYMENT STATUS                    
Full‑Time da da da da 3.9 4.0 2.1 2.3 4.1 4.3
Part‑Time da da da da 4.9 4.5 2.2 2.5 6.0 5.3
Unemployed da da da da 4.0 3.1 2.3 2.8 4.7 3.2
Other1 da da da da 6.7 6.6 3.1 3.0 7.1 6.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.57A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 920 977 64 31 857 946 76 118 781 828
SEX                    
Male 449 423 17 10 432 413 48 33 384 380
Female 472 554 47 21 425 533 28a 85 397 448
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 838 828 49 30 789 798 62 91 727 707
AIAN 14 1 * <1 13 1 * 1 13 *
Asian 13 23 * * 13 23 13 * * 23
Black or African American 42 30 3 7 39 23 5 6 34 17
NHPI * 1 * * * * * * * *
White 698 719 40 21 658 697 40 85 618 612
Two or More Races 72 54 6 * 66 54 4 * 62 54
Hispanic or Latino 82 150 14 1 68 148 14 27 54 121
EDUCATION LEVEL                    
< High School da da da da 30 66 15 2 15 64
High School Graduate da da da da 187 264 17 50 170 214
Some College/Associate’s Degree da da da da 286 261 40 32 246 229
College Graduate da da da da 354 356 4 35 351 321
EMPLOYMENT STATUS                    
Full‑Time da da da da 258 298 13 37 245 262
Part‑Time da da da da 78 93 25 27 54 66
Unemployed da da da da 45 40 5 11 40 30
Other1 da da da da 475 515 33 44 442 470

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.57B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3 0.3 0.2 0.1 0.3 0.4 0.2 0.3 0.3 0.4
SEX                    
Male 0.3 0.3 0.1 0.1 0.3 0.3 0.3 0.2 0.3 0.3
Female 0.3 0.4 0.4 0.2 0.3 0.4 0.2a 0.5 0.3 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4 0.4 0.3 0.2 0.4 0.4 0.2 0.3 0.4 0.4
AIAN 1.0 <0.1 * 0.1 1.1 <0.1 * 0.3 1.3 *
Asian 0.1 0.1 * * 0.1 0.1 0.5 * * 0.2
Black or African American 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1
NHPI * 0.1 * * * * * * * *
White 0.4 0.4 0.3 0.2 0.4 0.4 0.2 0.5 0.4 0.4
Two or More Races 1.1 0.6 0.6 * 1.2 0.7 0.4 * 1.4 0.8
Hispanic or Latino 0.2 0.3 0.2 <0.1 0.1 0.3 0.2 0.3 0.1 0.3
EDUCATION LEVEL                    
< High School da da da da 0.1 0.3 0.4 <0.1 0.1 0.3
High School Graduate da da da da 0.3 0.4 0.1 0.4 0.3 0.4
Some College/Associate’s Degree da da da da 0.4 0.3 0.3 0.2 0.4 0.4
College Graduate da da da da 0.4 0.4 0.1 0.6 0.4 0.4
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.2 0.3 0.1 0.3 0.2 0.3
Part‑Time da da da da 0.2 0.3 0.3 0.3 0.2 0.3
Unemployed da da da da 0.4 0.3 0.1 0.3 0.4 0.3
Other1 da da da da 0.5 0.5 0.4 0.5 0.5 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.58A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 254 306 11 8 243 298 35 13 208 285
SEX                    
Male 123 44 2 3 121 41 14 4 108 37
Female 130 263 9 5 122 257 21 9 100 248
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 245 241 10 8 235 232 27 8 208 225
AIAN 9 1 * * 8 1 * 1 8 *
Asian 2 * * * 2 * 2 * * *
Black or African American 26 3 <1 * 26 3 4 * 22 3
NHPI * * * * * * * * * *
White 195 185 4 8 191 177 22 7 169 170
Two or More Races 13 52 5 * 8 52 * * 8 *
Hispanic or Latino 8 66 1 * 8 66 7 5 <1 61
EDUCATION LEVEL                    
< High School da da da da 10 13 6 1 5 13
High School Graduate da da da da 64 47 12 9 52 38
Some College/Associate’s Degree da da da da 67 132 15 3 53 129
College Graduate da da da da 102 105 2 * 99 105
EMPLOYMENT STATUS                    
Full‑Time da da da da 112 107 4 2 107 105
Part‑Time da da da da 27a 3 10 3 17 *
Unemployed da da da da 27 9 3 5 24 4
Other1 da da da da 78 178 18 3 60 176

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.58B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1 0.1 <0.1 <0.1 0.1 0.1 0.1 <0.1 0.1 0.1
SEX                    
Male 0.1 <0.1 <0.1 <0.1 0.1 <0.1 0.1 <0.1 0.1 <0.1
Female 0.1 0.2 0.1 <0.1 0.1 0.2 0.1 <0.1 0.1 0.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1 0.1 0.1 <0.1 0.1 0.1 0.1 <0.1 0.1 0.1
AIAN 0.7 <0.1 * * 0.7 <0.1 * 0.3 0.8 *
Asian <0.1 * * * <0.1 * 0.1 * * *
Black or African American 0.1 <0.1 <0.1 * 0.1 <0.1 0.1 * 0.1 <0.1
NHPI * * * * * * * * * *
White 0.1 0.1 <0.1 0.1 0.1 0.1 0.1 <0.1 0.1 0.1
Two or More Races 0.2 0.5 0.4 * 0.2 0.6 * * 0.2 *
Hispanic or Latino <0.1 0.1 <0.1 * <0.1 0.1 0.1 0.1 <0.1 0.2
EDUCATION LEVEL                    
< High School da da da da <0.1 0.1 0.2 <0.1 <0.1 0.1
High School Graduate da da da da 0.1 0.1 0.1 0.1 0.1 0.1
Some College/Associate’s Degree da da da da 0.1 0.2 0.1 <0.1 0.1 0.2
College Graduate da da da da 0.1 0.1 <0.1 * 0.1 0.1
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.1 0.1 <0.1 <0.1 0.1 0.1
Part‑Time da da da da 0.1a <0.1 0.1 <0.1 0.1 *
Unemployed da da da da 0.2 0.1 0.1 0.1 0.3 <0.1
Other1 da da da da 0.1 0.2 0.2 <0.1 0.1 0.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.59A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 24,207a 22,280 371 398 23,835a 21,883 1,628 1,536 22,208a 20,346
SEX                    
Male 8,944 8,220 185 172 8,758 8,048 625 570 8,134 7,477
Female 15,263 14,061 186 226 15,077 13,835 1,003 966 14,074 12,869
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 21,251 19,685 282 323 20,969 19,362 1,281 1,196 19,688 18,166
AIAN 98 138 5 6 92 132 * 7 79 126
Asian 504 516 19 22 485 494 29 38 456 456
Black or African American 1,675 1,499 34 57 1,640 1,442 117 131 1,523 1,311
NHPI 111 37 * * 111 35 * * * 34
White 18,143 16,594 206 201 17,937 16,393 1,010 933 16,927 15,460
Two or More Races 721 901 18 36 703 865 109 86 595 779
Hispanic or Latino 2,955 2,596 89 75 2,866 2,521 347 341 2,520 2,180
EDUCATION LEVEL                    
< High School da da da da 1,568 1,524 115 189 1,453 1,335
High School Graduate da da da da 5,818 5,182 586 474 5,232 4,708
Some College/Associate’s Degree da da da da 8,000b 6,676 682 567 7,318a 6,108
College Graduate da da da da 8,450 8,501 245 306 8,206 8,195
EMPLOYMENT STATUS                    
Full‑Time da da da da 8,987 8,870 602 597 8,385 8,273
Part‑Time da da da da 3,408b 2,631 426 459 2,983b 2,171
Unemployed da da da da 1,011 901 147 191 863 710
Other1 da da da da 10,429 9,482 453b 289 9,977 9,192

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.59B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 8.4a 7.7 1.4 1.6 9.1b 8.3 4.7 4.3 9.8a 8.9
SEX                    
Male 6.3 5.8 1.4 1.3 6.9 6.3 3.6 3.1 7.4 6.8
Female 10.4a 9.4 1.5 1.8 11.2a 10.1 5.8 5.4 12.0a 10.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 9.1a 8.4 1.5 1.7 9.8a 9.0 4.9 4.5 10.5a 9.6
AIAN 7.2 7.5 2.6 2.1 8.0 8.4 * 3.2 7.9 9.2
Asian 2.7 2.7 1.3 1.4 2.8 2.8 1.2 1.5 3.1 3.0
Black or African American 4.8 4.3 1.0 1.7 5.2 4.6 2.5 2.8 5.6 5.0
NHPI 8.9 3.4 * * 9.6 3.5 * * * 3.7
White 10.6 9.9 1.6 1.7 11.4 10.5 5.7 5.4 12.1 11.2
Two or More Races 11.1 9.5 1.7 2.7 12.9 10.6 9.5 5.0 13.8 12.1
Hispanic or Latino 5.4 4.6 1.3 1.1 6.0 5.1 4.0 3.6 6.5 5.4
EDUCATION LEVEL                    
< High School da da da da 6.5 6.2 3.3 5.1 7.1 6.5
High School Graduate da da da da 8.3 7.3 4.8 3.7 9.0 8.1
Some College/Associate’s Degree da da da da 10.3b 8.6 5.1 4.3 11.3a 9.5
College Graduate da da da da 9.4 9.2 4.1 4.9 9.8 9.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 7.4 7.5 4.3 4.4 7.8 7.9
Part‑Time da da da da 10.5b 7.5 4.8 4.8 12.6b 8.6
Unemployed da da da da 7.8 6.6 4.0 4.7 9.4 7.4
Other1 da da da da 10.9a 9.6 5.4b 3.3 11.4 10.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.60A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,360 3,293 107 122 3,253 3,172 488 470 2,766 2,702
SEX                    
Male 1,668 1,389 38 45 1,630 1,343 183 188 1,447 1,155
Female 1,692 1,905 69 76 1,623 1,828 304 282 1,319 1,547
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2,826 2,763 79 97 2,747 2,666 355 332 2,393 2,334
AIAN 35 * * <1 34 * * 1 * *
Asian 70 73 * * 70 73 5 11 66 62
Black or African American 220 147 8 14 212 133 20 27 193 106
NHPI 9 1 * * 9 * * * 9 *
White 2,348 2,372 65 67 2,283 2,305 295 282 1,987 2,023
Two or More Races 143 143 5 15 139 128 28 11 111 118
Hispanic or Latino 534 530 28 25 506 505 133 138 373 368
EDUCATION LEVEL                    
< High School da da da da 242 345 41 61 200 284
High School Graduate da da da da 925 719 195 164 730 555
Some College/Associate’s Degree da da da da 1,082 1,108 198 155 884 953
College Graduate da da da da 1,004 1,000 53 90 952 910
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,298 1,198 163 169 1,135 1,028
Part‑Time da da da da 595 438 134 151 461 288
Unemployed da da da da 289 260 48 70 242 189
Other1 da da da da 1,072 1,276 143 80 929 1,197

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.60B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.2 1.1 0.4 0.5 1.2 1.2 1.4 1.3 1.2 1.2
SEX                    
Male 1.2 1.0 0.3 0.3 1.3 1.1 1.0 1.0 1.3 1.1
Female 1.1 1.3 0.5 0.6 1.2 1.3 1.8 1.6 1.1 1.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.2 1.2 0.4 0.5 1.3 1.2 1.4 1.3 1.3 1.2
AIAN 2.6 * * 0.1 3.0 * * 0.5 * *
Asian 0.4 0.4 * * 0.4 0.4 0.2 0.5 0.4 0.4
Black or African American 0.6 0.4 0.2 0.4 0.7 0.4 0.4 0.6 0.7 0.4
NHPI 0.8 0.1 * * 0.8 * * * 0.9 *
White 1.4 1.4 0.5 0.6 1.4 1.5 1.7 1.6 1.4 1.5
Two or More Races 2.2 1.5 0.5 1.1 2.5 1.6 2.4a 0.6 2.6 1.8
Hispanic or Latino 1.0 0.9 0.4 0.4 1.1 1.0 1.5 1.4 1.0 0.9
EDUCATION LEVEL                    
< High School da da da da 1.0 1.4 1.2 1.6 1.0 1.4
High School Graduate da da da da 1.3 1.0 1.6 1.3 1.3 1.0
Some College/Associate’s Degree da da da da 1.4 1.4 1.5 1.2 1.4 1.5
College Graduate da da da da 1.1 1.1 0.9 1.4 1.1 1.1
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.1 1.0 1.2 1.2 1.1 1.0
Part‑Time da da da da 1.8 1.3 1.5 1.6 2.0 1.1
Unemployed da da da da 2.2 1.9 1.3 1.7 2.6 2.0
Other1 da da da da 1.1 1.3 1.7 0.9 1.1 1.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.61A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 63,203 60,669 2,998 2,670 60,204 57,998 4,741 4,679 55,464 53,319
SEX                    
Male 29,398 27,588 1,502 1,362 27,896 26,226 2,098 2,040 25,798 24,186
Female 33,805 33,080 1,496 1,308 32,309 31,772 2,643 2,639 29,666 29,133
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 52,994 51,447 2,105 1,982 50,889 49,465 3,600 3,509 47,289 45,956
AIAN 333 415 24 43 310 372 39 40 271 332
Asian 2,397 1,849 119 125 2,278 1,724 226 259 2,053 1,465
Black or African American 7,678 8,103 424 359 7,255 7,744 668 682 6,586 7,062
NHPI 207 205 * * 194 195 * 2 175 *
White 40,908 38,612 1,386 1,280 39,522 37,332 2,457 2,313 37,065 35,019
Two or More Races 1,470b 2,263 140 164 1,330b 2,100 192 214 1,138b 1,886
Hispanic or Latino 10,209 9,222 894a 689 9,316 8,533 1,141 1,170 8,175 7,363
EDUCATION LEVEL                    
< High School da da da da 5,645 6,192 547 549 5,098 5,643
High School Graduate da da da da 16,730 16,519 1,841 1,607 14,889 14,912
Some College/Associate’s Degree da da da da 20,642 19,046 1,793 1,900 18,849a 17,147
College Graduate da da da da 17,188 16,240 561 623 16,627 15,617
EMPLOYMENT STATUS                    
Full‑Time da da da da 23,763a 21,843 1,852 1,759 21,911 20,084
Part‑Time da da da da 6,715 6,311 1,212 1,252 5,503 5,059
Unemployed da da da da 2,532 2,877 512 521 2,021 2,355
Other1 da da da da 27,194 26,968 1,166 1,148 26,029 25,820

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.61B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 21.9a 20.9 11.6 10.5 23.0a 21.9 13.6 13.0 24.4 23.3
SEX                    
Male 20.8 19.6 11.3 10.5 21.8 20.5 11.9 11.2 23.4 22.1
Female 23.0 22.1 11.8 10.5 24.0 23.1 15.2 14.7 25.3 24.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 22.7 22.0 11.1 10.6 23.7 23.0 13.8 13.2 25.1 24.3
AIAN 24.4 22.4 11.3 15.9 26.8 23.6 24.9 19.3 27.1 24.2
Asian 12.9a 9.6 7.8 8.1 13.3a 9.8 9.4 10.2 13.9a 9.7
Black or African American 21.8 23.5 11.9 10.5 22.9 24.9 14.5 14.6 24.3 26.7
NHPI 16.7 19.3 * * 16.7 19.5 * 2.4 17.3 *
White 24.0 23.0 11.0 10.7 25.0 23.9 13.9 13.3 26.4 25.3
Two or More Races 22.7 23.9 13.4 12.3 24.4 25.8 16.7 12.5 26.5 29.4
Hispanic or Latino 18.7a 16.3 12.9a 10.1 19.5a 17.2 13.0 12.3 21.0a 18.3
EDUCATION LEVEL                    
< High School da da da da 23.5 25.4 15.5 14.8 24.9 27.3
High School Graduate da da da da 23.8 23.3 15.1b 12.5 25.6 25.7
Some College/Associate’s Degree da da da da 26.5a 24.6 13.5 14.2 29.2a 26.8
College Graduate da da da da 19.1a 17.6 9.4 10.1 19.8a 18.1
EMPLOYMENT STATUS                    
Full‑Time da da da da 19.6 18.5 13.2 12.8 20.4 19.3
Part‑Time da da da da 20.7a 18.1 13.8 13.0 23.3a 20.0
Unemployed da da da da 19.6 21.0 13.9 12.8 21.9 24.5
Other1 da da da da 28.4 27.4 13.8 13.2 29.8 28.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.62A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 7,795 7,080 400 403 7,396 6,678 925 736 6,471 5,941
SEX                    
Male 4,080 3,807 161 200 3,919 3,608 395 378 3,524 3,230
Female 3,715 3,273 239 203 3,477 3,070 530a 358 2,946 2,711
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6,342 5,542 257 264 6,084 5,278 710 570 5,375 4,708
AIAN 51 66 8 10 43 56 * 3 36 53
Asian 258 151 13 14 244 137 28 19 217 118
Black or African American 1,048 826 32 45 1,016 781 141 82 875 698
NHPI 34 11 * * 34 10 * * 32 10
White 4,680 4,190 187 177 4,493 4,013 510 441 3,983 3,572
Two or More Races 272 297 18 17 254 281 22 25 232 256
Hispanic or Latino 1,454 1,539 142 139 1,311 1,400 215 167 1,096 1,233
EDUCATION LEVEL                    
< High School da da da da 942 998 113 110 829 888
High School Graduate da da da da 2,503 2,089 376 273 2,126 1,816
Some College/Associate’s Degree da da da da 2,486 2,211 345 279 2,142 1,933
College Graduate da da da da 1,465 1,378 91 75 1,374 1,304
EMPLOYMENT STATUS                    
Full‑Time da da da da 2,955 2,546 346 321 2,609 2,224
Part‑Time da da da da 877 693 226 132 651 560
Unemployed da da da da 602 573 138 115 464 458
Other1 da da da da 2,962 2,866 215 167 2,747 2,699

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.62B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2.7 2.4 1.5 1.6 2.8 2.5 2.6a 2.0 2.8 2.6
SEX                    
Male 2.9 2.7 1.2 1.5 3.1 2.8 2.2 2.1 3.2 3.0
Female 2.5 2.2 1.9 1.6 2.6 2.2 3.0a 2.0 2.5 2.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.7a 2.4 1.4 1.4 2.8a 2.5 2.7 2.1 2.9 2.5
AIAN 3.7 3.6 3.6 3.7 3.7 3.6 * 1.4 3.6 3.9
Asian 1.4 0.8 0.9 0.9 1.4 0.8 1.1 0.7 1.5 0.8
Black or African American 3.0 2.4 0.9 1.3 3.2 2.5 3.1 1.8 3.2 2.6
NHPI 2.7 1.1 * * 2.9 1.0 * * 3.1 1.1
White 2.7 2.5 1.5 1.5 2.8 2.6 2.9 2.5 2.8 2.6
Two or More Races 4.2 3.1 1.7 1.2 4.7 3.5 2.0 1.5 5.4 4.0
Hispanic or Latino 2.7 2.7 2.1 2.0 2.7 2.8 2.5 1.8 2.8 3.1
EDUCATION LEVEL                    
< High School da da da da 3.9 4.1 3.2 3.0 4.0 4.3
High School Graduate da da da da 3.6 2.9 3.1a 2.1 3.7 3.1
Some College/Associate’s Degree da da da da 3.2 2.9 2.6 2.1 3.3 3.0
College Graduate da da da da 1.6 1.5 1.5 1.2 1.6 1.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 2.4 2.2 2.5 2.3 2.4 2.1
Part‑Time da da da da 2.7 2.0 2.6a 1.4 2.8 2.2
Unemployed da da da da 4.7 4.2 3.7 2.8 5.0 4.8
Other1 da da da da 3.1 2.9 2.5 1.9 3.1 3.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.63A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,117 2,051 107 105 2,010 1,946 221 179 1,788 1,767
SEX                    
Male 1,039 1,144 28 55 1,011 1,089 83 129 927 960
Female 1,078 908 79 50 999 858 138a 51 861 807
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,666 1,617 59 72 1,607 1,545 138 151 1,468 1,394
AIAN 9 10 1 1 7 9 * <1 3 9
Asian 21 17 10 1 12 16 2 * 10 16
Black or African American 239 212 7 10 233 203 34a 8 199 195
NHPI 2 1 * * 2 1 * * * 1
White 1,286 1,189 37 59 1,249 1,131 92 139 1,157 991
Two or More Races 108 188 4 2 105 186 4 3 101 182
Hispanic or Latino 451 434 48 33 403 401 83 28 320 373
EDUCATION LEVEL                    
< High School da da da da 313 397 36 47 277 350
High School Graduate da da da da 667 525 111 69 557 456
Some College/Associate’s Degree da da da da 722 766 46 40 676 726
College Graduate da da da da 307 258 28 22 279 236
EMPLOYMENT STATUS                    
Full‑Time da da da da 620 845 46 87 574 759
Part‑Time da da da da 258a 143 73a 15 185 128
Unemployed da da da da 205 220 43 38 162 182
Other1 da da da da 926 738 59 39 867 699

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.63B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7 0.7 0.4 0.4 0.8 0.7 0.6 0.5 0.8 0.8
SEX                    
Male 0.7 0.8 0.2 0.4 0.8 0.9 0.5 0.7 0.8 0.9
Female 0.7 0.6 0.6 0.4 0.7 0.6 0.8b 0.3 0.7 0.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.7 0.3 0.4 0.7 0.7 0.5 0.6 0.8 0.7
AIAN 0.6 0.6 0.6 0.5 0.6 0.6 * 0.2 0.3 0.6
Asian 0.1 0.1 0.6 0.1 0.1 0.1 0.1 * 0.1 0.1
Black or African American 0.7 0.6 0.2 0.3 0.7 0.7 0.7a 0.2 0.7 0.7
NHPI 0.1 0.1 * * 0.1 0.1 * * * 0.1
White 0.8 0.7 0.3 0.5 0.8 0.7 0.5 0.8 0.8 0.7
Two or More Races 1.7 2.0 0.3 0.2 1.9 2.3 0.4 0.2 2.3 2.8
Hispanic or Latino 0.8 0.8 0.7 0.5 0.8 0.8 0.9a 0.3 0.8 0.9
EDUCATION LEVEL                    
< High School da da da da 1.3 1.6 1.0 1.3 1.4 1.7
High School Graduate da da da da 0.9 0.7 0.9 0.5 1.0 0.8
Some College/Associate’s Degree da da da da 0.9 1.0 0.3 0.3 1.0 1.1
College Graduate da da da da 0.3 0.3 0.5 0.4 0.3 0.3
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.5 0.7 0.3 0.6 0.5 0.7
Part‑Time da da da da 0.8a 0.4 0.8a 0.2 0.8 0.5
Unemployed da da da da 1.6 1.6 1.2 0.9 1.8 1.9
Other1 da da da da 1.0 0.7 0.7 0.4 1.0 0.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.64A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 24,907 25,821 1,890 1,909 23,017 23,912 4,191 4,292 18,827 19,620
SEX                    
Male 12,540 12,958 1,002 1,118 11,537 11,840 2,192 2,218 9,345 9,622
Female 12,367 12,863 887 791 11,480 12,072 1,998 2,074 9,482 9,998
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 21,225 21,550 1,576 1,524 19,649 20,026 3,359 3,377 16,290 16,648
AIAN 88b 229 10 10 78b 219 9 20 70a 199
Asian 828 601 57 32 771 569 192 152 579 416
Black or African American 1,818 1,919 134 145 1,684 1,774 239 273 1,445 1,501
NHPI * 57 * * * 55 * * * *
White 17,601 17,540 1,304 1,229 16,297 16,311 2,772 2,697 13,525 13,614
Two or More Races 810a 1,205 71 107 739a 1,098 145a 232 594 866
Hispanic or Latino 3,682 4,271 314 385 3,368 3,886 832 914 2,537 2,972
EDUCATION LEVEL                    
< High School da da da da 1,452 1,893 377 344 1,075a 1,549
High School Graduate da da da da 5,759 5,157 1,294 1,148 4,464 4,009
Some College/Associate’s Degree da da da da 7,734 8,219 1,727 1,778 6,006 6,441
College Graduate da da da da 8,073 8,643 792a 1,021 7,281 7,622
EMPLOYMENT STATUS                    
Full‑Time da da da da 11,958 11,934 1,686 1,665 10,272 10,269
Part‑Time da da da da 3,174 3,713 1,073 1,198 2,101 2,514
Unemployed da da da da 1,609 1,535 424 420 1,184 1,115
Other1 da da da da 6,277 6,731 1,007 1,009 5,270 5,722

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.64B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 8.6 8.9 7.3 7.5 8.8 9.0 12.0 11.9 8.3 8.6
SEX                    
Male 8.9 9.2 7.6 8.6 9.0 9.3 12.5 12.2 8.5 8.8
Female 8.4 8.6 7.0 6.4 8.5 8.8 11.5 11.6 8.1 8.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 9.1 9.2 8.3 8.2 9.2 9.3 12.8 12.7 8.6 8.8
AIAN 6.5a 12.4 4.7 3.7 6.8a 13.9 5.6 9.7 7.0a 14.5
Asian 4.4 3.1 3.8 2.1 4.5 3.2 8.0 6.0 3.9 2.8
Black or African American 5.2 5.6 3.7 4.2 5.3 5.7 5.2 5.9 5.3 5.7
NHPI * 5.4 * * * 5.5 * * * *
White 10.3 10.4 10.3 10.2 10.3 10.5 15.6 15.5 9.6 9.8
Two or More Races 12.5 12.7 6.8 8.0 13.6 13.5 12.6 13.6 13.8 13.5
Hispanic or Latino 6.7 7.6 4.5 5.6 7.1 7.8 9.5 9.6 6.5 7.4
EDUCATION LEVEL                    
< High School da da da da 6.0 7.8 10.7 9.3 5.2a 7.5
High School Graduate da da da da 8.2 7.3 10.6 8.9 7.7 6.9
Some College/Associate’s Degree da da da da 9.9 10.6 13.0 13.3 9.3 10.1
College Graduate da da da da 9.0 9.4 13.2a 16.5 8.7 8.8
EMPLOYMENT STATUS                    
Full‑Time da da da da 9.9 10.1 12.0 12.1 9.6 9.9
Part‑Time da da da da 9.8 10.6 12.2 12.4 8.9 10.0
Unemployed da da da da 12.5 11.2 11.6 10.3 12.8 11.6
Other1 da da da da 6.6 6.8 11.9 11.6 6.0 6.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.65A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 9,031 9,486 293 241 8,738 9,245 1,646 1,681 7,092 7,564
SEX                    
Male 5,633 5,631 133 96 5,500 5,535 852 891 4,648 4,644
Female 3,398 3,855 160 145 3,238 3,710 794 790 2,444 2,920
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7,531 7,630 230 179 7,301 7,451 1,286 1,297 6,015 6,154
AIAN 38 107 2 1 36 106 6 5 30 101
Asian 340 240 24 2 316 238 67 80 249 158
Black or African American 757 718 27 32 729 686 69 99 660 587
NHPI 15 26 <1 * 15 25 * * 13 *
White 6,029 6,054 162 120 5,866 5,934 1,096 1,046 4,771 4,888
Two or More Races 352 485 14 22 338 463 45 67 292 396
Hispanic or Latino 1,500 1,856 63 62 1,437 1,794 360 384 1,076 1,410
EDUCATION LEVEL                    
< High School da da da da 801 992 139 131 663 860
High School Graduate da da da da 2,658 2,179 509 402 2,149 1,776
Some College/Associate’s Degree da da da da 2,788 3,184 633 676 2,155 2,507
College Graduate da da da da 2,491 2,891 365 471 2,125 2,420
EMPLOYMENT STATUS                    
Full‑Time da da da da 4,388 4,307 756 751 3,633 3,556
Part‑Time da da da da 1,135 1,460 335 415 799 1,045
Unemployed da da da da 851 892 198 166 653 726
Other1 da da da da 2,363 2,586 357 349 2,006 2,237

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.65B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3.1 3.3 1.1 0.9 3.3 3.5 4.7 4.7 3.1 3.3
SEX                    
Male 4.0 4.0 1.0 0.7 4.3 4.3 4.9 4.9 4.2 4.2
Female 2.3 2.6 1.3 1.2 2.4 2.7 4.6 4.4 2.1 2.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.2 3.3 1.2 1.0 3.4 3.5 4.9 4.9 3.2 3.3
AIAN 2.8 5.8 1.0 0.5 3.1 6.7 4.0 2.4 3.0 7.4
Asian 1.8 1.2 1.6 0.1 1.8 1.3 2.8 3.1 1.7 1.0
Black or African American 2.1 2.1 0.8 0.9 2.3 2.2 1.5 2.1 2.4 2.2
NHPI 1.2 2.5 0.2 * 1.3 2.5 * * 1.3 *
White 3.5 3.6 1.3 1.0 3.7 3.8 6.2 6.0 3.4 3.5
Two or More Races 5.4 5.1 1.4 1.7 6.2 5.7 4.0 3.9 6.8 6.2
Hispanic or Latino 2.7 3.3 0.9 0.9 3.0 3.6 4.1 4.0 2.8 3.5
EDUCATION LEVEL                    
< High School da da da da 3.3 4.1 3.9 3.5 3.2 4.2
High School Graduate da da da da 3.8 3.1 4.2 3.1 3.7 3.1
Some College/Associate’s Degree da da da da 3.6 4.1 4.8 5.1 3.3 3.9
College Graduate da da da da 2.8 3.1 6.1 7.6 2.5 2.8
EMPLOYMENT STATUS                    
Full‑Time da da da da 3.6 3.7 5.4 5.5 3.4 3.4
Part‑Time da da da da 3.5 4.2 3.8 4.3 3.4 4.1
Unemployed da da da da 6.6 6.5 5.4 4.1 7.1 7.6
Other1 da da da da 2.5 2.6 4.2 4.0 2.3 2.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.66A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,934 4,465 80 54 3,854 4,411 466 623 3,388 3,789
SEX                    
Male 2,494 2,776 40 24 2,454 2,753 256 338 2,198 2,414
Female 1,439 1,689 40 30 1,400 1,659 210 284 1,189 1,375
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,318 3,474 66 40 3,252 3,434 346 462 2,906 2,972
AIAN 10 77 * <1 9 * <1 1 9 *
Asian 201 127 * 2 201 126 12 15 189 110
Black or African American 342 342 4 4 338 338 25 37 312 301
NHPI 2 9 <1 * 2 9 <1 * 2 8
White 2,528 2,710 55 32 2,473 2,679 293 393 2,180 2,286
Two or More Races 236 209 6 3 230 206 14 15 215 191
Hispanic or Latino 616a 991 14 14 602a 977 120 160 482a 817
EDUCATION LEVEL                    
< High School da da da da 429 678 57 46 372 632
High School Graduate da da da da 1,345 1,036 168 167 1,177 868
Some College/Associate’s Degree da da da da 1,226 1,536 167 278 1,059 1,258
College Graduate da da da da 854 1,161 74 131 780 1,030
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,726 1,776 209 288 1,518 1,488
Part‑Time da da da da 402b 821 79a 175 323a 646
Unemployed da da da da 401 522 38 53 362 469
Other1 da da da da 1,325 1,293 140 107 1,185 1,187

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.66B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.4 1.5 0.3 0.2 1.5 1.7 1.3 1.7 1.5 1.7
SEX                    
Male 1.8 2.0 0.3 0.2 1.9 2.2 1.5 1.9 2.0 2.2
Female 1.0 1.1 0.3 0.2 1.0 1.2 1.2 1.6 1.0 1.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.4 1.5 0.3 0.2 1.5 1.6 1.3 1.7 1.5 1.6
AIAN 0.7 4.2 * 0.1 0.8 * 0.2 0.7 0.9 *
Asian 1.1 0.7 * 0.1 1.2 0.7 0.5 0.6 1.3 0.7
Black or African American 1.0 1.0 0.1 0.1 1.1 1.1 0.6 0.8 1.2 1.1
NHPI 0.1 0.8 0.2 * 0.1 0.9 <0.1 * 0.2 0.9
White 1.5 1.6 0.4 0.3 1.6 1.7 1.7 2.3 1.6 1.6
Two or More Races 3.6 2.2 0.6 0.2 4.2 2.5 1.3 0.9 5.0 3.0
Hispanic or Latino 1.1a 1.8 0.2 0.2 1.3a 2.0 1.4 1.7 1.2a 2.0
EDUCATION LEVEL                    
< High School da da da da 1.8 2.8 1.6 1.2 1.8 3.1
High School Graduate da da da da 1.9 1.5 1.4 1.3 2.0 1.5
Some College/Associate’s Degree da da da da 1.6 2.0 1.3 2.1 1.6 2.0
College Graduate da da da da 0.9 1.3 1.2 2.1 0.9 1.2
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.4 1.5 1.5 2.1 1.4 1.4
Part‑Time da da da da 1.2a 2.4 0.9a 1.8 1.4a 2.6
Unemployed da da da da 3.1 3.8 1.0 1.3 3.9 4.9
Other1 da da da da 1.4 1.3 1.7 1.2 1.4 1.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.67A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 23,691 ‑‑ 1,131 ‑‑ 22,559 ‑‑ 4,015 ‑‑ 18,544
SEX                    
Male ‑‑ 13,266 ‑‑ 564 ‑‑ 12,701 ‑‑ 2,093 ‑‑ 10,608
Female ‑‑ 10,425 ‑‑ 567 ‑‑ 9,858 ‑‑ 1,921 ‑‑ 7,936
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 18,859 ‑‑ 800 ‑‑ 18,059 ‑‑ 2,962 ‑‑ 15,098
AIAN ‑‑ 220 ‑‑ 12 ‑‑ 208 ‑‑ 16 ‑‑ 192
Asian ‑‑ 678 ‑‑ 41 ‑‑ 637 ‑‑ 188 ‑‑ 449
Black or African American ‑‑ 2,095 ‑‑ 162 ‑‑ 1,934 ‑‑ 288 ‑‑ 1,645
NHPI ‑‑ 68 ‑‑ * ‑‑ 67 ‑‑ * ‑‑ *
White ‑‑ 14,757 ‑‑ 502 ‑‑ 14,254 ‑‑ 2,263 ‑‑ 11,991
Two or More Races ‑‑ 1,040 ‑‑ 81 ‑‑ 960 ‑‑ 205 ‑‑ 755
Hispanic or Latino ‑‑ 4,831 ‑‑ 332 ‑‑ 4,500 ‑‑ 1,053 ‑‑ 3,447
EDUCATION LEVEL                    
< High School da da da da ‑‑ 2,141 ‑‑ 363 ‑‑ 1,778
High School Graduate da da da da ‑‑ 5,499 ‑‑ 1,262 ‑‑ 4,237
Some College/Associate’s Degree da da da da ‑‑ 7,290 ‑‑ 1,530 ‑‑ 5,760
College Graduate da da da da ‑‑ 7,630 ‑‑ 861 ‑‑ 6,769
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 10,412 ‑‑ 1,624 ‑‑ 8,789
Part‑Time da da da da ‑‑ 3,395 ‑‑ 1,075 ‑‑ 2,321
Unemployed da da da da ‑‑ 1,948 ‑‑ 486 ‑‑ 1,462
Other1 da da da da ‑‑ 6,803 ‑‑ 830 ‑‑ 5,973

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.67B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 8.2 ‑‑ 4.4 ‑‑ 8.5 ‑‑ 11.1 ‑‑ 8.1
SEX                    
Male ‑‑ 9.4 ‑‑ 4.3 ‑‑ 9.9 ‑‑ 11.5 ‑‑ 9.7
Female ‑‑ 7.0 ‑‑ 4.6 ‑‑ 7.2 ‑‑ 10.7 ‑‑ 6.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 8.1 ‑‑ 4.3 ‑‑ 8.4 ‑‑ 11.1 ‑‑ 8.0
AIAN ‑‑ 11.9 ‑‑ 4.5 ‑‑ 13.2 ‑‑ 7.7 ‑‑ 14.0
Asian ‑‑ 3.5 ‑‑ 2.7 ‑‑ 3.6 ‑‑ 7.4 ‑‑ 3.0
Black or African American ‑‑ 6.1 ‑‑ 4.7 ‑‑ 6.2 ‑‑ 6.2 ‑‑ 6.2
NHPI ‑‑ 6.4 ‑‑ * ‑‑ 6.7 ‑‑ * ‑‑ *
White ‑‑ 8.8 ‑‑ 4.2 ‑‑ 9.1 ‑‑ 13.0 ‑‑ 8.7
Two or More Races ‑‑ 11.0 ‑‑ 6.1 ‑‑ 11.8 ‑‑ 12.0 ‑‑ 11.7
Hispanic or Latino ‑‑ 8.5 ‑‑ 4.9 ‑‑ 9.1 ‑‑ 11.1 ‑‑ 8.6
EDUCATION LEVEL                    
< High School da da da da ‑‑ 8.8 ‑‑ 9.8 ‑‑ 8.6
High School Graduate da da da da ‑‑ 7.8 ‑‑ 9.8 ‑‑ 7.3
Some College/Associate’s Degree da da da da ‑‑ 9.4 ‑‑ 11.5 ‑‑ 9.0
College Graduate da da da da ‑‑ 8.3 ‑‑ 13.9 ‑‑ 7.8
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 8.8 ‑‑ 11.9 ‑‑ 8.4
Part‑Time da da da da ‑‑ 9.7 ‑‑ 11.1 ‑‑ 9.2
Unemployed da da da da ‑‑ 14.2 ‑‑ 11.9 ‑‑ 15.2
Other1 da da da da ‑‑ 6.9 ‑‑ 9.6 ‑‑ 6.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.68A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 9,104 ‑‑ 329 ‑‑ 8,775 ‑‑ 1,373 ‑‑ 7,402
SEX                    
Male ‑‑ 5,289 ‑‑ 177 ‑‑ 5,113 ‑‑ 788 ‑‑ 4,325
Female ‑‑ 3,814 ‑‑ 152 ‑‑ 3,662 ‑‑ 585 ‑‑ 3,077
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 7,067 ‑‑ 219 ‑‑ 6,847 ‑‑ 988 ‑‑ 5,860
AIAN ‑‑ 107 ‑‑ 5 ‑‑ 103 ‑‑ 3 ‑‑ 100
Asian ‑‑ 255 ‑‑ 10 ‑‑ 245 ‑‑ 53 ‑‑ 191
Black or African American ‑‑ 754 ‑‑ 45 ‑‑ 709 ‑‑ 93 ‑‑ 615
NHPI ‑‑ 9 ‑‑ * ‑‑ 9 ‑‑ * ‑‑ 8
White ‑‑ 5,496 ‑‑ 148 ‑‑ 5,348 ‑‑ 783 ‑‑ 4,565
Two or More Races ‑‑ 445 ‑‑ 11 ‑‑ 434 ‑‑ 55 ‑‑ 380
Hispanic or Latino ‑‑ 2,037 ‑‑ 110 ‑‑ 1,928 ‑‑ 385 ‑‑ 1,542
EDUCATION LEVEL                    
< High School da da da da ‑‑ 1,216 ‑‑ 152 ‑‑ 1,065
High School Graduate da da da da ‑‑ 1,897 ‑‑ 458 ‑‑ 1,439
Some College/Associate’s Degree da da da da ‑‑ 3,113 ‑‑ 506 ‑‑ 2,607
College Graduate da da da da ‑‑ 2,549 ‑‑ 258 ‑‑ 2,291
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 3,943 ‑‑ 527 ‑‑ 3,415
Part‑Time da da da da ‑‑ 1,495 ‑‑ 401 ‑‑ 1,094
Unemployed da da da da ‑‑ 756 ‑‑ 169 ‑‑ 587
Other1 da da da da ‑‑ 2,582 ‑‑ 277 ‑‑ 2,305

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.68B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 3.1 ‑‑ 1.3 ‑‑ 3.3 ‑‑ 3.8 ‑‑ 3.2
SEX                    
Male ‑‑ 3.8 ‑‑ 1.4 ‑‑ 4.0 ‑‑ 4.3 ‑‑ 4.0
Female ‑‑ 2.5 ‑‑ 1.2 ‑‑ 2.7 ‑‑ 3.3 ‑‑ 2.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 3.0 ‑‑ 1.2 ‑‑ 3.2 ‑‑ 3.7 ‑‑ 3.1
AIAN ‑‑ 5.8 ‑‑ 1.7 ‑‑ 6.5 ‑‑ 1.4 ‑‑ 7.3
Asian ‑‑ 1.3 ‑‑ 0.7 ‑‑ 1.4 ‑‑ 2.1 ‑‑ 1.3
Black or African American ‑‑ 2.2 ‑‑ 1.3 ‑‑ 2.3 ‑‑ 2.0 ‑‑ 2.3
NHPI ‑‑ 0.9 ‑‑ * ‑‑ 0.9 ‑‑ * ‑‑ 0.9
White ‑‑ 3.3 ‑‑ 1.2 ‑‑ 3.4 ‑‑ 4.5 ‑‑ 3.3
Two or More Races ‑‑ 4.7 ‑‑ 0.8 ‑‑ 5.3 ‑‑ 3.2 ‑‑ 5.9
Hispanic or Latino ‑‑ 3.6 ‑‑ 1.6 ‑‑ 3.9 ‑‑ 4.0 ‑‑ 3.8
EDUCATION LEVEL                    
< High School da da da da ‑‑ 5.0 ‑‑ 4.1 ‑‑ 5.1
High School Graduate da da da da ‑‑ 2.7 ‑‑ 3.6 ‑‑ 2.5
Some College/Associate’s Degree da da da da ‑‑ 4.0 ‑‑ 3.8 ‑‑ 4.1
College Graduate da da da da ‑‑ 2.8 ‑‑ 4.2 ‑‑ 2.7
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 3.3 ‑‑ 3.8 ‑‑ 3.3
Part‑Time da da da da ‑‑ 4.3 ‑‑ 4.2 ‑‑ 4.3
Unemployed da da da da ‑‑ 5.5 ‑‑ 4.1 ‑‑ 6.1
Other1 da da da da ‑‑ 2.6 ‑‑ 3.2 ‑‑ 2.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.69A – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 3,486 3,536 816 1,007 668 768
AGE GROUP            
12‑17 137 195 41 37 38 34
18 or Older 3,348 3,341 774 971 630 734
18‑25 300 305 119 76 99 57
26 or Older 3,049 3,036 656 895 531 676
SEX            
Male 1,609 1,699 519 603 418 454
Female 1,876 1,838 297 404 250 314
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 2,891 2,895 667 806 557 607
AIAN 20a 56 9 6 4 5
Asian 46 92 9 51 8 51
Black or African American 370 497 81 128 73 121
NHPI 16 1 10 * 5 *
White 2,271 1,968 479 513 393 324
Two or More Races 168 281 78 108 73 106
Hispanic or Latino 595 642 149 201 111 162

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.69B – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 1.2 1.2 0.3 0.3 0.2 0.3
AGE GROUP            
12‑17 0.5 0.8 0.2 0.1 0.1 0.1
18 or Older 1.3 1.3 0.3 0.4 0.2 0.3
18‑25 0.9 0.8 0.3 0.2 0.3 0.2
26 or Older 1.3 1.3 0.3 0.4 0.2 0.3
SEX            
Male 1.1 1.2 0.4 0.4 0.3 0.3
Female 1.3 1.2 0.2 0.3 0.2 0.2
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1.2 1.2 0.3 0.3 0.2 0.3
AIAN 1.5 3.0 0.7 0.3 0.3 0.2
Asian 0.2 0.5 <0.1 0.3 <0.1 0.3
Black or African American 1.0 1.4 0.2 0.4 0.2 0.4
NHPI 1.3 0.1 0.8 * 0.4 *
White 1.3 1.2 0.3 0.3 0.2 0.2
Two or More Races 2.6 3.0 1.2 1.1 1.1 1.1
Hispanic or Latino 1.1 1.1 0.3 0.4 0.2 0.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.70A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 149,927 145,476 ‑‑ 4,149 143,653 141,327 18,697 18,125 124,955 123,202
GEOGRAPHIC DIVISION                    
Northeast 26,319 24,798 ‑‑ 624 25,350 24,174 3,360 2,946 21,991 21,229
New England 8,211 7,557 ‑‑ 181 7,914 7,376 1,007 919 6,908 6,456
Middle Atlantic 18,108 17,241 ‑‑ 442 17,436 16,799 2,353 2,026 15,083 14,772
Midwest 31,951 31,169 ‑‑ 807 30,746 30,362 4,048 4,098 26,698 26,264
East North Central 22,002 21,679 ‑‑ 548 21,201 21,131 2,764 2,919 18,437 18,211
West North Central 9,948 9,491 ‑‑ 259 9,545 9,232 1,284 1,179 8,262 8,053
South 53,493 52,657 ‑‑ 1,754 50,954 50,903 6,705 6,661 44,249 44,242
South Atlantic 29,696 29,225 ‑‑ 905 28,375 28,320 3,684 3,549 24,691 24,772
East South Central 8,125 8,061 ‑‑ 264 7,789 7,797 856 963 6,933 6,834
West South Central 15,672 15,370 ‑‑ 585 14,790 14,786 2,165 2,149 12,625 12,637
West 38,164 36,852 ‑‑ 964 36,602 35,888 4,584 4,421 32,017 31,467
Mountain 13,009 12,110 ‑‑ 378 12,430 11,731 1,578 1,529 10,852 10,202
Pacific 25,155 24,743 ‑‑ 586 24,171 24,157 3,006 2,892 21,165 21,265
COUNTY TYPE                    
Large Metro 85,864 82,069 ‑‑ 2,233 82,309 79,836 10,320 10,411 71,989 69,425
Small Metro 47,409 46,795 ‑‑ 1,494 45,336 45,301 6,300 5,774 39,037 39,527
Nonmetro 16,655 16,612 ‑‑ 423 16,007 16,190 2,078 1,941 13,929 14,249
Urbanized 6,668 6,344 ‑‑ 138 6,396 6,206 1,085 805 5,310 5,401
Less Urbanized 6,101 6,911 ‑‑ 195 5,897 6,715 661 782 5,236 5,933
Completely Rural 3,886 3,358 ‑‑ 89 3,714 3,268 331 353 3,383 2,915
POVERTY LEVEL1                    
Less Than 100% 21,637 22,883 ‑‑ 1,089 20,304 21,794 4,052a 4,814 16,252 16,980
100‑199% 26,152b 29,072 ‑‑ 1,072 24,733b 28,000 4,433 4,346 20,300b 23,654
200% or More 102,100b 93,370 ‑‑ 1,989 98,578b 91,381 10,174b 8,813 88,403a 82,568
HEALTH INSURANCE2                    
Private 93,310b 85,870 ‑‑ 1,919 89,932b 83,951 10,898 10,758 79,034b 73,193
Medicaid/CHIP 30,017 30,993 ‑‑ 2,126 27,312 28,867 4,551 4,478 22,761 24,389
Other3 37,855 39,543 ‑‑ 248 37,532 39,295 1,440a 1,169 36,092 38,126
No Coverage 12,664 12,652 ‑‑ 192 12,364 12,460 2,581 2,333 9,782 10,127

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.70B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 52.0b 50.1 ‑‑ 16.3 54.8a 53.3 53.5b 50.2 55.0 53.8
GEOGRAPHIC DIVISION                    
Northeast 52.9a 49.5 ‑‑ 15.6 55.5 52.4 56.9b 48.5 55.3 53.0
New England 61.4 56.2 ‑‑ 17.8 64.2 59.3 61.2 55.5 64.6 59.9
Middle Atlantic 49.8 47.0 ‑‑ 14.9 52.3 49.9 55.2b 45.9 51.9 50.5
Midwest 54.2 52.6 ‑‑ 15.2 57.5 56.3 55.5 54.9 57.8 56.5
East North Central 54.4 53.3 ‑‑ 15.4 57.6 56.9 55.8 57.6 57.8 56.8
West North Central 54.0 51.1 ‑‑ 14.9 57.2 54.9 55.0 49.1 57.6 55.8
South 48.0 46.7 ‑‑ 17.3 50.4 49.6 49.6 47.4 50.5 49.9
South Atlantic 50.2 48.9 ‑‑ 17.9 52.5 51.8 54.1 50.1 52.3 52.0
East South Central 48.5 47.7 ‑‑ 17.4 51.3 50.7 41.8 45.1 52.8 51.6
West South Central 44.0 42.6 ‑‑ 16.4 46.3 45.4 46.6 44.4 46.2 45.6
West 56.1 53.9 ‑‑ 16.0 59.1 57.5 55.6 52.0 59.6 58.4
Mountain 58.6a 54.1 ‑‑ 18.4 61.7a 57.7 56.2 52.4 62.6 58.6
Pacific 54.8 53.8 ‑‑ 14.8 57.8 57.4 55.4 51.9 58.2 58.3
COUNTY TYPE                    
Large Metro 51.7a 49.5 ‑‑ 15.4 54.5 52.7 53.9a 50.6 54.6 53.1
Small Metro 53.4a 51.4 ‑‑ 18.2 56.2 54.7 54.4b 49.5 56.5 55.5
Nonmetro 49.8 49.4 ‑‑ 15.4 52.2 52.5 49.3 50.2 52.6 52.8
Urbanized 50.0 52.2 ‑‑ 14.0 52.0 55.6 53.7 54.7 51.6 55.7
Less Urbanized 51.3 50.5 ‑‑ 16.8 54.3 53.7 48.7 49.7 55.1 54.2
Completely Rural 47.2 43.2 ‑‑ 14.9 49.4 45.5 39.6 43.2 50.7 45.8
POVERTY LEVEL1                    
Less Than 100% 46.6 46.9 ‑‑ 19.3 49.6 50.6 48.4 48.9 49.9 51.0
100‑199% 47.0 47.7 ‑‑ 18.8 49.1 50.7 52.2 51.3 48.5 50.6
200% or More 54.9b 51.7 ‑‑ 14.1 57.7b 54.9 56.7b 50.5 57.8b 55.4
HEALTH INSURANCE2                    
Private 53.1b 50.2 ‑‑ 13.8 55.8b 53.4 55.3a 52.1 55.9b 53.6
Medicaid/CHIP 50.9 50.7 ‑‑ 20.3 56.3 57.0 50.7 48.1 57.5 59.0
Other3 47.8 47.5 ‑‑ 17.1 48.2 48.0 51.5a 43.6 48.1 48.2
No Coverage 50.2 50.7 ‑‑ 17.1 51.5 52.3 51.2 47.2 51.6 53.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.71A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 73,637a 69,791 ‑‑ 2,851 69,720 66,940 13,299 13,094 56,421 53,846
GEOGRAPHIC DIVISION                    
Northeast 13,119 12,913 ‑‑ 387 12,497 12,526 2,417 2,204 10,080 10,322
New England 4,226 4,029 ‑‑ 129 4,038 3,900 731 679 3,308 3,221
Middle Atlantic 8,893 8,885 ‑‑ 259 8,459 8,626 1,686 1,525 6,772 7,101
Midwest 16,457 15,286 ‑‑ 585 15,700 14,701 2,952 3,044 12,748 11,657
East North Central 11,344 10,828 ‑‑ 392 10,815 10,436 2,028 2,181 8,787 8,255
West North Central 5,113 4,458 ‑‑ 193 4,886 4,265 924 862 3,961 3,402
South 24,808 23,137 ‑‑ 1,208 23,238 21,929 4,545 4,622 18,693 17,306
South Atlantic 14,127a 12,486 ‑‑ 614 13,317 11,872 2,577 2,526 10,740a 9,346
East South Central 3,563 3,506 ‑‑ 184 3,338 3,322 547 645 2,791 2,677
West South Central 7,117 7,145 ‑‑ 410 6,584 6,735 1,421 1,451 5,163 5,284
West 19,253 18,455 ‑‑ 670 18,285 17,785 3,385 3,224 14,900 14,561
Mountain 6,924 6,041 ‑‑ 264 6,547 5,776 1,169 1,018 5,378 4,759
Pacific 12,328 12,414 ‑‑ 406 11,738 12,008 2,216 2,206 9,522 9,802
COUNTY TYPE                    
Large Metro 42,792 40,682 ‑‑ 1,555 40,569 39,127 7,493 7,815 33,076 31,312
Small Metro 22,808 21,790 ‑‑ 1,000 21,497 20,790 4,359 3,970 17,139 16,820
Nonmetro 8,037 7,319 ‑‑ 295 7,654 7,024 1,447 1,310 6,207 5,714
Urbanized 3,242 2,845 ‑‑ 92 3,108 2,753 774 564 2,333 2,189
Less Urbanized 2,949 3,055 ‑‑ 128 2,823 2,927 449 508 2,374 2,418
Completely Rural 1,846 1,419 ‑‑ 76 1,723 1,344 224 237 1,499 1,106
POVERTY LEVEL1                    
Less Than 100% 13,325 13,677 ‑‑ 731 12,507 12,947 2,991a 3,655 9,516 9,292
100‑199% 13,964 15,192 ‑‑ 775 13,052 14,417 3,143 3,129 9,909a 11,288
200% or More 46,328b 40,788 ‑‑ 1,346 44,141b 39,442 7,145b 6,176 36,996b 33,266
HEALTH INSURANCE2                    
Private 42,764b 39,119 ‑‑ 1,347 40,668a 37,771 7,741 7,799 32,927a 29,973
Medicaid/CHIP 18,373 18,352 ‑‑ 1,466 16,661 16,886 3,207 3,236 13,454 13,650
Other3 13,580 13,015 ‑‑ 120 13,406 12,895 972 828 12,433 12,067
No Coverage 7,616 7,440 ‑‑ 127 7,433 7,312 1,909 1,638 5,524 5,675

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.71B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 25.5b 24.0 ‑‑ 11.2 26.6a 25.3 38.1 36.3 24.8a 23.5
GEOGRAPHIC DIVISION                    
Northeast 26.4 25.8 ‑‑ 9.7 27.4 27.2 40.9 36.3 25.4 25.8
New England 31.6 29.9 ‑‑ 12.6 32.7 31.4 44.4 41.0 30.9 29.9
Middle Atlantic 24.5 24.2 ‑‑ 8.7 25.4 25.6 39.6 34.5 23.3 24.3
Midwest 27.9a 25.8 ‑‑ 11.0 29.3 27.3 40.5 40.8 27.6a 25.1
East North Central 28.0 26.6 ‑‑ 11.0 29.4 28.1 40.9 43.1 27.6 25.8
West North Central 27.7a 24.0 ‑‑ 11.1 29.3a 25.4 39.6 35.9 27.6a 23.6
South 22.2a 20.5 ‑‑ 11.9 23.0a 21.4 33.6 32.9 21.3a 19.5
South Atlantic 23.9b 20.9 ‑‑ 12.2 24.6b 21.7 37.8 35.7 22.7b 19.6
East South Central 21.3 20.7 ‑‑ 12.1 22.0 21.6 26.7 30.2 21.2 20.2
West South Central 20.0 19.8 ‑‑ 11.5 20.6 20.7 30.6 30.0 18.9 19.1
West 28.3 27.0 ‑‑ 11.1 29.5 28.5 41.1 38.0 27.7 27.0
Mountain 31.2a 27.0 ‑‑ 12.9 32.5a 28.4 41.6a 34.9 31.0 27.3
Pacific 26.9 27.0 ‑‑ 10.2 28.1 28.5 40.8 39.6 26.2 26.9
COUNTY TYPE                    
Large Metro 25.8 24.5 ‑‑ 10.7 26.9 25.9 39.1 38.0 25.1 23.9
Small Metro 25.7a 23.9 ‑‑ 12.2 26.7 25.1 37.6a 34.0 24.8 23.6
Nonmetro 24.0 21.8 ‑‑ 10.8 24.9 22.8 34.3 33.9 23.5 21.2
Urbanized 24.3 23.4 ‑‑ 9.3 25.2 24.7 38.3 38.3 22.7 22.6
Less Urbanized 24.8 22.3 ‑‑ 11.0 26.0 23.4 33.0 32.3 25.0 22.1
Completely Rural 22.4 18.2 ‑‑ 12.6 22.9 18.7 26.8 29.0 22.4a 17.4
POVERTY LEVEL1                    
Less Than 100% 28.7 28.0 ‑‑ 12.9 30.6 30.0 35.8 37.1 29.2 27.9
100‑199% 25.1 24.9 ‑‑ 13.6 25.9 26.1 37.0 37.0 23.7 24.1
200% or More 24.9b 22.6 ‑‑ 9.6 25.8b 23.7 39.8b 35.4 24.2a 22.3
HEALTH INSURANCE2                    
Private 24.3a 22.9 ‑‑ 9.7 25.3 24.0 39.3 37.8 23.3 21.9
Medicaid/CHIP 31.1 30.0 ‑‑ 14.0 34.3 33.4 35.7 34.8 34.0 33.0
Other3 17.2 15.6 ‑‑ 8.3 17.2 15.8 34.8 30.8 16.6 15.2
No Coverage 30.2 29.8 ‑‑ 11.3 31.0 30.7 37.9a 33.1 29.1 30.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.72A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 48,224 47,546 1,950b 1,482 46,273 46,064 8,884 8,808 37,390 37,257
GEOGRAPHIC DIVISION                    
Northeast 9,027 8,800 332a 212 8,694 8,587 1,703 1,580 6,991 7,007
New England 3,013 2,796 123 80 2,891 2,717 524 516 2,367 2,201
Middle Atlantic 6,013 6,003 210 132 5,804 5,871 1,179 1,065 4,624 4,806
Midwest 10,872 10,789 374 319 10,499 10,470 2,019 2,021 8,480 8,449
East North Central 7,519 7,675 261 216 7,258 7,458 1,404 1,453 5,854 6,005
West North Central 3,353 3,114 113 103 3,241 3,011 615 567 2,625 2,444
South 15,843 15,064 784 615 15,059 14,449 2,940 3,026 12,119 11,423
South Atlantic 8,890 8,473 416 321 8,474 8,152 1,702 1,721 6,772 6,431
East South Central 2,219 2,122 97 79 2,122 2,043 355 400 1,766 1,642
West South Central 4,734 4,469 271 214 4,463 4,254 882 904 3,581 3,350
West 12,482 12,894 460 336 12,021 12,558 2,222 2,181 9,799 10,377
Mountain 4,462 4,167 198 129 4,264 4,038 745 705 3,519 3,333
Pacific 8,020 8,727 263 207 7,757 8,520 1,478 1,476 6,280 7,044
COUNTY TYPE                    
Large Metro 28,157 27,728 1,056a 801 27,101 26,927 5,070 5,260 22,030 21,667
Small Metro 14,657 14,888 688 544 13,969 14,344 2,839 2,651 11,129 11,693
Nonmetro 5,410 4,930 205 137 5,204 4,793 974 897 4,230 3,896
Urbanized 2,176 1,925 79a 40 2,096 1,886 512 398 1,585 1,488
Less Urbanized 2,008 1,997 72 59 1,936 1,938 307 324 1,629 1,614
Completely Rural 1,226 1,008 54 38 1,172 970 156 176 1,017 794
POVERTY LEVEL1                    
Less Than 100% 9,333 10,086 412 370 8,921 9,716 2,068a 2,531 6,853 7,185
100‑199% 9,454 10,411 465 440 8,988 9,971 2,007 2,148 6,981 7,823
200% or More 29,427a 26,973 1,073b 672 28,354 26,301 4,799b 4,053 23,555 22,248
HEALTH INSURANCE2                    
Private 26,666 25,557 1,004b 619 25,662 24,938 4,993 5,099 20,669 19,838
Medicaid/CHIP 13,093 13,504 865 871 12,228 12,633 2,233 2,281 9,996 10,352
Other3 8,718 8,751 101 64 8,617 8,687 638 535 7,979 8,152
No Coverage 5,429 5,281 108a 47 5,321 5,234 1,331 1,189 3,990 4,045

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.72B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 16.7 16.4 7.5b 5.8 17.6 17.4 25.4 24.4 16.4 16.3
GEOGRAPHIC DIVISION                    
Northeast 18.1 17.6 8.1a 5.3 19.0 18.6 28.8 26.0 17.6 17.5
New England 22.5 20.8 11.8 7.8 23.4 21.9 31.9 31.1 22.1 20.4
Middle Atlantic 16.5 16.4 6.9 4.4 17.4 17.4 27.7 24.1 15.9 16.4
Midwest 18.5 18.2 6.9 6.0 19.6 19.4 27.7 27.1 18.3 18.2
East North Central 18.6 18.9 7.2 6.1 19.7 20.1 28.3 28.7 18.4 18.7
West North Central 18.2 16.8 6.4 5.9 19.4 17.9 26.3 23.6 18.3 16.9
South 14.2 13.4 7.6 6.1 14.9 14.1 21.8 21.5 13.8 12.9
South Atlantic 15.0 14.2 8.1 6.4 15.7 14.9 25.0 24.3 14.3 13.5
East South Central 13.3 12.6 6.3 5.2 14.0 13.3 17.3 18.7 13.4 12.4
West South Central 13.3 12.4 7.4 6.0 14.0 13.1 19.0 18.7 13.1 12.1
West 18.3 18.9 7.5 5.6 19.4 20.1 27.0 25.7 18.2 19.3
Mountain 20.1 18.6 9.6a 6.3 21.2 19.9 26.5 24.2 20.3 19.1
Pacific 17.5 19.0 6.4 5.2 18.6 20.3 27.2 26.5 17.3 19.3
COUNTY TYPE                    
Large Metro 17.0 16.7 7.0a 5.5 17.9 17.8 26.5 25.6 16.7 16.6
Small Metro 16.5 16.4 8.5a 6.6 17.3 17.3 24.5 22.7 16.1 16.4
Nonmetro 16.2 14.7 7.4a 5.0 17.0 15.5 23.1 23.2 16.0 14.4
Urbanized 16.3 15.8 7.7a 4.0 17.0 16.9 25.3 27.0 15.4 15.4
Less Urbanized 16.9 14.6 7.0 5.1 17.8 15.5 22.6 20.6 17.1 14.8
Completely Rural 14.9 13.0 7.5 6.4 15.6 13.5 18.6 21.5 15.2 12.5
POVERTY LEVEL1                    
Less Than 100% 20.1 20.7 7.5 6.5 21.8 22.5 24.7 25.7 21.0 21.6
100‑199% 17.0 17.1 8.7 7.7 17.9 18.1 23.6 25.4 16.7 16.7
200% or More 15.8 14.9 7.1b 4.8 16.6 15.8 26.8b 23.2 15.4 14.9
HEALTH INSURANCE2                    
Private 15.2 14.9 6.9b 4.5 15.9 15.9 25.3 24.7 14.6 14.5
Medicaid/CHIP 22.2 22.1 8.3 8.3 25.2 25.0 24.9 24.5 25.3 25.1
Other3 11.0 10.5 7.3 4.4 11.1 10.6 22.8 20.0 10.6 10.3
No Coverage 21.5 21.2 8.9a 4.2 22.2 22.0 26.4 24.0 21.0 21.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.73A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 137,055 136,335 3,363a 2,915 133,692 133,420 17,068 17,221 116,624 116,199
GEOGRAPHIC DIVISION                    
Northeast 24,335 23,402 545 434 23,790 22,968 3,098 2,854 20,692 20,114
New England 7,829 7,275 184 131 7,645 7,144 942 886 6,704 6,259
Middle Atlantic 16,505 16,127 361 303 16,145 15,824 2,157 1,968 13,988 13,856
Midwest 29,569 29,572 659 551 28,910 29,021 3,791 3,877 25,119 25,144
East North Central 20,371 20,602 442 379 19,928 20,223 2,597 2,790 17,331 17,433
West North Central 9,199 8,969 217 172 8,982 8,797 1,194 1,087 7,788 7,710
South 48,550 48,786 1,360 1,224 47,191 47,562 5,938 6,314 41,253 41,248
South Atlantic 27,301 27,358 673 660 26,628 26,698 3,345 3,397 23,283 23,300
East South Central 7,355 7,480 231 172 7,124 7,309 767 910 6,358 6,399
West South Central 13,894 13,948 456 392 13,438 13,555 1,826 2,006 11,612 11,549
West 34,600 34,575 800 705 33,800 33,869 4,241 4,176 29,560 29,693
Mountain 11,765 11,332 294 270 11,470 11,062 1,463 1,417 10,008 9,645
Pacific 22,835 23,243 505 435 22,330 22,807 2,778 2,759 19,552 20,048
COUNTY TYPE                    
Large Metro 78,267 77,159 1,743 1,533 76,523 75,626 9,449 9,884 67,074 65,743
Small Metro 43,456 43,650 1,222 1,091 42,234 42,559 5,750 5,521 36,484 37,038
Nonmetro 15,331 15,526 397 291 14,935 15,234 1,869 1,816 13,065 13,418
Urbanized 6,121 5,939 150 103 5,971 5,836 984 747 4,987 5,089
Less Urbanized 5,648 6,466 128 130 5,520 6,336 585 736 4,935 5,600
Completely Rural 3,562 3,121 119a 58 3,443 3,063 300 333 3,143 2,729
POVERTY LEVEL1                    
Less Than 100% 18,997a 21,042 722 809 18,275a 20,233 3,693a 4,526 14,582 15,708
100‑199% 23,743b 26,759 805 708 22,938b 26,052 3,973 4,097 18,965b 21,955
200% or More 94,284a 88,393 1,836b 1,398 92,449a 86,995 9,372a 8,459 83,077a 78,537
HEALTH INSURANCE2                    
Private 85,783a 81,056 1,746b 1,294 84,038 79,762 9,976 10,251 74,062a 69,511
Medicaid/CHIP 26,608 28,334 1,562 1,529 25,047 26,805 4,155 4,187 20,892 22,618
Other3 35,161 36,927 171 194 34,991 36,734 1,252 1,138 33,739 35,596
No Coverage 11,584 11,857 154 142 11,430 11,715 2,365 2,222 9,065 9,493

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.73B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 47.5 46.9 13.0a 11.5 51.0 50.3 48.8 47.7 51.3 50.7
GEOGRAPHIC DIVISION                    
Northeast 48.9 46.7 13.3 10.9 52.1 49.8 52.4a 47.0 52.1 50.2
New England 58.5 54.1 17.6 12.9 62.0 57.5 57.3 53.4 62.7 58.1
Middle Atlantic 45.4 44.0 11.9 10.2 48.4 47.0 50.6 44.6 48.1 47.3
Midwest 50.2 49.9 12.2 10.4 54.0 53.8 52.0 51.9 54.4 54.1
East North Central 50.3 50.7 12.1 10.6 54.1 54.5 52.4 55.1 54.4 54.4
West North Central 49.9 48.3 12.3 9.9 53.9 52.3 51.1 45.2 54.3 53.5
South 43.5 43.3 13.2 12.1 46.6 46.3 44.0 44.9 47.1 46.6
South Atlantic 46.2 45.8 13.1 13.1 49.3 48.8 49.1 48.0 49.3 48.9
East South Central 43.9 44.2 14.9 11.3 46.9 47.5 37.4 42.6 48.4 48.3
West South Central 39.0 38.6 12.5 11.0 42.0 41.7 39.3 41.5 42.5 41.7
West 50.8 50.6 13.0 11.7 54.6 54.3 51.5 49.2 55.0 55.1
Mountain 53.0 50.7 14.3 13.2 57.0 54.4 52.0 48.6 57.8 55.4
Pacific 49.8 50.5 12.4 11.0 53.4 54.2 51.2 49.5 53.7 54.9
COUNTY TYPE                    
Large Metro 47.1 46.5 11.6 10.6 50.7 50.0 49.4 48.1 50.9 50.3
Small Metro 49.0 47.9 15.1 13.3 52.4 51.4 49.6 47.3 52.8 52.0
Nonmetro 45.8 46.2 14.2a 10.6 48.7 49.4 44.3 47.0 49.4 49.7
Urbanized 45.9 48.9 14.4 10.5 48.5 52.3 48.7 50.7 48.5 52.5
Less Urbanized 47.5 47.3 12.4 11.2 50.8 50.6 43.1 46.8 52.0 51.2
Completely Rural 43.2 40.1 16.5 9.7 45.8 42.7 35.8 40.8 47.1 42.9
POVERTY LEVEL1                    
Less Than 100% 40.9 43.2 13.1 14.3 44.6 46.9 44.2 46.0 44.8 47.2
100‑199% 42.7 43.9 15.1 12.4 45.6 47.2 46.8 48.4 45.3 46.9
200% or More 50.7a 49.0 12.1b 9.9 54.1a 52.3 52.2b 48.4 54.3 52.7
HEALTH INSURANCE2                    
Private 48.8a 47.4 11.9b 9.3 52.2 50.7 50.6 49.7 52.4 50.9
Medicaid/CHIP 45.1 46.4 14.9 14.6 51.6 53.0 46.3 45.0 52.8 54.8
Other3 44.4 44.3 12.4 13.3 45.0 44.9 44.8 42.4 45.0 45.0
No Coverage 46.0 47.5 12.7 12.6 47.6 49.2 46.9 44.9 47.8 50.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.74A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 64,194 61,590 2,694b 2,223 61,500 59,367 12,226 12,167 49,274 47,199
GEOGRAPHIC DIVISION                    
Northeast 11,785 11,666 463a 319 11,322 11,347 2,279 2,120 9,044 9,226
New England 3,939 3,727 141 102 3,798 3,625 702 640 3,096 2,985
Middle Atlantic 7,846 7,938 321 217 7,524 7,722 1,576 1,480 5,948 6,241
Midwest 14,775 13,797 538 446 14,236 13,351 2,776 2,793 11,460 10,558
East North Central 10,179 9,748 373 311 9,806 9,436 1,935 2,010 7,871 7,426
West North Central 4,596 4,049 165 135 4,431 3,914 842 783 3,589 3,132
South 20,846 19,858 1,067 947 19,779 18,911 4,041 4,293 15,738 14,619
South Atlantic 11,978 11,016 540 505 11,438 10,511 2,310 2,385 9,128 8,126
East South Central 2,907 2,925 163 133 2,744 2,792 486 599 2,258 2,193
West South Central 5,961 5,917 364 309 5,597 5,608 1,245 1,309 4,353 4,299
West 16,787 16,270 626 511 16,162 15,758 3,130 2,961 13,032 12,797
Mountain 6,081a 5,104 240 194 5,842 4,910 1,080 934 4,762 3,976
Pacific 10,706 11,166 386 317 10,320 10,848 2,050 2,027 8,270 8,821
COUNTY TYPE                    
Large Metro 37,276 36,081 1,443 1,231 35,833 34,851 6,909 7,279 28,924 27,572
Small Metro 19,886 19,192 963 786 18,923 18,406 3,970 3,684 14,952 14,722
Nonmetro 7,032 6,316 287 206 6,744 6,110 1,347 1,204 5,397 4,906
Urbanized 2,855 2,528 86 71 2,769 2,457 723a 509 2,046 1,948
Less Urbanized 2,635 2,558 100 84 2,535 2,474 415 474 2,120 2,000
Completely Rural 1,541 1,231 101 51 1,440 1,180 209 222 1,231 958
POVERTY LEVEL1                    
Less Than 100% 11,197 11,995 566 577 10,631 11,418 2,755a 3,361 7,876 8,058
100‑199% 12,055 13,252 665 578 11,390 12,674 2,872 2,864 8,518a 9,811
200% or More 40,923b 36,219 1,463b 1,069 39,461b 35,150 6,581a 5,819 32,880b 29,331
HEALTH INSURANCE2                    
Private 37,528a 34,759 1,396b 1,035 36,132a 33,724 7,133 7,259 28,999a 26,465
Medicaid/CHIP 15,792 16,122 1,230 1,169 14,562 14,952 2,928 2,969 11,634 11,983
Other3 11,449 10,846 125 105 11,324 10,741 881 797 10,443 9,943
No Coverage 6,698 6,617 128 101 6,571 6,516 1,751 1,529 4,820 4,988

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.74B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 22.3a 21.2 10.4b 8.7 23.4a 22.4 35.0 33.7 21.7 20.6
GEOGRAPHIC DIVISION                    
Northeast 23.7 23.3 11.3a 8.0 24.8 24.6 38.6 34.9 22.8 23.0
New England 29.5 27.7 13.5 10.0 30.8 29.2 42.7 38.6 29.0 27.7
Middle Atlantic 21.6 21.7 10.6 7.3 22.6 22.9 37.0 33.5 20.5 21.3
Midwest 25.1 23.3 10.0 8.4 26.6 24.8 38.1 37.4 24.8 22.7
East North Central 25.1 24.0 10.2 8.7 26.6 25.4 39.0 39.7 24.7 23.2
West North Central 24.9a 21.8 9.4 7.7 26.6a 23.3 36.0 32.6 25.0 21.7
South 18.7 17.6 10.3 9.3 19.5 18.4 29.9 30.5 18.0 16.5
South Atlantic 20.2 18.4 10.5 10.0 21.2 19.2 33.9 33.7 19.3a 17.1
East South Central 17.4 17.3 10.5 8.7 18.1 18.1 23.7 28.1 17.2 16.5
West South Central 16.7 16.4 10.0 8.7 17.5 17.2 26.8 27.0 15.9 15.5
West 24.7 23.8 10.2 8.5 26.1 25.3 38.0 34.9 24.3 23.7
Mountain 27.4b 22.8 11.6 9.5 29.0b 24.2 38.4a 32.0 27.5a 22.8
Pacific 23.3 24.3 9.5 8.0 24.7 25.8 37.8 36.4 22.7 24.2
COUNTY TYPE                    
Large Metro 22.5 21.8 9.6 8.5 23.7 23.0 36.1 35.4 21.9 21.1
Small Metro 22.4 21.1 11.9a 9.6 23.5 22.2 34.3 31.6 21.7 20.7
Nonmetro 21.0 18.8 10.3a 7.5 22.0 19.8 31.9 31.2 20.4 18.2
Urbanized 21.4 20.8 8.3 7.2 22.5 22.0 35.8 34.5 19.9 20.1
Less Urbanized 22.2 18.7 9.7 7.2 23.4 19.8 30.6 30.1 22.3 18.3
Completely Rural 18.7 15.8 14.0 8.5 19.2 16.4 24.9 27.2 18.4 15.1
POVERTY LEVEL1                    
Less Than 100% 24.1 24.6 10.3 10.2 26.0 26.5 32.9 34.2 24.2 24.2
100‑199% 21.7 21.7 12.5 10.1 22.6 22.9 33.8 33.8 20.4 21.0
200% or More 22.0b 20.1 9.7b 7.6 23.1b 21.1 36.7b 33.3 21.5b 19.7
HEALTH INSURANCE2                    
Private 21.4 20.3 9.5b 7.5 22.4 21.4 36.2 35.2 20.5 19.4
Medicaid/CHIP 26.8 26.4 11.8 11.1 30.0 29.5 32.6 31.9 29.4 29.0
Other3 14.5 13.0 9.1 7.2 14.6 13.1 31.5 29.7 13.9 12.6
No Coverage 26.6 26.5 10.6 8.9 27.4 27.3 34.7 30.9 25.4 26.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.75A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 44,266 43,776 1,554a 1,279 42,712 42,497 8,439 8,405 34,273 34,092
GEOGRAPHIC DIVISION                    
Northeast 8,366 8,240 255 196 8,112 8,044 1,645 1,528 6,466 6,516
New England 2,879 2,637 91 76 2,788 2,561 509 475 2,279 2,086
Middle Atlantic 5,487 5,603 164 119 5,324 5,483 1,136 1,053 4,187 4,430
Midwest 10,082 10,153 306 263 9,775 9,890 1,944 1,916 7,831 7,974
East North Central 6,968 7,166 207 187 6,761 6,979 1,367 1,379 5,394 5,599
West North Central 3,113 2,987 99 76 3,014 2,911 577 537 2,437 2,374
South 14,301 13,688 618 520 13,683 13,168 2,720 2,861 10,963 10,307
South Atlantic 8,049 7,818 309 290 7,740 7,528 1,599 1,625 6,141 5,903
East South Central 2,019 1,928 87 66 1,932 1,862 335 385 1,598 1,477
West South Central 4,232 3,941 222 163 4,010 3,778 786 851 3,224 2,927
West 11,517 11,695 375 300 11,142 11,395 2,130 2,100 9,013 9,296
Mountain 4,133 3,702 147 119 3,986 3,583 716 691 3,270 2,892
Pacific 7,384 7,993 228 181 7,156 7,812 1,413 1,408 5,742 6,404
COUNTY TYPE                    
Large Metro 25,818 25,652 798 712 25,020 24,940 4,813 5,024 20,207 19,916
Small Metro 13,456 13,573 592 475 12,865 13,099 2,703 2,498 10,161 10,601
Nonmetro 4,992 4,551 165a 92 4,827 4,458 923 882 3,904 3,576
Urbanized 2,015 1,791 54 35 1,961 1,756 493 386 1,468 1,370
Less Urbanized 1,874 1,811 62 38 1,812 1,773 288 321 1,524 1,452
Completely Rural 1,102 949 49 20 1,054 930 141 176 912 754
POVERTY LEVEL1                    
Less Than 100% 8,522 9,001 326 319 8,196 8,682 1,988 2,391 6,208 6,291
100‑199% 8,695 9,721 372 367 8,323 9,354 1,879 2,071 6,445 7,283
200% or More 27,038a 24,978 856b 593 26,182 24,385 4,562b 3,867 21,619 20,518
HEALTH INSURANCE2                    
Private 24,597 23,667 803b 539 23,794 23,128 4,705 4,892 19,089 18,236
Medicaid/CHIP 11,864 12,338 690 749 11,174 11,589 2,101 2,151 9,073 9,438
Other3 7,985 7,935 79 61 7,906 7,874 617 509 7,289 7,366
No Coverage 5,012 4,867 86 41 4,926 4,827 1,303 1,142 3,623 3,685

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.75B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 15.4 15.1 6.0a 5.0 16.3 16.0 24.1 23.3 15.1 14.9
GEOGRAPHIC DIVISION                    
Northeast 16.8 16.4 6.2 4.9 17.8 17.4 27.8 25.2 16.3 16.3
New England 21.5 19.6 8.8 7.5 22.6 20.6 30.9 28.6 21.3 19.4
Middle Atlantic 15.1 15.3 5.4 4.0 16.0 16.3 26.7 23.8 14.4 15.1
Midwest 17.1 17.1 5.7 5.0 18.3 18.3 26.7 25.7 16.9 17.2
East North Central 17.2 17.6 5.7 5.2 18.4 18.8 27.6 27.2 16.9 17.5
West North Central 16.9 16.1 5.6 4.4 18.1 17.3 24.7 22.3 17.0 16.5
South 12.8 12.1 6.0 5.1 13.5 12.8 20.1 20.4 12.5 11.6
South Atlantic 13.6 13.1 6.0 5.8 14.3 13.8 23.5 22.9 13.0 12.4
East South Central 12.1 11.4 5.6 4.4 12.7 12.1 16.3 18.0 12.2 11.1
West South Central 11.9 10.9 6.1 4.6 12.5 11.6 16.9 17.6 11.8 10.6
West 16.9 17.1 6.1 5.0 18.0 18.3 25.8 24.7 16.8 17.2
Mountain 18.6 16.5 7.1 5.8 19.8 17.6 25.5 23.7 18.9 16.6
Pacific 16.1 17.4 5.6 4.6 17.1 18.6 26.0 25.3 15.8 17.6
COUNTY TYPE                    
Large Metro 15.5 15.5 5.3 4.9 16.6 16.5 25.1 24.4 15.3 15.2
Small Metro 15.2 14.9 7.3 5.8 16.0 15.8 23.3 21.4 14.7 14.9
Nonmetro 14.9 13.5 5.9a 3.4 15.7 14.4 21.9 22.8 14.8 13.2
Urbanized 15.1 14.7 5.2 3.6 15.9 15.7 24.4 26.2 14.3 14.1
Less Urbanized 15.8 13.2 6.0 3.2 16.7 14.2 21.2 20.4 16.0 13.3
Completely Rural 13.4 12.2 6.8 3.3 14.0 12.9 16.9 21.5 13.7 11.8
POVERTY LEVEL1                    
Less Than 100% 18.3 18.5 5.9 5.6 20.0 20.1 23.8 24.3 19.1 18.9
100‑199% 15.6 15.9 7.0 6.4 16.5 16.9 22.1 24.5 15.4 15.6
200% or More 14.5 13.8 5.7b 4.2 15.3 14.7 25.4b 22.1 14.1 13.8
HEALTH INSURANCE2                    
Private 14.0 13.8 5.5b 3.9 14.8 14.7 23.9 23.7 13.5 13.3
Medicaid/CHIP 20.1 20.2 6.6 7.1 23.0 22.9 23.4 23.1 22.9 22.8
Other3 10.1 9.5 5.7 4.2 10.2 9.6 22.1 19.0 9.7 9.3
No Coverage 19.9 19.5 7.1 3.6 20.5 20.3 25.9 23.1 19.1 19.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.76A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 42,408 40,833 109 106 42,299 40,727 2,226 2,179 40,074 38,548
GEOGRAPHIC DIVISION                    
Northeast 7,569 7,423 3 4 7,566 7,419 398 334 7,168 7,085
New England 2,598 2,278 3 4 2,595 2,274 133 77 2,462 2,197
Middle Atlantic 4,972 5,145 * * 4,972 5,145 265 257 4,706 4,888
Midwest 8,024 8,205 16 25 8,008 8,180 498 449 7,510 7,731
East North Central 5,538 5,783 7 20 5,531 5,762 297 299 5,234 5,463
West North Central 2,486 2,423 9 5 2,477 2,418 201 150 2,276 2,268
South 15,160 13,708 66 44 15,093 13,664 738 744 14,356 12,920
South Atlantic 8,708 7,771 37 27 8,671 7,744 381 397 8,290 7,348
East South Central 2,233 1,912 1 <1 2,232 1,911 76 103 2,156 1,809
West South Central 4,219 4,025 29 16 4,190 4,008 281 245 3,910 3,764
West 11,655 11,497 23 34 11,632 11,463 592 652 11,040 10,811
Mountain 3,782 4,002 17 9 3,765 3,993 221 213 3,544 3,781
Pacific 7,874 7,495 7 25 7,867 7,470 370 439 7,497 7,031
COUNTY TYPE                    
Large Metro 23,995 23,902 33 61 23,962 23,841 1,207 1,325 22,755 22,516
Small Metro 13,577 12,564 66 44 13,511 12,520 710 606 12,802 11,914
Nonmetro 4,836 4,367 10 1 4,826 4,365 309 248 4,517 4,117
Urbanized 2,065 1,666 <1 1 2,064 1,664 183 111 1,882 1,553
Less Urbanized 1,636 1,901 9 * 1,627 1,901 92 109 1,535 1,793
Completely Rural 1,135 800 * <1 1,135 800 34 28 1,101 772
POVERTY LEVEL1                    
Less Than 100% 6,706 7,094 29 32 6,678 7,062 422 520 6,256 6,543
100‑199% 7,397 8,291 34 35 7,363 8,256 499 424 6,864 7,832
200% or More 28,304a 25,446 46 39 28,258a 25,407 1,304 1,234 26,954a 24,173
HEALTH INSURANCE2                    
Private 24,867a 22,345 45 55 24,822a 22,290 1,395 1,377 23,426a 20,913
Medicaid/CHIP 9,264 9,687 52 50 9,212 9,636 489 459 8,723 9,177
Other3 11,393 12,322 13 1 11,380 12,321 126 129 11,254 12,192
No Coverage 3,783 4,092 17 10 3,766 4,082 290 291 3,476 3,791

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.76B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 14.7 14.1 0.4 0.4 16.1 15.4 6.4 6.0 17.6 16.8
GEOGRAPHIC DIVISION                    
Northeast 15.2 14.8 0.1 0.1 16.6 16.1 6.7 5.5 18.0 17.7
New England 19.4 16.9 0.3 0.3 21.0 18.3 8.1 4.6 23.0 20.4
Middle Atlantic 13.7 14.0 * * 14.9 15.3 6.2 5.8 16.2 16.7
Midwest 13.6 13.9 0.3 0.5 15.0 15.2 6.8 6.0 16.2 16.6
East North Central 13.7 14.2 0.2 0.6 15.0 15.5 6.0 5.9 16.4 17.1
West North Central 13.5 13.1 0.5 0.3 14.9 14.4 8.6 6.2 15.9 15.7
South 13.6a 12.2 0.6 0.4 14.9a 13.3 5.5 5.3 16.4a 14.6
South Atlantic 14.7 13.0 0.7 0.5 16.0 14.2 5.6 5.6 17.6 15.4
East South Central 13.3 11.3 0.1 <0.1 14.7 12.4 3.7 4.8 16.4 13.7
West South Central 11.8 11.1 0.8 0.5 13.1 12.3 6.0 5.1 14.3 13.6
West 17.1 16.8 0.4 0.6 18.8 18.4 7.2 7.7 20.6 20.1
Mountain 17.0 17.9 0.8 0.4 18.7 19.6 7.9 7.3 20.5 21.7
Pacific 17.2 16.3 0.2 0.6 18.8 17.8 6.8 7.9 20.6 19.3
COUNTY TYPE                    
Large Metro 14.5 14.4 0.2 0.4 15.9 15.8 6.3 6.4 17.3 17.2
Small Metro 15.3a 13.8 0.8 0.5 16.8a 15.1 6.1 5.2 18.5a 16.7
Nonmetro 14.4 13.0 0.3 0.1 15.7 14.1 7.3 6.4 17.1 15.2
Urbanized 15.5 13.7 <0.1 0.1 16.8 14.9 9.0 7.6 18.3 16.0
Less Urbanized 13.8 13.9 0.9 * 15.0 15.2 6.8 6.9 16.2 16.4
Completely Rural 13.8a 10.3 * <0.1 15.1a 11.1 4.1 3.4 16.5a 12.1
POVERTY LEVEL1                    
Less Than 100% 14.4 14.5 0.5 0.6 16.3 16.4 5.0 5.3 19.2 19.7
100‑199% 13.3 13.6 0.6 0.6 14.6 14.9 5.9 5.0 16.4 16.7
200% or More 15.2a 14.1 0.3 0.3 16.5a 15.3 7.3 7.1 17.6a 16.2
HEALTH INSURANCE2                    
Private 14.2a 13.1 0.3 0.4 15.4a 14.2 7.1 6.7 16.6a 15.3
Medicaid/CHIP 15.7 15.9 0.5 0.5 19.0 19.0 5.4 4.9 22.0 22.2
Other3 14.4 14.8 0.9 0.1 14.6 15.1 4.5 4.8 15.0 15.4
No Coverage 15.0 16.4 1.4 0.9 15.7 17.1 5.8 5.9 18.3 20.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.77A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 4,257 4,937 72 57 4,185 4,881 811 950 3,374 3,930
GEOGRAPHIC DIVISION                    
Northeast 908 1,046 2 1 906 1,045 142 167 763 878
New England 166 253 2 1 163 251 29 26 135 226
Middle Atlantic 742 794 * * 742 794 114 141 629 653
Midwest 789 859 13 7 776 852 149 156 627 697
East North Central 539 648 4 4 535 645 95 114 440 530
West North Central 250 211 9 3 241 208 54 42 187 166
South 1,356 1,524 33 26 1,323 1,498 291 275 1,032 1,223
South Atlantic 732 900 10 23 722 877 152 166 569 711
East South Central 178 113 <1 <1 178 113 34 21 143 92
West South Central 446 510 23 2 423 508 104 88 320 420
West 1,203 1,508 23 23 1,180 1,485 229 353 952 1,132
Mountain 492 402 17a 3 476 399 72 115 404 284
Pacific 711a 1,105 6 19 705a 1,086 157 238 548 848
COUNTY TYPE                    
Large Metro 2,754 3,270 28 30 2,726 3,240 512 654 2,215 2,586
Small Metro 1,113 1,350 35 25 1,078 1,326 207 224 871 1,101
Nonmetro 390 317 9 1 381 315 93 72 288 243
Urbanized 192 181 <1 1 191 179 58 40 133 139
Less Urbanized 127 86 8 * 118 86 32 26 86 60
Completely Rural 71 50 * * 71 50 2 6 69 44
POVERTY LEVEL1                    
Less Than 100% 992 1,258 20 9 972 1,249 140a 260 832 989
100‑199% 850 983 20 14 830 968 181 178 648 791
200% or More 2,415 2,695 32 34 2,383 2,661 489 511 1,894 2,150
HEALTH INSURANCE2                    
Private 2,051 2,300 23 29 2,028 2,271 505 606 1,523 1,665
Medicaid/CHIP 1,333 1,604 38 30 1,295 1,574 176 209 1,119 1,365
Other3 386a 715 5 1 381a 714 45 70 335a 644
No Coverage 711 823 11 2 701 820 97 97 604 723

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.77B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.5 1.7 0.3 0.2 1.6 1.8 2.3 2.6 1.5 1.7
GEOGRAPHIC DIVISION                    
Northeast 1.8 2.1 0.1 <0.1 2.0 2.3 2.4 2.7 1.9 2.2
New England 1.2 1.9 0.2 0.1 1.3 2.0 1.8 1.6 1.3 2.1
Middle Atlantic 2.0 2.2 * * 2.2 2.4 2.7 3.2 2.2 2.2
Midwest 1.3 1.5 0.2 0.1 1.5 1.6 2.0 2.1 1.4 1.5
East North Central 1.3 1.6 0.1 0.1 1.5 1.7 1.9 2.3 1.4 1.7
West North Central 1.4 1.1 0.5 0.2 1.4 1.2 2.3 1.7 1.3 1.2
South 1.2 1.4 0.3 0.3 1.3 1.5 2.2 2.0 1.2 1.4
South Atlantic 1.2 1.5 0.2 0.5 1.3 1.6 2.2 2.3 1.2 1.5
East South Central 1.1 0.7 <0.1 <0.1 1.2 0.7 1.7 1.0 1.1 0.7
West South Central 1.3 1.4 0.6 0.1 1.3 1.6 2.2 1.8 1.2 1.5
West 1.8 2.2 0.4 0.4 1.9 2.4 2.8 4.2 1.8 2.1
Mountain 2.2 1.8 0.8a 0.2 2.4 2.0 2.6 3.9 2.3 1.6
Pacific 1.5a 2.4 0.1 0.5 1.7a 2.6 2.9 4.3 1.5 2.3
COUNTY TYPE                    
Large Metro 1.7 2.0 0.2 0.2 1.8 2.1 2.7 3.2 1.7 2.0
Small Metro 1.3 1.5 0.4 0.3 1.3 1.6 1.8 1.9 1.3 1.5
Nonmetro 1.2 0.9 0.3 <0.1 1.2 1.0 2.2 1.9 1.1 0.9
Urbanized 1.4 1.5 <0.1 0.1 1.6 1.6 2.9 2.7 1.3 1.4
Less Urbanized 1.1 0.6 0.8 * 1.1 0.7 2.4 1.7 0.9 0.6
Completely Rural 0.9 0.6 * * 1.0 0.7 0.3 0.7 1.0 0.7
POVERTY LEVEL1                    
Less Than 100% 2.1 2.6 0.4 0.2 2.4 2.9 1.7 2.6 2.6 3.0
100‑199% 1.5 1.6 0.4 0.3 1.6 1.8 2.1 2.1 1.5 1.7
200% or More 1.3 1.5 0.2 0.2 1.4 1.6 2.7 2.9 1.2 1.4
HEALTH INSURANCE2                    
Private 1.2 1.3 0.2 0.2 1.3 1.4 2.6 2.9 1.1 1.2
Medicaid/CHIP 2.3 2.6 0.4 0.3 2.7 3.1 2.0 2.2 2.8 3.3
Other3 0.5a 0.9 0.4 0.1 0.5a 0.9 1.6 2.6 0.4a 0.8
No Coverage 2.8 3.3 0.9 0.2 2.9 3.4 1.9 2.0 3.2 3.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.78A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,671 1,993 13 7 1,658 1,985 221a 353 1,437 1,633
GEOGRAPHIC DIVISION                    
Northeast 406 397 2 1 404 396 34 42 370 353
New England 65 116 2 1 63 115 6 14 57 101
Middle Atlantic 341 281 * * 341 281 27 28 314 252
Midwest 294 404 <1 2 293 402 39 47 255 354
East North Central 212 324 <1 2 212 322 24 40 188 283
West North Central 82 79 * * 82 79 15 8 67 72
South 566 578 3 <1 563 578 90 120 473 458
South Atlantic 306 307 <1 <1 306 307 59 67 246 240
East South Central 51 33 <1 * 51 33 3 13 48 19
West South Central 209 238 2 * 207 238 28 39 179 199
West 404 614 7 4 397 611 59a 143 339 467
Mountain 171 143 7a <1 164 143 10 37 154 106
Pacific 233a 471 * 4 233a 468 49 106 184a 361
COUNTY TYPE                    
Large Metro 1,117 1,320 4 <1 1,113 1,319 147 235 966 1,084
Small Metro 416 555 9 7 408 548 65 82 342 466
Nonmetro 138 118 1 * 137 118 9 36 128 82
Urbanized 94 75 <1 * 94 75 7 29 87 46
Less Urbanized 23 29 <1 * 22 29 1 6 21 24
Completely Rural 21 14 * * 21 14 1 1 20 13
POVERTY LEVEL1                    
Less Than 100% 502 647 3 2 499 645 41a 114 458 530
100‑199% 378 370 2 1 376 369 43 69 333 300
200% or More 790 975 7 4 783 971 137 168 645 802
HEALTH INSURANCE2                    
Private 587 854 6 1 581a 853 111a 219 470 634
Medicaid/CHIP 750 736 7 7 743 729 80 89 663 641
Other3 171 316 * 1 171 315 12 21 160 294
No Coverage 253 322 * * 253 322 26 44 227 278

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.78B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.6 0.7 <0.1 <0.1 0.6 0.7 0.6 1.0 0.6 0.7
GEOGRAPHIC DIVISION                    
Northeast 0.8 0.8 0.1 <0.1 0.9 0.9 0.6 0.7 0.9 0.9
New England 0.5 0.9 0.2 0.1 0.5 0.9 0.4 0.9 0.5 0.9
Middle Atlantic 0.9 0.8 * * 1.0 0.8 0.6 0.6 1.1 0.9
Midwest 0.5 0.7 <0.1 <0.1 0.5 0.7 0.5 0.6 0.6 0.8
East North Central 0.5 0.8 <0.1 0.1 0.6 0.9 0.5 0.8 0.6 0.9
West North Central 0.4 0.4 * * 0.5 0.5 0.6 0.3 0.5 0.5
South 0.5 0.5 <0.1 <0.1 0.6 0.6 0.7 0.9 0.5 0.5
South Atlantic 0.5 0.5 <0.1 <0.1 0.6 0.6 0.9 1.0 0.5 0.5
East South Central 0.3 0.2 <0.1 * 0.3 0.2 0.1 0.6 0.4 0.1
West South Central 0.6 0.7 0.1 * 0.6 0.7 0.6 0.8 0.7 0.7
West 0.6 0.9 0.1 0.1 0.6 1.0 0.7a 1.7 0.6 0.9
Mountain 0.8 0.6 0.3a <0.1 0.8 0.7 0.3 1.3 0.9 0.6
Pacific 0.5a 1.0 * 0.1 0.6a 1.1 0.9 1.9 0.5a 1.0
COUNTY TYPE                    
Large Metro 0.7 0.8 <0.1 <0.1 0.7 0.9 0.8 1.1 0.7 0.8
Small Metro 0.5 0.6 0.1 0.1 0.5 0.7 0.6 0.7 0.5 0.7
Nonmetro 0.4 0.4 <0.1 * 0.4 0.4 0.2 0.9 0.5 0.3
Urbanized 0.7 0.6 <0.1 * 0.8 0.7 0.4 1.9 0.8 0.5
Less Urbanized 0.2 0.2 <0.1 * 0.2 0.2 0.1 0.4 0.2 0.2
Completely Rural 0.3 0.2 * * 0.3 0.2 0.1 0.2 0.3 0.2
POVERTY LEVEL1                    
Less Than 100% 1.1 1.3 0.1 <0.1 1.2 1.5 0.5a 1.2 1.4 1.6
100‑199% 0.7 0.6 <0.1 <0.1 0.7 0.7 0.5 0.8 0.8 0.6
200% or More 0.4 0.5 <0.1 <0.1 0.5 0.6 0.8 1.0 0.4 0.5
HEALTH INSURANCE2                    
Private 0.3a 0.5 <0.1 <0.1 0.4a 0.5 0.6a 1.1 0.3 0.5
Medicaid/CHIP 1.3 1.2 0.1 0.1 1.5 1.4 0.9 1.0 1.7 1.6
Other3 0.2 0.4 * 0.1 0.2 0.4 0.4 0.8 0.2 0.4
No Coverage 1.0 1.3 * * 1.1 1.4 0.5 0.9 1.2 1.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.79A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 10,634 10,086 25 17 10,609 10,070 153 182 10,455 9,888
GEOGRAPHIC DIVISION                    
Northeast 1,988 1,592 1 <1 1,987 1,592 30a 8 1,957 1,584
New England 677 582 1 <1 676 582 8a 1 668 581
Middle Atlantic 1,311 1,010 * * 1,311 1,010 22 7 1,289 1,003
Midwest 2,187 2,366 * <1 2,187 2,365 38 54 2,148 2,311
East North Central 1,514 1,658 * <1 1,514 1,657 14 38 1,500 1,620
West North Central 673 708 * * 673 708 25 17 648 691
South 3,936 3,640 21 6 3,914 3,634 66 73 3,849 3,560
South Atlantic 2,110 2,043 4 * 2,106 2,043 40 24 2,066 2,019
East South Central 732 518 * * 732 518 2 23 729 495
West South Central 1,094 1,080 17 6 1,077 1,073 23 27 1,054 1,046
West 2,523 2,489 3 10 2,520 2,479 19 46 2,501 2,433
Mountain 770 1,003 3 1 767 1,002 7 22 760 980
Pacific 1,754 1,485 * 9 1,754 1,476 12 24 1,741 1,453
COUNTY TYPE                    
Large Metro 5,692 5,225 7 <1 5,685 5,225 79 91 5,606 5,134
Small Metro 3,489 3,421 15 16 3,475 3,405 47 60 3,428 3,345
Nonmetro 1,453 1,440 3 <1 1,449 1,440 28 31 1,422 1,409
Urbanized 559 559 * * 559 559 4 16 555 543
Less Urbanized 509 630 3 * 505 630 23 9 483 620
Completely Rural 385 251 * <1 385 251 1 5 384 246
POVERTY LEVEL1                    
Less Than 100% 3,009 3,146 4 <1 3,005 3,145 48 71 2,957 3,074
100‑199% 2,434 2,988 10 15 2,423 2,973 53 43 2,370 2,930
200% or More 5,191b 3,952 10 1 5,181b 3,951 52 68 5,128b 3,883
HEALTH INSURANCE2                    
Private 4,484a 3,660 3 1 4,481a 3,659 42 74 4,439a 3,585
Medicaid/CHIP 4,074 4,411 15 9 4,060 4,402 66 70 3,994 4,331
Other3 2,729 3,348 <1 * 2,729 3,348 5 12 2,724 3,336
No Coverage 1,129 1,079 * * 1,122 1,073 46 34 1,076 1,039

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.79B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3.7 3.5 0.1 0.1 4.0 3.8 0.4 0.5 4.6 4.3
GEOGRAPHIC DIVISION                    
Northeast 4.0 3.2 <0.1 <0.1 4.4 3.5 0.5a 0.1 4.9 4.0
New England 5.1 4.3 0.1 <0.1 5.5 4.7 0.5a 0.1 6.2 5.4
Middle Atlantic 3.6 2.8 * * 3.9 3.0 0.5 0.2 4.4 3.4
Midwest 3.7 4.0 * <0.1 4.1 4.4 0.5 0.7 4.6 5.0
East North Central 3.7 4.1 * <0.1 4.1 4.5 0.3 0.7 4.7 5.1
West North Central 3.6 3.8 * * 4.0 4.2 1.1 0.7 4.5 4.8
South 3.5 3.2 0.2 0.1 3.9 3.5 0.5 0.5 4.4 4.0
South Atlantic 3.6 3.4 0.1 * 3.9 3.7 0.6 0.3 4.4 4.2
East South Central 4.4 3.1 * * 4.8 3.4 0.1 1.1 5.5a 3.7
West South Central 3.1 3.0 0.5 0.2 3.4 3.3 0.5 0.6 3.9 3.8
West 3.7 3.6 <0.1 0.2 4.1 4.0 0.2 0.5 4.7 4.5
Mountain 3.5 4.5 0.1 0.1 3.8 4.9 0.2 0.8 4.4 5.6
Pacific 3.8 3.2 * 0.2 4.2 3.5 0.2 0.4 4.8 4.0
COUNTY TYPE                    
Large Metro 3.4 3.2 <0.1 <0.1 3.8 3.5 0.4 0.4 4.3 3.9
Small Metro 3.9 3.8 0.2 0.2 4.3 4.1 0.4 0.5 5.0 4.7
Nonmetro 4.3 4.3 0.1 <0.1 4.7 4.7 0.7 0.8 5.4 5.2
Urbanized 4.2 4.6 * * 4.5 5.0 0.2 1.1 5.4 5.6
Less Urbanized 4.3 4.6 0.3 * 4.7 5.0 1.7 0.6 5.1 5.7
Completely Rural 4.7 3.2 * <0.1 5.1 3.5 0.2 0.6 5.8 3.9
POVERTY LEVEL1                    
Less Than 100% 6.5 6.5 0.1 <0.1 7.3 7.3 0.6 0.7 9.1 9.2
100‑199% 4.4 4.9 0.2 0.3 4.8 5.4 0.6 0.5 5.7 6.3
200% or More 2.8a 2.2 0.1 <0.1 3.0a 2.4 0.3 0.4 3.4a 2.6
HEALTH INSURANCE2                    
Private 2.6 2.1 <0.1 <0.1 2.8 2.3 0.2 0.4 3.1 2.6
Medicaid/CHIP 6.9 7.2 0.1 0.1 8.4 8.7 0.7 0.8 10.1 10.5
Other3 3.4 4.0 <0.1 * 3.5 4.1 0.2 0.4 3.6 4.2
No Coverage 4.5 4.3 * * 4.7 4.5 0.9 0.7 5.7 5.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.80A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 749 986 8 9 741 977 46 23 695 954
GEOGRAPHIC DIVISION                    
Northeast 241 285 1 * 240 285 9a 1 231 284
New England 28 62 1 * 28 62 6 1 22 61
Middle Atlantic 212 223 * * 212 223 4 <1 208 223
Midwest 125 274 * <1 125 274 14 7 111 267
East North Central 86 204 * <1 86 204 3 1 83 203
West North Central 38 70 * * 38 70 10 6 28 64
South 311 216 4 * 307 216 19 6 288 211
South Atlantic 225 153 4 * 221 153 15 5 206 148
East South Central 29 15 * * 29 15 1 * 29 15
West South Central 57 49 * * 57 49 3 1 53 48
West 73a 210 3 9 70 201 5 9 65 192
Mountain 27 70 3 * 24 70 <1 2 24 67
Pacific 46 140 * 9 46 131 4 7 41 124
COUNTY TYPE                    
Large Metro 385 568 * <1 385 568 25 10 360 557
Small Metro 259 351 5 9 254 342 13 5 241 337
Nonmetro 105 67 3 * 101 67 8 8 93 59
Urbanized 51 29 * * 51 29 * * 51 23
Less Urbanized 27 18 3 * 24 18 8 2 16 16
Completely Rural 26 19 * * 26 19 <1 * 26 19
POVERTY LEVEL1                    
Less Than 100% 396 504 4 <1 392 503 13 15 379 488
100‑199% 204 328 3 9 200 319 26 6 174 313
200% or More 149 155 * * 149 155 8 2 141 153
HEALTH INSURANCE2                    
Private 83 179 3 * 79 179 5 5 74 174
Medicaid/CHIP 525 614 5 9 521 605 28 16 492 589
Other3 115a 309 <1 * 115a 309 1 3 114a 306
No Coverage 104 157 * * 104 157 15 4 89 154

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.80B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3 0.3 <0.1 <0.1 0.3 0.4 0.1 0.1 0.3 0.4
GEOGRAPHIC DIVISION                    
Northeast 0.5 0.6 <0.1 * 0.5 0.6 0.2a <0.1 0.6 0.7
New England 0.2 0.5 0.1 * 0.2 0.5 0.3 <0.1 0.2 0.6
Middle Atlantic 0.6 0.6 * * 0.6 0.7 0.1 <0.1 0.7 0.8
Midwest 0.2 0.5 * <0.1 0.2 0.5 0.2 0.1 0.2 0.6
East North Central 0.2 0.5 * <0.1 0.2 0.5 0.1 <0.1 0.3 0.6
West North Central 0.2 0.4 * * 0.2 0.4 0.4 0.3 0.2 0.4
South 0.3 0.2 <0.1 * 0.3 0.2 0.1 <0.1 0.3 0.2
South Atlantic 0.4 0.3 0.1 * 0.4 0.3 0.2 0.1 0.4 0.3
East South Central 0.2 0.1 * * 0.2 0.1 <0.1 * 0.2 0.1
West South Central 0.2 0.1 * * 0.2 0.1 0.1 <0.1 0.2 0.2
West 0.1a 0.3 <0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.4
Mountain 0.1 0.3 0.1 * 0.1 0.3 <0.1 0.1 0.1 0.4
Pacific 0.1 0.3 * 0.2 0.1 0.3 0.1 0.1 0.1 0.3
COUNTY TYPE                    
Large Metro 0.2 0.3 * <0.1 0.3 0.4 0.1 0.1 0.3 0.4
Small Metro 0.3 0.4 0.1 0.1 0.3 0.4 0.1 <0.1 0.3 0.5
Nonmetro 0.3 0.2 0.1 * 0.3 0.2 0.2 0.2 0.4 0.2
Urbanized 0.4 0.2 * * 0.4 0.3 * * 0.5 0.2
Less Urbanized 0.2 0.1 0.3 * 0.2 0.1 0.6 0.1 0.2 0.2
Completely Rural 0.3 0.2 * * 0.3 0.3 <0.1 * 0.4 0.3
POVERTY LEVEL1                    
Less Than 100% 0.9 1.0 0.1 <0.1 1.0 1.2 0.2 0.2 1.2 1.5
100‑199% 0.4 0.5 0.1 0.2 0.4 0.6 0.3 0.1 0.4 0.7
200% or More 0.1 0.1 * * 0.1 0.1 <0.1 <0.1 0.1 0.1
HEALTH INSURANCE2                    
Private <0.1 0.1 <0.1 * <0.1 0.1 <0.1 <0.1 0.1 0.1
Medicaid/CHIP 0.9 1.0 <0.1 0.1 1.1 1.2 0.3 0.2 1.2 1.4
Other3 0.1a 0.4 <0.1 * 0.1a 0.4 <0.1 0.1 0.2 0.4
No Coverage 0.4 0.6 * * 0.4 0.7 0.3 0.1 0.5 0.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.81A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 392 457 <1 * 392 457 13 8 378 449
GEOGRAPHIC DIVISION                    
Northeast 119 113 * * 119 113 2 1 117 112
New England 15 10 * * 15 10 1 <1 14 10
Middle Atlantic 104 103 * * 104 103 1 <1 102 102
Midwest 68 130 * * 68 130 3 1 65 129
East North Central 43 90 * * 43 90 * <1 43 89
West North Central 25 40 * * 25 40 3 1 22 40
South 170 122 <1 * 170 122 6 4 163 118
South Atlantic 155 80 <1 * 155 80 3 3 152 77
East South Central 8 3 * * 8 3 * * 8 3
West South Central 7 38 * * 7 38 3 1 4 37
West 35 92 * * 35 92 2 2 33 90
Mountain 1 13 * * 1 13 * 2 1 10
Pacific 34 80 * * 34 80 2 * 32 80
COUNTY TYPE                    
Large Metro 167 301 * * 167 301 6 4 161 297
Small Metro 174 135 <1 * 173 135 7 4 167 132
Nonmetro 51 21 * * 51 21 <1 1 50 20
Urbanized 33 18 * * 33 18 * * 33 18
Less Urbanized 1 3 * * 1 3 <1 1 1 2
Completely Rural 17 * * * 17 * * * 17 *
POVERTY LEVEL1                    
Less Than 100% 220 266 * * 220 266 6 7 213 259
100‑199% 128 112 <1 * 127 112 3 <1 125 112
200% or More 44 79 * * 44 79 4 1 41 78
HEALTH INSURANCE2                    
Private 43 76 * * 43 76 3 3 40 72
Medicaid/CHIP 294 261 <1 * 294 261 5 4 288 257
Other3 67 102 * * 67 102 <1 1 67 101
No Coverage 13a 89 * * 13a 89 5 3 9a 86

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.81B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1 0.2 <0.1 * 0.1 0.2 <0.1 <0.1 0.2 0.2
GEOGRAPHIC DIVISION                    
Northeast 0.2 0.2 * * 0.3 0.2 <0.1 <0.1 0.3 0.3
New England 0.1 0.1 * * 0.1 0.1 <0.1 <0.1 0.1 0.1
Middle Atlantic 0.3 0.3 * * 0.3 0.3 <0.1 <0.1 0.4 0.3
Midwest 0.1 0.2 * * 0.1 0.2 <0.1 <0.1 0.1 0.3
East North Central 0.1 0.2 * * 0.1 0.2 * <0.1 0.1 0.3
West North Central 0.1 0.2 * * 0.2 0.2 0.1 <0.1 0.2 0.3
South 0.2 0.1 <0.1 * 0.2 0.1 <0.1 <0.1 0.2 0.1
South Atlantic 0.3 0.1 <0.1 * 0.3 0.1 <0.1 <0.1 0.3 0.2
East South Central <0.1 <0.1 * * 0.1 <0.1 * * 0.1 <0.1
West South Central <0.1 0.1 * * <0.1 0.1 0.1 <0.1 <0.1 0.1
West 0.1 0.1 * * 0.1 0.1 <0.1 <0.1 0.1 0.2
Mountain <0.1 0.1 * * <0.1 0.1 * 0.1 <0.1 0.1
Pacific 0.1 0.2 * * 0.1 0.2 <0.1 * 0.1 0.2
COUNTY TYPE                    
Large Metro 0.1 0.2 * * 0.1 0.2 <0.1 <0.1 0.1 0.2
Small Metro 0.2 0.1 <0.1 * 0.2 0.2 0.1 <0.1 0.2 0.2
Nonmetro 0.2 0.1 * * 0.2 0.1 <0.1 <0.1 0.2 0.1
Urbanized 0.2 0.2 * * 0.3 0.2 * * 0.3 0.2
Less Urbanized <0.1 <0.1 * * <0.1 <0.1 <0.1 0.1 <0.1 <0.1
Completely Rural 0.2 * * * 0.2 * * * 0.3 *
POVERTY LEVEL1                    
Less Than 100% 0.5 0.5 * * 0.5 0.6 0.1 0.1 0.7 0.8
100‑199% 0.2 0.2 <0.1 * 0.3 0.2 <0.1 <0.1 0.3 0.2
200% or More <0.1 <0.1 * * <0.1 <0.1 <0.1 <0.1 <0.1 0.1
HEALTH INSURANCE2                    
Private <0.1 <0.1 * * <0.1 <0.1 <0.1 <0.1 <0.1 0.1
Medicaid/CHIP 0.5 0.4 <0.1 * 0.6 0.5 0.1 <0.1 0.7 0.6
Other3 0.1 0.1 * * 0.1 0.1 <0.1 <0.1 0.1 0.1
No Coverage 0.1a 0.4 * * 0.1a 0.4 0.1 0.1 <0.1a 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.82A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 51,559 50,765 591 570 50,968 50,194 5,661 5,245 45,307 44,949
GEOGRAPHIC DIVISION                    
Northeast 8,763 8,624 81 80 8,682 8,544 1,024 816 7,658 7,728
New England 3,056 2,740 34 31 3,021 2,709 341a 219 2,680 2,490
Middle Atlantic 5,707 5,884 46 49 5,660 5,835 683 597 4,977 5,238
Midwest 10,313 10,275 102 115 10,212 10,160 1,173 1,191 9,039 8,969
East North Central 7,099 7,143 75 80 7,024 7,063 771 800 6,253 6,264
West North Central 3,214 3,132 27 35 3,187 3,097 402 391 2,785 2,705
South 17,478 17,085 259 226 17,219 16,859 1,935 1,812 15,284 15,048
South Atlantic 9,929 9,455 121 117 9,809 9,337 1,063 952 8,746 8,385
East South Central 2,427 2,563 28 42 2,400 2,521 223 297 2,176 2,224
West South Central 5,121 5,068 110 67 5,010 5,001 649 563 4,361 4,438
West 15,005 14,780 150 150 14,855 14,631 1,529 1,426 13,327 13,205
Mountain 5,341 5,074 83 62 5,258 5,012 566 536 4,692 4,475
Pacific 9,664 9,707 67 87 9,598 9,619 963 890 8,635 8,729
COUNTY TYPE                    
Large Metro 29,831 29,394 282 282 29,549 29,111 3,169 3,106 26,380 26,005
Small Metro 16,159 15,819 233 225 15,926 15,595 1,835 1,613 14,091 13,981
Nonmetro 5,568 5,552 76 63 5,493 5,489 657 525 4,836 4,963
Urbanized 2,364 2,356 16 21 2,347 2,335 336 226 2,011 2,109
Less Urbanized 2,041 2,329 44 25 1,997 2,304 214 226 1,784 2,078
Completely Rural 1,164 867 16 18 1,148 849 107 73 1,041 776
POVERTY LEVEL1                    
Less Than 100% 7,015 7,927 129 148 6,885 7,780 1,068 1,164 5,818 6,616
100‑199% 8,715b 10,365 129 139 8,586b 10,227 1,287 1,346 7,299b 8,881
200% or More 35,827b 32,454 333 284 35,494a 32,169 3,304b 2,716 32,190a 29,453
HEALTH INSURANCE2                    
Private 31,423 29,313 320 282 31,103 29,031 3,324 3,327 27,779 25,703
Medicaid/CHIP 10,459 11,777 233 291 10,226 11,487 1,244 1,114 8,982a 10,372
Other3 11,432 12,319 30 34 11,401 12,285 405 300 10,996 11,985
No Coverage 4,979 5,057 55 28 4,924 5,030 886a 697 4,038 4,333

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.82B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 17.9 17.5 2.3 2.2 19.4 18.9 16.2a 14.5 19.9 19.6
GEOGRAPHIC DIVISION                    
Northeast 17.6 17.2 2.0 2.0 19.0 18.5 17.3a 13.4 19.3 19.3
New England 22.8 20.4 3.3 3.0 24.5 21.8 20.8a 13.2 25.1 23.1
Middle Atlantic 15.7 16.1 1.5 1.6 17.0 17.3 16.0 13.5 17.1 17.9
Midwest 17.5 17.3 1.9 2.2 19.1 18.8 16.1 15.9 19.6 19.3
East North Central 17.5 17.6 2.0 2.2 19.1 19.0 15.6 15.8 19.6 19.5
West North Central 17.4 16.9 1.5 2.0 19.1 18.4 17.2 16.3 19.4 18.8
South 15.7 15.1 2.5 2.2 17.0 16.4 14.3 12.9 17.4 17.0
South Atlantic 16.8 15.8 2.4 2.3 18.2 17.1 15.6 13.4 18.5 17.6
East South Central 14.5 15.2 1.8 2.7 15.8 16.4 10.9 13.9 16.6 16.8
West South Central 14.4 14.0 3.0 1.9 15.7 15.4 14.0 11.6 16.0 16.0
West 22.0 21.6 2.4 2.5 24.0 23.5 18.5 16.8 24.8 24.5
Mountain 24.1 22.7 4.0 3.0 26.1 24.7 20.1 18.4 27.1 25.7
Pacific 21.1 21.1 1.6 2.2 23.0 22.9 17.7 16.0 23.7 23.9
COUNTY TYPE                    
Large Metro 18.0 17.7 1.9 1.9 19.6 19.2 16.6 15.1 20.0 19.9
Small Metro 18.2 17.4 2.9 2.7 19.8 18.8 15.8 13.8 20.4 19.6
Nonmetro 16.6 16.5 2.7 2.3 17.9 17.8 15.6 13.6 18.3 18.4
Urbanized 17.7 19.4 1.6 2.1 19.1 20.9 16.6 15.3 19.5 21.8
Less Urbanized 17.2 17.0 4.2 2.1 18.4 18.4 15.7 14.4 18.8 19.0
Completely Rural 14.1 11.1 2.2 2.9 15.3 11.8 12.8 9.0 15.6 12.2
POVERTY LEVEL1                    
Less Than 100% 15.1 16.3 2.3 2.6 16.8 18.0 12.8 11.8 17.9 19.9
100‑199% 15.7 17.0 2.4 2.4 17.1 18.5 15.2 15.9 17.4 19.0
200% or More 19.3a 18.0 2.2 2.0 20.8a 19.3 18.4b 15.6 21.0 19.8
HEALTH INSURANCE2                    
Private 17.9 17.1 2.2 2.0 19.3 18.5 16.9 16.1 19.7 18.8
Medicaid/CHIP 17.7 19.3 2.2 2.8 21.1 22.7 13.9 12.0 22.7 25.1
Other3 14.4 14.8 2.2 2.3 14.7 15.0 14.5 11.2 14.7 15.1
No Coverage 19.8 20.3 4.5 2.5 20.5 21.1 17.6a 14.1 21.3 22.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.83A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 10,423a 9,139 405 360 10,018a 8,779 2,364 2,165 7,653a 6,614
GEOGRAPHIC DIVISION                    
Northeast 1,990 1,465 51 41 1,939 1,424 466 392 1,473 1,033
New England 670 436 32 20 638 415 131 114 507 301
Middle Atlantic 1,319 1,029 18 20 1,301 1,009 335 277 966 732
Midwest 1,653 1,845 63 74 1,590 1,772 403 447 1,187 1,325
East North Central 1,153 1,329 45 48 1,108 1,280 276 308 831 973
West North Central 500 517 18 25 482 491 127 139 355 352
South 3,304 2,982 183 149 3,121 2,833 784 701 2,337 2,132
South Atlantic 1,770 1,682 74 74 1,696 1,608 452 432 1,244 1,177
East South Central 388 318 20 19 368 298 75 103 293 195
West South Central 1,146 982 90 56 1,057 926 257 165 800 761
West 3,476 2,847 108 96 3,368 2,751 711 626 2,657 2,125
Mountain 1,166 978 60 47 1,106 931 235 240 871 691
Pacific 2,310 1,869 48 49 2,261 1,820 476 386 1,785 1,434
COUNTY TYPE                    
Large Metro 6,756 5,952 209 201 6,546 5,750 1,379 1,392 5,167 4,358
Small Metro 2,804 2,559 150 126 2,655 2,433 739 651 1,916 1,782
Nonmetro 863 628 46 32 817 596 246b 122 570 474
Urbanized 341 281 10 14 331 267 125a 54 205 213
Less Urbanized 325 271 28 11 297 260 83 49 214 211
Completely Rural 197 76 8 7 189 69 38 19 151 50
POVERTY LEVEL1                    
Less Than 100% 1,454 1,648 77 83 1,377 1,565 429 557 948 1,009
100‑199% 1,777 1,538 82 81 1,695 1,457 520 443 1,174 1,014
200% or More 7,191b 5,945 247 196 6,944b 5,749 1,414 1,158 5,530a 4,591
HEALTH INSURANCE2                    
Private 6,571b 5,424 227 197 6,344b 5,227 1,448 1,394 4,896b 3,834
Medicaid/CHIP 1,982 2,153 153 175 1,829 1,978 459 477 1,370 1,501
Other3 829 1,041 19 13 810 1,027 145 127 665 901
No Coverage 1,467 1,218 39 14 1,429 1,204 372a 243 1,057 961

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.83B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3.6a 3.1 1.6 1.4 3.8a 3.3 6.8 6.0 3.4a 2.9
GEOGRAPHIC DIVISION                    
Northeast 4.0a 2.9 1.2 1.0 4.2a 3.1 7.9 6.4 3.7 2.6
New England 5.0 3.2 3.1 2.0 5.2 3.3 8.0 6.9 4.7 2.8
Middle Atlantic 3.6 2.8 0.6 0.7 3.9 3.0 7.8 6.3 3.3 2.5
Midwest 2.8 3.1 1.2 1.4 3.0 3.3 5.5 6.0 2.6 2.9
East North Central 2.8 3.3 1.2 1.4 3.0 3.5 5.6 6.1 2.6 3.0
West North Central 2.7 2.8 1.0 1.5 2.9 2.9 5.4 5.8 2.5 2.4
South 3.0 2.6 1.8 1.5 3.1 2.8 5.8 5.0 2.7 2.4
South Atlantic 3.0 2.8 1.4 1.5 3.1 2.9 6.6 6.1 2.6 2.5
East South Central 2.3 1.9 1.3 1.3 2.4 1.9 3.7 4.8 2.2 1.5
West South Central 3.2 2.7 2.5 1.6 3.3 2.8 5.5 3.4 2.9 2.7
West 5.1a 4.2 1.8 1.6 5.4a 4.4 8.6 7.4 4.9 3.9
Mountain 5.3 4.4 2.9 2.3 5.5 4.6 8.4 8.2 5.0 4.0
Pacific 5.0 4.1 1.2 1.2 5.4 4.3 8.8 6.9 4.9 3.9
COUNTY TYPE                    
Large Metro 4.1 3.6 1.4 1.4 4.3 3.8 7.2 6.8 3.9 3.3
Small Metro 3.2 2.8 1.8 1.5 3.3 2.9 6.4 5.6 2.8 2.5
Nonmetro 2.6a 1.9 1.7 1.2 2.7a 1.9 5.8b 3.2 2.2 1.8
Urbanized 2.6 2.3 1.0 1.4 2.7 2.4 6.2 3.7 2.0 2.2
Less Urbanized 2.7 2.0 2.7 0.9 2.7 2.1 6.1a 3.1 2.3 1.9
Completely Rural 2.4 1.0 1.1 1.3 2.5 1.0 4.5 2.4 2.3 0.8
POVERTY LEVEL1                    
Less Than 100% 3.1 3.4 1.4 1.5 3.4 3.6 5.1 5.7 2.9 3.0
100‑199% 3.2 2.5 1.5 1.4 3.4 2.6 6.1 5.2 2.8 2.2
200% or More 3.9a 3.3 1.6 1.4 4.1a 3.5 7.9 6.6 3.6a 3.1
HEALTH INSURANCE2                    
Private 3.7a 3.2 1.5 1.4 3.9a 3.3 7.3 6.8 3.5a 2.8
Medicaid/CHIP 3.4 3.5 1.5 1.7 3.8 3.9 5.1 5.1 3.5 3.6
Other3 1.0 1.2 1.4 0.9 1.0 1.3 5.2 4.7 0.9 1.1
No Coverage 5.8 4.9 3.2 1.2 6.0 5.1 7.4a 4.9 5.6 5.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.84A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,783 2,722 123 101 2,660 2,621 489 634 2,171 1,987
GEOGRAPHIC DIVISION                    
Northeast 588 457 25 11 563 445 77 133 486 312
New England 170 161 * 2 153 159 21 44 132 115
Middle Atlantic 418 296 8 9 409 286 56 89 354 197
Midwest 461 538 12 26 449 512 91 115 358 397
East North Central 348 414 5 19 342 395 77 76 265 318
West North Central 113 124 7 7 106 117 13 39 93 79
South 844 877 67 55 777 822 169 210 608 612
South Atlantic 495 464 30 35 465 428 106 79 359 349
East South Central 60 105 <1 5 60 100 14 60 46 41
West South Central 289 308 37 15 252 293 49 71 203 222
West 890 851 18 9 871 842 152 176 719 666
Mountain 294 298 7 5 287 293 34 45 252 248
Pacific 595 553 11 4 585 549 117 131 467 418
COUNTY TYPE                    
Large Metro 1,871 1,769 72 67 1,799 1,702 290 425 1,509 1,277
Small Metro 755 788 43 24 712 764 172 191 541 573
Nonmetro 156 165 7 10 149 155 28 18 122 136
Urbanized 56 69 1 3 54 66 7 7 47 59
Less Urbanized 77 77 6 4 70 73 18 8 52 65
Completely Rural 24 19 * * 24 15 2 4 22 11
POVERTY LEVEL1                    
Less Than 100% 400 531 31 35 368 496 86b 185 282 311
100‑199% 458 416 24 10 434 406 110 105 324 301
200% or More 1,925 1,770 67 56 1,858 1,714 292 339 1,566 1,375
HEALTH INSURANCE2                    
Private 1,662 1,636 57 55 1,605 1,582 271a 427 1,334 1,155
Medicaid/CHIP 595 540 56 47 539 494 118 130 421 363
Other3 154a 286 1 * 153a 286 21 48 132 238
No Coverage 446 430 10 6 436 425 87 40 349 384

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.84B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.0 0.9 0.5 0.4 1.0 1.0 1.4 1.8 1.0 0.9
GEOGRAPHIC DIVISION                    
Northeast 1.2 0.9 0.6 0.3 1.2 1.0 1.3 2.2 1.2 0.8
New England 1.3 1.2 * 0.2 1.2 1.3 1.3 2.7 1.2 1.1
Middle Atlantic 1.1 0.8 0.3 0.3 1.2 0.8 1.3 2.0 1.2 0.7
Midwest 0.8 0.9 0.2 0.5 0.8 0.9 1.2 1.5 0.8 0.9
East North Central 0.9 1.0 0.1 0.5 0.9 1.1 1.6 1.5 0.8 1.0
West North Central 0.6 0.7 0.4 0.4 0.6 0.7 0.6 1.6 0.6 0.5
South 0.8 0.8 0.6 0.5 0.8 0.8 1.3 1.5 0.7 0.7
South Atlantic 0.8 0.8 0.6 0.7 0.9 0.8 1.6 1.1 0.8 0.7
East South Central 0.4 0.6 <0.1 0.3 0.4 0.7 0.7 2.8 0.3 0.3
West South Central 0.8 0.9 1.0 0.4 0.8 0.9 1.1 1.5 0.7 0.8
West 1.3 1.2 0.3 0.1 1.4 1.3 1.8 2.1 1.3 1.2
Mountain 1.3 1.3 0.4 0.2 1.4 1.4 1.2 1.5 1.5 1.4
Pacific 1.3 1.2 0.3 0.1 1.4 1.3 2.2 2.4 1.3 1.1
COUNTY TYPE                    
Large Metro 1.1 1.1 0.5 0.5 1.2 1.1 1.5 2.1 1.1 1.0
Small Metro 0.9 0.9 0.5 0.3 0.9 0.9 1.5 1.6 0.8 0.8
Nonmetro 0.5 0.5 0.3 0.4 0.5 0.5 0.7 0.5 0.5 0.5
Urbanized 0.4 0.6 0.1 0.3 0.4 0.6 0.4 0.5 0.5 0.6
Less Urbanized 0.6 0.6 0.6 0.3 0.6 0.6 1.3 0.5 0.6 0.6
Completely Rural 0.3 0.2 * * 0.3 0.2 0.3 0.4 0.3 0.2
POVERTY LEVEL1                    
Less Than 100% 0.9 1.1 0.6 0.6 0.9 1.1 1.0a 1.9 0.9 0.9
100‑199% 0.8 0.7 0.5 0.2 0.9 0.7 1.3 1.2 0.8 0.6
200% or More 1.0 1.0 0.4 0.4 1.1 1.0 1.6 1.9 1.0 0.9
HEALTH INSURANCE2                    
Private 0.9 1.0 0.4 0.4 1.0 1.0 1.4a 2.1 0.9 0.8
Medicaid/CHIP 1.0 0.9 0.5 0.4 1.1 1.0 1.3 1.4 1.1 0.9
Other3 0.2a 0.3 0.1 * 0.2a 0.4 0.7 1.8 0.2 0.3
No Coverage 1.8 1.7 0.8 0.5 1.8 1.8 1.7 0.8 1.8 2.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.85A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 21,884 ‑‑ 1,008 ‑‑ 20,876 ‑‑ 2,243 ‑‑ 18,634
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 3,753 ‑‑ 122 ‑‑ 3,632 ‑‑ 374 ‑‑ 3,257
New England ‑‑ 1,107 ‑‑ 29 ‑‑ 1,079 ‑‑ 79 ‑‑ 999
Middle Atlantic ‑‑ 2,646 ‑‑ 93 ‑‑ 2,553 ‑‑ 295 ‑‑ 2,258
Midwest ‑‑ 4,114 ‑‑ 182 ‑‑ 3,933 ‑‑ 481 ‑‑ 3,452
East North Central ‑‑ 2,928 ‑‑ 112 ‑‑ 2,816 ‑‑ 372 ‑‑ 2,444
West North Central ‑‑ 1,187 ‑‑ 70 ‑‑ 1,117 ‑‑ 109 ‑‑ 1,008
South ‑‑ 7,279 ‑‑ 451 ‑‑ 6,828 ‑‑ 662 ‑‑ 6,166
South Atlantic ‑‑ 4,472 ‑‑ 235 ‑‑ 4,237 ‑‑ 397 ‑‑ 3,840
East South Central ‑‑ 909 ‑‑ 59 ‑‑ 850 ‑‑ 90 ‑‑ 760
West South Central ‑‑ 1,898 ‑‑ 157 ‑‑ 1,741 ‑‑ 176 ‑‑ 1,565
West ‑‑ 6,738 ‑‑ 254 ‑‑ 6,483 ‑‑ 725 ‑‑ 5,758
Mountain ‑‑ 2,105 ‑‑ 87 ‑‑ 2,018 ‑‑ 211 ‑‑ 1,807
Pacific ‑‑ 4,633 ‑‑ 167 ‑‑ 4,466 ‑‑ 514 ‑‑ 3,951
COUNTY TYPE                    
Large Metro ‑‑ 12,888 ‑‑ 589 ‑‑ 12,299 ‑‑ 1,522 ‑‑ 10,777
Small Metro ‑‑ 6,712 ‑‑ 323 ‑‑ 6,389 ‑‑ 520 ‑‑ 5,869
Nonmetro ‑‑ 2,284 ‑‑ 96 ‑‑ 2,188 ‑‑ 200 ‑‑ 1,987
Urbanized ‑‑ 987 ‑‑ 33 ‑‑ 953 ‑‑ 86 ‑‑ 868
Less Urbanized ‑‑ 960 ‑‑ 42 ‑‑ 918 ‑‑ 96 ‑‑ 822
Completely Rural ‑‑ 337 ‑‑ 21 ‑‑ 316 ‑‑ 18 ‑‑ 298
POVERTY LEVEL1                    
Less Than 100% ‑‑ 3,751 ‑‑ 260 ‑‑ 3,490 ‑‑ 560 ‑‑ 2,931
100‑199% ‑‑ 4,800 ‑‑ 296 ‑‑ 4,504 ‑‑ 457 ‑‑ 4,047
200% or More ‑‑ 13,320 ‑‑ 452 ‑‑ 12,868 ‑‑ 1,212 ‑‑ 11,656
HEALTH INSURANCE2                    
Private ‑‑ 12,326 ‑‑ 437 ‑‑ 11,889 ‑‑ 1,405 ‑‑ 10,484
Medicaid/CHIP ‑‑ 5,794 ‑‑ 553 ‑‑ 5,242 ‑‑ 551 ‑‑ 4,691
Other3 ‑‑ 5,578 ‑‑ 44 ‑‑ 5,534 ‑‑ 119 ‑‑ 5,415
No Coverage ‑‑ 1,993 ‑‑ 56 ‑‑ 1,937 ‑‑ 251 ‑‑ 1,686

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.85B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 7.5 ‑‑ 4.0 ‑‑ 7.9 ‑‑ 6.2 ‑‑ 8.1
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 7.5 ‑‑ 3.0 ‑‑ 7.9 ‑‑ 6.2 ‑‑ 8.1
New England ‑‑ 8.2 ‑‑ 2.8 ‑‑ 8.7 ‑‑ 4.8 ‑‑ 9.3
Middle Atlantic ‑‑ 7.2 ‑‑ 3.1 ‑‑ 7.6 ‑‑ 6.7 ‑‑ 7.7
Midwest ‑‑ 6.9 ‑‑ 3.4 ‑‑ 7.3 ‑‑ 6.4 ‑‑ 7.4
East North Central ‑‑ 7.2 ‑‑ 3.1 ‑‑ 7.6 ‑‑ 7.3 ‑‑ 7.6
West North Central ‑‑ 6.4 ‑‑ 4.0 ‑‑ 6.6 ‑‑ 4.5 ‑‑ 7.0
South ‑‑ 6.5 ‑‑ 4.4 ‑‑ 6.7 ‑‑ 4.7 ‑‑ 7.0
South Atlantic ‑‑ 7.5 ‑‑ 4.7 ‑‑ 7.7 ‑‑ 5.6 ‑‑ 8.1
East South Central ‑‑ 5.4 ‑‑ 3.9 ‑‑ 5.5 ‑‑ 4.2 ‑‑ 5.7
West South Central ‑‑ 5.3 ‑‑ 4.4 ‑‑ 5.4 ‑‑ 3.6 ‑‑ 5.7
West ‑‑ 9.9 ‑‑ 4.2 ‑‑ 10.4 ‑‑ 8.5 ‑‑ 10.7
Mountain ‑‑ 9.4 ‑‑ 4.2 ‑‑ 9.9 ‑‑ 7.2 ‑‑ 10.4
Pacific ‑‑ 10.1 ‑‑ 4.2 ‑‑ 10.6 ‑‑ 9.2 ‑‑ 10.8
COUNTY TYPE                    
Large Metro ‑‑ 7.8 ‑‑ 4.1 ‑‑ 8.1 ‑‑ 7.4 ‑‑ 8.2
Small Metro ‑‑ 7.4 ‑‑ 3.9 ‑‑ 7.7 ‑‑ 4.5 ‑‑ 8.2
Nonmetro ‑‑ 6.8 ‑‑ 3.5 ‑‑ 7.1 ‑‑ 5.2 ‑‑ 7.4
Urbanized ‑‑ 8.1 ‑‑ 3.4 ‑‑ 8.5 ‑‑ 5.8 ‑‑ 9.0
Less Urbanized ‑‑ 7.0 ‑‑ 3.6 ‑‑ 7.3 ‑‑ 6.1 ‑‑ 7.5
Completely Rural ‑‑ 4.3 ‑‑ 3.4 ‑‑ 4.4 ‑‑ 2.3 ‑‑ 4.7
POVERTY LEVEL1                    
Less Than 100% ‑‑ 7.7 ‑‑ 4.6 ‑‑ 8.1 ‑‑ 5.7 ‑‑ 8.8
100‑199% ‑‑ 7.9 ‑‑ 5.2 ‑‑ 8.2 ‑‑ 5.4 ‑‑ 8.7
200% or More ‑‑ 7.4 ‑‑ 3.2 ‑‑ 7.7 ‑‑ 6.9 ‑‑ 7.8
HEALTH INSURANCE2                    
Private ‑‑ 7.2 ‑‑ 3.1 ‑‑ 7.6 ‑‑ 6.8 ‑‑ 7.7
Medicaid/CHIP ‑‑ 9.5 ‑‑ 5.3 ‑‑ 10.4 ‑‑ 5.9 ‑‑ 11.4
Other3 ‑‑ 6.7 ‑‑ 3.0 ‑‑ 6.8 ‑‑ 4.4 ‑‑ 6.8
No Coverage ‑‑ 8.0 ‑‑ 5.0 ‑‑ 8.1 ‑‑ 5.1 ‑‑ 8.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.86A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 2,385 ‑‑ 360 ‑‑ 2,026 ‑‑ 636 ‑‑ 1,390
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 464 ‑‑ 28 ‑‑ 436 ‑‑ 116 ‑‑ 320
New England ‑‑ 155 ‑‑ 11 ‑‑ 144 ‑‑ 28 ‑‑ 116
Middle Atlantic ‑‑ 308 ‑‑ 17 ‑‑ 291 ‑‑ 87 ‑‑ 204
Midwest ‑‑ 383 ‑‑ 71 ‑‑ 312 ‑‑ 132 ‑‑ 180
East North Central ‑‑ 270 ‑‑ 45 ‑‑ 225 ‑‑ 118 ‑‑ 107
West North Central ‑‑ 113 ‑‑ 26 ‑‑ 87 ‑‑ 14 ‑‑ 73
South ‑‑ 779 ‑‑ 155 ‑‑ 624 ‑‑ 128 ‑‑ 496
South Atlantic ‑‑ 438 ‑‑ 81 ‑‑ 356 ‑‑ 58 ‑‑ 298
East South Central ‑‑ 69 ‑‑ 19 ‑‑ 50 ‑‑ 9 ‑‑ 41
West South Central ‑‑ 273 ‑‑ 55 ‑‑ 218 ‑‑ 60 ‑‑ 157
West ‑‑ 760 ‑‑ 106 ‑‑ 654 ‑‑ 261 ‑‑ 393
Mountain ‑‑ 243 ‑‑ 31 ‑‑ 212 ‑‑ 37 ‑‑ 176
Pacific ‑‑ 517 ‑‑ 75 ‑‑ 442 ‑‑ 224 ‑‑ 217
COUNTY TYPE                    
Large Metro ‑‑ 1,719 ‑‑ 201 ‑‑ 1,518 ‑‑ 493 ‑‑ 1,026
Small Metro ‑‑ 535 ‑‑ 118 ‑‑ 417 ‑‑ 108 ‑‑ 309
Nonmetro ‑‑ 131 ‑‑ 41 ‑‑ 90 ‑‑ 36 ‑‑ 55
Urbanized ‑‑ 55 ‑‑ 14 ‑‑ 40 ‑‑ 24 ‑‑ 17
Less Urbanized ‑‑ 60 ‑‑ 16 ‑‑ 44 ‑‑ 9 ‑‑ 35
Completely Rural ‑‑ 16 ‑‑ 11 ‑‑ 5 ‑‑ 2 ‑‑ 3
POVERTY LEVEL1                    
Less Than 100% ‑‑ 498 ‑‑ 79 ‑‑ 419 ‑‑ 201 ‑‑ 217
100‑199% ‑‑ 516 ‑‑ 120 ‑‑ 396 ‑‑ 116 ‑‑ 280
200% or More ‑‑ 1,369 ‑‑ 161 ‑‑ 1,209 ‑‑ 316 ‑‑ 892
HEALTH INSURANCE2                    
Private ‑‑ 1,298 ‑‑ 152 ‑‑ 1,147 ‑‑ 388 ‑‑ 758
Medicaid/CHIP ‑‑ 732 ‑‑ 197 ‑‑ 536 ‑‑ 182 ‑‑ 354
Other3 ‑‑ 336 ‑‑ 13 ‑‑ 323 ‑‑ 53 ‑‑ 270
No Coverage ‑‑ 216 ‑‑ 14 ‑‑ 203 ‑‑ 37 ‑‑ 166

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.86B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.8 ‑‑ 1.4 ‑‑ 0.8 ‑‑ 1.8 ‑‑ 0.6
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 0.9 ‑‑ 0.7 ‑‑ 0.9 ‑‑ 1.9 ‑‑ 0.8
New England ‑‑ 1.2 ‑‑ 1.1 ‑‑ 1.2 ‑‑ 1.7 ‑‑ 1.1
Middle Atlantic ‑‑ 0.8 ‑‑ 0.6 ‑‑ 0.9 ‑‑ 2.0 ‑‑ 0.7
Midwest ‑‑ 0.6 ‑‑ 1.3 ‑‑ 0.6 ‑‑ 1.8 ‑‑ 0.4
East North Central ‑‑ 0.7 ‑‑ 1.3 ‑‑ 0.6 ‑‑ 2.3 ‑‑ 0.3
West North Central ‑‑ 0.6 ‑‑ 1.5 ‑‑ 0.5 ‑‑ 0.6 ‑‑ 0.5
South ‑‑ 0.7 ‑‑ 1.5 ‑‑ 0.6 ‑‑ 0.9 ‑‑ 0.6
South Atlantic ‑‑ 0.7 ‑‑ 1.6 ‑‑ 0.7 ‑‑ 0.8 ‑‑ 0.6
East South Central ‑‑ 0.4 ‑‑ 1.2 ‑‑ 0.3 ‑‑ 0.4 ‑‑ 0.3
West South Central ‑‑ 0.8 ‑‑ 1.5 ‑‑ 0.7 ‑‑ 1.3 ‑‑ 0.6
West ‑‑ 1.1 ‑‑ 1.8 ‑‑ 1.0 ‑‑ 3.1 ‑‑ 0.7
Mountain ‑‑ 1.1 ‑‑ 1.5 ‑‑ 1.0 ‑‑ 1.3 ‑‑ 1.0
Pacific ‑‑ 1.1 ‑‑ 1.9 ‑‑ 1.0 ‑‑ 4.0 ‑‑ 0.6
COUNTY TYPE                    
Large Metro ‑‑ 1.0 ‑‑ 1.4 ‑‑ 1.0 ‑‑ 2.4 ‑‑ 0.8
Small Metro ‑‑ 0.6 ‑‑ 1.4 ‑‑ 0.5 ‑‑ 0.9 ‑‑ 0.4
Nonmetro ‑‑ 0.4 ‑‑ 1.5 ‑‑ 0.3 ‑‑ 0.9 ‑‑ 0.2
Urbanized ‑‑ 0.5 ‑‑ 1.5 ‑‑ 0.4 ‑‑ 1.6 ‑‑ 0.2
Less Urbanized ‑‑ 0.4 ‑‑ 1.4 ‑‑ 0.4 ‑‑ 0.6 ‑‑ 0.3
Completely Rural ‑‑ 0.2 ‑‑ 1.8 ‑‑ 0.1 ‑‑ 0.3 ‑‑ <0.1
POVERTY LEVEL1                    
Less Than 100% ‑‑ 1.0 ‑‑ 1.4 ‑‑ 1.0 ‑‑ 2.0 ‑‑ 0.7
100‑199% ‑‑ 0.8 ‑‑ 2.1 ‑‑ 0.7 ‑‑ 1.4 ‑‑ 0.6
200% or More ‑‑ 0.8 ‑‑ 1.1 ‑‑ 0.7 ‑‑ 1.8 ‑‑ 0.6
HEALTH INSURANCE2                    
Private ‑‑ 0.8 ‑‑ 1.1 ‑‑ 0.7 ‑‑ 1.9 ‑‑ 0.6
Medicaid/CHIP ‑‑ 1.2 ‑‑ 1.9 ‑‑ 1.1 ‑‑ 2.0 ‑‑ 0.9
Other3 ‑‑ 0.4 ‑‑ 0.9 ‑‑ 0.4 ‑‑ 2.0 ‑‑ 0.3
No Coverage ‑‑ 0.9 ‑‑ 1.2 ‑‑ 0.9 ‑‑ 0.7 ‑‑ 0.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.87A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 992 ‑‑ 113 ‑‑ 879 ‑‑ 179 ‑‑ 700
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 150 ‑‑ 13 ‑‑ 137 ‑‑ 33 ‑‑ 104
New England ‑‑ 62 ‑‑ 2 ‑‑ 60 ‑‑ 5 ‑‑ 55
Middle Atlantic ‑‑ 87 ‑‑ 10 ‑‑ 77 ‑‑ 28 ‑‑ 49
Midwest ‑‑ 187 ‑‑ 19 ‑‑ 167 ‑‑ 52 ‑‑ 116
East North Central ‑‑ 115 ‑‑ 12 ‑‑ 102 ‑‑ 48 ‑‑ 54
West North Central ‑‑ 72 ‑‑ 7 ‑‑ 65 ‑‑ 3 ‑‑ 62
South ‑‑ 354 ‑‑ 57 ‑‑ 297 ‑‑ 15 ‑‑ 282
South Atlantic ‑‑ 201 ‑‑ 27 ‑‑ 173 ‑‑ 12 ‑‑ 162
East South Central ‑‑ 36 ‑‑ 3 ‑‑ 33 ‑‑ 2 ‑‑ 31
West South Central ‑‑ 117 ‑‑ 26 ‑‑ 91 ‑‑ 1 ‑‑ 90
West ‑‑ 302 ‑‑ 25 ‑‑ 277 ‑‑ 80 ‑‑ 197
Mountain ‑‑ 113 ‑‑ 7 ‑‑ 106 ‑‑ 18 ‑‑ 88
Pacific ‑‑ 189 ‑‑ 18 ‑‑ 171 ‑‑ 62 ‑‑ 109
COUNTY TYPE                    
Large Metro ‑‑ 719 ‑‑ 75 ‑‑ 643 ‑‑ 137 ‑‑ 506
Small Metro ‑‑ 222 ‑‑ 19 ‑‑ 203 ‑‑ 38 ‑‑ 165
Nonmetro ‑‑ 51 ‑‑ 19 ‑‑ 32 ‑‑ 4 ‑‑ 29
Urbanized ‑‑ 6 ‑‑ 2 ‑‑ 4 ‑‑ 2 ‑‑ 2
Less Urbanized ‑‑ 35 ‑‑ 6 ‑‑ 28 ‑‑ 1 ‑‑ 27
Completely Rural ‑‑ 10 ‑‑ 10 ‑‑ <1 ‑‑ * ‑‑ <1
POVERTY LEVEL1                    
Less Than 100% ‑‑ 185 ‑‑ 19 ‑‑ 166 ‑‑ 65 ‑‑ 101
100‑199% ‑‑ 231 ‑‑ 70 ‑‑ 161 ‑‑ 15 ‑‑ 146
200% or More ‑‑ 576 ‑‑ 25 ‑‑ 551 ‑‑ 98 ‑‑ 453
HEALTH INSURANCE2                    
Private ‑‑ 464 ‑‑ 20 ‑‑ 444 ‑‑ 127 ‑‑ 317
Medicaid/CHIP ‑‑ 324 ‑‑ 85 ‑‑ 239 ‑‑ 24 ‑‑ 216
Other3 ‑‑ 225 ‑‑ * ‑‑ 225 ‑‑ 25 ‑‑ 200
No Coverage ‑‑ 107 ‑‑ 11 ‑‑ 95 ‑‑ 10 ‑‑ 85

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.87B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.3 ‑‑ 0.4 ‑‑ 0.3 ‑‑ 0.5 ‑‑ 0.3
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.5 ‑‑ 0.3
New England ‑‑ 0.5 ‑‑ 0.2 ‑‑ 0.5 ‑‑ 0.3 ‑‑ 0.5
Middle Atlantic ‑‑ 0.2 ‑‑ 0.3 ‑‑ 0.2 ‑‑ 0.6 ‑‑ 0.2
Midwest ‑‑ 0.3 ‑‑ 0.4 ‑‑ 0.3 ‑‑ 0.7 ‑‑ 0.2
East North Central ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3 ‑‑ 1.0 ‑‑ 0.2
West North Central ‑‑ 0.4 ‑‑ 0.4 ‑‑ 0.4 ‑‑ 0.1 ‑‑ 0.4
South ‑‑ 0.3 ‑‑ 0.6 ‑‑ 0.3 ‑‑ 0.1 ‑‑ 0.3
South Atlantic ‑‑ 0.3 ‑‑ 0.5 ‑‑ 0.3 ‑‑ 0.2 ‑‑ 0.3
East South Central ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.1 ‑‑ 0.2
West South Central ‑‑ 0.3 ‑‑ 0.7 ‑‑ 0.3 ‑‑ <0.1 ‑‑ 0.3
West ‑‑ 0.4 ‑‑ 0.4 ‑‑ 0.4 ‑‑ 0.9 ‑‑ 0.4
Mountain ‑‑ 0.5 ‑‑ 0.3 ‑‑ 0.5 ‑‑ 0.6 ‑‑ 0.5
Pacific ‑‑ 0.4 ‑‑ 0.5 ‑‑ 0.4 ‑‑ 1.1 ‑‑ 0.3
COUNTY TYPE                    
Large Metro ‑‑ 0.4 ‑‑ 0.5 ‑‑ 0.4 ‑‑ 0.7 ‑‑ 0.4
Small Metro ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.3 ‑‑ 0.2
Nonmetro ‑‑ 0.2 ‑‑ 0.7 ‑‑ 0.1 ‑‑ 0.1 ‑‑ 0.1
Urbanized ‑‑ 0.1 ‑‑ 0.3 ‑‑ <0.1 ‑‑ 0.1 ‑‑ <0.1
Less Urbanized ‑‑ 0.3 ‑‑ 0.6 ‑‑ 0.2 ‑‑ 0.1 ‑‑ 0.2
Completely Rural ‑‑ 0.1 ‑‑ 1.7 ‑‑ <0.1 ‑‑ * ‑‑ <0.1
POVERTY LEVEL1                    
Less Than 100% ‑‑ 0.4 ‑‑ 0.3 ‑‑ 0.4 ‑‑ 0.7 ‑‑ 0.3
100‑199% ‑‑ 0.4 ‑‑ 1.2 ‑‑ 0.3 ‑‑ 0.2 ‑‑ 0.3
200% or More ‑‑ 0.3 ‑‑ 0.2 ‑‑ 0.3 ‑‑ 0.6 ‑‑ 0.3
HEALTH INSURANCE2                    
Private ‑‑ 0.3 ‑‑ 0.1 ‑‑ 0.3 ‑‑ 0.6 ‑‑ 0.2
Medicaid/CHIP ‑‑ 0.5 ‑‑ 0.8 ‑‑ 0.5 ‑‑ 0.3 ‑‑ 0.5
Other3 ‑‑ 0.3 ‑‑ * ‑‑ 0.3 ‑‑ 0.9 ‑‑ 0.3
No Coverage ‑‑ 0.4 ‑‑ 1.0 ‑‑ 0.4 ‑‑ 0.2 ‑‑ 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.88A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 15,294 15,279 87 53 15,206 15,226 464 468 14,742 14,758
GEOGRAPHIC DIVISION                    
Northeast 1,487 1,648 28 * 1,459 1,632 31 43 1,428 1,590
New England 324 332 * <1 301 332 3 7 299 325
Middle Atlantic 1,163 1,316 5 * 1,158 1,301 29 35 1,129 1,265
Midwest 2,963 3,038 7 7 2,956 3,031 148 128 2,808 2,903
East North Central 1,561 1,695 5 2 1,556 1,693 98 75 1,458 1,619
West North Central 1,402 1,342 2 5 1,400 1,338 50 53 1,350 1,285
South 5,540 5,175 40 14 5,499 5,161 184 212 5,315 4,949
South Atlantic 2,348 2,322 26 14 2,322 2,308 92 98 2,231 2,210
East South Central 1,068 847 2 * 1,066 847 29 44 1,037 803
West South Central 2,123 2,007 13 * 2,111 2,007 63 70 2,047 1,936
West 5,304 5,418 12 16 5,292 5,402 100 86 5,192 5,316
Mountain 1,712 1,899 4 <1 1,708 1,898 61 30 1,647 1,869
Pacific 3,592 3,520 8 16 3,584 3,504 39 57 3,545 3,447
COUNTY TYPE                    
Large Metro 7,426 7,253 51 12 7,376 7,241 171 234 7,205 7,007
Small Metro 5,207 5,642 29 40 5,178 5,602 158 150 5,020 5,453
Nonmetro 2,660 2,384 8 2 2,653 2,383 135 84 2,517 2,298
Urbanized 933 928 4 * 930 928 35 33 895 895
Less Urbanized 1,001 1,064 4 2 997 1,063 66 41 931 1,022
Completely Rural 726a 392 <1 <1 726a 392 34 11 692a 381
POVERTY LEVEL1                    
Less Than 100% 3,780 3,905 25 5 3,755 3,901 162 176 3,593 3,724
100‑199% 2,938b 4,523 15 12 2,923b 4,511 142 104 2,781b 4,407
200% or More 8,576b 6,851 47 36 8,528b 6,814 160 188 8,368b 6,626
HEALTH INSURANCE2                    
Private 7,351a 6,084 58 31 7,293a 6,053 164 225 7,128a 5,828
Medicaid/CHIP 4,941 5,721 28 24 4,912 5,697 214 164 4,698 5,533
Other3 3,852 4,089 * * 3,843 4,089 6 16 3,838 4,074
No Coverage 1,608 2,017 * 2 1,601 2,015 100 80 1,501 1,935

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.88B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 5.3 5.3 0.3 0.2 5.8 5.7 1.3 1.3 6.5 6.4
GEOGRAPHIC DIVISION                    
Northeast 3.0 3.3 0.7 * 3.2 3.5 0.5 0.7 3.6 4.0
New England 2.4 2.5 * <0.1 2.4 2.7 0.2 0.4 2.8 3.0
Middle Atlantic 3.2 3.6 0.2 * 3.5 3.9 0.7 0.8 3.9 4.3
Midwest 5.0 5.1 0.1 0.1 5.5 5.6 2.0 1.7 6.1 6.2
East North Central 3.9 4.2 0.1 0.1 4.2 4.6 2.0 1.5 4.6 5.1
West North Central 7.6 7.2 0.1 0.3 8.4 8.0 2.1 2.2 9.4 8.9
South 5.0 4.6 0.4 0.1 5.4 5.0 1.4 1.5 6.1 5.6
South Atlantic 4.0 3.9 0.5 0.3 4.3 4.2 1.3 1.4 4.7 4.6
East South Central 6.4 5.0 0.1 * 7.0 5.5 1.4 2.0 7.9 6.1
West South Central 6.0 5.6 0.3 * 6.6 6.2 1.4 1.5 7.5 7.0
West 7.8 7.9 0.2 0.3 8.5 8.7 1.2 1.0 9.7 9.9
Mountain 7.7 8.5 0.2 <0.1 8.5 9.3 2.2 1.0 9.5 10.7
Pacific 7.8 7.6 0.2 0.4 8.6 8.3 0.7 1.0 9.7 9.4
COUNTY TYPE                    
Large Metro 4.5 4.4 0.3 0.1 4.9 4.8 0.9 1.1 5.5 5.4
Small Metro 5.9 6.2 0.4 0.5 6.4 6.8 1.4 1.3 7.3 7.7
Nonmetro 7.9 7.1 0.3 0.1 8.6 7.7 3.2 2.2 9.5 8.5
Urbanized 7.0 7.6 0.3 * 7.6 8.3 1.7 2.2 8.7 9.2
Less Urbanized 8.4 7.8 0.4 0.1 9.2 8.5 4.9 2.6 9.8 9.3
Completely Rural 8.8b 5.0 <0.1 <0.1 9.7b 5.5 4.1a 1.4 10.4b 6.0
POVERTY LEVEL1                    
Less Than 100% 8.1 8.0 0.4 0.1 9.2 9.0 1.9 1.8 11.0 11.2
100‑199% 5.3b 7.4 0.3 0.2 5.8b 8.2 1.7 1.2 6.6b 9.4
200% or More 4.6b 3.8 0.3 0.3 5.0b 4.1 0.9 1.1 5.5b 4.4
HEALTH INSURANCE2                    
Private 4.2a 3.6 0.4 0.2 4.5a 3.8 0.8 1.1 5.0a 4.3
Medicaid/CHIP 8.4 9.4 0.3 0.2 10.1 11.3 2.4 1.8 11.9 13.4
Other3 4.9 4.9 * * 4.9 5.0 0.2 0.6 5.1 5.1
No Coverage 6.4a 8.1 * 0.1 6.7a 8.5 2.0 1.6 7.9a 10.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.89A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,384 2,653 57 32 2,327 2,621 161 145 2,166 2,475
GEOGRAPHIC DIVISION                    
Northeast 293 166 27 <1 266 166 11 5 255 160
New England 56 55 * <1 34 55 1 2 34 53
Middle Atlantic 237 111 5 * 231 111 11 3 221 108
Midwest 454 483 5 4 449 479 47 35 403 444
East North Central 209 209 4 1 205 208 25 20 180 188
West North Central 245 274 <1 3 245 271 22 15 223 255
South 991 1,069 13 12 979 1,057 71 74 907 983
South Atlantic 396 518 8 12 388 506 41 51 347 455
East South Central 221 211 1 * 220 211 5 4 216 207
West South Central 374 341 3 * 371 341 26 20 345 321
West 645 935 12 16 633 919 32 30 601 888
Mountain 224 379 4 <1 221 379 21 12 199 368
Pacific 421 555 8 16 413 539 11 19 402 521
COUNTY TYPE                    
Large Metro 1,195 1,205 38 12 1,157 1,194 54 77 1,103 1,116
Small Metro 620a 956 12 20 607a 936 67 47 541a 889
Nonmetro 569 491 7 <1 563 491 41 21 522 470
Urbanized 138 173 4 * 135 173 8 12 127 161
Less Urbanized 173 247 3 <1 169 247 29 7 140 241
Completely Rural 258a 71 * * 258a 71 3 3 255a 68
POVERTY LEVEL1                    
Less Than 100% 1,100 1,022 15 3 1,085 1,019 62 53 1,023 966
100‑199% 512a 863 8 10 504a 853 55 20 448a 833
200% or More 772 768 34 19 739 749 44 72 694 677
HEALTH INSURANCE2                    
Private 575 655 38 15 537 639 43 71 494 569
Medicaid/CHIP 1,302 1,268 19 20 1,283 1,247 92 62 1,191 1,186
Other3 289a 603 <1 * 288a 603 1 4 287a 600
No Coverage 373 503 * * 373 503 30 15 343 488

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.89B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.8 0.9 0.2 0.1 0.9 1.0 0.5 0.4 1.0 1.1
GEOGRAPHIC DIVISION                    
Northeast 0.6 0.3 0.7 <0.1 0.6 0.4 0.2 0.1 0.6 0.4
New England 0.4 0.4 * <0.1 0.3 0.4 <0.1 0.1 0.3 0.5
Middle Atlantic 0.7 0.3 0.2 * 0.7 0.3 0.2 0.1 0.8 0.4
Midwest 0.8 0.8 0.1 0.1 0.8 0.9 0.6 0.5 0.9 1.0
East North Central 0.5 0.5 0.1 <0.1 0.6 0.6 0.5 0.4 0.6 0.6
West North Central 1.3 1.5 <0.1 0.2 1.5 1.6 0.9 0.6 1.6 1.8
South 0.9 0.9 0.1 0.1 1.0 1.0 0.5 0.5 1.0 1.1
South Atlantic 0.7 0.9 0.2 0.2 0.7 0.9 0.6 0.7 0.7 1.0
East South Central 1.3 1.2 0.1 * 1.4 1.4 0.2 0.2 1.6 1.6
West South Central 1.0 0.9 0.1 * 1.2 1.0 0.6 0.4 1.3 1.2
West 0.9 1.4 0.2 0.3 1.0 1.5 0.4 0.4 1.1 1.6
Mountain 1.0 1.7 0.2 <0.1 1.1 1.9 0.8 0.4 1.1 2.1
Pacific 0.9 1.2 0.2 0.4 1.0 1.3 0.2 0.3 1.1 1.4
COUNTY TYPE                    
Large Metro 0.7 0.7 0.3 0.1 0.8 0.8 0.3 0.4 0.8 0.9
Small Metro 0.7a 1.1 0.1 0.2 0.8a 1.1 0.6 0.4 0.8a 1.2
Nonmetro 1.7 1.5 0.2 <0.1 1.8 1.6 1.0 0.6 2.0 1.7
Urbanized 1.0 1.4 0.3 * 1.1 1.5 0.4 0.8 1.2 1.7
Less Urbanized 1.5 1.8 0.3 <0.1 1.6 2.0 2.1a 0.4 1.5 2.2
Completely Rural 3.1a 0.9 * * 3.4a 1.0 0.4 0.4 3.8a 1.1
POVERTY LEVEL1                    
Less Than 100% 2.4 2.1 0.3 0.1 2.7 2.4 0.7 0.5 3.1 2.9
100‑199% 0.9 1.4 0.2 0.2 1.0 1.5 0.7 0.2 1.1 1.8
200% or More 0.4 0.4 0.2 0.1 0.4 0.5 0.2 0.4 0.5 0.5
HEALTH INSURANCE2                    
Private 0.3 0.4 0.3 0.1 0.3 0.4 0.2 0.3 0.3 0.4
Medicaid/CHIP 2.2 2.1 0.2 0.2 2.6 2.5 1.0 0.7 3.0 2.9
Other3 0.4a 0.7 <0.1 * 0.4a 0.7 <0.1 0.1 0.4a 0.8
No Coverage 1.5 2.0 * * 1.6 2.1 0.6 0.3 1.8 2.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.90A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,418 1,753 35 16 1,383 1,737 77 82 1,306 1,655
GEOGRAPHIC DIVISION                    
Northeast 184 97 24 * 160 97 5 3 155 94
New England 51 41 * * 29 41 <1 1 29 40
Middle Atlantic 133 56 3 * 130 56 5 2 126 54
Midwest 323 296 4 4 319 292 27 15 292 277
East North Central 169 120 4 1 165 119 14 11 151 109
West North Central 154 176 <1 3 153 173 13 4 141 169
South 527 610 5 12 522 598 36 43 486 555
South Atlantic 208 285 4 12 204 273 14 21 190 252
East South Central 119 83 1 * 118 83 1 2 116 81
West South Central 200 242 * * 200 242 21 20 179 223
West 384b 749 1 * 382b 749 8 22 374a 728
Mountain 146 268 1 * 145 268 4 10 141 258
Pacific 238a 482 <1 * 238a 482 4 12 233a 470
COUNTY TYPE                    
Large Metro 698 873 24 12 674 861 14 56 660 805
Small Metro 367 594 8 4 359 590 42 19 317a 571
Nonmetro 353 286 3 * 350 286 21 7 329 279
Urbanized 93 130 3 * 90 130 4 3 86 127
Less Urbanized 115 108 * * 115 108 17 5 98 103
Completely Rural 145 49 * * 145 49 <1 * 144 49
POVERTY LEVEL1                    
Less Than 100% 679 637 6 3 673 634 25 22 647 611
100‑199% 254b 603 2 1 253b 603 31 10 221b 593
200% or More 486 512 28 12 458 501 20 50 438 451
HEALTH INSURANCE2                    
Private 272 433 27 12 245 421 21 51 224 370
Medicaid/CHIP 833 866 9 4 824 862 41 26 783 836
Other3 198a 444 <1 * 197a 444 1 3 196a 441
No Coverage 231 271 * * 231 271 16 8 215 263

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.90B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5 0.6 0.1 0.1 0.5 0.7 0.2 0.2 0.6 0.7
GEOGRAPHIC DIVISION                    
Northeast 0.4 0.2 0.6 * 0.4 0.2 0.1 <0.1 0.4 0.2
New England 0.4 0.3 * * 0.2 0.3 <0.1 0.1 0.3 0.4
Middle Atlantic 0.4 0.2 0.1 * 0.4 0.2 0.1 <0.1 0.4 0.2
Midwest 0.5 0.5 0.1 0.1 0.6 0.5 0.4 0.2 0.6 0.6
East North Central 0.4 0.3 0.1 <0.1 0.4 0.3 0.3 0.2 0.5 0.3
West North Central 0.8 1.0 <0.1 0.2 0.9 1.0 0.5 0.2 1.0 1.2
South 0.5 0.5 0.1 0.1 0.5 0.6 0.3 0.3 0.6 0.6
South Atlantic 0.4 0.5 0.1 0.2 0.4 0.5 0.2 0.3 0.4 0.5
East South Central 0.7 0.5 0.1 * 0.8 0.5 0.1 0.1 0.9 0.6
West South Central 0.6 0.7 * * 0.6 0.7 0.5 0.4 0.7 0.8
West 0.6a 1.1 <0.1 * 0.6a 1.2 0.1 0.3 0.7a 1.4
Mountain 0.7 1.2 0.1 * 0.7 1.3 0.2 0.3 0.8 1.5
Pacific 0.5a 1.0 <0.1 * 0.6a 1.1 0.1 0.2 0.6a 1.3
COUNTY TYPE                    
Large Metro 0.4 0.5 0.2 0.1 0.4 0.6 0.1 0.3 0.5 0.6
Small Metro 0.4 0.7 0.1 <0.1 0.4 0.7 0.4 0.2 0.5a 0.8
Nonmetro 1.1 0.9 0.1 * 1.1 0.9 0.5 0.2 1.2 1.0
Urbanized 0.7 1.1 0.3 * 0.7 1.2 0.2 0.2 0.8 1.3
Less Urbanized 1.0 0.8 * * 1.1 0.9 1.2 0.3 1.0 0.9
Completely Rural 1.8 0.6 * * 1.9 0.7 <0.1 * 2.2 0.8
POVERTY LEVEL1                    
Less Than 100% 1.5 1.3 0.1 0.1 1.6 1.5 0.3 0.2 2.0 1.8
100‑199% 0.5a 1.0 <0.1 <0.1 0.5a 1.1 0.4 0.1 0.5b 1.3
200% or More 0.3 0.3 0.2 0.1 0.3 0.3 0.1 0.3 0.3 0.3
HEALTH INSURANCE2                    
Private 0.2 0.3 0.2 0.1 0.2a 0.3 0.1 0.2 0.2 0.3
Medicaid/CHIP 1.4 1.4 0.1 <0.1 1.7 1.7 0.5 0.3 2.0 2.0
Other3 0.2a 0.5 <0.1 * 0.3a 0.5 <0.1 0.1 0.3a 0.6
No Coverage 0.9 1.1 * * 1.0 1.1 0.3 0.2 1.1 1.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.91A – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 63,149 60,619 2,998 2,670 60,151 57,949 4,731 4,676 55,420 53,272
GEOGRAPHIC DIVISION                    
Northeast 9,140 8,410 444 405 8,696 8,005 678 623 8,017 7,382
New England 2,163 2,328 123 77 2,041 2,250 174 127 1,867 2,123
Middle Atlantic 6,977 6,082 322 328 6,655 5,754 505 496 6,150 5,259
Midwest 13,081 13,172 618 590 12,463 12,583 985 1,199 11,478 11,383
East North Central 8,574 8,931 400 416 8,174 8,515 677 759 7,497 7,756
West North Central 4,507 4,241 218 174 4,289 4,067 308a 440 3,981 3,628
South 26,115 25,008 1,226 1,104 24,889 23,905 2,052 1,742 22,837 22,162
South Atlantic 12,981 13,250 546 593 12,435 12,656 969 892 11,466 11,765
East South Central 4,777 4,243 206a 137 4,571 4,106 305 250 4,266 3,856
West South Central 8,357 7,515 474 373 7,883 7,142 779 601 7,105 6,542
West 14,813 14,029 709 572 14,104 13,457 1,016 1,112 13,088 12,345
Mountain 5,383 5,172 264 238 5,120 4,934 412 465 4,708 4,469
Pacific 9,430 8,856 445 333 8,984 8,523 604 647 8,380 7,876
COUNTY TYPE                    
Large Metro 34,417a 31,665 1,599 1,469 32,817 30,195 2,394 2,586 30,423a 27,610
Small Metro 20,283 20,709 1,034 915 19,249 19,794 1,664 1,574 17,585 18,220
Nonmetro 8,450 8,245 365 286 8,085 7,959 673 516 7,412 7,443
Urbanized 3,196 2,912 164 96 3,032 2,817 294 227 2,737 2,590
Less Urbanized 3,097 3,210 116 125 2,981 3,085 231 205 2,750 2,879
Completely Rural 2,157 2,123 85 65 2,072 2,058 148 84 1,924 1,974
POVERTY LEVEL1                    
Less Than 100% 11,191 11,311 589 555 10,602 10,756 1,173 1,278 9,430 9,478
100‑199% 13,321 13,567 675 658 12,647 12,909 1,139 1,153 11,508 11,756
200% or More 38,614a 35,699 1,734a 1,457 36,880a 34,242 2,398 2,203 34,482 32,039
HEALTH INSURANCE2                    
Private 35,943a 33,291 1,593 1,391 34,350a 31,900 2,555 2,565 31,796a 29,334
Medicaid/CHIP 15,358 15,436 1,345 1,126 14,013 14,310 1,444 1,451 12,569 12,859
Other3 22,748 23,127 154 160 22,594 22,966 412 431 22,181 22,535
No Coverage 3,922 3,813 119 123 3,803 3,690 556 480 3,247 3,210

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.91B – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 21.9a 20.9 11.6 10.5 22.9a 21.9 13.5 13.0 24.4 23.3
GEOGRAPHIC DIVISION                    
Northeast 18.4 16.8 10.9 10.1 19.0 17.4 11.5 10.3 20.2 18.4
New England 16.2 17.3 11.8 7.6 16.5 18.1 10.6 7.7 17.5 19.7
Middle Atlantic 19.2 16.6 10.6 11.0 20.0a 17.1 11.8 11.2 21.2 18.0
Midwest 22.2 22.2 11.4 11.1 23.3 23.3 13.5a 16.1 24.8 24.5
East North Central 21.2 22.0 11.0 11.7 22.2 22.9 13.7 15.0 23.5 24.2
West North Central 24.4 22.8 12.4 10.0 25.7 24.2 13.2a 18.3 27.8 25.2
South 23.4 22.2 11.9 10.9 24.6 23.3 15.2b 12.4 26.0 25.0
South Atlantic 21.9 22.2 10.6 11.8 23.0 23.1 14.2 12.6 24.3 24.7
East South Central 28.5 25.1 13.3a 9.0 30.1 26.7 14.9 11.7 32.5 29.1
West South Central 23.5 20.8 13.0 10.4 24.7 22.0 16.8a 12.4 26.0 23.6
West 21.8 20.5 11.6 9.5 22.8 21.6 12.3 13.1 24.4 22.9
Mountain 24.3 23.1 12.8 11.6 25.4 24.3 14.6 16.0 27.2 25.7
Pacific 20.5 19.2 10.9 8.4 21.5 20.3 11.1 11.6 23.0 21.6
COUNTY TYPE                    
Large Metro 20.7a 19.1 10.6 10.1 21.7a 20.0 12.5 12.6 23.1a 21.1
Small Metro 22.9 22.7 12.8 11.1 23.9 23.9 14.4 13.5 25.5 25.6
Nonmetro 25.2 24.5 13.1 10.4 26.4 25.8 16.0 13.4 28.0 27.6
Urbanized 23.9 24.0 15.8 9.8 24.6 25.2 14.6 15.4 26.6 26.7
Less Urbanized 26.1 23.5 11.3 10.8 27.5 24.6 17.0 13.1 29.0 26.3
Completely Rural 26.2 27.3 11.7 10.8 27.6 28.7 17.7a 10.3 28.8 31.0
POVERTY LEVEL1                    
Less Than 100% 24.1 23.2 10.7 9.8 25.9 25.0 14.0 13.0 29.0 28.5
100‑199% 23.9 22.3 12.7 11.5 25.1 23.4 13.4 13.6 27.5 25.1
200% or More 20.8 19.8 11.5 10.3 21.6 20.6 13.4 12.6 22.5 21.5
HEALTH INSURANCE2                    
Private 20.5 19.5 10.9 10.0 21.3 20.3 13.0 12.4 22.5 21.5
Medicaid/CHIP 26.0 25.3 12.9a 10.7 28.9 28.3 16.1 15.6 31.8 31.1
Other3 28.7 27.8 11.2 11.1 29.0 28.1 14.8 16.1 29.6 28.5
No Coverage 15.6 15.3 9.9 10.9 15.8 15.5 11.0 9.7 17.1 17.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.92A – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 7,570 6,881 395 402 7,176 6,479 897 733 6,279 5,746
GEOGRAPHIC DIVISION                    
Northeast 1,213 1,034 44 29 1,169 1,005 125 75 1,043 930
New England 391 176 13 7 377 169 35a 11 342 158
Middle Atlantic 822 858 31 22 791 836 90 64 701 772
Midwest 1,504 1,320 64 70 1,440 1,250 135 199 1,305 1,051
East North Central 1,045 926 45 50 999 876 97 99 903 777
West North Central 459 394 19 20 440 374 39a 100 402 274
South 3,161 2,906 207 223 2,954 2,683 457 298 2,498 2,385
South Atlantic 1,389 1,338 86 103 1,304 1,234 249a 136 1,055 1,098
East South Central 658 560 13 35 645 524 52 52 592 472
West South Central 1,113 1,008 107 84 1,006 924 156 110 850 815
West 1,693 1,621 80 80 1,613 1,541 180 160 1,433 1,381
Mountain 596 538 40 45 556 493 79 48 478 445
Pacific 1,097 1,084 40 36 1,057 1,048 101 112 955 936
COUNTY TYPE                    
Large Metro 4,121 3,633 220 223 3,901 3,410 469 427 3,432 2,983
Small Metro 2,295 2,352 123 129 2,171 2,222 297 219 1,874 2,003
Nonmetro 1,155 896 51 50 1,103 846 131 86 973 760
Urbanized 412 317 22 13 390 303 57 28 333 275
Less Urbanized 410 397 22 22 388 375 34 37 354 337
Completely Rural 332 183 7 14 325a 168 40 20 286 148
POVERTY LEVEL1                    
Less Than 100% 2,285 1,772 116 117 2,169 1,654 234 230 1,935a 1,424
100‑199% 1,820 1,942 113 127 1,707 1,816 237 197 1,470 1,618
200% or More 3,463 3,160 166 158 3,298 3,002 424 299 2,874 2,704
HEALTH INSURANCE2                    
Private 3,408 3,030 171 198 3,237 2,833 477 371 2,761 2,462
Medicaid/CHIP 2,819 2,470 207 200 2,612 2,270 286 246 2,326 2,023
Other3 1,634 1,856 16 7 1,618 1,849 78a 21 1,540 1,828
No Coverage 840 798 24 20 816 778 105 115 712 663

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.92B – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2.6 2.4 1.5 1.6 2.7 2.4 2.6 2.0 2.8 2.5
GEOGRAPHIC DIVISION                    
Northeast 2.4 2.1 1.1 0.7 2.6 2.2 2.1 1.2 2.6 2.3
New England 2.9 1.3 1.3 0.6 3.1 1.4 2.1a 0.7 3.2 1.5
Middle Atlantic 2.3 2.3 1.0 0.8 2.4 2.5 2.1 1.5 2.4 2.6
Midwest 2.6 2.2 1.2 1.3 2.7 2.3 1.9 2.7 2.8 2.3
East North Central 2.6 2.3 1.2 1.4 2.7 2.4 2.0 2.0 2.8 2.4
West North Central 2.5 2.1 1.1 1.2 2.6 2.2 1.7a 4.2 2.8 1.9
South 2.8 2.6 2.0 2.2 2.9 2.6 3.4a 2.1 2.8 2.7
South Atlantic 2.3 2.2 1.7 2.1 2.4 2.3 3.6a 1.9 2.2 2.3
East South Central 3.9 3.3 0.9 2.3 4.2 3.4 2.6 2.4 4.5 3.6
West South Central 3.1 2.8 2.9 2.4 3.1 2.8 3.4 2.3 3.1 2.9
West 2.5 2.4 1.3 1.3 2.6 2.5 2.2 1.9 2.7 2.6
Mountain 2.7 2.4 1.9 2.2 2.8 2.4 2.8 1.6 2.8 2.6
Pacific 2.4 2.4 1.0 0.9 2.5 2.5 1.9 2.0 2.6 2.6
COUNTY TYPE                    
Large Metro 2.5 2.2 1.5 1.5 2.6 2.3 2.4 2.1 2.6 2.3
Small Metro 2.6 2.6 1.5 1.6 2.7 2.7 2.6 1.9 2.7 2.8
Nonmetro 3.4 2.7 1.8 1.8 3.6 2.7 3.1 2.2 3.7 2.8
Urbanized 3.1 2.6 2.1 1.4 3.2 2.7 2.8 1.9 3.2 2.8
Less Urbanized 3.5 2.9 2.2 1.9 3.6 3.0 2.5 2.4 3.7 3.1
Completely Rural 4.0 2.3 0.9 2.4 4.3a 2.3 4.7 2.5 4.3 2.3
POVERTY LEVEL1                    
Less Than 100% 4.9a 3.6 2.1 2.1 5.3a 3.8 2.8 2.3 5.9a 4.3
100‑199% 3.3 3.2 2.1 2.2 3.4 3.3 2.8 2.3 3.5 3.5
200% or More 1.9 1.8 1.1 1.1 1.9 1.8 2.4 1.7 1.9 1.8
HEALTH INSURANCE2                    
Private 1.9 1.8 1.2 1.4 2.0 1.8 2.4 1.8 2.0 1.8
Medicaid/CHIP 4.8 4.0 2.0 1.9 5.4 4.5 3.2 2.6 5.9 4.9
Other3 2.1 2.2 1.1 0.5 2.1 2.3 2.8a 0.8 2.1 2.3
No Coverage 3.3 3.2 2.0 1.8 3.4 3.3 2.1 2.3 3.8 3.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.93A – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,951 1,816 106 105 1,845 1,711 214 176 1,631 1,535
GEOGRAPHIC DIVISION                    
Northeast 402 309 13 6 389 303 30a 4 359 299
New England 149 49 1 <1 148 48 6 3 * 46
Middle Atlantic 253 260 12 5 241 255 24 1 217 253
Midwest 381 313 5 26 376 287 39 61 337 226
East North Central 264 210 5 18 259 191 34 29 226 163
West North Central 117 103 <1 7 117 95 5 32 111 63
South 768 734 70 67 698 666 112 101 587 566
South Atlantic 361 427 43 31 318 397 83 38 235 358
East South Central 148 137 3 10 145 127 4 20 141 107
West South Central 260 169 24 26 236 143 25 42 211a 101
West 400 461 18 6 382 455 34a 10 348 445
Mountain 144 185 8 3 136 183 14 2 123 181
Pacific 256 276 11 4 245 272 20 8 225 264
COUNTY TYPE                    
Large Metro 1,094 1,035 78 41 1,016 995 120 99 895 895
Small Metro 508 624 18 41 490 583 61 65 429 518
Nonmetro 349b 157 10 23 339b 134 32 12 306b 122
Urbanized 119 47 4 2 115 45 13a 1 102 44
Less Urbanized 111 74 3 14 108 60 3 <1 104 60
Completely Rural 119a 36 3 8 116a 28 * * 100b 18
POVERTY LEVEL1                    
Less Than 100% 750 620 29 23 721 597 67 39 654 558
100‑199% 439 463 36 25 403 438 64 99 339 339
200% or More 762 733 42 57 721 676 84 38 637 638
HEALTH INSURANCE2                    
Private 689 730 46 67 643 663 95 78 547 584
Medicaid/CHIP 893 801 43 40 850 761 98 44 752 717
Other3 400 374 12 4 388 370 16 3 372 368
No Coverage 221 261 12 1 210 260 14 51 195 210

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.93B – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7 0.6 0.4 0.4 0.7 0.6 0.6 0.5 0.7 0.7
GEOGRAPHIC DIVISION                    
Northeast 0.8 0.6 0.3 0.1 0.9 0.7 0.5a 0.1 0.9 0.7
New England 1.1 0.4 0.1 <0.1 1.2 0.4 0.3 0.2 * 0.4
Middle Atlantic 0.7 0.7 0.4 0.2 0.7 0.8 0.6 <0.1 0.7 0.9
Midwest 0.6 0.5 0.1 0.5 0.7 0.5 0.5 0.8 0.7 0.5
East North Central 0.7 0.5 0.1 0.5 0.7 0.5 0.7 0.6 0.7 0.5
West North Central 0.6 0.6 <0.1 0.4 0.7 0.6 0.2 1.3 0.8 0.4
South 0.7 0.7 0.7 0.7 0.7 0.6 0.8 0.7 0.7 0.6
South Atlantic 0.6 0.7 0.8 0.6 0.6 0.7 1.2 0.5 0.5 0.8
East South Central 0.9 0.8 0.2 0.7 1.0 0.8 0.2 0.9 1.1 0.8
West South Central 0.7 0.5 0.7 0.7 0.7 0.4 0.5 0.9 0.8a 0.4
West 0.6 0.7 0.3 0.1 0.6 0.7 0.4a 0.1 0.6 0.8
Mountain 0.6 0.8 0.4 0.1 0.7 0.9 0.5 0.1 0.7 1.0
Pacific 0.6 0.6 0.3 0.1 0.6 0.6 0.4 0.1 0.6 0.7
COUNTY TYPE                    
Large Metro 0.7 0.6 0.5 0.3 0.7 0.7 0.6 0.5 0.7 0.7
Small Metro 0.6 0.7 0.2 0.5 0.6 0.7 0.5 0.6 0.6 0.7
Nonmetro 1.0b 0.5 0.4 0.8 1.1b 0.4 0.8 0.3 1.2b 0.5
Urbanized 0.9 0.4 0.4 0.2 0.9 0.4 0.7a 0.1 1.0 0.5
Less Urbanized 0.9 0.5 0.3 1.2 1.0 0.5 0.2 <0.1 1.1 0.5
Completely Rural 1.4a 0.5 0.4 1.3 1.5a 0.4 * * 1.5b 0.3
POVERTY LEVEL1                    
Less Than 100% 1.6 1.3 0.5 0.4 1.8 1.4 0.8 0.4 2.0 1.7
100‑199% 0.8 0.8 0.7 0.4 0.8 0.8 0.7 1.2 0.8 0.7
200% or More 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.2 0.4 0.4
HEALTH INSURANCE2                    
Private 0.4 0.4 0.3 0.5 0.4 0.4 0.5 0.4 0.4 0.4
Medicaid/CHIP 1.5 1.3 0.4 0.4 1.8 1.5 1.1 0.5 1.9 1.7
Other3 0.5 0.4 0.9 0.3 0.5 0.5 0.6 0.1 0.5 0.5
No Coverage 0.9 1.0 1.0 0.1 0.9 1.1 0.3 1.0 1.0 1.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.94A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 20,507 21,237 1,830 1,889 18,677 19,348 3,639 3,769 15,038 15,579
GEOGRAPHIC DIVISION                    
Northeast 3,290 3,326 254 235 3,037 3,091 649 699 2,388 2,392
New England 1,159 1,236 96 63 1,062 1,172 208 229 854 943
Middle Atlantic 2,132 2,090 157 172 1,974 1,918 440 470 1,534 1,448
Midwest 4,627 4,965 390 487 4,237 4,478 888 915 3,349 3,562
East North Central 2,986 3,271 267 332 2,719 2,939 585 623 2,134 2,316
West North Central 1,641 1,694 123 156 1,518 1,539 303 293 1,216 1,246
South 8,091 8,408 814 777 7,278 7,632 1,333 1,389 5,945 6,243
South Atlantic 4,038 4,303 407 379 3,631 3,924 734 737 2,897 3,186
East South Central 1,373 1,472 128 126 1,245 1,346 166 174 1,079 1,172
West South Central 2,681 2,634 279 272 2,402 2,362 433 478 1,969 1,884
West 4,498 4,537 373 389 4,125 4,148 770 766 3,356 3,382
Mountain 1,858 1,855 187 161 1,671 1,694 339 297 1,332 1,398
Pacific 2,640 2,682 186 229 2,454 2,453 430 469 2,024 1,984
COUNTY TYPE                    
Large Metro 11,179 11,828 1,008 1,048 10,171 10,781 1,928 2,038 8,244 8,742
Small Metro 7,107 7,168 643 633 6,464 6,535 1,337 1,359 5,126 5,176
Nonmetro 2,221 2,240 179 208 2,042 2,032 374 372 1,668 1,660
Urbanized 897 807 80 50 817 757 185 165 632 592
Less Urbanized 754 872 47 103 708 769 128 139 580 630
Completely Rural 570 561 53 54 518 507 61 68 456 439
POVERTY LEVEL1                    
Less Than 100% 2,994 3,367 254 268 2,740 3,099 767 859 1,973 2,240
100‑199% 3,047b 3,933 293 399 2,754b 3,533 686 849 2,068a 2,685
200% or More 14,453 13,908 1,284 1,222 13,169 12,687 2,173 2,033 10,996 10,654
HEALTH INSURANCE2                    
Private 13,863 13,680 1,204 1,270 12,659 12,411 2,542 2,642 10,118 9,768
Medicaid/CHIP 4,371 4,497 626 607 3,745 3,890 787 806 2,958 3,084
Other3 3,345 3,681 82 127 3,263 3,554 257 257 3,006 3,297
No Coverage 1,381 1,607 53 56 1,328 1,551 285 224 1,043 1,327

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.94B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 7.1 7.3 7.1 7.4 7.1 7.3 10.4 10.4 6.6 6.8
GEOGRAPHIC DIVISION                    
Northeast 6.6 6.6 6.2 5.9 6.7 6.7 11.0 11.5 6.0 6.0
New England 8.7 9.2 9.2 6.2 8.6 9.4 12.7 13.8 8.0 8.8
Middle Atlantic 5.9 5.7 5.2 5.8 5.9 5.7 10.3 10.6 5.3 4.9
Midwest 7.9 8.4 7.2 9.2 7.9 8.3 12.2 12.3 7.2 7.7
East North Central 7.4 8.0 7.3 9.3 7.4 7.9 11.8 12.3 6.7 7.2
West North Central 8.9 9.1 7.0 8.9 9.1 9.1 13.0 12.2 8.5 8.6
South 7.3 7.5 7.9 7.7 7.2 7.4 9.9 9.9 6.8 7.0
South Atlantic 6.8 7.2 7.9 7.5 6.7 7.2 10.8 10.4 6.1 6.7
East South Central 8.2 8.7 8.2 8.3 8.2 8.7 8.1 8.1 8.2 8.8
West South Central 7.5 7.3 7.7 7.6 7.5 7.3 9.3 9.9 7.2 6.8
West 6.6 6.6 6.1 6.5 6.7 6.6 9.3 9.0 6.2 6.3
Mountain 8.4 8.3 9.1 7.8 8.3 8.3 12.1 10.2 7.7 8.0
Pacific 5.8 5.8 4.6 5.8 5.9 5.8 7.9 8.4 5.6 5.4
COUNTY TYPE                    
Large Metro 6.7 7.1 6.7 7.2 6.7 7.1 10.1 9.9 6.3 6.7
Small Metro 8.0 7.9 7.9 7.7 8.0 7.9 11.5 11.6 7.4 7.3
Nonmetro 6.6 6.7 6.4 7.6 6.7 6.6 8.9 9.6 6.3 6.1
Urbanized 6.7 6.6 7.7 5.1 6.6 6.8 9.2 11.2 6.1 6.1
Less Urbanized 6.3 6.4 4.5 8.9 6.5 6.1 9.4 8.8 6.1 5.8
Completely Rural 6.9 7.2 7.3 9.1 6.9 7.1 7.3 8.3 6.8 6.9
POVERTY LEVEL1                    
Less Than 100% 6.4 6.9 4.6 4.7 6.7 7.2 9.2 8.7 6.1 6.7
100‑199% 5.5a 6.5 5.5 7.0 5.5 6.4 8.1 10.0 4.9 5.7
200% or More 7.8 7.7 8.5 8.7 7.7 7.6 12.1 11.6 7.2 7.2
HEALTH INSURANCE2                    
Private 7.9 8.0 8.2 9.2 7.9 7.9 12.9 12.8 7.2 7.1
Medicaid/CHIP 7.4 7.4 6.0 5.8 7.7 7.7 8.8 8.7 7.5 7.5
Other3 4.2 4.4 5.9 8.8 4.2 4.3 9.2 9.6 4.0 4.2
No Coverage 5.5 6.4 4.4 5.0 5.5 6.5 5.7 4.5 5.5 7.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.95A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,899 3,940 203 216 3,696 3,724 973 978 2,723 2,746
GEOGRAPHIC DIVISION                    
Northeast 789 570 21 24 767 546 181 149 586 396
New England 324 170 12 11 313 159 45 20 268 139
Middle Atlantic 464 400 10 13 455 386 136 129 318 257
Midwest 789 857 27 52 763 805 219 239 544 567
East North Central 496 605 11 25 485 580 125 178 360 402
West North Central 294 252 16 27 278 225 94 60 184 165
South 1,389 1,437 83 92 1,305 1,344 356 331 950 1,013
South Atlantic 719 765 45 44 674 720 185 157 489 563
East South Central 194 208 9 7 186 200 47 37 138 164
West South Central 476 464 30 41 446 424 123 137 323 286
West 932 1,077 72 48 861 1,029 217 259 644 770
Mountain 375 438 26 19 350 419 110 100 240 318
Pacific 557 639 46 29 511 610 107 159 404 451
COUNTY TYPE                    
Large Metro 2,316 2,290 108 131 2,208 2,159 502 627 1,706 1,532
Small Metro 1,236 1,237 78 58 1,158 1,179 371 271 787 908
Nonmetro 348 413 17 27 331 386 101 80 230 306
Urbanized 149 176 9 5 140 172 65 49 75 122
Less Urbanized 110 158 8 13 102 145 28 17 74 128
Completely Rural 89 79 * 10 89 69 8 13 81 56
POVERTY LEVEL1                    
Less Than 100% 570 761 13a 56 557 705 206 270 351 436
100‑199% 543 669 33 52 510 617 194 211 316 406
200% or More 2,785 2,502 158 109 2,627 2,393 572 489 2,056 1,904
HEALTH INSURANCE2                    
Private 2,583 2,416 146 120 2,437 2,296 672 728 1,765 1,568
Medicaid/CHIP 746 954 55 97 691 858 163 169 528 689
Other3 388 349 14 4 374 345 71 30 303 315
No Coverage 478 472 * 5 470 467 96 76 374 390

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.95B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.4 1.4 0.8 0.8 1.4 1.4 2.8 2.7 1.2 1.2
GEOGRAPHIC DIVISION                    
Northeast 1.6 1.1 0.5 0.6 1.7 1.2 3.1 2.5 1.5 1.0
New England 2.4 1.3 1.1 1.1 2.5 1.3 2.7 1.2 2.5 1.3
Middle Atlantic 1.3 1.1 0.3 0.4 1.4 1.1 3.2 2.9 1.1 0.9
Midwest 1.3 1.4 0.5 1.0 1.4 1.5 3.0 3.2 1.2 1.2
East North Central 1.2 1.5 0.3 0.7 1.3 1.6 2.5 3.5 1.1 1.3
West North Central 1.6 1.4 0.9 1.5 1.7 1.3 4.0 2.5 1.3 1.1
South 1.2 1.3 0.8 0.9 1.3 1.3 2.6 2.4 1.1 1.1
South Atlantic 1.2 1.3 0.9 0.9 1.2 1.3 2.7 2.2 1.0 1.2
East South Central 1.2 1.2 0.6 0.5 1.2 1.3 2.3 1.7 1.1 1.2
West South Central 1.3 1.3 0.8 1.1 1.4 1.3 2.6 2.8 1.2 1.0
West 1.4 1.6 1.2 0.8 1.4 1.6 2.6 3.0 1.2 1.4
Mountain 1.7 2.0 1.2 0.9 1.7 2.1 3.9 3.4 1.4 1.8
Pacific 1.2 1.4 1.1 0.7 1.2 1.5 2.0 2.8 1.1 1.2
COUNTY TYPE                    
Large Metro 1.4 1.4 0.7 0.9 1.5 1.4 2.6 3.0 1.3 1.2
Small Metro 1.4 1.4 1.0 0.7 1.4 1.4 3.2 2.3 1.1 1.3
Nonmetro 1.0 1.2 0.6 1.0 1.1 1.3 2.4 2.1 0.9 1.1
Urbanized 1.1 1.5 0.8 0.5 1.1 1.5 3.2 3.4 0.7 1.3
Less Urbanized 0.9 1.2 0.8 1.1 0.9 1.2 2.1 1.1 0.8 1.2
Completely Rural 1.1 1.0 * 1.6 1.2 1.0 0.9 1.6 1.2 0.9
POVERTY LEVEL1                    
Less Than 100% 1.2 1.6 0.2a 1.0 1.4 1.6 2.5 2.7 1.1 1.3
100‑199% 1.0 1.1 0.6 0.9 1.0 1.1 2.3 2.5 0.8 0.9
200% or More 1.5 1.4 1.0 0.8 1.5 1.4 3.2 2.8 1.3 1.3
HEALTH INSURANCE2                    
Private 1.5 1.4 1.0 0.9 1.5 1.5 3.4 3.5 1.2 1.1
Medicaid/CHIP 1.3 1.6 0.5 0.9 1.4 1.7 1.8 1.8 1.3 1.7
Other3 0.5 0.4 1.0 0.3 0.5 0.4 2.5 1.1 0.4 0.4
No Coverage 1.9 1.9 * 0.5 2.0 2.0 1.9 1.5 2.0 2.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.96A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,239 1,262 33 50 1,206 1,212 210 260 995 953
GEOGRAPHIC DIVISION                    
Northeast 275 244 4 4 271 239 52 53 219 186
New England 107 70 2 2 105 69 14 14 91 55
Middle Atlantic 167 173 2 3 165 171 37 39 128 132
Midwest 193 242 6 11 187 231 57 48 130 183
East North Central 117 173 5 4 112 170 40 38 71 132
West North Central 76 68 <1 7 75 61 17 10 59 51
South 497 427 20 23 477 404 63 115 414 289
South Atlantic 244 260 20 22 224 238 34 58 190 180
East South Central 73 64 <1 1 72 62 2 13 71 49
West South Central 181 103 <1 * 181 103 28 43 153 60
West 275 350 3 12 271 339 39 44 232 294
Mountain 90 142 2 8 88 134 20 27 68 107
Pacific 185 208 2 4 183 204 19 17 164 187
COUNTY TYPE                    
Large Metro 805 674 16 33 790 641 121 167 669 473
Small Metro 344 469 16 8 328 460 63 74 265 386
Nonmetro 90 119 1 8 88 111 27 18 62 93
Urbanized 44 48 * 2 44 46 13 11 31 35
Less Urbanized 41 65 1 3 39 62 13 7 26 55
Completely Rural 5 7 * * 5 3 * <1 5 3
POVERTY LEVEL1                    
Less Than 100% 144a 292 5 7 138a 285 54 90 84a 195
100‑199% 113 178 3 8 110 170 42 44 68 126
200% or More 983 792 25 34 958 758 114 125 844 633
HEALTH INSURANCE2                    
Private 861 748 24 31 837 717 159 192 677 525
Medicaid/CHIP 197a 402 10 21 187a 381 41 52 146a 329
Other3 91 97 * * 91 97 6 8 84 88
No Coverage 166 105 <1 1 166 104 7 15 159 89

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.96B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4 0.4 0.1 0.2 0.5 0.5 0.6 0.7 0.4 0.4
GEOGRAPHIC DIVISION                    
Northeast 0.6 0.5 0.1 0.1 0.6 0.5 0.9 0.9 0.6 0.5
New England 0.8 0.5 0.2 0.2 0.9 0.6 0.9 0.8 0.9 0.5
Middle Atlantic 0.5 0.5 0.1 0.1 0.5 0.5 0.9 0.9 0.4 0.4
Midwest 0.3 0.4 0.1 0.2 0.3 0.4 0.8 0.6 0.3 0.4
East North Central 0.3 0.4 0.1 0.1 0.3 0.5 0.8 0.7 0.2 0.4
West North Central 0.4 0.4 <0.1 0.4 0.5 0.4 0.7 0.4 0.4 0.4
South 0.4 0.4 0.2 0.2 0.5 0.4 0.5 0.8 0.5 0.3
South Atlantic 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.8 0.4 0.4
East South Central 0.4 0.4 <0.1 0.1 0.5 0.4 0.1 0.6 0.5 0.4
West South Central 0.5 0.3 <0.1 * 0.6 0.3 0.6 0.9 0.6 0.2
West 0.4 0.5 0.1 0.2 0.4 0.5 0.5 0.5 0.4 0.5
Mountain 0.4 0.6 0.1 0.4 0.4 0.7 0.7 0.9 0.4 0.6
Pacific 0.4 0.5 <0.1 0.1 0.4 0.5 0.4 0.3 0.5 0.5
COUNTY TYPE                    
Large Metro 0.5 0.4 0.1 0.2 0.5 0.4 0.6 0.8 0.5 0.4
Small Metro 0.4 0.5 0.2 0.1 0.4 0.6 0.5 0.6 0.4 0.5
Nonmetro 0.3 0.4 <0.1 0.3 0.3 0.4 0.6 0.5 0.2 0.3
Urbanized 0.3 0.4 * 0.2 0.4 0.4 0.7 0.7 0.3 0.4
Less Urbanized 0.3 0.5 0.1 0.2 0.4 0.5 1.0 0.5 0.3 0.5
Completely Rural 0.1 0.1 * * 0.1 <0.1 * <0.1 0.1 <0.1
POVERTY LEVEL1                    
Less Than 100% 0.3a 0.6 0.1 0.1 0.3a 0.7 0.7 0.9 0.3a 0.6
100‑199% 0.2 0.3 0.1 0.1 0.2 0.3 0.5 0.5 0.2 0.3
200% or More 0.5 0.4 0.2 0.2 0.6 0.5 0.6 0.7 0.6 0.4
HEALTH INSURANCE2                    
Private 0.5 0.4 0.2 0.2 0.5 0.5 0.8 0.9 0.5 0.4
Medicaid/CHIP 0.3a 0.7 0.1 0.2 0.4a 0.8 0.5 0.6 0.4a 0.8
Other3 0.1 0.1 * * 0.1 0.1 0.2 0.3 0.1 0.1
No Coverage 0.7 0.4 <0.1 0.1 0.7 0.4 0.1 0.3 0.8 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.97A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 39,709a 36,756 945 821 38,765a 35,935 2,477 2,461 36,288a 33,474
GEOGRAPHIC DIVISION                    
Northeast 6,499 6,400 130 140 6,369 6,260 451a 285 5,918 5,975
New England 2,057 2,093 28 20 2,029 2,073 179 126 1,850 1,947
Middle Atlantic 4,442 4,307 102 121 4,340 4,187 272a 159 4,068 4,028
Midwest 8,168 7,821 225 180 7,943 7,641 540 652 7,403 6,989
East North Central 5,454 5,136 144 120 5,310 5,015 368 438 4,942 4,577
West North Central 2,714 2,686 81 60 2,633 2,626 172 214 2,461 2,412
South 16,654a 14,882 383 323 16,270a 14,559 978 1,085 15,292a 13,474
South Atlantic 9,157 8,356 142 207 9,015 8,149 548 556 8,466 7,593
East South Central 2,545 2,286 69 41 2,477 2,245 120 149 2,357 2,096
West South Central 4,952 4,240 172a 75 4,779 4,166 310 381 4,469 3,785
West 8,389 7,653 207 178 8,182 7,474 507 439 7,675 7,036
Mountain 3,282 2,711 66 100 3,215a 2,612 224 177 2,991 2,434
Pacific 5,107 4,941 141 79 4,967 4,863 283 261 4,684 4,601
COUNTY TYPE                    
Large Metro 21,505a 19,504 500 496 21,004a 19,007 1,364 1,375 19,640a 17,633
Small Metro 13,446 12,691 350a 237 13,096 12,453 841 836 12,255 11,617
Nonmetro 4,758 4,562 94 88 4,664 4,474 271 250 4,393 4,224
Urbanized 1,828 1,877 44a 18 1,784 1,859 94 111 1,690 1,748
Less Urbanized 1,730 1,720 40 50 1,690 1,670 111 95 1,579 1,574
Completely Rural 1,200 965 10 20 1,191 945 66 43 1,124 902
POVERTY LEVEL1                    
Less Than 100% 5,756 5,486 204 165 5,551 5,321 535 613 5,016 4,709
100‑199% 7,268 7,023 163 180 7,105 6,843 602 560 6,503 6,284
200% or More 26,677a 24,230 577 477 26,100a 23,753 1,331 1,272 24,769a 22,482
HEALTH INSURANCE2                    
Private 24,223b 21,426 567 434 23,656b 20,991 1,456 1,546 22,201b 19,446
Medicaid/CHIP 8,387 7,616 403 352 7,984 7,263 762 635 7,222 6,629
Other3 14,759 14,131 35 47 14,724 14,083 216 147 14,508 13,936
No Coverage 1,934 2,081 20 23 1,915 2,058 215 232 1,700 1,826

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.97B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 13.8b 12.7 3.6 3.2 14.8b 13.6 7.1 6.8 16.0b 14.6
GEOGRAPHIC DIVISION                    
Northeast 13.1 12.8 3.2 3.5 14.0 13.6 7.6b 4.7 14.9 14.9
New England 15.4 15.6 2.7 1.9 16.5 16.7 10.9 7.6 17.3 18.1
Middle Atlantic 12.2 11.7 3.3 4.1 13.0 12.4 6.4a 3.6 14.0 13.8
Midwest 13.9 13.2 4.1 3.4 14.8 14.2 7.4 8.7 16.0 15.0
East North Central 13.5 12.6 3.9 3.4 14.4 13.5 7.4 8.7 15.5 14.3
West North Central 14.7 14.5 4.6 3.4 15.8 15.6 7.4 8.9 17.2 16.7
South 14.9b 13.2 3.7 3.2 16.1b 14.2 7.2 7.7 17.4b 15.2
South Atlantic 15.5 14.0 2.8 4.1 16.7 14.9 8.0 7.8 17.9 15.9
East South Central 15.2 13.5 4.4 2.7 16.3 14.6 5.8 7.0 17.9 15.8
West South Central 13.9a 11.7 4.7a 2.1 15.0a 12.8 6.7 7.9 16.4a 13.7
West 12.3 11.2 3.4 3.0 13.2 12.0 6.2 5.2 14.3 13.1
Mountain 14.8a 12.1 3.2 4.9 16.0a 12.9 8.0 6.1 17.3a 14.0
Pacific 11.1 10.7 3.5 2.0 11.9 11.6 5.2 4.7 12.9 12.6
COUNTY TYPE                    
Large Metro 13.0a 11.8 3.3 3.4 13.9a 12.6 7.1 6.7 14.9a 13.5
Small Metro 15.2 13.9 4.3a 2.9 16.2 15.0 7.3 7.2 17.7 16.3
Nonmetro 14.2 13.6 3.4 3.2 15.2 14.5 6.4 6.5 16.6 15.6
Urbanized 13.7 15.5 4.2a 1.9 14.5 16.6 4.7a 7.6 16.4 18.0
Less Urbanized 14.6 12.6 3.9 4.3 15.6 13.3 8.2 6.1 16.6 14.4
Completely Rural 14.6 12.4 1.3 3.3 15.8 13.2 7.9 5.3 16.8 14.2
POVERTY LEVEL1                    
Less Than 100% 12.4 11.3 3.7 2.9 13.6 12.3 6.4 6.2 15.4 14.2
100‑199% 13.1 11.5 3.1 3.1 14.1 12.4 7.1 6.6 15.5a 13.4
200% or More 14.3a 13.4 3.8 3.4 15.3a 14.3 7.4 7.3 16.2a 15.1
HEALTH INSURANCE2                    
Private 13.8b 12.5 3.9 3.1 14.7b 13.3 7.4 7.5 15.7b 14.2
Medicaid/CHIP 14.2a 12.5 3.9 3.4 16.4a 14.3 8.5 6.8 18.2a 16.0
Other3 18.6a 17.0 2.5 3.2 18.9a 17.2 7.7 5.5 19.3a 17.6
No Coverage 7.7 8.3 1.6 2.1 8.0 8.6 4.3 4.7 9.0 9.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.98A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 4,575 4,237 172 141 4,403 4,095 571 582 3,832 3,513
GEOGRAPHIC DIVISION                    
Northeast 725 945 21 27 704 917 47 70 657 848
New England 147 302 4 1 143 300 13 38 130 263
Middle Atlantic 578 643 17 26 561 617 33 32 527 585
Midwest 933 793 29 40 904 753 117 163 787 590
East North Central 623 526 10 27 613 499 90 116 523 384
West North Central 311 266 19 13 291 253 28 47 263 206
South 1,984 1,622 90 46 1,894 1,576 307 278 1,587 1,298
South Atlantic 1,179 922 34 32 1,145 890 192 162 953 728
East South Central 226 211 3 2 223 210 30 19 193 191
West South Central 579 488 52a 12 526 476 85 97 441 380
West 933 877 32 28 901 849 100 72 801 778
Mountain 439 302 11 18 428 284 50 27 378 257
Pacific 493 575 20 10 473 565 50 44 423 521
COUNTY TYPE                    
Large Metro 2,537 2,351 85 85 2,452 2,267 322 327 2,130 1,940
Small Metro 1,407 1,444 57 29 1,350 1,415 178 222 1,172 1,192
Nonmetro 630 442 29 27 600 414 71 33 530 381
Urbanized 269 147 12 2 257 144 20 10 237 135
Less Urbanized 177 239 17 22 160 217 14 18 146 199
Completely Rural 184a 56 <1 * 184a 53 38 5 146 47
POVERTY LEVEL1                    
Less Than 100% 931 849 26 31 906 818 137 172 769 645
100‑199% 914 1,082 42 37 871 1,046 150 178 721 867
200% or More 2,729 2,302 103 73 2,625 2,229 283 228 2,342 2,000
HEALTH INSURANCE2                    
Private 2,275 2,156 101 71 2,174 2,085 283 325 1,891 1,760
Medicaid/CHIP 1,448 1,184 77 71 1,371 1,113 210 163 1,161 950
Other3 1,034 1,153 6 * 1,028 1,153 41 19 988 1,135
No Coverage 462 472 3 2 459 470 54 88 405 381

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.98B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.6 1.5 0.7 0.6 1.7 1.5 1.6 1.6 1.7 1.5
GEOGRAPHIC DIVISION                    
Northeast 1.5 1.9 0.5 0.7 1.5 2.0 0.8 1.2 1.7 2.1
New England 1.1 2.2 0.4 0.1 1.2 2.4 0.8 2.3 1.2 2.4
Middle Atlantic 1.6 1.8 0.6 0.9 1.7 1.8 0.8 0.7 1.8 2.0
Midwest 1.6 1.3 0.5 0.8 1.7 1.4 1.6 2.2 1.7 1.3
East North Central 1.5 1.3 0.3 0.8 1.7 1.3 1.8 2.3 1.6 1.2
West North Central 1.7 1.4 1.1 0.8 1.7 1.5 1.2 2.0 1.8 1.4
South 1.8 1.4 0.9 0.5 1.9 1.5 2.3 2.0 1.8 1.5
South Atlantic 2.0 1.5 0.7 0.6 2.1 1.6 2.8 2.3 2.0 1.5
East South Central 1.3 1.3 0.2 0.1 1.5 1.4 1.5 0.9 1.5 1.4
West South Central 1.6 1.4 1.4a 0.3 1.6 1.5 1.8 2.0 1.6 1.4
West 1.4 1.3 0.5 0.5 1.5 1.4 1.2 0.8 1.5 1.4
Mountain 2.0 1.4 0.6 0.9 2.1 1.4 1.8 0.9 2.2 1.5
Pacific 1.1 1.2 0.5 0.2 1.1 1.3 0.9 0.8 1.2 1.4
COUNTY TYPE                    
Large Metro 1.5 1.4 0.6 0.6 1.6 1.5 1.7 1.6 1.6 1.5
Small Metro 1.6 1.6 0.7 0.4 1.7 1.7 1.5 1.9 1.7 1.7
Nonmetro 1.9 1.3 1.1 1.0 2.0 1.3 1.7 0.9 2.0 1.4
Urbanized 2.0 1.2 1.2 0.2 2.1 1.3 1.0 0.7 2.3 1.4
Less Urbanized 1.5 1.7 1.6 1.9 1.5 1.7 1.0 1.2 1.5 1.8
Completely Rural 2.2a 0.7 <0.1 * 2.4b 0.7 4.5 0.6 2.2a 0.7
POVERTY LEVEL1                    
Less Than 100% 2.0 1.7 0.5 0.6 2.2 1.9 1.6 1.7 2.4 1.9
100‑199% 1.6 1.8 0.8 0.6 1.7 1.9 1.8 2.1 1.7 1.9
200% or More 1.5 1.3 0.7 0.5 1.5 1.3 1.6 1.3 1.5 1.3
HEALTH INSURANCE2                    
Private 1.3 1.3 0.7 0.5 1.3 1.3 1.4 1.6 1.3 1.3
Medicaid/CHIP 2.5 1.9 0.7 0.7 2.8 2.2 2.3 1.8 2.9 2.3
Other3 1.3 1.4 0.4 * 1.3 1.4 1.5 0.7 1.3 1.4
No Coverage 1.8 1.9 0.2 0.2 1.9 2.0 1.1 1.8 2.1 2.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.99A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,480 1,187 38 29 1,442 1,158 160 150 1,282 1,008
GEOGRAPHIC DIVISION                    
Northeast 289 255 5 * 284 255 12 33 271 223
New England 31 67 3 * 28 67 2 24 27 43
Middle Atlantic 258 189 2 * 255 189 11 9 245 179
Midwest 326 210 13 21 313 189 41 21 272 168
East North Central 195 124 * 14 195 110 34 13 161 97
West North Central 131 86 13 7 118 79 7 8 111 71
South 568 497 16 7 552 489 74 79 479 411
South Atlantic 295 294 7 * 289 294 40 41 249 253
East South Central 89 53 <1 1 88 52 22 3 66 49
West South Central 184 150 9 6 175 144 11 35 164 109
West 297 225 4 1 293 224 33 18 260 207
Mountain 129 37 <1 1 129 36 10 2 119 34
Pacific 168 188 4 * 164 188 23 16 141 172
COUNTY TYPE                    
Large Metro 852 592 13 3 839 588 107 72 732 516
Small Metro 391 430 12 7 378 422 16 74 363 348
Nonmetro 238 165 13 18 225 147 38a 4 187 143
Urbanized 66 54 * 1 59 54 8 3 51 51
Less Urbanized 60 86 5 15 55 71 8 1 47 70
Completely Rural 112 26 <1 * 112 22 22 * 90 22
POVERTY LEVEL1                    
Less Than 100% 359 311 5 12 355 299 76 50 278 249
100‑199% 254 299 7 16 247 282 30 59 217 224
200% or More 867 578 26a 1 841 577 54 41 786 536
HEALTH INSURANCE2                    
Private 722 510 21 14 701 496 82 51 620 444
Medicaid/CHIP 519 391 17 17 502 374 74 58 428 316
Other3 309 460 * * 309 460 2 9 307 451
No Coverage 167 132 * 1 167 131 5a 34 161 97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.99B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5 0.4 0.1 0.1 0.5 0.4 0.5 0.4 0.6 0.4
GEOGRAPHIC DIVISION                    
Northeast 0.6 0.5 0.1 * 0.6 0.6 0.2 0.5 0.7 0.6
New England 0.2 0.5 0.3 * 0.2 0.5 0.1 1.4 0.2 0.4
Middle Atlantic 0.7 0.5 0.1 * 0.8 0.6 0.2 0.2 0.8 0.6
Midwest 0.6 0.4 0.2 0.4 0.6 0.4 0.6 0.3 0.6 0.4
East North Central 0.5 0.3 * 0.4 0.5 0.3 0.7 0.3 0.5 0.3
West North Central 0.7 0.5 0.7 0.4 0.7 0.5 0.3 0.3 0.8 0.5
South 0.5 0.4 0.2 0.1 0.5 0.5 0.5 0.6 0.5 0.5
South Atlantic 0.5 0.5 0.1 * 0.5 0.5 0.6 0.6 0.5 0.5
East South Central 0.5 0.3 <0.1 0.1 0.6 0.3 1.1 0.1 0.5 0.4
West South Central 0.5 0.4 0.2 0.2 0.5 0.4 0.2 0.7 0.6 0.4
West 0.4 0.3 0.1 <0.1 0.5 0.4 0.4 0.2 0.5 0.4
Mountain 0.6 0.2 <0.1 <0.1 0.6 0.2 0.3 0.1 0.7 0.2
Pacific 0.4 0.4 0.1 * 0.4 0.4 0.4 0.3 0.4 0.5
COUNTY TYPE                    
Large Metro 0.5 0.4 0.1 <0.1 0.6 0.4 0.6 0.4 0.6 0.4
Small Metro 0.4 0.5 0.2 0.1 0.5 0.5 0.1 0.6 0.5 0.5
Nonmetro 0.7 0.5 0.5 0.7 0.7 0.5 0.9a 0.1 0.7 0.5
Urbanized 0.5 0.4 * 0.1 0.5 0.5 0.4 0.2 0.5 0.5
Less Urbanized 0.5 0.6 0.5 1.3 0.5 0.6 0.6 0.1 0.5 0.6
Completely Rural 1.4 0.3 <0.1 * 1.5a 0.3 2.6 * 1.3 0.4
POVERTY LEVEL1                    
Less Than 100% 0.8 0.6 0.1 0.2 0.9 0.7 0.9 0.5 0.9 0.7
100‑199% 0.5 0.5 0.1 0.3 0.5 0.5 0.3 0.7 0.5 0.5
200% or More 0.5 0.3 0.2a <0.1 0.5 0.3 0.3 0.2 0.5 0.4
HEALTH INSURANCE2                    
Private 0.4 0.3 0.1 0.1 0.4 0.3 0.4 0.2 0.4 0.3
Medicaid/CHIP 0.9 0.6 0.2 0.2 1.0 0.7 0.8 0.6 1.1 0.8
Other3 0.4 0.6 * * 0.4 0.6 0.1 0.3 0.4 0.6
No Coverage 0.7 0.5 * 0.1 0.7 0.6 0.1a 0.7 0.9 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.100A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 31,451a 28,826 500 508 30,951a 28,318 1,944 1,811 29,007a 26,507
GEOGRAPHIC DIVISION                    
Northeast 5,388 5,255 82 98 5,306 5,157 350a 221 4,956 4,936
New England 1,677 1,696 21 6 1,656 1,689 144 120 1,511 1,569
Middle Atlantic 3,711 3,559 61 91 3,650 3,468 206b 101 3,444 3,367
Midwest 6,501 6,213 121 113 6,380 6,100 420 492 5,960 5,608
East North Central 4,395 4,158 68 76 4,328 4,082 283 332 4,044 3,750
West North Central 2,105 2,056 53 37 2,052 2,018 136 161 1,916 1,858
South 13,288b 11,345 209 177 13,079b 11,168 803 770 12,276b 10,399
South Atlantic 7,343 6,377 71 120 7,273 6,257 468 408 6,804 5,849
East South Central 2,020 1,722 48b 13 1,972 1,710 107 103 1,865 1,606
West South Central 3,925 3,246 90 44 3,834 3,202 228 258 3,606 2,944
West 6,274 6,012 88 120 6,186 5,893 371 328 5,815 5,565
Mountain 2,555 2,096 36 59 2,519 2,036 163 122 2,355 1,914
Pacific 3,720 3,917 52 60 3,668 3,856 208 206 3,460 3,650
COUNTY TYPE                    
Large Metro 16,941a 15,088 229 324 16,712a 14,764 1,063 1,005 15,649a 13,759
Small Metro 10,804 10,154 204a 128 10,600 10,027 662 640 9,937 9,387
Nonmetro 3,706 3,583 67 55 3,639 3,528 219 166 3,420 3,362
Urbanized 1,299 1,430 27a 8 1,271 1,422 77 75 1,194 1,348
Less Urbanized 1,354 1,409 34 36 1,320 1,373 93 64 1,227 1,310
Completely Rural 1,053 745 5 12 1,048 732 49 27 998 705
POVERTY LEVEL1                    
Less Than 100% 4,706 4,663 119 107 4,587 4,556 422 450 4,165 4,106
100‑199% 5,923 5,481 94 118 5,829 5,363 489 436 5,340 4,926
200% or More 20,816a 18,670 287 282 20,529a 18,388 1,027 913 19,502a 17,475
HEALTH INSURANCE2                    
Private 18,959b 16,646 287 276 18,671b 16,370 1,145 1,127 17,527b 15,243
Medicaid/CHIP 6,729 6,242 222 202 6,507 6,040 624 477 5,883 5,563
Other3 11,340 10,716 23 28 11,317 10,688 128 103 11,189 10,584
No Coverage 1,625 1,790 10 19 1,615 1,771 182 181 1,433 1,590

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.100B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 10.9b 9.9 1.9 2.0 11.8b 10.7 5.6 5.0 12.8b 11.6
GEOGRAPHIC DIVISION                    
Northeast 10.8 10.5 2.0 2.4 11.6 11.2 5.9a 3.6 12.5 12.3
New England 12.5 12.6 2.0 0.6 13.4 13.6 8.8 7.3 14.1 14.6
Middle Atlantic 10.2 9.7 2.0 3.1 11.0 10.3 4.8b 2.3 11.9 11.5
Midwest 11.0 10.5 2.2 2.1 11.9 11.3 5.8 6.6 12.9 12.1
East North Central 10.9 10.2 1.9 2.1 11.8 11.0 5.7 6.5 12.7 11.7
West North Central 11.4 11.1 3.0 2.2 12.3 12.0 5.8 6.7 13.4 12.9
South 11.9b 10.1 2.0 1.7 12.9b 10.9 5.9 5.5 14.0b 11.7
South Atlantic 12.4a 10.7 1.4 2.4 13.5a 11.4 6.9 5.8 14.4a 12.3
East South Central 12.1 10.2 3.1b 0.8 13.0 11.1 5.2 4.8 14.2 12.1
West South Central 11.0a 9.0 2.5 1.2 12.0a 9.8 4.9 5.3 13.2a 10.6
West 9.2 8.8 1.4 2.0 10.0 9.4 4.5 3.9 10.8 10.3
Mountain 11.5a 9.4 1.8 2.9 12.5a 10.0 5.8 4.2 13.6 11.0
Pacific 8.1 8.5 1.3 1.5 8.8 9.2 3.8 3.7 9.5 10.0
COUNTY TYPE                    
Large Metro 10.2b 9.1 1.5 2.2 11.1b 9.8 5.6 4.9 11.9b 10.5
Small Metro 12.2 11.2 2.5a 1.6 13.1 12.1 5.7 5.5 14.4 13.2
Nonmetro 11.1 10.7 2.4 2.0 11.9 11.4 5.2 4.3 12.9 12.5
Urbanized 9.7 11.8 2.6 0.8 10.3 12.7 3.8 5.1 11.6 13.9
Less Urbanized 11.4 10.3 3.3 3.1 12.2 11.0 6.8 4.0 12.9 12.0
Completely Rural 12.8 9.6 0.8 2.0 13.9 10.2 5.9 3.3 15.0 11.1
POVERTY LEVEL1                    
Less Than 100% 10.1 9.6 2.2 1.9 11.2 10.6 5.0 4.6 12.8 12.3
100‑199% 10.6a 9.0 1.8 2.1 11.6a 9.7 5.8 5.2 12.8a 10.5
200% or More 11.2a 10.3 1.9 2.0 12.0a 11.1 5.7 5.2 12.8a 11.7
HEALTH INSURANCE2                    
Private 10.8b 9.7 2.0 2.0 11.6b 10.4 5.8 5.5 12.4a 11.2
Medicaid/CHIP 11.4 10.2 2.1 1.9 13.4 11.9 7.0a 5.1 14.9 13.5
Other3 14.3a 12.9 1.6 1.9 14.5a 13.1 4.6 3.9 14.9a 13.4
No Coverage 6.4 7.2 0.9 1.7 6.7 7.4 3.6 3.7 7.6 8.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.101A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,829 3,665 126 119 3,703 3,546 522 515 3,181 3,031
GEOGRAPHIC DIVISION                    
Northeast 611 763 12 27 599 735 41 57 558 678
New England 134 179 4 1 130 178 9 37 121 141
Middle Atlantic 477 583 8 26 469 557 32 21 437 537
Midwest 813 699 26 29 787 670 92 142 695 528
East North Central 561 481 9 20 553 461 68 100 485 361
West North Central 251 218 17 9 234 209 24 42 210 167
South 1,692 1,429 70 42 1,622 1,387 301 250 1,321 1,137
South Atlantic 1,000 754 24 32 976 722 189 134 787 588
East South Central 195 202 3 1 192 201 26 19 166 182
West South Central 497 474 43 10 454 464 85 96 369 367
West 713 774 18 21 695 753 88 66 607 687
Mountain 329 262 5 11 324 251 49 25 275 226
Pacific 384 512 13 10 371 502 39 41 332 461
COUNTY TYPE                    
Large Metro 2,114 2,012 61 76 2,053 1,936 285 285 1,767 1,651
Small Metro 1,233 1,283 41 25 1,191 1,258 171 203 1,020 1,055
Nonmetro 482 370 23 19 459 351 65 27 393 325
Urbanized 156 119 9 2 147 117 17 10 129 107
Less Urbanized 156 202 14 16 142 186 14 15 128 170
Completely Rural 170a 49 <1 * 170a 49 34 2 136 47
POVERTY LEVEL1                    
Less Than 100% 780 756 13 28 767 727 129 143 638 585
100‑199% 822 882 31 31 791 851 144 171 647 680
200% or More 2,226 2,024 82 60 2,144 1,964 248 198 1,897 1,766
HEALTH INSURANCE2                    
Private 1,901 1,928 77 60 1,824 1,869 250 296 1,574 1,573
Medicaid/CHIP 1,217 1,022 55 61 1,162 961 196 150 966 811
Other3 785 851 6 * 779 851 38 16 741 834
No Coverage 432 445 2 1 430 444 51 65 379 379

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.101B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.3 1.3 0.5 0.5 1.4 1.3 1.5 1.4 1.4 1.3
GEOGRAPHIC DIVISION                    
Northeast 1.2 1.5 0.3 0.7 1.3 1.6 0.7 0.9 1.4 1.7
New England 1.0 1.3 0.4 0.1 1.1 1.4 0.5 2.2 1.1 1.3
Middle Atlantic 1.3 1.6 0.3 0.9 1.4 1.7 0.8 0.5 1.5 1.8
Midwest 1.4 1.2 0.5 0.6 1.5 1.2 1.3 1.9 1.5 1.1
East North Central 1.4 1.2 0.2 0.6 1.5 1.2 1.4 2.0 1.5 1.1
West North Central 1.4 1.2 1.0 0.5 1.4 1.2 1.0 1.7 1.5 1.2
South 1.5 1.3 0.7 0.4 1.6 1.4 2.2 1.8 1.5 1.3
South Atlantic 1.7 1.3 0.5 0.6 1.8 1.3 2.8 1.9 1.7 1.2
East South Central 1.2 1.2 0.2 <0.1 1.3 1.3 1.3 0.9 1.3 1.4
West South Central 1.4 1.3 1.2 0.3 1.4 1.4 1.8 2.0 1.4 1.3
West 1.0 1.1 0.3 0.3 1.1 1.2 1.1 0.8 1.1 1.3
Mountain 1.5 1.2 0.2 0.5 1.6 1.2 1.7 0.9 1.6 1.3
Pacific 0.8 1.1 0.3 0.2 0.9 1.2 0.7 0.7 0.9 1.3
COUNTY TYPE                    
Large Metro 1.3 1.2 0.4 0.5 1.4 1.3 1.5 1.4 1.3 1.3
Small Metro 1.4 1.4 0.5 0.3 1.5 1.5 1.5 1.7 1.5 1.5
Nonmetro 1.4 1.1 0.8 0.7 1.5 1.1 1.5 0.7 1.5 1.2
Urbanized 1.2 1.0 0.9 0.2 1.2 1.0 0.9 0.7 1.3 1.1
Less Urbanized 1.3 1.5 1.3 1.4 1.3 1.5 1.0 1.0 1.3 1.6
Completely Rural 2.1a 0.6 <0.1 * 2.3a 0.7 4.1 0.2 2.0 0.7
POVERTY LEVEL1                    
Less Than 100% 1.7 1.5 0.2 0.5 1.9 1.7 1.5 1.4 2.0 1.8
100‑199% 1.5 1.4 0.6 0.5 1.6 1.5 1.7 2.0 1.5 1.5
200% or More 1.2 1.1 0.5 0.4 1.3 1.2 1.4 1.1 1.2 1.2
HEALTH INSURANCE2                    
Private 1.1 1.1 0.5 0.4 1.1 1.2 1.3 1.4 1.1 1.2
Medicaid/CHIP 2.1 1.7 0.5 0.6 2.4 1.9 2.2 1.6 2.4 2.0
Other3 1.0 1.0 0.4 * 1.0 1.0 1.4 0.6 1.0 1.1
No Coverage 1.7 1.8 0.1 0.1 1.8 1.9 1.0 1.3 2.0 2.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.102A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,259 974 28 24 1,231 950 131 140 1,099 810
GEOGRAPHIC DIVISION                    
Northeast 220 214 5 * 215 214 12 32 203 182
New England 31 62 3 * 28 62 2 * 27 39
Middle Atlantic 189 152 2 * 187 152 11 9 176 143
Midwest 289 165 12 17 277 148 28 18 249 130
East North Central 175 108 * 10 175 99 24 10 151 89
West North Central 114 56 12 7 102 49 4 8 98 42
South 482 378 10 6 472 372 68 73 404 299
South Atlantic 258 199 5 * 253 199 38 36 215 163
East South Central 78 52 <1 <1 78 52 18 3 60 49
West South Central 145 126 5 6 140 120 11 34 129 86
West 268 217 1 1 267 216 24 17 243 199
Mountain 111 37 <1 1 111 36 5 1 105 34
Pacific 157 180 <1 * 156 180 18 16 138 165
COUNTY TYPE                    
Large Metro 687 499 8 2 678 497 85 64 594 433
Small Metro 352 338 8 6 344 332 13 72 331 259
Nonmetro 220 136 12 15 208 121 34 4 175 118
Urbanized 58 54 * 1 51 54 6 3 45 51
Less Urbanized 55 60 5 15 50 45 8 1 42 44
Completely Rural 107 22 * * 107 22 * * 88 22
POVERTY LEVEL1                    
Less Than 100% 310 233 1 9 309 225 66 49 243 176
100‑199% 214 262 5 14 208 248 26 56 182 191
200% or More 735 479 22a 1 713 477 39 34 674 443
HEALTH INSURANCE2                    
Private 592 443 17 14 575 428 58 49 517 379
Medicaid/CHIP 458 312 11 12 447 299 71 57 376 242
Other3 278 327 * * 278 327 <1 7 278 320
No Coverage 140 125 * * 140 125 3a 28 137 97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.102B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4 0.3 0.1 0.1 0.5 0.4 0.4 0.4 0.5 0.4
GEOGRAPHIC DIVISION                    
Northeast 0.4 0.4 0.1 * 0.5 0.5 0.2 0.5 0.5 0.5
New England 0.2 0.5 0.3 * 0.2 0.5 0.1 * 0.2 0.4
Middle Atlantic 0.5 0.4 0.1 * 0.6 0.5 0.2 0.2 0.6 0.5
Midwest 0.5 0.3 0.2 0.3 0.5 0.3 0.4 0.2 0.5 0.3
East North Central 0.4 0.3 * 0.3 0.5 0.3 0.5 0.2 0.5 0.3
West North Central 0.6 0.3 0.7 0.4 0.6 0.3 0.2 0.3 0.7 0.3
South 0.4 0.3 0.1 0.1 0.5 0.4 0.5 0.5 0.5 0.3
South Atlantic 0.4 0.3 0.1 * 0.5 0.4 0.6 0.5 0.5 0.3
East South Central 0.5 0.3 <0.1 <0.1 0.5 0.3 0.9 0.1 0.5 0.4
West South Central 0.4 0.3 0.1 0.2 0.4 0.4 0.2 0.7 0.5 0.3
West 0.4 0.3 <0.1 <0.1 0.4 0.3 0.3 0.2 0.5 0.4
Mountain 0.5 0.2 <0.1 <0.1 0.5 0.2 0.2 0.1 0.6 0.2
Pacific 0.3 0.4 <0.1 * 0.4 0.4 0.3 0.3 0.4 0.5
COUNTY TYPE                    
Large Metro 0.4 0.3 0.1 <0.1 0.4 0.3 0.4 0.3 0.5 0.3
Small Metro 0.4 0.4 0.1 0.1 0.4 0.4 0.1 0.6 0.5 0.4
Nonmetro 0.7 0.4 0.4 0.6 0.7 0.4 0.8 0.1 0.7 0.4
Urbanized 0.4 0.4 * 0.1 0.4 0.5 0.3 0.2 0.4 0.5
Less Urbanized 0.5 0.4 0.5 1.3 0.5 0.4 0.6 0.1 0.4 0.4
Completely Rural 1.3 0.3 * * 1.4 0.3 * * 1.3 0.4
POVERTY LEVEL1                    
Less Than 100% 0.7 0.5 <0.1 0.2 0.8 0.5 0.8 0.5 0.7 0.5
100‑199% 0.4 0.4 0.1 0.2 0.4 0.4 0.3 0.7 0.4 0.4
200% or More 0.4 0.3 0.1a <0.1 0.4 0.3 0.2 0.2 0.4 0.3
HEALTH INSURANCE2                    
Private 0.3 0.3 0.1 0.1 0.4 0.3 0.3 0.2 0.4 0.3
Medicaid/CHIP 0.8 0.5 0.1 0.1 0.9 0.6 0.8 0.6 0.9 0.6
Other3 0.4 0.4 * * 0.4 0.4 <0.1 0.2 0.4 0.4
No Coverage 0.6 0.5 * * 0.6 0.5 0.1a 0.6 0.7 0.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.103A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 13,762 13,659 545a 395 13,217 13,264 830 930 12,387 12,334
GEOGRAPHIC DIVISION                    
Northeast 1,891 2,241 69 60 1,823 2,181 127 80 1,695 2,101
New England 616 735 17 16 599 719 47b 8 552 711
Middle Atlantic 1,276 1,506 52 44 1,224 1,462 81 72 1,143 1,390
Midwest 2,715 2,554 116 84 2,600 2,470 235 202 2,365 2,269
East North Central 1,640 1,597 77 51 1,563 1,547 162 136 1,401 1,411
West North Central 1,075 957 38 33 1,037 924 73 66 964 858
South 6,010 6,057 225 180 5,785 5,876 287a 447 5,498 5,430
South Atlantic 3,263 3,399 91 116 3,172 3,283 152 199 3,020 3,084
East South Central 1,016 983 26 29 990 954 28a 81 962 872
West South Central 1,732 1,675 108a 35 1,623 1,640 108 167 1,516 1,473
West 3,145 2,808 135 71 3,010 2,736 181 202 2,829 2,534
Mountain 1,225 1,081 35 50 1,190 1,031 84 79 1,106 951
Pacific 1,921 1,727 100b 21 1,821 1,705 98 123 1,723 1,583
COUNTY TYPE                    
Large Metro 7,583 7,448 316 226 7,266 7,222 472 544 6,795 6,678
Small Metro 4,381 4,692 196a 124 4,185 4,568 268 276 3,917 4,292
Nonmetro 1,799 1,519 32 44 1,766 1,474 91 110 1,675 1,364
Urbanized 787 674 19 12 768 662 35 50 734 612
Less Urbanized 657 504 9 22 648 482 37 35 610 446
Completely Rural 355 341 4 11 350 330 19 25 331 305
POVERTY LEVEL1                    
Less Than 100% 2,105 1,795 108 73 1,997 1,722 217 230 1,780 1,492
100‑199% 2,393 2,686 84 74 2,309 2,612 199 184 2,110 2,428
200% or More 9,261 9,171 353 248 8,909 8,922 412 509 8,497 8,413
HEALTH INSURANCE2                    
Private 8,375 7,887 337a 201 8,037 7,686 449 573 7,589 7,113
Medicaid/CHIP 3,010 2,791 232 179 2,778 2,612 270 247 2,509 2,365
Other3 5,879 5,822 19 * 5,860 5,791 129 67 5,731 5,724
No Coverage 505 632 10 9 495 623 51 79 444 544

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.103B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 4.8 4.7 2.1a 1.6 5.0 5.0 2.4 2.6 5.4 5.4
GEOGRAPHIC DIVISION                    
Northeast 3.8 4.5 1.7 1.5 4.0 4.7 2.2 1.3 4.3 5.2
New England 4.6 5.5 1.6 1.6 4.9 5.8 2.8b 0.5 5.2 6.6
Middle Atlantic 3.5 4.1 1.7 1.5 3.7 4.3 1.9 1.6 3.9 4.8
Midwest 4.6 4.3 2.1 1.6 4.9 4.6 3.2 2.7 5.1 4.9
East North Central 4.1 3.9 2.1 1.4 4.2 4.2 3.3 2.7 4.4 4.4
West North Central 5.8 5.2 2.2 1.9 6.2 5.5 3.1 2.7 6.7 5.9
South 5.4 5.4 2.2 1.8 5.7 5.7 2.1a 3.2 6.3 6.1
South Atlantic 5.5 5.7 1.8 2.3 5.9 6.0 2.2 2.8 6.4 6.5
East South Central 6.1 5.8 1.7 1.9 6.5 6.2 1.4a 3.8 7.3 6.6
West South Central 4.9 4.6 3.0a 1.0 5.1 5.0 2.3 3.4 5.5 5.3
West 4.6 4.1 2.2 1.2 4.9 4.4 2.2 2.4 5.3 4.7
Mountain 5.5 4.8 1.7 2.4 5.9 5.1 3.0 2.7 6.4 5.5
Pacific 4.2 3.8 2.4b 0.5 4.4 4.1 1.8 2.2 4.7 4.3
COUNTY TYPE                    
Large Metro 4.6 4.5 2.1 1.6 4.8 4.8 2.5 2.6 5.2 5.1
Small Metro 4.9 5.2 2.4a 1.5 5.2 5.5 2.3 2.4 5.7 6.0
Nonmetro 5.4 4.5 1.2 1.6 5.8 4.8 2.2 2.9 6.3 5.1
Urbanized 5.9 5.5 1.8 1.2 6.2 5.9 1.7 3.4 7.1 6.3
Less Urbanized 5.5 3.7 0.9 1.9 6.0a 3.8 2.7 2.2 6.4a 4.1
Completely Rural 4.3 4.4 0.6 1.8 4.7 4.6 2.3 3.0 5.0 4.8
POVERTY LEVEL1                    
Less Than 100% 4.5 3.7 2.0 1.3 4.9 4.0 2.6 2.3 5.5 4.5
100‑199% 4.3 4.4 1.6 1.3 4.6 4.7 2.3 2.2 5.0 5.2
200% or More 5.0 5.1 2.3 1.8 5.2 5.4 2.3 2.9 5.6 5.6
HEALTH INSURANCE2                    
Private 4.8 4.6 2.3a 1.5 5.0 4.9 2.3 2.8 5.4 5.2
Medicaid/CHIP 5.1 4.6 2.2 1.7 5.7 5.2 3.0 2.6 6.3 5.7
Other3 7.4 7.0 1.4 * 7.5 7.1 4.6 2.5 7.6 7.2
No Coverage 2.0 2.5 0.8 0.8 2.1 2.6 1.0 1.6 2.3 2.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.104A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 920 977 64 31 857 946 76 118 781 828
GEOGRAPHIC DIVISION                    
Northeast 167 302 10 * 157 302 10 16 147 285
New England 24 177 1 * 23 177 9 2 14 175
Middle Atlantic 143 124 10 * 134 124 1 14 132 110
Midwest 136 140 3 14 133 126 31 28 101 98
East North Central 69 71 1 7 67 64 24 20 43 45
West North Central 67 68 2 7 65 61 7 8 58 53
South 368 389 33 8 335 381 14a 64 321 317
South Atlantic 216 279 12 1 204 279 9 34 195 244
East South Central 44 33 2 1 42 32 5 13 38 19
West South Central 108 77 19 6 89 70 <1 16 89 54
West 249 147 17 9 232 138 20 11 212 127
Mountain 121 46 6 8 115 39 6 2 109 36
Pacific 128 100 11 1 117 99 15 9 102 91
COUNTY TYPE                    
Large Metro 523 585 29 9 494 576 51 79 443 497
Small Metro 238 286 27 8 212 278 16 30 196 248
Nonmetro 159 107 8 15 151 92 9 9 142 83
Urbanized 119 35 4 1 115 34 5 2 110 32
Less Urbanized 25 60 3 10 21 50 1 3 21 47
Completely Rural 15 11 <1 * 15 8 4 4 11 4
POVERTY LEVEL1                    
Less Than 100% 218 208 13 10 205 198 22 42 183 156
100‑199% 123 284 13 9 110 275 10 18 100 257
200% or More 579 485 37 13 542 472 44 58 498 414
HEALTH INSURANCE2                    
Private 424 436 29 14 395 422 44 58 351 364
Medicaid/CHIP 314 323 34 18 280 305 22 32 258 274
Other3 278 383 * * 278 383 5 5 273 378
No Coverage 57 48 1 2 56 46 9 24 47 22

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.104B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3 0.3 0.2 0.1 0.3 0.4 0.2 0.3 0.3 0.4
GEOGRAPHIC DIVISION                    
Northeast 0.3 0.6 0.2 * 0.3 0.7 0.2 0.3 0.4 0.7
New England 0.2 1.3 0.1 * 0.2 1.4 0.5 0.1 0.1 1.6
Middle Atlantic 0.4 0.3 0.3 * 0.4 0.4 <0.1 0.3 0.5 0.4
Midwest 0.2 0.2 0.1 0.3 0.2 0.2 0.4 0.4 0.2 0.2
East North Central 0.2 0.2 <0.1 0.2 0.2 0.2 0.5 0.4 0.1 0.1
West North Central 0.4 0.4 0.1 0.4 0.4 0.4 0.3 0.3 0.4 0.4
South 0.3 0.3 0.3 0.1 0.3 0.4 0.1a 0.5 0.4 0.4
South Atlantic 0.4 0.5 0.2 <0.1 0.4 0.5 0.1 0.5 0.4 0.5
East South Central 0.3 0.2 0.1 0.1 0.3 0.2 0.2 0.6 0.3 0.1
West South Central 0.3 0.2 0.5 0.2 0.3 0.2 <0.1 0.3 0.3 0.2
West 0.4 0.2 0.3 0.2 0.4 0.2 0.2 0.1 0.4 0.2
Mountain 0.5 0.2 0.3 0.4 0.6 0.2 0.2 0.1 0.6 0.2
Pacific 0.3 0.2 0.3 <0.1 0.3 0.2 0.3 0.2 0.3 0.2
COUNTY TYPE                    
Large Metro 0.3 0.4 0.2 0.1 0.3 0.4 0.3 0.4 0.3 0.4
Small Metro 0.3 0.3 0.3 0.1 0.3 0.3 0.1 0.3 0.3 0.3
Nonmetro 0.5 0.3 0.3 0.5 0.5 0.3 0.2 0.2 0.5 0.3
Urbanized 0.9 0.3 0.4 0.1 0.9 0.3 0.2 0.2 1.1 0.3
Less Urbanized 0.2 0.4 0.3 0.9 0.2 0.4 <0.1 0.2 0.2 0.4
Completely Rural 0.2 0.1 <0.1 * 0.2 0.1 0.4 0.5 0.2 0.1
POVERTY LEVEL1                    
Less Than 100% 0.5 0.4 0.2 0.2 0.5 0.5 0.3 0.4 0.6 0.5
100‑199% 0.2 0.5 0.2 0.2 0.2 0.5 0.1 0.2 0.2 0.5
200% or More 0.3 0.3 0.2 0.1 0.3 0.3 0.2 0.3 0.3 0.3
HEALTH INSURANCE2                    
Private 0.2 0.3 0.2 0.1 0.2 0.3 0.2 0.3 0.2 0.3
Medicaid/CHIP 0.5 0.5 0.3 0.2 0.6 0.6 0.2 0.3 0.7 0.7
Other3 0.4 0.5 * * 0.4 0.5 0.2 0.2 0.4 0.5
No Coverage 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.2 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.105A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 254 306 11 8 243 298 35 13 208 285
GEOGRAPHIC DIVISION                    
Northeast 77 82 1 * 76 82 1 3 75 79
New England 4 5 1 * 3 5 1 1 3 4
Middle Atlantic 73 77 * * 73 77 * 2 73 75
Midwest 40 57 1 7 39 49 14 3 26 46
East North Central 23 24 * 4 23 20 10 3 13 16
West North Central 17 32 1 3 16 30 4 * 13 30
South 99 151 6 1 93 150 10 6 83 145
South Atlantic 42 119 1 * 41 119 7 5 34 114
East South Central 14 9 <1 1 14 8 4 * 10 8
West South Central 43 23 4 * 39 23 <1 1 39 23
West 38 17 4 * 34 17 10 1 24 16
Mountain 19 1 * * 19 1 5 1 14 1
Pacific 19 15 4 * 16 15 6 * 10 15
COUNTY TYPE                    
Large Metro 188 153 5 1 183 152 27 10 156 142
Small Metro 47 115 5 4 43 111 4 2 39 109
Nonmetro 18 38 1 3 17 35 4 <1 13 35
Urbanized 8 * 1 * 7 * 2 * 6 *
Less Urbanized 5 35 <1 * 5 35 <1 <1 5 35
Completely Rural 5 3 <1 * 4 * 2 * 2 *
POVERTY LEVEL1                    
Less Than 100% 61 95 5 3 56 92 14 1 43 90
100‑199% 43 70 2 5 41 65 6 2 35 63
200% or More 150 141 4 * 146 141 15 9 131 132
HEALTH INSURANCE2                    
Private 141 129 4 3 137 126 25 4 112 122
Medicaid/CHIP 77 129 7 7 70 122 6 1 64 121
Other3 42 151 * * 42 151 2 2 41 149
No Coverage 28 15 * 1 28 14 4 6 24 8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.105B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1 0.1 <0.1 <0.1 0.1 0.1 0.1 <0.1 0.1 0.1
GEOGRAPHIC DIVISION                    
Northeast 0.2 0.2 <0.1 * 0.2 0.2 <0.1 0.1 0.2 0.2
New England <0.1 <0.1 0.1 * <0.1 <0.1 <0.1 0.1 <0.1 <0.1
Middle Atlantic 0.2 0.2 * * 0.2 0.2 * <0.1 0.3 0.3
Midwest 0.1 0.1 <0.1 0.1 0.1 0.1 0.2 <0.1 0.1 0.1
East North Central 0.1 0.1 * 0.1 0.1 0.1 0.2 0.1 <0.1 0.1
West North Central 0.1 0.2 <0.1 0.2 0.1 0.2 0.2 * 0.1 0.2
South 0.1 0.1 0.1 <0.1 0.1 0.1 0.1 <0.1 0.1 0.2
South Atlantic 0.1 0.2 <0.1 * 0.1 0.2 0.1 0.1 0.1 0.2
East South Central 0.1 0.1 <0.1 0.1 0.1 0.1 0.2 * 0.1 0.1
West South Central 0.1 0.1 0.1 * 0.1 0.1 <0.1 <0.1 0.1 0.1
West 0.1 <0.1 0.1 * 0.1 <0.1 0.1 <0.1 <0.1 <0.1
Mountain 0.1 <0.1 * * 0.1 <0.1 0.2 <0.1 0.1 <0.1
Pacific <0.1 <0.1 0.1 * <0.1 <0.1 0.1 * <0.1 <0.1
COUNTY TYPE                    
Large Metro 0.1 0.1 <0.1 <0.1 0.1 0.1 0.1 <0.1 0.1 0.1
Small Metro 0.1 0.1 0.1 <0.1 0.1 0.1 <0.1 <0.1 0.1 0.2
Nonmetro 0.1 0.1 <0.1 0.1 0.1 0.1 0.1 <0.1 <0.1 0.1
Urbanized 0.1 * 0.1 * 0.1 * 0.1 * 0.1 *
Less Urbanized <0.1 0.3 <0.1 * <0.1 0.3 <0.1 <0.1 0.1 0.3
Completely Rural 0.1 <0.1 <0.1 * 0.1 * 0.3 * <0.1 *
POVERTY LEVEL1                    
Less Than 100% 0.1 0.2 0.1 0.1 0.1 0.2 0.2a <0.1 0.1 0.3
100‑199% 0.1 0.1 <0.1 0.1 0.1 0.1 0.1 <0.1 0.1 0.1
200% or More 0.1 0.1 <0.1 * 0.1 0.1 0.1 <0.1 0.1 0.1
HEALTH INSURANCE2                    
Private 0.1 0.1 <0.1 <0.1 0.1 0.1 0.1 <0.1 0.1 0.1
Medicaid/CHIP 0.1 0.2 0.1 0.1 0.1 0.2 0.1 <0.1 0.2 0.3
Other3 0.1 0.2 * * 0.1 0.2 0.1 0.1 0.1 0.2
No Coverage 0.1 0.1 * 0.1 0.1 0.1 0.1 0.1 0.1 <0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.106A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 24,207a 22,280 371 398 23,835a 21,883 1,628 1,536 22,208a 20,346
GEOGRAPHIC DIVISION                    
Northeast 4,248 4,207 60 74 4,188 4,133 283 197 3,905 3,936
New England 1,371 1,350 17 4 1,354 1,345 109 110 1,244 1,235
Middle Atlantic 2,877 2,857 43 70 2,834 2,788 174b 86 2,660 2,701
Midwest 5,248 4,925 84 86 5,164 4,839 344 407 4,819 4,431
East North Central 3,645 3,297 54 49 3,591 3,248 233 296 3,358 2,952
West North Central 1,603 1,628 30 37 1,573 1,591 111 112 1,462 1,479
South 10,103a 8,666 170 142 9,933a 8,524 687 654 9,246a 7,870
South Atlantic 5,660a 4,683 55 95 5,605a 4,588 416 355 5,189a 4,233
East South Central 1,463 1,417 29 12 1,433 1,405 80 74 1,353 1,331
West South Central 2,981 2,565 86 34 2,895 2,531 191 225 2,704 2,306
West 4,607 4,483 56 96 4,550 4,388 313 279 4,237 4,109
Mountain 1,762 1,528 17 49 1,745 1,479 128 104 1,617 1,375
Pacific 2,845 2,955 40 47 2,805 2,909 185 175 2,620 2,734
COUNTY TYPE                    
Large Metro 13,077 11,817 168 249 12,909 11,568 942 872 11,966 10,697
Small Metro 8,327 7,847 157 97 8,170 7,751 502 536 7,668 7,215
Nonmetro 2,803 2,616 46 52 2,757 2,564 183 129 2,573 2,435
Urbanized 1,056 991 10 5 1,046 985 65 60 982 925
Less Urbanized 998 993 31 36 967 958 80 42 887 916
Completely Rural 749 632 5 11 744 621 39 27 705 594
POVERTY LEVEL1                    
Less Than 100% 3,683 3,506 107 93 3,576 3,413 330 380 3,246 3,033
100‑199% 4,427 4,282 68 81 4,360 4,202 396 387 3,964 3,814
200% or More 16,091a 14,483 196 223 15,895a 14,260 897 761 14,997a 13,499
HEALTH INSURANCE2                    
Private 14,517a 12,993 194 246 14,324a 12,747 978 931 13,345a 11,816
Medicaid/CHIP 5,371 4,896 178 144 5,193 4,752 505 433 4,688 4,319
Other3 8,708 7,991 16 11 8,692 7,981 99 75 8,593 7,906
No Coverage 1,292 1,338 8 10 1,284 1,328 154 160 1,131 1,168

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.106B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 8.4a 7.7 1.4 1.6 9.1b 8.3 4.7 4.3 9.8a 8.9
GEOGRAPHIC DIVISION                    
Northeast 8.5 8.4 1.5 1.9 9.2 9.0 4.8 3.2 9.8 9.8
New England 10.2 10.0 1.6 0.4 11.0 10.8 6.6 6.7 11.6 11.5
Middle Atlantic 7.9 7.8 1.4 2.3 8.5 8.3 4.1b 2.0 9.2 9.2
Midwest 8.9 8.3 1.6 1.6 9.7 9.0 4.7 5.5 10.4 9.5
East North Central 9.0 8.1 1.5 1.4 9.8 8.8 4.7 5.8 10.5 9.2
West North Central 8.7 8.8 1.7 2.1 9.4 9.5 4.8 4.6 10.2 10.3
South 9.1b 7.7 1.6 1.4 9.8b 8.3 5.1 4.6 10.5b 8.9
South Atlantic 9.6a 7.8 1.1 1.9 10.4b 8.4 6.1 5.0 11.0a 8.9
East South Central 8.7 8.4 1.9 0.8 9.4 9.1 3.9 3.5 10.3 10.0
West South Central 8.4 7.1 2.4 1.0 9.1 7.8 4.1 4.7 9.9 8.3
West 6.8 6.6 0.9 1.6 7.3 7.0 3.8 3.3 7.9 7.6
Mountain 7.9 6.8 0.8 2.4 8.7 7.3 4.5 3.6 9.3 7.9
Pacific 6.2 6.4 1.0 1.2 6.7 6.9 3.4 3.1 7.2 7.5
COUNTY TYPE                    
Large Metro 7.9a 7.1 1.1 1.7 8.5a 7.6 4.9 4.2 9.1 8.2
Small Metro 9.4 8.6 1.9 1.2 10.1 9.4 4.3 4.6 11.1 10.1
Nonmetro 8.4 7.8 1.7 1.9 9.0 8.3 4.3 3.3 9.7 9.0
Urbanized 7.9 8.2 0.9 0.5 8.5 8.8 3.2 4.1 9.5 9.5
Less Urbanized 8.4 7.3 3.0 3.1 8.9 7.7 5.9a 2.6 9.3 8.4
Completely Rural 9.1 8.1 0.8 1.9 9.9 8.6 4.6 3.3 10.6 9.3
POVERTY LEVEL1                    
Less Than 100% 7.9 7.2 1.9 1.7 8.7 7.9 3.9 3.9 10.0 9.1
100‑199% 8.0 7.0 1.3 1.4 8.7 7.6 4.7 4.6 9.5 8.2
200% or More 8.7 8.0 1.3 1.6 9.3 8.6 5.0 4.4 9.8 9.1
HEALTH INSURANCE2                    
Private 8.3 7.6 1.3 1.8 8.9a 8.1 5.0 4.5 9.4 8.6
Medicaid/CHIP 9.1 8.0 1.7 1.4 10.7 9.4 5.6 4.6 11.8 10.5
Other3 11.0a 9.6 1.1 0.7 11.2a 9.8 3.6 2.8 11.5a 10.0
No Coverage 5.1 5.4 0.6 0.9 5.4 5.6 3.0 3.2 6.0 6.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.107A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,360 3,293 107 122 3,253 3,172 488 470 2,766 2,702
GEOGRAPHIC DIVISION                    
Northeast 494 713 10 27 483 685 40 57 443 628
New England 111 134 4 1 107 133 9 37 98 96
Middle Atlantic 383 578 6 26 376 552 31 21 345 532
Midwest 742 593 18 31 724 562 85 134 639a 428
East North Central 518 409 7 18 510 391 61 100 449 291
West North Central 225 184 11 13 213 171 24 34 190 137
South 1,476 1,373 61 44 1,415 1,329 286 211 1,129 1,118
South Atlantic 826 769 19 31 807 738 174 117 633 621
East South Central 190 170 3 1 187 170 26 8 161 162
West South Central 460 433 39 12 421 421 85 86 336 335
West 648 615 17 19 631 595 77 67 554 528
Mountain 282 212 7 10 275 202 37 25 238 177
Pacific 366 403 10 10 356 393 40 42 316 351
COUNTY TYPE                    
Large Metro 1,747 1,727 45 72 1,703 1,655 284 253 1,419 1,403
Small Metro 1,123 1,216 45 27 1,079 1,189 142 191 936 998
Nonmetro 490 351 17 23 472 328 62 27 410 301
Urbanized 179 116 3 2 176 114 17 10 159 104
Less Urbanized 145 185 14 20 132 165 14 15 118 150
Completely Rural 165a 49 <1 * 165a 49 31 2 134 47
POVERTY LEVEL1                    
Less Than 100% 642 746 17 28 625 718 125 131 500 587
100‑199% 659 809 28 32 631 777 126 161 505 617
200% or More 2,058 1,735 61 62 1,997 1,673 235 174 1,762 1,498
HEALTH INSURANCE2                    
Private 1,669 1,591 54 64 1,615 1,528 230 259 1,385 1,269
Medicaid/CHIP 1,092 1,017 58 60 1,033 957 192 132 841 825
Other3 604 751 2 * 602 751 28 16 574 735
No Coverage 406 429 1 1 405 428 51 69 354 359

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.107B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.2 1.1 0.4 0.5 1.2 1.2 1.4 1.3 1.2 1.2
GEOGRAPHIC DIVISION                    
Northeast 1.0 1.4 0.3 0.7 1.1 1.5 0.7 0.9 1.1 1.6
New England 0.8 1.0 0.4 0.1 0.9 1.1 0.5 2.2 0.9 0.9
Middle Atlantic 1.1 1.6 0.2 0.9 1.1 1.6 0.7 0.5 1.2 1.8
Midwest 1.3 1.0 0.3 0.6 1.4 1.0 1.2 1.8 1.4a 0.9
East North Central 1.3 1.0 0.2 0.5 1.4 1.1 1.2 2.0 1.4 0.9
West North Central 1.2 1.0 0.6 0.7 1.3 1.0 1.0 1.4 1.3 0.9
South 1.3 1.2 0.6 0.4 1.4 1.3 2.1 1.5 1.3 1.3
South Atlantic 1.4 1.3 0.4 0.6 1.5 1.3 2.6 1.7 1.3 1.3
East South Central 1.1 1.0 0.2 <0.1 1.2 1.1 1.3 0.4 1.2 1.2
West South Central 1.3 1.2 1.1 0.3 1.3 1.3 1.8 1.8 1.2 1.2
West 1.0 0.9 0.3 0.3 1.0 1.0 0.9 0.8 1.0 1.0
Mountain 1.3 0.9 0.3 0.5 1.4 1.0 1.3 0.9 1.4 1.0
Pacific 0.8 0.9 0.3 0.2 0.9 0.9 0.7 0.8 0.9 1.0
COUNTY TYPE                    
Large Metro 1.1 1.0 0.3 0.5 1.1 1.1 1.5 1.2 1.1 1.1
Small Metro 1.3 1.3 0.6 0.3 1.3 1.4 1.2 1.6 1.4 1.4
Nonmetro 1.5 1.0 0.6 0.8 1.5 1.1 1.5 0.7 1.6 1.1
Urbanized 1.3 1.0 0.3 0.2 1.4 1.0 0.8 0.7 1.5 1.1
Less Urbanized 1.2 1.4 1.3 1.8 1.2 1.3 1.0 1.0 1.2 1.4
Completely Rural 2.0a 0.6 <0.1 * 2.2a 0.7 3.7 0.2 2.0 0.7
POVERTY LEVEL1                    
Less Than 100% 1.4 1.5 0.3 0.5 1.5 1.7 1.5 1.3 1.5 1.8
100‑199% 1.2 1.3 0.5 0.6 1.3 1.4 1.5 1.9 1.2 1.3
200% or More 1.1 1.0 0.4 0.4 1.2 1.0 1.3 1.0 1.2 1.0
HEALTH INSURANCE2                    
Private 0.9 0.9 0.4 0.5 1.0 1.0 1.2 1.3 1.0 0.9
Medicaid/CHIP 1.9 1.7 0.6 0.6 2.1 1.9 2.1 1.4 2.1 2.0
Other3 0.8 0.9 0.1 * 0.8 0.9 1.0 0.6 0.8 0.9
No Coverage 1.6 1.7 0.1 0.1 1.7 1.8 1.0 1.4 1.9 1.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.108A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 63,203 60,669 2,998 2,670 60,204 57,998 4,741 4,679 55,464 53,319
GEOGRAPHIC DIVISION                    
Northeast 9,151 8,418 444 405 8,707 8,013 681 625 8,026 7,389
New England 2,164 2,334 123 77 2,042 2,256 174 127 1,868 2,129
Middle Atlantic 6,987 6,085 322 328 6,665 5,757 507 497 6,158 5,260
Midwest 13,086 13,184 618 590 12,468 12,595 985 1,200 11,483 11,395
East North Central 8,579 8,942 400 416 8,179 8,526 677 760 7,501 7,766
West North Central 4,507 4,243 218 174 4,289 4,069 308a 441 3,982 3,628
South 26,152 25,036 1,227 1,104 24,925 23,932 2,059 1,743 22,866 22,189
South Atlantic 12,997 13,274 547 594 12,450 12,681 973 892 11,477 11,789
East South Central 4,794 4,243 206a 137 4,588 4,106 305 250 4,283 3,856
West South Central 8,361 7,518 474 373 7,887 7,145 781 601 7,106 6,545
West 14,813 14,030 709 572 14,104 13,458 1,016 1,112 13,089 12,346
Mountain 5,383 5,172 264 238 5,120 4,934 412 465 4,708 4,469
Pacific 9,430 8,858 445 333 8,985 8,524 604 647 8,380 7,878
COUNTY TYPE                    
Large Metro 34,434a 31,682 1,599 1,470 32,835 30,212 2,397 2,588 30,438a 27,624
Small Metro 20,308 20,740 1,035 915 19,273 19,825 1,666 1,574 17,607 18,251
Nonmetro 8,461 8,248 365 286 8,096 7,962 677 517 7,419 7,444
Urbanized 3,199 2,914 164 96 3,035 2,818 296 227 2,740 2,591
Less Urbanized 3,104 3,211 116 125 2,988 3,086 234 206 2,754 2,879
Completely Rural 2,157 2,123 85 65 2,073 2,058 148 84 1,925 1,974
POVERTY LEVEL1                    
Less Than 100% 11,214 11,321 590 555 10,625 10,766 1,179 1,280 9,446 9,487
100‑199% 13,335 13,584 675 658 12,661 12,926 1,140 1,155 11,521 11,771
200% or More 38,631a 35,721 1,734a 1,457 36,897a 34,264 2,400 2,203 34,497 32,061
HEALTH INSURANCE2                    
Private 35,946a 33,304 1,593 1,391 34,353a 31,913 2,557 2,566 31,796a 29,346
Medicaid/CHIP 15,380 15,446 1,346 1,126 14,035 14,319 1,447 1,453 12,587 12,866
Other3 22,757 23,128 154 160 22,602 22,968 412 431 22,190 22,537
No Coverage 3,943 3,839 119 123 3,823 3,717 560 480 3,263 3,237

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.108B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 21.9a 20.9 11.6 10.5 23.0a 21.9 13.6 13.0 24.4 23.3
GEOGRAPHIC DIVISION                    
Northeast 18.4 16.8 10.9 10.1 19.1 17.4 11.5 10.3 20.2 18.5
New England 16.2 17.3 11.8 7.6 16.6 18.2 10.6 7.7 17.5 19.8
Middle Atlantic 19.2a 16.6 10.6 11.0 20.0a 17.1 11.9 11.3 21.2 18.0
Midwest 22.2 22.3 11.4 11.1 23.3 23.4 13.5a 16.1 24.8 24.5
East North Central 21.2 22.0 11.0 11.7 22.2 23.0 13.7 15.0 23.5 24.2
West North Central 24.4 22.9 12.4 10.0 25.7 24.2 13.2a 18.3 27.8 25.2
South 23.5 22.2 11.9 10.9 24.6 23.3 15.2b 12.4 26.1 25.1
South Atlantic 22.0 22.2 10.7 11.8 23.0 23.2 14.3 12.6 24.3 24.8
East South Central 28.6 25.1 13.3a 9.0 30.2 26.7 14.9 11.7 32.6 29.1
West South Central 23.5 20.8 13.0 10.4 24.7 22.0 16.8a 12.4 26.0 23.6
West 21.8 20.5 11.6 9.5 22.8 21.6 12.3 13.1 24.4 22.9
Mountain 24.3 23.1 12.8 11.6 25.4 24.3 14.6 16.0 27.2 25.7
Pacific 20.5 19.2 10.9 8.4 21.5 20.3 11.1 11.6 23.0 21.6
COUNTY TYPE                    
Large Metro 20.7a 19.1 10.6 10.1 21.7a 20.0 12.5 12.6 23.1a 21.1
Small Metro 22.9 22.8 12.8 11.1 23.9 23.9 14.4 13.5 25.5 25.6
Nonmetro 25.3 24.5 13.1 10.4 26.4 25.8 16.1 13.4 28.0 27.6
Urbanized 24.0 24.0 15.8 9.8 24.7 25.2 14.6 15.4 26.6 26.7
Less Urbanized 26.1 23.5 11.3 10.8 27.5 24.7 17.2 13.1 29.0 26.3
Completely Rural 26.2 27.3 11.7 10.8 27.6 28.7 17.7a 10.3 28.8 31.0
POVERTY LEVEL1                    
Less Than 100% 24.1 23.2 10.7 9.8 26.0 25.0 14.1 13.0 29.0 28.5
100‑199% 24.0 22.3 12.7 11.5 25.2 23.4 13.4 13.6 27.5 25.2
200% or More 20.8 19.8 11.5 10.3 21.6 20.6 13.4 12.6 22.6 21.5
HEALTH INSURANCE2                    
Private 20.5 19.5 10.9 10.0 21.3 20.3 13.0 12.4 22.5 21.5
Medicaid/CHIP 26.1 25.3 12.9a 10.7 28.9 28.3 16.1 15.6 31.8 31.1
Other3 28.7 27.8 11.2 11.1 29.1 28.1 14.8 16.1 29.6 28.5
No Coverage 15.6 15.4 9.9 10.9 15.9 15.6 11.1 9.7 17.2 17.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.109A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 7,795 7,080 400 403 7,396 6,678 925 736 6,471 5,941
GEOGRAPHIC DIVISION                    
Northeast 1,281 1,088 48 29 1,233 1,059 133 77 1,100 982
New England 406 188 13 7 393 181 35a 11 357 170
Middle Atlantic 875 901 35 22 841 878 98 66 743 812
Midwest 1,527 1,347 64 70 1,463 1,277 140 201 1,323 1,076
East North Central 1,063 951 45 50 1,017 901 101 100 916 802
West North Central 465 396 19 20 446 375 39a 101 408 275
South 3,261 2,993 208 223 3,054 2,770 472a 298 2,582 2,472
South Atlantic 1,458 1,389 87 104 1,371 1,285 262a 137 1,109 1,148
East South Central 680 576 13 35 667 541 52 52 614 489
West South Central 1,123 1,029 107 84 1,016 945 158 110 858 835
West 1,725 1,651 80 80 1,645 1,571 180 160 1,465 1,411
Mountain 602 557 40 45 563 513 79 48 484 465
Pacific 1,123 1,094 40 36 1,083 1,058 101 112 981 946
COUNTY TYPE                    
Large Metro 4,259 3,758 220 223 4,039 3,535 487 430 3,553 3,104
Small Metro 2,361 2,390 128 129 2,233 2,261 304 219 1,929 2,042
Nonmetro 1,175 932 51 50 1,124 882 135 87 989 795
Urbanized 417 319 22 13 395 306 59 28 336 278
Less Urbanized 420 420 22 22 397 398 36 38 361 359
Completely Rural 338 193 7 14 331 178 40 21 292 158
POVERTY LEVEL1                    
Less Than 100% 2,400 1,882 117 118 2,283 1,765 246 232 2,037 1,533
100‑199% 1,889 1,970 113 127 1,776 1,843 242 199 1,534 1,644
200% or More 3,504 3,221 170 158 3,334 3,063 435 299 2,899 2,764
HEALTH INSURANCE2                    
Private 3,433 3,075 175 198 3,258 2,878 493 372 2,765 2,506
Medicaid/CHIP 2,940 2,552 207 201 2,732 2,351 294 249 2,438 2,102
Other3 1,701 1,888 16 7 1,685 1,880 78a 21 1,606 1,859
No Coverage 879 862 24 20 855 842 108 116 747 727

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.109B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2.7 2.4 1.5 1.6 2.8 2.5 2.6a 2.0 2.8 2.6
GEOGRAPHIC DIVISION                    
Northeast 2.6 2.2 1.2 0.7 2.7 2.3 2.3 1.3 2.8 2.5
New England 3.0 1.4 1.3 0.7 3.2 1.5 2.2a 0.7 3.3 1.6
Middle Atlantic 2.4 2.5 1.1 0.8 2.5 2.6 2.3 1.5 2.6 2.8
Midwest 2.6 2.3 1.2 1.3 2.7 2.4 1.9 2.7 2.9 2.3
East North Central 2.6 2.3 1.2 1.4 2.8 2.4 2.0 2.0 2.9 2.5
West North Central 2.5 2.1 1.1 1.2 2.7 2.2 1.7a 4.2 2.8 1.9
South 2.9 2.7 2.0 2.2 3.0 2.7 3.5a 2.1 2.9 2.8
South Atlantic 2.5 2.3 1.7 2.1 2.5 2.3 3.8a 1.9 2.3 2.4
East South Central 4.1 3.4 0.9 2.3 4.4 3.5 2.6 2.4 4.7 3.7
West South Central 3.2 2.8 2.9 2.4 3.2 2.9 3.4 2.3 3.1 3.0
West 2.5 2.4 1.3 1.3 2.7 2.5 2.2 1.9 2.7 2.6
Mountain 2.7 2.5 1.9 2.2 2.8 2.5 2.8 1.6 2.8 2.7
Pacific 2.4 2.4 1.0 0.9 2.6 2.5 1.9 2.0 2.7 2.6
COUNTY TYPE                    
Large Metro 2.6 2.3 1.5 1.5 2.7 2.3 2.5 2.1 2.7 2.4
Small Metro 2.7 2.6 1.6 1.6 2.8 2.7 2.6 1.9 2.8 2.9
Nonmetro 3.5 2.8 1.8 1.8 3.7 2.9 3.2 2.2 3.7 2.9
Urbanized 3.1 2.6 2.1 1.4 3.2 2.7 2.9 1.9 3.3 2.9
Less Urbanized 3.5 3.1 2.2 1.9 3.7 3.2 2.7 2.4 3.8 3.3
Completely Rural 4.1 2.5 0.9 2.4 4.4 2.5 4.7 2.5 4.4 2.5
POVERTY LEVEL1                    
Less Than 100% 5.2a 3.9 2.1 2.1 5.6a 4.1 2.9 2.4 6.3a 4.6
100‑199% 3.4 3.2 2.1 2.2 3.5 3.3 2.9 2.4 3.7 3.5
200% or More 1.9 1.8 1.1 1.1 2.0 1.8 2.4 1.7 1.9 1.9
HEALTH INSURANCE2                    
Private 2.0 1.8 1.2 1.4 2.0 1.8 2.5 1.8 2.0 1.8
Medicaid/CHIP 5.0 4.2 2.0 1.9 5.6 4.6 3.3 2.7 6.2 5.1
Other3 2.1 2.3 1.1 0.5 2.2 2.3 2.8a 0.8 2.1 2.3
No Coverage 3.5 3.5 2.0 1.8 3.6 3.5 2.2 2.3 3.9 3.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.110A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,117 2,051 107 105 2,010 1,946 221 179 1,788 1,767
GEOGRAPHIC DIVISION                    
Northeast 449 358 14 6 435 353 33a 6 403 346
New England 158 56 1 <1 157 55 6 3 * 52
Middle Atlantic 291 303 12 5 279 297 27 3 252 294
Midwest 421 382 5 26 416 357 39 62 378 295
East North Central 300 278 5 18 296 259 34 29 262 230
West North Central 121 105 <1 7 121 97 5 33 115 64
South 826 813 70 67 756 746 114 101 642 645
South Atlantic 402 495 43 31 358 464 85 38 273 425
East South Central 157 143 3 10 154 133 4 20 150 113
West South Central 268 175 24 26 244 149 25 42 219a 107
West 420 497 18 6 401 491 35a 10 366 481
Mountain 155 187 8 3 147 184 14 2 134 182
Pacific 265 311 11 4 254 307 22 8 233 299
COUNTY TYPE                    
Large Metro 1,188 1,201 78 41 1,109 1,160 124 102 986 1,058
Small Metro 566 674 18 41 547 633 63 65 484 568
Nonmetro 363b 177 10 23 353b 154 34 13 319b 141
Urbanized 127 49 4 2 123 47 15a 1 108 46
Less Urbanized 115 84 3 14 112 70 3 1 109 69
Completely Rural 121a 45 3 8 118a 37 * * 102a 26
POVERTY LEVEL1                    
Less Than 100% 840 701 29 23 811 678 70 40 740 638
100‑199% 479 528 36 25 444 503 66 101 377 402
200% or More 797 822 42 57 755 765 84 38 671 727
HEALTH INSURANCE2                    
Private 702 801 46 67 655 734 95 79 560 655
Medicaid/CHIP 1,011 885 43 40 968 844 103 47 865 798
Other3 414 386 12 4 401 382 16 3 385 379
No Coverage 250 335 12 1 238 334 17 51 221 284

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.110B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7 0.7 0.4 0.4 0.8 0.7 0.6 0.5 0.8 0.8
GEOGRAPHIC DIVISION                    
Northeast 0.9 0.7 0.3 0.1 1.0 0.8 0.6a 0.1 1.0 0.9
New England 1.2 0.4 0.1 <0.1 1.3 0.4 0.4 0.2 * 0.5
Middle Atlantic 0.8 0.8 0.4 0.2 0.8 0.9 0.6 0.1 0.9 1.0
Midwest 0.7 0.6 0.1 0.5 0.8 0.7 0.5 0.8 0.8 0.6
East North Central 0.7 0.7 0.1 0.5 0.8 0.7 0.7 0.6 0.8 0.7
West North Central 0.7 0.6 <0.1 0.4 0.7 0.6 0.2 1.4 0.8 0.4
South 0.7 0.7 0.7 0.7 0.7 0.7 0.8 0.7 0.7 0.7
South Atlantic 0.7 0.8 0.8 0.6 0.7 0.8 1.2 0.5 0.6 0.9
East South Central 0.9 0.8 0.2 0.7 1.0 0.9 0.2 0.9 1.1 0.9
West South Central 0.8 0.5 0.7 0.7 0.8 0.5 0.5 0.9 0.8a 0.4
West 0.6 0.7 0.3 0.1 0.6 0.8 0.4a 0.1 0.7 0.9
Mountain 0.7 0.8 0.4 0.1 0.7 0.9 0.5 0.1 0.8 1.0
Pacific 0.6 0.7 0.3 0.1 0.6 0.7 0.4 0.1 0.6 0.8
COUNTY TYPE                    
Large Metro 0.7 0.7 0.5 0.3 0.7 0.8 0.6 0.5 0.7 0.8
Small Metro 0.6 0.7 0.2 0.5 0.7 0.8 0.5 0.6 0.7 0.8
Nonmetro 1.1b 0.5 0.4 0.8 1.1b 0.5 0.8 0.3 1.2b 0.5
Urbanized 1.0 0.4 0.4 0.2 1.0 0.4 0.7a 0.1 1.1 0.5
Less Urbanized 1.0 0.6 0.3 1.2 1.0 0.6 0.2 0.1 1.1 0.6
Completely Rural 1.5a 0.6 0.4 1.3 1.6a 0.5 * * 1.5a 0.4
POVERTY LEVEL1                    
Less Than 100% 1.8 1.4 0.5 0.4 2.0 1.6 0.8 0.4 2.3 1.9
100‑199% 0.9 0.9 0.7 0.4 0.9 0.9 0.8 1.2 0.9 0.9
200% or More 0.4 0.5 0.3 0.4 0.4 0.5 0.5 0.2 0.4 0.5
HEALTH INSURANCE2                    
Private 0.4 0.5 0.3 0.5 0.4 0.5 0.5 0.4 0.4 0.5
Medicaid/CHIP 1.7 1.4 0.4 0.4 2.0 1.7 1.1 0.5 2.2 1.9
Other3 0.5 0.5 0.9 0.3 0.5 0.5 0.6 0.1 0.5 0.5
No Coverage 1.0 1.3 1.0 0.1 1.0 1.4 0.3 1.0 1.2 1.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.111A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 24,907 25,821 1,890 1,909 23,017 23,912 4,191 4,292 18,827 19,620
GEOGRAPHIC DIVISION                    
Northeast 4,002 4,013 259 237 3,743 3,776 744 752 3,000 3,024
New England 1,261 1,386 96 65 1,165 1,321 226 240 939 1,081
Middle Atlantic 2,741 2,627 163 172 2,578 2,455 518 512 2,060 1,943
Midwest 5,417 5,737 403 490 5,014 5,247 999 991 4,015 4,256
East North Central 3,472 3,766 275 335 3,196 3,431 645 674 2,552 2,757
West North Central 1,946 1,971 128 156 1,818 1,816 355 316 1,463 1,499
South 9,680 10,083 828 783 8,852 9,300 1,529 1,592 7,323 7,707
South Atlantic 4,834 5,206 412 383 4,422 4,823 817 876 3,605 3,947
East South Central 1,623 1,706 129 126 1,495 1,580 192 185 1,303 1,395
West South Central 3,223 3,171 287 274 2,935 2,897 521 531 2,415 2,366
West 5,808 5,988 400 399 5,408 5,589 918 957 4,490 4,633
Mountain 2,313 2,298 204 161 2,109 2,138 393 346 1,716 1,792
Pacific 3,495 3,689 196 238 3,299 3,451 525 611 2,774 2,841
COUNTY TYPE                    
Large Metro 13,896 14,490 1,035 1,053 12,860 13,437 2,254 2,385 10,606 11,052
Small Metro 8,151 8,611 667 648 7,484 7,963 1,471 1,483 6,013 6,480
Nonmetro 2,860 2,720 188 208 2,672 2,512 465 424 2,207 2,088
Urbanized 1,109 989 83 50 1,025 938 228 201 797 737
Less Urbanized 942 1,103 52 104 891 999 171 152 720 847
Completely Rural 809 629 53 54 756 575 66 71 690 504
POVERTY LEVEL1                    
Less Than 100% 4,483 4,767 286 271 4,197 4,496 862 976 3,335 3,520
100‑199% 3,990b 5,129 300 414 3,690b 4,716 844 968 2,845b 3,747
200% or More 16,420 15,896 1,304 1,224 15,116 14,672 2,470 2,318 12,646 12,353
HEALTH INSURANCE2                    
Private 15,549 15,282 1,227 1,275 14,322 14,008 2,828 2,916 11,494 11,092
Medicaid/CHIP 6,163 6,339 660 623 5,503 5,716 930 945 4,573 4,771
Other3 3,833 4,564 85 128 3,748 4,435 284 292 3,464 4,143
No Coverage 2,046 2,440 57 56 1,989 2,384 384 310 1,604 2,074

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.111B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 8.6 8.9 7.3 7.5 8.8 9.0 12.0 11.9 8.3 8.6
GEOGRAPHIC DIVISION                    
Northeast 8.0 8.0 6.3 5.9 8.2 8.2 12.6 12.4 7.5 7.6
New England 9.4 10.3 9.2 6.3 9.4 10.6 13.7 14.5 8.8 10.0
Middle Atlantic 7.5 7.2 5.4 5.8 7.7 7.3 12.1 11.6 7.1 6.6
Midwest 9.2 9.7 7.5 9.2 9.4 9.7 13.7 13.3 8.7 9.2
East North Central 8.6 9.3 7.5 9.4 8.7 9.2 13.0 13.3 8.0 8.6
West North Central 10.6 10.6 7.3 8.9 10.9 10.8 15.2 13.2 10.2 10.4
South 8.7 8.9 8.0 7.7 8.7 9.1 11.3 11.3 8.4 8.7
South Atlantic 8.2 8.7 8.0 7.6 8.2 8.8 12.0 12.4 7.6 8.3
East South Central 9.7 10.1 8.3 8.3 9.8 10.3 9.4 8.7 9.9 10.5
West South Central 9.1 8.8 7.9 7.7 9.2 8.9 11.2 11.0 8.8 8.5
West 8.5 8.8 6.5 6.6 8.7 9.0 11.1 11.3 8.4 8.6
Mountain 10.4 10.3 9.9 7.8 10.5 10.5 14.0 11.9 9.9 10.3
Pacific 7.6 8.0 4.8 6.0 7.9 8.2 9.7 11.0 7.6 7.8
COUNTY TYPE                    
Large Metro 8.4 8.7 6.9 7.3 8.5 8.9 11.8 11.6 8.0 8.5
Small Metro 9.2 9.5 8.2 7.9 9.3 9.6 12.7 12.7 8.7 9.1
Nonmetro 8.5 8.1 6.7 7.6 8.7 8.1 11.0 11.0 8.3 7.7
Urbanized 8.3 8.1 8.0 5.1 8.3 8.4 11.3 13.7 7.7 7.6
Less Urbanized 7.9 8.1 5.0 8.9 8.2 8.0 12.6 9.6 7.6 7.7
Completely Rural 9.8 8.1 7.3 9.1 10.1 8.0 7.9 8.7 10.3 7.9
POVERTY LEVEL1                    
Less Than 100% 9.7 9.8 5.2 4.8 10.3 10.4 10.3 9.9 10.2 10.6
100‑199% 7.2a 8.4 5.6 7.2 7.3 8.5 9.9 11.4 6.8 8.0
200% or More 8.8 8.8 8.6 8.7 8.8 8.8 13.8 13.3 8.3 8.3
HEALTH INSURANCE2                    
Private 8.9 8.9 8.4 9.2 8.9 8.9 14.4 14.1 8.1 8.1
Medicaid/CHIP 10.4 10.4 6.3 5.9 11.3 11.3 10.4 10.1 11.6 11.6
Other3 4.8 5.5 6.2 8.9 4.8 5.4 10.2 10.9 4.6 5.2
No Coverage 8.1 9.8 4.7 5.0 8.3 10.0 7.6 6.3 8.5a 11.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.112A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 9,031 9,486 293 241 8,738 9,245 1,646 1,681 7,092 7,564
GEOGRAPHIC DIVISION                    
Northeast 1,607 1,427 49 26 1,559 1,401 282 257 1,277 1,144
New England 474 372 * 13 441 359 65 47 376 312
Middle Atlantic 1,133 1,056 15 13 1,118 1,042 217 210 902 832
Midwest 1,757 1,787 42 56 1,715 1,731 363 347 1,352 1,384
East North Central 1,088 1,206 19 29 1,069 1,177 208 255 861 921
West North Central 669 581 23 27 646 554 155 92 491 462
South 3,200 3,454 104 99 3,096 3,355 598 583 2,498 2,772
South Atlantic 1,594 1,881 55 48 1,539 1,833 295 319 1,244 1,514
East South Central 512 474 10 7 502 467 73 50 429 417
West South Central 1,094 1,098 38 43 1,055 1,055 230 214 825 842
West 2,467 2,818 99 61 2,368 2,758 403 494 1,964 2,264
Mountain 957 996 43 19 914 977 184 165 730 811
Pacific 1,510 1,822 57 41 1,454 1,781 219 328 1,234 1,453
COUNTY TYPE                    
Large Metro 5,461 5,538 163 136 5,299 5,402 884 1,089 4,415 4,312
Small Metro 2,496 2,950 105 77 2,391 2,873 557 443 1,834a 2,430
Nonmetro 1,073 999 26 28 1,048 970 205 148 843 822
Urbanized 399 426 12 6 386 420 113 89 273 331
Less Urbanized 339 419 13 13 326 406 79 42 247 364
Completely Rural 335a 155 * 10 335a 145 13 18 323a 127
POVERTY LEVEL1                    
Less Than 100% 2,215 2,388 46 59 2,170 2,329 319 439 1,851 1,890
100‑199% 1,654 2,022 45 66 1,609 1,956 373 355 1,236 1,601
200% or More 5,160 5,068 203 116 4,958 4,952 953 879 4,005 4,073
HEALTH INSURANCE2                    
Private 4,607 4,542 194 130 4,413 4,412 1,024 1,138 3,388 3,273
Medicaid/CHIP 2,811 3,044 95 116 2,716 2,928 353 339 2,363 2,589
Other3 967 1,348 16 5 951 1,343 112 82 838a 1,261
No Coverage 1,241 1,426 11 5 1,229 1,421 198 167 1,031 1,254

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.112B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3.1 3.3 1.1 0.9 3.3 3.5 4.7 4.7 3.1 3.3
GEOGRAPHIC DIVISION                    
Northeast 3.2 2.8 1.2 0.6 3.4 3.0 4.8 4.2 3.2 2.9
New England 3.5 2.8 * 1.2 3.6 2.9 4.0 2.8 3.5 2.9
Middle Atlantic 3.1 2.9 0.5 0.4 3.4 3.1 5.1 4.8 3.1 2.8
Midwest 3.0 3.0 0.8 1.1 3.2 3.2 5.0 4.7 2.9 3.0
East North Central 2.7 3.0 0.5 0.8 2.9 3.2 4.2 5.0 2.7 2.9
West North Central 3.6 3.1 1.3 1.5 3.9 3.3 6.6a 3.8 3.4 3.2
South 2.9 3.1 1.0 1.0 3.1 3.3 4.4 4.1 2.8 3.1
South Atlantic 2.7 3.1 1.1 1.0 2.8 3.4 4.3 4.5 2.6 3.2
East South Central 3.1 2.8 0.7 0.5 3.3 3.0 3.6 2.3 3.3 3.1
West South Central 3.1 3.0 1.0 1.2 3.3 3.2 5.0 4.4 3.0 3.0
West 3.6 4.1 1.6 1.0 3.8 4.4 4.9 5.8 3.7 4.2
Mountain 4.3 4.5 2.1 0.9 4.5 4.8 6.6 5.7 4.2 4.7
Pacific 3.3 4.0 1.4 1.0 3.5 4.2 4.0 5.9 3.4 4.0
COUNTY TYPE                    
Large Metro 3.3 3.3 1.1 0.9 3.5 3.6 4.6 5.3 3.3 3.3
Small Metro 2.8 3.2 1.3 0.9 3.0 3.5 4.8 3.8 2.7a 3.4
Nonmetro 3.2 3.0 0.9 1.0 3.4 3.1 4.9 3.8 3.2 3.0
Urbanized 3.0 3.5 1.2 0.6 3.1 3.8 5.6 6.0 2.7 3.4
Less Urbanized 2.9 3.1 1.3 1.1 3.0 3.2 5.8a 2.7 2.6 3.3
Completely Rural 4.1a 2.0 * 1.6 4.5a 2.0 1.5 2.1 4.8a 2.0
POVERTY LEVEL1                    
Less Than 100% 4.8 4.9 0.8 1.0 5.3 5.4 3.8 4.5 5.7 5.7
100‑199% 3.0 3.3 0.8 1.2 3.2 3.5 4.4 4.2 3.0 3.4
200% or More 2.8 2.8 1.3 0.8 2.9 3.0 5.3 5.0 2.6 2.7
HEALTH INSURANCE2                    
Private 2.6 2.7 1.3 0.9 2.7 2.8 5.2 5.5 2.4 2.4
Medicaid/CHIP 4.8 5.0 0.9 1.1 5.6 5.8 3.9 3.6 6.0 6.3
Other3 1.2 1.6 1.2 0.3 1.2 1.6 4.0 3.0 1.1 1.6
No Coverage 4.9 5.7 0.9 0.5 5.1 6.0 3.9 3.4 5.4 6.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.113A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 3,934 4,465 80 54 3,854 4,411 466 623 3,388 3,789
GEOGRAPHIC DIVISION                    
Northeast 777 625 30 5 747 620 90 98 657 522
New England 214 208 * 3 188 206 21 29 168 177
Middle Atlantic 563 417 5 3 558 414 69 69 489 345
Midwest 704 773 10 13 695 760 110 96 584 664
East North Central 444 530 9 6 434 524 66 76 368 448
West North Central 260 243 <1 7 260 236 44 20 216 215
South 1,461 1,497 28 24 1,432 1,473 166 255 1,267 1,219
South Atlantic 738 777 25 22 713 754 96 144 618 610
East South Central 224 166 1 1 223 165 6 20 217 145
West South Central 499 554 2 * 496 554 64 90 432 463
West 992b 1,570 12 12 980b 1,558 100 174 880a 1,384
Mountain 387 515 10 8 377 507 33 55 344 452
Pacific 605b 1,055 2 4 603b 1,051 67 119 536a 932
COUNTY TYPE                    
Large Metro 2,399 2,535 44 33 2,355 2,501 258a 408 2,098 2,094
Small Metro 1,038a 1,457 32 12 1,006a 1,445 152 160 854a 1,285
Nonmetro 497 473 4 8 492 465 56 55 436 410
Urbanized 185 228 3 2 182 226 25 37 157 189
Less Urbanized 163 176 1 3 161 174 30 17 131 157
Completely Rural 149 69 * * 149 65 1 1 148 64
POVERTY LEVEL1                    
Less Than 100% 1,144 1,340 14 10 1,131 1,330 103 193 1,028 1,137
100‑199% 719 984 7 10 712 975 108 114 604 861
200% or More 2,071 2,140 60 34 2,011 2,105 255 314 1,756 1,791
HEALTH INSURANCE2                    
Private 1,629 1,861 56 32 1,572 1,830 269a 412 1,303 1,418
Medicaid/CHIP 1,589 1,715 25 25 1,564 1,690 146 143 1,417 1,547
Other3 427a 797 <1 1 426a 796 19 28 408a 768
No Coverage 548 598 <1 1 548 597 45 65 502 531

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.113B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1.4 1.5 0.3 0.2 1.5 1.7 1.3 1.7 1.5 1.7
GEOGRAPHIC DIVISION                    
Northeast 1.6 1.2 0.7 0.1 1.6 1.3 1.5 1.6 1.7 1.3
New England 1.6 1.5 * 0.3 1.5 1.7 1.2 1.7 1.6 1.6
Middle Atlantic 1.5 1.1 0.2 0.1 1.7 1.2 1.6 1.6 1.7 1.2
Midwest 1.2 1.3 0.2 0.3 1.3 1.4 1.5 1.3 1.3 1.4
East North Central 1.1 1.3 0.3 0.2 1.2 1.4 1.3 1.5 1.2 1.4
West North Central 1.4 1.3 <0.1 0.4 1.6 1.4 1.9 0.9 1.5 1.5
South 1.3 1.3 0.3 0.2 1.4 1.4 1.2 1.8 1.4 1.4
South Atlantic 1.2 1.3 0.5 0.4 1.3 1.4 1.4 2.0 1.3 1.3
East South Central 1.3 1.0 0.1 0.1 1.5 1.1 0.3 0.9 1.7 1.1
West South Central 1.4 1.5 0.1 * 1.6 1.7 1.4 1.9 1.6 1.7
West 1.5b 2.3 0.2 0.2 1.6b 2.5 1.2 2.0 1.6a 2.6
Mountain 1.7 2.3 0.5 0.4 1.9 2.5 1.2 1.9 2.0 2.6
Pacific 1.3b 2.3 <0.1 0.1 1.4b 2.5 1.2 2.1 1.5a 2.6
COUNTY TYPE                    
Large Metro 1.4 1.5 0.3 0.2 1.6 1.7 1.3 2.0 1.6 1.6
Small Metro 1.2a 1.6 0.4 0.1 1.2a 1.7 1.3 1.4 1.2a 1.8
Nonmetro 1.5 1.4 0.2 0.3 1.6 1.5 1.3 1.4 1.6 1.5
Urbanized 1.4 1.9 0.3 0.2 1.5 2.0 1.2 2.5 1.5 1.9
Less Urbanized 1.4 1.3 0.1 0.2 1.5 1.4 2.2 1.1 1.4 1.4
Completely Rural 1.8 0.9 * * 2.0 0.9 0.1 0.2 2.2 1.0
POVERTY LEVEL1                    
Less Than 100% 2.5 2.7 0.2 0.2 2.8 3.1 1.2 2.0 3.2 3.4
100‑199% 1.3 1.6 0.1 0.2 1.4 1.8 1.3 1.3 1.4 1.8
200% or More 1.1 1.2 0.4 0.2 1.2 1.3 1.4 1.8 1.1 1.2
HEALTH INSURANCE2                    
Private 0.9 1.1 0.4 0.2 1.0 1.2 1.4 2.0 0.9 1.0
Medicaid/CHIP 2.7 2.8 0.2 0.2 3.2 3.3 1.6 1.5 3.6 3.7
Other3 0.5a 1.0 <0.1 0.1 0.5a 1.0 0.7 1.0 0.5a 1.0
No Coverage 2.2 2.4 <0.1 0.1 2.3 2.5 0.9 1.3 2.6 2.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.114A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 23,691 ‑‑ 1,131 ‑‑ 22,559 ‑‑ 4,015 ‑‑ 18,544
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 3,994 ‑‑ 121 ‑‑ 3,873 ‑‑ 606 ‑‑ 3,267
New England ‑‑ 1,072 ‑‑ 47 ‑‑ 1,025 ‑‑ 174 ‑‑ 851
Middle Atlantic ‑‑ 2,922 ‑‑ 74 ‑‑ 2,848 ‑‑ 432 ‑‑ 2,416
Midwest ‑‑ 4,630 ‑‑ 227 ‑‑ 4,403 ‑‑ 910 ‑‑ 3,494
East North Central ‑‑ 3,154 ‑‑ 139 ‑‑ 3,014 ‑‑ 612 ‑‑ 2,402
West North Central ‑‑ 1,477 ‑‑ 88 ‑‑ 1,389 ‑‑ 298 ‑‑ 1,091
South ‑‑ 8,511 ‑‑ 494 ‑‑ 8,017 ‑‑ 1,407 ‑‑ 6,610
South Atlantic ‑‑ 4,434 ‑‑ 228 ‑‑ 4,206 ‑‑ 769 ‑‑ 3,437
East South Central ‑‑ 1,229 ‑‑ 73 ‑‑ 1,155 ‑‑ 193 ‑‑ 962
West South Central ‑‑ 2,849 ‑‑ 193 ‑‑ 2,655 ‑‑ 445 ‑‑ 2,210
West ‑‑ 6,555 ‑‑ 289 ‑‑ 6,265 ‑‑ 1,092 ‑‑ 5,174
Mountain ‑‑ 2,326 ‑‑ 121 ‑‑ 2,204 ‑‑ 369 ‑‑ 1,836
Pacific ‑‑ 4,229 ‑‑ 168 ‑‑ 4,061 ‑‑ 723 ‑‑ 3,338
COUNTY TYPE                    
Large Metro ‑‑ 13,956 ‑‑ 611 ‑‑ 13,345 ‑‑ 2,553 ‑‑ 10,792
Small Metro ‑‑ 7,346 ‑‑ 383 ‑‑ 6,963 ‑‑ 1,138 ‑‑ 5,825
Nonmetro ‑‑ 2,388 ‑‑ 138 ‑‑ 2,251 ‑‑ 324 ‑‑ 1,927
Urbanized ‑‑ 886 ‑‑ 42 ‑‑ 844 ‑‑ 147 ‑‑ 696
Less Urbanized ‑‑ 1,129 ‑‑ 65 ‑‑ 1,064 ‑‑ 122 ‑‑ 941
Completely Rural ‑‑ 374 ‑‑ 30 ‑‑ 344 ‑‑ 54 ‑‑ 289
POVERTY LEVEL1                    
Less Than 100% ‑‑ 4,708 ‑‑ 285 ‑‑ 4,423 ‑‑ 1,040 ‑‑ 3,383
100‑199% ‑‑ 5,303 ‑‑ 328 ‑‑ 4,975 ‑‑ 936 ‑‑ 4,040
200% or More ‑‑ 13,656 ‑‑ 519 ‑‑ 13,137 ‑‑ 2,015 ‑‑ 11,122
HEALTH INSURANCE2                    
Private ‑‑ 12,658 ‑‑ 558 ‑‑ 12,099 ‑‑ 2,558 ‑‑ 9,541
Medicaid/CHIP ‑‑ 6,498 ‑‑ 563 ‑‑ 5,935 ‑‑ 934 ‑‑ 5,001
Other3 ‑‑ 4,539 ‑‑ 36 ‑‑ 4,503 ‑‑ 189 ‑‑ 4,314
No Coverage ‑‑ 2,825 ‑‑ 45 ‑‑ 2,779 ‑‑ 452 ‑‑ 2,327

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.114B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 8.2 ‑‑ 4.4 ‑‑ 8.5 ‑‑ 11.1 ‑‑ 8.1
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 8.0 ‑‑ 3.0 ‑‑ 8.4 ‑‑ 10.0 ‑‑ 8.2
New England ‑‑ 8.0 ‑‑ 4.6 ‑‑ 8.2 ‑‑ 10.5 ‑‑ 7.9
Middle Atlantic ‑‑ 8.0 ‑‑ 2.5 ‑‑ 8.5 ‑‑ 9.8 ‑‑ 8.3
Midwest ‑‑ 7.8 ‑‑ 4.3 ‑‑ 8.2 ‑‑ 12.2 ‑‑ 7.5
East North Central ‑‑ 7.8 ‑‑ 3.9 ‑‑ 8.1 ‑‑ 12.1 ‑‑ 7.5
West North Central ‑‑ 8.0 ‑‑ 5.0 ‑‑ 8.3 ‑‑ 12.4 ‑‑ 7.6
South ‑‑ 7.5 ‑‑ 4.9 ‑‑ 7.8 ‑‑ 10.0 ‑‑ 7.5
South Atlantic ‑‑ 7.4 ‑‑ 4.5 ‑‑ 7.7 ‑‑ 10.9 ‑‑ 7.2
East South Central ‑‑ 7.3 ‑‑ 4.8 ‑‑ 7.5 ‑‑ 9.0 ‑‑ 7.3
West South Central ‑‑ 7.9 ‑‑ 5.4 ‑‑ 8.2 ‑‑ 9.2 ‑‑ 8.0
West ‑‑ 9.6 ‑‑ 4.8 ‑‑ 10.0 ‑‑ 12.9 ‑‑ 9.6
Mountain ‑‑ 10.4 ‑‑ 5.9 ‑‑ 10.8 ‑‑ 12.6 ‑‑ 10.5
Pacific ‑‑ 9.2 ‑‑ 4.2 ‑‑ 9.7 ‑‑ 13.0 ‑‑ 9.1
COUNTY TYPE                    
Large Metro ‑‑ 8.4 ‑‑ 4.2 ‑‑ 8.8 ‑‑ 12.4 ‑‑ 8.3
Small Metro ‑‑ 8.1 ‑‑ 4.7 ‑‑ 8.4 ‑‑ 9.8 ‑‑ 8.2
Nonmetro ‑‑ 7.1 ‑‑ 5.0 ‑‑ 7.3 ‑‑ 8.4 ‑‑ 7.1
Urbanized ‑‑ 7.3 ‑‑ 4.3 ‑‑ 7.6 ‑‑ 10.0 ‑‑ 7.2
Less Urbanized ‑‑ 8.3 ‑‑ 5.6 ‑‑ 8.5 ‑‑ 7.8 ‑‑ 8.6
Completely Rural ‑‑ 4.8 ‑‑ 5.1 ‑‑ 4.8 ‑‑ 6.6 ‑‑ 4.5
POVERTY LEVEL1                    
Less Than 100% ‑‑ 9.7 ‑‑ 5.0 ‑‑ 10.3 ‑‑ 10.6 ‑‑ 10.2
100‑199% ‑‑ 8.7 ‑‑ 5.7 ‑‑ 9.0 ‑‑ 11.1 ‑‑ 8.6
200% or More ‑‑ 7.6 ‑‑ 3.7 ‑‑ 7.9 ‑‑ 11.5 ‑‑ 7.5
HEALTH INSURANCE2                    
Private ‑‑ 7.4 ‑‑ 4.0 ‑‑ 7.7 ‑‑ 12.4 ‑‑ 7.0
Medicaid/CHIP ‑‑ 10.6 ‑‑ 5.4 ‑‑ 11.7 ‑‑ 10.0 ‑‑ 12.1
Other3 ‑‑ 5.4 ‑‑ 2.5 ‑‑ 5.5 ‑‑ 7.0 ‑‑ 5.5
No Coverage ‑‑ 11.3 ‑‑ 4.0 ‑‑ 11.7 ‑‑ 9.1 ‑‑ 12.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.115A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 9,104 ‑‑ 329 ‑‑ 8,775 ‑‑ 1,373 ‑‑ 7,402
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 1,448 ‑‑ 34 ‑‑ 1,414 ‑‑ 216 ‑‑ 1,198
New England ‑‑ 430 ‑‑ 7 ‑‑ 424 ‑‑ 74 ‑‑ 350
Middle Atlantic ‑‑ 1,017 ‑‑ 28 ‑‑ 990 ‑‑ 142 ‑‑ 848
Midwest ‑‑ 1,643 ‑‑ 73 ‑‑ 1,571 ‑‑ 302 ‑‑ 1,269
East North Central ‑‑ 1,165 ‑‑ 44 ‑‑ 1,121 ‑‑ 213 ‑‑ 909
West North Central ‑‑ 478 ‑‑ 29 ‑‑ 449 ‑‑ 89 ‑‑ 360
South ‑‑ 3,196 ‑‑ 169 ‑‑ 3,027 ‑‑ 496 ‑‑ 2,531
South Atlantic ‑‑ 1,736 ‑‑ 80 ‑‑ 1,657 ‑‑ 255 ‑‑ 1,402
East South Central ‑‑ 421 ‑‑ 18 ‑‑ 403 ‑‑ 96 ‑‑ 306
West South Central ‑‑ 1,039 ‑‑ 72 ‑‑ 967 ‑‑ 145 ‑‑ 822
West ‑‑ 2,816 ‑‑ 52 ‑‑ 2,764 ‑‑ 360 ‑‑ 2,404
Mountain ‑‑ 941 ‑‑ 18 ‑‑ 923 ‑‑ 109 ‑‑ 814
Pacific ‑‑ 1,875 ‑‑ 34 ‑‑ 1,841 ‑‑ 251 ‑‑ 1,590
COUNTY TYPE                    
Large Metro ‑‑ 5,356 ‑‑ 178 ‑‑ 5,178 ‑‑ 892 ‑‑ 4,287
Small Metro ‑‑ 2,930 ‑‑ 96 ‑‑ 2,833 ‑‑ 396 ‑‑ 2,438
Nonmetro ‑‑ 818 ‑‑ 55 ‑‑ 763 ‑‑ 86 ‑‑ 677
Urbanized ‑‑ 297 ‑‑ 7 ‑‑ 290 ‑‑ 44 ‑‑ 245
Less Urbanized ‑‑ 394 ‑‑ 28 ‑‑ 366 ‑‑ 25 ‑‑ 340
Completely Rural ‑‑ 126 ‑‑ 19 ‑‑ 108 ‑‑ * ‑‑ 92
POVERTY LEVEL1                    
Less Than 100% ‑‑ 2,221 ‑‑ 83 ‑‑ 2,138 ‑‑ 398 ‑‑ 1,740
100‑199% ‑‑ 1,906 ‑‑ 106 ‑‑ 1,799 ‑‑ 297 ‑‑ 1,502
200% or More ‑‑ 4,971 ‑‑ 139 ‑‑ 4,832 ‑‑ 672 ‑‑ 4,160
HEALTH INSURANCE2                    
Private ‑‑ 4,390 ‑‑ 145 ‑‑ 4,245 ‑‑ 845 ‑‑ 3,400
Medicaid/CHIP ‑‑ 2,883 ‑‑ 179 ‑‑ 2,704 ‑‑ 325 ‑‑ 2,379
Other3 ‑‑ 1,676 ‑‑ 5 ‑‑ 1,671 ‑‑ 71 ‑‑ 1,600
No Coverage ‑‑ 1,260 ‑‑ 17 ‑‑ 1,243 ‑‑ 160 ‑‑ 1,083

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.115B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 3.1 ‑‑ 1.3 ‑‑ 3.3 ‑‑ 3.8 ‑‑ 3.2
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 2.9 ‑‑ 0.9 ‑‑ 3.1 ‑‑ 3.6 ‑‑ 3.0
New England ‑‑ 3.2 ‑‑ 0.6 ‑‑ 3.4 ‑‑ 4.5 ‑‑ 3.2
Middle Atlantic ‑‑ 2.8 ‑‑ 0.9 ‑‑ 2.9 ‑‑ 3.2 ‑‑ 2.9
Midwest ‑‑ 2.8 ‑‑ 1.4 ‑‑ 2.9 ‑‑ 4.0 ‑‑ 2.7
East North Central ‑‑ 2.9 ‑‑ 1.2 ‑‑ 3.0 ‑‑ 4.2 ‑‑ 2.8
West North Central ‑‑ 2.6 ‑‑ 1.7 ‑‑ 2.7 ‑‑ 3.7 ‑‑ 2.5
South ‑‑ 2.8 ‑‑ 1.7 ‑‑ 2.9 ‑‑ 3.5 ‑‑ 2.9
South Atlantic ‑‑ 2.9 ‑‑ 1.6 ‑‑ 3.0 ‑‑ 3.6 ‑‑ 2.9
East South Central ‑‑ 2.5 ‑‑ 1.2 ‑‑ 2.6 ‑‑ 4.5 ‑‑ 2.3
West South Central ‑‑ 2.9 ‑‑ 2.0 ‑‑ 3.0 ‑‑ 3.0 ‑‑ 3.0
West ‑‑ 4.1 ‑‑ 0.9 ‑‑ 4.4 ‑‑ 4.2 ‑‑ 4.5
Mountain ‑‑ 4.2 ‑‑ 0.9 ‑‑ 4.5 ‑‑ 3.7 ‑‑ 4.7
Pacific ‑‑ 4.1 ‑‑ 0.9 ‑‑ 4.4 ‑‑ 4.5 ‑‑ 4.4
COUNTY TYPE                    
Large Metro ‑‑ 3.2 ‑‑ 1.2 ‑‑ 3.4 ‑‑ 4.3 ‑‑ 3.3
Small Metro ‑‑ 3.2 ‑‑ 1.2 ‑‑ 3.4 ‑‑ 3.4 ‑‑ 3.4
Nonmetro ‑‑ 2.4 ‑‑ 2.0 ‑‑ 2.5 ‑‑ 2.2 ‑‑ 2.5
Urbanized ‑‑ 2.4 ‑‑ 0.8 ‑‑ 2.6 ‑‑ 3.0 ‑‑ 2.5
Less Urbanized ‑‑ 2.9 ‑‑ 2.4 ‑‑ 2.9 ‑‑ 1.6 ‑‑ 3.1
Completely Rural ‑‑ 1.6 ‑‑ 3.1 ‑‑ 1.5 ‑‑ * ‑‑ 1.4
POVERTY LEVEL1                    
Less Than 100% ‑‑ 4.6 ‑‑ 1.5 ‑‑ 5.0 ‑‑ 4.0 ‑‑ 5.2
100‑199% ‑‑ 3.1 ‑‑ 1.9 ‑‑ 3.3 ‑‑ 3.5 ‑‑ 3.2
200% or More ‑‑ 2.8 ‑‑ 1.0 ‑‑ 2.9 ‑‑ 3.8 ‑‑ 2.8
HEALTH INSURANCE2                    
Private ‑‑ 2.6 ‑‑ 1.0 ‑‑ 2.7 ‑‑ 4.1 ‑‑ 2.5
Medicaid/CHIP ‑‑ 4.7 ‑‑ 1.7 ‑‑ 5.3 ‑‑ 3.5 ‑‑ 5.8
Other3 ‑‑ 2.0 ‑‑ 0.3 ‑‑ 2.0 ‑‑ 2.7 ‑‑ 2.0
No Coverage ‑‑ 5.0 ‑‑ 1.5 ‑‑ 5.2 ‑‑ 3.2 ‑‑ 5.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.116A – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 3,486 3,536 816 1,007 668 768
GEOGRAPHIC DIVISION            
Northeast 590 727 183 233 145 174
New England 123 181 29 52 20 43
Middle Atlantic 468 547 154 181 126 132
Midwest 812 850 133 144 97 87
East North Central 474 650 75 129 44 78
West North Central 338 199 58 15 52 9
South 1,155 1,156 285 298 230 218
South Atlantic 505 683 111 184 94 127
East South Central 214 170 78 56 69 48
West South Central 436 303 96 59 66 43
West 929 804 215 332 196 289
Mountain 374 332 86 150 73 128
Pacific 555 472 128 182 123 161
COUNTY TYPE            
Large Metro 1,753 1,927 390 592 313 468
Small Metro 1,268 1,204 298 334 239 226
Nonmetro 465 406 127 82 116 74
Urbanized 139 174 68 38 62 34
Less Urbanized 268 167 40 29 35 26
Completely Rural 59 65 20 15 19 14
POVERTY LEVEL3            
Less Than 100% 1,180 1,091 380 486 328 371
100‑199% 741 906 234 335 190 278
200% or More 1,564 1,539 202 187 149 120
HEALTH INSURANCE4            
Private 1,386 1,462 156 266 100 162
Medicaid/CHIP 1,494 1,461 521 591 431 451
Other5 1,291 1,092 141 229 132 213
No Coverage 251 310 124 126 106 102

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.116B – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 1.2 1.2 0.3 0.3 0.2 0.3
GEOGRAPHIC DIVISION            
Northeast 1.2 1.5 0.4 0.5 0.3 0.3
New England 0.9 1.3 0.2 0.4 0.1 0.3
Middle Atlantic 1.3 1.5 0.4 0.5 0.3 0.4
Midwest 1.4 1.4 0.2 0.2 0.2 0.1
East North Central 1.2 1.6 0.2 0.3 0.1 0.2
West North Central 1.8 1.1 0.3 0.1 0.3 0.1
South 1.0 1.0 0.3 0.3 0.2 0.2
South Atlantic 0.9 1.1 0.2 0.3 0.2 0.2
East South Central 1.3 1.0 0.5 0.3 0.4 0.3
West South Central 1.2 0.8 0.3 0.2 0.2 0.1
West 1.4 1.2 0.3 0.5 0.3 0.4
Mountain 1.7 1.5 0.4 0.7 0.3 0.6
Pacific 1.2 1.0 0.3 0.4 0.3 0.3
COUNTY TYPE            
Large Metro 1.1 1.2 0.2 0.4 0.2 0.3
Small Metro 1.4 1.3 0.3 0.4 0.3 0.2
Nonmetro 1.4 1.2 0.4 0.2 0.3 0.2
Urbanized 1.0 1.4 0.5 0.3 0.5 0.3
Less Urbanized 2.3 1.2 0.3 0.2 0.3 0.2
Completely Rural 0.7 0.8 0.2 0.2 0.2 0.2
POVERTY LEVEL3            
Less Than 100% 2.5 2.2 0.8 1.0 0.7 0.8
100‑199% 1.3 1.5 0.4 0.5 0.3 0.5
200% or More 0.8 0.9 0.1 0.1 0.1 0.1
HEALTH INSURANCE4            
Private 0.8 0.9 0.1 0.2 0.1 0.1
Medicaid/CHIP 2.5 2.4 0.9 1.0 0.7 0.7
Other5 1.6 1.3 0.2 0.3 0.2 0.3
No Coverage 1.0 1.2 0.5 0.5 0.4 0.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.117A – Modes of Marijuana Use in Past Year: Among Past Year Marijuana Users Aged 12 or Older; Modes of Marijuana Use in Past Month: Among Past Month Marijuana Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Mode of Marijuana Use1 Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
PAST YEAR                    
Smoking 47,428 46,100 2,020 1,767 45,408 44,333 10,194 10,060 35,214 34,273
Vaping 25,573 24,165 1,945a 1,645 23,628 22,519 6,905 6,985 16,723 15,534
Dabbing waxes, shatter, or concentrates 9,033 8,912 459 372 8,575 8,539 2,955 2,807 5,619 5,732
Eating or drinking 31,937 30,321 1,053a 813 30,884 29,508 6,075 5,663 24,809 23,844
Other 9,076b 7,266 256 192 8,819b 7,074 1,137a 859 7,682b 6,215
Applying Lotion, Cream, or Patches to Skin 5,495b 4,286 108a 53 5,387b 4,233 649b 432 4,739a 3,801
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 2,944 2,666 78 46 2,866 2,620 383 320 2,483 2,300
Taking Pills 1,661 1,360 80 72 1,582 1,288 256 172 1,326 1,116
Some Other Way 499 509 59 72 441 437 62 65 379 371
PAST MONTH                    
Smoking 32,732 32,223 1,165 1,020 31,567 31,203 6,827 6,762 24,740 24,442
Vaping 16,818 16,239 1,106a 893 15,713 15,346 4,390 4,567 11,322 10,779
Dabbing waxes, shatter, or concentrates 5,491 5,434 218 194 5,273 5,239 1,657 1,632 3,616 3,607
Eating or drinking 16,970 17,227 391 406 16,579 16,821 3,051 2,998 13,528 13,823
Other 4,267 3,743 62 85 4,205 3,658 514 370 3,691 3,287
Applying Lotion, Cream, or Patches to Skin 2,548 2,229 33 10 2,515 2,219 292 203 2,224 2,016
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 1,401 1,301 18 12 1,383 1,290 170 141 1,213 1,148
Taking Pills 696 663 19 48 677 615 90 74 587 541
Some Other Way 198 182 12 20 186 162 37 10 149 152

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents could indicate multiple modes of marijuana use; thus, these response categories are not mutually exclusive.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.117B – Modes of Marijuana Use in Past Year: Among Past Year Marijuana Users Aged 12 or Older; Modes of Marijuana Use in Past Month: Among Past Month Marijuana Users Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Mode of Marijuana Use1 Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
PAST YEAR                    
Smoking 73.9 74.8 75.0 79.5 73.8 74.7 83.4 82.7 71.5 72.6
Vaping 39.8 39.2 72.2 74.0 38.4 37.9 56.5 57.4 33.9 32.9
Dabbing waxes, shatter, or concentrates 14.1 14.5 17.0 16.8 13.9 14.4 24.2 23.1 11.4 12.1
Eating or drinking 49.8 49.2 39.1 36.6 50.2 49.7 49.7 46.5 50.3 50.5
Other 14.1b 11.8 9.5 8.6 14.3b 11.9 9.3b 7.1 15.6b 13.2
Applying Lotion, Cream, or Patches to Skin 8.6b 7.0 4.0 2.4 8.8b 7.1 5.3b 3.6 9.6a 8.1
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 4.6 4.3 2.9 2.1 4.7 4.4 3.1 2.6 5.0 4.9
Taking Pills 2.6 2.2 3.0 3.2 2.6 2.2 2.1 1.4 2.7 2.4
Some Other Way 0.8 0.8 2.2 3.2 0.7 0.7 0.5 0.5 0.8 0.8
PAST MONTH                    
Smoking 73.9 73.6 74.9 79.7 73.9 73.4 80.9 80.5 72.2 71.7
Vaping 38.0 37.1 71.1 69.8 36.8 36.1 52.0 54.3 33.0 31.6
Dabbing waxes, shatter, or concentrates 12.4 12.4 14.0 15.2 12.3 12.3 19.6 19.4 10.5 10.6
Eating or drinking 38.3 39.4 25.2 31.7 38.8 39.6 36.1 35.7 39.5 40.5
Other 9.6 8.6 4.0 6.7 9.8 8.6 6.1 4.4 10.8 9.6
Applying Lotion, Cream, or Patches to Skin 5.8 5.1 2.1 0.8 5.9 5.2 3.5 2.4 6.5 5.9
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 3.2 3.0 1.2 0.9 3.2 3.0 2.0 1.7 3.5 3.4
Taking Pills 1.6 1.5 1.3 3.8 1.6 1.4 1.1 0.9 1.7 1.6
Some Other Way 0.4 0.4 0.8 1.5 0.4 0.4 0.4 0.1 0.4 0.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents could indicate multiple modes of marijuana use; thus, these response categories are not mutually exclusive.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.118A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 51,559 50,765 591 570 50,968 50,194 5,661 5,245 45,307 44,949
LSD 30,935 29,162 222 188 30,713 28,974 2,817 2,591 27,896 26,383
PCP 5,829 5,692 28 33 5,802 5,659 153 103 5,649 5,556
Peyote ‑‑ 4,912 ‑‑ 16 ‑‑ 4,896 ‑‑ 81 ‑‑ 4,815
Mescaline ‑‑ 6,399 ‑‑ 2 ‑‑ 6,397 ‑‑ 88 ‑‑ 6,309
Psilocybin 35,347 34,154 458 428 34,889 33,725 4,468 4,378 30,421 29,348
Ecstasy 22,060 22,359 127 148 21,933 22,211 1,920 1,828 20,013 20,383
Ketamine 5,973 6,078 73 55 5,900 6,023 555 725 5,345 5,298
DMT, AMT, or 5‑MeO‑DIPT/Foxy 4,221 4,276 40 51 4,181 4,225 473 568 3,707 3,657
Salvia divinorum 5,517 5,199 18 26 5,498 5,173 227 193 5,271 4,980
INHALANTS1 ‑‑ 21,884 ‑‑ 1,008 ‑‑ 20,876 ‑‑ 2,243 ‑‑ 18,634
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush2 ‑‑ 8,515 ‑‑ 56 ‑‑ 8,459 ‑‑ 913 ‑‑ 7,546
Correction Fluid, Degreaser, or Cleaning Fluid2 ‑‑ 1,153 ‑‑ 106 ‑‑ 1,047 ‑‑ 90 ‑‑ 957
Gasoline or Lighter Fluid2 ‑‑ 2,315 ‑‑ 180 ‑‑ 2,135 ‑‑ 121 ‑‑ 2,014
Glue, Shoe Polish, or Toluene2 ‑‑ 2,056 ‑‑ 183 ‑‑ 1,874 ‑‑ 164 ‑‑ 1,709
Halothane, Ether, or Other Anesthetics2 ‑‑ 857 ‑‑ 17 ‑‑ 841 ‑‑ 26 ‑‑ 815
Lacquer Thinner or Other Paint Solvents2 ‑‑ 952 ‑‑ 58 ‑‑ 894 ‑‑ 65 ‑‑ 830
Lighter Gases2 ‑‑ 590 ‑‑ 48 ‑‑ 542 ‑‑ 54 ‑‑ 488
Nitrous Oxide or Whippits2 ‑‑ 12,575 ‑‑ 132 ‑‑ 12,443 ‑‑ 1,131 ‑‑ 11,311
Felt‑Tip Pens or Felt‑Tip/Magic Markers2 ‑‑ 2,959 ‑‑ 679 ‑‑ 2,280 ‑‑ 485 ‑‑ 1,795
Spray Paints2 ‑‑ 1,339 ‑‑ 151 ‑‑ 1,188 ‑‑ 94 ‑‑ 1,095
Computer Cleaner/Air Duster2 ‑‑ 2,318 ‑‑ 68 ‑‑ 2,250 ‑‑ 203 ‑‑ 2,047
Other Aerosol Sprays2 ‑‑ 673 ‑‑ 48 ‑‑ 626 ‑‑ 46 ‑‑ 580
NEEDLE USE2,3 6,198 6,098 32 46 6,166 6,053 196 167 5,970 5,885
Heroin Needle Use2 3,215 3,262 2 <1 3,213 3,262 71 54 3,141 3,208
Cocaine Needle Use2 2,799 3,087 1 * 2,798 3,087 45 28 2,753 3,059
Methamphetamine Needle Use2 3,184 3,585 4 * 3,180 3,585 70 42 3,111 3,542
Illegally Made Fentanyl Needle Use2,3 818 565 17 24 800a 541 59a 9 741 532
HEROIN 6,515 6,436 22 6 6,493 6,430 180 179 6,313 6,251
Smoke Heroin2 3,049 3,033 16 * 3,033 3,033 127 127 2,905 2,906
Sniff or Snort Heroin2 4,879 4,297 17 <1 4,862 4,297 106 113 4,757 4,184

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

2 Respondents with unknown specific drug information were excluded from the respective analyses.

3 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.118B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 17.9 17.5 2.3 2.2 19.4 18.9 16.2a 14.5 19.9 19.6
LSD 10.7 10.0 0.9 0.7 11.7 10.9 8.1 7.2 12.3 11.5
PCP 2.0 2.0 0.1 0.1 2.2 2.1 0.4 0.3 2.5 2.4
Peyote ‑‑ 1.7 ‑‑ 0.1 ‑‑ 1.8 ‑‑ 0.2 ‑‑ 2.1
Mescaline ‑‑ 2.2 ‑‑ <0.1 ‑‑ 2.4 ‑‑ 0.2 ‑‑ 2.8
Psilocybin 12.3 11.8 1.8 1.7 13.3 12.7 12.8 12.1 13.4 12.8
Ecstasy 7.7 7.7 0.5 0.6 8.4 8.4 5.5 5.1 8.8 8.9
Ketamine 2.1 2.1 0.3 0.2 2.2 2.3 1.6 2.0 2.4 2.3
DMT, AMT, or 5‑MeO‑DIPT/Foxy 1.5 1.5 0.2 0.2 1.6 1.6 1.4 1.6 1.6 1.6
Salvia divinorum 1.9 1.8 0.1 0.1 2.1 2.0 0.7 0.5 2.3 2.2
INHALANTS1 ‑‑ 7.5 ‑‑ 4.0 ‑‑ 7.9 ‑‑ 6.2 ‑‑ 8.1
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush2 ‑‑ 2.9 ‑‑ 0.2 ‑‑ 3.2 ‑‑ 2.5 ‑‑ 3.3
Correction Fluid, Degreaser, or Cleaning Fluid2 ‑‑ 0.4 ‑‑ 0.4 ‑‑ 0.4 ‑‑ 0.2 ‑‑ 0.4
Gasoline or Lighter Fluid2 ‑‑ 0.8 ‑‑ 0.7 ‑‑ 0.8 ‑‑ 0.3 ‑‑ 0.9
Glue, Shoe Polish, or Toluene2 ‑‑ 0.7 ‑‑ 0.7 ‑‑ 0.7 ‑‑ 0.5 ‑‑ 0.7
Halothane, Ether, or Other Anesthetics2 ‑‑ 0.3 ‑‑ 0.1 ‑‑ 0.3 ‑‑ 0.1 ‑‑ 0.4
Lacquer Thinner or Other Paint Solvents2 ‑‑ 0.3 ‑‑ 0.2 ‑‑ 0.3 ‑‑ 0.2 ‑‑ 0.4
Lighter Gases2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2
Nitrous Oxide or Whippits2 ‑‑ 4.3 ‑‑ 0.5 ‑‑ 4.7 ‑‑ 3.1 ‑‑ 4.9
Felt‑Tip Pens or Felt‑Tip/Magic Markers2 ‑‑ 1.0 ‑‑ 2.7 ‑‑ 0.9 ‑‑ 1.3 ‑‑ 0.8
Spray Paints2 ‑‑ 0.5 ‑‑ 0.6 ‑‑ 0.4 ‑‑ 0.3 ‑‑ 0.5
Computer Cleaner/Air Duster2 ‑‑ 0.8 ‑‑ 0.3 ‑‑ 0.8 ‑‑ 0.6 ‑‑ 0.9
Other Aerosol Sprays2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.1 ‑‑ 0.3
NEEDLE USE2,3 2.2 2.1 0.1 0.2 2.4 2.3 0.6 0.5 2.6 2.6
Heroin Needle Use2 1.1 1.1 <0.1a <0.1 1.2 1.2 0.2 0.1 1.4 1.4
Cocaine Needle Use2 1.0 1.1 <0.1 * 1.1 1.2 0.1 0.1 1.2 1.3
Methamphetamine Needle Use2 1.1 1.2 <0.1 * 1.2 1.4 0.2 0.1 1.4 1.5
Illegally Made Fentanyl Needle Use2,3 0.3a 0.2 0.1 0.1 0.3a 0.2 0.2a <0.1 0.3 0.2
HEROIN 2.3 2.2 0.1 <0.1 2.5 2.4 0.5 0.5 2.8 2.7
Smoke Heroin2 1.1 1.0 0.1 * 1.2 1.1 0.4 0.4 1.3 1.3
Sniff or Snort Heroin2 1.7 1.5 0.1 <0.1 1.9 1.6 0.3 0.3 2.1 1.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

2 Respondents with unknown specific drug information were excluded from the respective analyses.

3 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.119A – Specific Hallucinogen, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 10,423a 9,139 405 360 10,018a 8,779 2,364 2,165 7,653a 6,614
LSD 1,619 1,400 112 96 1,507 1,304 369 413 1,137 891
PCP 103 123 1 30 102 93 27 17 76 77
Peyote ‑‑ 55 ‑‑ 2 ‑‑ 53 ‑‑ 12 ‑‑ 41
Mescaline ‑‑ 154 ‑‑ <1 ‑‑ 154 ‑‑ 36 ‑‑ 117
Psilocybin 7,890b 6,518 311 265 7,579b 6,253 1,898 1,621 5,681a 4,632
Ecstasy 2,013 1,957 57 70 1,956 1,887 405 505 1,551 1,382
Ketamine 1,293 1,269 23 37 1,270 1,232 203a 330 1,067 902
DMT, AMT, or 5‑MeO‑DIPT/Foxy 506 729 19 19 487 710 54b 174 433 536
Salvia divinorum 66 78 16 11 49 67 7 22 42 45
NEEDLE USE1,2 1,046 895 21 24 1,025 872 110a 36 915 836
Heroin Needle Use1 261 229 <1 * 261 229 17a 1 244 228
Cocaine Needle Use1 133 230 <1 * 133 230 12 1 121 230
Methamphetamine Needle Use1 580 614 3 * 576 614 31a 4 545 610
Illegally Made Fentanyl Needle Use1,2 259 176 17 7 241 168 42a 4 200 164
HEROIN 556 581 10 <1 546 580 51b 6 495 574
Smoke Heroin1 336 255 4 * 332 255 41b 3 291 252
Sniff or Snort Heroin1 364 417 9 * 356 417 28 10 328 407

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.119B – Specific Hallucinogen, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 3.6a 3.1 1.6 1.4 3.8a 3.3 6.8 6.0 3.4a 2.9
LSD 0.6 0.5 0.4 0.4 0.6 0.5 1.1 1.1 0.5 0.4
PCP <0.1 <0.1 <0.1 0.1 <0.1 <0.1 0.1 <0.1 <0.1 <0.1
Peyote ‑‑ <0.1 ‑‑ <0.1 ‑‑ <0.1 ‑‑ <0.1 ‑‑ <0.1
Mescaline ‑‑ 0.1 ‑‑ <0.1 ‑‑ 0.1 ‑‑ 0.1 ‑‑ 0.1
Psilocybin 2.7b 2.2 1.2 1.0 2.9b 2.4 5.4a 4.5 2.5a 2.0
Ecstasy 0.7 0.7 0.2 0.3 0.7 0.7 1.2 1.4 0.7 0.6
Ketamine 0.4 0.4 0.1 0.1 0.5 0.5 0.6a 0.9 0.5 0.4
DMT, AMT, or 5‑MeO‑DIPT/Foxy 0.2 0.3 0.1 0.1 0.2 0.3 0.2b 0.5 0.2 0.2
Salvia divinorum <0.1 <0.1 0.1 <0.1 <0.1 <0.1 <0.1 0.1 <0.1 <0.1
NEEDLE USE1,2 0.4 0.3 0.1 0.1 0.4 0.3 0.3a 0.1 0.4 0.4
Heroin Needle Use1 0.1 0.1 <0.1 * 0.1 0.1 <0.1a <0.1 0.1 0.1
Cocaine Needle Use1 <0.1 0.1 <0.1 * 0.1 0.1 <0.1 <0.1 0.1 0.1
Methamphetamine Needle Use1 0.2 0.2 <0.1 * 0.2 0.2 0.1a <0.1 0.2 0.3
Illegally Made Fentanyl Needle Use1,2 0.1 0.1 0.1 <0.1 0.1 0.1 0.1a <0.1 0.1 0.1
HEROIN 0.2 0.2 <0.1 <0.1 0.2 0.2 0.1b <0.1 0.2 0.3
Smoke Heroin1 0.1 0.1 <0.1 * 0.1 0.1 0.1b <0.1 0.1 0.1
Sniff or Snort Heroin1 0.1 0.1 <0.1 * 0.1 0.2 0.1 <0.1 0.1 0.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.120A – Specific Hallucinogen, Needle, and Heroin Use in Past Month: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 2,783 2,722 123 101 2,660 2,621 489 634 2,171 1,987
LSD 259 289 15 17 244 271 60 70 184 202
PCP 46 40 <1 9 46 31 8 2 37 29
Peyote ‑‑ 8 ‑‑ * ‑‑ 8 ‑‑ 2 ‑‑ 6
Mescaline ‑‑ 8 ‑‑ * ‑‑ 8 ‑‑ 1 ‑‑ 7
Psilocybin 1,749 1,617 63 73 1,686 1,544 307 401 1,379 1,143
Ecstasy 532 480 8 16 524 464 94 76 429 388
Ketamine 387 377 4 19 384 357 48 84 335 274
DMT, AMT, or 5‑MeO‑DIPT/Foxy 107 167 <1 4 107 163 3 47 104 117
Salvia divinorum 34 20 1 2 33 18 2 2 31 16
NEEDLE USE1,2 558 418 18 10 540 408 63a 7 477 401
Heroin Needle Use1 152 119 * * 152 119 3 <1 149 118
Cocaine Needle Use1 72 54 * * 72 54 7 1 66 53
Methamphetamine Needle Use1 237 295 * * 237 295 15 3 222 292
Illegally Made Fentanyl Needle Use1,2 210 86 17 7 193 79 33 2 160 77
HEROIN 259 412 1 <1 258 412 14 3 244 409
Smoke Heroin1 131 103 <1 * 131 103 8 <1 123 103
Sniff or Snort Heroin1 151 260 4 * 146 260 8 5 138 255

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.120B – Specific Hallucinogen, Needle, and Heroin Use in Past Month: Among People Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 1.0 0.9 0.5 0.4 1.0 1.0 1.4 1.8 1.0 0.9
LSD 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1
PCP <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Peyote ‑‑ <0.1 ‑‑ * ‑‑ <0.1 ‑‑ <0.1 ‑‑ <0.1
Mescaline ‑‑ <0.1 ‑‑ * ‑‑ <0.1 ‑‑ <0.1 ‑‑ <0.1
Psilocybin 0.6 0.6 0.2 0.3 0.6 0.6 0.9 1.1 0.6 0.5
Ecstasy 0.2 0.2 <0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.2
Ketamine 0.1 0.1 <0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1
DMT, AMT, or 5‑MeO‑DIPT/Foxy <0.1 0.1 <0.1 <0.1 <0.1 0.1 <0.1 0.1 <0.1 0.1
Salvia divinorum <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
NEEDLE USE1,2 0.2 0.1 0.1 <0.1 0.2 0.2 0.2b <0.1 0.2 0.2
Heroin Needle Use1 0.1 <0.1 * * 0.1 <0.1 <0.1 <0.1 0.1 0.1
Cocaine Needle Use1 <0.1 <0.1 * * <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Methamphetamine Needle Use1 0.1 0.1 * * 0.1 0.1 <0.1 <0.1 0.1 0.1
Illegally Made Fentanyl Needle Use1,2 0.1 <0.1 0.1 <0.1 0.1 <0.1 0.1 <0.1 0.1 <0.1
HEROIN 0.1 0.1 <0.1 <0.1 0.1 0.2 <0.1 <0.1 0.1 0.2
Smoke Heroin1 <0.1 <0.1 <0.1 * <0.1 <0.1 <0.1 <0.1 0.1 <0.1
Sniff or Snort Heroin1 0.1 0.1 <0.1 * 0.1 0.1 <0.1 <0.1 0.1 0.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.121A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 63,149 60,619 7,570 6,881 12.0 11.4
Hydrocodone Products2 34,674 32,894 3,402 2,832 9.8 8.6
Oxycodone Products2 22,016 20,963 2,140 2,133 9.7 10.2
OxyContin® 8,694 8,614 879 767 10.1 8.9
Tramadol Products2 15,038 15,298 1,201 1,071 8.0 7.0
Codeine Products2 19,790a 17,698 1,972 1,890 10.0 10.7
Morphine Products2 5,787 5,070 295 488 5.1a 9.7
Prescription Fentanyl Products3 3,119 3,113 390 556 12.5 17.8
Buprenorphine Products2 3,489 3,544 757 657 21.8 18.5
Oxymorphone Products2 960 1,156 73 162 7.6 14.1
Demerol®2 928 751 26 89 2.8 *
Hydromorphone Products2 1,717 1,436 95b 30 5.5a 2.1
Methadone2 1,317 1,482 214 215 16.3 14.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.121B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 21.9a 20.9 2.6 2.4 12.0 11.4
Hydrocodone Products2 12.1 11.3 1.2a 1.0 9.8 8.6
Oxycodone Products2 7.7 7.2 0.7 0.7 9.7 10.2
OxyContin® 3.0 3.0 0.3 0.3 10.1 8.9
Tramadol Products2 5.2 5.3 0.4 0.4 8.0 7.0
Codeine Products2 6.9b 6.1 0.7 0.7 10.0 10.7
Morphine Products2 2.0 1.7 0.1 0.2 5.1a 9.7
Prescription Fentanyl Products3 1.1 1.1 0.1 0.2 12.5 17.8
Buprenorphine Products2 1.2 1.2 0.3 0.2 21.8 18.5
Oxymorphone Products2 0.3 0.4 <0.1 0.1 7.6 14.1
Demerol®2 0.3 0.3 <0.1 <0.1 2.8 *
Hydromorphone Products2 0.6 0.5 <0.1b <0.1 5.5a 2.1
Methadone2 0.5 0.5 0.1 0.1 16.3 14.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.122A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 2,998 2,670 395 402 13.2 15.1
Hydrocodone Products2 737 658 88 94 11.9 14.3
Oxycodone Products2 675 582 114 82 17.0 14.2
OxyContin® 257 292 49 26 * 9.1
Tramadol Products2 328 280 51 26 15.4 9.1
Codeine Products2 1,469 1,349 208 194 14.2 14.4
Morphine Products2 201 265 10a 51 * *
Prescription Fentanyl Products3 105 161 4 2 * 1.4
Buprenorphine Products2 70 114 21 6 * *
Oxymorphone Products2 43 75 6 4 * *
Demerol®2 14 23 3 <1 * *
Hydromorphone Products2 30 27 1 5 * *
Methadone2 24 27 5 3 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.122B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 11.6 10.5 1.5 1.6 13.2 15.1
Hydrocodone Products2 2.9 2.6 0.3 0.4 11.9 14.3
Oxycodone Products2 2.6 2.3 0.4 0.3 17.0 14.2
OxyContin® 1.0 1.1 0.2 0.1 * 9.1
Tramadol Products2 1.3 1.1 0.2 0.1 15.4 9.1
Codeine Products2 5.7 5.3 0.8 0.8 14.2 14.4
Morphine Products2 0.8 1.0 <0.1a 0.2 * *
Prescription Fentanyl Products3 0.4 0.6 <0.1 <0.1 * 1.4
Buprenorphine Products2 0.3 0.4 0.1 <0.1 * *
Oxymorphone Products2 0.2 0.3 <0.1 <0.1 * *
Demerol®2 0.1 0.1 <0.1 <0.1 * *
Hydromorphone Products2 0.1 0.1 <0.1 <0.1 * *
Methadone2 0.1 0.1 <0.1 <0.1 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.123A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 60,151 57,949 7,176 6,479 11.9 11.2
Hydrocodone Products2 33,937 32,236 3,314 2,738 9.8 8.5
Oxycodone Products2 21,341 20,380 2,026 2,051 9.5 10.1
OxyContin® 8,438 8,321 830 740 9.8 8.9
Tramadol Products2 14,710 15,018 1,151 1,045 7.8 7.0
Codeine Products2 18,320a 16,349 1,764 1,696 9.6 10.4
Morphine Products2 5,586 4,805 286 437 5.1 9.1
Prescription Fentanyl Products3 3,015 2,952 386 553 12.8 18.7
Buprenorphine Products2 3,420 3,430 736 651 21.6 19.0
Oxymorphone Products2 917 1,081 67 158 7.3 14.7
Demerol®2 913 728 23 89 2.5 *
Hydromorphone Products2 1,686 1,409 94b 26 5.6a 1.8
Methadone2 1,293 1,455 209 213 16.2 14.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.123B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 22.9a 21.9 2.7 2.4 11.9 11.2
Hydrocodone Products2 13.0 12.2 1.3a 1.0 9.8 8.5
Oxycodone Products2 8.1 7.7 0.8 0.8 9.5 10.1
OxyContin® 3.2 3.1 0.3 0.3 9.8 8.9
Tramadol Products2 5.6 5.7 0.4 0.4 7.8 7.0
Codeine Products2 7.0b 6.2 0.7 0.6 9.6 10.4
Morphine Products2 2.1a 1.8 0.1 0.2 5.1 9.1
Prescription Fentanyl Products3 1.1 1.1 0.1 0.2 12.8 18.7
Buprenorphine Products2 1.3 1.3 0.3 0.2 21.6 19.0
Oxymorphone Products2 0.4 0.4 <0.1 0.1 7.3 14.7
Demerol®2 0.3 0.3 <0.1 <0.1 2.5 *
Hydromorphone Products2 0.6 0.5 <0.1b <0.1 5.6a 1.8
Methadone2 0.5 0.5 0.1 0.1 16.2 14.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.124A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 4,731 4,676 897 733 19.0 15.7
Hydrocodone Products2 2,121 1,886 347 286 16.4 15.2
Oxycodone Products2 1,543 1,586 332 251 21.6 15.9
OxyContin® 623 580 118 74 19.0 12.8
Tramadol Products2 745 724 147 84 19.8 11.7
Codeine Products2 1,612 1,596 349 250 21.8 15.7
Morphine Products2 548a 392 25 16 4.5 4.2
Prescription Fentanyl Products3 237 277 50 46 21.0 16.5
Buprenorphine Products2 149a 267 41 24 * 9.1
Oxymorphone Products2 88 124 12 8 * *
Demerol®2 19 30 4 8 * *
Hydromorphone Products2 80 79 6 6 * *
Methadone2 69 67 4 3 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.124B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 13.5 13.0 2.6 2.0 19.0 15.7
Hydrocodone Products2 6.1 5.2 1.0 0.8 16.4 15.2
Oxycodone Products2 4.4 4.4 1.0 0.7 21.6 15.9
OxyContin® 1.8 1.6 0.3 0.2 19.0 12.8
Tramadol Products2 2.1 2.0 0.4 0.2 19.8 11.7
Codeine Products2 4.6 4.4 1.0 0.7 21.8 15.7
Morphine Products2 1.6a 1.1 0.1 <0.1 4.5 4.2
Prescription Fentanyl Products3 0.7 0.8 0.1 0.1 21.0 16.5
Buprenorphine Products2 0.4a 0.7 0.1 0.1 * 9.1
Oxymorphone Products2 0.3 0.3 <0.1 <0.1 * *
Demerol®2 0.1 0.1 <0.1 <0.1 * *
Hydromorphone Products2 0.2 0.2 <0.1 <0.1 * *
Methadone2 0.2 0.2 <0.1 <0.1 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.125A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 55,420 53,272 6,279 5,746 11.3 10.8
Hydrocodone Products2 31,816 30,350 2,967 2,453 9.3 8.1
Oxycodone Products2 19,798 18,794 1,694 1,800 8.6 9.6
OxyContin® 7,815 7,742 712 666 9.1 8.6
Tramadol Products2 13,965 14,294 1,003 961 7.2 6.7
Codeine Products2 16,708a 14,754 1,415 1,446 8.5 9.8
Morphine Products2 5,038 4,413 261 421 5.2 9.6
Prescription Fentanyl Products3 2,777 2,675 337 508 12.1 19.0
Buprenorphine Products2 3,271 3,163 695 627 21.3 19.8
Oxymorphone Products2 829 957 55 150 6.7 *
Demerol®2 894 698 19 81 2.1 *
Hydromorphone Products2 1,606 1,331 88b 20 5.5b 1.5
Methadone2 1,225 1,388 205 210 16.8 15.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.125B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 24.4 23.3 2.8 2.5 11.3 10.8
Hydrocodone Products2 14.0 13.3 1.3 1.1 9.3 8.1
Oxycodone Products2 8.7 8.2 0.7 0.8 8.6 9.6
OxyContin® 3.4 3.4 0.3 0.3 9.1 8.6
Tramadol Products2 6.2 6.3 0.4 0.4 7.2 6.7
Codeine Products2 7.4b 6.5 0.6 0.6 8.5 9.8
Morphine Products2 2.2 1.9 0.1 0.2 5.2 9.6
Prescription Fentanyl Products3 1.2 1.2 0.1 0.2 12.1 19.0
Buprenorphine Products2 1.4 1.4 0.3 0.3 21.3 19.8
Oxymorphone Products2 0.4 0.4 <0.1 0.1 6.7 *
Demerol®2 0.4 0.3 <0.1 <0.1 2.1 *
Hydromorphone Products2 0.7 0.6 <0.1b <0.1 5.5b 1.5
Methadone2 0.5 0.6 0.1 0.1 16.8 15.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.126A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 20,507 21,237 3,899 3,940 19.0 18.6
Amphetamines or Methylphenidate Products1 16,168 17,407 3,616 3,786 22.4 21.8
Amphetamines1 13,790 14,957 3,318 3,478 24.1 23.3
Methylphenidate Products1 4,253 4,890 538 594 12.6 12.2
Anorectic (Weight‑Loss) Stimulants1 2,802 2,972 159 150 5.7 5.1
Provigil®1 474 426 55 68 * *
Any Other Prescription Stimulant1,2 2,515 2,443 121 26 * 1.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.126B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 7.1 7.3 1.4 1.4 19.0 18.6
Amphetamines or Methylphenidate Products1 5.6 6.0 1.3 1.3 22.4 21.8
Amphetamines1 4.8 5.2 1.2 1.2 24.1 23.3
Methylphenidate Products1 1.5 1.7 0.2 0.2 12.6 12.2
Anorectic (Weight‑Loss) Stimulants1 1.0 1.0 0.1 0.1 5.7 5.1
Provigil®1 0.2 0.1 <0.1 <0.1 * *
Any Other Prescription Stimulant1,2 0.9 0.8 <0.1 <0.1 * 1.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.127A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 1,830 1,889 203 216 11.1 11.4
Amphetamines or Methylphenidate Products1 1,647 1,713 200 205 12.1 12.0
Amphetamines1 1,107 1,106 162 161 14.7 14.5
Methylphenidate Products1 761 821 67 48 8.9 5.9
Anorectic (Weight‑Loss) Stimulants1 80 97 17 5 * *
Provigil®1 10 4 * 2 * *
Any Other Prescription Stimulant1,2 317 299 3 * 1.0 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.127B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 7.1 7.4 0.8 0.8 11.1 11.4
Amphetamines or Methylphenidate Products1 6.4 6.7 0.8 0.8 12.1 12.0
Amphetamines1 4.3 4.4 0.6 0.6 14.7 14.5
Methylphenidate Products1 2.9 3.2 0.3 0.2 8.9 5.9
Anorectic (Weight‑Loss) Stimulants1 0.3 0.4 0.1 <0.1 * *
Provigil®1 <0.1 <0.1 * <0.1 * *
Any Other Prescription Stimulant1,2 1.2 1.2 <0.1 * 1.0 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.128A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 18,677 19,348 3,696 3,724 19.8 19.2
Amphetamines or Methylphenidate Products1 14,522 15,694 3,416 3,580 23.5 22.8
Amphetamines1 12,683 13,851 3,155 3,317 24.9 24.0
Methylphenidate Products1 3,492 4,069 470 547 13.5 13.5
Anorectic (Weight‑Loss) Stimulants1 2,723 2,874 142 145 5.2 5.0
Provigil®1 464 422 55 66 * *
Any Other Prescription Stimulant1,2 2,198 2,144 118 26 * 1.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.128B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 7.1 7.3 1.4 1.4 19.8 19.2
Amphetamines or Methylphenidate Products1 5.5 5.9 1.3 1.4 23.5 22.8
Amphetamines1 4.8 5.2 1.2 1.3 24.9 24.0
Methylphenidate Products1 1.3 1.5 0.2 0.2 13.5 13.5
Anorectic (Weight‑Loss) Stimulants1 1.0 1.1 0.1 0.1 5.2 5.0
Provigil®1 0.2 0.2 <0.1 <0.1 * *
Any Other Prescription Stimulant1,2 0.8 0.8 <0.1 <0.1 * 1.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.129A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 3,639 3,769 973 978 26.7 25.9
Amphetamines or Methylphenidate Products1 3,267 3,512 949 964 29.1 27.4
Amphetamines1 2,688 2,998 883 919 32.9 30.7
Methylphenidate Products1 1,013 1,016 142 114 14.1 11.2
Anorectic (Weight‑Loss) Stimulants1 164 183 23 14 * *
Provigil®1 57 19 2 <1 * *
Any Other Prescription Stimulant1,2 371a 237 3 3 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.129B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 10.4 10.4 2.8 2.7 26.7 25.9
Amphetamines or Methylphenidate Products1 9.4 9.7 2.7 2.7 29.1 27.4
Amphetamines1 7.7 8.3 2.5 2.5 32.9 30.7
Methylphenidate Products1 2.9 2.8 0.4 0.3 14.1 11.2
Anorectic (Weight‑Loss) Stimulants1 0.5 0.5 0.1 <0.1 * *
Provigil®1 0.2 0.1 <0.1 <0.1 * *
Any Other Prescription Stimulant1,2 1.1a 0.7 <0.1 <0.1 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.130A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 15,038 15,579 2,723 2,746 18.1 17.6
Amphetamines or Methylphenidate Products1 11,255 12,182 2,467 2,617 21.9 21.5
Amphetamines1 9,994 10,853 2,272 2,398 22.8 22.2
Methylphenidate Products1 2,479a 3,054 328 433 13.2 14.2
Anorectic (Weight‑Loss) Stimulants1 2,558 2,691 119 131 4.6 4.9
Provigil®1 407 403 54 66 * *
Any Other Prescription Stimulant1,2 1,827 1,907 114 23 * 1.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.130B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 6.6 6.8 1.2 1.2 18.1 17.6
Amphetamines or Methylphenidate Products1 5.0 5.3 1.1 1.1 21.9 21.5
Amphetamines1 4.4 4.7 1.0 1.0 22.8 22.2
Methylphenidate Products1 1.1 1.3 0.1 0.2 13.2 14.2
Anorectic (Weight‑Loss) Stimulants1 1.1 1.2 0.1 0.1 4.6 4.9
Provigil®1 0.2 0.2 <0.1 <0.1 * *
Any Other Prescription Stimulant1,2 0.8 0.8 0.1 <0.1 * 1.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.131A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 31,451a 28,826 3,829 3,665 12.2 12.7
Benzodiazepine Tranquilizers1 23,172 21,414 3,252 3,181 14.0 14.9
Alprazolam Products1 12,505 11,889 2,128 2,363 17.0 19.9
Lorazepam Products1 6,398 6,269 504 551 7.9 8.8
Clonazepam Products1 5,654 4,992 895 761 15.8 15.3
Diazepam Products1 4,744 4,228 592 426 12.5 10.1
Muscle Relaxants1 7,465a 6,341 518 402 6.9 6.3
Cyclobenzaprine1 6,835b 5,618 475 344 7.0 6.1
Soma®1 697 786 36 66 5.2 8.4
Any Other Prescription Tranquilizer1,2 4,513 4,269 121 164 2.7 3.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.131B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 10.9b 9.9 1.3 1.3 12.2 12.7
Benzodiazepine Tranquilizers1 8.0a 7.4 1.1 1.1 14.0 14.9
Alprazolam Products1 4.3 4.1 0.7 0.8 17.0 19.9
Lorazepam Products1 2.2 2.2 0.2 0.2 7.9 8.8
Clonazepam Products1 2.0 1.7 0.3 0.3 15.8 15.3
Diazepam Products1 1.6 1.5 0.2 0.1 12.5 10.1
Muscle Relaxants1 2.6a 2.2 0.2 0.1 6.9 6.3
Cyclobenzaprine1 2.4b 1.9 0.2 0.1 7.0 6.1
Soma®1 0.2 0.3 <0.1 <0.1 5.2 8.4
Any Other Prescription Tranquilizer1,2 1.6 1.5 <0.1 0.1 2.7 3.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.132A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 500 508 126 119 25.2 23.5
Benzodiazepine Tranquilizers1 314 350 96 115 30.6 33.0
Alprazolam Products1 231 260 81 87 35.2 *
Lorazepam Products1 63 64 21 18 * *
Clonazepam Products1 57 39 18 8 * *
Diazepam Products1 67 77 21 14 * *
Muscle Relaxants1 37 43 6 4 * *
Cyclobenzaprine1 31 40 5 4 * *
Soma®1 12 2 <1 * * *
Any Other Prescription Tranquilizer1,2 167 149 3 7 2.3 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.132B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 1.9 2.0 0.5 0.5 25.2 23.5
Benzodiazepine Tranquilizers1 1.2 1.4 0.4 0.5 30.6 33.0
Alprazolam Products1 0.9 1.0 0.3 0.3 35.2 *
Lorazepam Products1 0.2 0.3 0.1 0.1 * *
Clonazepam Products1 0.2 0.2 0.1 <0.1 * *
Diazepam Products1 0.3 0.3 0.1 0.1 * *
Muscle Relaxants1 0.1 0.2 <0.1 <0.1 * *
Cyclobenzaprine1 0.1 0.2 <0.1 <0.1 * *
Soma®1 <0.1 <0.1 <0.1 * * *
Any Other Prescription Tranquilizer1,2 0.6 0.6 <0.1 <0.1 2.3 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.133A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 30,951a 28,318 3,703 3,546 12.0 12.5
Benzodiazepine Tranquilizers1 22,859a 21,063 3,156 3,066 13.8 14.6
Alprazolam Products1 12,274 11,630 2,046 2,276 16.7 19.6
Lorazepam Products1 6,335 6,205 483 533 7.6 8.6
Clonazepam Products1 5,597 4,953 877 753 15.7 15.3
Diazepam Products1 4,677 4,151 571 413 12.2 10.0
Muscle Relaxants1 7,428a 6,298 512 397 6.9 6.3
Cyclobenzaprine1 6,805b 5,577 470 340 6.9 6.1
Soma®1 685 784 36 66 5.3 8.5
Any Other Prescription Tranquilizer1,2 4,346 4,121 118 157 2.7 3.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.133B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 11.8b 10.7 1.4 1.3 12.0 12.5
Benzodiazepine Tranquilizers1 8.7a 7.9 1.2 1.2 13.8 14.6
Alprazolam Products1 4.7 4.4 0.8 0.9 16.7 19.6
Lorazepam Products1 2.4 2.3 0.2 0.2 7.6 8.6
Clonazepam Products1 2.1 1.9 0.3 0.3 15.7 15.3
Diazepam Products1 1.8 1.6 0.2 0.2 12.2 10.0
Muscle Relaxants1 2.8b 2.4 0.2 0.1 6.9 6.3
Cyclobenzaprine1 2.6b 2.1 0.2 0.1 6.9 6.1
Soma®1 0.3 0.3 <0.1 <0.1 5.3 8.5
Any Other Prescription Tranquilizer1,2 1.7 1.6 <0.1 0.1 2.7 3.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.134A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 1,944 1,811 522 515 26.8 28.4
Benzodiazepine Tranquilizers1 1,555 1,462 475 460 30.6 31.5
Alprazolam Products1 975 1,019 393 365 40.3 35.9
Lorazepam Products1 394 329 55 58 14.1 17.7
Clonazepam Products1 355 293 93 85 26.3 *
Diazepam Products1 263 191 70a 20 26.6a 10.5
Muscle Relaxants1 207 253 50 34 * 13.5
Cyclobenzaprine1 192 213 49 26 * *
Soma®1 17 41 4 8 * *
Any Other Prescription Tranquilizer1,2 375a 250 20 22 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.134B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 5.6 5.0 1.5 1.4 26.8 28.4
Benzodiazepine Tranquilizers1 4.4 4.1 1.4 1.3 30.6 31.5
Alprazolam Products1 2.8 2.8 1.1 1.0 40.3 35.9
Lorazepam Products1 1.1 0.9 0.2 0.2 14.1 17.7
Clonazepam Products1 1.0 0.8 0.3 0.2 26.3 *
Diazepam Products1 0.8 0.5 0.2a 0.1 26.6a 10.5
Muscle Relaxants1 0.6 0.7 0.1 0.1 * 13.5
Cyclobenzaprine1 0.5 0.6 0.1 0.1 * *
Soma®1 <0.1 0.1 <0.1 <0.1 * *
Any Other Prescription Tranquilizer1,2 1.1a 0.7 0.1 0.1 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.135A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 29,007a 26,507 3,181 3,031 11.0 11.4
Benzodiazepine Tranquilizers1 21,304 19,602 2,681 2,606 12.6 13.3
Alprazolam Products1 11,299 10,611 1,653 1,911 14.6 18.0
Lorazepam Products1 5,941 5,876 427 475 7.2 8.1
Clonazepam Products1 5,242 4,660 785 668 15.0 14.4
Diazepam Products1 4,414 3,960 501 393 11.4 9.9
Muscle Relaxants1 7,221a 6,045 462 363 6.4 6.0
Cyclobenzaprine1 6,613b 5,365 421 313 6.4 5.8
Soma®1 668 743 32 59 4.9 7.9
Any Other Prescription Tranquilizer1,2 3,971 3,871 97 136 2.5 3.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.135B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 12.8b 11.6 1.4 1.3 11.0 11.4
Benzodiazepine Tranquilizers1 9.4a 8.6 1.2 1.1 12.6 13.3
Alprazolam Products1 5.0 4.6 0.7 0.8 14.6 18.0
Lorazepam Products1 2.6 2.6 0.2 0.2 7.2 8.1
Clonazepam Products1 2.3 2.0 0.3 0.3 15.0 14.4
Diazepam Products1 1.9 1.7 0.2 0.2 11.4 9.9
Muscle Relaxants1 3.2b 2.6 0.2 0.2 6.4 6.0
Cyclobenzaprine1 2.9b 2.3 0.2 0.1 6.4 5.8
Soma®1 0.3 0.3 <0.1 <0.1 4.9 7.9
Any Other Prescription Tranquilizer1,2 1.7 1.7 <0.1 0.1 2.5 3.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.136A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 13,762 13,659 920 977 6.7 7.2
Zolpidem Products1 6,004 6,290 588 493 9.8 7.8
Eszopiclone Products1 1,022 1,009 48 52 4.7 5.2
Zaleplon Products1 331a 627 * 23 * 3.7
Benzodiazepine Sedatives1 1,602 1,527 100 161 6.2 10.5
Flurazepam1 44 105 4 41 * *
Temazepam Products1 850 715 70 78 * *
Triazolam Products1 740 804 26 82 3.5 *
Barbiturates1 512 574 32 33 6.3 5.7
Any Other Prescription Sedative1,2 6,258 5,997 134 130 2.2 2.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.136B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 4.8 4.7 0.3 0.3 6.7 7.2
Zolpidem Products1 2.1 2.2 0.2 0.2 9.8 7.8
Eszopiclone Products1 0.4 0.3 <0.1 <0.1 4.7 5.2
Zaleplon Products1 0.1a 0.2 * <0.1 * 3.7
Benzodiazepine Sedatives1 0.6 0.5 <0.1 0.1 6.2 10.5
Flurazepam1 <0.1 <0.1 <0.1 <0.1 * *
Temazepam Products1 0.3 0.2 <0.1 <0.1 * *
Triazolam Products1 0.3 0.3 <0.1 <0.1 3.5 *
Barbiturates1 0.2 0.2 <0.1 <0.1 6.3 5.7
Any Other Prescription Sedative1,2 2.2 2.1 <0.1 <0.1 2.2 2.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.137A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 545a 395 64 31 11.7 7.9
Zolpidem Products1 96 81 23 10 * *
Eszopiclone Products1 13 24 8 8 * *
Zaleplon Products1 17 19 * 5 * *
Benzodiazepine Sedatives1 63 58 15 10 * *
Flurazepam1 6 17 1 6 * *
Temazepam Products1 16 15 2 4 * *
Triazolam Products1 41 34 13 * * *
Barbiturates1 27 41 10 7 * *
Any Other Prescription Sedative1,2 421a 280 26 4 * 1.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.137B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 2.1a 1.6 0.2 0.1 11.7 7.9
Zolpidem Products1 0.4 0.3 0.1 <0.1 * *
Eszopiclone Products1 0.1 0.1 <0.1 <0.1 * *
Zaleplon Products1 0.1 0.1 * <0.1 * *
Benzodiazepine Sedatives1 0.2 0.2 0.1 <0.1 * *
Flurazepam1 <0.1 0.1 <0.1 <0.1 * *
Temazepam Products1 0.1 0.1 <0.1 <0.1 * *
Triazolam Products1 0.2 0.1 <0.1 * * *
Barbiturates1 0.1 0.2 <0.1 <0.1 * *
Any Other Prescription Sedative1,2 1.6a 1.1 0.1 <0.1 * 1.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.138A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 13,217 13,264 857 946 6.5 7.1
Zolpidem Products1 5,907 6,209 564 483 9.6 7.8
Eszopiclone Products1 1,008 984 40 44 4.0 4.5
Zaleplon Products1 314a 608 * 18 * 3.0
Benzodiazepine Sedatives1 1,539 1,469 84 151 5.5 10.3
Flurazepam1 38 88 3 35 * *
Temazepam Products1 834 700 69 73 * *
Triazolam Products1 699 770 13 82 1.9 *
Barbiturates1 485 533 22 26 * 4.8
Any Other Prescription Sedative1,2 5,837 5,717 108 125 1.9 2.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.138B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 5.0 5.0 0.3 0.4 6.5 7.1
Zolpidem Products1 2.3 2.3 0.2 0.2 9.6 7.8
Eszopiclone Products1 0.4 0.4 <0.1 <0.1 4.0 4.5
Zaleplon Products1 0.1a 0.2 * <0.1 * 3.0
Benzodiazepine Sedatives1 0.6 0.6 <0.1 0.1 5.5 10.3
Flurazepam1 <0.1 <0.1 <0.1 <0.1 * *
Temazepam Products1 0.3 0.3 <0.1 <0.1 * *
Triazolam Products1 0.3 0.3 <0.1 <0.1 1.9 *
Barbiturates1 0.2 0.2 <0.1 <0.1 * 4.8
Any Other Prescription Sedative1,2 2.2 2.2 <0.1 <0.1 1.9 2.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.139A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 830 930 76 118 9.1 12.7
Zolpidem Products1 179 239 38 32 21.4 *
Eszopiclone Products1 40 43 15 4 * *
Zaleplon Products1 34 39 * 1 * *
Benzodiazepine Sedatives1 115 112 10 6 * *
Flurazepam1 4 13 * * * *
Temazepam Products1 47 23 3 1 * *
Triazolam Products1 74 77 7 5 * *
Barbiturates1 32 44 3 7 * *
Any Other Prescription Sedative1,2 547 582 20 44 3.8 7.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.139B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 2.4 2.6 0.2 0.3 9.1 12.7
Zolpidem Products1 0.5 0.7 0.1 0.1 21.4 *
Eszopiclone Products1 0.1 0.1 <0.1 <0.1 * *
Zaleplon Products1 0.1 0.1 * <0.1 * *
Benzodiazepine Sedatives1 0.3 0.3 <0.1 <0.1 * *
Flurazepam1 <0.1 <0.1 * * * *
Temazepam Products1 0.1 0.1 <0.1 <0.1 * *
Triazolam Products1 0.2 0.2 <0.1 <0.1 * *
Barbiturates1 0.1 0.1 <0.1 <0.1 * *
Any Other Prescription Sedative1,2 1.6 1.6 0.1 0.1 3.8 7.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.140A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 12,387 12,334 781 828 6.3 6.7
Zolpidem Products1 5,729 5,970 526 451 9.2 7.6
Eszopiclone Products1 969 941 25 40 2.5 4.3
Zaleplon Products1 280a 569 * 17 * *
Benzodiazepine Sedatives1 1,424 1,357 74 144 5.2 10.6
Flurazepam1 34 75 3 35 * *
Temazepam Products1 787 677 65 72 * *
Triazolam Products1 625 693 6 76 0.9 *
Barbiturates1 453 489 19 19 * *
Any Other Prescription Sedative1,2 5,290 5,135 88 82 1.7 1.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.140B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 5.4 5.4 0.3 0.4 6.3 6.7
Zolpidem Products1 2.5 2.6 0.2 0.2 9.2 7.6
Eszopiclone Products1 0.4 0.4 <0.1 <0.1 2.5 4.3
Zaleplon Products1 0.1a 0.2 * <0.1 * *
Benzodiazepine Sedatives1 0.6 0.6 <0.1 0.1 5.2 10.6
Flurazepam1 <0.1 <0.1 <0.1 <0.1 * *
Temazepam Products1 0.3 0.3 <0.1 <0.1 * *
Triazolam Products1 0.3 0.3 <0.1 <0.1 0.9 *
Barbiturates1 0.2 0.2 <0.1 <0.1 * *
Any Other Prescription Sedative1,2 2.3 2.2 <0.1 <0.1 1.7 1.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.141A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 24,207a 22,280 3,360 3,293 13.9 14.8
Benzodiazepine Tranquilizers1 23,172 21,414 3,252 3,181 14.0 14.9
Alprazolam Products1 12,505 11,889 2,128 2,363 17.0 19.9
Lorazepam Products1 6,398 6,269 504 551 7.9 8.8
Clonazepam Products1 5,654 4,992 895 761 15.8 15.3
Diazepam Products1 4,744 4,228 592 426 12.5 10.1
Benzodiazepine Sedatives1 1,602 1,527 100 161 6.2 10.5
Flurazepam1 44 105 4 41 * *
Temazepam Products1 850 715 70 78 * *
Triazolam Products1 740 804 26 82 3.5 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 8 13 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.141B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 8.4a 7.7 1.2 1.1 13.9 14.8
Benzodiazepine Tranquilizers1 8.0a 7.4 1.1 1.1 14.0 14.9
Alprazolam Products1 4.3 4.1 0.7 0.8 17.0 19.9
Lorazepam Products1 2.2 2.2 0.2 0.2 7.9 8.8
Clonazepam Products1 2.0 1.7 0.3 0.3 15.8 15.3
Diazepam Products1 1.6 1.5 0.2 0.1 12.5 10.1
Benzodiazepine Sedatives1 0.6 0.5 <0.1 0.1 6.2 10.5
Flurazepam1 <0.1 <0.1 <0.1 <0.1 * *
Temazepam Products1 0.3 0.2 <0.1 <0.1 * *
Triazolam Products1 0.3 0.3 <0.1 <0.1 3.5 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.1 <0.1 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.142A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 371 398 107 122 28.7 30.6
Benzodiazepine Tranquilizers1 314 350 96 115 30.6 33.0
Alprazolam Products1 231 260 81 87 35.2 *
Lorazepam Products1 63 64 21 18 * *
Clonazepam Products1 57 39 18 8 * *
Diazepam Products1 67 77 21 14 * *
Benzodiazepine Sedatives1 63 58 15 10 * *
Flurazepam1 6 17 1 6 * *
Temazepam Products1 16 15 2 4 * *
Triazolam Products1 41 34 13 * * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 1 * da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.142B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 1.4 1.6 0.4 0.5 28.7 30.6
Benzodiazepine Tranquilizers1 1.2 1.4 0.4 0.5 30.6 33.0
Alprazolam Products1 0.9 1.0 0.3 0.3 35.2 *
Lorazepam Products1 0.2 0.3 0.1 0.1 * *
Clonazepam Products1 0.2 0.2 0.1 <0.1 * *
Diazepam Products1 0.3 0.3 0.1 0.1 * *
Benzodiazepine Sedatives1 0.2 0.2 0.1 <0.1 * *
Flurazepam1 <0.1 0.1 <0.1 <0.1 * *
Temazepam Products1 0.1 0.1 <0.1 <0.1 * *
Triazolam Products1 0.2 0.1 <0.1 * * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.1 * da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.143A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 23,835a 21,883 3,253 3,172 13.6 14.5
Benzodiazepine Tranquilizers1 22,859a 21,063 3,156 3,066 13.8 14.6
Alprazolam Products1 12,274 11,630 2,046 2,276 16.7 19.6
Lorazepam Products1 6,335 6,205 483 533 7.6 8.6
Clonazepam Products1 5,597 4,953 877 753 15.7 15.3
Diazepam Products1 4,677 4,151 571 413 12.2 10.0
Benzodiazepine Sedatives1 1,539 1,469 84 151 5.5 10.3
Flurazepam1 38 88 3 35 * *
Temazepam Products1 834 700 69 73 * *
Triazolam Products1 699 770 13 82 1.9 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 8 13 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.143B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 9.1b 8.3 1.2 1.2 13.6 14.5
Benzodiazepine Tranquilizers1 8.7a 7.9 1.2 1.2 13.8 14.6
Alprazolam Products1 4.7 4.4 0.8 0.9 16.7 19.6
Lorazepam Products1 2.4 2.3 0.2 0.2 7.6 8.6
Clonazepam Products1 2.1 1.9 0.3 0.3 15.7 15.3
Diazepam Products1 1.8 1.6 0.2 0.2 12.2 10.0
Benzodiazepine Sedatives1 0.6 0.6 <0.1 0.1 5.5 10.3
Flurazepam1 <0.1 <0.1 <0.1 <0.1 * *
Temazepam Products1 0.3 0.3 <0.1 <0.1 * *
Triazolam Products1 0.3 0.3 <0.1 <0.1 1.9 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.1 <0.1 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.144A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 1,628 1,536 488 470 30.0 30.6
Benzodiazepine Tranquilizers1 1,555 1,462 475 460 30.6 31.5
Alprazolam Products1 975 1,019 393 365 40.3 35.9
Lorazepam Products1 394 329 55 58 14.1 17.7
Clonazepam Products1 355 293 93 85 26.3 *
Diazepam Products1 263 191 70a 20 26.6a 10.5
Benzodiazepine Sedatives1 115 112 10 6 * *
Flurazepam1 4 13 * * * *
Temazepam Products1 47 23 3 1 * *
Triazolam Products1 74 77 7 5 * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 2 3 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.144B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 4.7 4.3 1.4 1.3 30.0 30.6
Benzodiazepine Tranquilizers1 4.4 4.1 1.4 1.3 30.6 31.5
Alprazolam Products1 2.8 2.8 1.1 1.0 40.3 35.9
Lorazepam Products1 1.1 0.9 0.2 0.2 14.1 17.7
Clonazepam Products1 1.0 0.8 0.3 0.2 26.3 *
Diazepam Products1 0.8 0.5 0.2a 0.1 26.6a 10.5
Benzodiazepine Sedatives1 0.3 0.3 <0.1 <0.1 * *
Flurazepam1 <0.1 <0.1 * * * *
Temazepam Products1 0.1 0.1 <0.1 <0.1 * *
Triazolam Products1 0.2 0.2 <0.1 <0.1 * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.1 <0.1 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.145A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 22,208a 20,346 2,766 2,702 12.5 13.3
Benzodiazepine Tranquilizers1 21,304 19,602 2,681 2,606 12.6 13.3
Alprazolam Products1 11,299 10,611 1,653 1,911 14.6 18.0
Lorazepam Products1 5,941 5,876 427 475 7.2 8.1
Clonazepam Products1 5,242 4,660 785 668 15.0 14.4
Diazepam Products1 4,414 3,960 501 393 11.4 9.9
Benzodiazepine Sedatives1 1,424 1,357 74 144 5.2 10.6
Flurazepam1 34 75 3 35 * *
Temazepam Products1 787 677 65 72 * *
Triazolam Products1 625 693 6 76 0.9 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 5 11 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.145B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 9.8a 8.9 1.2 1.2 12.5 13.3
Benzodiazepine Tranquilizers1 9.4a 8.6 1.2 1.1 12.6 13.3
Alprazolam Products1 5.0 4.6 0.7 0.8 14.6 18.0
Lorazepam Products1 2.6 2.6 0.2 0.2 7.2 8.1
Clonazepam Products1 2.3 2.0 0.3 0.3 15.0 14.4
Diazepam Products1 1.9 1.7 0.2 0.2 11.4 9.9
Benzodiazepine Sedatives1 0.6 0.6 <0.1 0.1 5.2 10.6
Flurazepam1 <0.1 <0.1 <0.1 <0.1 * *
Temazepam Products1 0.3 0.3 <0.1 <0.1 * *
Triazolam Products1 0.3 0.3 <0.1 <0.1 0.9 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.1 <0.1 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.1C – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 2,189 2,366 1,352 1,367 1,040 1,058
Marijuana 2,079 2,280 1,257 1,256 976 1,000
Cocaine 1,014 1,069 225 300 152 186
Crack 480 512 118 134 93 82
Heroin 333 370 87 97 68 88
Hallucinogens 1,109 1,210 409 386 181 191
LSD 834 913 139 136 59 53
Psilocybin 890 964 344 324 148 158
Ecstasy 616 667 137 153 69 63
Inhalants3 ‑‑ 727 ‑‑ 196 ‑‑ 124
Methamphetamine 556 581 186 236 151 183
Misuse of Prescription Psychotherapeutics nr nr 439 487 260 258
Pain Relievers nr nr 337 355 189 185
Prescription Opioids ‑‑ ‑‑ 321 341 184 168
Stimulants nr nr 213 221 119 124
Tranquilizers or Sedatives nr nr 251 293 147 155
Tranquilizers nr nr 223 256 132 141
Sedatives nr nr 127 170 61 78
Benzodiazepines ‑‑ ‑‑ 208 248 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 328 344 193 180
Misuse of Central Nervous System Stimulants nr nr 342 425 224 280
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 717 ‑‑ 408
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 333 354 199 182
Illegally Made Fentanyl 162 169 89 129 74 97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.1D – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Standard Errors of Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.40 0.44 0.35 0.35 0.29 0.30
Marijuana 0.40 0.44 0.34 0.33 0.28 0.29
Cocaine 0.30 0.30 0.08 0.10 0.05 0.06
Crack 0.16 0.17 0.04 0.05 0.03 0.03
Heroin 0.11 0.12 0.03 0.03 0.02 0.03
Hallucinogens 0.31 0.32 0.13 0.13 0.06 0.06
LSD 0.25 0.27 0.05 0.05 0.02 0.02
Psilocybin 0.26 0.28 0.11 0.11 0.05 0.05
Ecstasy 0.19 0.20 0.05 0.05 0.02 0.02
Inhalants3 ‑‑ 0.22 ‑‑ 0.07 ‑‑ 0.04
Methamphetamine 0.18 0.18 0.06 0.08 0.05 0.06
Misuse of Prescription Psychotherapeutics nr nr 0.14 0.15 0.09 0.09
Pain Relievers nr nr 0.11 0.12 0.06 0.06
Prescription Opioids ‑‑ ‑‑ 0.11 0.11 0.06 0.06
Stimulants nr nr 0.07 0.07 0.04 0.04
Tranquilizers or Sedatives nr nr 0.09 0.10 0.05 0.05
Tranquilizers nr nr 0.08 0.09 0.05 0.05
Sedatives nr nr 0.04 0.06 0.02 0.03
Benzodiazepines ‑‑ ‑‑ 0.07 0.08 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 0.11 0.11 0.07 0.06
Misuse of Central Nervous System Stimulants nr nr 0.11 0.14 0.08 0.09
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 0.22 ‑‑ 0.13
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 0.11 0.12 0.07 0.06
Illegally Made Fentanyl 0.05 0.06 0.03 0.04 0.03 0.03

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.1P – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.0012   0.0022   0.3837  
Marijuana 0.3000   0.0242   0.4677  
Cocaine 0.1196   0.0790   0.1989  
Crack 0.3482   0.1947   0.6183  
Heroin 0.7885   0.8753   0.1739  
Hallucinogens 0.3578   0.0108   0.7496  
LSD 0.0593   0.2287   0.7260  
Psilocybin 0.1826   0.0016   0.4979  
Ecstasy 0.8781   0.7214   0.5535  
Inhalants3 ‑‑   ‑‑   ‑‑  
Methamphetamine 0.8570   0.4002   0.1723  
Misuse of Prescription Psychotherapeutics nr   0.0724   0.1373  
Pain Relievers nr   0.0613   0.4988  
Prescription Opioids ‑‑   0.0992   0.5428  
Stimulants nr   0.9740   0.9385  
Tranquilizers or Sedatives nr   0.3236   0.1523  
Tranquilizers nr   0.5620   0.1257  
Sedatives nr   0.8152   0.6112  
Benzodiazepines ‑‑   0.7689   ‑‑  
Misuse of Opioids2 ‑‑   0.0910   0.7541  
Misuse of Central Nervous System Stimulants nr   0.4619   0.1563  
Illicit Drugs Other Than Marijuana2,3,4 nr   ‑‑   ‑‑  
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑   0.1038   0.5068  
Illegally Made Fentanyl 0.1788   0.5441   0.8809  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.2C – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 ‑‑ 176 ‑‑ 133 101 94
Marijuana 123 148 113 119 87 88
Cocaine 21 26 18 19 5 4
Crack 13 11 4 9 <1 *
Heroin 10 4 6 <1 1 <1
Hallucinogens 52 64 43 49 28 23
LSD 33 36 24 26 7 9
Psilocybin 46 60 37 41 17 22
Ecstasy 24 33 16 21 5 12
Inhalants3 ‑‑ 76 ‑‑ 41 ‑‑ 26
Methamphetamine 28 23 24 16 22 12
Misuse of Prescription Psychotherapeutics nr nr 54 56 26 28
Pain Relievers nr nr 44 50 20 25
Prescription Opioids ‑‑ ‑‑ 39 49 19 25
Stimulants nr nr 31 34 11 17
Tranquilizers or Sedatives nr nr 26 30 13 12
Tranquilizers nr nr 23 29 11 12
Sedatives nr nr 17 10 6 5
Benzodiazepines ‑‑ ‑‑ 20 29 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 39 49 19 25
Misuse of Central Nervous System Stimulants nr nr 41 36 26 17
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 77 ‑‑ 40
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 42 51 23 26
Illegally Made Fentanyl 17 16 15 15 13 9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.2D – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Standard Errors of Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 ‑‑ 0.58 ‑‑ 0.46 0.37 0.34
Marijuana 0.45 0.51 0.41 0.42 0.32 0.32
Cocaine 0.08 0.10 0.07 0.07 0.02 0.02
Crack 0.05 0.04 0.02 0.03 <0.01 *
Heroin 0.04 0.02 0.02 <0.01 <0.01 <0.01
Hallucinogens 0.20 0.24 0.16 0.19 0.11 0.09
LSD 0.13 0.14 0.09 0.10 0.03 0.03
Psilocybin 0.18 0.23 0.14 0.16 0.07 0.09
Ecstasy 0.09 0.13 0.06 0.08 0.02 0.05
Inhalants3 ‑‑ 0.29 ‑‑ 0.16 ‑‑ 0.10
Methamphetamine 0.11 0.09 0.09 0.06 0.09 0.05
Misuse of Prescription Psychotherapeutics nr nr 0.20 0.22 0.10 0.11
Pain Relievers nr nr 0.17 0.19 0.08 0.10
Prescription Opioids ‑‑ ‑‑ 0.15 0.19 0.07 0.10
Stimulants nr nr 0.12 0.13 0.04 0.07
Tranquilizers or Sedatives nr nr 0.10 0.12 0.05 0.05
Tranquilizers nr nr 0.09 0.11 0.04 0.05
Sedatives nr nr 0.07 0.04 0.02 0.02
Benzodiazepines ‑‑ ‑‑ 0.08 0.11 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 0.15 0.19 0.07 0.10
Misuse of Central Nervous System Stimulants nr nr 0.16 0.14 0.10 0.07
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 0.29 ‑‑ 0.15
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 0.16 0.20 0.09 0.10
Illegally Made Fentanyl 0.06 0.06 0.06 0.06 0.05 0.04

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.2P – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 ‑‑   ‑‑   0.0008  
Marijuana 0.0271   0.0056   0.0350  
Cocaine 0.9933   0.5909   0.3838  
Crack 0.6480   0.8576   *  
Heroin 0.1465   0.0990   0.2573  
Hallucinogens 0.9074   0.5550   0.5933  
LSD 0.5409   0.6857   0.8231  
Psilocybin 0.7705   0.4586   0.6744  
Ecstasy 0.5719   0.6137   0.5129  
Inhalants3 ‑‑   ‑‑   ‑‑  
Methamphetamine 0.3525   0.4159   0.4492  
Misuse of Prescription Psychotherapeutics nr   0.6317   0.5912  
Pain Relievers nr   0.9536   0.9612  
Prescription Opioids ‑‑   0.8057   0.9766  
Stimulants nr   0.7089   0.3918  
Tranquilizers or Sedatives nr   0.4910   0.6536  
Tranquilizers nr   0.9125   0.8247  
Sedatives nr   0.1060   0.7776  
Benzodiazepines ‑‑   0.6280   ‑‑  
Misuse of Opioids2 ‑‑   0.8659   0.9886  
Misuse of Central Nervous System Stimulants nr   0.3865   0.4175  
Illicit Drugs Other Than Marijuana2,3,4 nr   ‑‑   ‑‑  
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑   0.9057   0.7760  
Illegally Made Fentanyl 0.5536   0.8874   0.7202  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.3C – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Standard Errors of Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 2,129 2,327 1,320 1,347 1,018 1,049
Marijuana 2,047 2,250 1,231 1,243 957 994
Cocaine 1,015 1,067 225 301 152 186
Crack 480 512 118 134 93 82
Heroin 333 369 86 97 68 88
Hallucinogens 1,106 1,201 406 383 179 192
LSD 832 909 140 133 58 52
Psilocybin 890 957 341 325 148 159
Ecstasy 617 665 135 152 69 63
Inhalants3 ‑‑ 718 ‑‑ 192 ‑‑ 121
Methamphetamine 556 580 183 236 150 183
Misuse of Prescription Psychotherapeutics nr nr 432 483 259 257
Pain Relievers nr nr 332 351 189 183
Prescription Opioids ‑‑ ‑‑ 317 337 184 166
Stimulants nr nr 211 217 118 123
Tranquilizers or Sedatives nr nr 248 293 146 154
Tranquilizers nr nr 220 256 132 140
Sedatives nr nr 126 170 61 78
Benzodiazepines ‑‑ ‑‑ 207 248 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 324 340 192 178
Misuse of Central Nervous System Stimulants nr nr 341 423 225 281
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 705 ‑‑ 409
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 328 350 199 180
Illegally Made Fentanyl 161 168 88 129 73 97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.3D – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Standard Errors of Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.42 0.48 0.38 0.38 0.32 0.33
Marijuana 0.42 0.48 0.36 0.36 0.30 0.32
Cocaine 0.33 0.32 0.08 0.11 0.06 0.07
Crack 0.17 0.18 0.04 0.05 0.04 0.03
Heroin 0.12 0.13 0.03 0.04 0.03 0.03
Hallucinogens 0.34 0.35 0.15 0.14 0.07 0.07
LSD 0.28 0.29 0.05 0.05 0.02 0.02
Psilocybin 0.28 0.30 0.12 0.12 0.06 0.06
Ecstasy 0.21 0.22 0.05 0.06 0.03 0.02
Inhalants3 ‑‑ 0.24 ‑‑ 0.07 ‑‑ 0.05
Methamphetamine 0.20 0.20 0.07 0.09 0.06 0.07
Misuse of Prescription Psychotherapeutics nr nr 0.16 0.17 0.10 0.09
Pain Relievers nr nr 0.12 0.13 0.07 0.07
Prescription Opioids ‑‑ ‑‑ 0.12 0.12 0.07 0.06
Stimulants nr nr 0.08 0.08 0.04 0.05
Tranquilizers or Sedatives nr nr 0.09 0.11 0.06 0.06
Tranquilizers nr nr 0.08 0.09 0.05 0.05
Sedatives nr nr 0.05 0.06 0.02 0.03
Benzodiazepines ‑‑ ‑‑ 0.08 0.09 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 0.12 0.12 0.07 0.07
Misuse of Central Nervous System Stimulants nr nr 0.12 0.15 0.08 0.10
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 0.24 ‑‑ 0.15
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 0.12 0.13 0.07 0.07
Illegally Made Fentanyl 0.06 0.06 0.03 0.05 0.03 0.04

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.3P – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.0234   0.0141   0.5636  
Marijuana 0.3197   0.0422   0.5624  
Cocaine 0.0966   0.0771   0.1974  
Crack 0.3331   0.2017   0.6236  
Heroin 0.7871   0.8250   0.1738  
Hallucinogens 0.3108   0.0118   0.7948  
LSD 0.0518   0.2555   0.7496  
Psilocybin 0.1637   0.0020   0.4567  
Ecstasy 0.9543   0.6566   0.4827  
Inhalants3 ‑‑   ‑‑   ‑‑  
Methamphetamine 0.8510   0.3636   0.1503  
Misuse of Prescription Psychotherapeutics nr   0.0754   0.1478  
Pain Relievers nr   0.0558   0.4894  
Prescription Opioids ‑‑   0.0869   0.5339  
Stimulants nr   0.9689   0.9706  
Tranquilizers or Sedatives nr   0.3480   0.1583  
Tranquilizers nr   0.5556   0.1263  
Sedatives nr   0.7047   0.5987  
Benzodiazepines ‑‑   0.7141   ‑‑  
Misuse of Opioids2 ‑‑   0.0810   0.7451  
Misuse of Central Nervous System Stimulants nr   0.4261   0.1460  
Illicit Drugs Other Than Marijuana2,3,4 nr   ‑‑   ‑‑  
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑   0.0945   0.5234  
Illegally Made Fentanyl 0.1923   0.5316   0.9135  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.4C – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Standard Errors of Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 447 499 357 420 272 312
Marijuana 417 486 338 400 264 305
Cocaine 116 138 64 92 33 55
Crack 25 32 15 9 6 4
Heroin 27 39 14 2 5 2
Hallucinogens 205 218 120 145 51 71
LSD 144 145 47 70 15 21
Psilocybin 176 206 109 118 42 59
Ecstasy 109 118 49 68 23 20
Inhalants3 ‑‑ 145 ‑‑ 89 ‑‑ 39
Methamphetamine 51 57 29 36 20 25
Misuse of Prescription Psychotherapeutics nr nr 114 118 56 56
Pain Relievers nr nr 86 74 41 39
Prescription Opioids ‑‑ ‑‑ 84 72 39 36
Stimulants nr nr 74 93 31 47
Tranquilizers or Sedatives nr nr 56 63 32 37
Tranquilizers nr nr 54 60 30 36
Sedatives nr nr 19 28 12 6
Benzodiazepines ‑‑ ‑‑ 51 57 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 84 72 39 36
Misuse of Central Nervous System Stimulants nr nr 94 124 46 73
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 196 ‑‑ 102
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 86 73 44 36
Illegally Made Fentanyl 31 31 25 16 22 3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.4D – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Standard Errors of Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.67 0.80 0.65 0.77 0.57 0.66
Marijuana 0.68 0.80 0.64 0.74 0.56 0.66
Cocaine 0.31 0.37 0.18 0.24 0.09 0.15
Crack 0.07 0.09 0.04 0.02 0.02 0.01
Heroin 0.08 0.11 0.04 0.01 0.01 0.01
Hallucinogens 0.51 0.52 0.33 0.37 0.14 0.19
LSD 0.39 0.38 0.13 0.19 0.04 0.06
Psilocybin 0.45 0.50 0.30 0.31 0.12 0.16
Ecstasy 0.30 0.31 0.14 0.19 0.07 0.06
Inhalants3 ‑‑ 0.38 ‑‑ 0.24 ‑‑ 0.11
Methamphetamine 0.15 0.16 0.08 0.10 0.06 0.07
Misuse of Prescription Psychotherapeutics nr nr 0.31 0.30 0.16 0.15
Pain Relievers nr nr 0.24 0.20 0.12 0.11
Prescription Opioids ‑‑ ‑‑ 0.23 0.20 0.11 0.10
Stimulants nr nr 0.21 0.25 0.09 0.13
Tranquilizers or Sedatives nr nr 0.16 0.17 0.09 0.10
Tranquilizers nr nr 0.15 0.17 0.09 0.10
Sedatives nr nr 0.05 0.08 0.03 0.02
Benzodiazepines ‑‑ ‑‑ 0.14 0.16 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 0.23 0.20 0.11 0.10
Misuse of Central Nervous System Stimulants nr nr 0.26 0.32 0.13 0.20
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 0.48 ‑‑ 0.27
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 0.24 0.20 0.12 0.10
Illegally Made Fentanyl 0.09 0.08 0.07 0.04 0.06 0.01

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.4P – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.0017   0.0767   0.2410  
Marijuana 0.2814   0.1919   0.3185  
Cocaine 0.4922   0.3024   0.0539  
Crack 0.5717   0.1616   0.4502  
Heroin 0.8992   0.0014   0.0534  
Hallucinogens 0.0224   0.1265   0.1382  
LSD 0.1031   0.7064   0.7486  
Psilocybin 0.3290   0.0305   0.2540  
Ecstasy 0.3237   0.3013   0.5005  
Inhalants3 ‑‑   ‑‑   ‑‑  
Methamphetamine 0.8906   0.6413   0.9194  
Misuse of Prescription Psychotherapeutics nr   0.2567   0.7817  
Pain Relievers nr   0.0612   0.3709  
Prescription Opioids ‑‑   0.0788   0.3912  
Stimulants nr   0.8142   0.4519  
Tranquilizers or Sedatives nr   0.9293   0.7551  
Tranquilizers nr   0.7673   0.9339  
Sedatives nr   0.2443   0.0939  
Benzodiazepines ‑‑   0.6618   ‑‑  
Misuse of Opioids2 ‑‑   0.0468   0.3543  
Misuse of Central Nervous System Stimulants nr   0.8959   0.1030  
Illicit Drugs Other Than Marijuana2,3,4 nr   ‑‑   ‑‑  
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑   0.0217   0.1229  
Illegally Made Fentanyl 0.3284   0.1360   0.0123  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.5C – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Standard Errors of Numbers in Thousands, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 1,970 2,177 1,203 1,218 937 957
Marijuana 1,902 2,110 1,123 1,118 879 905
Cocaine 994 1,035 212 269 148 177
Crack 479 510 117 132 93 82
Heroin 331 368 86 97 68 88
Hallucinogens 1,066 1,143 389 344 170 176
LSD 804 872 130 111 57 48
Psilocybin 853 903 323 296 140 144
Ecstasy 598 634 125 127 65 59
Inhalants3 ‑‑ 688 ‑‑ 163 ‑‑ 114
Methamphetamine 551 570 180 234 148 181
Misuse of Prescription Psychotherapeutics nr nr 410 461 251 249
Pain Relievers nr nr 316 338 185 176
Prescription Opioids ‑‑ ‑‑ 301 327 180 161
Stimulants nr nr 197 186 112 112
Tranquilizers or Sedatives nr nr 239 287 143 150
Tranquilizers nr nr 211 250 129 135
Sedatives nr nr 124 168 60 78
Benzodiazepines ‑‑ ‑‑ 198 242 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 307 329 188 173
Misuse of Central Nervous System Stimulants nr nr 327 386 219 269
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 658 ‑‑ 395
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 311 341 194 176
Illegally Made Fentanyl 157 165 84 127 70 97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.5D – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Standard Errors of Percentages, 2024 and 2025
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.47 0.52 0.42 0.41 0.35 0.35
Marijuana 0.46 0.53 0.40 0.39 0.33 0.34
Cocaine 0.37 0.36 0.09 0.12 0.06 0.08
Crack 0.20 0.21 0.05 0.06 0.04 0.04
Heroin 0.14 0.16 0.04 0.04 0.03 0.04
Hallucinogens 0.37 0.39 0.16 0.14 0.07 0.08
LSD 0.30 0.32 0.06 0.05 0.02 0.02
Psilocybin 0.31 0.33 0.14 0.13 0.06 0.06
Ecstasy 0.24 0.25 0.05 0.05 0.03 0.03
Inhalants3 ‑‑ 0.27 ‑‑ 0.07 ‑‑ 0.05
Methamphetamine 0.23 0.23 0.08 0.10 0.06 0.08
Misuse of Prescription Psychotherapeutics nr nr 0.17 0.19 0.11 0.11
Pain Relievers nr nr 0.14 0.14 0.08 0.08
Prescription Opioids ‑‑ ‑‑ 0.13 0.14 0.08 0.07
Stimulants nr nr 0.08 0.08 0.05 0.05
Tranquilizers or Sedatives nr nr 0.10 0.12 0.06 0.06
Tranquilizers nr nr 0.09 0.11 0.06 0.06
Sedatives nr nr 0.05 0.07 0.03 0.03
Benzodiazepines ‑‑ ‑‑ 0.09 0.10 ‑‑ ‑‑
Misuse of Opioids2 ‑‑ ‑‑ 0.13 0.14 0.08 0.07
Misuse of Central Nervous System Stimulants nr nr 0.14 0.16 0.09 0.12
Illicit Drugs Other Than Marijuana2,3,4 nr nr ‑‑ 0.26 ‑‑ 0.17
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑ ‑‑ 0.13 0.14 0.08 0.08
Illegally Made Fentanyl 0.07 0.07 0.04 0.06 0.03 0.04

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.5P – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
ILLICIT DRUGS1,2 0.0995   0.0274   0.7242  
Marijuana 0.4342   0.0595   0.6930  
Cocaine 0.1216   0.1156   0.4199  
Crack 0.3368   0.1494   0.5859  
Heroin 0.8239   0.5575   0.1432  
Hallucinogens 0.5809   0.0281   0.4077  
LSD 0.0909   0.1356   0.8294  
Psilocybin 0.2187   0.0101   0.2183  
Ecstasy 0.7716   0.3079   0.6087  
Inhalants3 ‑‑   ‑‑   ‑‑  
Methamphetamine 0.9027   0.3150   0.1461  
Misuse of Prescription Psychotherapeutics nr   0.1169   0.1527  
Pain Relievers nr   0.1284   0.6100  
Prescription Opioids ‑‑   0.1835   0.6556  
Stimulants nr   0.9895   0.7516  
Tranquilizers or Sedatives nr   0.3461   0.1699  
Tranquilizers nr   0.5910   0.1108  
Sedatives nr   0.8428   0.4416  
Benzodiazepines ‑‑   0.7855   ‑‑  
Misuse of Opioids2 ‑‑   0.1894   0.8930  
Misuse of Central Nervous System Stimulants nr   0.3887   0.2721  
Illicit Drugs Other Than Marijuana2,3,4 nr   ‑‑   ‑‑  
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL ‑‑   0.2457   0.7543  
Illegally Made Fentanyl 0.2567   0.3518   0.7096  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

2 Does not include illegally made fentanyl (IMF).

3 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

4 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.6C – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 2,189 2,366 1,352 1,367 1,040 1,058
12‑20 ‑‑ 322 ‑‑ 270 168 190
21 or Older 2,079 2,280 1,286 1,304 991 1,025
12‑17 ‑‑ 176 ‑‑ 133 101 94
12‑13 ‑‑ 68 ‑‑ 48 30 37
14‑15 ‑‑ 85 ‑‑ 70 46 48
16‑17 ‑‑ 120 ‑‑ 98 78 71
18 or Older 2,129 2,327 1,320 1,347 1,018 1,049
18‑25 447 499 357 420 272 312
18‑20 187 257 161 230 129 165
21‑25 352 373 283 304 218 237
26 or Older 1,970 2,177 1,203 1,218 937 957
26‑49 1,153 1,205 800 832 612 655
26‑29 360 381 296 293 235 243
30‑34 428 532 308 380 232 285
35‑39 431 417 317 309 271 258
40‑44 377 432 274 328 224 268
45‑49 360 393 239 269 191 230
50 or Older 1,391 1,570 750 802 591 649
50‑54 542 569 350 405 282 335
55‑59 563 577 328 363 285 302
60‑64 560 576 307 335 248 281
65 or Older 827 973 419 461 295 353

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.6D – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.40 0.44 0.35 0.35 0.29 0.30
12‑20 ‑‑ 0.59 ‑‑ 0.54 0.39 0.41
21 or Older 0.44 0.49 0.40 0.39 0.33 0.34
12‑17 ‑‑ 0.58 ‑‑ 0.46 0.37 0.34
12‑13 ‑‑ 0.78 ‑‑ 0.59 0.37 0.46
14‑15 ‑‑ 0.89 ‑‑ 0.76 0.52 0.52
16‑17 ‑‑ 1.11 ‑‑ 0.94 0.78 0.74
18 or Older 0.42 0.48 0.38 0.38 0.32 0.33
18‑25 0.67 0.80 0.65 0.77 0.57 0.66
18‑20 1.09 1.19 1.00 1.17 0.88 0.94
21‑25 0.78 0.95 0.84 0.94 0.73 0.81
26 or Older 0.47 0.52 0.42 0.41 0.35 0.35
26‑49 0.60 0.61 0.55 0.57 0.45 0.49
26‑29 1.19 1.24 1.20 1.32 1.07 1.18
30‑34 1.05 1.16 0.98 1.12 0.81 0.94
35‑39 1.15 1.22 1.08 1.09 1.00 0.98
40‑44 1.19 1.24 1.04 1.26 0.90 1.09
45‑49 1.18 1.23 1.03 1.12 0.90 1.01
50 or Older 0.67 0.76 0.53 0.55 0.44 0.47
50‑54 1.81 2.02 1.52 1.87 1.31 1.63
55‑59 1.73 1.89 1.52 1.62 1.36 1.41
60‑64 1.54 1.73 1.20 1.33 1.00 1.13
65 or Older 0.89 0.98 0.64 0.67 0.47 0.53

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.6P – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.0012   0.0022   0.3837  
12‑20 ‑‑   ‑‑   0.0903  
21 or Older 0.0622   0.0145   0.5774  
12‑17 ‑‑   ‑‑   0.0008  
12‑13 ‑‑   ‑‑   0.3666  
14‑15 ‑‑   ‑‑   0.1779  
16‑17 ‑‑   ‑‑   0.0012  
18 or Older 0.0234   0.0141   0.5636  
18‑25 0.0017   0.0767   0.2410  
18‑20 0.0039   0.4902   0.6663  
21‑25 0.1130   0.1248   0.3361  
26 or Older 0.0995   0.0274   0.7242  
26‑49 0.4300   0.1086   0.6955  
26‑29 0.9318   0.0096   0.1636  
30‑34 0.5644   0.5931   0.1880  
35‑39 0.1727   0.1876   0.0732  
40‑44 0.6346   0.9175   0.6255  
45‑49 0.1124   0.4127   0.4974  
50 or Older 0.1451   0.1244   0.9917  
50‑54 0.8567   0.1869   0.0278  
55‑59 0.0679   0.0837   0.2879  
60‑64 0.1226   0.3016   0.7759  
65 or Older 0.9894   0.2952   0.7403  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.7C – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 2,079 2,280 1,257 1,256 976 1,000
12‑20 220 296 194 249 153 183
21 or Older 2,004 2,208 1,200 1,203 930 969
12‑17 123 148 113 119 87 88
12‑13 29 40 27 34 20 30
14‑15 61 72 54 60 41 44
16‑17 102 108 93 94 71 69
18 or Older 2,047 2,250 1,231 1,243 957 994
18‑25 417 486 338 400 264 305
18‑20 174 244 153 213 124 160
21‑25 331 365 267 290 213 233
26 or Older 1,902 2,110 1,123 1,118 879 905
26‑49 1,084 1,167 740 793 580 622
26‑29 348 374 285 285 228 239
30‑34 398 524 281 349 222 258
35‑39 411 400 296 290 263 246
40‑44 368 422 255 325 212 262
45‑49 345 380 222 258 178 222
50 or Older 1,364 1,517 696 700 566 613
50‑54 528 547 333 361 277 308
55‑59 538 564 313 311 270 278
60‑64 556 562 290 318 244 273
65 or Older 811 942 365 424 276 349

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.7D – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.40 0.44 0.34 0.33 0.28 0.29
12‑20 0.50 0.57 0.45 0.51 0.36 0.40
21 or Older 0.44 0.49 0.38 0.38 0.31 0.32
12‑17 0.45 0.51 0.41 0.42 0.32 0.32
12‑13 0.36 0.50 0.34 0.43 0.25 0.37
14‑15 0.68 0.77 0.61 0.66 0.46 0.48
16‑17 0.98 1.01 0.90 0.92 0.73 0.72
18 or Older 0.42 0.48 0.36 0.36 0.30 0.32
18‑25 0.68 0.80 0.64 0.74 0.56 0.66
18‑20 1.07 1.16 0.99 1.11 0.86 0.92
21‑25 0.79 0.96 0.81 0.89 0.73 0.81
26 or Older 0.46 0.53 0.40 0.39 0.33 0.34
26‑49 0.57 0.62 0.53 0.57 0.44 0.47
26‑29 1.19 1.25 1.19 1.33 1.06 1.16
30‑34 1.04 1.22 0.93 1.09 0.78 0.90
35‑39 1.12 1.19 1.05 1.06 0.98 0.94
40‑44 1.18 1.25 1.00 1.27 0.86 1.07
45‑49 1.18 1.26 0.98 1.10 0.85 0.97
50 or Older 0.68 0.76 0.49 0.50 0.42 0.46
50‑54 1.80 1.99 1.47 1.73 1.29 1.52
55‑59 1.74 1.92 1.48 1.44 1.30 1.32
60‑64 1.56 1.77 1.16 1.28 0.99 1.11
65 or Older 0.90 0.98 0.56 0.62 0.44 0.52

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.7P – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.3000   0.0242   0.4677  
12‑20 0.3263   0.2836   0.4840  
21 or Older 0.4050   0.0376   0.5524  
12‑17 0.0271   0.0056   0.0350  
12‑13 0.4994   0.8838   0.7168  
14‑15 0.6209   0.7449   0.7364  
16‑17 0.0020   0.0005   0.0070  
18 or Older 0.3197   0.0422   0.5624  
18‑25 0.2814   0.1919   0.3185  
18‑20 0.4476   0.7725   0.8203  
21‑25 0.6790   0.2130   0.3707  
26 or Older 0.4342   0.0595   0.6930  
26‑49 0.7148   0.2839   0.7233  
26‑29 0.5749   0.0345   0.2196  
30‑34 0.1629   0.5440   0.2586  
35‑39 0.2024   0.1112   0.0528  
40‑44 0.3959   0.4322   0.5116  
45‑49 0.5924   0.6873   0.3921  
50 or Older 0.2407   0.1142   0.9378  
50‑54 0.8489   0.3511   0.1102  
55‑59 0.1531   0.0285   0.2247  
60‑64 0.1603   0.5434   0.9625  
65 or Older 0.9216   0.4542   0.9751  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.8C – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 1,014 1,069 225 300 152 186
12‑20 42 47 34 36 15 21
21 or Older 1,012 1,065 222 299 151 185
12‑17 21 26 18 19 5 4
12‑13 6 9 5 9 1 <1
14‑15 14 8 12 4 1 1
16‑17 16 23 12 16 5 4
18 or Older 1,015 1,067 225 301 152 186
18‑25 116 138 64 92 33 55
18‑20 36 39 28 31 14 21
21‑25 107 132 58 87 30 51
26 or Older 994 1,035 212 269 148 177
26‑49 558 561 168 204 100 119
26‑29 186 185 85 84 44 47
30‑34 195 236 77 102 40 68
35‑39 243 239 74 93 47 49
40‑44 215 208 64 80 38 56
45‑49 199 216 67 61 49 42
50 or Older 761 807 120 167 103 123
50‑54 293 304 67 74 55 27
55‑59 320 325 75 98 73 93
60‑64 377 387 46 95 26 67
65 or Older 435 497 44 62 38 33

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.8D – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.30 0.30 0.08 0.10 0.05 0.06
12‑20 0.11 0.12 0.09 0.09 0.04 0.05
21 or Older 0.34 0.33 0.09 0.12 0.06 0.07
12‑17 0.08 0.10 0.07 0.07 0.02 0.02
12‑13 0.07 0.11 0.06 0.11 0.01 <0.01
14‑15 0.16 0.10 0.14 0.05 0.01 0.01
16‑17 0.18 0.26 0.14 0.18 0.05 0.05
18 or Older 0.33 0.32 0.08 0.11 0.06 0.07
18‑25 0.31 0.37 0.18 0.24 0.09 0.15
18‑20 0.28 0.29 0.22 0.22 0.11 0.15
21‑25 0.45 0.55 0.26 0.37 0.13 0.23
26 or Older 0.37 0.36 0.09 0.12 0.06 0.08
26‑49 0.45 0.44 0.15 0.19 0.09 0.11
26‑29 0.92 1.01 0.47 0.48 0.25 0.27
30‑34 0.71 0.82 0.32 0.41 0.17 0.29
35‑39 0.92 0.93 0.31 0.40 0.20 0.22
40‑44 0.88 0.85 0.28 0.36 0.17 0.25
45‑49 0.93 0.94 0.34 0.30 0.25 0.21
50 or Older 0.54 0.53 0.10 0.13 0.08 0.10
50‑54 1.34 1.48 0.34 0.40 0.28 0.15
55‑59 1.42 1.46 0.38 0.49 0.37 0.47
60‑64 1.35 1.47 0.21 0.42 0.11 0.30
65 or Older 0.67 0.70 0.07 0.10 0.06 0.05

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.8P – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.1196   0.0790   0.1989  
12‑20 0.9298   0.5766   0.5536  
21 or Older 0.1231   0.0631   0.2149  
12‑17 0.9933   0.5909   0.3838  
12‑13 0.8411   0.7190   0.3704  
14‑15 0.4385   0.1885   0.6929  
16‑17 0.7237   0.9490   0.3764  
18 or Older 0.0966   0.0771   0.1974  
18‑25 0.4922   0.3024   0.0539  
18‑20 0.8163   0.5650   0.4843  
21‑25 0.7258   0.1367   0.0608  
26 or Older 0.1216   0.1156   0.4199  
26‑49 0.3957   0.1735   0.1534  
26‑29 0.4208   0.4710   0.7186  
30‑34 0.1420   0.0606   0.1199  
35‑39 0.2679   0.4269   0.9950  
40‑44 0.1621   0.1898   0.1337  
45‑49 0.9071   0.8390   0.7582  
50 or Older 0.1828   0.3058   0.8711  
50‑54 0.2760   0.6024   0.0938  
55‑59 0.0429   0.6355   0.8892  
60‑64 0.0217   0.0945   0.1786  
65 or Older 0.6514   0.5287   0.5557  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.9C – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 480 512 118 134 93 82
12‑20 17 14 9 11 1 1
21 or Older 480 512 118 133 93 82
12‑17 13 11 4 9 <1 *
12‑13 1 9 1 9 <1 *
14‑15 11 1 4 * * *
16‑17 7 6 <1 <1 * *
18 or Older 480 512 118 134 93 82
18‑25 25 32 15 9 6 4
18‑20 11 9 8 6 1 1
21‑25 22 31 13 7 6 4
26 or Older 479 510 117 132 93 82
26‑49 226 230 60 82 48 53
26‑29 57 49 11 11 3 9
30‑34 70 92 22 44 7 30
35‑39 108 110 20 36 11 23
40‑44 105 116 24 42 16 14
45‑49 126 112 46 37 43 32
50 or Older 411 427 86 98 73 62
50‑54 210 194 36 43 35 22
55‑59 207 174 59 39 58 37
60‑64 224 227 46 68 26 45
65 or Older 174 231 21 40 9 4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.9D – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.16 0.17 0.04 0.05 0.03 0.03
12‑20 0.04 0.04 0.02 0.03 <0.01 <0.01
21 or Older 0.18 0.19 0.05 0.05 0.04 0.03
12‑17 0.05 0.04 0.02 0.03 <0.01 *
12‑13 0.01 0.11 0.01 0.11 <0.01 *
14‑15 0.13 0.01 0.05 * * *
16‑17 0.08 0.07 <0.01 <0.01 * *
18 or Older 0.17 0.18 0.04 0.05 0.04 0.03
18‑25 0.07 0.09 0.04 0.02 0.02 0.01
18‑20 0.09 0.07 0.06 0.04 <0.01 <0.01
21‑25 0.10 0.14 0.06 0.03 0.03 0.02
26 or Older 0.20 0.21 0.05 0.06 0.04 0.04
26‑49 0.20 0.21 0.06 0.08 0.05 0.05
26‑29 0.32 0.28 0.06 0.06 0.02 0.05
30‑34 0.29 0.38 0.09 0.19 0.03 0.13
35‑39 0.45 0.47 0.09 0.16 0.05 0.10
40‑44 0.46 0.51 0.11 0.19 0.07 0.06
45‑49 0.64 0.54 0.24 0.18 0.22 0.16
50 or Older 0.33 0.33 0.07 0.08 0.06 0.05
50‑54 1.02 1.02 0.18 0.24 0.18 0.12
55‑59 1.01 0.85 0.30 0.20 0.30 0.19
60‑64 0.94 0.96 0.21 0.30 0.11 0.20
65 or Older 0.29 0.36 0.04 0.06 0.02 0.01

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.9P – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.3482   0.1947   0.6183  
12‑20 0.4152   0.7091   0.5283  
21 or Older 0.3742   0.1817   0.6114  
12‑17 0.6480   0.8576   *  
12‑13 0.3593   0.3593   *  
14‑15 0.1577   *   *  
16‑17 0.9729   0.4857   *  
18 or Older 0.3331   0.2017   0.6236  
18‑25 0.5717   0.1616   0.4502  
18‑20 0.4224   0.4594   0.6500  
21‑25 0.3217   0.2380   0.5034  
26 or Older 0.3368   0.1494   0.5859  
26‑49 0.2327   0.0233   0.0553  
26‑29 0.2431   0.7706   0.3324  
30‑34 0.8180   0.0494   0.0607  
35‑39 0.5170   0.0809   0.0840  
40‑44 0.9589   0.3330   0.6389  
45‑49 0.3139   0.9138   0.8346  
50 or Older 0.6189   0.8402   0.4703  
50‑54 0.3181   0.8810   0.4187  
55‑59 0.1031   0.3975   0.4392  
60‑64 0.4113   0.4351   0.5636  
65 or Older 0.4671   0.6335   0.4504  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.10C – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 1,109 1,210 409 386 181 191
12‑20 98 122 71 93 36 58
21 or Older 1,096 1,198 405 375 178 186
12‑17 52 64 43 49 28 23
12‑13 14 17 9 9 4 6
14‑15 28 25 21 18 13 13
16‑17 42 55 36 42 24 18
18 or Older 1,106 1,201 406 383 179 192
18‑25 205 218 120 145 51 71
18‑20 83 102 55 79 24 54
21‑25 177 183 105 113 46 47
26 or Older 1,066 1,143 389 344 170 176
26‑49 675 686 319 297 149 161
26‑29 229 212 155 123 66 50
30‑34 242 338 122 138 63 90
35‑39 277 257 131 122 75 70
40‑44 247 268 115 107 64 61
45‑49 241 255 107 102 54 59
50 or Older 758 843 204 168 84 69
50‑54 332 361 161 121 59 36
55‑59 308 325 57 72 44 25
60‑64 353 333 83 63 35 43
65 or Older 400 474 71 63 22 27

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.10D – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.31 0.32 0.13 0.13 0.06 0.06
12‑20 0.25 0.29 0.18 0.23 0.09 0.15
21 or Older 0.35 0.37 0.15 0.14 0.07 0.07
12‑17 0.20 0.24 0.16 0.19 0.11 0.09
12‑13 0.18 0.22 0.11 0.11 0.05 0.07
14‑15 0.32 0.28 0.24 0.21 0.15 0.15
16‑17 0.46 0.58 0.39 0.46 0.26 0.20
18 or Older 0.34 0.35 0.15 0.14 0.07 0.07
18‑25 0.51 0.52 0.33 0.37 0.14 0.19
18‑20 0.62 0.66 0.43 0.53 0.18 0.38
21‑25 0.68 0.70 0.46 0.48 0.20 0.21
26 or Older 0.37 0.39 0.16 0.14 0.07 0.08
26‑49 0.51 0.50 0.28 0.27 0.14 0.15
26‑29 1.04 1.07 0.81 0.68 0.37 0.28
30‑34 0.84 1.08 0.49 0.54 0.26 0.36
35‑39 0.99 0.97 0.54 0.52 0.32 0.30
40‑44 0.98 1.05 0.49 0.48 0.28 0.28
45‑49 1.06 1.08 0.54 0.49 0.28 0.29
50 or Older 0.54 0.57 0.17 0.13 0.07 0.06
50‑54 1.49 1.69 0.79 0.65 0.30 0.20
55‑59 1.42 1.47 0.29 0.37 0.23 0.13
60‑64 1.33 1.33 0.37 0.27 0.16 0.19
65 or Older 0.61 0.67 0.12 0.10 0.04 0.04

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.10P – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.3578   0.0108   0.7496  
12‑20 0.5093   0.6370   0.0859  
21 or Older 0.4162   0.0128   0.4323  
12‑17 0.9074   0.5550   0.5933  
12‑13 0.4929   0.8642   0.6034  
14‑15 0.3153   0.3588   0.8358  
16‑17 0.8817   0.7565   0.3577  
18 or Older 0.3108   0.0118   0.7948  
18‑25 0.0224   0.1265   0.1382  
18‑20 0.1711   0.5721   0.0246  
21‑25 0.0989   0.1671   0.9627  
26 or Older 0.5809   0.0281   0.4077  
26‑49 0.9891   0.0087   0.5195  
26‑29 0.1365   0.0090   0.0311  
30‑34 0.1725   0.4121   0.6794  
35‑39 0.4752   0.0574   0.5485  
40‑44 0.9108   0.3340   0.8120  
45‑49 0.6186   0.7641   0.3044  
50 or Older 0.5374   0.8736   0.6768  
50‑54 0.3415   0.9921   0.3215  
55‑59 0.1337   0.4745   0.6253  
60‑64 0.1189   0.7163   0.8244  
65 or Older 0.4616   0.4928   0.1872  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.11C – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 727 ‑‑ 196 ‑‑ 124
12‑20 ‑‑ 99 ‑‑ 64 ‑‑ 32
21 or Older ‑‑ 714 ‑‑ 184 ‑‑ 120
12‑17 ‑‑ 76 ‑‑ 41 ‑‑ 26
12‑13 ‑‑ 43 ‑‑ 28 ‑‑ 21
14‑15 ‑‑ 38 ‑‑ 24 ‑‑ 13
16‑17 ‑‑ 45 ‑‑ 16 ‑‑ 9
18 or Older ‑‑ 718 ‑‑ 192 ‑‑ 121
18‑25 ‑‑ 145 ‑‑ 89 ‑‑ 39
18‑20 ‑‑ 60 ‑‑ 50 ‑‑ 19
21‑25 ‑‑ 126 ‑‑ 69 ‑‑ 34
26 or Older ‑‑ 688 ‑‑ 163 ‑‑ 114
26‑49 ‑‑ 365 ‑‑ 134 ‑‑ 68
26‑29 ‑‑ 139 ‑‑ 81 ‑‑ 39
30‑34 ‑‑ 145 ‑‑ 66 ‑‑ 37
35‑39 ‑‑ 155 ‑‑ 49 ‑‑ 22
40‑44 ‑‑ 169 ‑‑ 50 ‑‑ 33
45‑49 ‑‑ 158 ‑‑ 26 ‑‑ 13
50 or Older ‑‑ 546 ‑‑ 94 ‑‑ 92
50‑54 ‑‑ 221 ‑‑ 77 ‑‑ 77
55‑59 ‑‑ 232 ‑‑ 38 ‑‑ 32
60‑64 ‑‑ 259 ‑‑ 12 ‑‑ 11
65 or Older ‑‑ 319 ‑‑ 38 ‑‑ 37

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.11D – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 0.22 ‑‑ 0.07 ‑‑ 0.04
12‑20 ‑‑ 0.24 ‑‑ 0.16 ‑‑ 0.08
21 or Older ‑‑ 0.25 ‑‑ 0.07 ‑‑ 0.05
12‑17 ‑‑ 0.29 ‑‑ 0.16 ‑‑ 0.10
12‑13 ‑‑ 0.51 ‑‑ 0.35 ‑‑ 0.27
14‑15 ‑‑ 0.43 ‑‑ 0.27 ‑‑ 0.14
16‑17 ‑‑ 0.50 ‑‑ 0.18 ‑‑ 0.10
18 or Older ‑‑ 0.24 ‑‑ 0.07 ‑‑ 0.05
18‑25 ‑‑ 0.38 ‑‑ 0.24 ‑‑ 0.11
18‑20 ‑‑ 0.42 ‑‑ 0.36 ‑‑ 0.14
21‑25 ‑‑ 0.53 ‑‑ 0.30 ‑‑ 0.15
26 or Older ‑‑ 0.27 ‑‑ 0.07 ‑‑ 0.05
26‑49 ‑‑ 0.31 ‑‑ 0.12 ‑‑ 0.06
26‑29 ‑‑ 0.76 ‑‑ 0.46 ‑‑ 0.22
30‑34 ‑‑ 0.59 ‑‑ 0.28 ‑‑ 0.16
35‑39 ‑‑ 0.63 ‑‑ 0.22 ‑‑ 0.10
40‑44 ‑‑ 0.72 ‑‑ 0.23 ‑‑ 0.15
45‑49 ‑‑ 0.74 ‑‑ 0.13 ‑‑ 0.06
50 or Older ‑‑ 0.41 ‑‑ 0.08 ‑‑ 0.07
50‑54 ‑‑ 1.16 ‑‑ 0.42 ‑‑ 0.42
55‑59 ‑‑ 1.09 ‑‑ 0.19 ‑‑ 0.16
60‑64 ‑‑ 1.06 ‑‑ 0.05 ‑‑ 0.05
65 or Older ‑‑ 0.49 ‑‑ 0.06 ‑‑ 0.06

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.12C – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 556 581 186 236 151 183
12‑20 33 28 27 19 24 15
21 or Older 555 578 183 236 149 183
12‑17 28 23 24 16 22 12
12‑13 9 9 9 9 4 1
14‑15 10 16 6 3 3 *
16‑17 24 13 22 13 22 12
18 or Older 556 580 183 236 150 183
18‑25 51 57 29 36 20 25
18‑20 23 17 10 10 8 8
21‑25 45 54 27 34 18 23
26 or Older 551 570 180 234 148 181
26‑49 313 319 125 136 96 104
26‑29 82 75 42 24 30 13
30‑34 94 109 49 62 31 54
35‑39 145 147 63 79 43 48
40‑44 168 153 49 55 45 44
45‑49 133 168 68 60 53 56
50 or Older 442 453 133 173 99 140
50‑54 152 202 71 122 53 92
55‑59 208 241 77 72 74 61
60‑64 228 220 57 69 24 66
65 or Older 239 235 54 73 24 55

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.12D – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.18 0.18 0.06 0.08 0.05 0.06
12‑20 0.08 0.07 0.07 0.05 0.06 0.04
21 or Older 0.21 0.21 0.07 0.09 0.06 0.07
12‑17 0.11 0.09 0.09 0.06 0.09 0.05
12‑13 0.11 0.12 0.11 0.11 0.05 0.01
14‑15 0.11 0.18 0.06 0.04 0.03 *
16‑17 0.27 0.15 0.24 0.14 0.24 0.14
18 or Older 0.20 0.20 0.07 0.09 0.06 0.07
18‑25 0.15 0.16 0.08 0.10 0.06 0.07
18‑20 0.18 0.12 0.08 0.07 0.06 0.06
21‑25 0.20 0.24 0.12 0.15 0.08 0.10
26 or Older 0.23 0.23 0.08 0.10 0.06 0.08
26‑49 0.28 0.28 0.12 0.13 0.09 0.10
26‑29 0.46 0.43 0.24 0.14 0.17 0.07
30‑34 0.40 0.44 0.21 0.26 0.13 0.23
35‑39 0.59 0.62 0.27 0.34 0.19 0.21
40‑44 0.72 0.67 0.22 0.25 0.20 0.20
45‑49 0.66 0.79 0.35 0.29 0.27 0.27
50 or Older 0.35 0.34 0.11 0.14 0.08 0.11
50‑54 0.76 1.04 0.36 0.67 0.27 0.50
55‑59 1.02 1.17 0.39 0.36 0.38 0.31
60‑64 0.95 0.93 0.25 0.30 0.11 0.29
65 or Older 0.39 0.36 0.09 0.12 0.04 0.09

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.12P – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 0.8570   0.4002   0.1723  
12‑20 0.2169   0.3776   0.5952  
21 or Older 0.9380   0.3391   0.1483  
12‑17 0.3525   0.4159   0.4492  
12‑13 0.7697   0.6815   0.1132  
14‑15 0.7665   0.0715   *  
16‑17 0.3835   0.7988   0.7729  
18 or Older 0.8510   0.3636   0.1503  
18‑25 0.8906   0.6413   0.9194  
18‑20 0.4118   0.7048   0.6925  
21‑25 0.7560   0.7666   0.9916  
26 or Older 0.9027   0.3150   0.1461  
26‑49 0.6038   0.8565   0.6448  
26‑29 0.1081   0.0118   0.0674  
30‑34 0.7384   0.6802   0.1031  
35‑39 0.9920   0.3749   0.7718  
40‑44 0.3399   0.4830   0.2889  
45‑49 0.3337   0.8417   0.3848  
50 or Older 0.8103   0.1257   0.1052  
50‑54 0.0232   0.2627   0.3612  
55‑59 0.9439   0.9468   0.8618  
60‑64 0.5709   0.1092   0.0248  
65 or Older 0.5992   0.4468   0.3082  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.13C – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 1,236 1,300 321 341 184 168
12‑20 177 176 63 66 28 37
21 or Older 1,187 1,262 309 333 182 164
12‑17 120 126 39 49 19 25
12‑13 54 52 18 16 8 5
14‑15 70 69 24 25 12 13
16‑17 74 86 25 38 11 20
18 or Older 1,215 1,271 317 337 184 166
18‑25 183 197 84 72 39 36
18‑20 114 115 47 40 21 27
21‑25 134 149 63 60 32 22
26 or Older 1,158 1,246 301 327 180 161
26‑49 552 562 194 182 90 103
26‑29 176 166 69 60 36 26
30‑34 198 220 66 73 23 32
35‑39 247 228 95 106 46 66
40‑44 250 250 102 79 53 52
45‑49 226 237 83 82 35 39
50 or Older 940 1,039 246 274 153 123
50‑54 355 377 141 137 124 86
55‑59 310 402 113 160 47 54
60‑64 369 405 104 95 57 35
65 or Older 638 695 135 156 57 57

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.13D – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.32 0.35 0.11 0.11 0.06 0.06
12‑20 0.40 0.38 0.16 0.16 0.07 0.09
21 or Older 0.35 0.39 0.12 0.13 0.07 0.06
12‑17 0.42 0.44 0.15 0.19 0.07 0.10
12‑13 0.63 0.64 0.22 0.20 0.10 0.07
14‑15 0.74 0.74 0.28 0.29 0.14 0.15
16‑17 0.75 0.86 0.28 0.42 0.12 0.22
18 or Older 0.34 0.38 0.12 0.12 0.07 0.06
18‑25 0.44 0.45 0.23 0.20 0.11 0.10
18‑20 0.80 0.71 0.36 0.28 0.16 0.20
21‑25 0.51 0.59 0.27 0.27 0.14 0.10
26 or Older 0.39 0.43 0.13 0.14 0.08 0.07
26‑49 0.41 0.44 0.18 0.17 0.08 0.10
26‑29 0.91 0.90 0.39 0.35 0.20 0.15
30‑34 0.74 0.82 0.28 0.31 0.10 0.14
35‑39 0.90 0.87 0.40 0.46 0.20 0.29
40‑44 0.96 1.01 0.44 0.35 0.23 0.24
45‑49 1.00 1.02 0.42 0.40 0.18 0.19
50 or Older 0.61 0.68 0.20 0.21 0.12 0.10
50‑54 1.54 1.82 0.70 0.74 0.62 0.47
55‑59 1.40 1.73 0.56 0.80 0.24 0.28
60‑64 1.36 1.49 0.46 0.42 0.25 0.16
65 or Older 0.83 0.89 0.22 0.25 0.09 0.09

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.13P – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.0271   0.0992   0.5428  
12‑20 0.0475   0.7825   0.5844  
21 or Older 0.0558   0.1040   0.4736  
12‑17 0.0825   0.8057   0.9766  
12‑13 0.1072   0.2400   0.4726  
14‑15 0.0880   0.7048   0.5569  
16‑17 0.9612   0.2190   0.4162  
18 or Older 0.0357   0.0869   0.5339  
18‑25 0.3566   0.0788   0.3912  
18‑20 0.2041   0.4618   0.4961  
21‑25 0.8596   0.0942   0.0788  
26 or Older 0.0550   0.1835   0.6556  
26‑49 0.0003   0.0699   0.9456  
26‑29 0.0397   0.0386   0.2167  
30‑34 0.0774   0.9345   0.4423  
35‑39 0.0325   0.9238   0.6889  
40‑44 0.1597   0.0758   0.7326  
45‑49 0.1929   0.6531   0.8432  
50 or Older 0.7682   0.7877   0.6294  
50‑54 0.5136   0.7718   0.9357  
55‑59 0.4979   0.7071   0.8038  
60‑64 0.9184   0.3406   0.1021  
65 or Older 0.1958   0.7620   0.9364  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.14C – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 523 615 213 221 119 124
12‑20 131 145 51 56 24 27
21 or Older 496 580 208 210 114 122
12‑17 93 110 31 34 11 17
12‑13 37 49 5 12 2 4
14‑15 58 60 13 15 5 2
16‑17 64 71 27 29 10 16
18 or Older 509 594 211 217 118 123
18‑25 167 188 74 93 31 47
18‑20 89 89 40 44 21 20
21‑25 126 153 63 78 22 42
26 or Older 484 552 197 186 112 112
26‑49 340 393 168 165 104 105
26‑29 133 156 72 77 38 44
30‑34 144 176 69 91 51 48
35‑39 151 158 83 63 41 40
40‑44 145 170 60 66 44 51
45‑49 126 144 62 63 45 43
50 or Older 307 359 104 82 50 39
50‑54 168 156 49 50 31 7
55‑59 163 157 80 48 7 37
60‑64 120 169 35 36 26 5
65 or Older 138 213 28 25 28 7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.14D – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.16 0.19 0.07 0.07 0.04 0.04
12‑20 0.32 0.34 0.13 0.14 0.06 0.07
21 or Older 0.18 0.21 0.08 0.08 0.05 0.05
12‑17 0.34 0.41 0.12 0.13 0.04 0.07
12‑13 0.45 0.61 0.06 0.15 0.02 0.05
14‑15 0.63 0.66 0.15 0.17 0.05 0.02
16‑17 0.68 0.75 0.30 0.32 0.11 0.18
18 or Older 0.17 0.21 0.08 0.08 0.04 0.05
18‑25 0.43 0.46 0.21 0.25 0.09 0.13
18‑20 0.66 0.61 0.32 0.31 0.17 0.15
21‑25 0.51 0.62 0.27 0.34 0.10 0.19
26 or Older 0.19 0.23 0.08 0.08 0.05 0.05
26‑49 0.28 0.33 0.15 0.15 0.10 0.10
26‑29 0.71 0.84 0.40 0.43 0.22 0.25
30‑34 0.55 0.68 0.28 0.38 0.22 0.20
35‑39 0.61 0.67 0.35 0.28 0.18 0.18
40‑44 0.62 0.76 0.26 0.30 0.20 0.23
45‑49 0.62 0.65 0.32 0.31 0.23 0.21
50 or Older 0.25 0.28 0.09 0.07 0.04 0.03
50‑54 0.80 0.84 0.25 0.27 0.16 0.04
55‑59 0.81 0.77 0.41 0.25 0.03 0.19
60‑64 0.52 0.74 0.16 0.16 0.12 0.02
65 or Older 0.23 0.33 0.05 0.04 0.05 0.01

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.14P – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.4397   0.9740   0.9385  
12‑20 0.3051   0.9903   0.8386  
21 or Older 0.2814   0.9744   0.9686  
12‑17 0.4879   0.7089   0.3918  
12‑13 0.1079   0.1213   0.6095  
14‑15 0.2705   0.7781   0.3226  
16‑17 0.3567   0.8150   0.2895  
18 or Older 0.5085   0.9689   0.9706  
18‑25 0.9640   0.8142   0.4519  
18‑20 0.0105   0.6154   0.6420  
21‑25 0.0687   0.9199   0.2304  
26 or Older 0.5234   0.9895   0.7516  
26‑49 0.3320   0.6422   0.7554  
26‑29 0.5694   0.3733   0.8567  
30‑34 0.1879   0.2184   0.6246  
35‑39 0.6331   0.7060   0.5425  
40‑44 0.4878   0.3375   0.4491  
45‑49 0.8600   0.8335   0.8175  
50 or Older 0.8973   0.5570   0.1707  
50‑54 0.3810   0.5004   0.2240  
55‑59 0.6863   0.8640   0.3083  
60‑64 0.5805   0.7888   0.0861  
65 or Older 0.2062   0.7957   0.1904  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.15C – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 936 888 251 293 147 155
12‑20 97 88 41 44 21 19
21 or Older 920 881 245 291 145 154
12‑17 68 66 26 30 13 12
12‑13 31 30 7 3 6 *
14‑15 40 37 16 15 3 5
16‑17 39 44 20 26 11 12
18 or Older 928 884 248 293 146 154
18‑25 115 138 56 63 32 37
18‑20 65 59 32 32 16 15
21‑25 97 121 48 54 28 34
26 or Older 909 868 239 287 143 150
26‑49 406 411 143 150 79 74
26‑29 122 136 60 65 31 23
30‑34 156 168 54 66 34 30
35‑39 177 170 63 69 36 39
40‑44 194 219 78 80 48 48
45‑49 177 185 56 72 25 27
50 or Older 761 755 197 239 120 124
50‑54 295 286 66 83 50 8
55‑59 307 275 105 91 54 72
60‑64 295 295 91 55 58 25
65 or Older 479 513 119 197 75 97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.15D – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.26 0.25 0.09 0.10 0.05 0.05
12‑20 0.24 0.21 0.11 0.11 0.05 0.05
21 or Older 0.30 0.29 0.10 0.11 0.06 0.06
12‑17 0.25 0.25 0.10 0.12 0.05 0.05
12‑13 0.37 0.38 0.09 0.03 0.08 *
14‑15 0.45 0.42 0.19 0.17 0.03 0.05
16‑17 0.44 0.48 0.22 0.29 0.12 0.13
18 or Older 0.28 0.27 0.09 0.11 0.06 0.06
18‑25 0.30 0.36 0.16 0.17 0.09 0.10
18‑20 0.49 0.42 0.25 0.23 0.13 0.11
21‑25 0.41 0.51 0.21 0.24 0.12 0.15
26 or Older 0.32 0.31 0.10 0.12 0.06 0.06
26‑49 0.33 0.34 0.13 0.14 0.07 0.07
26‑29 0.64 0.78 0.33 0.37 0.18 0.13
30‑34 0.61 0.66 0.22 0.27 0.15 0.13
35‑39 0.71 0.71 0.27 0.30 0.16 0.17
40‑44 0.79 0.89 0.34 0.36 0.21 0.22
45‑49 0.85 0.84 0.29 0.35 0.13 0.13
50 or Older 0.52 0.51 0.16 0.19 0.10 0.10
50‑54 1.36 1.43 0.34 0.45 0.25 0.04
55‑59 1.36 1.32 0.53 0.46 0.27 0.37
60‑64 1.16 1.19 0.40 0.24 0.26 0.11
65 or Older 0.69 0.68 0.20 0.31 0.13 0.15

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.15P – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.0019   0.3236   0.1523  
12‑20 0.0382   0.4218   0.3090  
21 or Older 0.0044   0.3883   0.1936  
12‑17 0.2452   0.4910   0.6536  
12‑13 0.5462   0.0409   *  
14‑15 0.2097   0.5709   0.3878  
16‑17 0.8137   0.9940   0.8991  
18 or Older 0.0020   0.3480   0.1583  
18‑25 0.5706   0.9293   0.7551  
18‑20 0.0426   0.5503   0.3182  
21‑25 0.5096   0.7352   0.8385  
26 or Older 0.0027   0.3461   0.1699  
26‑49 0.0933   0.8978   0.2691  
26‑29 0.3688   0.3309   0.1197  
30‑34 0.7463   0.5730   0.7580  
35‑39 0.1207   0.6467   0.8320  
40‑44 0.8145   0.9258   0.7930  
45‑49 0.1353   0.4558   0.7213  
50 or Older 0.0110   0.3102   0.3492  
50‑54 0.3119   0.9041   0.0526  
55‑59 0.2194   0.2082   0.7460  
60‑64 0.0130   0.1150   0.1106  
65 or Older 0.4293   0.9250   0.9681  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.16C – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 763 759 223 256 132 141
12‑20 73 74 38 43 17 19
21 or Older 754 755 217 254 131 139
12‑17 46 56 23 29 11 12
12‑13 19 19 5 2 5 *
14‑15 27 33 14 14 2 3
16‑17 30 38 18 25 10 11
18 or Older 757 756 220 256 132 140
18‑25 100 116 54 60 30 36
18‑20 55 48 30 31 13 15
21‑25 86 103 46 51 27 34
26 or Older 747 746 211 250 129 135
26‑49 370 371 137 145 73 70
26‑29 111 124 58 61 28 11
30‑34 145 158 51 65 32 29
35‑39 157 146 58 58 33 38
40‑44 178 205 73 79 46 48
45‑49 164 172 55 72 25 23
50 or Older 625 652 160 197 108 108
50‑54 270 259 55 83 47 8
55‑59 270 248 91 91 25 69
60‑64 252 269 57 46 58 9
65 or Older 403 425 102 146 74 83

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.16D – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.22 0.23 0.08 0.09 0.05 0.05
12‑20 0.18 0.18 0.10 0.11 0.04 0.05
21 or Older 0.25 0.26 0.09 0.10 0.05 0.06
12‑17 0.18 0.22 0.09 0.11 0.04 0.05
12‑13 0.23 0.24 0.06 0.03 0.06 *
14‑15 0.30 0.37 0.16 0.16 0.03 0.04
16‑17 0.33 0.42 0.20 0.28 0.11 0.13
18 or Older 0.24 0.25 0.08 0.09 0.05 0.05
18‑25 0.27 0.31 0.15 0.17 0.09 0.10
18‑20 0.43 0.34 0.24 0.22 0.10 0.11
21‑25 0.37 0.44 0.20 0.23 0.12 0.15
26 or Older 0.27 0.28 0.09 0.11 0.06 0.06
26‑49 0.31 0.31 0.13 0.13 0.07 0.07
26‑29 0.59 0.72 0.32 0.35 0.16 0.07
30‑34 0.57 0.63 0.21 0.27 0.13 0.13
35‑39 0.64 0.62 0.25 0.25 0.14 0.17
40‑44 0.74 0.85 0.32 0.36 0.20 0.22
45‑49 0.81 0.80 0.28 0.35 0.13 0.11
50 or Older 0.44 0.47 0.13 0.16 0.09 0.09
50‑54 1.26 1.32 0.28 0.45 0.24 0.04
55‑59 1.25 1.21 0.47 0.46 0.13 0.35
60‑64 1.03 1.10 0.25 0.20 0.26 0.04
65 or Older 0.60 0.60 0.17 0.23 0.12 0.13

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.16P – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.0019   0.5620   0.1257  
12‑20 0.2544   0.8239   0.7155  
21 or Older 0.0030   0.5886   0.1368  
12‑17 0.8093   0.9125   0.8247  
12‑13 0.6263   0.2764   *  
14‑15 0.8080   0.8056   0.7546  
16‑17 0.6993   0.8462   0.9629  
18 or Older 0.0013   0.5556   0.1263  
18‑25 0.1862   0.7673   0.9339  
18‑20 0.0343   0.7263   0.7313  
21‑25 0.8499   0.9479   0.7704  
26 or Older 0.0028   0.5910   0.1108  
26‑49 0.0980   0.9794   0.3051  
26‑29 0.1601   0.2585   0.0284  
30‑34 0.8128   0.4833   0.9302  
35‑39 0.0356   0.3042   0.9435  
40‑44 0.5791   0.7316   0.8121  
45‑49 0.2978   0.3222   0.4196  
50 or Older 0.0139   0.5050   0.2117  
50‑54 0.3239   0.4468   0.0861  
55‑59 0.3573   0.4356   0.4216  
60‑64 0.0623   0.2918   0.0402  
65 or Older 0.2414   0.7397   0.6627  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.17C – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 536 555 127 170 61 78
12‑20 66 58 20 12 12 5
21 or Older 532 554 125 170 60 78
12‑17 52 43 17 10 6 5
12‑13 28 23 5 2 4 *
14‑15 33 22 14 7 1 5
16‑17 30 26 9 7 4 1
18 or Older 532 554 126 170 61 78
18‑25 67 78 19 28 12 6
18‑20 39 41 11 8 11 1
21‑25 53 63 15 27 6 6
26 or Older 529 548 124 168 60 78
26‑49 208 219 53 82 31 47
26‑29 61 81 17 22 15 20
30‑34 77 71 23 18 14 6
35‑39 98 98 32 41 17 8
40‑44 105 109 27 60 15 40
45‑49 99 104 14 30 7 14
50 or Older 446 497 112 146 51 62
50‑54 173 181 38 47 15 8
55‑59 171 188 52 25 47 25
60‑64 170 189 71 32 3 23
65 or Older 291 363 59 132 8 51

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.17D – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.17 0.17 0.04 0.06 0.02 0.03
12‑20 0.17 0.14 0.05 0.03 0.03 0.01
21 or Older 0.20 0.20 0.05 0.07 0.02 0.03
12‑17 0.20 0.16 0.07 0.04 0.02 0.02
12‑13 0.34 0.29 0.06 0.02 0.05 *
14‑15 0.38 0.25 0.16 0.08 0.01 0.05
16‑17 0.33 0.29 0.10 0.07 0.04 0.01
18 or Older 0.19 0.19 0.05 0.06 0.02 0.03
18‑25 0.18 0.21 0.05 0.08 0.03 0.02
18‑20 0.30 0.30 0.09 0.06 0.08 0.01
21‑25 0.23 0.27 0.07 0.12 0.03 0.03
26 or Older 0.22 0.22 0.05 0.07 0.03 0.03
26‑49 0.19 0.20 0.05 0.08 0.03 0.04
26‑29 0.34 0.47 0.10 0.13 0.08 0.12
30‑34 0.32 0.30 0.10 0.08 0.06 0.03
35‑39 0.41 0.42 0.14 0.18 0.07 0.04
40‑44 0.46 0.49 0.12 0.27 0.07 0.18
45‑49 0.50 0.50 0.07 0.15 0.04 0.07
50 or Older 0.35 0.37 0.09 0.12 0.04 0.05
50‑54 0.86 0.97 0.19 0.26 0.08 0.04
55‑59 0.84 0.93 0.26 0.13 0.24 0.13
60‑64 0.72 0.80 0.31 0.14 0.02 0.10
65 or Older 0.47 0.53 0.10 0.21 0.01 0.08

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.17P – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.7674   0.8152   0.6112  
12‑20 0.0252   0.0901   0.1620  
21 or Older 0.9944   0.6657   0.4837  
12‑17 0.0339   0.1060   0.7776  
12‑13 0.6029   0.0464   *  
14‑15 0.0277   0.2906   0.1751  
16‑17 0.3748   0.6713   0.4878  
18 or Older 0.8962   0.7047   0.5987  
18‑25 0.4714   0.2443   0.0939  
18‑20 0.3239   0.5233   0.1403  
21‑25 0.1021   0.1090   0.4353  
26 or Older 0.8410   0.8428   0.4416  
26‑49 0.5786   0.5129   0.7174  
26‑29 0.2248   0.8268   0.8494  
30‑34 0.8386   0.4715   0.1595  
35‑39 0.9855   0.9827   0.2717  
40‑44 0.3235   0.4954   0.3037  
45‑49 0.3711   0.2894   0.3585  
50 or Older 0.9771   0.8999   0.4897  
50‑54 0.8951   0.8932   0.8532  
55‑59 0.8086   0.5971   0.7890  
60‑64 0.3295   0.3284   0.4022  
65 or Older 0.7655   0.5186   0.2918  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.18C – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
TOTAL 653 674 208 248
12‑20 66 66 34 42
21 or Older 646 669 205 246
12‑17 43 50 20 29
12‑13 18 19 7 2
14‑15 23 23 13 14
16‑17 26 37 14 25
18 or Older 651 673 207 248
18‑25 95 104 51 57
18‑20 48 43 27 30
21‑25 84 94 45 49
26 or Older 639 660 198 242
26‑49 315 327 128 135
26‑29 108 115 57 61
30‑34 124 141 50 61
35‑39 145 130 52 55
40‑44 154 178 72 67
45‑49 143 145 43 61
50 or Older 538 570 149 197
50‑54 223 236 53 80
55‑59 220 202 89 88
60‑64 223 236 60 46
65 or Older 360 374 89 150

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.18D – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
TOTAL 0.20 0.20 0.07 0.08
12‑20 0.17 0.16 0.09 0.11
21 or Older 0.23 0.23 0.08 0.09
12‑17 0.17 0.19 0.08 0.11
12‑13 0.22 0.25 0.08 0.03
14‑15 0.26 0.26 0.15 0.16
16‑17 0.29 0.41 0.16 0.28
18 or Older 0.22 0.22 0.08 0.09
18‑25 0.26 0.28 0.14 0.16
18‑20 0.37 0.31 0.22 0.22
21‑25 0.36 0.41 0.20 0.22
26 or Older 0.25 0.25 0.09 0.10
26‑49 0.27 0.28 0.12 0.12
26‑29 0.58 0.66 0.32 0.35
30‑34 0.50 0.56 0.21 0.25
35‑39 0.60 0.55 0.22 0.24
40‑44 0.66 0.74 0.32 0.30
45‑49 0.71 0.69 0.22 0.30
50 or Older 0.40 0.42 0.12 0.16
50‑54 1.07 1.23 0.27 0.43
55‑59 1.05 1.00 0.45 0.44
60‑64 0.94 0.99 0.27 0.20
65 or Older 0.55 0.54 0.15 0.23

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.18P – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
TOTAL 0.0108   0.7689  
12‑20 0.6529   0.7014  
21 or Older 0.0131   0.7231  
12‑17 0.6065   0.6280  
12‑13 0.9395   0.0881  
14‑15 0.5416   0.8128  
16‑17 0.2229   0.4065  
18 or Older 0.0080   0.7141  
18‑25 0.2939   0.6618  
18‑20 0.1469   0.9550  
21‑25 0.7706   0.6870  
26 or Older 0.0134   0.7855  
26‑49 0.1569   0.9268  
26‑29 0.0807   0.2919  
30‑34 0.9303   0.5463  
35‑39 0.0285   0.5169  
40‑44 0.3927   0.7817  
45‑49 0.6208   0.1711  
50 or Older 0.0422   0.8126  
50‑54 0.9864   0.5361  
55‑59 0.3225   0.4351  
60‑64 0.0845   0.7155  
65 or Older 0.2027   0.9340  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.19C – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 1,237 1,302 328 344 193 180
12‑20 177 176 63 66 28 37
21 or Older 1,189 1,264 316 336 191 176
12‑17 120 126 39 49 19 25
12‑13 54 52 18 16 8 5
14‑15 70 69 25 25 12 13
16‑17 74 86 25 38 11 20
18 or Older 1,217 1,273 324 340 192 178
18‑25 183 197 84 72 39 36
18‑20 114 115 47 40 21 27
21‑25 134 149 62 60 32 22
26 or Older 1,160 1,248 307 329 188 173
26‑49 553 565 196 187 97 119
26‑29 176 166 69 61 36 28
30‑34 198 220 65 77 23 40
35‑39 247 228 96 106 50 72
40‑44 251 252 103 80 54 62
45‑49 226 237 83 83 37 41
50 or Older 940 1,039 249 276 154 126
50‑54 355 377 141 137 125 86
55‑59 310 402 117 160 47 54
60‑64 369 405 107 99 57 43
65 or Older 638 695 135 157 57 57

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Does not include illegally made fentanyl (IMF).

1 Any use of opioids includes the use of heroin or any use of prescription opioids.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.19D – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.32 0.35 0.11 0.11 0.07 0.06
12‑20 0.40 0.38 0.16 0.16 0.07 0.09
21 or Older 0.35 0.39 0.12 0.13 0.08 0.07
12‑17 0.42 0.44 0.15 0.19 0.07 0.10
12‑13 0.63 0.64 0.22 0.20 0.10 0.07
14‑15 0.74 0.74 0.28 0.29 0.14 0.15
16‑17 0.75 0.86 0.28 0.42 0.12 0.22
18 or Older 0.34 0.38 0.12 0.12 0.07 0.07
18‑25 0.44 0.45 0.23 0.20 0.11 0.10
18‑20 0.80 0.71 0.37 0.28 0.16 0.20
21‑25 0.51 0.59 0.27 0.27 0.14 0.10
26 or Older 0.39 0.43 0.13 0.14 0.08 0.07
26‑49 0.41 0.44 0.18 0.17 0.09 0.11
26‑29 0.91 0.90 0.39 0.35 0.21 0.16
30‑34 0.74 0.82 0.28 0.32 0.10 0.17
35‑39 0.90 0.87 0.40 0.46 0.21 0.32
40‑44 0.96 1.02 0.45 0.36 0.24 0.28
45‑49 1.00 1.02 0.43 0.41 0.19 0.20
50 or Older 0.61 0.68 0.20 0.21 0.13 0.10
50‑54 1.54 1.82 0.71 0.74 0.63 0.47
55‑59 1.40 1.73 0.58 0.80 0.24 0.28
60‑64 1.36 1.49 0.47 0.43 0.25 0.19
65 or Older 0.83 0.89 0.22 0.25 0.09 0.09

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Any use of opioids includes the use of heroin or any use of prescription opioids.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.19P – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.0271   0.0910   0.7541  
12‑20 0.0453   0.7094   0.6111  
21 or Older 0.0561   0.0988   0.6865  
12‑17 0.0821   0.8659   0.9886  
12‑13 0.1082   0.2458   0.4594  
14‑15 0.0866   0.6075   0.5569  
16‑17 0.9612   0.2210   0.4222  
18 or Older 0.0357   0.0810   0.7451  
18‑25 0.3412   0.0468   0.3543  
18‑20 0.1944   0.4242   0.5216  
21‑25 0.8466   0.0547   0.0702  
26 or Older 0.0555   0.1894   0.8930  
26‑49 0.0003   0.0816   0.6517  
26‑29 0.0391   0.0464   0.2734  
30‑34 0.0785   0.7891   0.0874  
35‑39 0.0332   0.8503   0.6910  
40‑44 0.1597   0.0662   0.9625  
45‑49 0.1952   0.7091   0.9559  
50 or Older 0.7690   0.7707   0.6210  
50‑54 0.5136   0.7675   0.9404  
55‑59 0.4979   0.8497   0.8450  
60‑64 0.9184   0.3917   0.2309  
65 or Older 0.1963   0.8262   0.9277  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Any use of opioids includes the use of heroin or any use of prescription opioids.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.20C – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 596 717 342 425 224 280
12‑20 134 146 59 64 29 32
21 or Older 571 683 339 419 222 280
12‑17 94 111 41 36 26 17
12‑13 38 50 11 15 4 4
14‑15 58 60 15 15 6 2
16‑17 65 72 36 29 24 16
18 or Older 583 698 341 423 225 281
18‑25 179 199 94 124 46 73
18‑20 94 92 46 52 26 27
21‑25 137 165 84 109 38 68
26 or Older 560 650 327 386 219 269
26‑49 396 449 262 274 169 181
26‑29 163 166 115 106 64 64
30‑34 161 204 105 137 65 99
35‑39 172 191 123 125 75 75
40‑44 157 187 89 109 70 79
45‑49 145 159 102 90 82 74
50 or Older 353 431 200 248 142 186
50‑54 192 201 107 147 80 96
55‑59 191 193 128 125 96 117
60‑64 137 201 81 115 43 88
65 or Older 153 234 72 101 50 64

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.20D – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.18 0.22 0.11 0.14 0.08 0.09
12‑20 0.33 0.35 0.15 0.16 0.07 0.08
21 or Older 0.20 0.25 0.13 0.16 0.09 0.11
12‑17 0.34 0.41 0.16 0.14 0.10 0.07
12‑13 0.46 0.63 0.14 0.19 0.05 0.05
14‑15 0.63 0.66 0.17 0.17 0.06 0.03
16‑17 0.68 0.75 0.40 0.32 0.27 0.18
18 or Older 0.19 0.24 0.12 0.15 0.08 0.10
18‑25 0.45 0.48 0.26 0.32 0.13 0.20
18‑20 0.69 0.63 0.36 0.37 0.21 0.19
21‑25 0.55 0.66 0.36 0.46 0.17 0.30
26 or Older 0.22 0.26 0.14 0.16 0.09 0.12
26‑49 0.32 0.36 0.23 0.24 0.15 0.16
26‑29 0.84 0.89 0.62 0.59 0.36 0.36
30‑34 0.61 0.75 0.43 0.54 0.27 0.41
35‑39 0.68 0.78 0.51 0.53 0.32 0.33
40‑44 0.67 0.83 0.39 0.49 0.31 0.36
45‑49 0.71 0.71 0.52 0.44 0.42 0.36
50 or Older 0.28 0.34 0.17 0.20 0.12 0.15
50‑54 0.92 1.07 0.54 0.79 0.41 0.52
55‑59 0.93 0.95 0.65 0.63 0.48 0.59
60‑64 0.59 0.87 0.36 0.50 0.19 0.39
65 or Older 0.26 0.36 0.12 0.16 0.08 0.10

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.20P – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Age Category Any Use in Past Year1
(2024)
Any Use in Past Year1
(2025)
Misuse in Past Year
(2024)
Misuse in Past Year
(2025)
Misuse in Past Month
(2024)
Misuse in Past Month
(2025)
TOTAL 0.3895   0.4619   0.1563  
12‑20 0.2783   0.4475   0.7123  
21 or Older 0.2507   0.3771   0.1395  
12‑17 0.6849   0.3865   0.4175  
12‑13 0.1384   0.5816   0.5446  
14‑15 0.1920   0.7509   0.0813  
16‑17 0.4723   0.2634   0.7030  
18 or Older 0.4254   0.4261   0.1460  
18‑25 0.8792   0.8959   0.1030  
18‑20 0.0206   0.5706   0.9554  
21‑25 0.1564   0.7626   0.0617  
26 or Older 0.4009   0.3887   0.2721  
26‑49 0.5244   0.8181   0.4988  
26‑29 0.4285   0.0375   0.4183  
30‑34 0.0760   0.0381   0.0991  
35‑39 0.9787   0.9149   0.9152  
40‑44 0.5772   0.3497   0.8572  
45‑49 0.9501   0.7447   0.9206  
50 or Older 0.4367   0.2272   0.3213  
50‑54 0.6224   0.7400   0.9162  
55‑59 0.6654   0.8922   0.5519  
60‑64 0.1600   0.1125   0.0715  
65 or Older 0.0966   0.2683   0.8834  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.21C – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2024 and 2025
Age Category Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 717 ‑‑ 408
12‑20 ‑‑ 133 ‑‑ 76
21 or Older ‑‑ 694 ‑‑ 405
12‑17 ‑‑ 77 ‑‑ 40
12‑13 ‑‑ 36 ‑‑ 23
14‑15 ‑‑ 41 ‑‑ 23
16‑17 ‑‑ 51 ‑‑ 25
18 or Older ‑‑ 705 ‑‑ 409
18‑25 ‑‑ 196 ‑‑ 102
18‑20 ‑‑ 105 ‑‑ 64
21‑25 ‑‑ 156 ‑‑ 78
26 or Older ‑‑ 658 ‑‑ 395
26‑49 ‑‑ 442 ‑‑ 267
26‑29 ‑‑ 174 ‑‑ 85
30‑34 ‑‑ 208 ‑‑ 135
35‑39 ‑‑ 184 ‑‑ 122
40‑44 ‑‑ 178 ‑‑ 119
45‑49 ‑‑ 152 ‑‑ 97
50 or Older ‑‑ 465 ‑‑ 271
50‑54 ‑‑ 235 ‑‑ 156
55‑59 ‑‑ 216 ‑‑ 142
60‑64 ‑‑ 163 ‑‑ 105
65 or Older ‑‑ 276 ‑‑ 128

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.21D – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2024 and 2025
Age Category Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL ‑‑ 0.22 ‑‑ 0.13
12‑20 ‑‑ 0.31 ‑‑ 0.19
21 or Older ‑‑ 0.24 ‑‑ 0.15
12‑17 ‑‑ 0.29 ‑‑ 0.15
12‑13 ‑‑ 0.44 ‑‑ 0.29
14‑15 ‑‑ 0.46 ‑‑ 0.26
16‑17 ‑‑ 0.55 ‑‑ 0.28
18 or Older ‑‑ 0.24 ‑‑ 0.15
18‑25 ‑‑ 0.48 ‑‑ 0.27
18‑20 ‑‑ 0.67 ‑‑ 0.45
21‑25 ‑‑ 0.63 ‑‑ 0.34
26 or Older ‑‑ 0.26 ‑‑ 0.17
26‑49 ‑‑ 0.36 ‑‑ 0.24
26‑29 ‑‑ 0.94 ‑‑ 0.48
30‑34 ‑‑ 0.74 ‑‑ 0.52
35‑39 ‑‑ 0.74 ‑‑ 0.52
40‑44 ‑‑ 0.79 ‑‑ 0.54
45‑49 ‑‑ 0.72 ‑‑ 0.47
50 or Older ‑‑ 0.35 ‑‑ 0.21
50‑54 ‑‑ 1.21 ‑‑ 0.84
55‑59 ‑‑ 1.06 ‑‑ 0.71
60‑64 ‑‑ 0.70 ‑‑ 0.46
65 or Older ‑‑ 0.43 ‑‑ 0.20

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.22C – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2024 and 2025
Prescription Drug/Age Group Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Misuse in Past Year among Past Year Any Users
(2024)
Misuse in Past Year among Past Year Any Users
(2025)
PRESCRIPTION PSYCHOTHERAPEUTICS 1,669 1,701 439 487 439 487
12‑17 160 176 54 56 54 56
18 or Older 1,630 1,654 432 483 432 483
18‑25 270 312 114 118 114 118
26 or Older 1,541 1,600 410 461 410 461
PAIN RELIEVERS 1,311 1,383 337 355 337 355
12‑17 123 132 44 50 44 50
18 or Older 1,292 1,350 332 351 332 351
18‑25 195 214 86 74 86 74
26 or Older 1,229 1,320 316 338 316 338
PRESCRIPTION OPIOIDS 1,236 1,300 321 341 321 341
12‑17 120 126 39 49 39 49
18 or Older 1,215 1,271 317 337 317 337
18‑25 183 197 84 72 84 72
26 or Older 1,158 1,246 301 327 301 327
STIMULANTS 523 615 213 221 213 221
12‑17 93 110 31 34 31 34
18 or Older 509 594 211 217 211 217
18‑25 167 188 74 93 74 93
26 or Older 484 552 197 186 197 186
TRANQUILIZERS OR SEDATIVES 936 888 251 293 251 293
12‑17 68 66 26 30 26 30
18 or Older 928 884 248 293 248 293
18‑25 115 138 56 63 56 63
26 or Older 909 868 239 287 239 287
TRANQUILIZERS 763 759 223 256 223 256
12‑17 46 56 23 29 23 29
18 or Older 757 756 220 256 220 256
18‑25 100 116 54 60 54 60
26 or Older 747 746 211 250 211 250
SEDATIVES 536 555 127 170 127 170
12‑17 52 43 17 10 17 10
18 or Older 532 554 126 170 126 170
18‑25 67 78 19 28 19 28
26 or Older 529 548 124 168 124 168
BENZODIAZEPINES 653 674 208 248 208 248
12‑17 43 50 20 29 20 29
18 or Older 651 673 207 248 207 248
18‑25 95 104 51 57 51 57
26 or Older 639 660 198 242 198 242

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.22D – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2024 and 2025
Prescription Drug/Age Group Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Misuse in Past Year among Past Year Any Users
(2024)
Misuse in Past Year among Past Year Any Users
(2025)
PRESCRIPTION PSYCHOTHERAPEUTICS 0.35 0.39 0.14 0.15 0.40 0.45
12‑17 0.51 0.58 0.20 0.22 1.01 1.11
18 or Older 0.38 0.41 0.16 0.17 0.41 0.47
18‑25 0.56 0.65 0.31 0.30 1.07 1.12
26 or Older 0.42 0.47 0.17 0.19 0.44 0.49
PAIN RELIEVERS 0.32 0.36 0.11 0.12 0.44 0.48
12‑17 0.43 0.46 0.17 0.19 1.28 1.56
18 or Older 0.35 0.39 0.12 0.13 0.46 0.49
18‑25 0.47 0.48 0.24 0.20 1.43 1.28
26 or Older 0.39 0.44 0.14 0.14 0.48 0.52
PRESCRIPTION OPIOIDS 0.32 0.35 0.11 0.11 0.47 0.51
12‑17 0.42 0.44 0.15 0.19 1.25 1.69
18 or Older 0.34 0.38 0.12 0.12 0.49 0.53
18‑25 0.44 0.45 0.23 0.20 1.55 1.40
26 or Older 0.39 0.43 0.13 0.14 0.51 0.56
STIMULANTS 0.16 0.19 0.07 0.07 0.88 0.91
12‑17 0.34 0.41 0.12 0.13 1.52 1.63
18 or Older 0.17 0.21 0.08 0.08 0.94 0.98
18‑25 0.43 0.46 0.21 0.25 1.68 2.05
26 or Older 0.19 0.23 0.08 0.08 1.11 1.07
TRANQUILIZERS OR SEDATIVES 0.26 0.25 0.09 0.10 0.60 0.73
12‑17 0.25 0.25 0.10 0.12 2.48 3.12
18 or Older 0.28 0.27 0.09 0.11 0.61 0.75
18‑25 0.30 0.36 0.16 0.17 1.94 2.26
26 or Older 0.32 0.31 0.10 0.12 0.63 0.79
TRANQUILIZERS 0.22 0.23 0.08 0.09 0.67 0.81
12‑17 0.18 0.22 0.09 0.11 3.71 4.55
18 or Older 0.24 0.25 0.08 0.09 0.68 0.83
18‑25 0.27 0.31 0.15 0.17 2.23 2.82
26 or Older 0.27 0.28 0.09 0.11 0.69 0.87
SEDATIVES 0.17 0.17 0.04 0.06 0.88 1.19
12‑17 0.20 0.16 0.07 0.04 2.96 2.38
18 or Older 0.19 0.19 0.05 0.06 0.91 1.23
18‑25 0.18 0.21 0.05 0.08 2.20 2.82
26 or Older 0.22 0.22 0.05 0.07 0.95 1.30
BENZODIAZEPINES 0.20 0.20 0.07 0.08 0.81 0.98
12‑17 0.17 0.19 0.08 0.11 4.37 5.47
18 or Older 0.22 0.22 0.08 0.09 0.82 1.00
18‑25 0.26 0.28 0.14 0.16 2.53 3.17
26 or Older 0.25 0.25 0.09 0.10 0.85 1.06

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.22P – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Prescription Drug/Age Group Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Misuse in Past Year among Past Year Any Users
(2024)
Misuse in Past Year among Past Year Any Users
(2025)
PRESCRIPTION PSYCHOTHERAPEUTICS 0.0028   0.0724   0.4109  
12‑17 0.0856   0.6317   0.9190  
18 or Older 0.0036   0.0754   0.3984  
18‑25 0.7250   0.2567   0.2826  
26 or Older 0.0043   0.1169   0.4889  
PAIN RELIEVERS 0.0207   0.0613   0.2409  
12‑17 0.1089   0.9536   0.5301  
18 or Older 0.0258   0.0558   0.2076  
18‑25 0.3686   0.0612   0.0881  
26 or Older 0.0403   0.1284   0.3555  
PRESCRIPTION OPIOIDS 0.0271   0.0992   0.3589  
12‑17 0.0825   0.8057   0.3669  
18 or Older 0.0357   0.0869   0.2992  
18‑25 0.3566   0.0788   0.1148  
26 or Older 0.0550   0.1835   0.4725  
STIMULANTS 0.4397   0.9740   0.7140  
12‑17 0.4879   0.7089   0.8750  
18 or Older 0.5085   0.9689   0.6888  
18‑25 0.9640   0.8142   0.7622  
26 or Older 0.5234   0.9895   0.7542  
TRANQUILIZERS OR SEDATIVES 0.0019   0.3236   0.9947  
12‑17 0.2452   0.4910   0.8074  
18 or Older 0.0020   0.3480   0.9680  
18‑25 0.5706   0.9293   0.8390  
26 or Older 0.0027   0.3461   0.9491  
TRANQUILIZERS 0.0019   0.5620   0.6077  
12‑17 0.8093   0.9125   0.7803  
18 or Older 0.0013   0.5556   0.6022  
18‑25 0.1862   0.7673   0.6570  
26 or Older 0.0028   0.5910   0.6734  
SEDATIVES 0.7674   0.8152   0.7525  
12‑17 0.0339   0.1060   0.3193  
18 or Older 0.8962   0.7047   0.6694  
18‑25 0.4714   0.2443   0.3191  
26 or Older 0.8410   0.8428   0.8003  
BENZODIAZEPINES 0.0108   0.7689   0.4812  
12‑17 0.6065   0.6280   0.7896  
18 or Older 0.0080   0.7141   0.5157  
18‑25 0.2939   0.6618   0.8775  
26 or Older 0.0134   0.7855   0.5443  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.23C – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,189 2,366 ‑‑ 176 2,129 2,327 447 499 1,970 2,177
SEX                    
Male 1,386 1,497 ‑‑ 123 1,364 1,480 281 306 1,287 1,415
Female 1,218 1,367 ‑‑ 110 1,190 1,352 270 306 1,112 1,268
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,979 2,107 ‑‑ 149 1,934 2,073 377 427 1,811 1,967
AIAN 74 116 ‑‑ 10 74 115 14 19 70 114
Asian 323 349 ‑‑ 18 315 348 91 100 284 335
Black or African American 654 612 ‑‑ 69 633 603 133 137 596 570
NHPI * * ‑‑ * * * * * * *
White 1,724 1,844 ‑‑ 115 1,691 1,821 308 344 1,593 1,724
Two or More Races 232 292 ‑‑ 30 232 289 60 79 224 276
Hispanic or Latino 710 801 ‑‑ 92 691 778 200 202 625 707
EDUCATION LEVEL                    
< High School da da da da 438 476 84 108 420 447
High School Graduate da da da da 892 1,020 206 225 832 961
Some College/Associate’s Degree da da da da 970 1,049 268 327 911 975
College Graduate da da da da 1,165 1,284 161 198 1,124 1,228
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,301 1,407 258 268 1,244 1,327
Part‑Time da da da da 535 598 199 226 494 535
Unemployed da da da da 320 359 109 121 290 328
Other1 da da da da 1,060 1,187 152 188 1,038 1,155

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.23D – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.40 0.44 ‑‑ 0.58 0.42 0.48 0.67 0.80 0.47 0.52
SEX                    
Male 0.57 0.58 ‑‑ 0.80 0.61 0.64 0.95 1.07 0.67 0.72
Female 0.52 0.59 ‑‑ 0.76 0.55 0.64 0.90 1.04 0.62 0.69
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.42 0.47 ‑‑ 0.66 0.44 0.51 0.77 0.91 0.48 0.56
AIAN 3.27 3.82 ‑‑ 3.05 3.70 4.31 5.97 5.09 4.15 4.96
Asian 1.37 1.50 ‑‑ 1.14 1.44 1.61 2.89 2.97 1.59 1.84
Black or African American 1.04 1.11 ‑‑ 1.62 1.14 1.22 1.61 1.99 1.30 1.39
NHPI * * ‑‑ * * * * * * *
White 0.45 0.53 ‑‑ 0.81 0.47 0.55 0.90 1.07 0.52 0.60
Two or More Races 1.92 1.79 ‑‑ 1.93 2.22 2.05 2.80 2.98 2.75 2.44
Hispanic or Latino 0.88 0.97 ‑‑ 1.20 0.96 1.09 1.42 1.51 1.11 1.26
EDUCATION LEVEL                    
< High School da da da da 1.36 1.44 1.78 2.05 1.55 1.64
High School Graduate da da da da 0.83 0.88 1.08 1.20 0.97 1.02
Some College/Associate’s Degree da da da da 0.69 0.80 1.16 1.26 0.81 0.91
College Graduate da da da da 0.65 0.75 1.53 1.88 0.69 0.78
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.59 0.65 0.99 1.22 0.64 0.71
Part‑Time da da da da 1.02 1.01 1.39 1.32 1.31 1.33
Unemployed da da da da 1.51 1.55 1.88 2.10 2.01 1.99
Other1 da da da da 0.67 0.76 1.31 1.40 0.72 0.81

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.23P – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0012   ‑‑   0.0234   0.0017   0.0995  
SEX                    
Male 0.0834   ‑‑   0.3252   0.0226   0.6623  
Female 0.0025   ‑‑   0.0220   0.0171   0.0625  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0017   ‑‑   0.0255   0.0030   0.0998  
AIAN 0.9249   ‑‑   0.7914   0.6701   0.7318  
Asian 0.0099   ‑‑   0.0330   0.9031   0.0237  
Black or African American 0.2359   ‑‑   0.4187   0.0151   0.7883  
NHPI *   ‑‑   *   *   *  
White 0.0156   ‑‑   0.0797   0.0218   0.1897  
Two or More Races 0.0992   ‑‑   0.1949   0.0330   0.4705  
Hispanic or Latino 0.2793   ‑‑   0.5533   0.2781   0.7351  
EDUCATION LEVEL                    
< High School da   da   0.8966   0.6602   0.8290  
High School Graduate da   da   0.7554   0.0490   0.8617  
Some College/Associate’s Degree da   da   0.0833   0.0098   0.2960  
College Graduate da   da   0.0187   0.4069   0.0230  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1094   0.1634   0.1718  
Part‑Time da   da   0.3620   0.0664   0.8222  
Unemployed da   da   0.6145   0.1255   0.8889  
Other1 da   da   0.1637   0.0497   0.2761  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.24C – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,352 1,367 ‑‑ 133 1,320 1,347 357 420 1,203 1,218
SEX                    
Male 919 899 ‑‑ 95 906 887 233 267 848 824
Female 728 801 ‑‑ 84 711 794 223 251 650 726
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,215 1,218 ‑‑ 113 1,191 1,203 304 360 1,097 1,107
AIAN 52 78 ‑‑ 10 51 78 12 14 47 76
Asian 191 169 ‑‑ 15 188 169 70 84 170 156
Black or African American 419 386 ‑‑ 52 408 376 111 113 373 347
NHPI 54 60 ‑‑ * 52 59 * * 51 *
White 1,008 1,068 ‑‑ 91 991 1,057 248 289 918 976
Two or More Races 149 230 ‑‑ 27 150 228 52 72 138 217
Hispanic or Latino 457 498 ‑‑ 73 446 482 157 164 402 431
EDUCATION LEVEL                    
< High School da da da da 265 335 73 89 250 311
High School Graduate da da da da 576 637 168 180 530 590
Some College/Associate’s Degree da da da da 647 655 221 286 605 565
College Graduate da da da da 670 755 132 156 635 702
EMPLOYMENT STATUS                    
Full‑Time da da da da 827 844 208 208 790 793
Part‑Time da da da da 355 405 169 203 304 348
Unemployed da da da da 248 268 89 109 229 242
Other1 da da da da 635 711 127 155 615 682

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.24D – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.35 0.35 ‑‑ 0.46 0.38 0.38 0.65 0.77 0.42 0.41
SEX                    
Male 0.51 0.49 ‑‑ 0.65 0.56 0.54 0.90 1.05 0.62 0.61
Female 0.41 0.43 ‑‑ 0.62 0.44 0.47 0.89 0.96 0.48 0.51
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.39 0.40 ‑‑ 0.53 0.42 0.43 0.73 0.85 0.46 0.46
AIAN 2.97 3.53 ‑‑ 3.05 3.44 4.11 5.59 4.54 3.76 4.67
Asian 0.97 0.84 ‑‑ 0.97 1.03 0.91 2.48 2.80 1.12 0.98
Black or African American 0.87 0.92 ‑‑ 1.35 0.96 1.01 1.61 1.90 1.07 1.12
NHPI 4.21 5.42 ‑‑ * 4.39 5.73 * * 4.94 *
White 0.44 0.47 ‑‑ 0.68 0.47 0.50 0.86 1.03 0.51 0.54
Two or More Races 1.81 1.90 ‑‑ 1.83 2.16 2.19 2.81 3.06 2.56 2.69
Hispanic or Latino 0.71 0.70 ‑‑ 1.01 0.79 0.78 1.34 1.37 0.90 0.90
EDUCATION LEVEL                    
< High School da da da da 1.02 1.19 1.69 1.86 1.13 1.33
High School Graduate da da da da 0.66 0.70 1.00 1.08 0.76 0.82
Some College/Associate’s Degree da da da da 0.64 0.68 1.15 1.33 0.75 0.73
College Graduate da da da da 0.58 0.63 1.63 1.74 0.59 0.65
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.55 0.55 0.98 1.18 0.60 0.60
Part‑Time da da da da 0.91 0.92 1.33 1.39 1.10 1.16
Unemployed da da da da 1.44 1.63 1.80 2.02 1.93 2.14
Other1 da da da da 0.55 0.60 1.25 1.31 0.59 0.64

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.24P – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0022   ‑‑   0.0141   0.0767   0.0274  
SEX                    
Male 0.0122   ‑‑   0.0310   0.5635   0.0305  
Female 0.0383   ‑‑   0.1469   0.0348   0.3274  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0028   ‑‑   0.0162   0.1379   0.0278  
AIAN 0.9786   ‑‑   0.9712   0.2477   0.7989  
Asian 0.0659   ‑‑   0.1159   0.7506   0.0618  
Black or African American 0.2739   ‑‑   0.4350   0.0988   0.6847  
NHPI 0.7569   ‑‑   0.7347   *   *  
White 0.0035   ‑‑   0.0134   0.3519   0.0193  
Two or More Races 0.8664   ‑‑   0.9352   0.1498   0.7290  
Hispanic or Latino 0.4030   ‑‑   0.5319   0.3469   0.6638  
EDUCATION LEVEL                    
< High School da   da   0.1043   0.9603   0.0928  
High School Graduate da   da   0.1036   0.0699   0.1951  
Some College/Associate’s Degree da   da   0.0159   0.3013   0.0225  
College Graduate da   da   0.1368   0.7586   0.1315  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.0588   0.0882   0.1196  
Part‑Time da   da   0.5756   0.6672   0.6356  
Unemployed da   da   0.5721   0.4347   0.3557  
Other1 da   da   0.1070   0.0925   0.1879  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.25C – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,040 1,058 101 94 1,018 1,049 272 312 937 957
SEX                    
Male 755 702 66 71 744 698 183 207 708 650
Female 559 624 74 57 547 619 174 182 497 574
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 956 973 83 78 939 967 233 265 867 894
AIAN 39 70 6 4 38 69 11 13 33 68
Asian 147 124 15 9 146 123 51 53 134 113
Black or African American 320 316 38 32 311 310 95 84 280 294
NHPI 38 49 1 * 38 49 * * 37 *
White 797 844 69 65 787 837 185 217 738 773
Two or More Races 136 209 17 16 135 208 45 60 125 196
Hispanic or Latino 326 386 54 56 317 379 126 129 283 344
EDUCATION LEVEL                    
< High School da da da da 218 294 64 78 203 276
High School Graduate da da da da 472 508 132 154 443 468
Some College/Associate’s Degree da da da da 518 509 172 198 489 447
College Graduate da da da da 484 570 102 114 456 538
EMPLOYMENT STATUS                    
Full‑Time da da da da 630 673 166 178 598 628
Part‑Time da da da da 281 328 123 145 244 292
Unemployed da da da da 198 222 71 85 183 205
Other1 da da da da 506 552 101 116 495 534

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.25D – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.29 0.30 0.37 0.34 0.32 0.33 0.57 0.66 0.35 0.35
SEX                    
Male 0.45 0.42 0.48 0.51 0.49 0.47 0.80 0.93 0.55 0.51
Female 0.34 0.36 0.55 0.43 0.37 0.39 0.81 0.80 0.40 0.42
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.33 0.35 0.41 0.39 0.36 0.38 0.65 0.74 0.38 0.41
AIAN 2.48 3.21 2.84 1.54 2.89 3.71 5.47 4.30 2.97 4.23
Asian 0.76 0.63 1.01 0.56 0.82 0.68 1.98 1.89 0.88 0.73
Black or African American 0.72 0.81 0.97 0.87 0.78 0.89 1.50 1.54 0.86 1.01
NHPI 3.05 4.49 1.16 * 3.28 4.78 * * 3.59 *
White 0.38 0.41 0.50 0.51 0.41 0.44 0.76 0.92 0.44 0.47
Two or More Races 1.73 1.84 1.58 1.14 2.04 2.12 2.81 2.86 2.41 2.56
Hispanic or Latino 0.57 0.60 0.77 0.77 0.62 0.68 1.21 1.21 0.71 0.78
EDUCATION LEVEL                    
< High School da da da da 0.86 1.08 1.56 1.73 0.95 1.21
High School Graduate da da da da 0.58 0.63 0.89 1.01 0.67 0.72
Some College/Associate’s Degree da da da da 0.55 0.56 1.01 1.05 0.64 0.61
College Graduate da da da da 0.45 0.52 1.37 1.46 0.46 0.54
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.44 0.47 0.88 1.08 0.48 0.51
Part‑Time da da da da 0.77 0.79 1.14 1.17 0.93 1.00
Unemployed da da da da 1.29 1.46 1.64 1.80 1.70 1.90
Other1 da da da da 0.46 0.50 1.08 1.06 0.50 0.53

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.25P – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3837   0.0008   0.5636   0.2410   0.7242  
SEX                    
Male 0.3345   0.3262   0.3651   0.8513   0.3437  
Female 0.8383   0.0001   0.8287   0.1102   0.4980  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1288   0.0004   0.2162   0.1690   0.3198  
AIAN 0.7596   0.1660   0.6533   0.2997   0.4904  
Asian 0.0966   0.3783   0.1096   0.8412   0.0669  
Black or African American 0.9254   0.1364   0.9503   0.0232   0.5029  
NHPI 0.4809   *   0.4716   *   *  
White 0.1097   0.0036   0.1654   0.7562   0.1730  
Two or More Races 0.5803   0.4079   0.5213   0.0775   0.8872  
Hispanic or Latino 0.1275   0.4256   0.1018   0.9142   0.0971  
EDUCATION LEVEL                    
< High School da   da   0.0177   0.8980   0.0150  
High School Graduate da   da   0.4026   0.4222   0.4688  
Some College/Associate’s Degree da   da   0.0782   0.3527   0.1104  
College Graduate da   da   0.7720   0.6367   0.6971  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.8588   0.4431   0.9946  
Part‑Time da   da   0.5790   0.8760   0.5068  
Unemployed da   da   0.6115   0.9446   0.5611  
Other1 da   da   0.3615   0.1806   0.5077  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.26C – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,079 2,280 123 148 2,047 2,250 417 486 1,902 2,110
SEX                    
Male 1,307 1,447 86 103 1,295 1,438 257 293 1,226 1,379
Female 1,176 1,317 87 92 1,161 1,303 254 300 1,087 1,224
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,882 2,050 104 124 1,858 2,025 357 416 1,746 1,923
AIAN 63 115 6 10 63 114 14 19 58 113
Asian 284 333 18 8 284 333 73 94 260 320
Black or African American 615 588 52 54 602 579 128 135 569 549
NHPI 100 * 1 * * * * * * *
White 1,653 1,788 87 96 1,632 1,774 295 334 1,542 1,681
Two or More Races 228 290 24 27 228 287 58 78 221 274
Hispanic or Latino 659 743 67 79 652 727 183 200 593 660
EDUCATION LEVEL                    
< High School da da da da 389 452 78 103 372 428
High School Graduate da da da da 866 993 197 218 810 934
Some College/Associate’s Degree da da da da 946 992 252 316 893 923
College Graduate da da da da 1,119 1,240 155 191 1,080 1,185
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,243 1,362 241 265 1,193 1,286
Part‑Time da da da da 518 582 183 218 480 521
Unemployed da da da da 308 345 108 116 278 318
Other1 da da da da 1,024 1,119 141 175 1,005 1,093

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.26D – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.40 0.44 0.45 0.51 0.42 0.48 0.68 0.80 0.46 0.53
SEX                    
Male 0.57 0.59 0.61 0.72 0.61 0.64 0.91 1.05 0.67 0.73
Female 0.52 0.58 0.63 0.66 0.55 0.63 0.92 1.03 0.62 0.69
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.42 0.48 0.51 0.58 0.44 0.51 0.80 0.92 0.48 0.57
AIAN 3.30 3.83 2.56 2.99 3.88 4.29 6.01 5.33 4.27 4.93
Asian 1.27 1.45 1.18 0.49 1.36 1.57 2.62 3.04 1.50 1.78
Black or African American 1.02 1.12 1.31 1.35 1.11 1.24 1.61 1.96 1.27 1.41
NHPI 6.23 * 1.83 * * * * * * *
White 0.47 0.53 0.62 0.72 0.49 0.56 0.94 1.07 0.53 0.61
Two or More Races 1.99 1.81 2.11 1.77 2.26 2.07 2.86 2.99 2.81 2.46
Hispanic or Latino 0.90 0.96 0.95 1.09 0.99 1.07 1.40 1.51 1.14 1.24
EDUCATION LEVEL                    
< High School da da da da 1.31 1.39 1.75 2.03 1.49 1.60
High School Graduate da da da da 0.82 0.88 1.11 1.18 0.96 1.02
Some College/Associate’s Degree da da da da 0.72 0.80 1.19 1.25 0.83 0.91
College Graduate da da da da 0.64 0.76 1.62 1.90 0.67 0.79
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.58 0.65 0.98 1.23 0.64 0.70
Part‑Time da da da da 1.03 1.05 1.39 1.32 1.31 1.37
Unemployed da da da da 1.56 1.56 1.92 2.08 2.06 1.99
Other1 da da da da 0.68 0.75 1.32 1.37 0.73 0.80

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.26P – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3000   0.0271   0.3197   0.2814   0.4342  
SEX                    
Male 0.7642   0.2554   0.7851   0.3771   0.9733  
Female 0.2341   0.0315   0.2594   0.4626   0.3098  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3239   0.0080   0.3853   0.3144   0.5071  
AIAN 0.1908   0.6246   0.2208   0.8020   0.1956  
Asian 0.2645   0.1030   0.2906   0.2560   0.1510  
Black or African American 0.4739   0.7952   0.4568   0.0854   0.7147  
NHPI *   *   *   *   *  
White 0.4895   0.0039   0.5608   0.5114   0.6435  
Two or More Races 0.6512   0.5622   0.4504   0.0795   0.7871  
Hispanic or Latino 0.8391   0.9955   0.7403   0.8008   0.7643  
EDUCATION LEVEL                    
< High School da   da   0.3215   0.5336   0.3816  
High School Graduate da   da   0.8902   0.4130   0.7160  
Some College/Associate’s Degree da   da   0.2793   0.3303   0.4047  
College Graduate da   da   0.1534   0.6957   0.1605  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.7987   0.9495   0.7806  
Part‑Time da   da   0.5442   0.8378   0.5875  
Unemployed da   da   0.9741   0.1274   0.5298  
Other1 da   da   0.3695   0.3274   0.4524  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.27C – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,257 1,256 113 119 1,231 1,243 338 400 1,123 1,118
SEX                    
Male 856 840 75 86 846 832 220 254 793 763
Female 680 731 80 73 666 725 211 238 610 666
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,127 1,130 95 100 1,108 1,120 288 341 1,018 1,029
AIAN 44 66 5 10 44 65 12 13 39 64
Asian 175 158 17 6 175 158 59 69 162 149
Black or African American 389 370 44 43 381 362 110 112 346 335
NHPI 50 54 1 * 50 53 * * 48 *
White 948 973 81 80 931 967 237 274 861 889
Two or More Races 139 227 21 23 139 225 51 70 127 214
Hispanic or Latino 419 440 60 66 409 431 147 161 370 374
EDUCATION LEVEL                    
< High School da da da da 227 289 69 85 213 269
High School Graduate da da da da 553 602 159 173 510 554
Some College/Associate’s Degree da da da da 614 590 210 273 577 501
College Graduate da da da da 620 692 126 145 583 646
EMPLOYMENT STATUS                    
Full‑Time da da da da 774 791 196 201 740 742
Part‑Time da da da da 332 377 157 195 280 316
Unemployed da da da da 224 251 85 103 204 227
Other1 da da da da 589 621 119 137 568 598

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.27D – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.34 0.33 0.41 0.42 0.36 0.36 0.64 0.74 0.40 0.39
SEX                    
Male 0.49 0.47 0.53 0.61 0.53 0.52 0.87 1.02 0.59 0.57
Female 0.39 0.41 0.58 0.54 0.42 0.44 0.89 0.91 0.46 0.48
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.37 0.38 0.47 0.48 0.40 0.41 0.73 0.81 0.43 0.45
AIAN 2.70 3.19 2.48 2.98 3.16 3.72 5.58 4.30 3.31 4.21
Asian 0.90 0.78 1.08 0.40 0.97 0.84 2.24 2.34 1.07 0.94
Black or African American 0.83 0.90 1.16 1.12 0.91 1.00 1.62 1.88 1.01 1.11
NHPI 3.87 4.91 1.69 * 4.15 5.18 * * 4.63 *
White 0.43 0.45 0.59 0.61 0.45 0.48 0.87 1.00 0.49 0.51
Two or More Races 1.73 1.91 1.85 1.64 2.06 2.20 2.81 3.04 2.41 2.71
Hispanic or Latino 0.68 0.65 0.83 0.93 0.76 0.72 1.31 1.37 0.86 0.81
EDUCATION LEVEL                    
< High School da da da da 0.89 1.07 1.63 1.82 0.98 1.19
High School Graduate da da da da 0.65 0.68 0.99 1.07 0.74 0.78
Some College/Associate’s Degree da da da da 0.62 0.64 1.13 1.27 0.73 0.68
College Graduate da da da da 0.55 0.60 1.56 1.62 0.56 0.61
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.52 0.53 0.94 1.15 0.57 0.58
Part‑Time da da da da 0.87 0.88 1.29 1.37 1.03 1.07
Unemployed da da da da 1.35 1.60 1.77 1.98 1.79 2.06
Other1 da da da da 0.51 0.55 1.20 1.19 0.55 0.59

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.27P – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0242   0.0056   0.0422   0.1919   0.0595  
SEX                    
Male 0.0412   0.4102   0.0444   0.6435   0.0399  
Female 0.1939   0.0008   0.3368   0.1273   0.5404  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0222   0.0021   0.0417   0.3868   0.0492  
AIAN 0.9141   0.7313   0.8544   0.1260   0.9020  
Asian 0.3626   0.0948   0.4293   0.4148   0.2399  
Black or African American 0.7491   0.5822   0.7830   0.1380   0.9318  
NHPI 0.6880   *   0.7725   *   *  
White 0.0065   0.0017   0.0129   0.7462   0.0122  
Two or More Races 0.5969   0.5319   0.6611   0.1109   0.3419  
Hispanic or Latino 0.7213   0.7280   0.7117   0.3132   0.8943  
EDUCATION LEVEL                    
< High School da   da   0.0896   0.9388   0.0777  
High School Graduate da   da   0.2087   0.1092   0.3353  
Some College/Associate’s Degree da   da   0.0406   0.7134   0.0339  
College Graduate da   da   0.1717   0.6446   0.1758  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1413   0.2078   0.2200  
Part‑Time da   da   0.9348   0.8291   0.8051  
Unemployed da   da   0.6054   0.6426   0.4343  
Other1 da   da   0.1030   0.0688   0.1920  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.28C – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 976 1,000 87 88 957 994 264 305 879 905
SEX                    
Male 697 677 61 65 688 674 176 201 653 627
Female 536 597 62 53 525 592 170 180 478 549
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 901 921 69 74 886 916 226 260 816 845
AIAN 38 58 5 4 38 57 11 13 33 56
Asian 135 116 14 4 135 116 49 51 123 105
Black or African American 305 310 33 31 298 304 95 84 267 288
NHPI 38 48 1 * 38 48 * * 36 *
White 755 789 58 61 745 785 180 215 698 723
Two or More Races 126 207 16 15 125 206 45 59 114 195
Hispanic or Latino 301 364 50 51 294 359 121 130 260 320
EDUCATION LEVEL                    
< High School da da da da 201 260 62 73 186 244
High School Graduate da da da da 455 498 131 152 427 458
Some College/Associate’s Degree da da da da 498 484 167 194 467 424
College Graduate da da da da 451 530 100 110 424 501
EMPLOYMENT STATUS                    
Full‑Time da da da da 599 630 163 174 568 588
Part‑Time da da da da 267 300 119 137 229 265
Unemployed da da da da 190 212 70 83 174 195
Other1 da da da da 483 532 97 113 472 512

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.28D – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.28 0.29 0.32 0.32 0.30 0.32 0.56 0.66 0.33 0.34
SEX                    
Male 0.42 0.41 0.44 0.47 0.45 0.45 0.78 0.92 0.51 0.50
Female 0.33 0.35 0.47 0.41 0.36 0.38 0.81 0.79 0.38 0.41
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.31 0.34 0.35 0.37 0.33 0.36 0.64 0.73 0.36 0.39
AIAN 2.45 2.80 2.16 1.52 2.87 3.25 5.47 4.32 2.94 3.69
Asian 0.70 0.59 0.89 0.25 0.75 0.64 1.93 1.81 0.82 0.68
Black or African American 0.70 0.80 0.87 0.84 0.76 0.88 1.49 1.53 0.83 1.00
NHPI 3.01 4.43 1.16 * 3.23 4.72 * * 3.53 *
White 0.36 0.39 0.44 0.49 0.38 0.42 0.76 0.93 0.42 0.45
Two or More Races 1.66 1.86 1.50 1.09 1.95 2.14 2.80 2.85 2.29 2.58
Hispanic or Latino 0.53 0.57 0.71 0.72 0.59 0.65 1.20 1.21 0.65 0.73
EDUCATION LEVEL                    
< High School da da da da 0.80 0.98 1.52 1.67 0.87 1.09
High School Graduate da da da da 0.56 0.62 0.88 1.01 0.65 0.71
Some College/Associate’s Degree da da da da 0.54 0.54 0.99 1.06 0.62 0.59
College Graduate da da da da 0.43 0.49 1.35 1.41 0.43 0.50
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.42 0.45 0.88 1.06 0.46 0.48
Part‑Time da da da da 0.74 0.72 1.12 1.12 0.87 0.91
Unemployed da da da da 1.23 1.42 1.64 1.77 1.62 1.81
Other1 da da da da 0.44 0.49 1.05 1.03 0.48 0.52

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.28P – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4677   0.0350   0.5624   0.3185   0.6930  
SEX                    
Male 0.3233   0.7573   0.3154   0.9088   0.2806  
Female 0.9603   0.0045   0.7556   0.1579   0.4630  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1831   0.0312   0.2328   0.2774   0.3109  
AIAN 0.7476   0.5891   0.7658   0.2691   0.9530  
Asian 0.1296   0.3311   0.1466   0.8062   0.0900  
Black or African American 0.7731   0.7552   0.7620   0.0376   0.3810  
NHPI 0.4799   *   0.4706   *   *  
White 0.1044   0.0317   0.1347   0.9828   0.1229  
Two or More Races 0.9928   0.9707   0.8522   0.0622   0.7038  
Hispanic or Latino 0.1381   0.5626   0.1214   0.9705   0.1011  
EDUCATION LEVEL                    
< High School da   da   0.0514   0.9076   0.0462  
High School Graduate da   da   0.5171   0.5991   0.5437  
Some College/Associate’s Degree da   da   0.1176   0.4165   0.1548  
College Graduate da   da   0.8192   0.5422   0.7206  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.7018   0.4330   0.8438  
Part‑Time da   da   0.6084   0.9804   0.5901  
Unemployed da   da   0.8144   0.8229   0.8545  
Other1 da   da   0.4755   0.3679   0.5839  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.29C – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,014 1,069 21 26 1,015 1,067 116 138 994 1,035
SEX                    
Male 754 766 15 22 753 765 80 94 745 746
Female 546 606 16 14 546 605 77 93 537 592
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 922 988 18 15 923 987 103 115 908 962
AIAN 31 73 1 <1 31 73 8 6 30 73
Asian 128 124 * * 128 124 17 30 126 120
Black or African American 284 267 5 3 283 267 18 19 281 265
NHPI 29 30 <1 * 29 30 * * 29 31
White 834 898 17 14 835 898 93 102 821 878
Two or More Races 111 195 1 5 111 195 16 22 110 190
Hispanic or Latino 363 371 10 21 364 367 48 68 354 354
EDUCATION LEVEL                    
< High School da da da da 245 272 28 24 241 270
High School Graduate da da da da 444 558 61 75 432 549
Some College/Associate’s Degree da da da da 516 521 68 80 506 510
College Graduate da da da da 565 553 58 68 557 534
EMPLOYMENT STATUS                    
Full‑Time da da da da 633 657 79 97 624 644
Part‑Time da da da da 313 324 49 63 310 317
Unemployed da da da da 157 212 37 40 152 207
Other1 da da da da 564 600 49 43 563 597

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.29D – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.30 0.30 0.08 0.10 0.33 0.32 0.31 0.37 0.37 0.36
SEX                    
Male 0.46 0.45 0.11 0.17 0.50 0.49 0.44 0.51 0.56 0.55
Female 0.35 0.35 0.13 0.11 0.38 0.38 0.43 0.50 0.42 0.43
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.33 0.34 0.09 0.08 0.35 0.37 0.37 0.42 0.39 0.40
AIAN 2.02 3.28 0.26 0.16 2.39 3.75 4.33 2.58 2.70 4.27
Asian 0.67 0.63 * * 0.73 0.68 0.74 1.12 0.83 0.77
Black or African American 0.71 0.74 0.13 0.10 0.79 0.82 0.39 0.42 0.90 0.95
NHPI 2.40 2.94 0.18 * 2.57 3.14 * * 2.95 3.53
White 0.39 0.42 0.13 0.12 0.42 0.44 0.48 0.57 0.46 0.48
Two or More Races 1.55 1.81 0.09 0.36 1.84 2.08 1.45 1.26 2.30 2.52
Hispanic or Latino 0.61 0.59 0.15 0.31 0.69 0.66 0.54 0.69 0.82 0.78
EDUCATION LEVEL                    
< High School da da da da 0.95 1.00 0.78 0.64 1.10 1.17
High School Graduate da da da da 0.56 0.67 0.48 0.57 0.66 0.80
Some College/Associate’s Degree da da da da 0.56 0.58 0.49 0.57 0.66 0.69
College Graduate da da da da 0.52 0.48 0.91 1.02 0.54 0.50
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.45 0.46 0.52 0.67 0.50 0.51
Part‑Time da da da da 0.86 0.81 0.52 0.62 1.14 1.09
Unemployed da da da da 1.13 1.37 0.96 0.95 1.51 1.87
Other1 da da da da 0.52 0.53 0.56 0.48 0.56 0.58

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.29P – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1196   0.9933   0.0966   0.4922   0.1216  
SEX                    
Male 0.0631   0.9400   0.0530   0.2192   0.0860  
Female 0.8515   0.9144   0.7944   0.7930   0.7693  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2154   0.3370   0.1949   0.1444   0.2711  
AIAN 0.0545   0.6181   0.0540   0.0639   0.0259  
Asian 0.5430   *   0.5386   0.9246   0.5219  
Black or African American 0.4499   0.6581   0.4382   0.8277   0.4454  
NHPI 0.6276   *   0.6293   *   0.8146  
White 0.1730   0.2989   0.1507   0.1238   0.2045  
Two or More Races 0.3728   0.4538   0.4773   0.8501   0.4504  
Hispanic or Latino 0.3205   0.3561   0.2592   0.2021   0.1836  
EDUCATION LEVEL                    
< High School da   da   0.6851   0.1304   0.8425  
High School Graduate da   da   0.9481   0.5902   0.7943  
Some College/Associate’s Degree da   da   0.3274   0.9864   0.3364  
College Graduate da   da   0.0534   0.8670   0.0497  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1940   0.7022   0.2067  
Part‑Time da   da   0.3340   0.3580   0.2649  
Unemployed da   da   0.7117   0.3439   0.4741  
Other1 da   da   0.3654   0.2484   0.4141  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.30C – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 225 300 18 19 225 301 64 92 212 269
SEX                    
Male 195 240 11 14 195 239 44 67 186 218
Female 108 143 14 12 109 142 49 52 94 128
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 203 252 16 14 203 252 58 67 194 230
AIAN 6 7 * <1 6 7 3 1 5 7
Asian 45 52 * * 45 52 12 14 44 50
Black or African American 75 93 4 3 75 93 10 17 74 91
NHPI 2 * <1 * 2 * * * 2 *
White 174 209 15 14 174 210 54 58 163 191
Two or More Races 43 51 1 * 43 51 5 18 42 47
Hispanic or Latino 100 154 7 12 100 153 29 55 91 137
EDUCATION LEVEL                    
< High School da da da da 61 106 16 17 57 105
High School Graduate da da da da 139 138 36 43 133 126
Some College/Associate’s Degree da da da da 113 141 41 57 105 126
College Graduate da da da da 114 166 34 48 109 149
EMPLOYMENT STATUS                    
Full‑Time da da da da 153 187 49 60 140 170
Part‑Time da da da da 83 127 25 41 76 120
Unemployed da da da da 66 80 22 25 62 75
Other1 da da da da 118 149 29 37 114 142

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.30D – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.08 0.10 0.07 0.07 0.08 0.11 0.18 0.24 0.09 0.12
SEX                    
Male 0.14 0.17 0.08 0.11 0.15 0.18 0.25 0.36 0.17 0.20
Female 0.07 0.09 0.11 0.10 0.08 0.10 0.28 0.29 0.08 0.11
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.09 0.10 0.08 0.08 0.09 0.11 0.22 0.24 0.10 0.12
AIAN 0.45 0.41 * 0.16 0.54 0.48 2.14 0.41 0.52 0.55
Asian 0.24 0.27 * * 0.27 0.29 0.51 0.55 0.30 0.33
Black or African American 0.21 0.27 0.10 0.10 0.23 0.30 0.22 0.37 0.27 0.34
NHPI 0.18 * 0.18 * 0.20 * * * 0.16 *
White 0.10 0.12 0.12 0.11 0.11 0.13 0.29 0.32 0.11 0.13
Two or More Races 0.65 0.52 0.07 * 0.77 0.61 0.46 1.02 0.97 0.73
Hispanic or Latino 0.18 0.27 0.11 0.18 0.21 0.30 0.33 0.56 0.23 0.34
EDUCATION LEVEL                    
< High School da da da da 0.25 0.43 0.46 0.45 0.28 0.50
High School Graduate da da da da 0.20 0.19 0.30 0.33 0.23 0.22
Some College/Associate’s Degree da da da da 0.14 0.18 0.30 0.41 0.16 0.19
College Graduate da da da da 0.12 0.17 0.56 0.75 0.13 0.17
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.12 0.15 0.34 0.42 0.13 0.16
Part‑Time da da da da 0.25 0.36 0.28 0.42 0.32 0.47
Unemployed da da da da 0.50 0.57 0.59 0.62 0.66 0.77
Other1 da da da da 0.12 0.15 0.34 0.42 0.13 0.16

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.30P – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0790   0.5909   0.0771   0.3024   0.1156  
SEX                    
Male 0.3462   0.6694   0.3410   0.2301   0.4963  
Female 0.0361   0.7367   0.0339   0.8152   0.0242  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4731   0.5363   0.4604   0.7595   0.4898  
AIAN 0.7179   *   0.7603   0.1822   0.3535  
Asian 0.9383   *   0.9353   0.7938   0.9905  
Black or African American 0.3941   0.9357   0.4017   0.2384   0.5110  
NHPI *   *   *   *   *  
White 0.6873   0.5655   0.6707   0.9568   0.6293  
Two or More Races 0.7754   *   0.7370   0.1625   0.4935  
Hispanic or Latino 0.0216   0.9564   0.0223   0.1514   0.0467  
EDUCATION LEVEL                    
< High School da   da   0.1946   0.8107   0.1705  
High School Graduate da   da   0.3845   0.7238   0.4082  
Some College/Associate’s Degree da   da   0.0359   0.3440   0.0562  
College Graduate da   da   0.1373   0.1982   0.2328  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.4737   0.5710   0.5595  
Part‑Time da   da   0.0978   0.0356   0.2879  
Unemployed da   da   0.5735   0.8793   0.4966  
Other1 da   da   0.3449   0.7324   0.2848  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.31C – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 152 186 5 4 152 186 33 55 148 177
SEX                    
Male 133 150 4 <1 133 150 27 41 129 145
Female 72 93 2 4 72 93 19 29 68 89
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 140 147 3 4 140 147 27 44 137 136
AIAN 1 6 * * 1 6 * <1 1 6
Asian 41 31 * * 41 31 3 9 41 30
Black or African American 55 59 * <1 55 59 6 12 54 58
NHPI 2 1 <1 * 2 1 <1 * 2 <1
White 117 127 3 4 117 127 26 39 113 117
Two or More Races 40 25 1 * 40 25 4 10 39 23
Hispanic or Latino 54 107 3 1 54 107 19 27 51 103
EDUCATION LEVEL                    
< High School da da da da 50 102 14 8 47 102
High School Graduate da da da da 100 70 16 26 97 65
Some College/Associate’s Degree da da da da 71 91 17 32 69 84
College Graduate da da da da 62 96 18 31 60 90
EMPLOYMENT STATUS                    
Full‑Time da da da da 83 100 24 36 78 93
Part‑Time da da da da 61 98 11 30 60 94
Unemployed da da da da 43 43 7 10 42 43
Other1 da da da da 91 115 18 19 89 114

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.31D – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.06 0.02 0.02 0.06 0.07 0.09 0.15 0.06 0.08
SEX                    
Male 0.09 0.11 0.03 <0.01 0.10 0.12 0.16 0.22 0.12 0.13
Female 0.05 0.06 0.02 0.03 0.05 0.07 0.11 0.16 0.06 0.07
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.06 0.06 0.02 0.02 0.07 0.07 0.10 0.17 0.07 0.07
AIAN 0.04 0.35 * * 0.05 0.41 * 0.21 0.06 0.47
Asian 0.22 0.16 * * 0.24 0.18 0.11 0.37 0.28 0.20
Black or African American 0.16 0.17 * 0.01 0.17 0.19 0.13 0.25 0.20 0.22
NHPI 0.13 0.06 0.18 * 0.14 0.06 0.01 * 0.16 0.02
White 0.07 0.07 0.02 0.03 0.07 0.08 0.15 0.22 0.08 0.08
Two or More Races 0.61 0.26 0.07 * 0.72 0.31 0.35 0.57 0.91 0.36
Hispanic or Latino 0.10 0.19 0.05 0.02 0.11 0.21 0.21 0.28 0.13 0.25
EDUCATION LEVEL                    
< High School da da da da 0.21 0.41 0.40 0.20 0.23 0.49
High School Graduate da da da da 0.14 0.10 0.13 0.20 0.17 0.11
Some College/Associate’s Degree da da da da 0.09 0.12 0.13 0.24 0.11 0.13
College Graduate da da da da 0.07 0.10 0.31 0.50 0.07 0.10
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.07 0.08 0.18 0.26 0.07 0.09
Part‑Time da da da da 0.19 0.28 0.12 0.31 0.25 0.37
Unemployed da da da da 0.33 0.31 0.20 0.24 0.45 0.44
Other1 da da da da 0.09 0.12 0.21 0.22 0.10 0.13

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.31P – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1989   0.3838   0.1974   0.0539   0.4199  
SEX                    
Male 0.5350   0.0201   0.5113   0.0853   0.8089  
Female 0.1062   0.3712   0.1168   0.2652   0.1903  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6498   0.9544   0.6588   0.0576   0.9624  
AIAN 0.0393   *   0.0403   *   0.0498  
Asian 0.4973   *   0.4958   0.4617   0.4072  
Black or African American 0.5493   *   0.5576   0.3093   0.6613  
NHPI 0.6197   *   0.6787   *   0.3818  
White 0.4927   0.9031   0.5038   0.0860   0.8276  
Two or More Races 0.2011   *   0.1969   0.8142   0.2055  
Hispanic or Latino 0.0699   0.1439   0.0653   0.4570   0.0895  
EDUCATION LEVEL                    
< High School da   da   0.1339   0.5026   0.1060  
High School Graduate da   da   0.0997   0.5071   0.0594  
Some College/Associate’s Degree da   da   0.1300   0.0341   0.3606  
College Graduate da   da   0.1300   0.2860   0.2162  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.3274   0.2486   0.5309  
Part‑Time da   da   0.2470   0.0199   0.5815  
Unemployed da   da   0.6043   0.6270   0.6430  
Other1 da   da   0.9496   0.9018   0.9307  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.32C – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 480 512 13 11 480 512 25 32 479 510
SEX                    
Male 412 399 7 6 412 399 19 22 411 398
Female 225 288 11 9 226 288 16 23 226 286
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 454 488 12 1 454 488 21 32 453 486
AIAN 21 48 * <1 21 48 2 2 21 48
Asian 25 42 * * 25 42 6 1 25 42
Black or African American 189 143 * * 189 143 3 6 189 142
NHPI 16 * * * 16 * * * 16 *
White 398 447 12 1 398 447 20 30 398 445
Two or More Races 54 117 * * 54 117 3 8 54 117
Hispanic or Latino 152 153 4 11 151 153 13 6 150 153
EDUCATION LEVEL                    
< High School da da da da 167 187 12 7 166 187
High School Graduate da da da da 271 331 19 24 272 330
Some College/Associate’s Degree da da da da 273 275 9 20 273 274
College Graduate da da da da 175 140 1 2 175 140
EMPLOYMENT STATUS                    
Full‑Time da da da da 278 281 14 26 278 279
Part‑Time da da da da 177 166 5 14 176 165
Unemployed da da da da 85 108 8 9 84 108
Other1 da da da da 299 325 18 10 299 325

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.32D – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.16 0.17 0.05 0.04 0.17 0.18 0.07 0.09 0.20 0.21
SEX                    
Male 0.28 0.27 0.05 0.05 0.31 0.30 0.11 0.12 0.35 0.35
Female 0.15 0.19 0.09 0.07 0.17 0.20 0.09 0.13 0.19 0.23
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.18 0.20 0.06 0.01 0.20 0.22 0.08 0.12 0.23 0.25
AIAN 1.50 2.49 * 0.16 1.77 2.89 1.21 0.74 2.04 3.31
Asian 0.14 0.21 * * 0.15 0.23 0.24 0.02 0.17 0.27
Black or African American 0.51 0.42 * * 0.56 0.46 0.06 0.12 0.65 0.53
NHPI 1.29 * * * 1.38 * * * 1.60 *
White 0.22 0.25 0.10 0.01 0.24 0.27 0.11 0.17 0.27 0.31
Two or More Races 0.79 1.19 * * 0.94 1.38 0.22 0.44 1.20 1.73
Hispanic or Latino 0.27 0.26 0.06 0.16 0.31 0.30 0.14 0.07 0.38 0.37
EDUCATION LEVEL                    
< High School da da da da 0.69 0.74 0.35 0.19 0.80 0.87
High School Graduate da da da da 0.37 0.44 0.16 0.19 0.45 0.54
Some College/Associate’s Degree da da da da 0.34 0.34 0.07 0.15 0.40 0.41
College Graduate da da da da 0.19 0.15 0.01 0.03 0.20 0.16
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.22 0.23 0.10 0.19 0.25 0.26
Part‑Time da da da da 0.53 0.46 0.06 0.15 0.72 0.63
Unemployed da da da da 0.64 0.76 0.22 0.23 0.89 1.08
Other1 da da da da 0.30 0.32 0.21 0.11 0.33 0.35

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.32P – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3482   0.6480   0.3331   0.5717   0.3368  
SEX                    
Male 0.0997   0.9544   0.0945   0.6665   0.1008  
Female 0.3964   0.6087   0.4041   0.7120   0.4133  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4282   0.2043   0.4247   0.3593   0.4035  
AIAN 0.4936   *   0.5085   0.6091   0.4926  
Asian 0.7047   *   0.7069   0.2460   0.5957  
Black or African American 0.0286   *   0.0272   0.6877   0.0270  
NHPI *   *   *   *   *  
White 0.7281   0.1910   0.7231   0.3808   0.6746  
Two or More Races 0.2645   *   0.3012   0.2766   0.3326  
Hispanic or Latino 0.6432   0.5077   0.5949   0.4565   0.6598  
EDUCATION LEVEL                    
< High School da   da   0.9321   0.5571   0.9876  
High School Graduate da   da   0.7539   0.7185   0.7886  
Some College/Associate’s Degree da   da   0.8486   0.4379   0.8341  
College Graduate da   da   0.0847   0.3233   0.0834  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.2974   0.2749   0.2592  
Part‑Time da   da   0.8496   0.0698   0.7838  
Unemployed da   da   0.9914   0.4554   0.8668  
Other1 da   da   0.5738   0.2110   0.6127  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.33C – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 118 134 4 9 118 134 15 9 117 132
SEX                    
Male 106 99 * * 106 99 12 8 105 99
Female 44 72 4 9 44 71 8 4 43 71
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 114 122 <1 <1 114 122 9 9 113 121
AIAN 1 6 * <1 1 6 <1 <1 1 6
Asian 16 27 * * 16 27 * * 16 27
Black or African American 40 56 * * 40 56 2 * 40 56
NHPI 2 * * * 2 * * * 2 *
White 98 92 <1 * 98 92 9 7 98 91
Two or More Races 8 32 * * 8 32 * 5 8 31
Hispanic or Latino 31 66 4 9 30 65 12 1 28 65
EDUCATION LEVEL                    
< High School da da da da 37 57 11 4 35 57
High School Graduate da da da da 92 77 9 6 92 76
Some College/Associate’s Degree da da da da 39 62 4 5 39 59
College Graduate da da da da 22 44 * <1 22 44
EMPLOYMENT STATUS                    
Full‑Time da da da da 23 38 2 8 23 37
Part‑Time da da da da 48 39 4 2 48 39
Unemployed da da da da 30 51 4 1 29 51
Other1 da da da da 91 109 14 4 90 109

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.33D – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.04 0.05 0.02 0.03 0.04 0.05 0.04 0.02 0.05 0.06
SEX                    
Male 0.07 0.07 * * 0.08 0.08 0.07 0.04 0.09 0.09
Female 0.03 0.05 0.03 0.07 0.03 0.05 0.05 0.02 0.04 0.06
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.05 <0.01 <0.01 0.05 0.06 0.03 0.03 0.06 0.06
AIAN 0.04 0.31 * 0.16 0.05 0.36 0.14 0.13 0.05 0.41
Asian 0.09 0.14 * * 0.09 0.15 * * 0.11 0.18
Black or African American 0.11 0.16 * * 0.13 0.18 0.05 * 0.15 0.21
NHPI 0.13 * * * 0.14 * * * 0.16 *
White 0.06 0.05 <0.01 * 0.06 0.06 0.05 0.04 0.07 0.07
Two or More Races 0.12 0.33 * * 0.15 0.39 * 0.29 0.19 0.48
Hispanic or Latino 0.06 0.12 0.06 0.13 0.06 0.13 0.14 0.01 0.07 0.16
EDUCATION LEVEL                    
< High School da da da da 0.15 0.23 0.32 0.11 0.17 0.27
High School Graduate da da da da 0.13 0.11 0.08 0.05 0.16 0.13
Some College/Associate’s Degree da da da da 0.05 0.08 0.03 0.04 0.06 0.09
College Graduate da da da da 0.02 0.05 * <0.01 0.03 0.05
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.02 0.03 0.01 0.06 0.02 0.04
Part‑Time da da da da 0.15 0.11 0.04 0.02 0.20 0.15
Unemployed da da da da 0.23 0.37 0.10 0.03 0.31 0.53
Other1 da da da da 0.09 0.11 0.17 0.04 0.10 0.12

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.33P – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1947   0.8576   0.2017   0.1616   0.1494  
SEX                    
Male 0.5222   *   0.5271   0.4699   0.4661  
Female 0.0930   0.8584   0.0970   0.1355   0.0657  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3944   0.4834   0.4004   0.7551   0.3803  
AIAN 0.0922   *   0.1080   0.8773   0.1097  
Asian 0.2664   *   0.2671   *   0.2654  
Black or African American 0.6797   *   0.6842   *   0.6434  
NHPI *   *   *   *   *  
White 0.8888   *   0.8953   0.6140   0.8626  
Two or More Races 0.0864   *   0.0895   *   0.1199  
Hispanic or Latino 0.2155   0.8878   0.2206   0.0958   0.1206  
EDUCATION LEVEL                    
< High School da   da   0.2760   0.3984   0.2026  
High School Graduate da   da   0.4764   0.2418   0.5589  
Some College/Associate’s Degree da   da   0.0143   0.7632   0.0101  
College Graduate da   da   0.2168   *   0.2176  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.0171   0.1444   0.0308  
Part‑Time da   da   0.8560   0.2467   0.7866  
Unemployed da   da   0.2241   0.0728   0.1654  
Other1 da   da   0.8767   0.0991   0.7435  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.34C – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 93 82 <1 * 93 82 6 4 93 82
SEX                    
Male 83 61 * * 83 61 6 1 82 61
Female 36 55 <1 * 36 55 1 4 36 55
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 93 68 * * 93 68 4 4 93 68
AIAN * 6 * * * 6 * * * 6
Asian 16 22 * * 16 22 * * 16 22
Black or African American 37 42 * * 37 42 * * 37 42
NHPI 2 * * * 2 * * * 2 *
White 83 48 * * 83 48 4 4 83 48
Two or More Races 7 2 * * 7 2 * 1 7 2
Hispanic or Latino 11 46 <1 * 11 46 5 1 10 46
EDUCATION LEVEL                    
< High School da da da da 32 53 1 4 31 52
High School Graduate da da da da 69 20 5 1 69 20
Some College/Associate’s Degree da da da da 30 52 3 * 30 52
College Graduate da da da da 17 28 * * 17 28
EMPLOYMENT STATUS                    
Full‑Time da da da da 11 28 * 1 11 28
Part‑Time da da da da 45 31 3 2 45 31
Unemployed da da da da 27 26 2 1 26 26
Other1 da da da da 64 65 4 3 64 65

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.34D – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.03 0.03 <0.01 * 0.04 0.03 0.02 0.01 0.04 0.04
SEX                    
Male 0.06 0.04 * * 0.06 0.05 0.03 0.01 0.07 0.06
Female 0.02 0.04 <0.01 * 0.03 0.04 <0.01 0.02 0.03 0.05
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.04 0.03 * * 0.04 0.03 0.01 0.01 0.05 0.04
AIAN * 0.30 * * * 0.35 * * * 0.41
Asian 0.09 0.11 * * 0.09 0.12 * * 0.11 0.15
Black or African American 0.10 0.12 * * 0.12 0.13 * * 0.14 0.16
NHPI 0.13 * * * 0.14 * * * 0.16 *
White 0.05 0.03 * * 0.05 0.03 0.02 0.02 0.06 0.03
Two or More Races 0.11 0.02 * * 0.13 0.03 * 0.03 0.17 0.04
Hispanic or Latino 0.02 0.08 <0.01 * 0.02 0.09 0.05 0.01 0.02 0.11
EDUCATION LEVEL                    
< High School da da da da 0.13 0.21 0.04 0.11 0.15 0.25
High School Graduate da da da da 0.10 0.03 0.04 0.01 0.12 0.04
Some College/Associate’s Degree da da da da 0.04 0.07 0.02 * 0.05 0.08
College Graduate da da da da 0.02 0.03 * * 0.02 0.03
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.01 0.02 * 0.01 0.01 0.03
Part‑Time da da da da 0.14 0.09 0.04 0.02 0.19 0.12
Unemployed da da da da 0.21 0.19 0.05 0.02 0.28 0.27
Other1 da da da da 0.07 0.07 0.05 0.04 0.07 0.07

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.34P – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.6183   *   0.6236   0.4502   0.5859  
SEX                    
Male 0.6941   *   0.6906   0.0863   0.7739  
Female 0.1132   *   0.1140   0.1993   0.1309  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8631   *   0.8581   0.9002   0.8565  
AIAN *   *   *   *   *  
Asian 0.6939   *   0.6948   *   0.6924  
Black or African American 0.9405   *   0.9446   *   0.9362  
NHPI *   *   *   *   *  
White 0.7292   *   0.7249   0.9458   0.7210  
Two or More Races 0.4877   *   0.4809   *   0.4525  
Hispanic or Latino 0.0764   *   0.0763   0.2061   0.0551  
EDUCATION LEVEL                    
< High School da   da   0.2493   0.2765   0.2735  
High School Graduate da   da   0.0607   0.1475   0.0756  
Some College/Associate’s Degree da   da   0.1203   *   0.1062  
College Graduate da   da   0.2948   *   0.2947  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.0431   *   0.0488  
Part‑Time da   da   0.8159   0.5294   0.8527  
Unemployed da   da   0.8149   0.2996   0.7475  
Other1 da   da   0.9602   0.6330   0.9831  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.35C – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,109 1,210 52 64 1,106 1,201 205 218 1,066 1,143
SEX                    
Male 811 839 34 51 812 836 144 144 793 812
Female 578 682 37 37 575 676 135 135 552 646
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,022 1,119 46 53 1,019 1,113 168 182 984 1,073
AIAN 45 93 2 4 45 93 11 8 43 92
Asian 129 229 6 9 129 228 38 37 122 221
Black or African American 227 241 14 15 226 240 58 46 210 234
NHPI 57 57 1 * 57 57 * * 56 *
White 949 1,006 44 44 945 1,002 142 159 917 964
Two or More Races 129 212 6 17 129 212 35 35 122 206
Hispanic or Latino 345 355 25 34 345 347 100 107 326 314
EDUCATION LEVEL                    
< High School da da da da 211 235 51 52 200 225
High School Graduate da da da da 453 570 97 115 439 555
Some College/Associate’s Degree da da da da 563 576 124 131 545 547
College Graduate da da da da 644 704 91 92 630 673
EMPLOYMENT STATUS                    
Full‑Time da da da da 720 734 132 146 696 702
Part‑Time da da da da 321 367 90 107 306 338
Unemployed da da da da 198 221 64 55 189 209
Other1 da da da da 545 627 79 78 540 622

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.35D – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.31 0.32 0.20 0.24 0.34 0.35 0.51 0.52 0.37 0.39
SEX                    
Male 0.47 0.48 0.25 0.37 0.52 0.52 0.74 0.70 0.58 0.59
Female 0.35 0.39 0.29 0.30 0.38 0.42 0.69 0.70 0.42 0.46
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.34 0.37 0.24 0.27 0.37 0.40 0.55 0.59 0.41 0.44
AIAN 2.71 4.08 0.83 1.34 3.15 4.64 5.48 3.50 3.62 5.22
Asian 0.67 1.11 0.39 0.57 0.73 1.20 1.53 1.36 0.80 1.36
Black or African American 0.59 0.66 0.39 0.43 0.66 0.73 1.11 0.97 0.73 0.84
NHPI 4.36 5.19 0.82 * 4.66 5.58 * * 5.27 *
White 0.43 0.44 0.33 0.36 0.46 0.46 0.66 0.76 0.50 0.51
Two or More Races 1.78 1.83 0.53 1.21 2.11 2.12 2.76 1.96 2.53 2.58
Hispanic or Latino 0.61 0.59 0.36 0.48 0.70 0.66 1.06 1.04 0.80 0.74
EDUCATION LEVEL                    
< High School da da da da 0.83 0.88 1.32 1.28 0.93 0.99
High School Graduate da da da da 0.57 0.68 0.74 0.82 0.67 0.80
Some College/Associate’s Degree da da da da 0.60 0.64 0.83 0.81 0.70 0.74
College Graduate da da da da 0.55 0.58 1.32 1.26 0.57 0.60
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.50 0.49 0.81 0.95 0.53 0.53
Part‑Time da da da da 0.86 0.89 0.92 1.01 1.11 1.12
Unemployed da da da da 1.29 1.43 1.51 1.27 1.72 1.92
Other1 da da da da 0.49 0.56 0.87 0.79 0.54 0.61

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.35P – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3578   0.9074   0.3108   0.0224   0.5809  
SEX                    
Male 0.1032   0.1463   0.0738   0.0185   0.1839  
Female 0.5727   0.0663   0.5408   0.3374   0.3886  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4919   0.7340   0.4579   0.0028   0.8480  
AIAN 0.3941   0.6253   0.4148   0.0340   0.2470  
Asian 0.2211   0.5238   0.2328   0.2201   0.1323  
Black or African American 0.5385   0.4583   0.5895   0.0865   0.3353  
NHPI 0.6118   *   0.6090   *   *  
White 0.1004   0.1365   0.0973   0.0799   0.1622  
Two or More Races 0.4640   0.0115   0.7378   0.0052   0.2968  
Hispanic or Latino 0.5353   0.7408   0.4633   0.6807   0.3592  
EDUCATION LEVEL                    
< High School da   da   0.6865   0.0901   0.9820  
High School Graduate da   da   0.3228   0.6972   0.2550  
Some College/Associate’s Degree da   da   0.3655   0.0408   0.6604  
College Graduate da   da   0.1124   0.3377   0.1383  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.3111   0.7508   0.3235  
Part‑Time da   da   0.5580   0.8055   0.4557  
Unemployed da   da   0.3902   0.0052   0.9604  
Other1 da   da   0.6380   0.0093   0.9101  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.36C – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 409 386 43 49 406 383 120 145 389 344
SEX                    
Male 316 279 29 41 315 276 91 100 298 258
Female 213 221 30 27 209 218 76 87 198 192
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 370 333 38 40 367 333 106 115 353 306
AIAN 26 33 1 * 26 33 * 5 * 33
Asian 85 88 * 5 85 88 25 28 80 84
Black or African American 84 74 13 11 83 73 34 24 75 68
NHPI 9 * 1 * 9 * 2 * 9 *
White 322 302 36 36 318 302 90 105 305 272
Two or More Races 79 73 4 11 79 72 27 24 75 67
Hispanic or Latino 140 162 20 27 138 158 52 72 130 139
EDUCATION LEVEL                    
< High School da da da da 75 74 30 31 69 66
High School Graduate da da da da 139 142 59 73 126 123
Some College/Associate’s Degree da da da da 225 192 80 93 212 165
College Graduate da da da da 267 265 52 60 262 253
EMPLOYMENT STATUS                    
Full‑Time da da da da 299 273 82 87 283 253
Part‑Time da da da da 131 148 55 82 124 115
Unemployed da da da da 100 97 39 39 93 88
Other1 da da da da 181 146 49 46 175 140

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.36D – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.13 0.13 0.16 0.19 0.15 0.14 0.33 0.37 0.16 0.14
SEX                    
Male 0.22 0.19 0.22 0.31 0.24 0.21 0.51 0.52 0.26 0.23
Female 0.14 0.14 0.23 0.22 0.15 0.15 0.43 0.46 0.17 0.16
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.15 0.14 0.20 0.21 0.16 0.15 0.39 0.40 0.18 0.16
AIAN 1.84 1.70 0.70 * 2.16 1.97 * 2.34 * 2.24
Asian 0.44 0.45 * 0.30 0.48 0.49 1.01 1.05 0.53 0.55
Black or African American 0.23 0.21 0.37 0.33 0.26 0.23 0.71 0.54 0.28 0.26
NHPI 0.78 * 0.82 * 0.83 * 1.41 * 0.93 *
White 0.18 0.17 0.27 0.30 0.19 0.18 0.48 0.55 0.21 0.19
Two or More Races 1.14 0.75 0.39 0.80 1.36 0.87 2.21 1.36 1.62 1.04
Hispanic or Latino 0.26 0.27 0.29 0.39 0.29 0.31 0.59 0.72 0.33 0.34
EDUCATION LEVEL                    
< High School da da da da 0.31 0.30 0.82 0.80 0.33 0.32
High School Graduate da da da da 0.20 0.20 0.48 0.55 0.22 0.21
Some College/Associate’s Degree da da da da 0.28 0.24 0.58 0.62 0.32 0.25
College Graduate da da da da 0.27 0.26 0.85 0.91 0.29 0.27
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.24 0.22 0.56 0.62 0.25 0.23
Part‑Time da da da da 0.39 0.40 0.61 0.79 0.51 0.43
Unemployed da da da da 0.72 0.69 1.01 0.93 0.93 0.91
Other1 da da da da 0.19 0.15 0.57 0.50 0.20 0.15

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.36P – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0108   0.5550   0.0118   0.1265   0.0281  
SEX                    
Male 0.0080   0.4180   0.0053   0.1564   0.0112  
Female 0.4013   0.0470   0.5456   0.4257   0.7303  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0017   0.5341   0.0020   0.0353   0.0094  
AIAN 0.4700   *   0.4588   *   *  
Asian 0.6754   *   0.6358   0.8973   0.6426  
Black or African American 0.1532   0.6951   0.1303   0.0906   0.3332  
NHPI *   *   *   *   *  
White 0.0028   0.1720   0.0042   0.1672   0.0098  
Two or More Races 0.1106   0.0266   0.0578   0.0556   0.1871  
Hispanic or Latino 0.5091   0.8870   0.5025   0.5987   0.6635  
EDUCATION LEVEL                    
< High School da   da   0.8674   0.3168   0.5644  
High School Graduate da   da   0.1872   0.5982   0.1813  
Some College/Associate’s Degree da   da   0.0546   0.2754   0.0972  
College Graduate da   da   0.1170   0.4733   0.1473  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.0136   0.1559   0.0289  
Part‑Time da   da   0.7246   0.5190   0.4249  
Unemployed da   da   0.1439   0.1957   0.3024  
Other1 da   da   0.6886   0.1268   0.9755  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.37C – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 181 191 28 23 179 192 51 71 170 176
SEX                    
Male 152 141 19 20 151 140 38 56 148 125
Female 90 115 19 12 88 114 36 43 79 106
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 168 168 25 20 166 169 45 55 160 159
AIAN 5 15 <1 * 5 15 * 1 2 15
Asian 37 31 * * 37 31 3 12 37 29
Black or African American 50 33 <1 6 50 33 22 12 45 31
NHPI 7 2 * * 7 2 1 * * 2
White 145 155 25 19 143 157 38 49 138 148
Two or More Races 40 29 4 <1 40 29 6 13 39 26
Hispanic or Latino 63 80 11 11 62 79 26 45 57 67
EDUCATION LEVEL                    
< High School da da da da 48 49 14 24 46 42
High School Graduate da da da da 78 77 29 49 72 59
Some College/Associate’s Degree da da da da 81 91 29 43 76 80
College Graduate da da da da 127 143 26 32 123 136
EMPLOYMENT STATUS                    
Full‑Time da da da da 145 155 35 51 138 143
Part‑Time da da da da 58 70 22 33 54 63
Unemployed da da da da 35 32 19 28 29 14
Other1 da da da da 77 74 24 27 73 70

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.37D – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.06 0.06 0.11 0.09 0.07 0.07 0.14 0.19 0.07 0.08
SEX                    
Male 0.11 0.10 0.15 0.15 0.12 0.11 0.21 0.30 0.13 0.11
Female 0.06 0.08 0.15 0.10 0.07 0.08 0.21 0.24 0.07 0.09
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.07 0.07 0.13 0.11 0.08 0.08 0.17 0.21 0.08 0.08
AIAN 0.37 0.82 0.19 * 0.43 0.95 * 0.41 0.19 1.09
Asian 0.20 0.16 * * 0.21 0.18 0.11 0.45 0.25 0.19
Black or African American 0.14 0.10 0.01 0.17 0.16 0.10 0.47 0.27 0.17 0.12
NHPI 0.53 0.18 * * 0.57 0.19 0.66 * * 0.20
White 0.08 0.09 0.20 0.16 0.09 0.10 0.21 0.28 0.10 0.11
Two or More Races 0.61 0.31 0.39 0.03 0.72 0.36 0.56 0.78 0.90 0.41
Hispanic or Latino 0.12 0.14 0.16 0.17 0.13 0.15 0.29 0.46 0.15 0.16
EDUCATION LEVEL                    
< High School da da da da 0.20 0.20 0.40 0.63 0.22 0.21
High School Graduate da da da da 0.11 0.11 0.24 0.38 0.12 0.10
Some College/Associate’s Degree da da da da 0.10 0.12 0.22 0.32 0.12 0.12
College Graduate da da da da 0.14 0.15 0.44 0.50 0.14 0.15
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.12 0.13 0.24 0.37 0.13 0.13
Part‑Time da da da da 0.18 0.19 0.25 0.34 0.23 0.24
Unemployed da da da da 0.27 0.23 0.52 0.69 0.32 0.15
Other1 da da da da 0.08 0.08 0.28 0.30 0.08 0.08

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.37P – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7496   0.5933   0.7948   0.1382   0.4077  
SEX                    
Male 0.4856   0.6533   0.4400   0.1371   0.1726  
Female 0.6367   0.1671   0.4926   0.6112   0.5980  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3674   0.5990   0.4002   0.5841   0.2873  
AIAN 0.3129   *   0.3763   *   0.1907  
Asian 0.6546   *   0.6522   0.2605   0.4574  
Black or African American 0.0495   0.0520   0.0303   0.1896   0.0734  
NHPI 0.4213   *   0.4211   *   *  
White 0.9308   0.4488   0.9877   0.3920   0.8070  
Two or More Races 0.1213   0.2153   0.1367   0.4698   0.0852  
Hispanic or Latino 0.1914   0.8834   0.1824   0.0797   0.6433  
EDUCATION LEVEL                    
< High School da   da   0.2518   0.3853   0.3959  
High School Graduate da   da   0.5345   0.5394   0.2469  
Some College/Associate’s Degree da   da   0.5624   0.1823   0.9921  
College Graduate da   da   0.4088   0.9870   0.3882  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.4342   0.8335   0.3665  
Part‑Time da   da   0.3846   0.1678   0.7737  
Unemployed da   da   0.4706   0.6427   0.1217  
Other1 da   da   0.5373   0.2022   0.8328  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.38C – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 727 ‑‑ 76 ‑‑ 718 ‑‑ 145 ‑‑ 688
SEX                    
Male ‑‑ 569 ‑‑ 50 ‑‑ 563 ‑‑ 94 ‑‑ 546
Female ‑‑ 374 ‑‑ 54 ‑‑ 367 ‑‑ 96 ‑‑ 352
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 672 ‑‑ 61 ‑‑ 664 ‑‑ 127 ‑‑ 637
AIAN ‑‑ 43 ‑‑ 4 ‑‑ 42 ‑‑ 6 ‑‑ 42
Asian ‑‑ 107 ‑‑ 14 ‑‑ 107 ‑‑ 54 ‑‑ 93
Black or African American ‑‑ 116 ‑‑ 31 ‑‑ 114 ‑‑ 31 ‑‑ 110
NHPI ‑‑ 8 ‑‑ * ‑‑ 8 ‑‑ * ‑‑ 7
White ‑‑ 603 ‑‑ 48 ‑‑ 600 ‑‑ 101 ‑‑ 583
Two or More Races ‑‑ 166 ‑‑ 13 ‑‑ 165 ‑‑ 24 ‑‑ 159
Hispanic or Latino ‑‑ 210 ‑‑ 39 ‑‑ 206 ‑‑ 63 ‑‑ 197
EDUCATION LEVEL                    
< High School da da da da ‑‑ 164 ‑‑ 24 ‑‑ 161
High School Graduate da da da da ‑‑ 360 ‑‑ 67 ‑‑ 352
Some College/Associate’s Degree da da da da ‑‑ 411 ‑‑ 103 ‑‑ 390
College Graduate da da da da ‑‑ 369 ‑‑ 64 ‑‑ 355
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 433 ‑‑ 83 ‑‑ 415
Part‑Time da da da da ‑‑ 246 ‑‑ 75 ‑‑ 233
Unemployed da da da da ‑‑ 142 ‑‑ 38 ‑‑ 137
Other1 da da da da ‑‑ 420 ‑‑ 60 ‑‑ 419

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.38D – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.22 ‑‑ 0.29 ‑‑ 0.24 ‑‑ 0.38 ‑‑ 0.27
SEX                    
Male ‑‑ 0.37 ‑‑ 0.37 ‑‑ 0.40 ‑‑ 0.50 ‑‑ 0.46
Female ‑‑ 0.23 ‑‑ 0.42 ‑‑ 0.25 ‑‑ 0.51 ‑‑ 0.28
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 0.25 ‑‑ 0.31 ‑‑ 0.27 ‑‑ 0.44 ‑‑ 0.30
AIAN ‑‑ 2.18 ‑‑ 1.35 ‑‑ 2.49 ‑‑ 2.80 ‑‑ 2.85
Asian ‑‑ 0.54 ‑‑ 0.93 ‑‑ 0.59 ‑‑ 1.95 ‑‑ 0.60
Black or African American ‑‑ 0.33 ‑‑ 0.88 ‑‑ 0.36 ‑‑ 0.67 ‑‑ 0.41
NHPI ‑‑ 0.75 ‑‑ * ‑‑ 0.80 ‑‑ * ‑‑ 0.79
White ‑‑ 0.32 ‑‑ 0.39 ‑‑ 0.34 ‑‑ 0.54 ‑‑ 0.37
Two or More Races ‑‑ 1.59 ‑‑ 0.92 ‑‑ 1.83 ‑‑ 1.34 ‑‑ 2.21
Hispanic or Latino ‑‑ 0.36 ‑‑ 0.55 ‑‑ 0.41 ‑‑ 0.65 ‑‑ 0.48
EDUCATION LEVEL                    
< High School da da da da ‑‑ 0.65 ‑‑ 0.64 ‑‑ 0.75
High School Graduate da da da da ‑‑ 0.48 ‑‑ 0.51 ‑‑ 0.57
Some College/Associate’s Degree da da da da ‑‑ 0.49 ‑‑ 0.73 ‑‑ 0.56
College Graduate da da da da ‑‑ 0.34 ‑‑ 0.97 ‑‑ 0.36
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 0.33 ‑‑ 0.58 ‑‑ 0.36
Part‑Time da da da da ‑‑ 0.66 ‑‑ 0.73 ‑‑ 0.86
Unemployed da da da da ‑‑ 0.99 ‑‑ 0.91 ‑‑ 1.35
Other1 da da da da ‑‑ 0.41 ‑‑ 0.64 ‑‑ 0.45

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.39C – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 196 ‑‑ 41 ‑‑ 192 ‑‑ 89 ‑‑ 163
SEX                    
Male ‑‑ 163 ‑‑ 29 ‑‑ 160 ‑‑ 53 ‑‑ 147
Female ‑‑ 95 ‑‑ 27 ‑‑ 90 ‑‑ 60 ‑‑ 65
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 148 ‑‑ 30 ‑‑ 144 ‑‑ 67 ‑‑ 122
AIAN ‑‑ 2 ‑‑ 1 ‑‑ 2 ‑‑ 1 ‑‑ 1
Asian ‑‑ 37 ‑‑ 12 ‑‑ 35 ‑‑ 32 ‑‑ 16
Black or African American ‑‑ 51 ‑‑ 14 ‑‑ 49 ‑‑ 23 ‑‑ 43
NHPI ‑‑ 2 ‑‑ * ‑‑ 2 ‑‑ * ‑‑ 2
White ‑‑ 121 ‑‑ 24 ‑‑ 118 ‑‑ 49 ‑‑ 101
Two or More Races ‑‑ 51 ‑‑ 9 ‑‑ 51 ‑‑ 16 ‑‑ 47
Hispanic or Latino ‑‑ 116 ‑‑ 26 ‑‑ 114 ‑‑ 50 ‑‑ 102
EDUCATION LEVEL                    
< High School da da da da ‑‑ 62 ‑‑ 13 ‑‑ 61
High School Graduate da da da da ‑‑ 57 ‑‑ 30 ‑‑ 48
Some College/Associate’s Degree da da da da ‑‑ 125 ‑‑ 69 ‑‑ 105
College Graduate da da da da ‑‑ 112 ‑‑ 37 ‑‑ 97
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 122 ‑‑ 40 ‑‑ 113
Part‑Time da da da da ‑‑ 100 ‑‑ 45 ‑‑ 89
Unemployed da da da da ‑‑ 64 ‑‑ 29 ‑‑ 57
Other1 da da da da ‑‑ 66 ‑‑ 41 ‑‑ 52

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.39D – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.07 ‑‑ 0.16 ‑‑ 0.07 ‑‑ 0.24 ‑‑ 0.07
SEX                    
Male ‑‑ 0.11 ‑‑ 0.22 ‑‑ 0.12 ‑‑ 0.29 ‑‑ 0.13
Female ‑‑ 0.06 ‑‑ 0.22 ‑‑ 0.07 ‑‑ 0.33 ‑‑ 0.05
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 0.06 ‑‑ 0.16 ‑‑ 0.07 ‑‑ 0.24 ‑‑ 0.06
AIAN ‑‑ 0.10 ‑‑ 0.28 ‑‑ 0.10 ‑‑ 0.45 ‑‑ 0.10
Asian ‑‑ 0.20 ‑‑ 0.77 ‑‑ 0.20 ‑‑ 1.22 ‑‑ 0.10
Black or African American ‑‑ 0.15 ‑‑ 0.41 ‑‑ 0.16 ‑‑ 0.49 ‑‑ 0.16
NHPI ‑‑ 0.17 ‑‑ * ‑‑ 0.18 ‑‑ * ‑‑ 0.20
White ‑‑ 0.07 ‑‑ 0.19 ‑‑ 0.07 ‑‑ 0.27 ‑‑ 0.07
Two or More Races ‑‑ 0.53 ‑‑ 0.68 ‑‑ 0.61 ‑‑ 0.91 ‑‑ 0.73
Hispanic or Latino ‑‑ 0.20 ‑‑ 0.38 ‑‑ 0.23 ‑‑ 0.52 ‑‑ 0.25
EDUCATION LEVEL                    
< High School da da da da ‑‑ 0.26 ‑‑ 0.34 ‑‑ 0.29
High School Graduate da da da da ‑‑ 0.08 ‑‑ 0.23 ‑‑ 0.08
Some College/Associate’s Degree da da da da ‑‑ 0.16 ‑‑ 0.50 ‑‑ 0.16
College Graduate da da da da ‑‑ 0.12 ‑‑ 0.59 ‑‑ 0.11
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 0.10 ‑‑ 0.29 ‑‑ 0.11
Part‑Time da da da da ‑‑ 0.28 ‑‑ 0.45 ‑‑ 0.35
Unemployed da da da da ‑‑ 0.46 ‑‑ 0.71 ‑‑ 0.59
Other1 da da da da ‑‑ 0.07 ‑‑ 0.46 ‑‑ 0.06

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.40C – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 124 ‑‑ 26 ‑‑ 121 ‑‑ 39 ‑‑ 114
SEX                    
Male ‑‑ 114 ‑‑ 22 ‑‑ 112 ‑‑ 31 ‑‑ 107
Female ‑‑ 45 ‑‑ 14 ‑‑ 43 ‑‑ 22 ‑‑ 37
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 98 ‑‑ 16 ‑‑ 97 ‑‑ 33 ‑‑ 91
AIAN ‑‑ 2 ‑‑ <1 ‑‑ 2 ‑‑ 1 ‑‑ 1
Asian ‑‑ 21 ‑‑ 8 ‑‑ 20 ‑‑ 13 ‑‑ 14
Black or African American ‑‑ 16 ‑‑ 8 ‑‑ 13 ‑‑ 9 ‑‑ 10
NHPI ‑‑ <1 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 83 ‑‑ 11 ‑‑ 82 ‑‑ 24 ‑‑ 78
Two or More Races ‑‑ 45 ‑‑ 1 ‑‑ 45 ‑‑ 11 ‑‑ 43
Hispanic or Latino ‑‑ 77 ‑‑ 21 ‑‑ 74 ‑‑ 22 ‑‑ 70
EDUCATION LEVEL                    
< High School da da da da ‑‑ 59 ‑‑ 11 ‑‑ 58
High School Graduate da da da da ‑‑ 30 ‑‑ 12 ‑‑ 28
Some College/Associate’s Degree da da da da ‑‑ 82 ‑‑ 29 ‑‑ 76
College Graduate da da da da ‑‑ 61 ‑‑ 22 ‑‑ 57
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 67 ‑‑ 23 ‑‑ 63
Part‑Time da da da da ‑‑ 87 ‑‑ 19 ‑‑ 84
Unemployed da da da da ‑‑ 33 ‑‑ 4 ‑‑ 33
Other1 da da da da ‑‑ 41 ‑‑ 25 ‑‑ 32

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.40D – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.04 ‑‑ 0.10 ‑‑ 0.05 ‑‑ 0.11 ‑‑ 0.05
SEX                    
Male ‑‑ 0.08 ‑‑ 0.17 ‑‑ 0.09 ‑‑ 0.17 ‑‑ 0.10
Female ‑‑ 0.03 ‑‑ 0.11 ‑‑ 0.03 ‑‑ 0.12 ‑‑ 0.03
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 0.04 ‑‑ 0.08 ‑‑ 0.04 ‑‑ 0.12 ‑‑ 0.05
AIAN ‑‑ 0.09 ‑‑ 0.17 ‑‑ 0.10 ‑‑ 0.43 ‑‑ 0.09
Asian ‑‑ 0.11 ‑‑ 0.50 ‑‑ 0.11 ‑‑ 0.52 ‑‑ 0.10
Black or African American ‑‑ 0.05 ‑‑ 0.24 ‑‑ 0.04 ‑‑ 0.20 ‑‑ 0.04
NHPI ‑‑ 0.03 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 0.05 ‑‑ 0.09 ‑‑ 0.05 ‑‑ 0.14 ‑‑ 0.06
Two or More Races ‑‑ 0.47 ‑‑ 0.05 ‑‑ 0.54 ‑‑ 0.66 ‑‑ 0.67
Hispanic or Latino ‑‑ 0.13 ‑‑ 0.31 ‑‑ 0.15 ‑‑ 0.23 ‑‑ 0.17
EDUCATION LEVEL                    
< High School da da da da ‑‑ 0.24 ‑‑ 0.29 ‑‑ 0.28
High School Graduate da da da da ‑‑ 0.04 ‑‑ 0.09 ‑‑ 0.05
Some College/Associate’s Degree da da da da ‑‑ 0.11 ‑‑ 0.21 ‑‑ 0.12
College Graduate da da da da ‑‑ 0.07 ‑‑ 0.34 ‑‑ 0.07
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 0.06 ‑‑ 0.16 ‑‑ 0.06
Part‑Time da da da da ‑‑ 0.25 ‑‑ 0.20 ‑‑ 0.33
Unemployed da da da da ‑‑ 0.24 ‑‑ 0.09 ‑‑ 0.34
Other1 da da da da ‑‑ 0.04 ‑‑ 0.29 ‑‑ 0.04

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.41C – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 556 581 28 23 556 580 51 57 551 570
SEX                    
Male 454 433 11 12 454 433 40 36 450 430
Female 279 354 25 19 279 354 30 42 276 350
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 502 542 27 21 501 540 38 51 497 530
AIAN 24 60 * * 24 60 * * 24 60
Asian 54 62 * * 53 62 5 * 53 62
Black or African American 74 65 3 3 74 65 5 14 73 64
NHPI 11 31 * * 11 * * * 11 *
White 481 503 25 20 481 501 37 47 478 493
Two or More Races 77 148 4 2 77 148 4 7 77 148
Hispanic or Latino 227 198 7 9 226 197 34 25 222 196
EDUCATION LEVEL                    
< High School da da da da 134 176 17 17 132 174
High School Graduate da da da da 288 343 38 34 285 340
Some College/Associate’s Degree da da da da 326 336 25 39 324 332
College Graduate da da da da 232 213 9 9 231 213
EMPLOYMENT STATUS                    
Full‑Time da da da da 321 325 22 35 320 321
Part‑Time da da da da 182 210 14 27 181 207
Unemployed da da da da 109 148 23 19 107 146
Other1 da da da da 339 367 32 27 337 364

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.41D – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.18 0.18 0.11 0.09 0.20 0.20 0.15 0.16 0.23 0.23
SEX                    
Male 0.30 0.29 0.08 0.09 0.33 0.31 0.22 0.20 0.38 0.36
Female 0.19 0.22 0.20 0.15 0.20 0.24 0.17 0.23 0.23 0.28
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.20 0.21 0.14 0.11 0.22 0.23 0.15 0.19 0.24 0.26
AIAN 1.67 2.88 * * 1.97 3.32 * * 2.27 3.80
Asian 0.28 0.32 * * 0.31 0.35 0.22 * 0.36 0.41
Black or African American 0.21 0.19 0.07 0.10 0.23 0.21 0.12 0.29 0.27 0.24
NHPI 0.93 2.88 * * 1.00 * * * 1.17 *
White 0.26 0.28 0.20 0.17 0.28 0.30 0.20 0.27 0.32 0.33
Two or More Races 1.12 1.41 0.35 0.12 1.32 1.62 0.36 0.44 1.68 2.04
Hispanic or Latino 0.40 0.33 0.10 0.13 0.46 0.37 0.39 0.26 0.55 0.46
EDUCATION LEVEL                    
< High School da da da da 0.56 0.68 0.47 0.44 0.65 0.80
High School Graduate da da da da 0.38 0.45 0.31 0.27 0.46 0.55
Some College/Associate’s Degree da da da da 0.39 0.41 0.19 0.29 0.47 0.49
College Graduate da da da da 0.24 0.22 0.15 0.14 0.26 0.23
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.25 0.26 0.16 0.25 0.29 0.29
Part‑Time da da da da 0.55 0.57 0.16 0.27 0.74 0.77
Unemployed da da da da 0.81 1.03 0.63 0.45 1.11 1.44
Other1 da da da da 0.34 0.35 0.38 0.31 0.37 0.38

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.41P – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.8570   0.3525   0.8510   0.8906   0.9027  
SEX                    
Male 0.1364   0.2698   0.1365   0.4460   0.1733  
Female 0.0743   0.6390   0.0757   0.5556   0.0817  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7624   0.4070   0.7597   0.3286   0.8086  
AIAN 0.3005   *   0.3076   *   0.3001  
Asian 0.2926   *   0.3390   *   0.3878  
Black or African American 0.9881   0.8718   0.9849   0.1045   0.8001  
NHPI 0.2435   *   *   *   *  
White 0.8020   0.6848   0.7823   0.4445   0.7164  
Two or More Races 0.0958   0.1826   0.1077   0.9364   0.1070  
Hispanic or Latino 0.2674   0.6580   0.2545   0.0913   0.3947  
EDUCATION LEVEL                    
< High School da   da   0.5207   0.7405   0.4740  
High School Graduate da   da   0.5318   0.4103   0.4137  
Some College/Associate’s Degree da   da   0.7452   0.4463   0.7070  
College Graduate da   da   0.2726   0.9353   0.2710  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.4732   0.2055   0.4021  
Part‑Time da   da   0.2608   0.4251   0.2743  
Unemployed da   da   0.7882   0.4149   0.9686  
Other1 da   da   0.7983   0.1356   0.8995  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.42C – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 186 236 24 16 183 236 29 36 180 234
SEX                    
Male 160 177 5 12 160 176 25 15 157 176
Female 87 145 24 11 83 145 13 32 83 143
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 172 216 24 13 169 216 22 35 167 214
AIAN 8 43 * * 8 * <1 1 8 *
Asian 25 37 * * 24 37 * * 24 37
Black or African American 37 27 3 3 37 27 4 6 36 26
NHPI 5 2 * * 5 2 * * 5 2
White 159 194 22 13 157 194 21 34 156 192
Two or More Races 26 64 4 * 25 64 4 2 25 64
Hispanic or Latino 86 94 4 9 86 93 18 9 84 93
EDUCATION LEVEL                    
< High School da da da da 74 74 13 7 72 73
High School Graduate da da da da 115 133 21 18 113 131
Some College/Associate’s Degree da da da da 102 148 14 29 102 145
College Graduate da da da da 39 72 1 8 39 72
EMPLOYMENT STATUS                    
Full‑Time da da da da 77 108 10 23 76 107
Part‑Time da da da da 60 99 3 25 60 96
Unemployed da da da da 66 75 14 8 64 74
Other1 da da da da 130 151 21 9 128 150

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.42D – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.06 0.08 0.09 0.06 0.07 0.09 0.08 0.10 0.08 0.10
SEX                    
Male 0.11 0.12 0.04 0.09 0.12 0.14 0.14 0.08 0.14 0.16
Female 0.06 0.10 0.19 0.09 0.06 0.10 0.08 0.18 0.07 0.12
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.07 0.09 0.13 0.07 0.08 0.10 0.09 0.13 0.09 0.11
AIAN 0.62 2.24 * * 0.73 * 0.24 0.32 0.84 *
Asian 0.14 0.19 * * 0.14 0.21 * * 0.16 0.24
Black or African American 0.11 0.08 0.07 0.10 0.12 0.09 0.10 0.14 0.13 0.10
NHPI 0.43 0.17 * * 0.46 0.18 * * 0.53 0.20
White 0.09 0.11 0.18 0.11 0.10 0.12 0.12 0.19 0.11 0.14
Two or More Races 0.40 0.67 0.34 * 0.47 0.78 0.35 0.14 0.59 0.98
Hispanic or Latino 0.16 0.16 0.06 0.13 0.18 0.18 0.21 0.09 0.21 0.22
EDUCATION LEVEL                    
< High School da da da da 0.31 0.30 0.37 0.19 0.35 0.35
High School Graduate da da da da 0.16 0.18 0.17 0.14 0.19 0.22
Some College/Associate’s Degree da da da da 0.13 0.19 0.11 0.22 0.16 0.22
College Graduate da da da da 0.04 0.08 0.01 0.13 0.05 0.08
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.06 0.09 0.07 0.16 0.07 0.10
Part‑Time da da da da 0.19 0.28 0.04 0.25 0.25 0.38
Unemployed da da da da 0.50 0.53 0.37 0.21 0.68 0.76
Other1 da da da da 0.14 0.15 0.25 0.11 0.15 0.17

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.42P – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4002   0.4159   0.3636   0.6413   0.3150  
SEX                    
Male 0.8244   0.8311   0.8245   0.0592   0.9694  
Female 0.0664   0.4220   0.0482   0.3221   0.0742  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3159   0.3413   0.2750   0.8162   0.2843  
AIAN 0.2340   *   *   0.8229   *  
Asian 0.6784   *   0.5420   *   0.5386  
Black or African American 0.4467   0.8718   0.4474   0.8026   0.4210  
NHPI 0.2902   *   0.2904   *   0.2824  
White 0.4443   0.6788   0.4261   0.6592   0.4668  
Two or More Races 0.6903   *   0.6411   0.0830   0.5377  
Hispanic or Latino 0.8551   0.8083   0.8254   0.1415   0.9672  
EDUCATION LEVEL                    
< High School da   da   0.7087   0.2854   0.8324  
High School Graduate da   da   0.4875   0.2566   0.6264  
Some College/Associate’s Degree da   da   0.0770   0.6161   0.0864  
College Graduate da   da   0.1252   0.2393   0.1542  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1012   0.3927   0.1347  
Part‑Time da   da   0.1976   0.1500   0.3066  
Unemployed da   da   0.5313   0.3775   0.6646  
Other1 da   da   0.7356   0.0069   0.9823  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.43C – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 151 183 22 12 150 183 20 25 148 181
SEX                    
Male 129 155 4 12 129 154 18 8 127 154
Female 62 88 22 3 58 88 6 23 58 85
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 130 163 22 12 128 163 17 23 126 161
AIAN 3 * * * 3 * <1 1 3 *
Asian 19 37 * * 19 37 * * 19 37
Black or African American 28 20 3 3 28 20 4 6 27 19
NHPI 2 2 * * 2 2 * * 2 2
White 117 144 22 12 115 144 16 22 113 143
Two or More Races 24 39 3 * 24 39 3 * 24 39
Hispanic or Latino 66 80 1 * 66 80 10 9 65 79
EDUCATION LEVEL                    
< High School da da da da 48 68 4 6 46 67
High School Graduate da da da da 96 88 14 13 95 87
Some College/Associate’s Degree da da da da 78 126 13 18 77 125
College Graduate da da da da 36 61 * 8 36 61
EMPLOYMENT STATUS                    
Full‑Time da da da da 54 86 7 22 53 83
Part‑Time da da da da 19 95 <1 10 19 95
Unemployed da da da da 58 62 5 5 57 62
Other1 da da da da 112 108 17 2 110 108

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.43D – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.06 0.09 0.05 0.06 0.07 0.06 0.07 0.06 0.08
SEX                    
Male 0.09 0.11 0.03 0.09 0.10 0.12 0.10 0.04 0.11 0.14
Female 0.04 0.06 0.17 0.03 0.04 0.06 0.04 0.13 0.05 0.07
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.06 0.07 0.12 0.07 0.06 0.08 0.06 0.09 0.07 0.09
AIAN 0.21 * * * 0.25 * 0.14 0.32 0.29 *
Asian 0.10 0.19 * * 0.11 0.21 * * 0.13 0.24
Black or African American 0.08 0.06 0.07 0.10 0.09 0.06 0.10 0.13 0.10 0.07
NHPI 0.13 0.17 * * 0.14 0.18 * * 0.16 0.20
White 0.07 0.09 0.17 0.10 0.07 0.09 0.09 0.13 0.08 0.10
Two or More Races 0.38 0.40 0.26 * 0.45 0.47 0.26 * 0.56 0.59
Hispanic or Latino 0.12 0.14 0.01 * 0.14 0.16 0.11 0.09 0.17 0.19
EDUCATION LEVEL                    
< High School da da da da 0.20 0.27 0.11 0.16 0.23 0.32
High School Graduate da da da da 0.13 0.12 0.11 0.10 0.16 0.15
Some College/Associate’s Degree da da da da 0.10 0.16 0.10 0.14 0.12 0.19
College Graduate da da da da 0.04 0.07 * 0.13 0.04 0.07
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.04 0.07 0.05 0.16 0.05 0.08
Part‑Time da da da da 0.06 0.27 <0.01 0.11 0.08 0.37
Unemployed da da da da 0.44 0.44 0.14 0.13 0.61 0.63
Other1 da da da da 0.12 0.11 0.20 0.02 0.13 0.12

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.43P – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1723   0.4492   0.1503   0.9194   0.1461  
SEX                    
Male 0.4038   0.7741   0.4180   0.0654   0.3058  
Female 0.1389   0.3023   0.0858   0.0898   0.1705  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2534   0.4714   0.2200   0.8679   0.2209  
AIAN *   *   *   0.4214   *  
Asian 0.3970   *   0.3977   *   0.3954  
Black or African American 0.8997   0.8404   0.9173   0.9374   0.9039  
NHPI 0.8565   *   0.8581   *   0.8816  
White 0.3218   0.5854   0.2898   0.7071   0.3114  
Two or More Races 0.2922   *   0.3124   *   0.3796  
Hispanic or Latino 0.4042   *   0.4081   0.9229   0.3873  
EDUCATION LEVEL                    
< High School da   da   0.5675   0.5408   0.5909  
High School Graduate da   da   0.3618   0.6607   0.4073  
Some College/Associate’s Degree da   da   0.0236   0.9400   0.0209  
College Graduate da   da   0.2420   *   0.2909  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.0511   0.1766   0.0912  
Part‑Time da   da   0.0094   0.0984   0.0143  
Unemployed da   da   0.8381   0.4684   0.8206  
Other1 da   da   0.4953   0.0052   0.7095  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.44C – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,236 1,300 120 126 1,215 1,271 183 197 1,158 1,246
SEX                    
Male 772 829 86 91 763 813 126 117 736 795
Female 789 866 89 83 777 857 123 143 758 846
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,138 1,155 97 107 1,118 1,135 158 163 1,077 1,120
AIAN 43 54 5 11 43 52 10 9 40 51
Asian 250 196 25 26 248 198 47 52 242 190
Black or African American 376 422 43 42 371 417 59 69 357 406
NHPI 52 57 * * 50 57 * 1 49 *
White 991 1,024 82 85 977 1,012 135 129 942 1,000
Two or More Races 110 193 19 24 108 189 26 32 104 184
Hispanic or Latino 442 496 71 64 439 476 91 102 416 455
EDUCATION LEVEL                    
< High School da da da da 330 381 51 60 322 374
High School Graduate da da da da 581 678 100 97 568 666
Some College/Associate’s Degree da da da da 616 587 112 134 595 571
College Graduate da da da da 580 581 58 66 568 574
EMPLOYMENT STATUS                    
Full‑Time da da da da 657 708 105 117 641 698
Part‑Time da da da da 319 316 87 105 304 297
Unemployed da da da da 167 216 46 51 159 211
Other1 da da da da 804 848 89 86 788 843

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.44D – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.32 0.35 0.42 0.44 0.34 0.38 0.44 0.45 0.39 0.43
SEX                    
Male 0.43 0.50 0.60 0.63 0.47 0.54 0.65 0.57 0.53 0.63
Female 0.43 0.46 0.64 0.61 0.46 0.49 0.62 0.67 0.52 0.56
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.36 0.38 0.46 0.50 0.39 0.41 0.51 0.52 0.43 0.46
AIAN 2.79 2.83 2.54 3.52 3.34 3.31 5.33 3.74 3.67 3.82
Asian 1.19 0.98 1.62 1.55 1.29 1.07 1.80 1.89 1.46 1.20
Black or African American 0.80 0.97 1.09 1.12 0.89 1.07 1.15 1.33 1.03 1.24
NHPI 3.91 5.19 * * 4.03 5.57 * 1.45 4.57 *
White 0.42 0.46 0.58 0.61 0.45 0.49 0.66 0.67 0.50 0.54
Two or More Races 1.58 1.73 1.77 1.68 1.85 1.99 2.13 1.75 2.30 2.41
Hispanic or Latino 0.66 0.75 0.94 0.88 0.75 0.82 0.93 0.95 0.91 0.97
EDUCATION LEVEL                    
< High School da da da da 1.17 1.29 1.34 1.47 1.34 1.50
High School Graduate da da da da 0.68 0.78 0.73 0.68 0.82 0.94
Some College/Associate’s Degree da da da da 0.61 0.62 0.73 0.86 0.71 0.73
College Graduate da da da da 0.52 0.53 0.89 0.98 0.55 0.56
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.45 0.50 0.68 0.75 0.50 0.57
Part‑Time da da da da 0.84 0.78 0.88 0.93 1.10 1.02
Unemployed da da da da 1.15 1.36 1.18 1.19 1.54 1.92
Other1 da da da da 0.64 0.67 0.95 0.87 0.69 0.73

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.44P – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0271   0.0825   0.0357   0.3566   0.0550  
SEX                    
Male 0.0576   0.3334   0.0672   0.4034   0.1015  
Female 0.1668   0.1466   0.1994   0.6380   0.2310  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1822   0.5398   0.1840   0.4714   0.2278  
AIAN 0.6165   0.2851   0.4891   0.3873   0.5836  
Asian 0.0366   0.8920   0.0350   0.7627   0.0250  
Black or African American 0.1758   0.3903   0.1485   0.9412   0.1362  
NHPI 0.6922   *   0.6859   *   *  
White 0.1188   0.7024   0.1111   0.5687   0.1225  
Two or More Races 0.6235   0.6497   0.6406   0.1421   0.4223  
Hispanic or Latino 0.0181   0.0272   0.0354   0.6002   0.0461  
EDUCATION LEVEL                    
< High School da   da   0.2836   0.7729   0.2398  
High School Graduate da   da   0.6642   0.0097   0.9223  
Some College/Associate’s Degree da   da   0.0299   0.5336   0.0187  
College Graduate da   da   0.0424   0.6018   0.0332  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1097   0.7424   0.1198  
Part‑Time da   da   0.0215   0.5374   0.0280  
Unemployed da   da   0.4293   0.4993   0.2827  
Other1 da   da   0.2687   0.6731   0.2856  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.45C – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 321 341 39 49 317 337 84 72 301 327
SEX                    
Male 255 262 25 38 253 257 49 50 246 252
Female 188 210 30 29 185 208 60 50 176 201
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 296 296 32 39 294 292 73 66 281 283
AIAN 11 21 4 4 10 20 * 1 9 20
Asian 51 45 8 8 50 44 15 11 48 43
Black or African American 109 116 8 15 108 115 25 19 106 114
NHPI 16 6 * * 16 6 * * 16 6
White 257 257 29 33 256 255 66 60 246 247
Two or More Races 54 69 6 9 54 68 6 9 54 68
Hispanic or Latino 126 174 24 29 124 169 39 30 117 167
EDUCATION LEVEL                    
< High School da da da da 107 116 20 26 105 114
High School Graduate da da da da 176 207 47 37 172 203
Some College/Associate’s Degree da da da da 199 205 51 49 190 196
College Graduate da da da da 129 135 24 23 128 133
EMPLOYMENT STATUS                    
Full‑Time da da da da 184 185 47 52 178 176
Part‑Time da da da da 90 93 45 31 77 88
Unemployed da da da da 73 87 22 24 69 84
Other1 da da da da 228 270 35 28 226 268

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.45D – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.11 0.11 0.15 0.19 0.12 0.12 0.23 0.20 0.13 0.14
SEX                    
Male 0.18 0.18 0.19 0.28 0.20 0.20 0.27 0.27 0.22 0.23
Female 0.13 0.14 0.23 0.23 0.14 0.15 0.34 0.28 0.15 0.17
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.12 0.12 0.16 0.21 0.13 0.13 0.27 0.24 0.15 0.14
AIAN 0.81 1.09 1.97 1.41 0.88 1.26 * 0.53 0.89 1.44
Asian 0.27 0.23 0.54 0.52 0.29 0.25 0.62 0.42 0.32 0.28
Black or African American 0.30 0.33 0.23 0.45 0.33 0.37 0.53 0.41 0.38 0.43
NHPI 1.27 0.61 * * 1.36 0.64 * * 1.57 0.71
White 0.15 0.15 0.23 0.27 0.16 0.16 0.36 0.34 0.17 0.17
Two or More Races 0.79 0.72 0.56 0.66 0.95 0.83 0.51 0.51 1.18 1.04
Hispanic or Latino 0.23 0.30 0.35 0.43 0.26 0.33 0.43 0.31 0.30 0.40
EDUCATION LEVEL                    
< High School da da da da 0.44 0.47 0.56 0.68 0.51 0.54
High School Graduate da da da da 0.25 0.28 0.38 0.29 0.29 0.34
Some College/Associate’s Degree da da da da 0.25 0.26 0.38 0.36 0.29 0.30
College Graduate da da da da 0.14 0.15 0.40 0.36 0.15 0.15
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.15 0.15 0.33 0.37 0.16 0.17
Part‑Time da da da da 0.27 0.26 0.50 0.31 0.33 0.34
Unemployed da da da da 0.55 0.62 0.57 0.58 0.73 0.85
Other1 da da da da 0.23 0.26 0.41 0.32 0.25 0.29

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.45P – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0992   0.8057   0.0869   0.0788   0.1835  
SEX                    
Male 0.4951   0.3448   0.4131   0.7246   0.4528  
Female 0.0738   0.5122   0.0865   0.0310   0.2474  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0491   0.7474   0.0422   0.1932   0.0751  
AIAN 0.8769   0.9895   0.8740   *   0.6489  
Asian 0.0942   0.9937   0.0899   0.5813   0.1078  
Black or African American 0.1535   0.3992   0.1227   0.0576   0.2413  
NHPI 0.2448   *   0.2121   *   0.2401  
White 0.2722   0.9351   0.2596   0.6578   0.2943  
Two or More Races 0.3107   0.5988   0.3185   0.6346   0.3402  
Hispanic or Latino 0.8237   0.9770   0.8238   0.1850   0.5742  
EDUCATION LEVEL                    
< High School da   da   0.8957   0.8906   0.9226  
High School Graduate da   da   0.1564   0.0762   0.3070  
Some College/Associate’s Degree da   da   0.3630   0.3684   0.4793  
College Graduate da   da   0.5821   0.5594   0.6539  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1728   0.8524   0.1706  
Part‑Time da   da   0.0634   0.0415   0.2723  
Unemployed da   da   0.7643   0.5428   0.9178  
Other1 da   da   0.6193   0.2836   0.7180  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.46C – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 184 168 19 25 184 166 39 36 180 161
SEX                    
Male 150 128 9 20 150 126 19 34 149 121
Female 100 106 17 13 100 106 32 14 94 104
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 166 144 14 20 166 142 25 35 165 136
AIAN 6 3 1 1 5 3 * * 1 3
Asian 12 11 7 1 10 11 2 * 10 11
Black or African American 50 54 4 5 50 54 9 4 49 53
NHPI 2 1 * * 2 1 * * * 1
White 154 115 11 19 153 112 23 33 152 105
Two or More Races 39 60 2 1 39 60 2 2 39 60
Hispanic or Latino 72 89 12 15 71 88 27 8 66 87
EDUCATION LEVEL                    
< High School da da da da 61 72 13 20 59 69
High School Graduate da da da da 88 77 23 19 84 75
Some College/Associate’s Degree da da da da 137 112 20 17 136 110
College Graduate da da da da 59 56 14 15 58 54
EMPLOYMENT STATUS                    
Full‑Time da da da da 73 104 11 28 73 100
Part‑Time da da da da 47 31 25 7 40 31
Unemployed da da da da 35 53 14 15 32 52
Other1 da da da da 157 109 19 14 156 108

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.46D – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.06 0.06 0.07 0.10 0.07 0.06 0.11 0.10 0.08 0.07
SEX                    
Male 0.11 0.09 0.07 0.16 0.12 0.10 0.11 0.18 0.13 0.11
Female 0.07 0.07 0.13 0.11 0.07 0.08 0.18 0.08 0.08 0.09
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.07 0.06 0.07 0.11 0.08 0.07 0.10 0.13 0.09 0.07
AIAN 0.40 0.16 0.51 0.23 0.46 0.18 * * 0.11 0.21
Asian 0.07 0.06 0.49 0.05 0.06 0.06 0.08 * 0.07 0.07
Black or African American 0.14 0.16 0.11 0.15 0.16 0.17 0.20 0.09 0.18 0.20
NHPI 0.13 0.05 * * 0.14 0.05 * * * 0.06
White 0.09 0.07 0.09 0.15 0.10 0.07 0.13 0.19 0.11 0.07
Two or More Races 0.59 0.63 0.19 0.11 0.71 0.73 0.14 0.11 0.89 0.93
Hispanic or Latino 0.13 0.16 0.18 0.21 0.15 0.18 0.30 0.08 0.17 0.22
EDUCATION LEVEL                    
< High School da da da da 0.25 0.29 0.37 0.54 0.29 0.33
High School Graduate da da da da 0.12 0.11 0.19 0.15 0.14 0.13
Some College/Associate’s Degree da da da da 0.17 0.14 0.15 0.13 0.21 0.17
College Graduate da da da da 0.07 0.06 0.24 0.24 0.07 0.06
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.06 0.09 0.08 0.20 0.07 0.10
Part‑Time da da da da 0.14 0.09 0.27 0.07 0.17 0.12
Unemployed da da da da 0.27 0.39 0.38 0.36 0.35 0.53
Other1 da da da da 0.16 0.11 0.23 0.16 0.18 0.12

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.46P – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5428   0.9766   0.5339   0.3912   0.6556  
SEX                    
Male 0.9090   0.2032   0.9728   0.2609   0.8011  
Female 0.2372   0.2001   0.3154   0.0118   0.6836  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.5238   0.5394   0.4750   0.7175   0.4220  
AIAN 0.5574   0.8205   0.5823   *   0.5068  
Asian 0.7617   0.2285   0.7790   *   0.6789  
Black or African American 0.5086   0.6703   0.4817   0.0156   0.7156  
NHPI 0.5648   *   0.5644   *   *  
White 0.4588   0.2744   0.3792   0.2026   0.2341  
Two or More Races 0.6440   0.4187   0.6488   0.8956   0.6460  
Hispanic or Latino 0.9081   0.4601   0.9968   0.0345   0.5688  
EDUCATION LEVEL                    
< High School da   da   0.7894   0.6221   0.8820  
High School Graduate da   da   0.2387   0.1356   0.4110  
Some College/Associate’s Degree da   da   0.9085   0.8182   0.8733  
College Graduate da   da   0.5190   0.7299   0.5645  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1856   0.1651   0.3050  
Part‑Time da   da   0.0339   0.0185   0.2406  
Unemployed da   da   0.9450   0.7557   0.8452  
Other1 da   da   0.2610   0.3954   0.3046  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.47C – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 523 615 93 110 509 594 167 188 484 552
SEX                    
Male 353 409 66 87 342 391 126 136 318 365
Female 353 425 72 66 346 416 94 114 332 390
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 487 545 90 94 473 531 141 160 448 506
AIAN 12 35 2 3 11 35 1 7 11 34
Asian 104 86 19 14 102 85 43 42 94 76
Black or African American 126 150 20 26 122 146 31 33 115 141
NHPI * 23 * * * * * * * *
White 435 503 85 83 420 488 127 141 396 468
Two or More Races 85 100 13 22 84 99 20 34 82 93
Hispanic or Latino 176 230 37 53 170 223 82 88 147 194
EDUCATION LEVEL                    
< High School da da da da 86 149 48 44 71 142
High School Graduate da da da da 224 242 76 80 210 228
Some College/Associate’s Degree da da da da 273 317 109 127 257 292
College Graduate da da da da 320 362 57 85 312 348
EMPLOYMENT STATUS                    
Full‑Time da da da da 362 409 99 101 351 394
Part‑Time da da da da 157 194 73 91 137 166
Unemployed da da da da 111 104 47 54 98 89
Other1 da da da da 261 331 82 84 251 317

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.47D – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.16 0.19 0.34 0.41 0.17 0.21 0.43 0.46 0.19 0.23
SEX                    
Male 0.23 0.27 0.48 0.63 0.25 0.29 0.64 0.67 0.27 0.32
Female 0.23 0.27 0.54 0.51 0.25 0.28 0.51 0.59 0.27 0.31
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.18 0.21 0.44 0.47 0.20 0.23 0.47 0.54 0.22 0.25
AIAN 0.87 1.80 1.13 1.13 0.99 2.07 0.92 3.13 1.16 2.33
Asian 0.52 0.44 1.21 0.87 0.56 0.48 1.68 1.60 0.60 0.49
Black or African American 0.35 0.43 0.56 0.76 0.38 0.47 0.66 0.72 0.42 0.53
NHPI * 2.13 * * * * * * * *
White 0.23 0.26 0.60 0.63 0.24 0.28 0.62 0.70 0.26 0.30
Two or More Races 1.26 1.00 1.22 1.48 1.48 1.16 1.72 1.87 1.83 1.39
Hispanic or Latino 0.33 0.39 0.52 0.74 0.36 0.44 0.92 0.86 0.37 0.48
EDUCATION LEVEL                    
< High School da da da da 0.36 0.58 1.31 1.15 0.35 0.66
High School Graduate da da da da 0.31 0.34 0.58 0.61 0.35 0.39
Some College/Associate’s Degree da da da da 0.33 0.39 0.75 0.82 0.38 0.44
College Graduate da da da da 0.31 0.35 0.88 1.18 0.32 0.36
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.27 0.32 0.63 0.70 0.30 0.34
Part‑Time da da da da 0.46 0.51 0.77 0.85 0.55 0.61
Unemployed da da da da 0.84 0.75 1.19 1.26 1.05 0.92
Other1 da da da da 0.26 0.33 0.92 0.87 0.27 0.34

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.47P – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4397   0.4879   0.5085   0.9640   0.5234  
SEX                    
Male 0.3152   0.1160   0.4792   0.7176   0.4113  
Female 0.9226   0.4583   0.8225   0.6128   0.9336  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6942   0.9194   0.6988   0.8791   0.7374  
AIAN 0.0149   0.4647   0.0103   0.0386   0.0268  
Asian 0.0951   0.4413   0.1209   0.4897   0.1624  
Black or African American 0.5613   0.4533   0.6422   0.6904   0.7056  
NHPI *   *   *   *   *  
White 0.6242   0.9736   0.6034   0.7809   0.6413  
Two or More Races 0.9393   0.3499   0.7764   0.8789   0.7351  
Hispanic or Latino 0.2319   0.1767   0.3584   0.9671   0.3066  
EDUCATION LEVEL                    
< High School da   da   0.0571   0.3558   0.0164  
High School Graduate da   da   0.3159   0.0920   0.5873  
Some College/Associate’s Degree da   da   0.5981   0.6787   0.7061  
College Graduate da   da   0.5157   0.0275   0.8582  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.4923   0.9106   0.4979  
Part‑Time da   da   0.6287   0.9551   0.6211  
Unemployed da   da   0.3312   0.5395   0.4136  
Other1 da   da   0.5739   0.8098   0.6022  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.48C – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 213 221 31 34 211 217 74 93 197 186
SEX                    
Male 164 157 22 25 161 154 53 60 154 136
Female 126 145 23 23 125 144 52 70 112 120
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 203 199 27 28 201 197 63 79 191 173
AIAN 3 23 1 <1 3 23 * 2 3 23
Asian 49 44 10 2 48 44 18 36 44 24
Black or African American 44 35 4 12 44 33 11 16 42 29
NHPI 5 3 * * 5 4 * * 5 4
White 188 185 24 23 186 183 58 66 175 164
Two or More Races 32 39 4 12 31 38 6 7 31 37
Hispanic or Latino 65 87 15 19 63 84 39 46 48 71
EDUCATION LEVEL                    
< High School da da da da 30 57 21 18 21 54
High School Graduate da da da da 109 78 32 29 101 71
Some College/Associate’s Degree da da da da 115 121 52 69 103 100
College Graduate da da da da 134 143 34 46 129 133
EMPLOYMENT STATUS                    
Full‑Time da da da da 158 151 46 55 148 141
Part‑Time da da da da 72 70 38 45 61 54
Unemployed da da da da 47 61 26 19 38 58
Other1 da da da da 104 102 35 48 99 88

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.48D – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.07 0.07 0.12 0.13 0.08 0.08 0.21 0.25 0.08 0.08
SEX                    
Male 0.11 0.11 0.17 0.19 0.12 0.12 0.30 0.32 0.14 0.12
Female 0.08 0.10 0.18 0.19 0.09 0.10 0.29 0.39 0.09 0.10
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.08 0.08 0.14 0.15 0.09 0.09 0.23 0.28 0.10 0.09
AIAN 0.23 1.23 0.57 0.16 0.25 1.43 * 1.14 0.27 1.64
Asian 0.26 0.23 0.69 0.11 0.27 0.25 0.76 1.40 0.30 0.16
Black or African American 0.12 0.10 0.10 0.35 0.14 0.11 0.24 0.34 0.16 0.11
NHPI 0.45 0.33 * * 0.48 0.45 * * 0.52 0.49
White 0.11 0.11 0.19 0.19 0.12 0.11 0.32 0.36 0.12 0.12
Two or More Races 0.48 0.41 0.43 0.86 0.57 0.46 0.55 0.39 0.71 0.57
Hispanic or Latino 0.12 0.15 0.21 0.28 0.13 0.17 0.45 0.47 0.12 0.18
EDUCATION LEVEL                    
< High School da da da da 0.13 0.23 0.59 0.48 0.10 0.26
High School Graduate da da da da 0.15 0.11 0.27 0.22 0.17 0.12
Some College/Associate’s Degree da da da da 0.15 0.16 0.38 0.50 0.16 0.16
College Graduate da da da da 0.14 0.15 0.56 0.70 0.15 0.15
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.13 0.12 0.32 0.39 0.13 0.13
Part‑Time da da da da 0.22 0.20 0.43 0.44 0.26 0.21
Unemployed da da da da 0.37 0.45 0.68 0.47 0.42 0.61
Other1 da da da da 0.11 0.10 0.41 0.54 0.11 0.10

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.48P – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.9740   0.7089   0.9689   0.8142   0.9895  
SEX                    
Male 0.8967   0.8400   0.9116   0.9814   0.8756  
Female 0.8212   0.4674   0.9258   0.7671   0.8038  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8287   0.8476   0.7971   0.9195   0.7365  
AIAN 0.1979   0.2348   0.1659   *   0.1911  
Asian 0.3343   0.1945   0.4462   0.5557   0.1453  
Black or African American 0.3639   0.3121   0.2405   0.4763   0.1224  
NHPI 0.7629   *   0.9302   *   0.7807  
White 0.9167   0.9327   0.9181   0.9875   0.9077  
Two or More Races 0.9346   0.3521   0.7513   0.0622   0.9660  
Hispanic or Latino 0.4790   0.6809   0.5338   0.5671   0.2753  
EDUCATION LEVEL                    
< High School da   da   0.3800   0.3821   0.1737  
High School Graduate da   da   0.2635   0.1754   0.4376  
Some College/Associate’s Degree da   da   0.8126   0.9677   0.7844  
College Graduate da   da   0.8143   0.2354   0.9039  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.6938   0.9598   0.6853  
Part‑Time da   da   0.8960   0.8469   0.9966  
Unemployed da   da   0.8525   0.0879   0.3248  
Other1 da   da   0.6577   0.6921   0.7518  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.49C – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 119 124 11 17 118 123 31 47 112 112
SEX                    
Male 87 84 10 15 86 82 20 35 84 73
Female 75 91 5 8 75 90 25 31 67 84
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 115 106 10 15 114 105 26 38 109 98
AIAN 1 <1 * <1 1 <1 <1 <1 1 *
Asian 43 24 * 2 43 24 * 5 42 24
Black or African American 20 9 * 3 20 9 5 3 20 8
NHPI * * * * * * * * * *
White 102 97 10 14 101 96 24 38 95 88
Two or More Races 29 31 1 3 29 30 2 2 28 30
Hispanic or Latino 32 61 5 8 32 61 16 28 25 54
EDUCATION LEVEL                    
< High School da da da da 13 25 11 8 7 23
High School Graduate da da da da 43 54 19 16 37 51
Some College/Associate’s Degree da da da da 80 64 20 40 77 50
College Graduate da da da da 70 80 9 15 70 80
EMPLOYMENT STATUS                    
Full‑Time da da da da 106 84 23 28 101 82
Part‑Time da da da da 29 45 16 28 25 35
Unemployed da da da da 10 45 8 7 6 45
Other1 da da da da 41 53 13 23 39 44

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.49D – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.04 0.04 0.04 0.07 0.04 0.05 0.09 0.13 0.05 0.05
SEX                    
Male 0.06 0.06 0.07 0.11 0.07 0.06 0.11 0.19 0.08 0.07
Female 0.05 0.06 0.04 0.07 0.06 0.07 0.14 0.18 0.06 0.07
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.04 0.05 0.08 0.05 0.05 0.10 0.14 0.06 0.05
AIAN 0.11 0.02 * 0.10 0.09 0.01 0.03 0.07 0.10 *
Asian 0.23 0.13 * 0.11 0.25 0.14 * 0.19 0.28 0.16
Black or African American 0.06 0.03 * 0.10 0.06 0.03 0.11 0.06 0.07 0.03
NHPI * * * * * * * * * *
White 0.06 0.06 0.08 0.12 0.06 0.06 0.14 0.22 0.07 0.06
Two or More Races 0.44 0.32 0.11 0.21 0.52 0.37 0.18 0.09 0.66 0.47
Hispanic or Latino 0.06 0.11 0.07 0.12 0.07 0.12 0.19 0.29 0.06 0.14
EDUCATION LEVEL                    
< High School da da da da 0.06 0.10 0.32 0.21 0.04 0.11
High School Graduate da da da da 0.06 0.08 0.16 0.12 0.06 0.09
Some College/Associate’s Degree da da da da 0.10 0.08 0.15 0.30 0.12 0.08
College Graduate da da da da 0.08 0.09 0.14 0.24 0.08 0.09
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.09 0.07 0.16 0.20 0.09 0.08
Part‑Time da da da da 0.09 0.13 0.18 0.29 0.11 0.14
Unemployed da da da da 0.08 0.33 0.21 0.17 0.07 0.46
Other1 da da da da 0.04 0.05 0.16 0.27 0.05 0.05

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.49P – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.9385   0.3918   0.9706   0.4519   0.7516  
SEX                    
Male 0.6424   0.9352   0.6254   0.2575   0.3472  
Female 0.5541   0.1050   0.6557   0.9419   0.6088  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4877   0.4955   0.4316   0.5005   0.2935  
AIAN 0.1977   *   0.3422   0.5454   *  
Asian 0.1982   *   0.1868   *   0.2126  
Black or African American 0.0721   *   0.0480   0.6267   0.0558  
NHPI *   *   *   *   *  
White 0.9828   0.6488   0.9637   0.3161   0.6910  
Two or More Races 0.6583   0.9439   0.6380   0.4534   0.6714  
Hispanic or Latino 0.0759   0.5893   0.0875   0.7323   0.0779  
EDUCATION LEVEL                    
< High School da   da   0.1518   0.4648   0.0400  
High School Graduate da   da   0.9291   0.4118   0.6906  
Some College/Associate’s Degree da   da   0.3887   0.2153   0.1168  
College Graduate da   da   0.7299   0.2888   0.8634  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.3141   0.5286   0.2188  
Part‑Time da   da   0.1979   0.6165   0.2226  
Unemployed da   da   0.1385   0.6470   0.1040  
Other1 da   da   0.9502   0.7293   0.9339  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.50C – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 936 888 68 66 928 884 115 138 909 868
SEX                    
Male 539 535 52 45 535 532 67 89 528 523
Female 655 644 48 48 649 642 92 94 640 631
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 844 837 58 59 840 834 102 114 823 826
AIAN 30 44 2 5 30 44 7 3 29 43
Asian 124 160 16 16 123 161 24 24 120 159
Black or African American 225 212 17 23 223 211 29 40 219 207
NHPI 47 35 * * 47 35 * * 47 35
White 766 780 51 50 762 776 91 99 749 766
Two or More Races 122 166 10 16 122 165 25 22 118 163
Hispanic or Latino 344 271 38 28 341 269 55 66 337 260
EDUCATION LEVEL                    
< High School da da da da 179 257 26 42 176 251
High School Graduate da da da da 399 444 63 73 392 436
Some College/Associate’s Degree da da da da 489 477 82 98 484 462
College Graduate da da da da 504 505 41 54 499 502
EMPLOYMENT STATUS                    
Full‑Time da da da da 487 507 74 78 478 498
Part‑Time da da da da 296 266 60 75 286 256
Unemployed da da da da 138 130 28 45 134 121
Other1 da da da da 601 612 58 55 595 611

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.50D – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.26 0.25 0.25 0.25 0.28 0.27 0.30 0.36 0.32 0.31
SEX                    
Male 0.34 0.34 0.38 0.34 0.37 0.37 0.37 0.47 0.43 0.42
Female 0.38 0.36 0.36 0.38 0.41 0.39 0.49 0.50 0.46 0.44
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.28 0.29 0.29 0.31 0.30 0.31 0.36 0.40 0.34 0.35
AIAN 2.07 2.19 1.17 1.96 2.45 2.51 3.99 1.67 2.76 2.86
Asian 0.64 0.82 1.05 1.00 0.69 0.89 0.96 0.93 0.78 1.03
Black or African American 0.56 0.61 0.45 0.67 0.62 0.67 0.63 0.82 0.72 0.78
NHPI 3.63 3.25 * * 3.90 3.46 * * 4.44 3.82
White 0.34 0.36 0.39 0.40 0.37 0.39 0.48 0.54 0.41 0.43
Two or More Races 1.70 1.55 0.97 1.14 1.99 1.79 2.06 1.24 2.41 2.25
Hispanic or Latino 0.59 0.45 0.53 0.40 0.67 0.51 0.59 0.68 0.81 0.61
EDUCATION LEVEL                    
< High School da da da da 0.73 0.99 0.73 1.07 0.85 1.14
High School Graduate da da da da 0.52 0.57 0.51 0.54 0.61 0.68
Some College/Associate’s Degree da da da da 0.53 0.55 0.58 0.70 0.63 0.64
College Graduate da da da da 0.45 0.45 0.65 0.79 0.47 0.47
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.35 0.38 0.49 0.55 0.38 0.42
Part‑Time da da da da 0.82 0.71 0.63 0.72 1.07 0.93
Unemployed da da da da 1.00 0.91 0.74 1.06 1.35 1.23
Other1 da da da da 0.53 0.53 0.66 0.62 0.57 0.58

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.50P – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0019   0.2452   0.0020   0.5706   0.0027  
SEX                    
Male 0.2141   0.0722   0.2720   0.8884   0.2816  
Female 0.0013   0.8281   0.0009   0.3767   0.0013  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0389   0.5347   0.0383   0.4843   0.0481  
AIAN 0.3864   0.6147   0.3415   0.1746   0.4543  
Asian 0.9152   0.6859   0.9487   0.5075   0.9562  
Black or African American 0.5180   0.5798   0.4723   0.0645   0.3094  
NHPI 0.7746   *   0.7568   *   0.7499  
White 0.0716   0.2924   0.0730   0.4921   0.0852  
Two or More Races 0.5629   0.5266   0.4452   0.0478   0.6859  
Hispanic or Latino 0.0030   0.2180   0.0037   0.8855   0.0031  
EDUCATION LEVEL                    
< High School da   da   0.6284   0.2256   0.7503  
High School Graduate da   da   0.0080   0.1498   0.0175  
Some College/Associate’s Degree da   da   0.0019   0.4872   0.0025  
College Graduate da   da   0.9042   0.2594   0.8121  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.5579   0.6469   0.6071  
Part‑Time da   da   0.0051   0.7729   0.0030  
Unemployed da   da   0.2403   0.2762   0.1374  
Other1 da   da   0.0156   0.0844   0.0244  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.51C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 251 293 26 30 248 293 56 63 239 287
SEX                    
Male 197 191 13 23 195 190 31 38 193 187
Female 159 219 23 19 159 221 47 52 153 216
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 220 272 23 28 218 273 47 50 213 267
AIAN 19 22 * <1 19 * * 1 18 *
Asian 33 34 * * 33 34 12 7 31 34
Black or African American 49 55 4 7 49 55 10 12 47 53
NHPI 7 1 * * 7 * * * 7 *
White 201 258 22 25 199 256 42 47 194 251
Two or More Races 53 54 4 10 53 53 10 12 52 52
Hispanic or Latino 110 114 13 11 109 113 31 36 105 107
EDUCATION LEVEL                    
< High School da da da da 63 69 15 23 61 65
High School Graduate da da da da 115 181 36 35 109 177
Some College/Associate’s Degree da da da da 148 173 37 40 143 169
College Graduate da da da da 149 137 17 28 149 134
EMPLOYMENT STATUS                    
Full‑Time da da da da 136 120 33 33 130 117
Part‑Time da da da da 109 88 33 38 102 81
Unemployed da da da da 67 54 13 24 66 49
Other1 da da da da 169 244 31 29 166 242

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.51D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.09 0.10 0.10 0.12 0.09 0.11 0.16 0.17 0.10 0.12
SEX                    
Male 0.14 0.13 0.10 0.18 0.15 0.15 0.18 0.21 0.17 0.17
Female 0.11 0.14 0.18 0.15 0.12 0.16 0.26 0.29 0.13 0.18
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.09 0.11 0.12 0.15 0.10 0.12 0.18 0.19 0.11 0.14
AIAN 1.38 1.16 * 0.09 1.63 * * 0.33 1.81 *
Asian 0.18 0.18 * * 0.20 0.19 0.49 0.29 0.21 0.22
Black or African American 0.14 0.16 0.10 0.20 0.15 0.18 0.22 0.26 0.17 0.20
NHPI 0.54 0.11 * * 0.58 * * * 0.67 *
White 0.11 0.15 0.18 0.20 0.12 0.16 0.24 0.26 0.14 0.17
Two or More Races 0.79 0.57 0.40 0.76 0.94 0.65 0.84 0.72 1.17 0.80
Hispanic or Latino 0.20 0.20 0.19 0.16 0.23 0.23 0.35 0.38 0.27 0.26
EDUCATION LEVEL                    
< High School da da da da 0.26 0.28 0.41 0.61 0.30 0.31
High School Graduate da da da da 0.16 0.25 0.30 0.27 0.19 0.30
Some College/Associate’s Degree da da da da 0.19 0.22 0.28 0.29 0.22 0.26
College Graduate da da da da 0.16 0.15 0.28 0.45 0.17 0.15
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.11 0.10 0.23 0.24 0.12 0.11
Part‑Time da da da da 0.33 0.25 0.36 0.39 0.43 0.32
Unemployed da da da da 0.52 0.38 0.36 0.59 0.71 0.51
Other1 da da da da 0.18 0.24 0.37 0.33 0.19 0.26

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.51P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3236   0.4910   0.3480   0.9293   0.3461  
SEX                    
Male 0.0662   0.9076   0.0641   0.8521   0.0670  
Female 0.6486   0.4085   0.5956   0.9746   0.5930  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4076   0.7874   0.4151   0.7314   0.4462  
AIAN 0.3145   *   *   *   *  
Asian 0.6033   *   0.6015   0.6243   0.6891  
Black or African American 0.3659   0.3650   0.3114   0.6667   0.2562  
NHPI 0.2420   *   *   *   *  
White 0.8274   0.4896   0.8715   0.9491   0.8794  
Two or More Races 0.1578   0.5562   0.1258   0.4540   0.1584  
Hispanic or Latino 0.5828   0.2981   0.6469   0.7405   0.5523  
EDUCATION LEVEL                    
< High School da   da   0.8568   0.6418   0.9620  
High School Graduate da   da   0.2311   0.4386   0.2937  
Some College/Associate’s Degree da   da   0.9159   0.4912   0.9494  
College Graduate da   da   0.6632   0.0850   0.4702  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.5810   0.9828   0.5633  
Part‑Time da   da   0.1362   0.9540   0.1074  
Unemployed da   da   0.4663   0.4986   0.3360  
Other1 da   da   0.9746   0.4390   0.9348  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.52C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 147 155 13 12 146 154 32 37 143 150
SEX                    
Male 122 73 6 10 122 72 13 25 122 67
Female 83 138 11 7 82 139 29 27 78 136
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 142 126 13 12 141 126 27 30 139 122
AIAN 7 * * <1 6 * * 1 6 *
Asian 20 17 * * 20 17 2 <1 19 17
Black or African American 19 16 2 3 19 16 5 7 18 14
NHPI * * * * * * * * * *
White 132 108 12 12 132 107 27 29 129 103
Two or More Races 36 48 4 1 36 48 4 2 36 48
Hispanic or Latino 38 93 1 * 38 93 16 21 34 90
EDUCATION LEVEL                    
< High School da da da da 19 35 4 19 18 29
High School Graduate da da da da 79 48 21 13 76 46
Some College/Associate’s Degree da da da da 80 133 21 29 78 129
College Graduate da da da da 91 52 10 5 91 51
EMPLOYMENT STATUS                    
Full‑Time da da da da 83 62 16 17 81 59
Part‑Time da da da da 84 32 16 26 82 19
Unemployed da da da da 43 32 5 19 42 27
Other1 da da da da 75 131 21 8 72 131

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.52D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.05 0.05 0.05 0.06 0.06 0.09 0.10 0.06 0.06
SEX                    
Male 0.09 0.05 0.04 0.08 0.10 0.06 0.07 0.14 0.11 0.06
Female 0.06 0.09 0.09 0.06 0.06 0.10 0.17 0.15 0.07 0.11
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.06 0.05 0.07 0.07 0.07 0.06 0.10 0.11 0.07 0.06
AIAN 0.48 * * 0.05 0.56 * * 0.33 0.64 *
Asian 0.11 0.09 * * 0.11 0.10 0.08 0.01 0.13 0.12
Black or African American 0.05 0.05 0.07 0.10 0.06 0.05 0.10 0.16 0.07 0.05
NHPI * * * * * * * * * *
White 0.08 0.06 0.09 0.10 0.08 0.07 0.15 0.17 0.09 0.07
Two or More Races 0.54 0.50 0.39 0.10 0.65 0.59 0.35 0.13 0.82 0.74
Hispanic or Latino 0.07 0.16 0.01 * 0.08 0.19 0.18 0.22 0.09 0.22
EDUCATION LEVEL                    
< High School da da da da 0.08 0.14 0.10 0.49 0.09 0.14
High School Graduate da da da da 0.11 0.07 0.17 0.10 0.13 0.08
Some College/Associate’s Degree da da da da 0.10 0.17 0.16 0.22 0.12 0.20
College Graduate da da da da 0.10 0.06 0.17 0.09 0.11 0.06
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.07 0.05 0.11 0.12 0.08 0.06
Part‑Time da da da da 0.26 0.09 0.18 0.27 0.34 0.08
Unemployed da da da da 0.33 0.23 0.14 0.47 0.45 0.28
Other1 da da da da 0.08 0.13 0.25 0.09 0.08 0.14

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.52P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1523   0.6536   0.1583   0.7551   0.1699  
SEX                    
Male 0.0126   0.7650   0.0111   0.3221   0.0054  
Female 0.7517   0.3800   0.7040   0.2855   0.5051  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0312   0.7148   0.0326   0.5521   0.0401  
AIAN *   *   *   *   *  
Asian 0.5345   *   0.5335   0.4159   0.5737  
Black or African American 0.2601   0.8202   0.2368   0.6831   0.1560  
NHPI *   *   *   *   *  
White 0.0473   0.8789   0.0472   0.6081   0.0557  
Two or More Races 0.3717   0.3954   0.3973   0.3947   0.4389  
Hispanic or Latino 0.2963   *   0.2949   0.7354   0.3213  
EDUCATION LEVEL                    
< High School da   da   0.0985   0.2814   0.1893  
High School Graduate da   da   0.0269   0.1637   0.0566  
Some College/Associate’s Degree da   da   0.5518   0.7671   0.5871  
College Graduate da   da   0.0185   0.3777   0.0231  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.3804   0.8847   0.3863  
Part‑Time da   da   0.0029   0.9674   0.0017  
Unemployed da   da   0.8670   0.2283   0.5332  
Other1 da   da   0.6749   0.1156   0.5021  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.53C – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 763 759 46 56 757 756 100 116 747 746
SEX                    
Male 457 437 32 37 455 435 58 77 452 430
Female 563 580 34 39 559 578 81 80 554 571
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 691 710 40 48 687 708 86 98 678 702
AIAN 25 37 2 2 25 37 * 3 25 36
Asian 114 121 11 13 113 120 14 16 112 119
Black or African American 192 189 10 19 191 188 24 25 189 187
NHPI 47 32 <1 * 47 32 * * * 32
White 627 659 35 38 623 656 77 89 618 649
Two or More Races 112 158 10 14 112 157 24 21 110 156
Hispanic or Latino 287 248 21 24 286 246 51 59 283 237
EDUCATION LEVEL                    
< High School da da da da 146 205 22 40 144 199
High School Graduate da da da da 348 380 57 65 342 374
Some College/Associate’s Degree da da da da 428 417 68 72 427 407
College Graduate da da da da 414 452 38 49 408 448
EMPLOYMENT STATUS                    
Full‑Time da da da da 413 435 64 68 407 430
Part‑Time da da da da 267 225 54 63 259 215
Unemployed da da da da 121 119 23 39 119 111
Other1 da da da da 514 535 50 42 509 534

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.53D – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.22 0.23 0.18 0.22 0.24 0.25 0.27 0.31 0.27 0.28
SEX                    
Male 0.30 0.30 0.24 0.28 0.33 0.33 0.33 0.41 0.38 0.37
Female 0.34 0.34 0.26 0.31 0.37 0.36 0.44 0.43 0.42 0.41
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.24 0.26 0.21 0.25 0.26 0.29 0.31 0.35 0.30 0.32
AIAN 1.78 1.80 1.03 0.92 2.10 2.07 * 1.47 2.36 2.35
Asian 0.59 0.63 0.72 0.84 0.64 0.68 0.58 0.62 0.73 0.78
Black or African American 0.50 0.55 0.26 0.56 0.55 0.61 0.52 0.53 0.64 0.71
NHPI 3.61 2.98 <0.01 * 3.86 3.19 * * * 3.52
White 0.30 0.33 0.27 0.31 0.32 0.35 0.42 0.49 0.36 0.39
Two or More Races 1.57 1.51 0.95 1.05 1.84 1.73 2.03 1.17 2.27 2.18
Hispanic or Latino 0.50 0.42 0.30 0.34 0.57 0.47 0.55 0.62 0.69 0.56
EDUCATION LEVEL                    
< High School da da da da 0.60 0.81 0.63 1.02 0.70 0.92
High School Graduate da da da da 0.46 0.49 0.46 0.49 0.54 0.60
Some College/Associate’s Degree da da da da 0.48 0.49 0.50 0.52 0.57 0.58
College Graduate da da da da 0.38 0.43 0.60 0.75 0.41 0.45
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.30 0.34 0.43 0.49 0.34 0.37
Part‑Time da da da da 0.75 0.61 0.58 0.61 0.98 0.79
Unemployed da da da da 0.90 0.84 0.61 0.94 1.23 1.14
Other1 da da da da 0.46 0.49 0.58 0.48 0.50 0.54

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.53P – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0019   0.8093   0.0013   0.1862   0.0028  
SEX                    
Male 0.1826   0.4823   0.1912   0.7257   0.2281  
Female 0.0024   0.3152   0.0014   0.1401   0.0030  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0167   0.9047   0.0137   0.2051   0.0230  
AIAN 0.5273   0.5648   0.5420   *   0.7035  
Asian 0.3762   0.9343   0.3667   0.9114   0.3725  
Black or African American 0.5699   0.3162   0.5015   0.5831   0.4696  
NHPI 0.6365   *   0.6163   *   *  
White 0.0319   0.7023   0.0279   0.3556   0.0372  
Two or More Races 0.8577   0.9157   0.7630   0.0507   0.9374  
Hispanic or Latino 0.0280   0.7443   0.0217   0.6855   0.0262  
EDUCATION LEVEL                    
< High School da   da   0.6896   0.1300   0.8804  
High School Graduate da   da   0.0116   0.1007   0.0277  
Some College/Associate’s Degree da   da   0.0027   0.1009   0.0065  
College Graduate da   da   0.6626   0.5173   0.6111  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.5983   0.4591   0.6866  
Part‑Time da   da   0.0003   0.7889   0.0003  
Unemployed da   da   0.4449   0.3179   0.3142  
Other1 da   da   0.0257   0.0172   0.0444  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.54C – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 223 256 23 29 220 256 54 60 211 250
SEX                    
Male 173 145 11 22 172 143 28 36 170 140
Female 141 209 20 18 140 211 46 51 133 205
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 188 235 20 27 186 236 44 48 179 230
AIAN 18 22 * <1 18 * * 1 * *
Asian 31 34 * * 31 34 4 7 31 34
Black or African American 46 53 3 5 46 53 9 11 44 52
NHPI 7 1 * * 7 * * * 7 *
White 169 223 20 24 167 222 41 44 161 216
Two or More Races 39 31 <1 10 39 29 10 12 38 27
Hispanic or Latino 109 106 11 11 108 105 30 34 104 99
EDUCATION LEVEL                    
< High School da da da da 62 69 13 23 61 65
High School Graduate da da da da 104 131 36 32 98 128
Some College/Associate’s Degree da da da da 134 162 34 38 129 157
College Graduate da da da da 119 132 17 26 117 129
EMPLOYMENT STATUS                    
Full‑Time da da da da 125 115 33 31 119 112
Part‑Time da da da da 106 84 31 37 101 77
Unemployed da da da da 66 52 13 24 64 47
Other1 da da da da 133 202 29 26 130 200

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.54D – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.08 0.09 0.09 0.11 0.08 0.09 0.15 0.17 0.09 0.11
SEX                    
Male 0.12 0.10 0.08 0.17 0.13 0.11 0.16 0.20 0.15 0.13
Female 0.10 0.14 0.16 0.14 0.10 0.15 0.26 0.28 0.11 0.17
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.08 0.10 0.11 0.14 0.09 0.11 0.17 0.18 0.09 0.12
AIAN 1.31 1.16 * 0.09 1.54 * * 0.33 * *
Asian 0.17 0.18 * * 0.18 0.19 0.15 0.29 0.21 0.22
Black or African American 0.13 0.16 0.08 0.15 0.14 0.17 0.20 0.24 0.16 0.20
NHPI 0.54 0.11 * * 0.58 * * * 0.67 *
White 0.10 0.13 0.16 0.20 0.10 0.14 0.23 0.25 0.11 0.15
Two or More Races 0.59 0.33 0.02 0.76 0.70 0.36 0.84 0.72 0.86 0.41
Hispanic or Latino 0.20 0.19 0.16 0.16 0.23 0.21 0.34 0.35 0.27 0.25
EDUCATION LEVEL                    
< High School da da da da 0.26 0.28 0.37 0.61 0.29 0.31
High School Graduate da da da da 0.15 0.18 0.30 0.25 0.17 0.22
Some College/Associate’s Degree da da da da 0.17 0.21 0.26 0.28 0.20 0.24
College Graduate da da da da 0.13 0.14 0.28 0.42 0.14 0.15
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.10 0.10 0.23 0.22 0.11 0.11
Part‑Time da da da da 0.32 0.24 0.34 0.38 0.43 0.30
Unemployed da da da da 0.51 0.37 0.35 0.57 0.69 0.49
Other1 da da da da 0.14 0.20 0.34 0.30 0.15 0.22

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.54P – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5620   0.9125   0.5556   0.7673   0.5910  
SEX                    
Male 0.0744   0.8082   0.0664   0.9484   0.0610  
Female 0.4111   0.7043   0.3980   0.7001   0.3281  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8051   0.9796   0.7917   0.5999   0.8785  
AIAN 0.6076   *   *   *   *  
Asian 0.7998   *   0.7978   0.4168   0.6891  
Black or African American 0.3684   0.6824   0.3456   0.6658   0.2888  
NHPI 0.2420   *   *   *   *  
White 0.7365   0.6524   0.7066   0.6361   0.6201  
Two or More Races 0.1520   0.1634   0.0846   0.4581   0.1148  
Hispanic or Latino 0.4366   0.7512   0.4431   0.8259   0.3762  
EDUCATION LEVEL                    
< High School da   da   0.7267   0.3945   0.9059  
High School Graduate da   da   0.0617   0.2413   0.1084  
Some College/Associate’s Degree da   da   0.8725   0.5806   0.7591  
College Graduate da   da   0.7522   0.2055   0.9237  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.7906   0.6609   0.8754  
Part‑Time da   da   0.1165   0.8133   0.0802  
Unemployed da   da   0.4403   0.6272   0.3435  
Other1 da   da   0.6584   0.4276   0.5610  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.55C – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 132 141 11 12 132 140 30 36 129 135
SEX                    
Male 111 72 6 10 110 71 12 25 110 66
Female 75 122 10 6 74 122 27 27 70 120
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 127 110 11 12 126 109 25 30 124 105
AIAN 2 * * <1 2 * * <1 2 *
Asian 19 17 * * 19 17 * <1 19 17
Black or African American 13 16 2 3 13 15 4 7 12 14
NHPI * * * * * * * * * *
White 119 99 11 11 118 98 24 29 116 93
Two or More Races 36 18 * 1 36 18 4 2 36 18
Hispanic or Latino 37 91 1 * 37 91 15 20 34 88
EDUCATION LEVEL                    
< High School da da da da 18 35 2 19 18 29
High School Graduate da da da da 75 39 20 12 72 37
Some College/Associate’s Degree da da da da 78 120 18 29 75 117
College Graduate da da da da 74 46 10 5 74 46
EMPLOYMENT STATUS                    
Full‑Time da da da da 65 53 15 17 63 51
Part‑Time da da da da 83 32 16 26 81 19
Unemployed da da da da 39 32 5 19 39 26
Other1 da da da da 72 118 19 7 70 117

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.55D – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.05 0.04 0.05 0.05 0.05 0.09 0.10 0.06 0.06
SEX                    
Male 0.08 0.05 0.04 0.08 0.09 0.06 0.07 0.14 0.10 0.06
Female 0.05 0.08 0.08 0.05 0.06 0.09 0.15 0.15 0.06 0.10
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.05 0.06 0.06 0.06 0.05 0.10 0.11 0.07 0.05
AIAN 0.17 * * 0.05 0.20 * * 0.16 0.22 *
Asian 0.10 0.09 * * 0.11 0.10 * 0.01 0.13 0.12
Black or African American 0.04 0.05 0.07 0.10 0.04 0.05 0.09 0.16 0.04 0.05
NHPI * * * * * * * * * *
White 0.07 0.06 0.09 0.09 0.07 0.06 0.14 0.17 0.08 0.07
Two or More Races 0.55 0.19 * 0.10 0.65 0.22 0.35 0.13 0.82 0.28
Hispanic or Latino 0.07 0.16 0.01 * 0.08 0.18 0.18 0.22 0.09 0.22
EDUCATION LEVEL                    
< High School da da da da 0.08 0.14 0.05 0.49 0.09 0.14
High School Graduate da da da da 0.11 0.05 0.17 0.09 0.12 0.06
Some College/Associate’s Degree da da da da 0.10 0.15 0.14 0.22 0.12 0.18
College Graduate da da da da 0.08 0.05 0.17 0.09 0.09 0.05
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.05 0.05 0.11 0.12 0.06 0.05
Part‑Time da da da da 0.25 0.09 0.18 0.27 0.34 0.08
Unemployed da da da da 0.30 0.23 0.13 0.46 0.42 0.27
Other1 da da da da 0.07 0.12 0.22 0.09 0.08 0.13

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.55P – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1257   0.8247   0.1263   0.9339   0.1108  
SEX                    
Male 0.0357   0.6499   0.0313   0.2282   0.0143  
Female 0.9057   0.4295   0.9488   0.4459   0.8854  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0278   0.8948   0.0274   0.9099   0.0254  
AIAN *   *   *   *   *  
Asian 0.5804   *   0.5794   *   0.5737  
Black or African American 0.7553   0.8000   0.7096   0.4972   0.4679  
NHPI *   *   *   *   *  
White 0.0583   0.7950   0.0595   0.9085   0.0561  
Two or More Races 0.0647   *   0.0585   0.3947   0.0708  
Hispanic or Latino 0.4479   *   0.4455   0.7502   0.4822  
EDUCATION LEVEL                    
< High School da   da   0.0824   0.2142   0.1843  
High School Graduate da   da   0.0251   0.1522   0.0557  
Some College/Associate’s Degree da   da   0.8179   0.4884   0.9472  
College Graduate da   da   0.0222   0.4975   0.0265  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.3832   0.9652   0.3718  
Part‑Time da   da   0.0068   0.7739   0.0030  
Unemployed da   da   0.8576   0.2686   0.8190  
Other1 da   da   0.9651   0.2048   0.8119  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.56C – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 536 555 52 43 532 554 67 78 529 548
SEX                    
Male 329 375 42 26 328 375 40 53 325 372
Female 374 376 34 35 370 374 53 54 368 368
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 492 533 41 38 492 533 61 68 487 529
AIAN 19 28 2 5 19 28 2 3 19 28
Asian 66 111 12 9 64 112 21 14 59 111
Black or African American 132 154 14 13 132 154 16 34 130 152
NHPI 8 14 * * 8 * * * 5 *
White 462 463 36 34 462 462 54 55 459 460
Two or More Races 53 122 4 6 53 122 5 13 53 121
Hispanic or Latino 187 159 33 21 182 157 27 36 179 152
EDUCATION LEVEL                    
< High School da da da da 88 201 16 17 85 201
High School Graduate da da da da 226 255 35 43 226 251
Some College/Associate’s Degree da da da da 294 294 50 56 289 286
College Graduate da da da da 301 309 20 29 300 308
EMPLOYMENT STATUS                    
Full‑Time da da da da 290 294 42 44 289 290
Part‑Time da da da da 158 169 29 39 156 165
Unemployed da da da da 82 67 17 25 79 61
Other1 da da da da 358 425 39 42 355 424

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.56D – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.17 0.17 0.20 0.16 0.19 0.19 0.18 0.21 0.22 0.22
SEX                    
Male 0.22 0.25 0.31 0.20 0.25 0.27 0.23 0.29 0.28 0.32
Female 0.24 0.23 0.26 0.27 0.26 0.25 0.29 0.30 0.30 0.29
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.19 0.21 0.21 0.20 0.21 0.23 0.23 0.25 0.24 0.25
AIAN 1.40 1.49 0.74 1.75 1.65 1.72 1.50 1.41 1.88 1.96
Asian 0.35 0.57 0.82 0.59 0.37 0.62 0.86 0.53 0.40 0.73
Black or African American 0.36 0.44 0.38 0.38 0.40 0.49 0.35 0.70 0.46 0.56
NHPI 0.64 1.29 * * 0.69 * * * 0.49 *
White 0.24 0.25 0.28 0.28 0.26 0.27 0.29 0.31 0.30 0.30
Two or More Races 0.81 1.23 0.42 0.47 0.96 1.42 0.45 0.77 1.20 1.78
Hispanic or Latino 0.33 0.28 0.47 0.30 0.37 0.31 0.30 0.37 0.44 0.37
EDUCATION LEVEL                    
< High School da da da da 0.37 0.80 0.44 0.46 0.42 0.94
High School Graduate da da da da 0.31 0.35 0.29 0.33 0.38 0.42
Some College/Associate’s Degree da da da da 0.36 0.36 0.37 0.41 0.42 0.42
College Graduate da da da da 0.31 0.31 0.33 0.46 0.33 0.33
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.23 0.23 0.29 0.32 0.26 0.26
Part‑Time da da da da 0.48 0.47 0.31 0.39 0.64 0.63
Unemployed da da da da 0.62 0.49 0.45 0.60 0.83 0.64
Other1 da da da da 0.36 0.40 0.45 0.47 0.39 0.44

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.56P – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7674   0.0339   0.8962   0.4714   0.8410  
SEX                    
Male 0.6850   0.0229   0.5300   0.3199   0.5974  
Female 0.3980   0.5347   0.4089   0.9288   0.4020  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6326   0.1383   0.5652   0.5510   0.6078  
AIAN 0.6468   0.3667   0.5486   0.8164   0.5234  
Asian 0.4654   0.4345   0.4091   0.2702   0.2875  
Black or African American 0.9375   0.8139   0.9507   0.0454   0.6683  
NHPI 0.5852   *   *   *   *  
White 0.8378   0.1306   0.7667   0.9672   0.7766  
Two or More Races 0.1976   0.4664   0.2335   0.3700   0.2700  
Hispanic or Latino 0.0412   0.1203   0.0648   0.6182   0.0491  
EDUCATION LEVEL                    
< High School da   da   0.0565   0.6482   0.0478  
High School Graduate da   da   0.3612   0.7645   0.4034  
Some College/Associate’s Degree da   da   0.1586   0.4018   0.1123  
College Graduate da   da   0.3652   0.2466   0.4153  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.5698   0.5742   0.6244  
Part‑Time da   da   0.5488   0.4853   0.4604  
Unemployed da   da   0.2674   0.4842   0.1726  
Other1 da   da   0.8122   0.7743   0.8338  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.57C – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 127 170 17 10 126 170 19 28 124 168
SEX                    
Male 98 137 7 5 98 137 15 14 97 136
Female 80 102 15 8 79 102 11 24 78 99
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 124 161 15 10 123 161 17 24 122 159
AIAN 7 1 * <1 7 1 * 1 7 *
Asian 11 18 * * 11 18 11 * * 18
Black or African American 16 13 2 5 16 13 3 4 15 12
NHPI * 1 * * * * * * * *
White 117 153 15 8 116 152 12 23 115 151
Two or More Races 37 44 4 * 36 44 3 * 36 44
Hispanic or Latino 26 53 7 1 25 53 7 16 24 51
EDUCATION LEVEL                    
< High School da da da da 10 47 7 1 7 47
High School Graduate da da da da 51 125 7 19 51 124
Some College/Associate’s Degree da da da da 65 70 16 11 63 69
College Graduate da da da da 94 76 2 17 94 74
EMPLOYMENT STATUS                    
Full‑Time da da da da 61 67 6 15 61 65
Part‑Time da da da da 21 27 12 11 17 25
Unemployed da da da da 20 15 3 6 20 14
Other1 da da da da 106 152 13 19 105 150

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.57D – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.04 0.06 0.07 0.04 0.05 0.06 0.05 0.08 0.05 0.07
SEX                    
Male 0.07 0.10 0.05 0.04 0.08 0.11 0.09 0.08 0.09 0.12
Female 0.05 0.07 0.12 0.06 0.06 0.07 0.07 0.13 0.07 0.08
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.07 0.08 0.05 0.06 0.07 0.07 0.09 0.06 0.08
AIAN 0.54 0.03 * 0.05 0.63 0.04 * 0.29 0.73 *
Asian 0.06 0.09 * * 0.07 0.10 0.47 * * 0.12
Black or African American 0.04 0.04 0.06 0.14 0.05 0.04 0.07 0.09 0.06 0.04
NHPI * 0.11 * * * * * * * *
White 0.07 0.09 0.12 0.07 0.07 0.10 0.07 0.13 0.08 0.11
Two or More Races 0.56 0.47 0.40 * 0.66 0.55 0.29 * 0.84 0.69
Hispanic or Latino 0.05 0.09 0.10 0.01 0.05 0.11 0.08 0.17 0.06 0.13
EDUCATION LEVEL                    
< High School da da da da 0.04 0.19 0.20 0.02 0.04 0.23
High School Graduate da da da da 0.07 0.18 0.05 0.15 0.09 0.21
Some College/Associate’s Degree da da da da 0.08 0.09 0.12 0.08 0.10 0.11
College Graduate da da da da 0.10 0.08 0.03 0.27 0.11 0.09
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.05 0.06 0.05 0.11 0.06 0.06
Part‑Time da da da da 0.06 0.08 0.14 0.11 0.07 0.10
Unemployed da da da da 0.15 0.11 0.07 0.14 0.21 0.15
Other1 da da da da 0.11 0.15 0.15 0.22 0.12 0.17

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.57P – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.8152   0.1060   0.7047   0.2443   0.8428  
SEX                    
Male 0.8833   0.4482   0.9124   0.4387   0.9920  
Female 0.5708   0.1497   0.4458   0.0339   0.7340  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.9530   0.3056   0.9769   0.3362   0.9132  
AIAN 0.0777   *   0.0980   *   *  
Asian 0.6544   *   0.6553   *   *  
Black or African American 0.5835   0.3659   0.4257   0.9554   0.4000  
NHPI *   *   *   *   *  
White 0.8667   0.3128   0.8009   0.0768   0.9922  
Two or More Races 0.4659   *   0.5265   *   0.5821  
Hispanic or Latino 0.2782   0.0665   0.1899   0.4930   0.2467  
EDUCATION LEVEL                    
< High School da   da   0.4637   0.0601   0.3047  
High School Graduate da   da   0.5758   0.1085   0.7406  
Some College/Associate’s Degree da   da   0.8067   0.6418   0.8793  
College Graduate da   da   0.9497   0.0671   0.7491  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.5997   0.1387   0.7937  
Part‑Time da   da   0.8120   0.9947   0.7858  
Unemployed da   da   0.7594   0.4876   0.6287  
Other1 da   da   0.8884   0.6581   0.9318  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.58C – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 61 78 6 5 61 78 12 6 60 78
SEX                    
Male 52 17 1 3 52 17 6 3 52 17
Female 32 77 6 4 31 77 11 5 29 77
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 61 66 6 5 61 66 11 4 60 66
AIAN 6 1 * * 6 1 * 1 6 *
Asian 2 * * * 2 * 2 * * *
Black or African American 14 3 <1 * 14 3 3 * 14 3
NHPI * * * * * * * * * *
White 58 49 4 5 58 49 11 3 57 49
Two or More Races 8 44 4 * 7 44 * * 7 *
Hispanic or Latino 4 37 1 * 4 37 4 5 <1 37
EDUCATION LEVEL                    
< High School da da da da 5 9 4 1 4 9
High School Graduate da da da da 24 28 6 5 23 27
Some College/Associate’s Degree da da da da 22 57 10 2 20 57
College Graduate da da da da 51 40 2 * 51 40
EMPLOYMENT STATUS                    
Full‑Time da da da da 52 34 4 1 52 34
Part‑Time da da da da 11 2 5 2 10 *
Unemployed da da da da 17 6 2 5 17 3
Other1 da da da da 23 66 10 2 21 66

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.58D – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.02 0.03 0.02 0.02 0.02 0.03 0.03 0.02 0.03 0.03
SEX                    
Male 0.04 0.01 0.01 0.02 0.04 0.01 0.03 0.01 0.05 0.02
Female 0.02 0.05 0.04 0.03 0.02 0.06 0.06 0.03 0.02 0.06
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.01 0.03 0.03
AIAN 0.45 0.03 * * 0.52 0.04 * 0.29 0.60 *
Asian 0.01 * * * 0.01 * 0.08 * * *
Black or African American 0.04 0.01 <0.01 * 0.04 0.01 0.06 * 0.05 0.01
NHPI * * * * * * * * * *
White 0.03 0.03 0.03 0.04 0.04 0.03 0.06 0.02 0.04 0.04
Two or More Races 0.13 0.47 0.39 * 0.13 0.55 * * 0.17 *
Hispanic or Latino 0.01 0.07 0.01 * 0.01 0.07 0.05 0.05 <0.01 0.09
EDUCATION LEVEL                    
< High School da da da da 0.02 0.04 0.10 0.01 0.02 0.05
High School Graduate da da da da 0.03 0.04 0.05 0.04 0.04 0.05
Some College/Associate’s Degree da da da da 0.03 0.07 0.07 0.02 0.03 0.09
College Graduate da da da da 0.06 0.04 0.03 * 0.06 0.05
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.04 0.03 0.03 0.01 0.05 0.03
Part‑Time da da da da 0.04 0.01 0.05 0.02 0.04 *
Unemployed da da da da 0.13 0.04 0.05 0.12 0.18 0.03
Other1 da da da da 0.02 0.07 0.12 0.03 0.02 0.07

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.58P – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.6112   0.7776   0.5987   0.0939   0.4416  
SEX                    
Male 0.1481   0.7155   0.1413   0.1053   0.1950  
Female 0.1194   0.6196   0.1098   0.2927   0.0760  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.9555   0.8576   0.9646   0.0957   0.8549  
AIAN 0.1389   *   0.1849   *   *  
Asian *   *   *   *   *  
Black or African American 0.1062   *   0.1075   *   0.1714  
NHPI *   *   *   *   *  
White 0.9305   0.4441   0.8792   0.2024   0.9684  
Two or More Races 0.4749   *   0.3891   *   *  
Hispanic or Latino 0.1263   *   0.1217   0.6444   0.0992  
EDUCATION LEVEL                    
< High School da   da   0.7954   0.1489   0.4300  
High School Graduate da   da   0.6449   0.6354   0.7143  
Some College/Associate’s Degree da   da   0.2843   0.2636   0.2023  
College Graduate da   da   0.9935   *   0.9622  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.9849   0.5912   0.9844  
Part‑Time da   da   0.0393   0.1491   *  
Unemployed da   da   0.3071   0.7482   0.2473  
Other1 da   da   0.1635   0.1601   0.1029  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.59C – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 653 674 43 50 651 673 95 104 639 660
SEX                    
Male 392 376 29 34 390 375 57 67 385 367
Female 481 518 31 33 480 518 75 76 471 512
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 597 645 36 43 595 644 82 92 585 638
AIAN 24 41 2 2 24 40 * 3 23 40
Asian 89 110 10 12 88 109 10 14 87 108
Black or African American 171 158 9 18 170 158 24 25 167 155
NHPI 46 18 * * 46 19 * * * 19
White 547 599 31 34 545 597 72 83 537 589
Two or More Races 108 136 7 14 108 135 25 19 106 133
Hispanic or Latino 250 214 21 20 249 212 47 47 244 203
EDUCATION LEVEL                    
< High School da da da da 160 181 21 38 156 174
High School Graduate da da da da 303 347 54 63 299 343
Some College/Associate’s Degree da da da da 359 354 65 62 355 346
College Graduate da da da da 364 403 33 46 360 398
EMPLOYMENT STATUS                    
Full‑Time da da da da 340 389 58 67 334 385
Part‑Time da da da da 233 185 50 59 223 174
Unemployed da da da da 107 107 23 35 104 101
Other1 da da da da 455 474 48 35 448 473

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.59D – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.20 0.20 0.17 0.19 0.22 0.22 0.26 0.28 0.25 0.25
SEX                    
Male 0.26 0.26 0.22 0.26 0.29 0.28 0.32 0.36 0.33 0.32
Female 0.30 0.30 0.24 0.26 0.33 0.33 0.41 0.41 0.37 0.38
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.22 0.24 0.19 0.23 0.24 0.26 0.30 0.34 0.27 0.29
AIAN 1.69 2.05 0.97 0.89 1.99 2.38 * 1.44 2.22 2.71
Asian 0.48 0.57 0.67 0.78 0.51 0.61 0.43 0.55 0.59 0.70
Black or African American 0.45 0.45 0.26 0.52 0.50 0.50 0.52 0.53 0.58 0.58
NHPI 3.56 1.75 * * 3.80 1.92 * * * 2.11
White 0.27 0.31 0.25 0.28 0.30 0.33 0.39 0.46 0.33 0.37
Two or More Races 1.55 1.33 0.65 1.02 1.82 1.53 2.08 1.06 2.26 1.90
Hispanic or Latino 0.45 0.36 0.30 0.28 0.51 0.41 0.51 0.50 0.61 0.48
EDUCATION LEVEL                    
< High School da da da da 0.65 0.73 0.59 0.98 0.75 0.83
High School Graduate da da da da 0.41 0.46 0.44 0.47 0.49 0.56
Some College/Associate’s Degree da da da da 0.42 0.42 0.48 0.45 0.50 0.50
College Graduate da da da da 0.35 0.39 0.54 0.70 0.38 0.41
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.26 0.30 0.39 0.48 0.28 0.34
Part‑Time da da da da 0.67 0.51 0.55 0.58 0.88 0.66
Unemployed da da da da 0.79 0.76 0.60 0.83 1.07 1.04
Other1 da da da da 0.43 0.44 0.56 0.41 0.46 0.49

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.59P – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0108   0.6065   0.0080   0.2939   0.0134  
SEX                    
Male 0.1733   0.8222   0.1707   0.3839   0.2332  
Female 0.0221   0.3285   0.0155   0.5175   0.0194  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0355   0.3944   0.0268   0.3781   0.0375  
AIAN 0.9131   0.7232   0.9039   *   0.7141  
Asian 0.9853   0.8553   0.9663   0.6980   0.9336  
Black or African American 0.5267   0.2153   0.4455   0.7190   0.4160  
NHPI 0.1658   *   0.1578   *   *  
White 0.0670   0.9096   0.0574   0.5881   0.0656  
Two or More Races 0.4340   0.4109   0.3377   0.0581   0.5614  
Hispanic or Latino 0.1570   0.6354   0.1550   0.6017   0.1840  
EDUCATION LEVEL                    
< High School da   da   0.7760   0.1092   0.5724  
High School Graduate da   da   0.1194   0.0817   0.2320  
Some College/Associate’s Degree da   da   0.0061   0.1745   0.0121  
College Graduate da   da   0.7214   0.3322   0.6420  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.7865   0.9164   0.7950  
Part‑Time da   da   0.0004   0.9257   0.0003  
Unemployed da   da   0.2515   0.5101   0.1852  
Other1 da   da   0.0399   0.0036   0.0754  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.60C – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 208 248 20 29 207 248 51 57 198 242
SEX                    
Male 166 140 10 22 164 138 29 36 162 134
Female 127 201 18 18 127 203 43 47 120 198
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 181 224 18 27 180 225 40 45 175 220
AIAN 19 * * <1 19 * * 1 * *
Asian 30 34 * * 30 34 4 7 30 34
Black or African American 42 41 4 7 42 40 8 11 40 39
NHPI 7 1 * * 7 * * * 7 *
White 164 210 17 24 163 209 38 43 158 204
Two or More Races 39 53 4 10 39 52 10 4 38 51
Hispanic or Latino 92 106 10 11 92 105 31 32 87 100
EDUCATION LEVEL                    
< High School da da da da 43 68 14 23 40 64
High School Graduate da da da da 100 126 33 29 95 124
Some College/Associate’s Degree da da da da 126 159 34 35 120 155
College Graduate da da da da 117 119 17 24 116 116
EMPLOYMENT STATUS                    
Full‑Time da da da da 117 104 29 31 112 100
Part‑Time da da da da 93 70 31 36 88 62
Unemployed da da da da 64 52 13 24 63 47
Other1 da da da da 127 200 29 19 123 199

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.60D – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.07 0.08 0.08 0.11 0.08 0.09 0.14 0.16 0.09 0.10
SEX                    
Male 0.12 0.10 0.08 0.17 0.13 0.11 0.16 0.19 0.15 0.12
Female 0.09 0.13 0.14 0.15 0.09 0.14 0.24 0.26 0.10 0.16
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.08 0.09 0.09 0.14 0.08 0.10 0.15 0.17 0.09 0.11
AIAN 1.33 * * 0.09 1.57 * * 0.33 * *
Asian 0.16 0.18 * * 0.17 0.19 0.15 0.29 0.20 0.22
Black or African American 0.12 0.12 0.10 0.20 0.13 0.13 0.18 0.23 0.14 0.15
NHPI 0.54 0.11 * * 0.58 * * * 0.67 *
White 0.09 0.12 0.13 0.20 0.10 0.13 0.21 0.25 0.11 0.14
Two or More Races 0.58 0.55 0.39 0.76 0.70 0.63 0.84 0.23 0.86 0.80
Hispanic or Latino 0.17 0.19 0.15 0.16 0.19 0.21 0.34 0.34 0.22 0.25
EDUCATION LEVEL                    
< High School da da da da 0.18 0.28 0.40 0.61 0.20 0.31
High School Graduate da da da da 0.14 0.18 0.27 0.23 0.16 0.21
Some College/Associate’s Degree da da da da 0.16 0.20 0.25 0.26 0.18 0.24
College Graduate da da da da 0.13 0.13 0.28 0.38 0.14 0.13
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.10 0.09 0.20 0.23 0.10 0.10
Part‑Time da da da da 0.28 0.20 0.34 0.36 0.37 0.25
Unemployed da da da da 0.50 0.37 0.34 0.57 0.68 0.49
Other1 da da da da 0.13 0.20 0.35 0.22 0.14 0.22

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.60P – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7689   0.6280   0.7141   0.6618   0.7855  
SEX                    
Male 0.1999   0.7297   0.1795   0.9702   0.1747  
Female 0.4380   0.7339   0.4707   0.6187   0.3791  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8078   0.5428   0.7444   0.6469   0.8155  
AIAN *   *   *   *   *  
Asian 0.9902   *   0.9922   0.4400   0.8993  
Black or African American 0.2330   0.3873   0.1855   0.5830   0.1319  
NHPI 0.2420   *   *   *   *  
White 0.8133   0.8754   0.8380   0.8932   0.8095  
Two or More Races 0.3844   0.4571   0.3052   0.0419   0.5214  
Hispanic or Latino 0.8786   0.8713   0.8802   0.8841   0.8995  
EDUCATION LEVEL                    
< High School da   da   0.2196   0.5203   0.2833  
High School Graduate da   da   0.1867   0.3575   0.2644  
Some College/Associate’s Degree da   da   0.8683   0.3606   0.6865  
College Graduate da   da   0.8538   0.2289   0.6890  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.6705   0.8098   0.6089  
Part‑Time da   da   0.0944   0.9350   0.0668  
Unemployed da   da   0.5782   0.5220   0.4395  
Other1 da   da   0.4607   0.0593   0.2994  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.61C – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,237 1,302 120 126 1,217 1,273 183 197 1,160 1,248
SEX                    
Male 772 831 86 91 764 815 126 117 737 797
Female 790 866 89 83 778 857 123 143 760 846
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,138 1,157 97 107 1,119 1,137 158 163 1,077 1,122
AIAN 43 54 5 11 43 52 10 9 40 51
Asian 250 196 25 26 248 198 47 52 242 190
Black or African American 376 422 43 42 371 417 59 69 357 406
NHPI 52 57 * * 50 57 * 1 49 *
White 992 1,026 82 85 977 1,013 135 129 942 1,001
Two or More Races 110 193 19 24 108 189 26 32 104 185
Hispanic or Latino 442 496 71 64 439 477 91 102 416 455
EDUCATION LEVEL                    
< High School da da da da 330 381 52 60 322 375
High School Graduate da da da da 582 678 100 97 568 666
Some College/Associate’s Degree da da da da 616 588 112 134 596 572
College Graduate da da da da 580 581 58 66 568 574
EMPLOYMENT STATUS                    
Full‑Time da da da da 658 709 105 117 642 699
Part‑Time da da da da 319 316 87 105 304 297
Unemployed da da da da 167 216 46 51 159 211
Other1 da da da da 805 848 89 86 789 844

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.61D – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.32 0.35 0.42 0.44 0.34 0.38 0.44 0.45 0.39 0.43
SEX                    
Male 0.43 0.50 0.60 0.63 0.47 0.54 0.65 0.57 0.53 0.63
Female 0.43 0.46 0.64 0.61 0.46 0.49 0.62 0.67 0.52 0.56
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.36 0.38 0.46 0.50 0.39 0.41 0.51 0.52 0.43 0.46
AIAN 2.79 2.83 2.54 3.52 3.34 3.31 5.33 3.74 3.67 3.82
Asian 1.19 0.98 1.62 1.55 1.29 1.07 1.80 1.89 1.46 1.20
Black or African American 0.80 0.97 1.09 1.12 0.89 1.07 1.15 1.33 1.03 1.24
NHPI 3.91 5.19 * * 4.03 5.57 * 1.45 4.57 *
White 0.42 0.46 0.58 0.61 0.45 0.49 0.66 0.67 0.50 0.54
Two or More Races 1.58 1.74 1.77 1.68 1.85 1.99 2.14 1.75 2.30 2.41
Hispanic or Latino 0.66 0.75 0.94 0.88 0.75 0.82 0.93 0.95 0.91 0.97
EDUCATION LEVEL                    
< High School da da da da 1.17 1.30 1.35 1.47 1.34 1.50
High School Graduate da da da da 0.68 0.78 0.73 0.68 0.82 0.94
Some College/Associate’s Degree da da da da 0.61 0.62 0.73 0.86 0.71 0.73
College Graduate da da da da 0.52 0.53 0.89 0.98 0.55 0.56
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.45 0.50 0.68 0.75 0.50 0.57
Part‑Time da da da da 0.84 0.78 0.88 0.93 1.10 1.02
Unemployed da da da da 1.15 1.36 1.18 1.19 1.54 1.92
Other1 da da da da 0.64 0.67 0.95 0.87 0.69 0.73

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.61P – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0271   0.0821   0.0357   0.3412   0.0555  
SEX                    
Male 0.0613   0.3337   0.0713   0.3958   0.1078  
Female 0.1582   0.1455   0.1895   0.6173   0.2217  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1813   0.5418   0.1830   0.4534   0.2283  
AIAN 0.6150   0.2851   0.4877   0.3913   0.5812  
Asian 0.0366   0.8920   0.0350   0.7627   0.0250  
Black or African American 0.1764   0.3937   0.1493   0.9558   0.1361  
NHPI 0.6922   *   0.6859   *   *  
White 0.1159   0.7028   0.1083   0.5569   0.1200  
Two or More Races 0.5910   0.6497   0.6078   0.1316   0.3896  
Hispanic or Latino 0.0181   0.0266   0.0354   0.5938   0.0465  
EDUCATION LEVEL                    
< High School da   da   0.2813   0.7270   0.2335  
High School Graduate da   da   0.6419   0.0091   0.9447  
Some College/Associate’s Degree da   da   0.0319   0.5336   0.0201  
College Graduate da   da   0.0421   0.6018   0.0330  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1107   0.7179   0.1223  
Part‑Time da   da   0.0215   0.5417   0.0279  
Unemployed da   da   0.4436   0.4860   0.2913  
Other1 da   da   0.2686   0.6619   0.2864  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.62C – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 328 344 39 49 324 340 84 72 307 329
SEX                    
Male 263 263 25 38 261 259 50 50 254 253
Female 188 212 31 29 185 210 61 50 176 202
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 304 298 32 39 301 295 73 66 288 285
AIAN 12 21 4 4 11 20 * 1 10 20
Asian 51 45 8 8 50 44 15 11 48 43
Black or African American 110 119 8 15 109 118 25 19 107 116
NHPI 16 6 * * 16 6 * * 16 6
White 265 259 29 33 263 257 66 60 253 249
Two or More Races 54 69 6 9 54 69 6 9 54 68
Hispanic or Latino 127 174 24 29 124 170 39 30 118 167
EDUCATION LEVEL                    
< High School da da da da 108 122 20 26 106 119
High School Graduate da da da da 180 206 48 37 176 202
Some College/Associate’s Degree da da da da 200 206 51 49 191 197
College Graduate da da da da 132 136 24 23 132 134
EMPLOYMENT STATUS                    
Full‑Time da da da da 186 187 48 52 179 178
Part‑Time da da da da 90 93 45 31 77 88
Unemployed da da da da 77 87 23 24 71 84
Other1 da da da da 236 270 35 28 233 269

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.62D – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.11 0.11 0.15 0.19 0.12 0.12 0.23 0.20 0.13 0.14
SEX                    
Male 0.18 0.18 0.19 0.28 0.20 0.20 0.28 0.27 0.23 0.23
Female 0.13 0.14 0.24 0.23 0.14 0.15 0.34 0.28 0.15 0.17
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.13 0.12 0.17 0.21 0.14 0.13 0.27 0.24 0.15 0.15
AIAN 0.88 1.09 1.97 1.41 0.97 1.26 * 0.56 1.01 1.44
Asian 0.27 0.23 0.54 0.52 0.29 0.25 0.62 0.42 0.32 0.28
Black or African American 0.30 0.34 0.23 0.45 0.33 0.37 0.53 0.41 0.38 0.43
NHPI 1.27 0.61 * * 1.36 0.64 * * 1.57 0.71
White 0.15 0.15 0.23 0.27 0.16 0.16 0.37 0.34 0.18 0.17
Two or More Races 0.80 0.73 0.56 0.66 0.95 0.84 0.52 0.51 1.18 1.06
Hispanic or Latino 0.23 0.30 0.35 0.43 0.26 0.33 0.43 0.31 0.30 0.40
EDUCATION LEVEL                    
< High School da da da da 0.44 0.49 0.56 0.68 0.51 0.57
High School Graduate da da da da 0.25 0.28 0.39 0.29 0.30 0.34
Some College/Associate’s Degree da da da da 0.25 0.26 0.38 0.36 0.29 0.30
College Graduate da da da da 0.14 0.15 0.40 0.36 0.15 0.15
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.15 0.15 0.33 0.37 0.17 0.17
Part‑Time da da da da 0.28 0.27 0.50 0.31 0.33 0.34
Unemployed da da da da 0.58 0.62 0.61 0.58 0.75 0.85
Other1 da da da da 0.24 0.26 0.41 0.32 0.26 0.29

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.62P – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0910   0.8659   0.0810   0.0468   0.1894  
SEX                    
Male 0.4681   0.3467   0.3895   0.6542   0.4381  
Female 0.0707   0.4455   0.0857   0.0178   0.2738  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0483   0.8098   0.0423   0.1198   0.0851  
AIAN 0.9195   0.9895   0.9138   *   0.8803  
Asian 0.0942   0.9937   0.0899   0.5813   0.1078  
Black or African American 0.2013   0.3887   0.1632   0.0526   0.3100  
NHPI 0.2448   *   0.2121   *   0.2401  
White 0.2391   0.9873   0.2319   0.4977   0.2888  
Two or More Races 0.3312   0.5988   0.3382   0.5013   0.3741  
Hispanic or Latino 0.8696   0.9610   0.8683   0.1806   0.6121  
EDUCATION LEVEL                    
< High School da   da   0.7968   0.7907   0.7456  
High School Graduate da   da   0.1052   0.0448   0.2419  
Some College/Associate’s Degree da   da   0.3526   0.3314   0.4785  
College Graduate da   da   0.5072   0.5594   0.5732  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.1993   0.8005   0.2049  
Part‑Time da   da   0.0592   0.0429   0.2540  
Unemployed da   da   0.5727   0.2762   0.8120  
Other1 da   da   0.6054   0.2362   0.7132  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.63C – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 193 180 19 25 192 178 39 36 188 173
SEX                    
Male 157 138 9 20 157 137 19 34 156 132
Female 104 110 17 13 103 109 32 14 98 108
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 174 157 14 20 174 155 25 35 172 149
AIAN 6 4 1 1 5 4 * <1 1 4
Asian 12 11 7 1 10 11 2 * 10 11
Black or African American 50 59 4 5 50 59 10 4 49 59
NHPI 2 1 * * 2 1 * * * 1
White 162 127 11 19 161 125 23 33 160 118
Two or More Races 40 61 2 1 40 61 2 2 40 61
Hispanic or Latino 73 90 12 15 72 88 27 8 67 88
EDUCATION LEVEL                    
< High School da da da da 64 85 13 20 63 82
High School Graduate da da da da 89 79 23 20 85 77
Some College/Associate’s Degree da da da da 139 117 20 17 138 114
College Graduate da da da da 60 57 14 15 58 55
EMPLOYMENT STATUS                    
Full‑Time da da da da 77 115 11 28 76 111
Part‑Time da da da da 48 32 25 7 41 32
Unemployed da da da da 36 55 14 15 33 53
Other1 da da da da 165 114 19 14 164 113

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.63D – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.07 0.06 0.07 0.10 0.07 0.07 0.11 0.10 0.08 0.07
SEX                    
Male 0.11 0.10 0.07 0.16 0.12 0.11 0.11 0.18 0.14 0.12
Female 0.07 0.07 0.13 0.11 0.08 0.08 0.18 0.08 0.08 0.09
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.07 0.07 0.07 0.11 0.08 0.07 0.10 0.13 0.09 0.08
AIAN 0.40 0.23 0.51 0.23 0.46 0.26 * 0.14 0.12 0.30
Asian 0.07 0.06 0.49 0.05 0.06 0.06 0.08 * 0.07 0.07
Black or African American 0.14 0.17 0.11 0.15 0.16 0.19 0.21 0.09 0.18 0.22
NHPI 0.13 0.05 * * 0.14 0.05 * * * 0.06
White 0.09 0.07 0.09 0.15 0.10 0.08 0.13 0.19 0.11 0.08
Two or More Races 0.61 0.64 0.19 0.11 0.72 0.74 0.19 0.11 0.91 0.94
Hispanic or Latino 0.13 0.16 0.18 0.21 0.15 0.18 0.30 0.08 0.17 0.22
EDUCATION LEVEL                    
< High School da da da da 0.27 0.34 0.37 0.54 0.31 0.39
High School Graduate da da da da 0.13 0.11 0.19 0.15 0.15 0.13
Some College/Associate’s Degree da da da da 0.18 0.15 0.15 0.13 0.21 0.18
College Graduate da da da da 0.07 0.06 0.24 0.24 0.07 0.06
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.06 0.10 0.08 0.20 0.07 0.11
Part‑Time da da da da 0.15 0.09 0.27 0.07 0.17 0.13
Unemployed da da da da 0.28 0.39 0.38 0.36 0.36 0.54
Other1 da da da da 0.17 0.11 0.23 0.16 0.18 0.12

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.63P – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7541   0.9886   0.7451   0.3543   0.8930  
SEX                    
Male 0.6066   0.2071   0.7064   0.2776   0.8496  
Female 0.2119   0.1964   0.2819   0.0098   0.6276  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8250   0.5369   0.7684   0.8164   0.7321  
AIAN 0.8757   0.8205   0.9063   *   0.2563  
Asian 0.7617   0.2285   0.7790   *   0.6789  
Black or African American 0.7727   0.6332   0.7385   0.0106   0.9873  
NHPI 0.5648   *   0.5644   *   *  
White 0.7034   0.2791   0.6114   0.2244   0.4390  
Two or More Races 0.7215   0.4187   0.7299   0.4323   0.7045  
Hispanic or Latino 0.7817   0.4425   0.8754   0.0407   0.7008  
EDUCATION LEVEL                    
< High School da   da   0.4555   0.6978   0.4968  
High School Graduate da   da   0.2176   0.1261   0.3838  
Some College/Associate’s Degree da   da   0.7838   0.8182   0.7476  
College Graduate da   da   0.4918   0.7299   0.5349  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.0764   0.1651   0.1317  
Part‑Time da   da   0.0267   0.0187   0.1951  
Unemployed da   da   0.9726   0.6525   0.8360  
Other1 da   da   0.2858   0.3709   0.3331  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Does not include illegally made fentanyl (IMF).

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.64C – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 596 717 94 111 583 698 179 199 560 650
SEX                    
Male 429 485 66 87 420 468 130 142 401 444
Female 379 453 73 68 371 444 107 121 356 416
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 547 636 91 94 533 622 152 167 509 591
AIAN 15 51 2 3 15 51 4 7 15 50
Asian 117 99 20 14 114 98 45 44 106 90
Black or African American 148 173 21 26 145 171 32 32 139 166
NHPI * 27 * * * 27 * * * *
White 490 575 85 84 475 563 136 145 450 536
Two or More Races 91 125 13 22 90 123 21 36 88 117
Hispanic or Latino 224 279 37 55 220 273 87 97 197 242
EDUCATION LEVEL                    
< High School da da da da 123 193 50 47 108 187
High School Graduate da da da da 276 292 84 88 262 278
Some College/Associate’s Degree da da da da 300 365 115 129 285 341
College Graduate da da da da 341 398 66 93 330 377
EMPLOYMENT STATUS                    
Full‑Time da da da da 396 451 108 112 384 430
Part‑Time da da da da 185 245 77 96 166 219
Unemployed da da da da 135 133 50 57 123 121
Other1 da da da da 310 371 86 88 300 364

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.64D – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.18 0.22 0.34 0.41 0.19 0.24 0.45 0.48 0.22 0.26
SEX                    
Male 0.28 0.32 0.49 0.63 0.30 0.34 0.66 0.70 0.34 0.38
Female 0.25 0.28 0.54 0.52 0.26 0.30 0.57 0.63 0.29 0.33
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.20 0.25 0.44 0.47 0.22 0.26 0.49 0.55 0.24 0.29
AIAN 1.14 2.53 1.13 1.14 1.34 2.92 2.27 3.16 1.52 3.30
Asian 0.59 0.51 1.29 0.87 0.63 0.55 1.77 1.64 0.67 0.58
Black or African American 0.40 0.49 0.58 0.76 0.44 0.54 0.68 0.70 0.49 0.62
NHPI * 2.53 * * * 2.72 * * * *
White 0.25 0.30 0.60 0.63 0.27 0.32 0.64 0.70 0.29 0.35
Two or More Races 1.35 1.22 1.26 1.48 1.58 1.41 1.76 1.96 1.96 1.72
Hispanic or Latino 0.41 0.46 0.53 0.76 0.46 0.51 0.95 0.93 0.49 0.57
EDUCATION LEVEL                    
< High School da da da da 0.51 0.74 1.34 1.22 0.53 0.85
High School Graduate da da da da 0.37 0.40 0.64 0.66 0.43 0.47
Some College/Associate’s Degree da da da da 0.36 0.44 0.77 0.83 0.41 0.50
College Graduate da da da da 0.33 0.38 1.00 1.27 0.34 0.39
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.29 0.34 0.68 0.75 0.32 0.37
Part‑Time da da da da 0.54 0.64 0.80 0.89 0.67 0.81
Unemployed da da da da 0.99 0.93 1.23 1.32 1.28 1.20
Other1 da da da da 0.31 0.37 0.94 0.90 0.33 0.39

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.64P – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3895   0.6849   0.4254   0.8792   0.4009  
SEX                    
Male 0.4534   0.1903   0.5979   0.7578   0.5467  
Female 0.6191   0.3884   0.5223   0.9112   0.5294  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7008   0.8835   0.6823   0.8677   0.6522  
AIAN 0.0333   0.5310   0.0276   0.2842   0.0386  
Asian 0.0927   0.2778   0.1258   0.4112   0.1862  
Black or African American 0.5253   0.5970   0.5757   0.5065   0.6642  
NHPI *   *   *   *   *  
White 0.7420   0.9107   0.7237   0.9027   0.6843  
Two or More Races 0.8894   0.5387   0.9784   0.7128   0.8989  
Hispanic or Latino 0.1818   0.2390   0.2660   0.9244   0.2386  
EDUCATION LEVEL                    
< High School da   da   0.0562   0.4371   0.0254  
High School Graduate da   da   0.0955   0.0675   0.2257  
Some College/Associate’s Degree da   da   0.2164   0.8006   0.2323  
College Graduate da   da   0.4397   0.0438   0.7350  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.5700   0.8988   0.5802  
Part‑Time da   da   0.3170   0.8388   0.3176  
Unemployed da   da   0.3490   0.4792   0.4817  
Other1 da   da   0.5618   0.8267   0.5153  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.65C – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 342 425 41 36 341 423 94 124 327 386
SEX                    
Male 284 316 24 25 283 315 66 84 274 293
Female 179 238 34 25 181 236 70 84 165 216
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 315 369 38 29 314 370 83 100 303 342
AIAN 11 43 1 1 11 43 3 2 10 43
Asian 67 64 13 2 66 64 24 38 62 51
Black or African American 92 98 6 12 92 97 14 22 89 95
NHPI 7 15 <1 * 7 15 * * 7 *
White 277 324 34 24 277 324 76 85 266 301
Two or More Races 57 86 6 12 57 85 8 19 56 83
Hispanic or Latino 144 185 16 21 143 183 47 64 130 165
EDUCATION LEVEL                    
< High School da da da da 95 136 24 25 90 134
High School Graduate da da da da 196 187 49 49 188 176
Some College/Associate’s Degree da da da da 178 219 63 84 170 199
College Graduate da da da da 178 228 49 62 170 210
EMPLOYMENT STATUS                    
Full‑Time da da da da 225 259 65 78 211 242
Part‑Time da da da da 123 167 46 55 112 157
Unemployed da da da da 93 107 34 31 86 103
Other1 da da da da 192 206 45 56 187 199

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.65D – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.11 0.14 0.16 0.14 0.12 0.15 0.26 0.32 0.14 0.16
SEX                    
Male 0.20 0.22 0.18 0.19 0.21 0.24 0.37 0.44 0.24 0.26
Female 0.12 0.15 0.27 0.20 0.13 0.17 0.38 0.46 0.14 0.18
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.13 0.15 0.20 0.15 0.14 0.17 0.30 0.35 0.16 0.18
AIAN 0.80 2.28 0.57 0.23 0.94 2.65 2.15 1.22 1.03 3.03
Asian 0.35 0.33 0.85 0.11 0.37 0.36 0.97 1.44 0.41 0.34
Black or African American 0.25 0.28 0.16 0.35 0.28 0.31 0.31 0.48 0.32 0.36
NHPI 0.60 1.44 0.18 * 0.65 1.56 * * 0.72 *
White 0.16 0.18 0.27 0.20 0.17 0.20 0.40 0.46 0.18 0.21
Two or More Races 0.86 0.87 0.55 0.86 1.03 1.01 0.74 1.11 1.29 1.25
Hispanic or Latino 0.26 0.31 0.23 0.30 0.30 0.35 0.53 0.65 0.33 0.39
EDUCATION LEVEL                    
< High School da da da da 0.39 0.54 0.67 0.66 0.44 0.63
High School Graduate da da da da 0.27 0.26 0.40 0.37 0.32 0.30
Some College/Associate’s Degree da da da da 0.22 0.28 0.45 0.59 0.26 0.30
College Graduate da da da da 0.19 0.23 0.79 0.93 0.19 0.23
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.18 0.21 0.43 0.54 0.19 0.22
Part‑Time da da da da 0.37 0.47 0.50 0.54 0.47 0.61
Unemployed da da da da 0.70 0.76 0.88 0.75 0.91 1.03
Other1 da da da da 0.20 0.21 0.51 0.62 0.21 0.22

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.65P – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4619   0.3865   0.4261   0.8959   0.3887  
SEX                    
Male 0.9793   0.3092   0.9278   0.9420   0.9475  
Female 0.1770   0.7743   0.1693   0.7987   0.1135  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8537   0.3236   0.7935   0.9438   0.7773  
AIAN 0.2154   0.3760   0.2023   0.5187   0.1711  
Asian 0.2322   0.0935   0.3359   0.8402   0.2238  
Black or African American 0.8610   0.6646   0.8185   0.2847   0.6538  
NHPI 0.4293   *   0.4743   *   *  
White 0.7663   0.3921   0.7219   0.7905   0.6501  
Two or More Races 0.8034   0.7685   0.7200   0.9761   0.7196  
Hispanic or Latino 0.1856   0.9930   0.1934   0.9288   0.1466  
EDUCATION LEVEL                    
< High School da   da   0.2765   0.6798   0.2293  
High School Graduate da   da   0.0600   0.0547   0.1457  
Some College/Associate’s Degree da   da   0.1286   0.6964   0.1408  
College Graduate da   da   0.2277   0.2207   0.3587  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.9077   0.8909   0.9388  
Part‑Time da   da   0.2533   0.4989   0.3301  
Unemployed da   da   0.9288   0.2401   0.7293  
Other1 da   da   0.5848   0.8020   0.5292  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.66C – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 224 280 26 17 225 281 46 73 219 269
SEX                    
Male 191 223 11 15 191 223 35 50 186 217
Female 112 144 23 9 116 144 31 47 110 136
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 209 234 25 15 210 235 39 60 205 226
AIAN 3 42 * <1 3 * <1 1 3 *
Asian 59 45 * 2 59 45 10 11 58 44
Black or African American 62 63 3 3 62 63 9 14 61 61
NHPI 2 4 <1 * 2 4 <1 * 2 4
White 182 207 24 14 183 208 36 55 177 200
Two or More Races 55 59 3 3 55 59 4 10 54 58
Hispanic or Latino 91 140 6 9 91 140 26 39 86 135
EDUCATION LEVEL                    
< High School da da da da 66 122 18 12 63 122
High School Graduate da da da da 138 121 25 31 135 116
Some College/Associate’s Degree da da da da 117 148 29 51 114 138
College Graduate da da da da 97 148 20 34 96 144
EMPLOYMENT STATUS                    
Full‑Time da da da da 139 160 33 48 132 153
Part‑Time da da da da 70 139 19 41 67 133
Unemployed da da da da 69 86 11 13 67 86
Other1 da da da da 131 151 28 31 127 147

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.66D – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.08 0.09 0.10 0.07 0.08 0.10 0.13 0.20 0.09 0.12
SEX                    
Male 0.13 0.16 0.08 0.11 0.15 0.17 0.20 0.27 0.17 0.20
Female 0.08 0.10 0.18 0.07 0.09 0.10 0.18 0.26 0.09 0.11
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.09 0.10 0.13 0.08 0.10 0.11 0.15 0.22 0.11 0.12
AIAN 0.24 2.23 * 0.10 0.27 * 0.15 0.37 0.31 *
Asian 0.31 0.23 * 0.11 0.34 0.25 0.41 0.41 0.39 0.29
Black or African American 0.17 0.18 0.07 0.10 0.19 0.20 0.20 0.29 0.22 0.23
NHPI 0.13 0.42 0.18 * 0.14 0.45 0.01 * 0.16 0.49
White 0.11 0.12 0.19 0.12 0.11 0.13 0.21 0.31 0.12 0.14
Two or More Races 0.83 0.61 0.28 0.21 0.99 0.71 0.40 0.57 1.25 0.88
Hispanic or Latino 0.17 0.24 0.08 0.12 0.19 0.27 0.30 0.41 0.22 0.33
EDUCATION LEVEL                    
< High School da da da da 0.28 0.49 0.50 0.33 0.31 0.57
High School Graduate da da da da 0.19 0.17 0.20 0.24 0.23 0.20
Some College/Associate’s Degree da da da da 0.15 0.19 0.22 0.38 0.17 0.21
College Graduate da da da da 0.11 0.16 0.33 0.53 0.11 0.16
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.11 0.13 0.23 0.35 0.12 0.14
Part‑Time da da da da 0.22 0.39 0.22 0.41 0.28 0.52
Unemployed da da da da 0.53 0.61 0.30 0.32 0.72 0.87
Other1 da da da da 0.14 0.15 0.33 0.36 0.15 0.16

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.66P – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1563   0.4175   0.1460   0.1030   0.2721  
SEX                    
Male 0.3219   0.3904   0.3028   0.2337   0.4151  
Female 0.2231   0.7077   0.2179   0.2365   0.3602  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6267   0.3883   0.5861   0.1173   0.8453  
AIAN 0.1267   *   *   0.2164   *  
Asian 0.2826   *   0.2720   0.8841   0.2509  
Black or African American 0.9335   0.9027   0.9360   0.4933   0.9667  
NHPI 0.1365   *   0.1283   *   0.1630  
White 0.4081   0.4494   0.3808   0.1042   0.6125  
Two or More Races 0.1685   0.3215   0.1666   0.5999   0.1833  
Hispanic or Latino 0.0337   0.9919   0.0351   0.5361   0.0437  
EDUCATION LEVEL                    
< High School da   da   0.0761   0.5370   0.0566  
High School Graduate da   da   0.0793   0.8132   0.0812  
Some College/Associate’s Degree da   da   0.0859   0.0594   0.2294  
College Graduate da   da   0.1036   0.1612   0.1794  
EMPLOYMENT STATUS                    
Full‑Time da   da   0.6361   0.1421   0.9509  
Part‑Time da   da   0.0132   0.0490   0.0446  
Unemployed da   da   0.3867   0.5730   0.4021  
Other1 da   da   0.7295   0.3801   0.8671  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.67C – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 717 ‑‑ 77 ‑‑ 705 ‑‑ 196 ‑‑ 658
SEX                    
Male ‑‑ 518 ‑‑ 57 ‑‑ 512 ‑‑ 134 ‑‑ 489
Female ‑‑ 423 ‑‑ 53 ‑‑ 417 ‑‑ 124 ‑‑ 390
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 622 ‑‑ 62 ‑‑ 615 ‑‑ 155 ‑‑ 583
AIAN ‑‑ 58 ‑‑ 4 ‑‑ 58 ‑‑ 6 ‑‑ 57
Asian ‑‑ 110 ‑‑ 15 ‑‑ 110 ‑‑ 53 ‑‑ 96
Black or African American ‑‑ 169 ‑‑ 27 ‑‑ 167 ‑‑ 39 ‑‑ 160
NHPI ‑‑ 30 ‑‑ * ‑‑ 30 ‑‑ * ‑‑ *
White ‑‑ 568 ‑‑ 53 ‑‑ 562 ‑‑ 136 ‑‑ 533
Two or More Races ‑‑ 115 ‑‑ 19 ‑‑ 113 ‑‑ 30 ‑‑ 108
Hispanic or Latino ‑‑ 308 ‑‑ 44 ‑‑ 300 ‑‑ 99 ‑‑ 275
EDUCATION LEVEL                    
< High School da da da da ‑‑ 193 ‑‑ 44 ‑‑ 185
High School Graduate da da da da ‑‑ 339 ‑‑ 91 ‑‑ 322
Some College/Associate’s Degree da da da da ‑‑ 363 ‑‑ 131 ‑‑ 334
College Graduate da da da da ‑‑ 408 ‑‑ 87 ‑‑ 385
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 432 ‑‑ 117 ‑‑ 406
Part‑Time da da da da ‑‑ 235 ‑‑ 99 ‑‑ 214
Unemployed da da da da ‑‑ 159 ‑‑ 56 ‑‑ 147
Other1 da da da da ‑‑ 424 ‑‑ 80 ‑‑ 416

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.67D – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.22 ‑‑ 0.29 ‑‑ 0.24 ‑‑ 0.48 ‑‑ 0.26
SEX                    
Male ‑‑ 0.34 ‑‑ 0.42 ‑‑ 0.37 ‑‑ 0.66 ‑‑ 0.42
Female ‑‑ 0.26 ‑‑ 0.42 ‑‑ 0.28 ‑‑ 0.64 ‑‑ 0.31
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 0.24 ‑‑ 0.32 ‑‑ 0.26 ‑‑ 0.51 ‑‑ 0.28
AIAN ‑‑ 2.86 ‑‑ 1.44 ‑‑ 3.31 ‑‑ 2.65 ‑‑ 3.77
Asian ‑‑ 0.57 ‑‑ 0.96 ‑‑ 0.62 ‑‑ 1.99 ‑‑ 0.63
Black or African American ‑‑ 0.46 ‑‑ 0.78 ‑‑ 0.51 ‑‑ 0.84 ‑‑ 0.58
NHPI ‑‑ 2.82 ‑‑ * ‑‑ 3.02 ‑‑ * ‑‑ *
White ‑‑ 0.29 ‑‑ 0.43 ‑‑ 0.31 ‑‑ 0.67 ‑‑ 0.34
Two or More Races ‑‑ 1.15 ‑‑ 1.36 ‑‑ 1.32 ‑‑ 1.69 ‑‑ 1.62
Hispanic or Latino ‑‑ 0.48 ‑‑ 0.62 ‑‑ 0.54 ‑‑ 0.95 ‑‑ 0.61
EDUCATION LEVEL                    
< High School da da da da ‑‑ 0.75 ‑‑ 1.11 ‑‑ 0.85
High School Graduate da da da da ‑‑ 0.44 ‑‑ 0.65 ‑‑ 0.51
Some College/Associate’s Degree da da da da ‑‑ 0.43 ‑‑ 0.85 ‑‑ 0.48
College Graduate da da da da ‑‑ 0.39 ‑‑ 1.24 ‑‑ 0.40
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 0.33 ‑‑ 0.79 ‑‑ 0.35
Part‑Time da da da da ‑‑ 0.62 ‑‑ 0.93 ‑‑ 0.79
Unemployed da da da da ‑‑ 1.08 ‑‑ 1.30 ‑‑ 1.44
Other1 da da da da ‑‑ 0.40 ‑‑ 0.81 ‑‑ 0.43

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.68C – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 408 ‑‑ 40 ‑‑ 409 ‑‑ 102 ‑‑ 395
SEX                    
Male ‑‑ 296 ‑‑ 33 ‑‑ 296 ‑‑ 78 ‑‑ 286
Female ‑‑ 251 ‑‑ 24 ‑‑ 248 ‑‑ 63 ‑‑ 240
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 353 ‑‑ 32 ‑‑ 353 ‑‑ 83 ‑‑ 342
AIAN ‑‑ 45 ‑‑ 3 ‑‑ 45 ‑‑ 1 ‑‑ 45
Asian ‑‑ 56 ‑‑ 8 ‑‑ 56 ‑‑ 21 ‑‑ 52
Black or African American ‑‑ 97 ‑‑ 11 ‑‑ 96 ‑‑ 19 ‑‑ 93
NHPI ‑‑ 4 ‑‑ * ‑‑ 4 ‑‑ * ‑‑ 4
White ‑‑ 318 ‑‑ 28 ‑‑ 318 ‑‑ 74 ‑‑ 307
Two or More Races ‑‑ 84 ‑‑ 6 ‑‑ 84 ‑‑ 14 ‑‑ 83
Hispanic or Latino ‑‑ 196 ‑‑ 26 ‑‑ 196 ‑‑ 56 ‑‑ 188
EDUCATION LEVEL                    
< High School da da da da ‑‑ 159 ‑‑ 33 ‑‑ 156
High School Graduate da da da da ‑‑ 154 ‑‑ 61 ‑‑ 140
Some College/Associate’s Degree da da da da ‑‑ 238 ‑‑ 64 ‑‑ 230
College Graduate da da da da ‑‑ 222 ‑‑ 44 ‑‑ 217
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 268 ‑‑ 68 ‑‑ 257
Part‑Time da da da da ‑‑ 169 ‑‑ 56 ‑‑ 160
Unemployed da da da da ‑‑ 94 ‑‑ 34 ‑‑ 89
Other1 da da da da ‑‑ 222 ‑‑ 40 ‑‑ 219

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.68D – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.13 ‑‑ 0.15 ‑‑ 0.15 ‑‑ 0.27 ‑‑ 0.17
SEX                    
Male ‑‑ 0.21 ‑‑ 0.25 ‑‑ 0.23 ‑‑ 0.41 ‑‑ 0.26
Female ‑‑ 0.16 ‑‑ 0.20 ‑‑ 0.18 ‑‑ 0.35 ‑‑ 0.20
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 0.14 ‑‑ 0.17 ‑‑ 0.16 ‑‑ 0.30 ‑‑ 0.18
AIAN ‑‑ 2.34 ‑‑ 0.93 ‑‑ 2.71 ‑‑ 0.53 ‑‑ 3.11
Asian ‑‑ 0.29 ‑‑ 0.51 ‑‑ 0.32 ‑‑ 0.79 ‑‑ 0.34
Black or African American ‑‑ 0.27 ‑‑ 0.34 ‑‑ 0.30 ‑‑ 0.42 ‑‑ 0.35
NHPI ‑‑ 0.43 ‑‑ * ‑‑ 0.46 ‑‑ * ‑‑ 0.50
White ‑‑ 0.18 ‑‑ 0.23 ‑‑ 0.19 ‑‑ 0.41 ‑‑ 0.21
Two or More Races ‑‑ 0.87 ‑‑ 0.45 ‑‑ 1.02 ‑‑ 0.82 ‑‑ 1.27
Hispanic or Latino ‑‑ 0.33 ‑‑ 0.38 ‑‑ 0.38 ‑‑ 0.58 ‑‑ 0.45
EDUCATION LEVEL                    
< High School da da da da ‑‑ 0.63 ‑‑ 0.85 ‑‑ 0.73
High School Graduate da da da da ‑‑ 0.21 ‑‑ 0.46 ‑‑ 0.24
Some College/Associate’s Degree da da da da ‑‑ 0.30 ‑‑ 0.45 ‑‑ 0.34
College Graduate da da da da ‑‑ 0.23 ‑‑ 0.69 ‑‑ 0.24
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 0.21 ‑‑ 0.49 ‑‑ 0.24
Part‑Time da da da da ‑‑ 0.47 ‑‑ 0.55 ‑‑ 0.61
Unemployed da da da da ‑‑ 0.66 ‑‑ 0.82 ‑‑ 0.91
Other1 da da da da ‑‑ 0.22 ‑‑ 0.45 ‑‑ 0.24

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.69C – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Demographic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 236 263 97 148 89 129
AGE GROUP            
12‑17 26 39 15 16 15 15
18 or Older 233 260 96 147 88 129
18‑25 39 40 26 18 25 16
26 or Older 229 256 92 146 84 127
SEX            
Male 165 174 80 110 74 91
Female 165 194 52 86 50 77
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 214 236 89 120 84 101
AIAN 6 17 5 3 2 2
Asian 20 37 8 29 8 29
Black or African American 73 120 25 61 24 61
NHPI 8 1 7 * 5 *
White 194 183 77 84 72 53
Two or More Races 46 77 35 50 35 50
Hispanic or Latino 103 127 35 86 29 81

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.69D – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2024 and 2025
Demographic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 0.08 0.09 0.03 0.05 0.03 0.04
AGE GROUP            
12‑17 0.10 0.15 0.06 0.06 0.06 0.06
18 or Older 0.09 0.10 0.04 0.06 0.03 0.05
18‑25 0.11 0.11 0.07 0.05 0.07 0.04
26 or Older 0.10 0.11 0.04 0.06 0.04 0.06
SEX            
Male 0.11 0.12 0.06 0.08 0.05 0.06
Female 0.11 0.13 0.04 0.06 0.03 0.05
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.09 0.10 0.04 0.05 0.04 0.04
AIAN 0.47 0.90 0.40 0.15 0.16 0.13
Asian 0.11 0.20 0.04 0.15 0.04 0.15
Black or African American 0.21 0.35 0.07 0.18 0.07 0.18
NHPI 0.66 0.11 0.55 * 0.38 *
White 0.11 0.11 0.04 0.05 0.04 0.03
Two or More Races 0.71 0.80 0.54 0.53 0.54 0.53
Hispanic or Latino 0.18 0.22 0.06 0.15 0.05 0.14

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.69P – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Demographic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 0.9467   0.2933   0.5441  
AGE GROUP            
12‑17 0.1899   0.8580   0.8874  
18 or Older 0.9024   0.2837   0.5316  
18‑25 0.9407   0.1473   0.1360  
26 or Older 0.9194   0.1728   0.3518  
SEX            
Male 0.6916   0.5232   0.7529  
Female 0.7774   0.3121   0.5149  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.9974   0.3521   0.7093  
AIAN 0.1275   0.3968   0.7725  
Asian 0.2940   0.1603   0.1523  
Black or African American 0.3325   0.4569   0.4487  
NHPI 0.0769   *   *  
White 0.3062   0.7115   0.4797  
Two or More Races 0.7253   0.9290   0.9921  
Hispanic or Latino 0.8712   0.6106   0.5867  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.70C – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,189 2,366 ‑‑ 176 2,129 2,327 447 499 1,970 2,177
GEOGRAPHIC DIVISION                    
Northeast 1,060 1,075 ‑‑ 78 1,027 1,056 168 232 956 988
New England 618 501 ‑‑ 32 601 500 100 117 560 455
Middle Atlantic 867 934 ‑‑ 71 838 911 136 203 779 861
Midwest 885 942 ‑‑ 60 866 929 206 223 794 847
East North Central 772 793 ‑‑ 54 754 781 168 204 705 696
West North Central 453 490 ‑‑ 27 446 486 115 97 403 448
South 1,295 1,385 ‑‑ 126 1,258 1,348 290 280 1,147 1,269
South Atlantic 1,045 1,058 ‑‑ 92 1,018 1,031 236 240 934 950
East South Central 391 413 ‑‑ 40 384 405 64 91 375 389
West South Central 637 762 ‑‑ 73 610 738 160 169 550 681
West 1,169 1,330 ‑‑ 76 1,136 1,313 234 224 1,047 1,220
Mountain 611 580 ‑‑ 45 595 574 113 118 550 525
Pacific 1,014 1,224 ‑‑ 62 987 1,209 208 193 903 1,123
COUNTY TYPE                    
Large Metro 1,836 1,944 ‑‑ 133 1,783 1,919 319 386 1,666 1,767
Small Metro 1,261 1,275 ‑‑ 109 1,216 1,246 306 312 1,094 1,159
Nonmetro 746 743 ‑‑ 45 718 726 151 140 645 654
Urbanized 511 438 ‑‑ 21 486 430 122 86 418 397
Less Urbanized 488 544 ‑‑ 34 477 529 87 96 436 474
Completely Rural 392 355 ‑‑ 20 376 346 49 58 350 309
POVERTY LEVEL1                    
Less Than 100% 662 752 ‑‑ 83 645 737 212 292 578 654
100‑199% 667 848 ‑‑ 85 649 841 171 181 598 799
200% or More 1,789 1,790 ‑‑ 112 1,746 1,769 284 272 1,660 1,687
HEALTH INSURANCE2                    
Private 1,645 1,650 ‑‑ 109 1,602 1,630 326 387 1,508 1,551
Medicaid/CHIP 808 949 ‑‑ 125 786 920 174 197 730 858
Other3 907 1,099 ‑‑ 39 905 1,099 100 87 893 1,090
No Coverage 445 471 ‑‑ 33 440 471 122 134 408 445

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.70D – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.40 0.44 ‑‑ 0.58 0.42 0.48 0.67 0.80 0.47 0.52
GEOGRAPHIC DIVISION                    
Northeast 1.04 1.21 ‑‑ 1.61 1.10 1.33 1.75 1.93 1.20 1.44
New England 1.83 2.05 ‑‑ 2.52 1.85 2.29 2.99 4.22 2.10 2.43
Middle Atlantic 1.23 1.42 ‑‑ 2.00 1.32 1.55 2.09 2.26 1.43 1.69
Midwest 0.76 0.77 ‑‑ 1.03 0.80 0.83 1.40 1.47 0.89 0.92
East North Central 1.01 0.98 ‑‑ 1.37 1.07 1.04 1.59 1.79 1.20 1.15
West North Central 0.99 1.19 ‑‑ 1.42 1.07 1.28 2.58 2.35 1.20 1.41
South 0.63 0.70 ‑‑ 1.02 0.67 0.75 1.12 1.16 0.74 0.81
South Atlantic 0.88 0.94 ‑‑ 1.36 0.95 1.01 1.56 1.62 1.04 1.09
East South Central 1.26 1.60 ‑‑ 2.11 1.37 1.77 2.21 3.15 1.59 1.99
West South Central 1.12 1.27 ‑‑ 1.90 1.14 1.31 2.05 2.05 1.27 1.43
West 0.89 0.95 ‑‑ 1.09 0.91 1.01 1.44 1.81 0.97 1.10
Mountain 1.21 1.33 ‑‑ 1.80 1.28 1.45 2.40 2.73 1.35 1.56
Pacific 1.16 1.30 ‑‑ 1.33 1.19 1.37 1.77 2.38 1.26 1.48
COUNTY TYPE                    
Large Metro 0.59 0.64 ‑‑ 0.78 0.63 0.69 0.93 1.13 0.69 0.75
Small Metro 0.63 0.70 ‑‑ 1.03 0.67 0.75 1.18 1.28 0.72 0.82
Nonmetro 0.99 1.05 ‑‑ 1.32 1.06 1.12 1.93 2.03 1.16 1.24
Urbanized 1.64 1.75 ‑‑ 1.71 1.74 1.88 2.95 2.31 1.96 2.13
Less Urbanized 1.68 1.85 ‑‑ 2.45 1.76 1.92 3.22 3.72 1.94 2.12
Completely Rural 1.70 1.83 ‑‑ 2.68 1.81 2.00 3.49 3.77 2.01 2.21
POVERTY LEVEL1                    
Less Than 100% 0.95 0.94 ‑‑ 1.28 1.04 1.05 1.44 1.46 1.22 1.27
100‑199% 0.80 0.92 ‑‑ 1.27 0.87 1.01 1.30 1.37 1.00 1.15
200% or More 0.47 0.55 ‑‑ 0.66 0.50 0.58 0.90 1.10 0.54 0.62
HEALTH INSURANCE2                    
Private 0.48 0.54 ‑‑ 0.68 0.51 0.57 0.89 0.99 0.57 0.63
Medicaid/CHIP 0.85 0.89 ‑‑ 0.98 0.98 1.03 1.23 1.37 1.13 1.19
Other3 0.74 0.84 ‑‑ 2.53 0.76 0.85 2.33 2.65 0.78 0.87
No Coverage 1.20 1.28 ‑‑ 2.46 1.24 1.33 1.60 1.86 1.48 1.59

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.70P – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0012   ‑‑   0.0234   0.0017   0.0995  
GEOGRAPHIC DIVISION                    
Northeast 0.0318   ‑‑   0.0732   0.0013   0.2199  
New England 0.0583   ‑‑   0.0998   0.2658   0.1430  
Middle Atlantic 0.1404   ‑‑   0.2296   0.0025   0.5194  
Midwest 0.1372   ‑‑   0.3163   0.7453   0.3345  
East North Central 0.4549   ‑‑   0.6803   0.4465   0.5478  
West North Central 0.0678   ‑‑   0.1575   0.0913   0.3410  
South 0.1732   ‑‑   0.4455   0.1631   0.6333  
South Atlantic 0.3153   ‑‑   0.5859   0.0797   0.8486  
East South Central 0.6723   ‑‑   0.7846   0.3913   0.6406  
West South Central 0.3923   ‑‑   0.6338   0.4460   0.7584  
West 0.0948   ‑‑   0.2523   0.1211   0.4051  
Mountain 0.0129   ‑‑   0.0386   0.3034   0.0505  
Pacific 0.5468   ‑‑   0.8363   0.2379   0.9537  
COUNTY TYPE                    
Large Metro 0.0108   ‑‑   0.0582   0.0249   0.1361  
Small Metro 0.0308   ‑‑   0.1230   0.0053   0.3557  
Nonmetro 0.8214   ‑‑   0.8544   0.7302   0.9347  
Urbanized 0.3454   ‑‑   0.1590   0.7881   0.1582  
Less Urbanized 0.7491   ‑‑   0.8018   0.8269   0.7541  
Completely Rural 0.1077   ‑‑   0.1480   0.4853   0.1055  
POVERTY LEVEL1                    
Less Than 100% 0.7928   ‑‑   0.5157   0.8126   0.5162  
100‑199% 0.5657   ‑‑   0.2441   0.6475   0.1786  
200% or More 0.0000   ‑‑   0.0003   0.0000   0.0044  
HEALTH INSURANCE2                    
Private 0.0001   ‑‑   0.0014   0.0170   0.0056  
Medicaid/CHIP 0.8970   ‑‑   0.5874   0.1534   0.3508  
Other3 0.7652   ‑‑   0.8396   0.0245   0.9715  
No Coverage 0.7975   ‑‑   0.6772   0.0967   0.3524  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics, even though the lifetime misuse of prescription psychotherapeutics estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.71C – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,352 1,367 ‑‑ 133 1,320 1,347 357 420 1,203 1,218
GEOGRAPHIC DIVISION                    
Northeast 612 663 ‑‑ 46 593 654 131 202 538 609
New England 355 362 ‑‑ 22 344 364 79 84 305 333
Middle Atlantic 498 552 ‑‑ 41 483 542 107 186 441 515
Midwest 605 576 ‑‑ 46 595 565 169 191 533 493
East North Central 508 501 ‑‑ 39 497 493 135 177 444 410
West North Central 313 269 ‑‑ 24 309 264 94 78 280 241
South 730 733 ‑‑ 101 716 712 223 223 640 638
South Atlantic 597 533 ‑‑ 74 584 521 184 197 521 435
East South Central 214 244 ‑‑ 32 209 239 48 81 202 205
West South Central 319 444 ‑‑ 59 313 426 124 131 279 389
West 716 809 ‑‑ 61 698 796 185 194 641 709
Mountain 391 389 ‑‑ 39 383 381 92 93 342 343
Pacific 611 727 ‑‑ 47 595 715 163 172 544 638
COUNTY TYPE                    
Large Metro 1,096 1,130 ‑‑ 101 1,071 1,115 264 329 984 994
Small Metro 753 727 ‑‑ 84 730 713 240 261 650 640
Nonmetro 418 402 ‑‑ 35 404 393 114 101 353 354
Urbanized 270 248 ‑‑ 18 263 243 95 63 215 222
Less Urbanized 267 285 ‑‑ 23 259 278 60 66 233 250
Completely Rural 221 180 ‑‑ 19 208 171 37 44 191 151
POVERTY LEVEL1                    
Less Than 100% 516 527 ‑‑ 65 505 520 172 256 455 439
100‑199% 445 565 ‑‑ 71 433 557 139 152 395 525
200% or More 1,041 1,011 ‑‑ 82 1,023 1,004 228 222 958 933
HEALTH INSURANCE2                    
Private 926 944 ‑‑ 87 911 935 265 331 845 856
Medicaid/CHIP 575 644 ‑‑ 97 559 626 138 161 519 576
Other3 515 565 ‑‑ 25 514 567 81 73 505 560
No Coverage 305 319 ‑‑ 26 302 316 104 105 279 287

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.71D – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.35 0.35 ‑‑ 0.46 0.38 0.38 0.65 0.77 0.42 0.41
GEOGRAPHIC DIVISION                    
Northeast 0.85 0.93 ‑‑ 1.07 0.92 1.00 1.59 1.92 1.00 1.09
New England 1.48 1.80 ‑‑ 1.85 1.59 1.98 2.71 3.14 1.75 2.19
Middle Atlantic 1.01 1.05 ‑‑ 1.30 1.10 1.14 1.93 2.44 1.18 1.27
Midwest 0.74 0.71 ‑‑ 0.82 0.81 0.76 1.35 1.49 0.88 0.80
East North Central 0.94 0.92 ‑‑ 1.05 1.02 0.98 1.56 1.94 1.09 1.00
West North Central 1.12 0.97 ‑‑ 1.31 1.21 1.06 2.30 2.02 1.39 1.20
South 0.50 0.50 ‑‑ 0.85 0.55 0.54 1.03 1.09 0.60 0.58
South Atlantic 0.72 0.68 ‑‑ 1.15 0.78 0.75 1.48 1.56 0.84 0.76
East South Central 1.06 1.27 ‑‑ 1.80 1.17 1.40 1.84 3.11 1.33 1.43
West South Central 0.83 0.90 ‑‑ 1.55 0.90 0.95 1.89 1.89 1.00 1.12
West 0.78 0.82 ‑‑ 0.93 0.84 0.89 1.51 1.62 0.92 0.97
Mountain 1.13 1.32 ‑‑ 1.76 1.26 1.43 2.15 2.53 1.38 1.57
Pacific 1.00 1.07 ‑‑ 1.02 1.07 1.15 1.99 2.11 1.17 1.25
COUNTY TYPE                    
Large Metro 0.50 0.50 ‑‑ 0.63 0.54 0.55 0.94 1.11 0.59 0.59
Small Metro 0.54 0.55 ‑‑ 0.84 0.60 0.61 1.12 1.24 0.66 0.66
Nonmetro 0.89 0.85 ‑‑ 1.07 0.94 0.91 1.92 1.71 0.98 1.01
Urbanized 1.41 1.49 ‑‑ 1.62 1.47 1.59 3.09 2.22 1.54 1.81
Less Urbanized 1.49 1.39 ‑‑ 1.66 1.60 1.49 3.03 2.88 1.71 1.68
Completely Rural 1.66 1.54 ‑‑ 2.61 1.73 1.62 3.48 3.77 1.87 1.69
POVERTY LEVEL1                    
Less Than 100% 0.86 0.82 ‑‑ 1.09 0.94 0.91 1.37 1.44 1.12 1.07
100‑199% 0.68 0.76 ‑‑ 1.11 0.75 0.84 1.34 1.39 0.83 0.94
200% or More 0.43 0.44 ‑‑ 0.52 0.47 0.48 0.86 0.99 0.51 0.51
HEALTH INSURANCE2                    
Private 0.42 0.45 ‑‑ 0.57 0.46 0.48 0.85 0.98 0.50 0.52
Medicaid/CHIP 0.76 0.78 ‑‑ 0.83 0.88 0.92 1.19 1.27 1.02 1.07
Other3 0.59 0.61 ‑‑ 1.60 0.60 0.63 2.15 2.34 0.61 0.64
No Coverage 1.00 1.05 ‑‑ 2.01 1.04 1.09 1.61 1.66 1.26 1.25

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.71P – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0022   ‑‑   0.0141   0.0767   0.0274  
GEOGRAPHIC DIVISION                    
Northeast 0.6287   ‑‑   0.8779   0.0641   0.7776  
New England 0.4802   ‑‑   0.5875   0.4037   0.7070  
Middle Atlantic 0.8788   ‑‑   0.8859   0.1071   0.5806  
Midwest 0.0386   ‑‑   0.0601   0.9015   0.0363  
East North Central 0.2868   ‑‑   0.3810   0.3944   0.2247  
West North Central 0.0124   ‑‑   0.0145   0.2283   0.0281  
South 0.0142   ‑‑   0.0380   0.6112   0.0342  
South Atlantic 0.0026   ‑‑   0.0066   0.3167   0.0061  
East South Central 0.7401   ‑‑   0.8329   0.3325   0.5958  
West South Central 0.8689   ‑‑   0.9380   0.8238   0.9059  
West 0.2539   ‑‑   0.4083   0.1592   0.5894  
Mountain 0.0160   ‑‑   0.0321   0.0434   0.0773  
Pacific 0.9398   ‑‑   0.7601   0.6677   0.6846  
COUNTY TYPE                    
Large Metro 0.0795   ‑‑   0.1880   0.4309   0.1714  
Small Metro 0.0229   ‑‑   0.0660   0.0326   0.2047  
Nonmetro 0.0691   ‑‑   0.0941   0.8720   0.1035  
Urbanized 0.6703   ‑‑   0.7836   1.0000   0.9654  
Less Urbanized 0.2242   ‑‑   0.2316   0.8673   0.2280  
Completely Rural 0.0656   ‑‑   0.0750   0.6650   0.0451  
POVERTY LEVEL1                    
Less Than 100% 0.5929   ‑‑   0.6927   0.4827   0.4063  
100‑199% 0.8703   ‑‑   0.8801   0.9811   0.7191  
200% or More 0.0002   ‑‑   0.0016   0.0006   0.0107  
HEALTH INSURANCE2                    
Private 0.0155   ‑‑   0.0632   0.2490   0.0605  
Medicaid/CHIP 0.3076   ‑‑   0.4518   0.5709   0.5200  
Other3 0.0727   ‑‑   0.0883   0.2158   0.1322  
No Coverage 0.7805   ‑‑   0.8459   0.0389   0.6082  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.72C – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,040 1,058 101 94 1,018 1,049 272 312 937 957
GEOGRAPHIC DIVISION                    
Northeast 476 492 50 34 463 485 103 146 428 453
New England 289 278 30 16 280 276 62 66 249 257
Middle Atlantic 379 401 41 30 370 394 84 133 347 374
Midwest 464 468 35 34 457 464 128 137 412 415
East North Central 385 407 30 30 380 406 101 122 344 351
West North Central 229 226 20 16 227 222 70 63 207 209
South 571 558 62 71 558 548 168 168 501 486
South Atlantic 452 422 44 54 441 417 137 137 395 359
East South Central 169 183 16 18 167 180 40 67 157 156
West South Central 269 312 40 42 262 303 92 93 240 274
West 537 653 49 42 531 645 145 165 497 585
Mountain 281 320 27 25 277 315 66 77 263 287
Pacific 461 584 42 34 456 576 131 147 419 518
COUNTY TYPE                    
Large Metro 849 888 83 70 834 877 201 249 777 786
Small Metro 558 544 50 62 543 534 182 181 488 493
Nonmetro 304 311 28 22 294 307 83 87 261 277
Urbanized 197 204 16 8 191 202 66 57 159 185
Less Urbanized 195 199 15 16 191 196 47 55 173 174
Completely Rural 149 146 18 13 143 140 30 36 133 127
POVERTY LEVEL1                    
Less Than 100% 420 420 40 42 412 417 133 174 376 368
100‑199% 357 453 48 55 350 449 113 125 319 426
200% or More 777 786 73 57 767 781 176 182 714 728
HEALTH INSURANCE2                    
Private 695 732 72 57 683 726 205 244 630 665
Medicaid/CHIP 475 525 59 76 464 517 111 130 443 482
Other3 395 449 21 20 394 449 65 60 389 444
No Coverage 262 261 22 12 259 261 89 88 239 239

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.72D – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.29 0.30 0.37 0.34 0.32 0.33 0.57 0.66 0.35 0.35
GEOGRAPHIC DIVISION                    
Northeast 0.73 0.76 1.16 0.78 0.79 0.84 1.31 1.60 0.87 0.92
New England 1.45 1.59 2.70 1.36 1.54 1.71 2.60 2.42 1.68 1.96
Middle Atlantic 0.83 0.84 1.25 0.93 0.91 0.93 1.52 2.03 1.01 1.03
Midwest 0.61 0.62 0.62 0.64 0.67 0.68 1.17 1.22 0.73 0.73
East North Central 0.76 0.81 0.73 0.85 0.83 0.88 1.34 1.53 0.91 0.93
West North Central 0.92 0.90 1.13 0.88 1.01 0.98 1.92 1.88 1.14 1.11
South 0.43 0.41 0.56 0.63 0.46 0.44 0.89 0.95 0.50 0.46
South Atlantic 0.58 0.57 0.78 0.92 0.63 0.63 1.29 1.30 0.68 0.65
East South Central 0.89 1.02 0.94 1.03 0.99 1.12 1.67 2.88 1.09 1.12
West South Central 0.77 0.68 1.02 1.13 0.82 0.73 1.58 1.49 0.90 0.81
West 0.67 0.73 0.77 0.67 0.72 0.79 1.35 1.56 0.80 0.86
Mountain 0.95 1.18 1.12 1.20 1.04 1.28 1.96 2.25 1.19 1.41
Pacific 0.86 0.96 1.00 0.80 0.93 1.03 1.78 2.08 1.01 1.10
COUNTY TYPE                    
Large Metro 0.42 0.43 0.52 0.46 0.46 0.46 0.82 0.96 0.50 0.49
Small Metro 0.47 0.47 0.56 0.66 0.50 0.52 1.00 0.99 0.56 0.57
Nonmetro 0.72 0.71 0.92 0.75 0.75 0.77 1.62 1.72 0.79 0.85
Urbanized 1.19 1.32 1.53 0.84 1.23 1.43 2.65 2.69 1.28 1.61
Less Urbanized 1.23 1.07 1.31 1.27 1.31 1.15 2.61 2.85 1.42 1.27
Completely Rural 1.20 1.30 2.10 1.86 1.26 1.38 2.98 3.19 1.39 1.48
POVERTY LEVEL1                    
Less Than 100% 0.75 0.69 0.69 0.72 0.83 0.78 1.18 1.14 0.99 0.93
100‑199% 0.57 0.66 0.83 0.90 0.62 0.73 1.16 1.24 0.69 0.81
200% or More 0.35 0.37 0.46 0.39 0.38 0.40 0.77 0.90 0.41 0.43
HEALTH INSURANCE2                    
Private 0.34 0.37 0.47 0.39 0.37 0.40 0.78 0.85 0.40 0.43
Medicaid/CHIP 0.68 0.69 0.55 0.67 0.79 0.81 1.04 1.14 0.94 0.95
Other3 0.47 0.51 1.43 1.33 0.47 0.51 1.89 2.03 0.49 0.53
No Coverage 0.91 0.93 1.75 1.08 0.94 0.97 1.52 1.50 1.12 1.12

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.72P – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3837   0.0008   0.5636   0.2410   0.7242  
GEOGRAPHIC DIVISION                    
Northeast 0.5772   0.0424   0.7154   0.1761   0.9439  
New England 0.4191   0.1938   0.4913   0.8376   0.5052  
Middle Atlantic 0.8902   0.1146   0.9914   0.1627   0.7241  
Midwest 0.7840   0.3151   0.8276   0.7041   0.8751  
East North Central 0.7910   0.3327   0.7456   0.8616   0.7716  
West North Central 0.2735   0.7341   0.2780   0.3090   0.3957  
South 0.1496   0.0698   0.2086   0.8533   0.1744  
South Atlantic 0.2994   0.1510   0.3784   0.7088   0.3694  
East South Central 0.6034   0.4476   0.6412   0.6760   0.5006  
West South Central 0.3697   0.3461   0.4172   0.8905   0.4018  
West 0.6006   0.0617   0.4997   0.5320   0.3906  
Mountain 0.3294   0.0441   0.4283   0.4376   0.5263  
Pacific 0.2476   0.3422   0.2196   0.7840   0.1711  
COUNTY TYPE                    
Large Metro 0.6872   0.0310   0.8069   0.4722   0.8377  
Small Metro 0.8007   0.0311   0.9889   0.2060   0.6983  
Nonmetro 0.1398   0.0464   0.1838   0.9602   0.1798  
Urbanized 0.7986   0.0383   0.9392   0.6541   0.9794  
Less Urbanized 0.1601   0.2993   0.1790   0.5994   0.2089  
Completely Rural 0.2762   0.7035   0.2629   0.5025   0.1764  
POVERTY LEVEL1                    
Less Than 100% 0.5615   0.3586   0.5120   0.5419   0.6813  
100‑199% 0.9143   0.3919   0.8390   0.3060   0.9691  
200% or More 0.0878   0.0001   0.1562   0.0028   0.4318  
HEALTH INSURANCE2                    
Private 0.6284   0.0001   0.8866   0.5847   0.8590  
Medicaid/CHIP 0.9215   0.9802   0.8393   0.7987   0.8847  
Other3 0.4637   0.1412   0.5090   0.2989   0.6352  
No Coverage 0.7698   0.0218   0.8735   0.2643   0.8165  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.73C – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 2,079 2,280 123 148 2,047 2,250 417 486 1,902 2,110
GEOGRAPHIC DIVISION                    
Northeast 1,000 1,047 58 65 980 1,028 160 228 912 964
New England 609 498 30 23 599 495 94 114 555 453
Middle Atlantic 799 906 49 60 780 886 131 199 726 838
Midwest 834 919 50 50 824 909 200 213 754 829
East North Central 726 776 45 44 716 766 163 195 669 684
West North Central 435 480 25 22 431 478 112 91 388 439
South 1,227 1,321 79 107 1,206 1,296 268 270 1,107 1,224
South Atlantic 1,000 1,023 54 83 985 1,003 219 231 908 927
East South Central 371 404 28 32 366 394 57 88 361 380
West South Central 583 690 51 57 569 678 147 163 517 627
West 1,116 1,278 65 69 1,101 1,265 217 220 1,015 1,172
Mountain 573 559 31 40 566 555 107 110 522 507
Pacific 976 1,176 57 57 962 1,165 192 190 881 1,082
COUNTY TYPE                    
Large Metro 1,743 1,873 96 108 1,719 1,853 299 374 1,608 1,709
Small Metro 1,191 1,213 75 100 1,165 1,193 289 303 1,054 1,111
Nonmetro 699 704 41 37 682 693 137 135 621 625
Urbanized 472 422 25 18 460 416 113 83 398 385
Less Urbanized 464 512 22 28 456 503 73 92 424 451
Completely Rural 368 334 25 17 357 328 47 56 332 293
POVERTY LEVEL1                    
Less Than 100% 602 708 53 71 592 697 201 282 528 622
100‑199% 640 807 60 69 633 801 160 172 589 759
200% or More 1,706 1,742 92 91 1,683 1,726 266 268 1,600 1,650
HEALTH INSURANCE2                    
Private 1,554 1,604 93 87 1,531 1,591 310 379 1,438 1,514
Medicaid/CHIP 758 878 80 107 746 854 164 184 696 797
Other3 886 1,061 25 35 884 1,061 91 87 874 1,053
No Coverage 424 460 24 29 422 461 118 130 392 434

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.73D – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.40 0.44 0.45 0.51 0.42 0.48 0.68 0.80 0.46 0.53
GEOGRAPHIC DIVISION                    
Northeast 1.05 1.19 1.25 1.44 1.10 1.30 1.74 1.98 1.19 1.41
New England 1.91 2.02 2.92 1.87 1.91 2.24 2.88 4.32 2.13 2.39
Middle Atlantic 1.22 1.40 1.40 1.81 1.29 1.52 2.10 2.28 1.39 1.66
Midwest 0.76 0.79 0.86 0.89 0.81 0.86 1.40 1.46 0.90 0.94
East North Central 1.01 1.01 1.14 1.20 1.07 1.08 1.60 1.78 1.20 1.18
West North Central 1.03 1.24 1.35 1.18 1.10 1.33 2.64 2.32 1.23 1.45
South 0.60 0.70 0.70 0.90 0.64 0.75 1.14 1.13 0.71 0.83
South Atlantic 0.86 0.96 0.97 1.32 0.92 1.04 1.69 1.61 1.00 1.12
East South Central 1.22 1.64 1.56 1.71 1.33 1.77 1.96 3.16 1.55 1.98
West South Central 1.02 1.15 1.25 1.52 1.06 1.21 2.00 1.91 1.19 1.38
West 0.90 0.96 0.98 1.02 0.95 1.01 1.45 1.79 1.00 1.10
Mountain 1.24 1.32 1.28 1.76 1.31 1.43 2.45 2.67 1.36 1.52
Pacific 1.19 1.33 1.32 1.25 1.24 1.40 1.76 2.35 1.31 1.52
COUNTY TYPE                    
Large Metro 0.59 0.63 0.60 0.67 0.62 0.68 0.95 1.11 0.68 0.74
Small Metro 0.63 0.70 0.79 0.99 0.67 0.76 1.20 1.28 0.73 0.85
Nonmetro 1.03 1.06 1.07 1.18 1.10 1.14 1.96 2.03 1.18 1.26
Urbanized 1.69 1.85 1.59 1.65 1.81 1.97 3.06 2.56 1.98 2.23
Less Urbanized 1.78 1.83 1.54 2.09 1.87 1.94 3.22 3.64 2.02 2.15
Completely Rural 1.69 1.77 2.71 2.46 1.79 1.92 3.49 3.63 1.99 2.11
POVERTY LEVEL1                    
Less Than 100% 0.94 0.94 0.93 1.15 1.02 1.05 1.46 1.48 1.19 1.27
100‑199% 0.80 0.91 0.99 1.10 0.89 0.98 1.34 1.34 1.01 1.12
200% or More 0.47 0.55 0.57 0.57 0.50 0.58 0.89 1.08 0.54 0.63
HEALTH INSURANCE2                    
Private 0.48 0.54 0.60 0.56 0.51 0.58 0.92 1.00 0.55 0.64
Medicaid/CHIP 0.86 0.89 0.73 0.90 0.98 1.02 1.29 1.31 1.13 1.18
Other3 0.75 0.83 1.69 2.32 0.76 0.84 2.32 2.64 0.78 0.86
No Coverage 1.20 1.29 1.89 2.35 1.25 1.33 1.64 1.82 1.49 1.59

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.73P – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3000   0.0271   0.3197   0.2814   0.4342  
GEOGRAPHIC DIVISION                    
Northeast 0.1619   0.1944   0.1776   0.0388   0.3237  
New England 0.1100   0.1685   0.1249   0.4609   0.1485  
Middle Atlantic 0.4503   0.4617   0.4618   0.0525   0.7141  
Midwest 0.8092   0.1463   0.8534   0.9624   0.8587  
East North Central 0.8158   0.3665   0.7956   0.2659   0.9811  
West North Central 0.3280   0.1719   0.3644   0.0930   0.6608  
South 0.7598   0.3360   0.7611   0.5518   0.6546  
South Atlantic 0.7748   0.9868   0.7241   0.6297   0.7925  
East South Central 0.8817   0.1214   0.7889   0.1628   0.9692  
West South Central 0.7963   0.4346   0.8131   0.4370   0.6569  
West 0.8396   0.3615   0.8451   0.3201   0.9676  
Mountain 0.1937   0.6091   0.1910   0.3400   0.2471  
Pacific 0.6766   0.4410   0.6612   0.5665   0.5461  
COUNTY TYPE                    
Large Metro 0.4759   0.2612   0.4362   0.3743   0.5439  
Small Metro 0.2752   0.1550   0.3215   0.1932   0.4704  
Nonmetro 0.7903   0.0242   0.6661   0.3428   0.8503  
Urbanized 0.2290   0.0860   0.1622   0.6103   0.1792  
Less Urbanized 0.9241   0.6363   0.9354   0.4473   0.7925  
Completely Rural 0.2028   0.0652   0.2288   0.3280   0.1511  
POVERTY LEVEL1                    
Less Than 100% 0.0897   0.4074   0.1176   0.3742   0.1600  
100‑199% 0.3087   0.0633   0.2284   0.3957   0.2850  
200% or More 0.0176   0.0058   0.0175   0.0065   0.0558  
HEALTH INSURANCE2                    
Private 0.0435   0.0016   0.0567   0.4806   0.0713  
Medicaid/CHIP 0.3054   0.7533   0.3360   0.4628   0.2287  
Other3 0.9471   0.7345   0.9339   0.4977   0.9883  
No Coverage 0.3788   0.9770   0.4044   0.4105   0.2632  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.74C – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,257 1,256 113 119 1,231 1,243 338 400 1,123 1,118
GEOGRAPHIC DIVISION                    
Northeast 586 586 54 45 570 576 128 199 513 535
New England 344 350 24 20 337 349 76 81 298 320
Middle Atlantic 476 471 48 40 461 459 105 182 418 434
Midwest 558 532 45 42 550 525 162 175 493 463
East North Central 463 460 40 37 454 455 130 162 405 384
West North Central 295 256 23 19 293 253 88 70 269 231
South 664 661 74 89 651 648 211 217 577 568
South Atlantic 549 492 50 68 537 480 171 188 473 400
East South Central 198 221 23 25 194 217 42 79 187 183
West South Central 288 393 50 50 278 385 119 130 248 336
West 653 762 56 55 643 752 173 184 595 668
Mountain 355 333 26 35 350 327 81 86 319 289
Pacific 561 698 50 42 551 690 155 163 506 616
COUNTY TYPE                    
Large Metro 1,008 1,049 88 88 995 1,037 249 310 915 919
Small Metro 693 653 64 79 673 643 227 251 602 575
Nonmetro 379 357 34 28 368 352 109 95 320 317
Urbanized 251 229 16 14 246 226 94 56 199 210
Less Urbanized 246 240 19 18 240 238 53 64 218 211
Completely Rural 192 162 24 16 179 155 35 43 165 134
POVERTY LEVEL1                    
Less Than 100% 464 479 46 56 455 476 165 242 403 399
100‑199% 410 534 57 64 403 527 134 144 361 493
200% or More 967 925 82 72 953 917 215 214 892 844
HEALTH INSURANCE2                    
Private 857 876 83 77 843 868 253 314 784 794
Medicaid/CHIP 532 586 72 88 519 572 129 154 482 524
Other3 473 502 22 23 471 503 78 73 463 496
No Coverage 284 292 23 24 281 290 99 100 258 260

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.74D – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.34 0.33 0.41 0.42 0.36 0.36 0.64 0.74 0.40 0.39
GEOGRAPHIC DIVISION                    
Northeast 0.82 0.86 1.18 1.05 0.89 0.94 1.60 1.92 0.96 1.03
New England 1.45 1.78 2.35 1.66 1.58 1.94 2.67 3.19 1.73 2.15
Middle Atlantic 0.98 0.94 1.38 1.29 1.06 1.04 1.93 2.39 1.13 1.14
Midwest 0.71 0.67 0.79 0.77 0.76 0.72 1.34 1.41 0.83 0.77
East North Central 0.88 0.87 1.04 1.02 0.95 0.93 1.54 1.82 1.01 0.96
West North Central 1.08 0.97 1.26 1.07 1.18 1.06 2.22 1.91 1.36 1.20
South 0.47 0.46 0.67 0.76 0.51 0.50 1.04 1.07 0.56 0.53
South Atlantic 0.68 0.63 0.91 1.12 0.73 0.69 1.52 1.54 0.78 0.70
East South Central 1.01 1.25 1.35 1.35 1.12 1.37 1.67 3.10 1.26 1.37
West South Central 0.80 0.78 1.26 1.33 0.85 0.84 1.88 1.86 0.93 0.96
West 0.74 0.81 0.84 0.85 0.80 0.87 1.45 1.52 0.88 0.95
Mountain 1.10 1.17 1.09 1.62 1.20 1.27 2.06 2.43 1.34 1.38
Pacific 0.94 1.07 1.13 0.94 1.01 1.15 1.90 1.96 1.11 1.26
COUNTY TYPE                    
Large Metro 0.47 0.48 0.55 0.56 0.51 0.52 0.92 1.04 0.56 0.56
Small Metro 0.54 0.52 0.69 0.81 0.58 0.57 1.15 1.24 0.64 0.62
Nonmetro 0.86 0.80 1.04 0.90 0.91 0.86 1.83 1.69 0.95 0.95
Urbanized 1.41 1.43 1.56 1.33 1.48 1.52 3.05 2.25 1.54 1.75
Less Urbanized 1.40 1.26 1.42 1.31 1.52 1.36 2.73 2.93 1.63 1.53
Completely Rural 1.63 1.46 2.59 2.37 1.69 1.54 3.37 3.76 1.81 1.58
POVERTY LEVEL1                    
Less Than 100% 0.80 0.79 0.81 0.96 0.88 0.89 1.35 1.42 1.03 1.03
100‑199% 0.65 0.75 0.95 1.04 0.71 0.82 1.29 1.36 0.78 0.91
200% or More 0.42 0.42 0.52 0.47 0.45 0.45 0.83 0.94 0.48 0.48
HEALTH INSURANCE2                    
Private 0.40 0.42 0.54 0.51 0.43 0.46 0.85 0.94 0.47 0.49
Medicaid/CHIP 0.72 0.76 0.65 0.77 0.84 0.89 1.17 1.23 0.97 1.03
Other3 0.54 0.56 1.48 1.51 0.55 0.57 2.12 2.34 0.56 0.58
No Coverage 0.97 0.98 1.81 1.95 1.00 1.01 1.58 1.64 1.21 1.17

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.74P – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0242   0.0056   0.0422   0.1919   0.0595  
GEOGRAPHIC DIVISION                    
Northeast 0.7270   0.0343   0.8812   0.1441   0.8370  
New England 0.4492   0.2245   0.5126   0.3289   0.6470  
Middle Atlantic 0.9551   0.0806   0.8158   0.2605   0.5942  
Midwest 0.0665   0.1620   0.0778   0.7226   0.0675  
East North Central 0.3402   0.3058   0.3687   0.7926   0.2783  
West North Central 0.0327   0.3170   0.0374   0.2379   0.0682  
South 0.0991   0.3242   0.1182   0.6784   0.0606  
South Atlantic 0.0508   0.7112   0.0525   0.9141   0.0303  
East South Central 0.9684   0.3613   0.9638   0.2188   0.7324  
West South Central 0.7503   0.4637   0.8179   0.9253   0.7585  
West 0.4270   0.1588   0.4822   0.1387   0.6888  
Mountain 0.0044   0.2661   0.0058   0.0453   0.0159  
Pacific 0.5138   0.3247   0.4700   0.6066   0.3890  
COUNTY TYPE                    
Large Metro 0.2995   0.1629   0.3346   0.6153   0.2797  
Small Metro 0.0744   0.0313   0.1237   0.1130   0.2755  
Nonmetro 0.0593   0.0431   0.0814   0.7581   0.0980  
Urbanized 0.7699   0.6140   0.8132   0.7444   0.9309  
Less Urbanized 0.0659   0.1982   0.0792   0.9074   0.0709  
Completely Rural 0.1882   0.1158   0.2324   0.6528   0.1597  
POVERTY LEVEL1                    
Less Than 100% 0.6588   0.9642   0.6784   0.5325   0.9785  
100‑199% 0.9353   0.0891   0.7706   0.9964   0.6077  
200% or More 0.0010   0.0027   0.0020   0.0076   0.0080  
HEALTH INSURANCE2                    
Private 0.0708   0.0054   0.1147   0.4169   0.0937  
Medicaid/CHIP 0.7119   0.5334   0.7093   0.6571   0.7855  
Other3 0.0646   0.3856   0.0706   0.5716   0.0929  
No Coverage 0.9638   0.5384   0.9781   0.0919   0.5586  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.75C – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 976 1,000 87 88 957 994 264 305 879 905
GEOGRAPHIC DIVISION                    
Northeast 445 460 42 33 436 454 102 147 399 428
New England 278 267 20 16 272 265 62 63 242 246
Middle Atlantic 350 372 37 29 342 365 83 133 318 349
Midwest 432 452 32 31 426 449 126 132 383 402
East North Central 357 390 27 27 351 389 100 117 319 338
West North Central 218 225 18 15 218 222 67 60 199 207
South 540 528 54 66 529 522 161 159 474 462
South Atlantic 425 396 37 52 417 390 132 127 370 341
East South Central 165 181 15 17 163 178 38 65 154 152
West South Central 252 291 37 35 246 286 87 92 229 256
West 507 611 44 41 503 604 142 162 472 543
Mountain 267 283 19 24 265 279 62 76 252 251
Pacific 433 552 40 33 429 545 130 144 395 488
COUNTY TYPE                    
Large Metro 783 841 68 66 774 833 196 242 718 747
Small Metro 530 504 48 60 515 495 177 171 465 461
Nonmetro 293 300 26 17 286 297 79 86 255 268
Urbanized 192 198 12 8 189 196 65 56 157 180
Less Urbanized 190 190 14 11 187 188 43 55 171 166
Completely Rural 138 140 18 9 132 135 26 36 125 121
POVERTY LEVEL1                    
Less Than 100% 394 388 35 39 387 386 130 167 352 340
100‑199% 344 444 43 51 338 440 108 122 308 414
200% or More 724 734 63 53 714 730 173 178 664 678
HEALTH INSURANCE2                    
Private 662 696 62 53 651 691 199 238 602 629
Medicaid/CHIP 445 495 52 72 436 487 107 122 416 455
Other3 375 433 19 19 373 433 64 59 369 428
No Coverage 254 244 20 11 252 244 88 86 231 222

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.75D – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.28 0.29 0.32 0.32 0.30 0.32 0.56 0.66 0.33 0.34
GEOGRAPHIC DIVISION                    
Northeast 0.68 0.73 0.98 0.76 0.74 0.81 1.33 1.65 0.81 0.90
New England 1.39 1.54 1.90 1.37 1.50 1.66 2.64 2.52 1.63 1.88
Middle Atlantic 0.76 0.81 1.16 0.89 0.83 0.90 1.53 2.04 0.92 1.00
Midwest 0.57 0.61 0.56 0.58 0.62 0.66 1.17 1.20 0.68 0.71
East North Central 0.71 0.78 0.69 0.77 0.77 0.85 1.34 1.51 0.84 0.90
West North Central 0.89 0.91 1.05 0.82 0.99 0.99 1.86 1.82 1.12 1.11
South 0.41 0.39 0.49 0.60 0.44 0.43 0.88 0.92 0.48 0.45
South Atlantic 0.55 0.54 0.67 0.91 0.60 0.60 1.30 1.24 0.63 0.62
East South Central 0.87 1.03 0.91 0.99 0.96 1.12 1.59 2.82 1.06 1.12
West South Central 0.72 0.64 0.95 0.98 0.77 0.69 1.52 1.48 0.87 0.77
West 0.63 0.70 0.70 0.65 0.68 0.75 1.36 1.54 0.76 0.81
Mountain 0.94 1.07 0.86 1.16 1.03 1.16 1.88 2.23 1.17 1.27
Pacific 0.80 0.91 0.95 0.77 0.87 0.98 1.82 2.05 0.95 1.05
COUNTY TYPE                    
Large Metro 0.38 0.41 0.44 0.43 0.42 0.44 0.81 0.96 0.46 0.47
Small Metro 0.45 0.45 0.55 0.64 0.48 0.49 1.01 0.95 0.54 0.54
Nonmetro 0.69 0.71 0.82 0.57 0.74 0.76 1.57 1.70 0.77 0.84
Urbanized 1.14 1.32 1.13 0.79 1.21 1.43 2.63 2.64 1.25 1.61
Less Urbanized 1.23 1.04 1.25 0.90 1.32 1.12 2.43 2.84 1.42 1.24
Completely Rural 1.14 1.30 2.10 1.34 1.20 1.38 2.72 3.19 1.33 1.46
POVERTY LEVEL1                    
Less Than 100% 0.71 0.67 0.62 0.68 0.79 0.75 1.16 1.14 0.93 0.89
100‑199% 0.55 0.65 0.76 0.85 0.60 0.71 1.12 1.22 0.67 0.79
200% or More 0.33 0.35 0.41 0.36 0.35 0.38 0.77 0.89 0.38 0.40
HEALTH INSURANCE2                    
Private 0.33 0.36 0.41 0.37 0.35 0.39 0.77 0.84 0.38 0.41
Medicaid/CHIP 0.64 0.67 0.48 0.64 0.75 0.79 1.03 1.09 0.89 0.92
Other3 0.44 0.50 1.29 1.25 0.45 0.50 1.89 2.01 0.46 0.52
No Coverage 0.90 0.88 1.61 1.00 0.93 0.92 1.51 1.49 1.10 1.06

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.75P – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4677   0.0350   0.5624   0.3185   0.6930  
GEOGRAPHIC DIVISION                    
Northeast 0.7051   0.2765   0.7682   0.2053   0.9964  
New England 0.3554   0.5918   0.3709   0.5297   0.4312  
Middle Atlantic 0.8636   0.3469   0.8045   0.2710   0.5937  
Midwest 0.9730   0.3773   0.9387   0.5437   0.8235  
East North Central 0.7028   0.6670   0.6955   0.8565   0.6521  
West North Central 0.5334   0.3484   0.5834   0.3617   0.7376  
South 0.2229   0.2678   0.2578   0.8644   0.1844  
South Atlantic 0.5001   0.8029   0.5024   0.7734   0.4888  
East South Central 0.6242   0.3572   0.6732   0.5991   0.5080  
West South Central 0.3164   0.2682   0.3680   0.7587   0.2876  
West 0.8446   0.2415   0.7833   0.5849   0.6728  
Mountain 0.1444   0.3606   0.1627   0.5402   0.1898  
Pacific 0.2920   0.4044   0.2655   0.7782   0.2104  
COUNTY TYPE                    
Large Metro 0.8822   0.5263   0.8783   0.5700   0.8795  
Small Metro 0.6840   0.0723   0.8338   0.1667   0.8190  
Nonmetro 0.1658   0.0113   0.2253   0.6770   0.1858  
Urbanized 0.8368   0.2427   0.9085   0.6306   0.9446  
Less Urbanized 0.1162   0.0716   0.1451   0.8333   0.1406  
Completely Rural 0.4936   0.1608   0.5559   0.2717   0.3594  
POVERTY LEVEL1                    
Less Than 100% 0.9075   0.7728   0.9141   0.7401   0.9059  
100‑199% 0.7024   0.6173   0.6682   0.1576   0.8707  
200% or More 0.1473   0.0079   0.1992   0.0051   0.5145  
HEALTH INSURANCE2                    
Private 0.7229   0.0040   0.8952   0.8782   0.7768  
Medicaid/CHIP 0.9300   0.5070   0.9116   0.8345   0.9524  
Other3 0.3999   0.3946   0.4222   0.2581   0.5502  
No Coverage 0.7620   0.0668   0.8333   0.1905   0.7916  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.76C – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,014 1,069 21 26 1,015 1,067 116 138 994 1,035
GEOGRAPHIC DIVISION                    
Northeast 477 486 2 2 477 486 46 50 474 473
New England 292 282 2 2 292 282 25 18 287 280
Middle Atlantic 373 392 * * 373 392 38 47 373 378
Midwest 378 429 7 15 378 429 52 55 366 417
East North Central 328 366 4 15 328 365 40 48 323 355
West North Central 191 213 6 4 191 213 38 26 180 207
South 619 661 18 17 620 658 72 82 608 636
South Atlantic 497 520 11 15 496 518 48 68 492 499
East South Central 176 195 1 <1 176 195 17 25 174 193
West South Central 288 334 14 9 291 330 51 47 282 317
West 559 598 7 13 559 598 64 76 544 578
Mountain 252 296 6 5 251 296 38 31 245 288
Pacific 508 533 4 12 508 532 52 69 495 514
COUNTY TYPE                    
Large Metro 827 881 11 22 828 881 88 113 817 847
Small Metro 561 588 18 14 559 586 65 70 542 577
Nonmetro 331 299 6 1 332 299 51 41 312 291
Urbanized 239 173 <1 1 239 173 46 25 218 167
Less Urbanized 205 232 6 * 205 232 19 30 198 227
Completely Rural 149 113 * <1 149 113 12 10 144 112
POVERTY LEVEL1                    
Less Than 100% 356 396 10 16 356 396 44 70 351 386
100‑199% 352 427 9 14 352 427 55 48 345 421
200% or More 828 807 16 16 828 807 89 105 813 791
HEALTH INSURANCE2                    
Private 773 744 14 22 773 743 93 110 758 727
Medicaid/CHIP 432 463 15 15 431 462 47 56 425 451
Other3 473 570 9 1 472 570 31 27 472 570
No Coverage 242 294 10 7 242 294 37 41 236 290

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.76D – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.30 0.30 0.08 0.10 0.33 0.32 0.31 0.37 0.37 0.36
GEOGRAPHIC DIVISION                    
Northeast 0.79 0.78 0.05 0.06 0.85 0.83 0.77 0.84 0.96 0.92
New England 1.62 1.61 0.19 0.24 1.72 1.72 1.47 1.01 1.94 1.94
Middle Atlantic 0.87 0.87 * * 0.94 0.94 0.89 1.11 1.06 1.02
Midwest 0.51 0.60 0.13 0.28 0.56 0.65 0.64 0.71 0.64 0.74
East North Central 0.65 0.75 0.11 0.41 0.71 0.81 0.76 0.90 0.81 0.93
West North Central 0.80 0.93 0.33 0.21 0.88 1.02 1.27 1.10 1.00 1.14
South 0.48 0.50 0.17 0.17 0.52 0.54 0.49 0.57 0.59 0.60
South Atlantic 0.69 0.72 0.22 0.29 0.75 0.78 0.65 0.89 0.85 0.87
East South Central 0.86 1.03 0.05 0.01 0.93 1.15 0.80 1.12 1.05 1.33
West South Central 0.79 0.80 0.38 0.25 0.87 0.86 1.03 0.90 1.00 0.97
West 0.66 0.66 0.12 0.21 0.72 0.71 0.77 0.80 0.79 0.80
Mountain 0.96 1.06 0.29 0.25 1.06 1.14 1.27 1.00 1.23 1.26
Pacific 0.88 0.85 0.11 0.30 0.95 0.92 0.96 1.10 1.02 1.03
COUNTY TYPE                    
Large Metro 0.44 0.42 0.07 0.15 0.48 0.46 0.45 0.51 0.53 0.51
Small Metro 0.50 0.53 0.22 0.18 0.54 0.57 0.51 0.58 0.62 0.65
Nonmetro 0.75 0.70 0.21 0.05 0.82 0.77 0.97 1.00 0.91 0.87
Urbanized 1.35 1.08 0.04 0.14 1.46 1.18 1.73 1.53 1.67 1.35
Less Urbanized 1.32 1.27 0.57 * 1.40 1.40 1.25 1.81 1.52 1.58
Completely Rural 1.21 1.06 * 0.01 1.35 1.16 1.28 1.22 1.49 1.31
POVERTY LEVEL1                    
Less Than 100% 0.69 0.71 0.17 0.28 0.77 0.79 0.49 0.69 0.95 0.98
100‑199% 0.57 0.62 0.17 0.24 0.63 0.68 0.64 0.55 0.74 0.78
200% or More 0.38 0.37 0.10 0.11 0.41 0.39 0.47 0.57 0.45 0.43
HEALTH INSURANCE2                    
Private 0.38 0.36 0.09 0.15 0.41 0.39 0.44 0.51 0.45 0.44
Medicaid/CHIP 0.64 0.66 0.15 0.14 0.75 0.78 0.51 0.57 0.89 0.92
Other3 0.55 0.61 0.63 0.07 0.56 0.62 1.08 0.98 0.58 0.64
No Coverage 0.89 1.02 0.83 0.60 0.94 1.06 0.71 0.81 1.15 1.31

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.76P – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1196   0.9933   0.0966   0.4922   0.1216  
GEOGRAPHIC DIVISION                    
Northeast 0.7146   0.7994   0.6854   0.2767   0.7996  
New England 0.2758   0.7957   0.2589   0.0532   0.3368  
Middle Atlantic 0.7683   *   0.7882   0.7816   0.7314  
Midwest 0.7672   0.5725   0.8134   0.3896   0.6869  
East North Central 0.5872   0.3688   0.6353   0.9378   0.6079  
West North Central 0.7247   0.5265   0.7215   0.1584   0.9258  
South 0.0378   0.3794   0.0334   0.8222   0.0344  
South Atlantic 0.0869   0.6162   0.0810   0.9953   0.0791  
East South Central 0.1292   0.3996   0.1244   0.4202   0.1033  
West South Central 0.5312   0.4713   0.5193   0.4694   0.6033  
West 0.7411   0.4556   0.6918   0.6561   0.6602  
Mountain 0.5523   0.3262   0.5429   0.7166   0.4729  
Pacific 0.4748   0.1406   0.4243   0.4696   0.3583  
COUNTY TYPE                    
Large Metro 0.9473   0.2326   0.8573   0.8403   0.9524  
Small Metro 0.0389   0.3260   0.0375   0.2285   0.0449  
Nonmetro 0.1584   0.1750   0.1587   0.5183   0.1481  
Urbanized 0.3097   0.5153   0.3200   0.5215   0.2896  
Less Urbanized 0.9396   *   0.9154   0.9453   0.9183  
Completely Rural 0.0306   *   0.0263   0.7152   0.0280  
POVERTY LEVEL1                    
Less Than 100% 0.9087   0.8916   0.9491   0.7741   0.7369  
100‑199% 0.7122   0.9144   0.7302   0.3018   0.7514  
200% or More 0.0348   0.8801   0.0266   0.7797   0.0256  
HEALTH INSURANCE2                    
Private 0.0371   0.6246   0.0292   0.5474   0.0444  
Medicaid/CHIP 0.8704   0.9346   0.9540   0.5033   0.8912  
Other3 0.6239   0.1676   0.6105   0.8219   0.6481  
No Coverage 0.3069   0.6219   0.3112   0.9112   0.3186  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.77C – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 225 300 18 19 225 301 64 92 212 269
GEOGRAPHIC DIVISION                    
Northeast 114 144 2 1 114 144 25 40 112 128
New England 35 61 2 1 35 61 11 10 32 59
Middle Atlantic 108 129 * * 108 129 23 39 107 113
Midwest 85 111 7 4 84 110 27 34 81 99
East North Central 73 97 4 2 73 97 22 31 69 88
West North Central 46 53 6 3 46 53 15 14 43 45
South 128 163 14 15 127 162 43 43 117 149
South Atlantic 100 119 6 15 100 118 30 38 94 104
East South Central 34 37 <1 <1 34 37 13 8 31 37
West South Central 74 105 13 2 73 105 29 24 65 99
West 118 172 7 11 118 171 35 61 108 149
Mountain 77 68 6 2 77 68 18 26 71 61
Pacific 89 157 4 11 89 156 30 55 81 136
COUNTY TYPE                    
Large Metro 185 249 11 15 184 249 55 79 174 221
Small Metro 117 158 13 11 116 158 29 43 106 145
Nonmetro 68 52 6 1 67 52 21 21 64 46
Urbanized 57 45 <1 1 57 45 17 18 54 40
Less Urbanized 23 21 6 * 22 21 12 10 18 18
Completely Rural 30 16 * * 30 16 1 4 30 16
POVERTY LEVEL1                    
Less Than 100% 118 138 8 4 117 138 24 52 115 128
100‑199% 103 131 9 10 102 131 36 32 95 126
200% or More 159 215 13 16 158 216 48 64 146 195
HEALTH INSURANCE2                    
Private 139 195 8 15 139 196 49 71 128 171
Medicaid/CHIP 141 171 13 12 141 171 30 37 139 165
Other3 70 114 4 1 70 114 23 20 66 111
No Coverage 82 113 8 2 80 113 19 26 78 109

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.77D – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.08 0.10 0.07 0.07 0.08 0.11 0.18 0.24 0.09 0.12
GEOGRAPHIC DIVISION                    
Northeast 0.23 0.29 0.05 0.03 0.25 0.31 0.43 0.67 0.28 0.32
New England 0.26 0.44 0.19 0.12 0.29 0.47 0.64 0.63 0.31 0.53
Middle Atlantic 0.29 0.35 * * 0.32 0.39 0.54 0.89 0.36 0.39
Midwest 0.14 0.18 0.13 0.07 0.15 0.20 0.36 0.43 0.17 0.21
East North Central 0.17 0.23 0.10 0.05 0.19 0.25 0.44 0.58 0.21 0.27
West North Central 0.25 0.28 0.33 0.19 0.27 0.31 0.63 0.57 0.30 0.31
South 0.11 0.14 0.14 0.14 0.12 0.15 0.31 0.30 0.13 0.17
South Atlantic 0.17 0.19 0.11 0.29 0.18 0.21 0.42 0.51 0.20 0.21
East South Central 0.19 0.22 0.01 0.01 0.21 0.24 0.63 0.36 0.23 0.28
West South Central 0.21 0.28 0.36 0.06 0.22 0.31 0.60 0.48 0.24 0.35
West 0.17 0.24 0.12 0.18 0.19 0.26 0.41 0.65 0.20 0.27
Mountain 0.34 0.29 0.29 0.11 0.37 0.32 0.66 0.83 0.41 0.34
Pacific 0.19 0.32 0.11 0.27 0.21 0.35 0.53 0.89 0.22 0.36
COUNTY TYPE                    
Large Metro 0.11 0.15 0.07 0.10 0.12 0.16 0.28 0.37 0.13 0.17
Small Metro 0.13 0.17 0.15 0.14 0.14 0.19 0.25 0.35 0.15 0.20
Nonmetro 0.20 0.15 0.21 0.05 0.22 0.16 0.45 0.53 0.24 0.16
Urbanized 0.41 0.34 0.03 0.14 0.45 0.37 0.74 1.21 0.52 0.38
Less Urbanized 0.19 0.14 0.57 * 0.20 0.15 0.82 0.62 0.19 0.16
Completely Rural 0.36 0.21 * * 0.40 0.23 0.17 0.47 0.44 0.24
POVERTY LEVEL1                    
Less Than 100% 0.25 0.28 0.14 0.08 0.28 0.31 0.27 0.51 0.34 0.37
100‑199% 0.18 0.21 0.18 0.17 0.20 0.24 0.43 0.38 0.22 0.27
200% or More 0.08 0.12 0.08 0.11 0.09 0.13 0.26 0.36 0.09 0.13
HEALTH INSURANCE2                    
Private 0.08 0.11 0.05 0.11 0.08 0.12 0.25 0.33 0.09 0.12
Medicaid/CHIP 0.24 0.27 0.13 0.11 0.28 0.33 0.33 0.39 0.34 0.39
Other3 0.09 0.14 0.26 0.07 0.09 0.14 0.81 0.72 0.09 0.14
No Coverage 0.32 0.44 0.64 0.19 0.33 0.46 0.37 0.51 0.41 0.57

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.77P – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0790   0.5909   0.0771   0.3024   0.1156  
GEOGRAPHIC DIVISION                    
Northeast 0.4760   0.6083   0.4794   0.6714   0.5210  
New England 0.2115   0.6066   0.2049   0.8364   0.1744  
Middle Atlantic 0.7892   *   0.7981   0.6134   0.9008  
Midwest 0.6283   0.4293   0.6045   0.9445   0.5966  
East North Central 0.3627   0.9322   0.3677   0.6441   0.4199  
West North Central 0.5578   0.3755   0.6109   0.4894   0.7233  
South 0.4528   0.7398   0.4395   0.6485   0.3363  
South Atlantic 0.2827   0.3877   0.3287   0.8716   0.3192  
East South Central 0.1809   0.8626   0.1786   0.3353   0.2733  
West South Central 0.6500   0.1241   0.5401   0.5863   0.4108  
West 0.1336   0.9778   0.1354   0.0737   0.3226  
Mountain 0.3458   0.0338   0.4165   0.1941   0.1896  
Pacific 0.0224   0.2434   0.0277   0.1818   0.0508  
COUNTY TYPE                    
Large Metro 0.0862   0.8353   0.0939   0.2714   0.1586  
Small Metro 0.2770   0.5174   0.2548   0.7459   0.2501  
Nonmetro 0.3703   0.2253   0.4144   0.6327   0.5195  
Urbanized 0.9236   0.4580   0.9291   0.9242   0.8312  
Less Urbanized 0.0671   *   0.1177   0.4805   0.1611  
Completely Rural 0.5810   *   0.5681   0.4009   0.4956  
POVERTY LEVEL1                    
Less Than 100% 0.2304   0.1781   0.2111   0.0959   0.4063  
100‑199% 0.7604   0.6032   0.7337   0.9490   0.6863  
200% or More 0.1756   0.8308   0.1908   0.6513   0.1980  
HEALTH INSURANCE2                    
Private 0.1914   0.6654   0.2101   0.3654   0.3505  
Medicaid/CHIP 0.3102   0.6695   0.3084   0.5792   0.3588  
Other3 0.0228   0.2636   0.0209   0.3580   0.0280  
No Coverage 0.3887   0.3141   0.3604   0.9368   0.3607  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.78C – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 152 186 5 4 152 186 33 55 148 177
GEOGRAPHIC DIVISION                    
Northeast 79 78 2 1 79 78 14 17 78 80
New England 17 45 2 1 17 45 4 9 16 44
Middle Atlantic 77 64 * * 77 64 14 15 76 67
Midwest 56 83 <1 1 56 83 12 15 54 81
East North Central 51 74 <1 1 51 74 11 15 49 72
West North Central 23 40 * * 23 40 6 4 22 37
South 96 102 2 <1 96 102 22 29 91 98
South Atlantic 78 55 <1 <1 78 55 19 23 75 50
East South Central 19 11 <1 * 19 11 2 7 18 8
West South Central 54 86 2 * 54 86 11 17 48 84
West 65 98 3 4 64 98 16 39 64 86
Mountain 49 41 3 <1 48 41 3 15 48 38
Pacific 43 85 * 4 43 85 16 36 42 73
COUNTY TYPE                    
Large Metro 116 141 3 <1 116 141 30 48 111 133
Small Metro 83 109 4 4 83 109 14 20 80 107
Nonmetro 48 33 <1 * 48 33 3 17 48 28
Urbanized 45 30 <1 * 45 30 3 17 44 25
Less Urbanized 10 11 <1 * 10 11 1 5 10 10
Completely Rural 16 9 * * 16 9 1 1 16 9
POVERTY LEVEL1                    
Less Than 100% 96 96 2 2 96 96 13 28 94 93
100‑199% 78 73 1 1 77 73 16 20 76 70
200% or More 85 130 4 4 85 130 25 41 82 125
HEALTH INSURANCE2                    
Private 69 120 3 1 68 120 23 44 65 111
Medicaid/CHIP 118 123 3 4 118 123 21 23 116 118
Other3 51 78 * 1 51 78 7 11 50 78
No Coverage 50 66 * * 50 66 7 17 49 64

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.78D – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.06 0.02 0.02 0.06 0.07 0.09 0.15 0.06 0.08
GEOGRAPHIC DIVISION                    
Northeast 0.16 0.16 0.05 0.03 0.17 0.17 0.24 0.29 0.19 0.20
New England 0.13 0.33 0.19 0.10 0.14 0.35 0.21 0.54 0.16 0.40
Middle Atlantic 0.21 0.18 * * 0.23 0.19 0.33 0.34 0.26 0.23
Midwest 0.09 0.14 0.01 0.03 0.10 0.15 0.16 0.20 0.12 0.17
East North Central 0.12 0.18 0.01 0.04 0.14 0.20 0.21 0.28 0.15 0.22
West North Central 0.12 0.21 * * 0.14 0.23 0.24 0.16 0.15 0.26
South 0.09 0.09 0.02 <0.01 0.10 0.10 0.17 0.21 0.10 0.11
South Atlantic 0.13 0.09 0.01 0.01 0.14 0.10 0.28 0.32 0.16 0.10
East South Central 0.11 0.06 0.01 * 0.12 0.07 0.11 0.31 0.14 0.06
West South Central 0.15 0.24 0.06 * 0.17 0.26 0.23 0.34 0.18 0.30
West 0.09 0.14 0.06 0.06 0.10 0.15 0.19 0.44 0.12 0.16
Mountain 0.22 0.18 0.17 <0.01 0.24 0.20 0.11 0.51 0.28 0.21
Pacific 0.09 0.18 * 0.10 0.10 0.19 0.29 0.62 0.12 0.19
COUNTY TYPE                    
Large Metro 0.07 0.08 0.02 <0.01 0.08 0.09 0.16 0.23 0.08 0.10
Small Metro 0.09 0.12 0.05 0.05 0.10 0.13 0.12 0.17 0.12 0.15
Nonmetro 0.14 0.10 0.01 * 0.16 0.10 0.08 0.44 0.18 0.10
Urbanized 0.33 0.24 0.03 * 0.36 0.26 0.16 1.10 0.43 0.25
Less Urbanized 0.09 0.08 0.02 * 0.09 0.09 0.05 0.30 0.11 0.09
Completely Rural 0.19 0.11 * * 0.21 0.12 0.08 0.15 0.24 0.14
POVERTY LEVEL1                    
Less Than 100% 0.20 0.20 0.04 0.03 0.23 0.22 0.16 0.28 0.29 0.28
100‑199% 0.14 0.12 0.02 0.01 0.15 0.13 0.19 0.23 0.18 0.15
200% or More 0.05 0.07 0.02 0.03 0.05 0.08 0.14 0.23 0.05 0.08
HEALTH INSURANCE2                    
Private 0.04 0.07 0.02 0.01 0.04 0.08 0.12 0.21 0.05 0.08
Medicaid/CHIP 0.20 0.20 0.03 0.04 0.24 0.24 0.24 0.25 0.29 0.28
Other3 0.06 0.09 * 0.07 0.07 0.10 0.26 0.40 0.07 0.10
No Coverage 0.20 0.26 * * 0.21 0.28 0.15 0.34 0.26 0.34

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.78P – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1989   0.3838   0.1974   0.0539   0.4199  
GEOGRAPHIC DIVISION                    
Northeast 0.9090   0.5388   0.9119   0.7347   0.8595  
New England 0.2861   0.5369   0.2727   0.4141   0.3421  
Middle Atlantic 0.5311   *   0.5257   0.9938   0.5303  
Midwest 0.2779   0.2694   0.2888   0.6871   0.3122  
East North Central 0.2100   0.2691   0.2196   0.3949   0.2807  
West North Central 0.9505   *   0.9478   0.2831   0.9185  
South 0.9717   0.2673   0.9662   0.4912   0.8803  
South Atlantic 0.9835   0.7654   0.9783   0.8534   0.9221  
East South Central 0.3830   *   0.3851   0.1454   0.1495  
West South Central 0.7989   *   0.7872   0.6238   0.8561  
West 0.0697   0.5588   0.0664   0.0433   0.2275  
Mountain 0.6453   0.0438   0.7219   0.0790   0.4199  
Pacific 0.0102   *   0.0117   0.1413   0.0323  
COUNTY TYPE                    
Large Metro 0.2613   0.2045   0.2634   0.1770   0.4630  
Small Metro 0.3525   0.7313   0.3463   0.4967   0.4003  
Nonmetro 0.7261   *   0.7296   0.1144   0.3902  
Urbanized 0.8185   *   0.8272   0.1535   0.4576  
Less Urbanized 0.8254   *   0.8176   0.3462   0.9601  
Completely Rural 0.7387   *   0.7309   0.6667   0.7043  
POVERTY LEVEL1                    
Less Than 100% 0.3837   0.7835   0.3872   0.0355   0.6362  
100‑199% 0.6894   0.2821   0.6962   0.2945   0.5063  
200% or More 0.1745   0.5825   0.1740   0.4709   0.2382  
HEALTH INSURANCE2                    
Private 0.0389   0.2146   0.0367   0.0414   0.1567  
Medicaid/CHIP 0.8124   1.0000   0.7907   0.8596   0.7576  
Other3 0.1520   *   0.1551   0.4625   0.1803  
No Coverage 0.3837   *   0.3889   0.2975   0.5212  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.79C – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 480 512 13 11 480 512 25 32 479 510
GEOGRAPHIC DIVISION                    
Northeast 261 208 1 <1 261 208 10 4 261 208
New England 185 150 1 <1 185 150 4 <1 185 150
Middle Atlantic 184 144 * * 184 144 9 4 185 144
Midwest 197 244 * <1 197 244 11 15 196 242
East North Central 173 209 * <1 173 209 5 13 173 208
West North Central 93 121 * * 93 121 10 8 90 120
South 277 308 13 6 277 307 19 25 276 306
South Atlantic 213 255 3 * 213 255 16 10 213 254
East South Central 92 82 * * 92 82 1 15 92 80
West South Central 143 147 12 6 142 147 10 18 142 146
West 256 241 3 9 255 241 6 13 255 240
Mountain 104 135 3 1 104 135 4 7 104 134
Pacific 234 198 * 9 234 198 5 10 234 198
COUNTY TYPE                    
Large Metro 391 385 7 <1 391 385 19 27 391 383
Small Metro 268 292 10 11 268 291 12 15 267 290
Nonmetro 156 156 3 <1 156 156 11 10 154 156
Urbanized 106 104 * * 106 104 2 8 106 103
Less Urbanized 82 94 3 * 82 94 11 5 78 94
Completely Rural 82 75 * <1 82 75 1 4 82 75
POVERTY LEVEL1                    
Less Than 100% 253 250 2 <1 253 250 12 16 252 248
100‑199% 208 279 8 11 208 279 16 13 207 279
200% or More 338 311 10 1 338 311 14 25 338 309
HEALTH INSURANCE2                    
Private 295 288 3 1 296 288 12 25 295 287
Medicaid/CHIP 312 336 10 9 312 336 15 17 311 335
Other3 227 312 <1 * 227 312 3 4 227 312
No Coverage 128 133 * * 127 133 15 10 126 132

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.79D – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.16 0.17 0.05 0.04 0.17 0.18 0.07 0.09 0.20 0.21
GEOGRAPHIC DIVISION                    
Northeast 0.50 0.40 0.01 <0.01 0.54 0.44 0.16 0.06 0.62 0.50
New England 1.24 1.05 0.05 <0.01 1.33 1.13 0.22 0.03 1.52 1.31
Middle Atlantic 0.49 0.39 * * 0.54 0.42 0.21 0.08 0.62 0.49
Midwest 0.31 0.39 * 0.01 0.34 0.42 0.15 0.20 0.39 0.49
East North Central 0.40 0.49 * 0.01 0.44 0.53 0.09 0.25 0.51 0.61
West North Central 0.48 0.60 * * 0.53 0.65 0.43 0.32 0.60 0.75
South 0.24 0.26 0.12 0.06 0.26 0.29 0.14 0.18 0.30 0.33
South Atlantic 0.33 0.40 0.06 * 0.36 0.44 0.24 0.14 0.41 0.51
East South Central 0.54 0.47 * * 0.59 0.52 0.06 0.67 0.68 0.60
West South Central 0.41 0.40 0.34 0.18 0.45 0.44 0.21 0.37 0.53 0.52
West 0.36 0.34 0.05 0.15 0.39 0.38 0.08 0.15 0.45 0.43
Mountain 0.45 0.58 0.14 0.05 0.50 0.64 0.13 0.26 0.58 0.73
Pacific 0.49 0.42 * 0.22 0.54 0.46 0.10 0.19 0.61 0.53
COUNTY TYPE                    
Large Metro 0.23 0.22 0.05 <0.01 0.25 0.24 0.10 0.13 0.28 0.28
Small Metro 0.28 0.30 0.13 0.13 0.31 0.33 0.10 0.13 0.36 0.39
Nonmetro 0.44 0.42 0.11 <0.01 0.48 0.46 0.26 0.26 0.55 0.52
Urbanized 0.75 0.75 * * 0.81 0.82 0.09 0.54 0.97 0.94
Less Urbanized 0.63 0.60 0.31 * 0.68 0.66 0.74 0.32 0.75 0.75
Completely Rural 0.88 0.84 * 0.01 0.97 0.91 0.12 0.43 1.10 1.03
POVERTY LEVEL1                    
Less Than 100% 0.52 0.48 0.04 0.01 0.59 0.54 0.15 0.17 0.73 0.68
100‑199% 0.35 0.44 0.14 0.19 0.39 0.48 0.19 0.15 0.47 0.56
200% or More 0.18 0.17 0.07 0.01 0.19 0.18 0.08 0.14 0.22 0.20
HEALTH INSURANCE2                    
Private 0.17 0.16 0.02 0.01 0.18 0.18 0.06 0.12 0.21 0.21
Medicaid/CHIP 0.49 0.51 0.10 0.08 0.59 0.61 0.17 0.19 0.71 0.74
Other3 0.28 0.37 0.01 * 0.29 0.37 0.09 0.17 0.30 0.39
No Coverage 0.50 0.51 * * 0.52 0.53 0.30 0.20 0.65 0.67

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.79P – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3482   0.6480   0.3331   0.5717   0.3368  
GEOGRAPHIC DIVISION                    
Northeast 0.1983   0.3486   0.1938   0.0347   0.2250  
New England 0.6510   0.3408   0.6465   0.0453   0.6697  
Middle Atlantic 0.1758   *   0.1725   0.1321   0.2023  
Midwest 0.5676   *   0.5807   0.4384   0.6007  
East North Central 0.5930   *   0.6052   0.0877   0.6601  
West North Central 0.8308   *   0.8371   0.4984   0.7770  
South 0.3922   0.2937   0.3967   0.8753   0.4068  
South Atlantic 0.7764   *   0.7741   0.3544   0.8349  
East South Central 0.0679   *   0.0658   0.1545   0.0464  
West South Central 0.8840   0.4442   0.9107   0.8996   0.9145  
West 0.8924   0.4443   0.8613   0.0709   0.8198  
Mountain 0.1682   0.5588   0.1646   0.0744   0.1810  
Pacific 0.3576   *   0.3326   0.3471   0.3206  
COUNTY TYPE                    
Large Metro 0.3832   0.3495   0.3688   0.8472   0.4128  
Small Metro 0.6725   0.9263   0.6610   0.5071   0.6155  
Nonmetro 0.9264   0.3206   0.9279   0.7032   0.8385  
Urbanized 0.6950   *   0.6836   0.1010   0.8781  
Less Urbanized 0.7097   *   0.6921   0.1856   0.5803  
Completely Rural 0.2333   *   0.2200   0.2668   0.2103  
POVERTY LEVEL1                    
Less Than 100% 0.9715   0.1177   0.9571   0.4936   0.8714  
100‑199% 0.3467   0.7676   0.3590   0.6186   0.4124  
200% or More 0.0142   0.3805   0.0134   0.5506   0.0119  
HEALTH INSURANCE2                    
Private 0.0765   0.5415   0.0733   0.2831   0.0753  
Medicaid/CHIP 0.6606   0.6987   0.6953   0.9368   0.7010  
Other3 0.2189   *   0.2189   0.1397   0.2358  
No Coverage 0.8298   *   0.8171   0.5329   0.8538  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.80C – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 118 134 4 9 118 134 15 9 117 132
GEOGRAPHIC DIVISION                    
Northeast 76 65 1 * 76 65 4 <1 76 65
New England 11 29 1 * 11 29 3 <1 11 29
Middle Atlantic 75 57 * * 75 57 2 <1 75 57
Midwest 35 87 * <1 35 87 8 5 34 85
East North Central 29 77 * <1 29 77 2 1 29 77
West North Central 19 41 * * 19 41 8 5 18 36
South 79 46 3 * 79 46 12 4 78 46
South Atlantic 73 41 3 * 73 41 11 4 72 41
East South Central 14 6 * * 14 6 <1 * 14 6
West South Central 26 20 * * 26 20 3 1 26 20
West 25 64 3 9 24 63 3 6 23 63
Mountain 9 39 3 * 9 39 <1 2 9 39
Pacific 23 51 * 9 23 50 3 6 21 50
COUNTY TYPE                    
Large Metro 80 101 * <1 80 101 12 5 79 99
Small Metro 76 82 2 9 75 82 5 3 75 82
Nonmetro 39 21 3 * 39 21 7 6 38 21
Urbanized 32 15 * * 32 15 * * 32 14
Less Urbanized 11 11 3 * 11 11 7 1 8 11
Completely Rural 20 11 * * 20 11 <1 * 20 11
POVERTY LEVEL1                    
Less Than 100% 90 96 2 <1 90 96 5 6 90 96
100‑199% 57 82 3 9 57 81 13 6 55 81
200% or More 37 37 * * 37 37 4 1 37 37
HEALTH INSURANCE2                    
Private 27 54 3 * 26 54 4 2 26 54
Medicaid/CHIP 106 115 2 9 106 115 12 8 106 113
Other3 40 84 <1 * 40 84 <1 2 40 84
No Coverage 28 41 * * 28 41 8 3 26 41

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.80D – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.04 0.05 0.02 0.03 0.04 0.05 0.04 0.02 0.05 0.06
GEOGRAPHIC DIVISION                    
Northeast 0.15 0.13 0.01 * 0.16 0.14 0.07 0.01 0.19 0.16
New England 0.08 0.22 0.05 * 0.09 0.24 0.20 0.02 0.10 0.27
Middle Atlantic 0.20 0.16 * * 0.22 0.17 0.05 0.01 0.25 0.20
Midwest 0.06 0.15 * 0.01 0.06 0.16 0.11 0.07 0.07 0.18
East North Central 0.07 0.19 * 0.01 0.08 0.21 0.04 0.01 0.09 0.24
West North Central 0.10 0.22 * * 0.12 0.24 0.33 0.21 0.12 0.25
South 0.07 0.04 0.03 * 0.08 0.04 0.09 0.03 0.09 0.05
South Atlantic 0.12 0.07 0.06 * 0.13 0.07 0.17 0.05 0.15 0.08
East South Central 0.08 0.04 * * 0.09 0.04 0.02 * 0.10 0.05
West South Central 0.07 0.06 * * 0.08 0.06 0.07 0.02 0.09 0.07
West 0.04 0.09 0.05 0.15 0.04 0.10 0.03 0.07 0.04 0.12
Mountain 0.04 0.17 0.14 * 0.04 0.19 0.01 0.06 0.05 0.22
Pacific 0.05 0.11 * 0.22 0.05 0.12 0.05 0.11 0.06 0.14
COUNTY TYPE                    
Large Metro 0.05 0.06 * <0.01 0.05 0.07 0.06 0.03 0.06 0.08
Small Metro 0.08 0.09 0.03 0.11 0.09 0.10 0.05 0.03 0.11 0.11
Nonmetro 0.12 0.06 0.11 * 0.13 0.07 0.17 0.16 0.15 0.08
Urbanized 0.24 0.12 * * 0.26 0.13 * * 0.31 0.14
Less Urbanized 0.09 0.08 0.31 * 0.10 0.09 0.52 0.08 0.09 0.10
Completely Rural 0.23 0.14 * * 0.26 0.15 0.05 * 0.29 0.17
POVERTY LEVEL1                    
Less Than 100% 0.19 0.20 0.04 0.01 0.22 0.22 0.06 0.07 0.27 0.28
100‑199% 0.10 0.13 0.06 0.16 0.11 0.15 0.16 0.07 0.13 0.17
200% or More 0.02 0.02 * * 0.02 0.02 0.02 0.01 0.02 0.02
HEALTH INSURANCE2                    
Private 0.02 0.03 0.02 * 0.02 0.03 0.02 0.01 0.02 0.04
Medicaid/CHIP 0.18 0.19 0.02 0.08 0.22 0.22 0.14 0.09 0.26 0.27
Other3 0.05 0.10 0.01 * 0.05 0.10 0.01 0.06 0.05 0.11
No Coverage 0.11 0.16 * * 0.11 0.17 0.16 0.07 0.14 0.22

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.80P – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1947   0.8576   0.2017   0.1616   0.1494  
GEOGRAPHIC DIVISION                    
Northeast 0.6710   *   0.6715   0.0322   0.6045  
New England 0.2910   *   0.2826   0.1208   0.2153  
Middle Atlantic 0.9230   *   0.9276   0.1295   0.8916  
Midwest 0.1092   *   0.1111   0.4498   0.0870  
East North Central 0.1500   *   0.1525   0.1967   0.1428  
West North Central 0.4811   *   0.4820   0.6207   0.3693  
South 0.2851   *   0.3029   0.2932   0.3748  
South Atlantic 0.3767   *   0.4019   0.3917   0.4726  
East South Central 0.3297   *   0.3286   *   0.3496  
West South Central 0.7929   *   0.7885   0.4991   0.8448  
West 0.0462   0.5128   0.0549   0.5151   0.0604  
Mountain 0.2824   *   0.2501   0.2328   0.2719  
Pacific 0.0918   *   0.1231   0.7310   0.1267  
COUNTY TYPE                    
Large Metro 0.1549   *   0.1594   0.2417   0.1139  
Small Metro 0.4515   0.6396   0.4750   0.1922   0.4314  
Nonmetro 0.3944   *   0.4325   0.9676   0.4151  
Urbanized 0.5917   *   0.5933   *   0.4477  
Less Urbanized 0.4488   *   0.5797   0.3918   0.8768  
Completely Rural 0.7954   *   0.7864   *   0.8011  
POVERTY LEVEL1                    
Less Than 100% 0.5125   0.1177   0.4994   0.9497   0.4397  
100‑199% 0.3068   0.5841   0.3319   0.1836   0.2472  
200% or More 0.8446   *   0.8525   0.1892   0.7682  
HEALTH INSURANCE2                    
Private 0.1010   *   0.0909   0.8629   0.0860  
Medicaid/CHIP 0.6534   0.6031   0.6918   0.3842   0.6301  
Other3 0.0473   *   0.0472   0.2185   0.0502  
No Coverage 0.2686   *   0.2719   0.2223   0.1824  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.81C – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 93 82 <1 * 93 82 6 4 93 82
GEOGRAPHIC DIVISION                    
Northeast 50 45 * * 50 45 1 <1 50 45
New England 9 4 * * 9 4 1 <1 9 4
Middle Atlantic 49 44 * * 49 44 1 <1 49 44
Midwest 28 48 * * 28 48 3 1 28 48
East North Central 22 35 * * 22 35 * <1 22 35
West North Central 17 33 * * 17 33 3 1 17 33
South 70 34 <1 * 70 34 4 3 70 34
South Atlantic 70 27 <1 * 70 27 3 3 70 27
East South Central 7 2 * * 7 2 * * 7 2
West South Central 4 20 * * 4 20 3 1 3 20
West 22 36 * * 22 36 1 2 21 36
Mountain 1 6 * * 1 6 * 2 1 6
Pacific 22 35 * * 22 35 1 * 21 35
COUNTY TYPE                    
Large Metro 49 74 * * 49 74 4 2 49 74
Small Metro 73 32 <1 * 73 32 4 3 73 32
Nonmetro 32 13 * * 32 13 <1 1 32 13
Urbanized 27 13 * * 27 13 * * 27 13
Less Urbanized 1 1 * * 1 1 <1 1 1 1
Completely Rural 16 * * * 16 * * * 16 *
POVERTY LEVEL1                    
Less Than 100% 74 62 * * 74 62 4 4 74 62
100‑199% 53 45 <1 * 53 45 2 <1 53 45
200% or More 20 29 * * 20 29 3 1 20 29
HEALTH INSURANCE2                    
Private 22 25 * * 22 25 3 2 21 25
Medicaid/CHIP 85 65 <1 * 85 65 3 2 85 65
Other3 35 37 * * 35 37 <1 1 35 37
No Coverage 6 35 * * 6 35 3 3 4 35

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.81D – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.03 0.03 <0.01 * 0.04 0.03 0.02 0.01 0.04 0.04
GEOGRAPHIC DIVISION                    
Northeast 0.10 0.09 * * 0.11 0.10 0.02 0.01 0.13 0.11
New England 0.07 0.03 * * 0.07 0.03 0.04 0.01 0.08 0.04
Middle Atlantic 0.13 0.12 * * 0.15 0.13 0.02 0.01 0.17 0.15
Midwest 0.05 0.08 * * 0.05 0.09 0.04 0.01 0.06 0.10
East North Central 0.05 0.09 * * 0.06 0.09 * 0.01 0.07 0.11
West North Central 0.09 0.18 * * 0.10 0.20 0.14 0.02 0.12 0.23
South 0.06 0.03 <0.01 * 0.07 0.03 0.03 0.02 0.08 0.04
South Atlantic 0.12 0.05 <0.01 * 0.13 0.05 0.04 0.05 0.15 0.06
East South Central 0.04 0.01 * * 0.05 0.01 * * 0.05 0.02
West South Central 0.01 0.05 * * 0.01 0.06 0.07 0.02 0.01 0.07
West 0.03 0.05 * * 0.04 0.06 0.02 0.02 0.04 0.07
Mountain <0.01 0.03 * * 0.01 0.03 * 0.06 0.01 0.03
Pacific 0.05 0.08 * * 0.05 0.08 0.03 * 0.06 0.10
COUNTY TYPE                    
Large Metro 0.03 0.04 * * 0.03 0.05 0.02 0.01 0.04 0.06
Small Metro 0.08 0.03 <0.01 * 0.09 0.04 0.04 0.03 0.10 0.04
Nonmetro 0.09 0.04 * * 0.10 0.04 0.01 0.02 0.12 0.05
Urbanized 0.20 0.11 * * 0.22 0.12 * * 0.26 0.14
Less Urbanized 0.01 0.01 * * 0.01 0.01 0.02 0.06 0.01 0.01
Completely Rural 0.19 * * * 0.21 * * * 0.23 *
POVERTY LEVEL1                    
Less Than 100% 0.16 0.13 * * 0.18 0.14 0.05 0.04 0.23 0.18
100‑199% 0.09 0.07 <0.01 * 0.10 0.08 0.02 <0.01 0.12 0.10
200% or More 0.01 0.02 * * 0.01 0.02 0.02 <0.01 0.01 0.02
HEALTH INSURANCE2                    
Private 0.01 0.01 * * 0.01 0.02 0.02 0.01 0.02 0.02
Medicaid/CHIP 0.14 0.11 <0.01 * 0.17 0.13 0.04 0.02 0.21 0.16
Other3 0.04 0.04 * * 0.04 0.05 0.01 0.04 0.05 0.05
No Coverage 0.02 0.14 * * 0.02 0.15 0.07 0.07 0.02 0.19

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.81P – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.6183   *   0.6236   0.4502   0.5859  
GEOGRAPHIC DIVISION                    
Northeast 0.9201   *   0.9167   0.2867   0.9371  
New England 0.6319   *   0.6302   0.4855   0.6660  
Middle Atlantic 0.9763   *   0.9732   0.4146   0.9885  
Midwest 0.2740   *   0.2756   0.4948   0.2560  
East North Central 0.2615   *   0.2631   *   0.2663  
West North Central 0.6966   *   0.6977   0.4032   0.6426  
South 0.5293   *   0.5276   0.7132   0.5472  
South Atlantic 0.3123   *   0.3118   0.9654   0.3111  
East South Central 0.5666   *   0.5659   *   0.5675  
West South Central 0.1179   *   0.1183   0.4991   0.0904  
West 0.1744   *   0.1755   0.8686   0.1700  
Mountain 0.0774   *   0.0775   *   0.1441  
Pacific 0.2676   *   0.2691   *   0.2407  
COUNTY TYPE                    
Large Metro 0.1342   *   0.1363   0.5057   0.1222  
Small Metro 0.5963   *   0.5964   0.5634   0.6212  
Nonmetro 0.3859   *   0.3849   0.4840   0.3690  
Urbanized 0.6872   *   0.6887   *   0.6683  
Less Urbanized 0.4009   *   0.4019   0.5389   0.5604  
Completely Rural *   *   *   *   *  
POVERTY LEVEL1                    
Less Than 100% 0.7228   *   0.7289   0.9205   0.6728  
100‑199% 0.7008   *   0.7007   0.1307   0.7082  
200% or More 0.2975   *   0.3000   0.4096   0.2637  
HEALTH INSURANCE2                    
Private 0.3036   *   0.3056   0.9579   0.3011  
Medicaid/CHIP 0.6881   *   0.6771   0.7255   0.6848  
Other3 0.5500   *   0.5501   0.4909   0.5620  
No Coverage 0.0327   *   0.0328   0.8200   0.0288  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.82C – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,109 1,210 52 64 1,106 1,201 205 218 1,066 1,143
GEOGRAPHIC DIVISION                    
Northeast 507 573 23 21 504 571 75 84 488 549
New England 297 276 16 13 293 275 46 39 278 265
Middle Atlantic 409 489 17 16 407 488 60 78 398 471
Midwest 468 487 23 23 465 485 86 89 436 457
East North Central 398 416 21 22 396 414 65 76 376 386
West North Central 230 245 8 9 229 244 51 48 213 236
South 616 692 34 49 615 683 132 125 588 645
South Atlantic 496 544 22 39 494 537 87 95 483 502
East South Central 183 217 9 16 182 215 28 62 176 202
West South Central 304 340 24 26 303 336 96 80 274 312
West 634 683 25 27 633 680 112 122 606 638
Mountain 326 338 16 18 324 336 62 62 302 314
Pacific 547 609 18 20 548 607 93 105 528 570
COUNTY TYPE                    
Large Metro 898 996 39 46 897 990 144 177 870 934
Small Metro 612 628 33 42 605 621 134 123 573 593
Nonmetro 340 353 16 16 337 352 70 57 303 339
Urbanized 241 244 5 8 241 243 56 36 210 232
Less Urbanized 224 241 13 9 222 240 35 41 206 230
Completely Rural 159 116 8 10 157 116 25 18 150 115
POVERTY LEVEL1                    
Less Than 100% 355 421 26 33 354 416 85 100 338 399
100‑199% 365 460 20 27 365 456 91 95 348 442
200% or More 905 933 39 39 902 933 147 152 875 890
HEALTH INSURANCE2                    
Private 817 838 40 42 815 837 150 173 786 799
Medicaid/CHIP 455 545 32 45 454 541 86 90 437 520
Other3 446 558 12 12 446 558 50 45 443 557
No Coverage 266 293 15 11 265 291 71 59 252 283

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.82D – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.31 0.32 0.20 0.24 0.34 0.35 0.51 0.52 0.37 0.39
GEOGRAPHIC DIVISION                    
Northeast 0.82 0.88 0.56 0.50 0.88 0.95 1.12 1.09 0.98 1.04
New England 1.45 1.47 1.51 1.16 1.52 1.60 2.21 1.98 1.69 1.79
Middle Atlantic 0.96 1.06 0.54 0.54 1.04 1.15 1.27 1.42 1.16 1.25
Midwest 0.64 0.68 0.42 0.43 0.69 0.73 0.88 0.98 0.76 0.81
East North Central 0.79 0.86 0.58 0.60 0.86 0.93 1.01 1.19 0.96 1.03
West North Central 0.94 1.07 0.42 0.50 1.04 1.17 1.55 1.68 1.17 1.33
South 0.46 0.50 0.31 0.47 0.50 0.54 0.86 0.82 0.55 0.60
South Atlantic 0.67 0.74 0.41 0.72 0.72 0.80 1.08 1.09 0.82 0.88
East South Central 0.88 1.19 0.59 0.97 0.94 1.32 1.24 2.60 1.06 1.45
West South Central 0.82 0.75 0.65 0.75 0.89 0.80 1.88 1.46 0.93 0.88
West 0.72 0.73 0.41 0.43 0.78 0.79 1.23 1.18 0.84 0.87
Mountain 1.13 1.14 0.77 0.84 1.25 1.24 1.92 1.73 1.36 1.36
Pacific 0.89 0.96 0.45 0.49 0.97 1.03 1.57 1.53 1.04 1.13
COUNTY TYPE                    
Large Metro 0.44 0.46 0.25 0.32 0.48 0.50 0.70 0.74 0.53 0.55
Small Metro 0.51 0.55 0.39 0.47 0.55 0.59 0.93 0.82 0.61 0.67
Nonmetro 0.75 0.86 0.54 0.55 0.81 0.94 1.20 1.34 0.86 1.04
Urbanized 1.26 1.55 0.47 0.74 1.35 1.68 1.74 2.24 1.49 1.83
Less Urbanized 1.31 1.34 1.17 0.72 1.39 1.47 2.05 2.32 1.45 1.67
Completely Rural 1.41 1.17 1.04 1.63 1.55 1.28 2.53 1.93 1.70 1.51
POVERTY LEVEL1                    
Less Than 100% 0.66 0.74 0.46 0.58 0.74 0.83 0.88 0.81 0.89 1.01
100‑199% 0.60 0.66 0.38 0.47 0.66 0.72 0.99 1.03 0.77 0.83
200% or More 0.39 0.41 0.25 0.27 0.42 0.44 0.75 0.79 0.46 0.47
HEALTH INSURANCE2                    
Private 0.37 0.39 0.27 0.30 0.41 0.42 0.66 0.70 0.44 0.47
Medicaid/CHIP 0.66 0.75 0.30 0.42 0.78 0.89 0.87 0.90 0.91 1.03
Other3 0.52 0.59 0.84 0.81 0.53 0.60 1.61 1.56 0.55 0.62
No Coverage 0.98 1.01 1.22 1.00 1.02 1.05 1.30 1.16 1.23 1.28

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.82P – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3578   0.9074   0.3108   0.0224   0.5809  
GEOGRAPHIC DIVISION                    
Northeast 0.7335   0.9839   0.7072   0.0129   0.9803  
New England 0.2300   0.8822   0.2204   0.0114   0.4246  
Middle Atlantic 0.8026   0.8765   0.8268   0.1904   0.6510  
Midwest 0.8644   0.6305   0.8084   0.9122   0.8214  
East North Central 0.9828   0.8215   0.9767   0.8871   0.9614  
West North Central 0.6929   0.4437   0.6527   0.6850   0.7089  
South 0.4421   0.6250   0.4236   0.2274   0.5853  
South Atlantic 0.3353   0.9781   0.3146   0.1611   0.4439  
East South Central 0.6568   0.4005   0.7189   0.2972   0.9024  
West South Central 0.7542   0.2391   0.7994   0.3265   0.9629  
West 0.6761   0.9351   0.6344   0.3009   0.7971  
Mountain 0.3885   0.3782   0.4100   0.5001   0.4761  
Pacific 0.9803   0.3895   0.9526   0.4166   0.8991  
COUNTY TYPE                    
Large Metro 0.7018   0.8576   0.6266   0.1556   0.8683  
Small Metro 0.2654   0.8222   0.2530   0.1072   0.3952  
Nonmetro 0.9192   0.6024   0.9236   0.2685   0.9351  
Urbanized 0.3995   0.5308   0.3934   0.6434   0.3493  
Less Urbanized 0.9400   0.1254   0.9931   0.6632   0.9224  
Completely Rural 0.1034   0.6854   0.0861   0.2300   0.1355  
POVERTY LEVEL1                    
Less Than 100% 0.2459   0.7184   0.2679   0.4364   0.1339  
100‑199% 0.1337   0.9898   0.1379   0.6040   0.1717  
200% or More 0.0230   0.6153   0.0184   0.0087   0.0530  
HEALTH INSURANCE2                    
Private 0.1632   0.7054   0.1467   0.4376   0.1917  
Medicaid/CHIP 0.1234   0.2927   0.1682   0.1294   0.0796  
Other3 0.6564   0.9153   0.6584   0.1435   0.5648  
No Coverage 0.7188   0.1871   0.6912   0.0448   0.3557  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.83C – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 409 386 43 49 406 383 120 145 389 344
GEOGRAPHIC DIVISION                    
Northeast 219 171 18 13 218 170 52 48 216 162
New England 139 57 16 10 138 56 31 27 133 53
Middle Atlantic 168 164 7 9 168 164 42 45 168 155
Midwest 127 149 15 16 126 147 43 57 107 128
East North Central 111 133 14 14 109 132 31 50 98 114
West North Central 66 67 5 8 66 67 25 29 55 58
South 216 209 30 38 216 208 75 95 196 179
South Atlantic 152 171 17 26 151 169 56 76 140 142
East South Central 66 63 9 11 66 64 15 41 64 47
West South Central 136 119 23 25 135 118 48 40 122 105
West 237 228 22 22 234 225 76 78 223 204
Mountain 135 117 15 17 132 114 37 42 121 100
Pacific 195 194 16 13 193 193 67 66 187 177
COUNTY TYPE                    
Large Metro 356 341 32 41 354 339 100 122 344 302
Small Metro 185 182 27 25 181 180 70 76 156 163
Nonmetro 102 64 13 9 100 63 34 19 89 59
Urbanized 61 44 4 5 61 43 27 12 47 41
Less Urbanized 52 43 11 5 51 43 16 12 48 41
Completely Rural 62 17 7 4 61 16 15 9 59 12
POVERTY LEVEL1                    
Less Than 100% 163 136 21 25 162 133 46 72 155 113
100‑199% 151 134 17 21 149 132 58 54 136 117
200% or More 327 310 34 34 323 309 95 101 307 287
HEALTH INSURANCE2                    
Private 310 291 32 36 307 288 95 117 295 270
Medicaid/CHIP 175 157 27 35 172 151 47 65 164 134
Other3 104 120 8 7 103 120 30 26 99 117
No Coverage 132 125 13 6 131 125 46 36 123 115

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.83D – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.13 0.13 0.16 0.19 0.15 0.14 0.33 0.37 0.16 0.14
GEOGRAPHIC DIVISION                    
Northeast 0.41 0.34 0.43 0.33 0.45 0.37 0.85 0.71 0.51 0.40
New England 0.96 0.42 1.50 0.91 1.04 0.46 1.86 1.49 1.15 0.50
Middle Atlantic 0.44 0.45 0.25 0.30 0.47 0.48 0.93 0.91 0.55 0.52
Midwest 0.21 0.23 0.28 0.31 0.23 0.25 0.53 0.69 0.23 0.26
East North Central 0.27 0.30 0.38 0.41 0.29 0.33 0.58 0.85 0.30 0.34
West North Central 0.34 0.35 0.30 0.46 0.38 0.38 0.91 1.15 0.37 0.38
South 0.19 0.18 0.28 0.37 0.21 0.19 0.53 0.65 0.22 0.19
South Atlantic 0.25 0.27 0.32 0.51 0.27 0.29 0.78 0.99 0.29 0.29
East South Central 0.39 0.38 0.57 0.68 0.42 0.42 0.75 1.89 0.47 0.36
West South Central 0.39 0.31 0.61 0.72 0.43 0.34 0.98 0.81 0.45 0.36
West 0.32 0.30 0.36 0.36 0.34 0.32 0.94 0.84 0.38 0.35
Mountain 0.56 0.48 0.70 0.80 0.60 0.53 1.25 1.32 0.66 0.55
Pacific 0.39 0.36 0.39 0.34 0.42 0.40 1.26 1.07 0.46 0.43
COUNTY TYPE                    
Large Metro 0.20 0.19 0.20 0.28 0.22 0.21 0.51 0.56 0.25 0.22
Small Metro 0.19 0.19 0.32 0.29 0.21 0.21 0.56 0.57 0.21 0.22
Nonmetro 0.29 0.18 0.44 0.32 0.31 0.19 0.77 0.50 0.33 0.21
Urbanized 0.45 0.32 0.35 0.53 0.48 0.34 1.23 0.85 0.45 0.38
Less Urbanized 0.38 0.30 0.95 0.41 0.42 0.32 1.09 0.74 0.46 0.35
Completely Rural 0.71 0.22 0.88 0.68 0.78 0.22 1.68 1.06 0.86 0.20
POVERTY LEVEL1                    
Less Than 100% 0.34 0.27 0.38 0.44 0.38 0.30 0.51 0.63 0.46 0.34
100‑199% 0.27 0.22 0.32 0.36 0.29 0.23 0.67 0.61 0.32 0.25
200% or More 0.17 0.16 0.22 0.23 0.18 0.17 0.52 0.55 0.19 0.18
HEALTH INSURANCE2                    
Private 0.17 0.16 0.21 0.26 0.18 0.17 0.47 0.51 0.20 0.19
Medicaid/CHIP 0.29 0.25 0.26 0.33 0.35 0.29 0.52 0.67 0.41 0.32
Other3 0.13 0.14 0.59 0.51 0.13 0.15 1.05 0.96 0.13 0.15
No Coverage 0.51 0.49 1.04 0.54 0.53 0.52 0.89 0.73 0.64 0.60

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.83P – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0108   0.5550   0.0118   0.1265   0.0281  
GEOGRAPHIC DIVISION                    
Northeast 0.0440   0.6783   0.0461   0.1932   0.0823  
New England 0.0922   0.5397   0.1071   0.6461   0.1194  
Middle Atlantic 0.1880   0.8534   0.1814   0.2279   0.2759  
Midwest 0.3261   0.5913   0.3592   0.6037   0.4155  
East North Central 0.2988   0.8288   0.3098   0.6319   0.3468  
West North Central 0.8862   0.4272   0.9584   0.8055   0.9441  
South 0.2185   0.5159   0.2546   0.3256   0.3812  
South Atlantic 0.6283   0.9538   0.6158   0.6693   0.6881  
East South Central 0.4173   0.9861   0.4138   0.5599   0.1988  
West South Central 0.3101   0.3406   0.3978   0.0966   0.7541  
West 0.0300   0.7362   0.0294   0.3179   0.0504  
Mountain 0.2293   0.5348   0.2529   0.9496   0.2159  
Pacific 0.0671   0.8971   0.0609   0.2632   0.1235  
COUNTY TYPE                    
Large Metro 0.0879   1.0000   0.0816   0.5638   0.0776  
Small Metro 0.1916   0.4737   0.2244   0.3185   0.3750  
Nonmetro 0.0390   0.3724   0.0473   0.0036   0.3009  
Urbanized 0.6690   0.4633   0.6199   0.0927   0.7341  
Less Urbanized 0.1167   0.0791   0.2103   0.0229   0.5739  
Completely Rural 0.0591   0.9195   0.0549   0.2731   0.0941  
POVERTY LEVEL1                    
Less Than 100% 0.5650   0.8994   0.5840   0.5130   0.8335  
100‑199% 0.0526   0.7899   0.0523   0.3257   0.1152  
200% or More 0.0141   0.4587   0.0157   0.0986   0.0449  
HEALTH INSURANCE2                    
Private 0.0144   0.6977   0.0146   0.3900   0.0168  
Medicaid/CHIP 0.6667   0.6225   0.7562   0.9973   0.7372  
Other3 0.2978   0.5344   0.2771   0.7388   0.2034  
No Coverage 0.1865   0.0965   0.2246   0.0314   0.5786  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.84C – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 181 191 28 23 179 192 51 71 170 176
GEOGRAPHIC DIVISION                    
Northeast 84 85 15 7 82 85 21 24 79 76
New England 37 41 * 1 34 41 8 21 31 36
Middle Atlantic 76 82 5 7 76 81 20 20 74 73
Midwest 65 68 5 9 65 67 16 26 62 58
East North Central 59 61 4 8 59 61 16 21 57 54
West North Central 26 30 4 4 26 30 4 15 25 23
South 100 111 21 20 98 111 33 50 89 101
South Atlantic 70 85 13 16 69 84 25 19 64 82
East South Central 15 39 <1 4 15 39 6 37 14 18
West South Central 71 60 17 11 69 62 20 28 61 55
West 106 114 7 4 106 114 30 35 102 109
Mountain 56 53 3 3 56 53 8 12 55 51
Pacific 90 100 6 4 90 101 28 33 86 95
COUNTY TYPE                    
Large Metro 162 173 20 21 161 175 40 64 156 159
Small Metro 80 90 19 8 77 89 29 36 66 81
Nonmetro 26 30 4 5 26 29 8 7 24 29
Urbanized 13 21 1 2 13 20 2 4 13 20
Less Urbanized 20 20 4 4 19 20 7 5 17 20
Completely Rural 10 7 * * 10 6 1 3 10 5
POVERTY LEVEL1                    
Less Than 100% 68 63 16 14 66 62 18 30 63 53
100‑199% 80 64 10 5 80 64 25 28 75 58
200% or More 151 169 20 18 149 170 40 58 141 157
HEALTH INSURANCE2                    
Private 140 156 18 18 138 157 38 61 131 144
Medicaid/CHIP 80 68 20 15 78 66 24 30 75 59
Other3 34 50 1 * 34 50 8 18 32 46
No Coverage 73 72 6 4 72 73 23 14 68 71

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.84D – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.06 0.06 0.11 0.09 0.07 0.07 0.14 0.19 0.07 0.08
GEOGRAPHIC DIVISION                    
Northeast 0.17 0.17 0.37 0.18 0.18 0.18 0.36 0.41 0.20 0.19
New England 0.25 0.31 * 0.10 0.25 0.34 0.48 1.19 0.27 0.34
Middle Atlantic 0.21 0.22 0.17 0.24 0.23 0.24 0.45 0.48 0.25 0.25
Midwest 0.11 0.11 0.10 0.16 0.12 0.12 0.21 0.34 0.13 0.12
East North Central 0.15 0.15 0.11 0.21 0.16 0.16 0.31 0.40 0.18 0.16
West North Central 0.14 0.16 0.21 0.25 0.15 0.18 0.17 0.64 0.17 0.16
South 0.09 0.10 0.20 0.19 0.10 0.11 0.24 0.35 0.10 0.11
South Atlantic 0.12 0.14 0.25 0.31 0.12 0.15 0.37 0.27 0.13 0.17
East South Central 0.09 0.23 0.01 0.23 0.10 0.26 0.29 1.73 0.10 0.14
West South Central 0.20 0.16 0.46 0.32 0.22 0.18 0.43 0.56 0.23 0.19
West 0.15 0.15 0.12 0.07 0.17 0.17 0.35 0.41 0.19 0.19
Mountain 0.25 0.23 0.16 0.12 0.27 0.25 0.28 0.41 0.31 0.28
Pacific 0.19 0.20 0.16 0.09 0.21 0.22 0.52 0.58 0.23 0.24
COUNTY TYPE                    
Large Metro 0.10 0.10 0.13 0.15 0.11 0.11 0.21 0.31 0.12 0.12
Small Metro 0.09 0.09 0.23 0.10 0.09 0.10 0.24 0.30 0.09 0.11
Nonmetro 0.08 0.09 0.15 0.19 0.08 0.09 0.18 0.18 0.09 0.11
Urbanized 0.10 0.17 0.09 0.22 0.11 0.18 0.12 0.26 0.12 0.20
Less Urbanized 0.16 0.15 0.40 0.29 0.17 0.16 0.55 0.30 0.17 0.18
Completely Rural 0.13 0.09 * * 0.14 0.09 0.17 0.42 0.15 0.09
POVERTY LEVEL1                    
Less Than 100% 0.15 0.13 0.28 0.25 0.16 0.14 0.20 0.30 0.19 0.16
100‑199% 0.14 0.10 0.18 0.08 0.16 0.11 0.30 0.33 0.18 0.12
200% or More 0.08 0.09 0.13 0.13 0.09 0.10 0.22 0.33 0.09 0.10
HEALTH INSURANCE2                    
Private 0.08 0.09 0.12 0.13 0.09 0.10 0.19 0.29 0.09 0.10
Medicaid/CHIP 0.14 0.11 0.20 0.14 0.16 0.13 0.26 0.32 0.19 0.14
Other3 0.04 0.06 0.07 * 0.04 0.06 0.28 0.68 0.04 0.06
No Coverage 0.29 0.28 0.46 0.33 0.30 0.30 0.45 0.29 0.36 0.37

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.84P – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7496   0.5933   0.7948   0.1382   0.4077  
GEOGRAPHIC DIVISION                    
Northeast 0.2521   0.4300   0.2958   0.1000   0.1048  
New England 0.8484   *   0.9365   0.2773   0.6869  
Middle Atlantic 0.2594   0.8728   0.2517   0.2900   0.1241  
Midwest 0.4214   0.1717   0.5158   0.4609   0.6604  
East North Central 0.4436   0.1019   0.5520   0.9179   0.5050  
West North Central 0.7985   1.0000   0.7972   0.1189   0.6616  
South 0.8782   0.7094   0.8227   0.5807   0.9871  
South Atlantic 0.7415   0.7525   0.6927   0.3347   0.8991  
East South Central 0.2977   0.1857   0.3528   0.2327   0.8072  
West South Central 0.8756   0.2849   0.6924   0.5692   0.8421  
West 0.7727   0.2670   0.8123   0.6675   0.6955  
Mountain 0.9895   0.5086   0.9634   0.5301   0.9396  
Pacific 0.7320   0.3643   0.7631   0.8059   0.6810  
COUNTY TYPE                    
Large Metro 0.6683   0.9299   0.6660   0.1352   0.3126  
Small Metro 0.9105   0.3370   0.7793   0.6881   0.8761  
Nonmetro 0.8471   0.6595   0.9067   0.4802   0.7425  
Urbanized 0.4391   0.5180   0.4644   0.7434   0.5165  
Less Urbanized 0.7167   0.6180   0.7861   0.1821   0.8517  
Completely Rural 0.7218   *   0.4941   0.6682   0.3916  
POVERTY LEVEL1                    
Less Than 100% 0.2403   0.8891   0.2407   0.0184   0.7831  
100‑199% 0.4330   0.1636   0.5175   0.9062   0.5494  
200% or More 0.6543   0.8030   0.6641   0.4377   0.4659  
HEALTH INSURANCE2                    
Private 0.9324   0.9768   0.9447   0.0469   0.4736  
Medicaid/CHIP 0.4758   0.7056   0.5123   0.8452   0.4364  
Other3 0.0447   *   0.0424   0.1531   0.0874  
No Coverage 0.9073   0.5698   0.9306   0.0905   0.7107  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.85C – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 727 ‑‑ 76 ‑‑ 718 ‑‑ 145 ‑‑ 688
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 321 ‑‑ 32 ‑‑ 322 ‑‑ 50 ‑‑ 314
New England ‑‑ 178 ‑‑ 10 ‑‑ 178 ‑‑ 17 ‑‑ 176
Middle Atlantic ‑‑ 270 ‑‑ 30 ‑‑ 269 ‑‑ 47 ‑‑ 262
Midwest ‑‑ 274 ‑‑ 27 ‑‑ 272 ‑‑ 60 ‑‑ 258
East North Central ‑‑ 239 ‑‑ 24 ‑‑ 237 ‑‑ 57 ‑‑ 224
West North Central ‑‑ 126 ‑‑ 13 ‑‑ 125 ‑‑ 21 ‑‑ 120
South ‑‑ 385 ‑‑ 54 ‑‑ 376 ‑‑ 71 ‑‑ 364
South Atlantic ‑‑ 324 ‑‑ 38 ‑‑ 318 ‑‑ 57 ‑‑ 305
East South Central ‑‑ 99 ‑‑ 15 ‑‑ 98 ‑‑ 19 ‑‑ 99
West South Central ‑‑ 179 ‑‑ 35 ‑‑ 170 ‑‑ 39 ‑‑ 168
West ‑‑ 433 ‑‑ 33 ‑‑ 431 ‑‑ 98 ‑‑ 407
Mountain ‑‑ 219 ‑‑ 16 ‑‑ 218 ‑‑ 44 ‑‑ 211
Pacific ‑‑ 377 ‑‑ 28 ‑‑ 376 ‑‑ 87 ‑‑ 351
COUNTY TYPE                    
Large Metro ‑‑ 554 ‑‑ 66 ‑‑ 545 ‑‑ 127 ‑‑ 513
Small Metro ‑‑ 405 ‑‑ 35 ‑‑ 403 ‑‑ 58 ‑‑ 393
Nonmetro ‑‑ 211 ‑‑ 19 ‑‑ 209 ‑‑ 35 ‑‑ 201
Urbanized ‑‑ 160 ‑‑ 10 ‑‑ 159 ‑‑ 18 ‑‑ 153
Less Urbanized ‑‑ 125 ‑‑ 14 ‑‑ 123 ‑‑ 27 ‑‑ 118
Completely Rural ‑‑ 56 ‑‑ 7 ‑‑ 55 ‑‑ 8 ‑‑ 53
POVERTY LEVEL1                    
Less Than 100% ‑‑ 260 ‑‑ 35 ‑‑ 256 ‑‑ 82 ‑‑ 239
100‑199% ‑‑ 346 ‑‑ 41 ‑‑ 343 ‑‑ 54 ‑‑ 337
200% or More ‑‑ 515 ‑‑ 49 ‑‑ 513 ‑‑ 90 ‑‑ 496
HEALTH INSURANCE2                    
Private ‑‑ 500 ‑‑ 46 ‑‑ 494 ‑‑ 106 ‑‑ 473
Medicaid/CHIP ‑‑ 340 ‑‑ 58 ‑‑ 333 ‑‑ 74 ‑‑ 323
Other3 ‑‑ 409 ‑‑ 12 ‑‑ 408 ‑‑ 26 ‑‑ 408
No Coverage ‑‑ 166 ‑‑ 18 ‑‑ 164 ‑‑ 33 ‑‑ 160

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.85D – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.22 ‑‑ 0.29 ‑‑ 0.24 ‑‑ 0.38 ‑‑ 0.27
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 0.58 ‑‑ 0.76 ‑‑ 0.63 ‑‑ 0.83 ‑‑ 0.71
New England ‑‑ 1.19 ‑‑ 0.94 ‑‑ 1.28 ‑‑ 1.06 ‑‑ 1.46
Middle Atlantic ‑‑ 0.66 ‑‑ 0.98 ‑‑ 0.72 ‑‑ 1.09 ‑‑ 0.81
Midwest ‑‑ 0.42 ‑‑ 0.50 ‑‑ 0.45 ‑‑ 0.74 ‑‑ 0.51
East North Central ‑‑ 0.54 ‑‑ 0.66 ‑‑ 0.58 ‑‑ 0.99 ‑‑ 0.65
West North Central ‑‑ 0.64 ‑‑ 0.73 ‑‑ 0.70 ‑‑ 0.91 ‑‑ 0.78
South ‑‑ 0.30 ‑‑ 0.52 ‑‑ 0.32 ‑‑ 0.48 ‑‑ 0.36
South Atlantic ‑‑ 0.47 ‑‑ 0.72 ‑‑ 0.51 ‑‑ 0.70 ‑‑ 0.56
East South Central ‑‑ 0.55 ‑‑ 0.99 ‑‑ 0.60 ‑‑ 0.81 ‑‑ 0.70
West South Central ‑‑ 0.43 ‑‑ 1.00 ‑‑ 0.46 ‑‑ 0.82 ‑‑ 0.52
West ‑‑ 0.55 ‑‑ 0.52 ‑‑ 0.60 ‑‑ 1.08 ‑‑ 0.66
Mountain ‑‑ 0.84 ‑‑ 0.70 ‑‑ 0.93 ‑‑ 1.44 ‑‑ 1.05
Pacific ‑‑ 0.69 ‑‑ 0.69 ‑‑ 0.76 ‑‑ 1.43 ‑‑ 0.83
COUNTY TYPE                    
Large Metro ‑‑ 0.30 ‑‑ 0.44 ‑‑ 0.32 ‑‑ 0.58 ‑‑ 0.35
Small Metro ‑‑ 0.39 ‑‑ 0.42 ‑‑ 0.43 ‑‑ 0.46 ‑‑ 0.49
Nonmetro ‑‑ 0.57 ‑‑ 0.65 ‑‑ 0.62 ‑‑ 0.82 ‑‑ 0.68
Urbanized ‑‑ 1.15 ‑‑ 0.88 ‑‑ 1.25 ‑‑ 0.99 ‑‑ 1.39
Less Urbanized ‑‑ 0.81 ‑‑ 1.22 ‑‑ 0.88 ‑‑ 1.63 ‑‑ 0.98
Completely Rural ‑‑ 0.60 ‑‑ 1.09 ‑‑ 0.65 ‑‑ 0.97 ‑‑ 0.72
POVERTY LEVEL1                    
Less Than 100% ‑‑ 0.49 ‑‑ 0.60 ‑‑ 0.54 ‑‑ 0.78 ‑‑ 0.66
100‑199% ‑‑ 0.53 ‑‑ 0.67 ‑‑ 0.58 ‑‑ 0.62 ‑‑ 0.67
200% or More ‑‑ 0.25 ‑‑ 0.34 ‑‑ 0.28 ‑‑ 0.51 ‑‑ 0.30
HEALTH INSURANCE2                    
Private ‑‑ 0.26 ‑‑ 0.32 ‑‑ 0.28 ‑‑ 0.48 ‑‑ 0.31
Medicaid/CHIP ‑‑ 0.51 ‑‑ 0.52 ‑‑ 0.60 ‑‑ 0.75 ‑‑ 0.71
Other3 ‑‑ 0.47 ‑‑ 0.80 ‑‑ 0.48 ‑‑ 0.95 ‑‑ 0.49
No Coverage ‑‑ 0.64 ‑‑ 1.50 ‑‑ 0.66 ‑‑ 0.65 ‑‑ 0.81

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.86C – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 196 ‑‑ 41 ‑‑ 192 ‑‑ 89 ‑‑ 163
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 97 ‑‑ 10 ‑‑ 97 ‑‑ 39 ‑‑ 78
New England ‑‑ 53 ‑‑ 4 ‑‑ 53 ‑‑ 11 ‑‑ 49
Middle Atlantic ‑‑ 81 ‑‑ 9 ‑‑ 81 ‑‑ 37 ‑‑ 60
Midwest ‑‑ 76 ‑‑ 15 ‑‑ 74 ‑‑ 35 ‑‑ 65
East North Central ‑‑ 52 ‑‑ 12 ‑‑ 51 ‑‑ 34 ‑‑ 38
West North Central ‑‑ 54 ‑‑ 10 ‑‑ 54 ‑‑ 8 ‑‑ 53
South ‑‑ 98 ‑‑ 28 ‑‑ 92 ‑‑ 32 ‑‑ 87
South Atlantic ‑‑ 72 ‑‑ 17 ‑‑ 71 ‑‑ 15 ‑‑ 69
East South Central ‑‑ 25 ‑‑ 7 ‑‑ 24 ‑‑ 4 ‑‑ 23
West South Central ‑‑ 60 ‑‑ 21 ‑‑ 54 ‑‑ 27 ‑‑ 47
West ‑‑ 118 ‑‑ 23 ‑‑ 115 ‑‑ 62 ‑‑ 94
Mountain ‑‑ 84 ‑‑ 10 ‑‑ 83 ‑‑ 15 ‑‑ 82
Pacific ‑‑ 83 ‑‑ 21 ‑‑ 79 ‑‑ 60 ‑‑ 47
COUNTY TYPE                    
Large Metro ‑‑ 177 ‑‑ 33 ‑‑ 173 ‑‑ 80 ‑‑ 145
Small Metro ‑‑ 84 ‑‑ 20 ‑‑ 82 ‑‑ 28 ‑‑ 76
Nonmetro ‑‑ 30 ‑‑ 12 ‑‑ 28 ‑‑ 14 ‑‑ 24
Urbanized ‑‑ 17 ‑‑ 7 ‑‑ 15 ‑‑ 13 ‑‑ 8
Less Urbanized ‑‑ 24 ‑‑ 8 ‑‑ 22 ‑‑ 4 ‑‑ 22
Completely Rural ‑‑ 7 ‑‑ 6 ‑‑ 2 ‑‑ 2 ‑‑ 2
POVERTY LEVEL1                    
Less Than 100% ‑‑ 78 ‑‑ 19 ‑‑ 77 ‑‑ 52 ‑‑ 56
100‑199% ‑‑ 100 ‑‑ 27 ‑‑ 97 ‑‑ 37 ‑‑ 89
200% or More ‑‑ 134 ‑‑ 24 ‑‑ 132 ‑‑ 51 ‑‑ 120
HEALTH INSURANCE2                    
Private ‑‑ 136 ‑‑ 23 ‑‑ 134 ‑‑ 63 ‑‑ 111
Medicaid/CHIP ‑‑ 113 ‑‑ 32 ‑‑ 109 ‑‑ 44 ‑‑ 99
Other3 ‑‑ 79 ‑‑ 6 ‑‑ 78 ‑‑ 16 ‑‑ 77
No Coverage ‑‑ 48 ‑‑ 7 ‑‑ 48 ‑‑ 12 ‑‑ 46

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.86D – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.07 ‑‑ 0.16 ‑‑ 0.07 ‑‑ 0.24 ‑‑ 0.07
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 0.19 ‑‑ 0.24 ‑‑ 0.21 ‑‑ 0.64 ‑‑ 0.19
New England ‑‑ 0.40 ‑‑ 0.42 ‑‑ 0.43 ‑‑ 0.68 ‑‑ 0.46
Middle Atlantic ‑‑ 0.22 ‑‑ 0.29 ‑‑ 0.24 ‑‑ 0.84 ‑‑ 0.21
Midwest ‑‑ 0.13 ‑‑ 0.28 ‑‑ 0.13 ‑‑ 0.45 ‑‑ 0.14
East North Central ‑‑ 0.13 ‑‑ 0.33 ‑‑ 0.14 ‑‑ 0.64 ‑‑ 0.12
West North Central ‑‑ 0.29 ‑‑ 0.53 ‑‑ 0.32 ‑‑ 0.34 ‑‑ 0.37
South ‑‑ 0.09 ‑‑ 0.28 ‑‑ 0.09 ‑‑ 0.22 ‑‑ 0.10
South Atlantic ‑‑ 0.12 ‑‑ 0.34 ‑‑ 0.13 ‑‑ 0.21 ‑‑ 0.14
East South Central ‑‑ 0.15 ‑‑ 0.44 ‑‑ 0.16 ‑‑ 0.21 ‑‑ 0.18
West South Central ‑‑ 0.16 ‑‑ 0.60 ‑‑ 0.16 ‑‑ 0.57 ‑‑ 0.16
West ‑‑ 0.17 ‑‑ 0.38 ‑‑ 0.18 ‑‑ 0.70 ‑‑ 0.17
Mountain ‑‑ 0.37 ‑‑ 0.46 ‑‑ 0.40 ‑‑ 0.49 ‑‑ 0.46
Pacific ‑‑ 0.17 ‑‑ 0.52 ‑‑ 0.18 ‑‑ 1.03 ‑‑ 0.13
COUNTY TYPE                    
Large Metro ‑‑ 0.11 ‑‑ 0.23 ‑‑ 0.11 ‑‑ 0.38 ‑‑ 0.11
Small Metro ‑‑ 0.09 ‑‑ 0.25 ‑‑ 0.10 ‑‑ 0.24 ‑‑ 0.11
Nonmetro ‑‑ 0.09 ‑‑ 0.44 ‑‑ 0.09 ‑‑ 0.37 ‑‑ 0.09
Urbanized ‑‑ 0.13 ‑‑ 0.67 ‑‑ 0.14 ‑‑ 0.90 ‑‑ 0.08
Less Urbanized ‑‑ 0.17 ‑‑ 0.70 ‑‑ 0.18 ‑‑ 0.28 ‑‑ 0.20
Completely Rural ‑‑ 0.08 ‑‑ 1.03 ‑‑ 0.03 ‑‑ 0.22 ‑‑ 0.03
POVERTY LEVEL1                    
Less Than 100% ‑‑ 0.16 ‑‑ 0.34 ‑‑ 0.18 ‑‑ 0.52 ‑‑ 0.17
100‑199% ‑‑ 0.16 ‑‑ 0.46 ‑‑ 0.17 ‑‑ 0.43 ‑‑ 0.19
200% or More ‑‑ 0.07 ‑‑ 0.17 ‑‑ 0.08 ‑‑ 0.29 ‑‑ 0.08
HEALTH INSURANCE2                    
Private ‑‑ 0.08 ‑‑ 0.17 ‑‑ 0.08 ‑‑ 0.30 ‑‑ 0.08
Medicaid/CHIP ‑‑ 0.18 ‑‑ 0.30 ‑‑ 0.21 ‑‑ 0.46 ‑‑ 0.24
Other3 ‑‑ 0.09 ‑‑ 0.40 ‑‑ 0.10 ‑‑ 0.59 ‑‑ 0.10
No Coverage ‑‑ 0.19 ‑‑ 0.65 ‑‑ 0.20 ‑‑ 0.23 ‑‑ 0.24

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.87C – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 124 ‑‑ 26 ‑‑ 121 ‑‑ 39 ‑‑ 114
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 47 ‑‑ 8 ‑‑ 47 ‑‑ 22 ‑‑ 41
New England ‑‑ 35 ‑‑ 1 ‑‑ 35 ‑‑ 3 ‑‑ 35
Middle Atlantic ‑‑ 32 ‑‑ 8 ‑‑ 31 ‑‑ 22 ‑‑ 22
Midwest ‑‑ 60 ‑‑ 7 ‑‑ 59 ‑‑ 18 ‑‑ 57
East North Central ‑‑ 28 ‑‑ 5 ‑‑ 27 ‑‑ 18 ‑‑ 21
West North Central ‑‑ 53 ‑‑ 5 ‑‑ 53 ‑‑ 3 ‑‑ 53
South ‑‑ 69 ‑‑ 21 ‑‑ 65 ‑‑ 6 ‑‑ 65
South Atlantic ‑‑ 51 ‑‑ 11 ‑‑ 50 ‑‑ 6 ‑‑ 50
East South Central ‑‑ 22 ‑‑ 2 ‑‑ 22 ‑‑ 2 ‑‑ 22
West South Central ‑‑ 40 ‑‑ 18 ‑‑ 35 ‑‑ 1 ‑‑ 35
West ‑‑ 71 ‑‑ 11 ‑‑ 70 ‑‑ 27 ‑‑ 64
Mountain ‑‑ 57 ‑‑ 4 ‑‑ 56 ‑‑ 12 ‑‑ 55
Pacific ‑‑ 42 ‑‑ 10 ‑‑ 41 ‑‑ 24 ‑‑ 33
COUNTY TYPE                    
Large Metro ‑‑ 104 ‑‑ 24 ‑‑ 102 ‑‑ 37 ‑‑ 94
Small Metro ‑‑ 64 ‑‑ 6 ‑‑ 64 ‑‑ 14 ‑‑ 62
Nonmetro ‑‑ 22 ‑‑ 8 ‑‑ 21 ‑‑ 2 ‑‑ 21
Urbanized ‑‑ 3 ‑‑ 2 ‑‑ 2 ‑‑ 1 ‑‑ 1
Less Urbanized ‑‑ 21 ‑‑ 4 ‑‑ 21 ‑‑ 1 ‑‑ 21
Completely Rural ‑‑ 6 ‑‑ 6 ‑‑ <1 ‑‑ * ‑‑ <1
POVERTY LEVEL1                    
Less Than 100% ‑‑ 40 ‑‑ 8 ‑‑ 39 ‑‑ 26 ‑‑ 29
100‑199% ‑‑ 66 ‑‑ 24 ‑‑ 62 ‑‑ 6 ‑‑ 62
200% or More ‑‑ 96 ‑‑ 9 ‑‑ 95 ‑‑ 29 ‑‑ 90
HEALTH INSURANCE2                    
Private ‑‑ 70 ‑‑ 7 ‑‑ 69 ‑‑ 34 ‑‑ 59
Medicaid/CHIP ‑‑ 89 ‑‑ 24 ‑‑ 86 ‑‑ 9 ‑‑ 85
Other3 ‑‑ 71 ‑‑ * ‑‑ 71 ‑‑ 13 ‑‑ 70
No Coverage ‑‑ 35 ‑‑ 7 ‑‑ 34 ‑‑ 8 ‑‑ 33

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.87D – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.04 ‑‑ 0.10 ‑‑ 0.05 ‑‑ 0.11 ‑‑ 0.05
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 0.09 ‑‑ 0.21 ‑‑ 0.10 ‑‑ 0.36 ‑‑ 0.10
New England ‑‑ 0.26 ‑‑ 0.14 ‑‑ 0.28 ‑‑ 0.21 ‑‑ 0.32
Middle Atlantic ‑‑ 0.09 ‑‑ 0.27 ‑‑ 0.09 ‑‑ 0.49 ‑‑ 0.08
Midwest ‑‑ 0.10 ‑‑ 0.14 ‑‑ 0.11 ‑‑ 0.24 ‑‑ 0.12
East North Central ‑‑ 0.07 ‑‑ 0.14 ‑‑ 0.07 ‑‑ 0.35 ‑‑ 0.06
West North Central ‑‑ 0.28 ‑‑ 0.30 ‑‑ 0.31 ‑‑ 0.12 ‑‑ 0.36
South ‑‑ 0.06 ‑‑ 0.21 ‑‑ 0.06 ‑‑ 0.04 ‑‑ 0.07
South Atlantic ‑‑ 0.09 ‑‑ 0.21 ‑‑ 0.09 ‑‑ 0.08 ‑‑ 0.10
East South Central ‑‑ 0.13 ‑‑ 0.11 ‑‑ 0.15 ‑‑ 0.07 ‑‑ 0.17
West South Central ‑‑ 0.11 ‑‑ 0.52 ‑‑ 0.10 ‑‑ 0.01 ‑‑ 0.12
West ‑‑ 0.10 ‑‑ 0.18 ‑‑ 0.11 ‑‑ 0.31 ‑‑ 0.12
Mountain ‑‑ 0.25 ‑‑ 0.20 ‑‑ 0.28 ‑‑ 0.40 ‑‑ 0.32
Pacific ‑‑ 0.09 ‑‑ 0.24 ‑‑ 0.10 ‑‑ 0.42 ‑‑ 0.09
COUNTY TYPE                    
Large Metro ‑‑ 0.06 ‑‑ 0.17 ‑‑ 0.07 ‑‑ 0.18 ‑‑ 0.07
Small Metro ‑‑ 0.07 ‑‑ 0.07 ‑‑ 0.08 ‑‑ 0.12 ‑‑ 0.09
Nonmetro ‑‑ 0.07 ‑‑ 0.28 ‑‑ 0.07 ‑‑ 0.04 ‑‑ 0.08
Urbanized ‑‑ 0.02 ‑‑ 0.21 ‑‑ 0.02 ‑‑ 0.09 ‑‑ 0.01
Less Urbanized ‑‑ 0.16 ‑‑ 0.34 ‑‑ 0.17 ‑‑ 0.08 ‑‑ 0.19
Completely Rural ‑‑ 0.08 ‑‑ 1.02 ‑‑ <0.01 ‑‑ * ‑‑ <0.01
POVERTY LEVEL1                    
Less Than 100% ‑‑ 0.08 ‑‑ 0.13 ‑‑ 0.09 ‑‑ 0.26 ‑‑ 0.09
100‑199% ‑‑ 0.11 ‑‑ 0.41 ‑‑ 0.11 ‑‑ 0.08 ‑‑ 0.13
200% or More ‑‑ 0.05 ‑‑ 0.06 ‑‑ 0.06 ‑‑ 0.16 ‑‑ 0.06
HEALTH INSURANCE2                    
Private ‑‑ 0.04 ‑‑ 0.05 ‑‑ 0.04 ‑‑ 0.16 ‑‑ 0.04
Medicaid/CHIP ‑‑ 0.14 ‑‑ 0.23 ‑‑ 0.17 ‑‑ 0.10 ‑‑ 0.21
Other3 ‑‑ 0.09 ‑‑ * ‑‑ 0.09 ‑‑ 0.48 ‑‑ 0.09
No Coverage ‑‑ 0.14 ‑‑ 0.64 ‑‑ 0.14 ‑‑ 0.17 ‑‑ 0.17

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.88C – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 556 581 28 23 556 580 51 57 551 570
GEOGRAPHIC DIVISION                    
Northeast 200 234 22 * 199 233 10 22 199 232
New England 79 54 * <1 76 54 1 3 76 54
Middle Atlantic 183 228 4 * 183 227 10 22 184 226
Midwest 224 226 3 4 224 226 30 24 218 222
East North Central 159 163 3 2 159 163 26 18 154 160
West North Central 145 152 2 4 144 152 16 15 140 149
South 330 336 14 12 330 335 31 42 327 330
South Atlantic 233 234 11 12 234 232 22 29 232 226
East South Central 98 122 1 * 98 122 8 16 96 122
West South Central 204 202 8 * 204 202 20 25 203 200
West 343 365 9 10 342 365 25 18 341 360
Mountain 140 209 3 <1 140 209 22 8 137 208
Pacific 311 305 8 10 310 305 12 16 310 300
COUNTY TYPE                    
Large Metro 422 431 25 12 422 430 31 44 420 423
Small Metro 307 359 11 19 307 359 32 31 305 353
Nonmetro 225 211 4 1 225 211 26 15 217 208
Urbanized 136 130 3 * 136 130 11 10 133 126
Less Urbanized 140 151 3 1 140 151 20 11 131 150
Completely Rural 116 71 <1 <1 116 71 12 4 114 71
POVERTY LEVEL1                    
Less Than 100% 249 265 11 4 248 265 27 39 245 261
100‑199% 215 324 8 9 215 324 29 19 212 322
200% or More 419 372 24 20 419 371 30 34 419 368
HEALTH INSURANCE2                    
Private 378 354 25 20 379 351 30 41 377 348
Medicaid/CHIP 293 352 11 11 292 352 34 33 287 346
Other3 291 328 * * 290 328 2 5 291 328
No Coverage 128 186 * 2 126 186 22 16 125 185

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.88D – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.18 0.18 0.11 0.09 0.20 0.20 0.15 0.16 0.23 0.23
GEOGRAPHIC DIVISION                    
Northeast 0.39 0.43 0.54 * 0.42 0.46 0.17 0.37 0.48 0.53
New England 0.55 0.40 * 0.02 0.58 0.44 0.06 0.16 0.66 0.51
Middle Atlantic 0.49 0.57 0.13 * 0.53 0.61 0.24 0.50 0.60 0.70
Midwest 0.34 0.35 0.06 0.08 0.38 0.38 0.41 0.32 0.43 0.44
East North Central 0.36 0.38 0.07 0.04 0.39 0.41 0.52 0.36 0.45 0.48
West North Central 0.69 0.71 0.09 0.21 0.77 0.78 0.69 0.63 0.88 0.88
South 0.28 0.28 0.13 0.12 0.31 0.30 0.23 0.29 0.35 0.35
South Atlantic 0.38 0.37 0.22 0.24 0.42 0.40 0.31 0.40 0.47 0.45
East South Central 0.57 0.66 0.09 * 0.63 0.74 0.41 0.73 0.72 0.87
West South Central 0.54 0.53 0.21 * 0.59 0.58 0.42 0.50 0.68 0.67
West 0.47 0.47 0.14 0.17 0.52 0.52 0.30 0.21 0.59 0.59
Mountain 0.61 0.83 0.14 0.01 0.67 0.91 0.76 0.27 0.78 1.04
Pacific 0.63 0.57 0.20 0.26 0.69 0.62 0.23 0.29 0.78 0.71
COUNTY TYPE                    
Large Metro 0.24 0.24 0.16 0.08 0.26 0.26 0.16 0.21 0.30 0.29
Small Metro 0.32 0.35 0.13 0.23 0.35 0.38 0.27 0.26 0.40 0.44
Nonmetro 0.57 0.56 0.15 0.05 0.62 0.61 0.60 0.39 0.71 0.69
Urbanized 0.80 0.97 0.26 * 0.88 1.05 0.56 0.66 1.05 1.17
Less Urbanized 1.03 0.94 0.32 0.12 1.11 1.03 1.36 0.70 1.21 1.17
Completely Rural 1.04 0.75 0.03 0.01 1.14 0.81 1.25 0.52 1.28 0.92
POVERTY LEVEL1                    
Less Than 100% 0.50 0.50 0.19 0.06 0.57 0.57 0.32 0.39 0.70 0.71
100‑199% 0.36 0.49 0.15 0.16 0.40 0.54 0.34 0.23 0.47 0.63
200% or More 0.22 0.20 0.16 0.14 0.24 0.21 0.17 0.19 0.26 0.24
HEALTH INSURANCE2                    
Private 0.20 0.20 0.17 0.14 0.22 0.21 0.15 0.20 0.25 0.24
Medicaid/CHIP 0.47 0.52 0.10 0.11 0.56 0.62 0.38 0.34 0.68 0.75
Other3 0.36 0.38 * * 0.37 0.39 0.06 0.19 0.38 0.40
No Coverage 0.51 0.69 * 0.14 0.53 0.72 0.43 0.32 0.65 0.90

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.88P – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.8570   0.3525   0.8510   0.8906   0.9027  
GEOGRAPHIC DIVISION                    
Northeast 0.6030   *   0.5803   0.6798   0.5946  
New England 0.9453   *   0.7573   0.1145   0.7962  
Middle Atlantic 0.6002   *   0.6321   0.8207   0.6352  
Midwest 0.8397   0.9870   0.8590   0.5384   0.7772  
East North Central 0.5494   0.3740   0.5532   0.4258   0.4637  
West North Central 0.7062   0.4858   0.6839   0.9463   0.6846  
South 0.3363   0.1522   0.3478   0.6942   0.3349  
South Atlantic 0.8740   0.4826   0.8895   0.9381   0.8958  
East South Central 0.1171   *   0.1190   0.4555   0.1044  
West South Central 0.5892   *   0.6007   0.8935   0.5998  
West 0.8441   0.7381   0.8736   0.5893   0.8129  
Mountain 0.4550   0.1795   0.4501   0.1471   0.3434  
Pacific 0.8338   0.5258   0.7958   0.4176   0.7797  
COUNTY TYPE                    
Large Metro 0.7681   0.1643   0.7853   0.3458   0.7977  
Small Metro 0.4862   0.6316   0.5099   0.8305   0.5132  
Nonmetro 0.2822   0.1745   0.2849   0.1537   0.3088  
Urbanized 0.6101   *   0.5836   0.5730   0.7347  
Less Urbanized 0.6457   0.4471   0.6493   0.1381   0.7853  
Completely Rural 0.0033   0.4447   0.0028   0.0458   0.0057  
POVERTY LEVEL1                    
Less Than 100% 0.8570   0.0752   0.8761   0.7770   0.8704  
100‑199% 0.0005   0.7337   0.0005   0.2787   0.0005  
200% or More 0.0056   0.7926   0.0050   0.4618   0.0040  
HEALTH INSURANCE2                    
Private 0.0276   0.4405   0.0284   0.3088   0.0272  
Medicaid/CHIP 0.1575   0.7719   0.1759   0.2186   0.1305  
Other3 0.9322   *   0.9166   0.0517   0.9580  
No Coverage 0.0464   *   0.0456   0.4997   0.0363  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.89C – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 186 236 24 16 183 236 29 36 180 234
GEOGRAPHIC DIVISION                    
Northeast 71 49 22 <1 67 49 6 2 66 49
New England 33 34 * <1 24 34 1 1 24 34
Middle Atlantic 63 36 4 * 63 36 6 2 61 36
Midwest 72 108 3 3 72 108 13 13 72 107
East North Central 54 45 3 1 54 45 9 11 54 43
West North Central 49 91 <1 3 49 91 10 7 48 90
South 137 153 5 12 136 152 21 31 134 150
South Atlantic 102 97 4 12 101 97 17 25 100 95
East South Central 43 88 1 * 43 88 2 2 43 88
West South Central 79 78 3 * 79 78 13 18 77 76
West 95 134 9 10 94 133 13 13 93 133
Mountain 40 83 3 <1 40 83 12 6 38 83
Pacific 84 104 8 10 84 104 5 11 83 103
COUNTY TYPE                    
Large Metro 153 147 24 12 151 147 17 26 150 144
Small Metro 73 142 4 11 73 142 19 24 69 142
Nonmetro 96 108 4 <1 96 108 13 7 95 107
Urbanized 41 43 3 * 41 43 4 6 40 43
Less Urbanized 40 95 3 <1 39 95 12 3 36 95
Completely Rural 77 23 * * 77 23 3 2 77 23
POVERTY LEVEL1                    
Less Than 100% 130 126 9 3 130 126 16 25 128 123
100‑199% 88 151 4 9 88 150 18 8 86 150
200% or More 112 113 22 13 110 112 16 25 109 109
HEALTH INSURANCE2                    
Private 97 93 23 12 94 93 16 24 93 90
Medicaid/CHIP 126 154 9 11 126 153 21 26 124 153
Other3 68 111 <1 * 68 111 1 2 68 111
No Coverage 62 109 * * 62 109 11 5 60 109

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.89D – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.06 0.08 0.09 0.06 0.07 0.09 0.08 0.10 0.08 0.10
GEOGRAPHIC DIVISION                    
Northeast 0.14 0.10 0.54 <0.01 0.15 0.10 0.10 0.04 0.17 0.12
New England 0.24 0.25 * 0.02 0.20 0.27 0.03 0.08 0.23 0.31
Middle Atlantic 0.17 0.10 0.13 * 0.19 0.10 0.14 0.05 0.21 0.12
Midwest 0.12 0.18 0.05 0.06 0.13 0.20 0.18 0.17 0.15 0.23
East North Central 0.13 0.11 0.07 0.02 0.14 0.12 0.18 0.21 0.17 0.13
West North Central 0.26 0.48 0.01 0.19 0.29 0.53 0.42 0.28 0.34 0.61
South 0.12 0.13 0.05 0.12 0.13 0.14 0.16 0.22 0.15 0.17
South Atlantic 0.17 0.16 0.08 0.23 0.19 0.17 0.25 0.35 0.21 0.20
East South Central 0.26 0.50 0.08 * 0.28 0.55 0.11 0.08 0.33 0.64
West South Central 0.22 0.21 0.07 * 0.24 0.23 0.27 0.36 0.28 0.26
West 0.14 0.20 0.14 0.17 0.15 0.22 0.15 0.15 0.17 0.25
Mountain 0.18 0.36 0.14 0.01 0.20 0.40 0.40 0.20 0.23 0.46
Pacific 0.18 0.23 0.20 0.26 0.20 0.25 0.09 0.20 0.23 0.29
COUNTY TYPE                    
Large Metro 0.09 0.09 0.16 0.08 0.10 0.09 0.09 0.12 0.11 0.11
Small Metro 0.08 0.15 0.05 0.13 0.09 0.17 0.17 0.20 0.10 0.20
Nonmetro 0.28 0.31 0.15 0.01 0.30 0.34 0.29 0.19 0.35 0.39
Urbanized 0.30 0.35 0.26 * 0.33 0.38 0.18 0.44 0.38 0.43
Less Urbanized 0.32 0.67 0.31 0.01 0.34 0.73 0.81 0.18 0.37 0.84
Completely Rural 0.86 0.28 * * 0.94 0.31 0.34 0.23 1.07 0.34
POVERTY LEVEL1                    
Less Than 100% 0.27 0.25 0.16 0.06 0.31 0.28 0.19 0.25 0.38 0.36
100‑199% 0.16 0.24 0.08 0.16 0.17 0.27 0.21 0.09 0.20 0.32
200% or More 0.06 0.06 0.15 0.09 0.06 0.07 0.09 0.14 0.07 0.07
HEALTH INSURANCE2                    
Private 0.06 0.05 0.15 0.09 0.06 0.06 0.08 0.12 0.07 0.07
Medicaid/CHIP 0.21 0.24 0.09 0.10 0.25 0.29 0.24 0.27 0.30 0.36
Other3 0.09 0.13 0.01 * 0.09 0.14 0.02 0.08 0.09 0.14
No Coverage 0.24 0.43 * * 0.26 0.45 0.22 0.10 0.32 0.56

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.89P – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4002   0.4159   0.3636   0.6413   0.3150  
GEOGRAPHIC DIVISION                    
Northeast 0.1311   0.2186   0.2156   0.3425   0.2430  
New England 0.9800   *   0.6210   0.2548   0.6518  
Middle Atlantic 0.0756   *   0.0879   0.2158   0.1075  
Midwest 0.8369   0.8590   0.8385   0.5053   0.7598  
East North Central 0.9851   0.1531   0.9761   0.6999   0.9120  
West North Central 0.7881   0.3619   0.8146   0.5632   0.7574  
South 0.7417   0.9699   0.7491   1.0000   0.7389  
South Atlantic 0.4017   0.7519   0.4195   0.7917   0.4455  
East South Central 0.8919   *   0.8969   0.7609   0.9112  
West South Central 0.7259   *   0.7395   0.7439   0.7912  
West 0.0826   0.7381   0.0881   0.8738   0.0806  
Mountain 0.0928   0.1795   0.0853   0.4158   0.0624  
Pacific 0.3259   0.5258   0.3587   0.5246   0.3814  
COUNTY TYPE                    
Large Metro 0.9546   0.3356   0.8705   0.5362   0.9141  
Small Metro 0.0435   0.4966   0.0493   0.4987   0.0346  
Nonmetro 0.5645   0.1173   0.5916   0.2318   0.6531  
Urbanized 0.4020   *   0.3653   0.4172   0.4504  
Less Urbanized 0.6306   0.3331   0.6078   0.0375   0.4300  
Completely Rural 0.0139   *   0.0135   0.9143   0.0141  
POVERTY LEVEL1                    
Less Than 100% 0.4640   0.2104   0.4941   0.5215   0.6497  
100‑199% 0.0876   0.9155   0.0891   0.0775   0.0599  
200% or More 0.9053   0.6176   0.8484   0.3171   0.9955  
HEALTH INSURANCE2                    
Private 0.4751   0.4041   0.3771   0.3757   0.4755  
Medicaid/CHIP 0.6793   0.9124   0.6435   0.3133   0.7664  
Other3 0.0246   *   0.0246   0.2290   0.0264  
No Coverage 0.2748   *   0.2793   0.2490   0.2314  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.90C – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 151 183 22 12 150 183 20 25 148 181
GEOGRAPHIC DIVISION                    
Northeast 56 40 22 * 51 40 3 2 50 40
New England 33 33 * * 24 33 <1 1 24 33
Middle Atlantic 45 23 3 * 45 23 3 2 44 23
Midwest 64 82 3 3 64 82 11 7 63 82
East North Central 46 33 3 1 46 33 6 7 46 33
West North Central 44 73 <1 3 44 73 9 2 43 73
South 97 98 3 12 96 97 15 21 95 95
South Atlantic 78 66 2 12 78 65 9 11 77 64
East South Central 26 27 1 * 26 27 1 1 26 27
West South Central 50 66 * * 50 66 12 18 48 63
West 69 122 1 * 69 122 4 11 69 121
Mountain 32 69 1 * 32 69 3 6 32 69
Pacific 61 100 <1 * 61 100 3 9 61 100
COUNTY TYPE                    
Large Metro 118 124 22 12 116 124 6 23 115 122
Small Metro 51 111 3 3 51 111 16 7 48 111
Nonmetro 71 67 3 * 71 67 10 3 70 66
Urbanized 38 42 3 * 38 42 3 2 37 42
Less Urbanized 34 44 * * 34 44 9 2 32 44
Completely Rural 50 21 * * 50 21 <1 * 50 21
POVERTY LEVEL1                    
Less Than 100% 101 93 4 3 101 93 8 10 99 93
100‑199% 48 118 1 1 48 118 14 4 46 118
200% or More 92 97 22 12 90 96 11 22 89 93
HEALTH INSURANCE2                    
Private 53 78 22 12 49 77 12 22 47 74
Medicaid/CHIP 116 131 4 3 116 131 12 11 115 131
Other3 45 96 <1 * 45 96 1 2 45 96
No Coverage 52 64 * * 52 64 9 4 51 63

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.90D – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.06 0.09 0.05 0.06 0.07 0.06 0.07 0.06 0.08
GEOGRAPHIC DIVISION                    
Northeast 0.11 0.08 0.53 * 0.11 0.08 0.05 0.03 0.13 0.10
New England 0.24 0.24 * * 0.20 0.26 0.03 0.04 0.23 0.30
Middle Atlantic 0.12 0.06 0.09 * 0.14 0.07 0.07 0.04 0.15 0.08
Midwest 0.11 0.14 0.05 0.06 0.12 0.15 0.15 0.09 0.13 0.17
East North Central 0.11 0.08 0.07 0.02 0.12 0.09 0.13 0.13 0.14 0.10
West North Central 0.24 0.39 0.01 0.19 0.26 0.43 0.37 0.08 0.30 0.50
South 0.09 0.09 0.03 0.12 0.10 0.09 0.11 0.15 0.11 0.11
South Atlantic 0.13 0.11 0.05 0.23 0.14 0.12 0.13 0.16 0.16 0.13
East South Central 0.16 0.16 0.08 * 0.17 0.18 0.04 0.07 0.20 0.20
West South Central 0.14 0.18 * * 0.16 0.20 0.26 0.36 0.18 0.23
West 0.10 0.18 0.02 * 0.11 0.20 0.05 0.13 0.13 0.23
Mountain 0.14 0.31 0.06 * 0.16 0.34 0.12 0.20 0.18 0.39
Pacific 0.13 0.22 <0.01 * 0.15 0.24 0.05 0.17 0.17 0.28
COUNTY TYPE                    
Large Metro 0.07 0.07 0.14 0.08 0.08 0.08 0.03 0.11 0.09 0.09
Small Metro 0.06 0.12 0.04 0.04 0.06 0.13 0.13 0.06 0.07 0.16
Nonmetro 0.21 0.20 0.10 * 0.23 0.21 0.23 0.08 0.26 0.24
Urbanized 0.28 0.34 0.26 * 0.31 0.37 0.14 0.11 0.35 0.42
Less Urbanized 0.28 0.32 * * 0.31 0.35 0.66 0.16 0.33 0.40
Completely Rural 0.57 0.27 * * 0.63 0.29 0.05 * 0.71 0.33
POVERTY LEVEL1                    
Less Than 100% 0.21 0.19 0.06 0.06 0.24 0.21 0.09 0.11 0.30 0.27
100‑199% 0.09 0.19 0.02 0.01 0.10 0.21 0.16 0.05 0.11 0.25
200% or More 0.05 0.05 0.15 0.08 0.05 0.06 0.06 0.12 0.06 0.06
HEALTH INSURANCE2                    
Private 0.03 0.05 0.15 0.08 0.03 0.05 0.06 0.11 0.03 0.05
Medicaid/CHIP 0.19 0.21 0.04 0.03 0.24 0.25 0.14 0.12 0.29 0.31
Other3 0.06 0.12 0.01 * 0.06 0.12 0.02 0.08 0.06 0.12
No Coverage 0.21 0.25 * * 0.22 0.26 0.18 0.08 0.27 0.33

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.90P – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1723   0.4492   0.1503   0.9194   0.1461  
GEOGRAPHIC DIVISION                    
Northeast 0.1966   *   0.3229   0.5041   0.3379  
New England 0.8268   *   0.7708   0.5031   0.7824  
Middle Atlantic 0.1241   *   0.1361   0.3971   0.1448  
Midwest 0.7825   0.9930   0.7779   0.3337   0.8738  
East North Central 0.3731   0.2096   0.4027   0.6851   0.4364  
West North Central 0.7967   0.3327   0.8290   0.3328   0.7454  
South 0.5759   0.5933   0.6148   0.8461   0.6295  
South Atlantic 0.4672   0.5234   0.5149   0.6511   0.5500  
East South Central 0.3211   *   0.3336   0.6156   0.3282  
West South Central 0.6316   *   0.6388   0.9150   0.6048  
West 0.0101   *   0.0102   0.2676   0.0125  
Mountain 0.1130   *   0.1091   0.4460   0.1208  
Pacific 0.0402   *   0.0414   0.4135   0.0470  
COUNTY TYPE                    
Large Metro 0.2984   0.6281   0.2673   0.0873   0.3622  
Small Metro 0.0772   0.3930   0.0725   0.1857   0.0458  
Nonmetro 0.4769   *   0.4927   0.1853   0.5555  
Urbanized 0.4020   *   0.3703   0.9052   0.3895  
Less Urbanized 0.6701   *   0.6677   0.1642   0.8591  
Completely Rural 0.0721   *   0.0710   *   0.0730  
POVERTY LEVEL1                    
Less Than 100% 0.5882   0.5627   0.5922   0.5837   0.7124  
100‑199% 0.0116   0.4898   0.0115   0.1358   0.0070  
200% or More 0.7543   0.5488   0.6721   0.2104   0.8491  
HEALTH INSURANCE2                    
Private 0.0728   0.5765   0.0452   0.2498   0.0775  
Medicaid/CHIP 0.9866   0.3406   0.9885   0.3149   0.9149  
Other3 0.0282   *   0.0281   0.3495   0.0298  
No Coverage 0.6018   *   0.6084   0.4225   0.5429  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.91C – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,236 1,300 120 126 1,215 1,271 183 197 1,158 1,246
GEOGRAPHIC DIVISION                    
Northeast 483 520 51 60 472 511 66 80 454 507
New England 205 207 30 20 196 202 26 36 192 198
Middle Atlantic 441 473 42 54 432 463 60 71 414 461
Midwest 484 522 47 50 474 510 75 91 454 492
East North Central 423 450 42 43 415 439 63 75 400 418
West North Central 245 274 22 26 238 267 39 53 229 264
South 845 834 80 85 831 816 125 120 792 798
South Atlantic 654 621 52 67 646 603 91 88 620 589
East South Central 248 276 26 21 244 273 32 33 243 271
West South Central 434 466 55 47 421 460 77 76 395 446
West 583 638 63 54 576 628 85 94 550 609
Mountain 331 289 34 34 324 282 51 70 310 281
Pacific 488 569 52 42 484 561 68 62 461 540
COUNTY TYPE                    
Large Metro 943 1,010 95 105 928 984 128 146 899 965
Small Metro 724 727 67 69 709 713 113 114 668 696
Nonmetro 447 471 55 35 435 460 63 56 404 443
Urbanized 301 260 48 18 288 255 42 33 269 243
Less Urbanized 282 285 21 25 274 274 36 38 257 263
Completely Rural 230 299 18 16 226 295 32 22 210 287
POVERTY LEVEL1                    
Less Than 100% 456 509 53 54 449 500 81 105 431 480
100‑199% 496 565 50 59 489 560 85 91 476 553
200% or More 920 999 94 95 905 977 116 123 881 959
HEALTH INSURANCE2                    
Private 862 922 90 86 849 904 132 142 824 890
Medicaid/CHIP 520 605 82 80 506 588 93 107 489 571
Other3 708 781 24 35 707 781 47 57 704 781
No Coverage 234 245 22 23 232 244 54 56 225 240

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.91D – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.32 0.35 0.42 0.44 0.34 0.38 0.44 0.45 0.39 0.43
GEOGRAPHIC DIVISION                    
Northeast 0.74 0.80 1.08 1.31 0.80 0.87 1.00 1.03 0.89 1.02
New England 1.25 1.19 2.67 1.81 1.30 1.31 1.56 1.76 1.45 1.54
Middle Atlantic 0.89 0.99 1.15 1.59 0.98 1.07 1.24 1.21 1.08 1.24
Midwest 0.59 0.64 0.81 0.82 0.64 0.68 0.86 0.95 0.72 0.77
East North Central 0.75 0.81 1.06 1.05 0.82 0.86 1.07 1.15 0.92 0.98
West North Central 1.02 0.99 1.17 1.31 1.11 1.07 1.41 1.76 1.25 1.24
South 0.55 0.58 0.69 0.75 0.60 0.63 0.73 0.76 0.68 0.71
South Atlantic 0.80 0.81 0.91 1.12 0.86 0.87 1.03 1.08 0.95 0.98
East South Central 1.31 1.29 1.50 1.33 1.46 1.42 1.38 1.31 1.70 1.63
West South Central 0.89 1.07 1.31 1.25 0.96 1.17 1.29 1.37 1.10 1.32
West 0.63 0.73 0.91 0.81 0.69 0.79 0.90 0.91 0.78 0.90
Mountain 1.04 1.00 1.36 1.53 1.12 1.07 1.44 1.98 1.24 1.26
Pacific 0.79 0.96 1.15 0.94 0.86 1.03 1.12 0.89 0.97 1.16
COUNTY TYPE                    
Large Metro 0.43 0.49 0.57 0.64 0.47 0.53 0.60 0.61 0.53 0.60
Small Metro 0.55 0.57 0.72 0.72 0.60 0.62 0.75 0.79 0.68 0.71
Nonmetro 0.85 0.95 1.52 1.12 0.93 1.01 1.21 1.13 1.01 1.13
Urbanized 1.46 1.49 2.95 1.54 1.62 1.62 1.69 1.54 1.82 1.83
Less Urbanized 1.45 1.31 1.90 1.89 1.55 1.37 1.89 1.97 1.71 1.54
Completely Rural 1.38 2.32 2.24 2.19 1.51 2.53 2.91 2.29 1.70 2.76
POVERTY LEVEL1                    
Less Than 100% 0.77 0.83 0.89 0.90 0.85 0.92 0.84 0.85 1.04 1.17
100‑199% 0.70 0.75 0.89 0.97 0.77 0.83 0.91 0.97 0.90 0.96
200% or More 0.39 0.45 0.57 0.60 0.41 0.48 0.58 0.63 0.45 0.53
HEALTH INSURANCE2                    
Private 0.38 0.45 0.56 0.55 0.41 0.48 0.57 0.58 0.46 0.55
Medicaid/CHIP 0.68 0.73 0.71 0.68 0.81 0.86 0.92 0.96 0.98 1.06
Other3 0.70 0.75 1.66 2.16 0.71 0.76 1.54 1.93 0.74 0.79
No Coverage 0.82 0.87 1.70 1.82 0.85 0.90 1.01 1.05 1.04 1.12

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.91P – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0271   0.0825   0.0357   0.3566   0.0550  
GEOGRAPHIC DIVISION                    
Northeast 0.1454   0.6545   0.1559   0.3931   0.1995  
New England 0.5125   0.1967   0.4003   0.2225   0.2898  
Middle Atlantic 0.0517   0.8352   0.0469   0.7214   0.0518  
Midwest 0.9680   0.7843   0.9658   0.0480   0.7517  
East North Central 0.4836   0.6480   0.5262   0.3999   0.6079  
West North Central 0.2623   0.1769   0.3175   0.0235   0.1387  
South 0.1199   0.3289   0.1320   0.0078   0.2951  
South Atlantic 0.8389   0.4400   0.9231   0.2758   0.7609  
East South Central 0.0615   0.0347   0.0936   0.0959   0.1534  
West South Central 0.0563   0.1546   0.0733   0.0214   0.1651  
West 0.1973   0.0940   0.2547   0.5497   0.2184  
Mountain 0.4291   0.5696   0.4581   0.5936   0.3948  
Pacific 0.2927   0.0905   0.3640   0.7443   0.3407  
COUNTY TYPE                    
Large Metro 0.0122   0.5701   0.0116   0.9377   0.0142  
Small Metro 0.8858   0.1138   0.9820   0.4274   0.8968  
Nonmetro 0.5757   0.1623   0.6816   0.1169   0.7705  
Urbanized 0.9890   0.0709   0.7972   0.7110   0.9689  
Less Urbanized 0.1852   0.8565   0.1746   0.1491   0.2509  
Completely Rural 0.6828   0.7722   0.7131   0.0464   0.4966  
POVERTY LEVEL1                    
Less Than 100% 0.4290   0.4977   0.4493   0.3909   0.7665  
100‑199% 0.1042   0.3780   0.1208   0.8737   0.0728  
200% or More 0.0994   0.1719   0.1148   0.3797   0.1389  
HEALTH INSURANCE2                    
Private 0.0877   0.2793   0.0984   0.5129   0.1504  
Medicaid/CHIP 0.4390   0.0295   0.6159   0.7016   0.6627  
Other3 0.3490   0.9707   0.3470   0.5951   0.3058  
No Coverage 0.8130   0.6772   0.7702   0.3593   0.9342  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.92C – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 321 341 39 49 317 337 84 72 301 327
GEOGRAPHIC DIVISION                    
Northeast 161 173 11 10 161 173 26 27 158 171
New England 116 33 6 3 116 33 9 6 115 34
Middle Atlantic 112 170 9 9 112 169 24 26 107 167
Midwest 123 125 17 17 121 123 25 32 116 117
East North Central 104 108 16 15 102 107 21 20 97 104
West North Central 63 61 7 8 62 61 12 25 60 53
South 203 202 29 41 199 196 66 49 186 191
South Atlantic 138 130 17 29 137 128 44 35 126 122
East South Central 83 89 5 12 82 88 11 17 81 87
West South Central 122 126 23 26 116 120 49 30 109 119
West 146 184 18 19 144 183 35 31 138 178
Mountain 84 91 13 14 83 90 23 15 78 90
Pacific 122 162 13 12 122 160 27 27 117 154
COUNTY TYPE                    
Large Metro 244 250 32 40 241 248 64 57 233 239
Small Metro 173 206 20 24 170 205 43 38 160 201
Nonmetro 119 116 12 13 117 114 31 20 112 110
Urbanized 76 58 7 5 75 58 19 11 72 53
Less Urbanized 73 87 9 11 71 85 13 13 70 84
Completely Rural 57 51 4 6 57 51 19 12 53 50
POVERTY LEVEL1                    
Less Than 100% 207 171 21 25 206 166 34 41 202 159
100‑199% 145 192 21 25 142 191 41 36 136 187
200% or More 204 229 27 31 202 228 55 44 191 223
HEALTH INSURANCE2                    
Private 211 226 26 36 210 224 61 52 199 218
Medicaid/CHIP 212 223 28 32 210 220 43 40 202 213
Other3 147 211 7 4 146 211 25 7 145 211
No Coverage 92 96 11 7 90 96 17 27 88 92

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.92D – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.11 0.11 0.15 0.19 0.12 0.12 0.23 0.20 0.13 0.14
GEOGRAPHIC DIVISION                    
Northeast 0.31 0.34 0.27 0.24 0.34 0.36 0.43 0.43 0.39 0.41
New England 0.84 0.24 0.56 0.29 0.91 0.26 0.53 0.34 1.04 0.32
Middle Atlantic 0.30 0.45 0.31 0.30 0.33 0.48 0.56 0.58 0.36 0.55
Midwest 0.20 0.20 0.32 0.32 0.22 0.22 0.35 0.42 0.25 0.24
East North Central 0.25 0.26 0.43 0.41 0.27 0.28 0.42 0.39 0.30 0.32
West North Central 0.33 0.31 0.40 0.47 0.36 0.35 0.51 1.01 0.41 0.35
South 0.18 0.18 0.28 0.39 0.19 0.19 0.47 0.34 0.21 0.21
South Atlantic 0.23 0.21 0.33 0.56 0.25 0.23 0.60 0.47 0.26 0.26
East South Central 0.50 0.51 0.30 0.78 0.55 0.56 0.51 0.76 0.64 0.65
West South Central 0.33 0.34 0.62 0.72 0.35 0.36 1.01 0.61 0.39 0.42
West 0.21 0.25 0.30 0.31 0.23 0.28 0.42 0.35 0.26 0.31
Mountain 0.36 0.39 0.61 0.67 0.40 0.42 0.78 0.51 0.44 0.49
Pacific 0.27 0.33 0.32 0.31 0.29 0.36 0.49 0.47 0.32 0.40
COUNTY TYPE                    
Large Metro 0.14 0.15 0.21 0.27 0.15 0.16 0.32 0.27 0.17 0.18
Small Metro 0.19 0.22 0.25 0.30 0.20 0.24 0.36 0.32 0.22 0.27
Nonmetro 0.34 0.33 0.41 0.48 0.36 0.35 0.70 0.52 0.41 0.39
Urbanized 0.52 0.45 0.65 0.48 0.55 0.49 0.92 0.72 0.66 0.51
Less Urbanized 0.56 0.59 0.80 0.92 0.61 0.64 0.88 0.80 0.70 0.72
Completely Rural 0.64 0.64 0.56 0.96 0.71 0.69 2.10 1.44 0.77 0.76
POVERTY LEVEL1                    
Less Than 100% 0.42 0.34 0.37 0.43 0.48 0.37 0.40 0.40 0.59 0.46
100‑199% 0.25 0.30 0.39 0.44 0.28 0.33 0.47 0.42 0.32 0.39
200% or More 0.11 0.12 0.18 0.21 0.12 0.13 0.31 0.25 0.12 0.15
HEALTH INSURANCE2                    
Private 0.12 0.13 0.17 0.26 0.13 0.14 0.30 0.25 0.14 0.16
Medicaid/CHIP 0.35 0.34 0.27 0.30 0.42 0.41 0.47 0.41 0.49 0.49
Other3 0.19 0.25 0.49 0.29 0.19 0.26 0.89 0.26 0.19 0.26
No Coverage 0.36 0.37 0.86 0.64 0.37 0.39 0.34 0.53 0.45 0.48

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.92P – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0992   0.8057   0.0869   0.0788   0.1835  
GEOGRAPHIC DIVISION                    
Northeast 0.4165   0.3225   0.4472   0.1505   0.5932  
New England 0.0649   0.3117   0.0721   0.0196   0.1100  
Middle Atlantic 0.8800   0.5524   0.8536   0.4115   0.7322  
Midwest 0.2586   0.7589   0.2297   0.1345   0.1045  
East North Central 0.3964   0.7935   0.3644   0.9897   0.3510  
West North Central 0.4191   0.8684   0.4000   0.0267   0.0947  
South 0.2985   0.6852   0.2533   0.0305   0.6004  
South Atlantic 0.7255   0.5624   0.6458   0.0238   0.8471  
East South Central 0.3856   0.0826   0.2868   0.8994   0.2980  
West South Central 0.4795   0.5318   0.5426   0.3607   0.7666  
West 0.7262   0.9356   0.7116   0.5834   0.7940  
Mountain 0.5968   0.7717   0.5620   0.2131   0.7625  
Pacific 0.9329   0.8338   0.9396   0.8285   0.9066  
COUNTY TYPE                    
Large Metro 0.1508   0.8217   0.1359   0.3792   0.1925  
Small Metro 0.9910   0.8920   0.9739   0.1561   0.7784  
Nonmetro 0.0946   0.9752   0.0913   0.3144   0.1294  
Urbanized 0.4824   0.3405   0.5402   0.4233   0.6375  
Less Urbanized 0.5012   0.8179   0.5128   0.9364   0.5185  
Completely Rural 0.0627   0.1856   0.0443   0.3796   0.0705  
POVERTY LEVEL1                    
Less Than 100% 0.0178   0.9641   0.0159   0.4162   0.0269  
100‑199% 0.8344   0.8725   0.8109   0.4630   0.9162  
200% or More 0.5027   0.9256   0.4827   0.0989   0.7409  
HEALTH INSURANCE2                    
Private 0.3369   0.4027   0.2727   0.1100   0.4730  
Medicaid/CHIP 0.1318   0.8655   0.1249   0.3858   0.1577  
Other3 0.5979   0.2518   0.5725   0.0286   0.4336  
No Coverage 0.7920   0.8301   0.7992   0.6859   0.7105  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.93C – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 184 168 19 25 184 166 39 36 180 161
GEOGRAPHIC DIVISION                    
Northeast 130 78 6 3 130 78 13 2 129 78
New England 115 16 1 <1 115 16 3 1 * 16
Middle Atlantic 60 77 6 3 60 76 12 1 59 76
Midwest 62 56 2 12 63 55 16 19 61 52
East North Central 51 49 2 11 51 48 15 10 48 46
West North Central 36 27 <1 4 36 28 3 16 36 23
South 82 100 16 21 82 97 31 30 77 92
South Atlantic 63 86 13 16 63 84 29 18 56 82
East South Central 31 30 2 5 31 30 2 12 31 27
West South Central 47 41 10 13 46 36 11 20 44 30
West 78 96 6 4 78 96 11 4 77 95
Mountain 38 68 3 1 38 68 7 1 38 68
Pacific 68 67 5 3 68 67 8 4 67 67
COUNTY TYPE                    
Large Metro 160 128 17 16 160 127 27 27 158 124
Small Metro 71 101 6 15 70 100 21 19 67 97
Nonmetro 57 34 4 11 57 32 18 11 54 30
Urbanized 42 19 3 2 42 19 6 1 41 19
Less Urbanized 27 24 3 10 27 21 2 <1 27 21
Completely Rural 31 15 2 5 31 14 * * 28 9
POVERTY LEVEL1                    
Less Than 100% 147 104 10 11 146 103 18 17 145 102
100‑199% 66 87 11 11 65 86 22 29 62 81
200% or More 86 95 11 19 85 93 24 10 82 92
HEALTH INSURANCE2                    
Private 84 95 12 23 84 93 25 24 80 90
Medicaid/CHIP 150 120 11 10 149 119 26 14 147 119
Other3 77 78 6 4 77 78 7 2 77 78
No Coverage 43 62 7 1 43 62 6 21 43 59

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.93D – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.06 0.06 0.07 0.10 0.07 0.06 0.11 0.10 0.08 0.07
GEOGRAPHIC DIVISION                    
Northeast 0.26 0.16 0.15 0.08 0.28 0.17 0.21 0.03 0.32 0.20
New England 0.85 0.12 0.07 0.05 0.92 0.13 0.19 0.09 * 0.15
Middle Atlantic 0.16 0.22 0.21 0.10 0.18 0.23 0.29 0.02 0.20 0.27
Midwest 0.10 0.09 0.04 0.22 0.12 0.10 0.22 0.25 0.13 0.11
East North Central 0.13 0.12 0.06 0.30 0.14 0.13 0.31 0.20 0.15 0.14
West North Central 0.19 0.15 0.01 0.23 0.21 0.17 0.15 0.66 0.25 0.16
South 0.07 0.09 0.16 0.21 0.08 0.09 0.22 0.21 0.09 0.10
South Atlantic 0.10 0.14 0.25 0.31 0.11 0.15 0.41 0.25 0.12 0.17
East South Central 0.19 0.18 0.13 0.33 0.21 0.20 0.08 0.55 0.25 0.21
West South Central 0.13 0.11 0.26 0.37 0.14 0.11 0.24 0.41 0.16 0.11
West 0.11 0.14 0.10 0.06 0.12 0.15 0.13 0.05 0.14 0.17
Mountain 0.17 0.30 0.17 0.07 0.19 0.33 0.23 0.04 0.22 0.38
Pacific 0.15 0.14 0.13 0.08 0.16 0.16 0.15 0.07 0.18 0.18
COUNTY TYPE                    
Large Metro 0.09 0.08 0.11 0.11 0.10 0.08 0.14 0.13 0.12 0.09
Small Metro 0.08 0.11 0.08 0.18 0.08 0.12 0.18 0.16 0.10 0.14
Nonmetro 0.17 0.10 0.16 0.41 0.19 0.10 0.41 0.28 0.21 0.11
Urbanized 0.31 0.15 0.26 0.16 0.34 0.17 0.29 0.05 0.40 0.19
Less Urbanized 0.23 0.18 0.28 0.86 0.25 0.17 0.17 0.02 0.29 0.20
Completely Rural 0.38 0.19 0.31 0.81 0.41 0.20 * * 0.43 0.14
POVERTY LEVEL1                    
Less Than 100% 0.31 0.21 0.18 0.20 0.35 0.24 0.22 0.17 0.44 0.30
100‑199% 0.12 0.14 0.21 0.20 0.13 0.15 0.25 0.34 0.15 0.17
200% or More 0.05 0.05 0.07 0.13 0.05 0.06 0.13 0.06 0.05 0.06
HEALTH INSURANCE2                    
Private 0.05 0.06 0.08 0.16 0.05 0.06 0.13 0.12 0.06 0.07
Medicaid/CHIP 0.25 0.19 0.11 0.09 0.30 0.23 0.29 0.15 0.37 0.28
Other3 0.10 0.09 0.47 0.27 0.10 0.10 0.25 0.06 0.10 0.10
No Coverage 0.17 0.25 0.61 0.06 0.18 0.26 0.12 0.42 0.22 0.31

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.93P – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5428   0.9766   0.5339   0.3912   0.6556  
GEOGRAPHIC DIVISION                    
Northeast 0.5277   0.3126   0.5554   0.0436   0.6775  
New England 0.3809   0.7463   0.3810   0.4042   *  
Middle Atlantic 0.9603   0.3283   0.9089   0.0635   0.7209  
Midwest 0.3997   0.0773   0.2709   0.3998   0.1548  
East North Central 0.4340   0.2153   0.3206   0.7622   0.3392  
West North Central 0.7409   0.0737   0.6281   0.0994   0.2536  
South 0.7330   0.9523   0.7391   0.7153   0.8211  
South Atlantic 0.5487   0.5648   0.4718   0.1578   0.2169  
East South Central 0.7933   0.1706   0.6631   0.1778   0.4171  
West South Central 0.1215   0.8712   0.0960   0.4843   0.0351  
West 0.6217   0.1112   0.5597   0.0335   0.4259  
Mountain 0.5993   0.2006   0.5571   0.0773   0.4533  
Pacific 0.8359   0.2754   0.7846   0.1787   0.6791  
COUNTY TYPE                    
Large Metro 0.7758   0.1303   0.9059   0.4494   0.9723  
Small Metro 0.4000   0.1578   0.5149   0.9214   0.5187  
Nonmetro 0.0038   0.2786   0.0016   0.3453   0.0028  
Urbanized 0.1431   0.4945   0.1566   0.0395   0.2295  
Less Urbanized 0.1785   0.3405   0.0958   0.1853   0.1153  
Completely Rural 0.0214   0.3074   0.0125   *   0.0069  
POVERTY LEVEL1                    
Less Than 100% 0.3605   0.6600   0.3745   0.1463   0.5342  
100‑199% 0.8779   0.4246   0.9699   0.3178   0.7030  
200% or More 0.9575   0.3871   0.8345   0.0831   0.8832  
HEALTH INSURANCE2                    
Private 0.6380   0.3517   0.7750   0.5472   0.6397  
Medicaid/CHIP 0.5234   0.8438   0.5187   0.0577   0.7249  
Other3 0.6786   0.2634   0.7358   0.0614   0.8251  
No Coverage 0.5780   0.1321   0.4851   0.0947   0.8323  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.94C – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 523 615 93 110 509 594 167 188 484 552
GEOGRAPHIC DIVISION                    
Northeast 224 258 41 38 213 256 63 88 202 234
New England 145 156 27 19 139 158 40 51 129 143
Middle Atlantic 171 202 31 33 161 197 49 73 153 183
Midwest 228 270 35 47 221 262 70 79 196 244
East North Central 188 240 30 43 181 232 55 68 162 214
West North Central 119 122 17 20 119 120 42 39 101 112
South 333 398 68 76 324 381 120 127 313 360
South Atlantic 259 288 45 53 248 276 92 102 228 252
East South Central 133 141 24 24 134 138 25 28 129 139
West South Central 183 261 45 50 178 250 72 76 186 219
West 270 287 42 53 263 275 74 71 247 249
Mountain 142 166 31 30 132 161 49 42 111 149
Pacific 224 240 29 43 222 228 55 60 217 204
COUNTY TYPE                    
Large Metro 409 486 74 84 396 476 124 137 377 434
Small Metro 310 357 57 65 297 339 106 124 274 305
Nonmetro 151 179 26 33 144 173 44 46 130 159
Urbanized 92 100 16 11 88 97 33 29 76 88
Less Urbanized 90 97 12 27 88 91 23 30 80 83
Completely Rural 82 113 16 16 77 111 18 18 72 105
POVERTY LEVEL1                    
Less Than 100% 188 250 28 41 185 246 78 98 164 219
100‑199% 166 244 33 48 159 239 64 78 144 225
200% or More 453 515 81 85 442 503 124 125 427 467
HEALTH INSURANCE2                    
Private 424 485 78 91 416 465 140 159 397 430
Medicaid/CHIP 220 259 49 53 211 253 66 77 198 233
Other3 217 281 24 28 216 278 38 44 212 273
No Coverage 115 161 14 21 114 160 36 30 105 157

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.94D – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.16 0.19 0.34 0.41 0.17 0.21 0.43 0.46 0.19 0.23
GEOGRAPHIC DIVISION                    
Northeast 0.39 0.50 0.95 0.95 0.40 0.53 0.99 1.37 0.46 0.57
New England 0.89 0.99 2.45 1.87 0.95 1.11 2.19 2.87 1.05 1.17
Middle Atlantic 0.41 0.55 0.97 1.10 0.42 0.57 1.07 1.51 0.48 0.62
Midwest 0.35 0.40 0.61 0.83 0.38 0.43 0.81 0.92 0.40 0.47
East North Central 0.43 0.53 0.76 1.12 0.46 0.56 0.93 1.17 0.49 0.61
West North Central 0.54 0.55 0.89 1.07 0.59 0.60 1.41 1.42 0.59 0.68
South 0.27 0.32 0.62 0.70 0.28 0.35 0.78 0.79 0.32 0.38
South Atlantic 0.38 0.45 0.81 0.96 0.40 0.48 1.11 1.17 0.42 0.51
East South Central 0.69 0.81 1.46 1.40 0.76 0.88 1.07 1.29 0.84 1.03
West South Central 0.50 0.61 1.21 1.35 0.54 0.66 1.47 1.39 0.66 0.71
West 0.37 0.36 0.65 0.80 0.40 0.38 0.86 0.78 0.43 0.41
Mountain 0.58 0.62 1.28 1.28 0.61 0.68 1.62 1.38 0.61 0.74
Pacific 0.45 0.44 0.70 1.03 0.50 0.47 0.98 0.99 0.55 0.49
COUNTY TYPE                    
Large Metro 0.22 0.26 0.47 0.54 0.24 0.28 0.59 0.60 0.26 0.31
Small Metro 0.29 0.36 0.61 0.74 0.31 0.38 0.76 0.88 0.35 0.41
Nonmetro 0.39 0.45 0.90 1.13 0.40 0.48 0.89 1.04 0.44 0.53
Urbanized 0.55 0.72 1.63 1.13 0.56 0.76 1.44 1.57 0.63 0.83
Less Urbanized 0.67 0.60 1.18 2.16 0.72 0.64 1.27 1.73 0.78 0.70
Completely Rural 0.85 1.17 1.92 2.29 0.89 1.28 1.76 1.94 0.98 1.41
POVERTY LEVEL1                    
Less Than 100% 0.39 0.48 0.53 0.70 0.43 0.54 0.84 0.83 0.49 0.63
100‑199% 0.29 0.39 0.59 0.83 0.31 0.42 0.71 0.86 0.34 0.47
200% or More 0.21 0.26 0.50 0.54 0.23 0.28 0.63 0.68 0.25 0.29
HEALTH INSURANCE2                    
Private 0.21 0.26 0.50 0.59 0.23 0.28 0.62 0.67 0.25 0.30
Medicaid/CHIP 0.36 0.40 0.47 0.51 0.42 0.47 0.69 0.78 0.49 0.53
Other3 0.27 0.32 1.67 1.73 0.27 0.32 1.26 1.56 0.28 0.33
No Coverage 0.46 0.61 1.11 1.72 0.47 0.64 0.73 0.61 0.55 0.79

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.94P – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4397   0.4879   0.5085   0.9640   0.5234  
GEOGRAPHIC DIVISION                    
Northeast 0.9729   0.8087   0.9396   0.7556   0.9620  
New England 0.6944   0.3293   0.5758   0.7502   0.6258  
Middle Atlantic 0.8136   0.6843   0.7458   0.8668   0.6739  
Midwest 0.3229   0.0549   0.5022   0.9533   0.4968  
East North Central 0.3304   0.1428   0.4574   0.7502   0.4957  
West North Central 0.7704   0.1599   0.9599   0.6948   0.8530  
South 0.6332   0.8132   0.5875   0.9892   0.5934  
South Atlantic 0.5245   0.7324   0.4689   0.8253   0.4037  
East South Central 0.6371   0.9819   0.6381   0.9787   0.6355  
West South Central 0.7678   0.9811   0.7662   0.7859   0.6782  
West 0.9579   0.6947   0.9846   0.7803   0.9632  
Mountain 0.9225   0.4895   0.9687   0.3726   0.7238  
Pacific 0.9044   0.3251   0.9580   0.7275   0.8681  
COUNTY TYPE                    
Large Metro 0.2452   0.4551   0.2963   0.8502   0.2840  
Small Metro 0.7680   0.8142   0.7961   0.9276   0.7746  
Nonmetro 0.9606   0.4213   0.9094   0.5805   0.8233  
Urbanized 0.9332   0.1958   0.8819   0.3313   0.9689  
Less Urbanized 0.9737   0.0770   0.6958   0.7888   0.7385  
Completely Rural 0.8415   0.5498   0.9139   0.7120   0.9696  
POVERTY LEVEL1                    
Less Than 100% 0.4567   0.8704   0.4721   0.7097   0.3963  
100‑199% 0.0439   0.1436   0.0751   0.0817   0.1677  
200% or More 0.8455   0.8082   0.8166   0.6103   0.9232  
HEALTH INSURANCE2                    
Private 0.7613   0.2301   0.9324   0.9157   0.9814  
Medicaid/CHIP 0.9266   0.7693   0.9630   0.9120   0.9906  
Other3 0.6440   0.2395   0.7284   0.8487   0.7182  
No Coverage 0.2099   0.7825   0.2203   0.2366   0.1148  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.95C – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 213 221 31 34 211 217 74 93 197 186
GEOGRAPHIC DIVISION                    
Northeast 97 86 8 13 98 86 30 34 93 77
New England 74 43 6 8 75 45 16 10 72 44
Middle Atlantic 63 72 5 10 63 71 26 32 58 62
Midwest 73 79 9 12 72 79 32 40 69 67
East North Central 60 69 6 8 60 68 24 36 58 58
West North Central 47 39 8 9 46 38 21 19 40 32
South 124 143 22 26 120 141 46 58 109 120
South Atlantic 85 115 17 18 83 113 32 42 75 94
East South Central 33 42 4 4 33 42 14 11 31 39
West South Central 79 72 14 19 75 71 30 38 67 60
West 125 117 17 13 125 117 38 50 117 101
Mountain 61 76 12 7 61 75 28 25 49 69
Pacific 110 91 12 11 109 91 25 44 106 76
COUNTY TYPE                    
Large Metro 179 162 26 31 177 160 56 74 167 136
Small Metro 106 130 15 13 105 128 43 52 94 110
Nonmetro 51 59 8 8 51 59 24 18 43 55
Urbanized 33 35 7 3 32 35 21 15 21 31
Less Urbanized 23 40 5 6 23 39 10 7 20 38
Completely Rural 32 27 * 5 32 27 6 8 31 24
POVERTY LEVEL1                    
Less Than 100% 97 101 6 16 97 100 34 58 91 80
100‑199% 72 78 10 15 71 77 33 39 61 67
200% or More 171 166 29 26 169 163 56 56 159 149
HEALTH INSURANCE2                    
Private 168 165 27 28 167 162 63 81 157 135
Medicaid/CHIP 104 112 15 20 103 110 28 37 98 101
Other3 99 60 8 3 99 60 20 10 97 59
No Coverage 73 68 * 3 70 67 21 18 67 65

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.95D – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.07 0.07 0.12 0.13 0.08 0.08 0.21 0.25 0.08 0.08
GEOGRAPHIC DIVISION                    
Northeast 0.19 0.17 0.21 0.33 0.20 0.19 0.50 0.55 0.22 0.19
New England 0.51 0.31 0.62 0.78 0.56 0.34 0.94 0.59 0.62 0.39
Middle Atlantic 0.17 0.20 0.18 0.35 0.19 0.21 0.59 0.72 0.20 0.22
Midwest 0.12 0.13 0.17 0.22 0.13 0.15 0.43 0.51 0.15 0.14
East North Central 0.14 0.17 0.15 0.22 0.16 0.18 0.47 0.66 0.18 0.18
West North Central 0.25 0.21 0.44 0.49 0.27 0.23 0.82 0.75 0.28 0.23
South 0.11 0.12 0.22 0.26 0.12 0.13 0.33 0.39 0.12 0.13
South Atlantic 0.14 0.19 0.34 0.35 0.15 0.20 0.44 0.55 0.15 0.19
East South Central 0.20 0.24 0.28 0.27 0.22 0.27 0.67 0.48 0.23 0.29
West South Central 0.22 0.20 0.38 0.53 0.24 0.21 0.65 0.77 0.24 0.21
West 0.18 0.16 0.28 0.22 0.20 0.18 0.46 0.58 0.22 0.18
Mountain 0.26 0.32 0.54 0.34 0.29 0.35 0.98 0.82 0.27 0.37
Pacific 0.24 0.19 0.31 0.28 0.26 0.21 0.47 0.78 0.29 0.20
COUNTY TYPE                    
Large Metro 0.11 0.10 0.17 0.21 0.12 0.10 0.29 0.35 0.13 0.10
Small Metro 0.11 0.14 0.18 0.15 0.12 0.15 0.35 0.43 0.13 0.15
Nonmetro 0.15 0.17 0.29 0.30 0.16 0.18 0.56 0.44 0.16 0.20
Urbanized 0.24 0.27 0.67 0.28 0.25 0.29 1.04 0.89 0.19 0.31
Less Urbanized 0.20 0.28 0.44 0.51 0.21 0.31 0.76 0.43 0.22 0.35
Completely Rural 0.37 0.33 * 0.86 0.41 0.36 0.73 0.91 0.45 0.36
POVERTY LEVEL1                    
Less Than 100% 0.21 0.21 0.11 0.29 0.23 0.23 0.39 0.56 0.28 0.24
100‑199% 0.13 0.13 0.18 0.27 0.14 0.14 0.39 0.45 0.15 0.14
200% or More 0.09 0.09 0.19 0.18 0.10 0.09 0.31 0.32 0.10 0.10
HEALTH INSURANCE2                    
Private 0.09 0.09 0.18 0.20 0.10 0.10 0.31 0.38 0.11 0.10
Medicaid/CHIP 0.18 0.18 0.15 0.19 0.21 0.22 0.31 0.38 0.25 0.24
Other3 0.13 0.07 0.54 0.22 0.13 0.07 0.70 0.37 0.13 0.07
No Coverage 0.29 0.27 * 0.25 0.29 0.28 0.42 0.36 0.35 0.34

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.95P – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.9740   0.7089   0.9689   0.8142   0.9895  
GEOGRAPHIC DIVISION                    
Northeast 0.0811   0.8159   0.0743   0.4151   0.1015  
New England 0.0506   0.9789   0.0557   0.1702   0.0998  
Middle Atlantic 0.4801   0.7384   0.4435   0.7731   0.4583  
Midwest 0.5569   0.0855   0.7321   0.7822   0.8337  
East North Central 0.2353   0.1375   0.3061   0.2245   0.6219  
West North Central 0.4712   0.3293   0.3532   0.1732   0.7006  
South 0.8648   0.7655   0.9124   0.5857   0.7372  
South Atlantic 0.7808   0.9834   0.7834   0.4757   0.5526  
East South Central 0.8342   0.7816   0.8135   0.4803   0.6251  
West South Central 0.8668   0.6262   0.7716   0.8532   0.6500  
West 0.4047   0.2938   0.3349   0.5770   0.4126  
Mountain 0.5202   0.6213   0.4767   0.7100   0.3357  
Pacific 0.5687   0.3414   0.4947   0.3412   0.7173  
COUNTY TYPE                    
Large Metro 0.9227   0.4878   0.8177   0.3419   0.4480  
Small Metro 0.8482   0.2777   0.9477   0.1140   0.4980  
Nonmetro 0.4006   0.3805   0.4787   0.6567   0.3001  
Urbanized 0.3515   0.6082   0.3015   0.9316   0.1426  
Less Urbanized 0.5096   0.6801   0.5495   0.2776   0.3397  
Completely Rural 0.8919   *   0.6825   0.5330   0.5534  
POVERTY LEVEL1                    
Less Than 100% 0.2520   0.0150   0.4034   0.6907   0.5244  
100‑199% 0.4978   0.3690   0.5960   0.7169   0.5806  
200% or More 0.3788   0.3033   0.4619   0.3872   0.6385  
HEALTH INSURANCE2                    
Private 0.6593   0.6283   0.7078   0.8076   0.4858  
Medicaid/CHIP 0.2395   0.1045   0.3699   0.9956   0.3360  
Other3 0.6258   0.2159   0.6879   0.0734   0.9673  
No Coverage 0.9927   *   1.0000   0.5230   0.8480  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.96C – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 119 124 11 17 118 123 31 47 112 112
GEOGRAPHIC DIVISION                    
Northeast 51 58 2 3 51 58 14 25 49 49
New England 36 22 1 1 36 22 10 9 33 20
Middle Atlantic 36 50 2 3 36 50 10 23 36 45
Midwest 29 38 3 6 29 38 15 14 24 37
East North Central 24 32 3 3 24 32 12 11 20 32
West North Central 19 20 <1 5 19 20 8 8 18 18
South 73 75 10 14 72 74 17 34 69 63
South Atlantic 46 63 10 14 45 62 13 26 43 53
East South Central 20 25 <1 1 20 25 1 7 20 25
West South Central 52 31 <1 * 52 31 11 20 49 24
West 74 68 2 6 74 68 16 15 69 66
Mountain 35 42 1 5 35 42 13 13 25 40
Pacific 66 53 1 4 66 54 10 7 65 53
COUNTY TYPE                    
Large Metro 105 85 8 15 104 84 22 38 102 77
Small Metro 52 81 7 5 51 81 17 26 43 75
Nonmetro 23 31 1 5 23 30 13 8 15 29
Urbanized 19 15 * 2 19 15 10 7 11 13
Less Urbanized 13 26 1 3 13 26 8 5 11 26
Completely Rural 3 4 * * 3 2 * <1 3 2
POVERTY LEVEL1                    
Less Than 100% 29 59 4 5 29 59 14 35 24 44
100‑199% 34 46 2 4 34 46 15 17 30 43
200% or More 109 96 10 16 109 95 22 26 105 92
HEALTH INSURANCE2                    
Private 103 92 10 15 103 91 28 39 99 84
Medicaid/CHIP 38 76 5 8 37 76 12 24 35 72
Other3 31 27 * * 31 27 3 4 31 26
No Coverage 44 26 <1 1 44 26 5 6 44 26

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.96D – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.04 0.04 0.04 0.07 0.04 0.05 0.09 0.13 0.05 0.05
GEOGRAPHIC DIVISION                    
Northeast 0.10 0.12 0.05 0.08 0.11 0.13 0.25 0.41 0.12 0.12
New England 0.27 0.16 0.13 0.15 0.30 0.17 0.61 0.57 0.31 0.18
Middle Atlantic 0.10 0.14 0.05 0.09 0.11 0.15 0.24 0.52 0.12 0.15
Midwest 0.05 0.06 0.06 0.11 0.05 0.07 0.20 0.18 0.05 0.08
East North Central 0.06 0.08 0.08 0.07 0.07 0.09 0.25 0.22 0.06 0.10
West North Central 0.10 0.11 0.01 0.29 0.12 0.12 0.32 0.32 0.12 0.13
South 0.07 0.07 0.10 0.14 0.07 0.07 0.12 0.24 0.08 0.07
South Atlantic 0.08 0.10 0.19 0.28 0.08 0.11 0.18 0.36 0.09 0.11
East South Central 0.12 0.15 0.01 0.05 0.13 0.16 0.06 0.32 0.15 0.18
West South Central 0.15 0.09 <0.01 * 0.16 0.10 0.24 0.42 0.18 0.08
West 0.11 0.10 0.03 0.11 0.12 0.11 0.20 0.17 0.13 0.12
Mountain 0.15 0.18 0.05 0.25 0.17 0.20 0.44 0.45 0.14 0.22
Pacific 0.14 0.11 0.03 0.10 0.16 0.12 0.19 0.12 0.18 0.14
COUNTY TYPE                    
Large Metro 0.06 0.05 0.05 0.11 0.07 0.06 0.12 0.18 0.08 0.06
Small Metro 0.06 0.09 0.09 0.06 0.06 0.10 0.15 0.22 0.06 0.10
Nonmetro 0.07 0.09 0.04 0.18 0.08 0.10 0.30 0.22 0.06 0.11
Urbanized 0.14 0.12 * 0.20 0.15 0.13 0.50 0.45 0.10 0.13
Less Urbanized 0.11 0.19 0.12 0.22 0.12 0.20 0.56 0.34 0.11 0.23
Completely Rural 0.03 0.05 * * 0.04 0.02 * 0.03 0.04 0.03
POVERTY LEVEL1                    
Less Than 100% 0.06 0.12 0.08 0.09 0.07 0.14 0.17 0.35 0.07 0.13
100‑199% 0.06 0.08 0.03 0.07 0.07 0.08 0.18 0.20 0.07 0.09
200% or More 0.06 0.05 0.07 0.11 0.06 0.06 0.12 0.15 0.07 0.06
HEALTH INSURANCE2                    
Private 0.06 0.05 0.07 0.11 0.06 0.06 0.14 0.19 0.07 0.06
Medicaid/CHIP 0.06 0.12 0.05 0.07 0.08 0.15 0.13 0.26 0.09 0.17
Other3 0.04 0.03 * * 0.04 0.03 0.10 0.14 0.04 0.03
No Coverage 0.17 0.11 0.01 0.09 0.18 0.11 0.09 0.13 0.23 0.14

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.96P – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.9385   0.3918   0.9706   0.4519   0.7516  
GEOGRAPHIC DIVISION                    
Northeast 0.6690   0.9308   0.6609   1.0000   0.6191  
New England 0.3774   0.9023   0.3785   0.9663   0.3404  
Middle Atlantic 0.9400   0.8547   0.9521   0.9821   0.9626  
Midwest 0.3187   0.4092   0.3748   0.5914   0.2383  
East North Central 0.1652   0.6907   0.1532   0.8425   0.1139  
West North Central 0.7780   0.1784   0.5884   0.4963   0.7628  
South 0.4664   0.8502   0.4359   0.1919   0.1640  
South Atlantic 0.8627   0.8989   0.8827   0.4164   0.8590  
East South Central 0.7650   0.1412   0.7337   0.0970   0.4805  
West South Central 0.1938   *   0.1918   0.5422   0.0819  
West 0.4558   0.2152   0.5110   0.8446   0.5205  
Mountain 0.3331   0.2484   0.3908   0.7152   0.4002  
Pacific 0.7875   0.5939   0.8126   0.8450   0.7861  
COUNTY TYPE                    
Large Metro 0.3330   0.2967   0.2613   0.4027   0.1354  
Small Metro 0.2253   0.3637   0.1954   0.7300   0.1868  
Nonmetro 0.4434   0.1689   0.5598   0.6705   0.3683  
Urbanized 0.7362   *   0.7970   0.9388   0.7012  
Less Urbanized 0.5470   0.7089   0.5712   0.4550   0.3818  
Completely Rural 0.6487   *   0.6134   *   0.5683  
POVERTY LEVEL1                    
Less Than 100% 0.0346   0.7770   0.0368   0.4903   0.0333  
100‑199% 0.3629   0.2675   0.4068   0.9241   0.3617  
200% or More 0.2512   0.5368   0.2113   0.6837   0.1653  
HEALTH INSURANCE2                    
Private 0.4999   0.6699   0.4556   0.6026   0.3050  
Medicaid/CHIP 0.0211   0.2551   0.0291   0.7139   0.0294  
Other3 0.9742   *   0.9743   0.6576   0.9923  
No Coverage 0.2464   0.3581   0.2358   0.2876   0.1713  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.97C – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 936 888 68 66 928 884 115 138 909 868
GEOGRAPHIC DIVISION                    
Northeast 378 432 23 28 373 434 48 46 367 431
New England 213 239 8 7 213 239 29 39 206 233
Middle Atlantic 314 370 22 27 307 373 39 28 305 374
Midwest 334 361 34 28 333 354 49 62 327 340
East North Central 285 295 29 25 284 289 44 52 278 276
West North Central 182 196 18 12 178 191 23 34 173 187
South 615 544 46 43 610 541 75 101 599 525
South Atlantic 498 430 24 37 494 426 56 68 486 417
East South Central 191 196 12 10 191 196 21 29 186 193
West South Central 288 315 37 18 283 314 47 70 276 299
West 488 439 34 30 480 436 52 53 471 428
Mountain 222 218 12 24 218 216 33 33 212 209
Pacific 435 380 32 19 428 379 40 40 420 373
COUNTY TYPE                    
Large Metro 728 688 56 58 718 684 89 108 705 663
Small Metro 532 526 39 29 526 523 68 84 511 510
Nonmetro 291 321 18 19 287 317 34 32 278 312
Urbanized 198 225 11 5 195 225 17 17 190 222
Less Urbanized 179 191 14 17 174 187 21 22 167 182
Completely Rural 152 140 4 8 152 138 21 15 147 135
POVERTY LEVEL1                    
Less Than 100% 317 337 28 28 312 336 52 69 305 328
100‑199% 355 397 24 29 352 393 59 57 342 389
200% or More 766 691 55 50 759 689 84 101 742 676
HEALTH INSURANCE2                    
Private 710 659 53 47 702 655 89 116 687 641
Medicaid/CHIP 378 377 42 42 370 373 61 61 361 364
Other3 563 571 11 23 563 571 40 27 561 571
No Coverage 173 198 7 9 173 197 26 36 169 194

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.97D – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.26 0.25 0.25 0.25 0.28 0.27 0.30 0.36 0.32 0.31
GEOGRAPHIC DIVISION                    
Northeast 0.60 0.72 0.56 0.68 0.64 0.79 0.76 0.76 0.72 0.88
New England 1.15 1.58 0.85 0.68 1.24 1.72 1.50 2.24 1.39 1.94
Middle Atlantic 0.70 0.80 0.70 0.89 0.75 0.88 0.89 0.65 0.84 0.98
Midwest 0.46 0.48 0.62 0.51 0.51 0.52 0.65 0.74 0.58 0.59
East North Central 0.55 0.60 0.79 0.68 0.61 0.64 0.84 0.89 0.69 0.72
West North Central 0.83 0.76 0.97 0.69 0.89 0.82 0.92 1.31 1.01 0.93
South 0.44 0.40 0.42 0.41 0.48 0.44 0.50 0.67 0.55 0.49
South Atlantic 0.65 0.57 0.44 0.70 0.71 0.62 0.72 0.83 0.80 0.71
East South Central 0.96 1.12 0.77 0.64 1.07 1.25 0.90 1.30 1.23 1.42
West South Central 0.67 0.72 0.98 0.51 0.73 0.80 0.93 1.37 0.83 0.87
West 0.58 0.55 0.54 0.49 0.63 0.59 0.56 0.59 0.71 0.67
Mountain 0.76 0.84 0.53 1.08 0.82 0.91 1.06 1.08 0.95 1.04
Pacific 0.78 0.70 0.78 0.47 0.84 0.76 0.65 0.69 0.94 0.86
COUNTY TYPE                    
Large Metro 0.35 0.33 0.36 0.38 0.39 0.36 0.43 0.49 0.43 0.40
Small Metro 0.45 0.50 0.45 0.33 0.49 0.55 0.52 0.67 0.56 0.61
Nonmetro 0.68 0.77 0.59 0.66 0.73 0.83 0.76 0.76 0.82 0.94
Urbanized 1.15 1.50 1.05 0.46 1.20 1.63 0.83 1.00 1.36 1.86
Less Urbanized 1.09 1.07 1.19 1.34 1.17 1.15 1.31 1.25 1.29 1.31
Completely Rural 1.54 1.40 0.50 1.25 1.71 1.52 2.23 1.84 1.92 1.69
POVERTY LEVEL1                    
Less Than 100% 0.62 0.62 0.49 0.47 0.69 0.71 0.61 0.63 0.86 0.89
100‑199% 0.58 0.60 0.45 0.49 0.64 0.65 0.66 0.66 0.75 0.76
200% or More 0.33 0.31 0.36 0.34 0.35 0.33 0.42 0.56 0.39 0.37
HEALTH INSURANCE2                    
Private 0.32 0.33 0.35 0.32 0.34 0.35 0.42 0.53 0.38 0.39
Medicaid/CHIP 0.57 0.54 0.40 0.38 0.67 0.64 0.65 0.62 0.80 0.77
Other3 0.60 0.57 0.78 1.50 0.61 0.58 1.31 0.97 0.63 0.60
No Coverage 0.64 0.74 0.57 0.78 0.67 0.77 0.52 0.70 0.82 0.96

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.97P – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0019   0.2452   0.0020   0.5706   0.0027  
GEOGRAPHIC DIVISION                    
Northeast 0.7531   0.7073   0.7108   0.0062   0.9770  
New England 0.9285   0.4799   0.9170   0.2219   0.7496  
Middle Atlantic 0.6607   0.5322   0.6066   0.0117   0.8553  
Midwest 0.3261   0.3462   0.3551   0.1798   0.2380  
East North Central 0.2988   0.5881   0.3071   0.3162   0.2191  
West North Central 0.8218   0.3282   0.8823   0.3418   0.7538  
South 0.0034   0.3693   0.0038   0.5674   0.0025  
South Atlantic 0.0836   0.1064   0.0587   0.8529   0.0642  
East South Central 0.2534   0.0803   0.2956   0.4788   0.2610  
West South Central 0.0283   0.0171   0.0485   0.4709   0.0257  
West 0.1573   0.5792   0.1567   0.2248   0.2054  
Mountain 0.0188   0.1732   0.0115   0.2089   0.0204  
Pacific 0.7095   0.1065   0.7802   0.5816   0.8372  
COUNTY TYPE                    
Large Metro 0.0136   0.8496   0.0103   0.4997   0.0164  
Small Metro 0.0706   0.0106   0.1000   0.9157   0.0848  
Nonmetro 0.5321   0.8486   0.5229   0.9774   0.4449  
Urbanized 0.3527   0.0380   0.2879   0.0266   0.4872  
Less Urbanized 0.1944   0.8365   0.1759   0.2489   0.2242  
Completely Rural 0.2976   0.1475   0.2405   0.3611   0.2981  
POVERTY LEVEL1                    
Less Than 100% 0.1959   0.2452   0.2189   0.8426   0.3127  
100‑199% 0.0650   0.9039   0.0590   0.6070   0.0482  
200% or More 0.0421   0.3830   0.0404   0.8445   0.0391  
HEALTH INSURANCE2                    
Private 0.0056   0.1190   0.0067   0.8783   0.0072  
Medicaid/CHIP 0.0253   0.3687   0.0239   0.0625   0.0478  
Other3 0.0434   0.6738   0.0413   0.1706   0.0463  
No Coverage 0.4969   0.6620   0.5218   0.6219   0.5791  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.98C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 251 293 26 30 248 293 56 63 239 287
GEOGRAPHIC DIVISION                    
Northeast 97 197 7 14 96 200 13 20 94 199
New England 38 131 2 1 38 131 5 19 37 130
Middle Atlantic 89 149 7 14 88 152 12 13 87 151
Midwest 105 90 11 13 105 89 25 34 98 79
East North Central 84 72 6 12 84 71 24 30 77 64
West North Central 66 48 9 6 65 48 9 16 63 44
South 173 163 21 21 171 161 44 47 165 155
South Atlantic 157 136 12 20 155 135 38 38 150 129
East South Central 32 44 2 1 32 44 11 10 30 43
West South Central 64 83 17 7 61 83 17 29 58 76
West 106 123 10 9 105 123 22 16 101 121
Mountain 77 69 5 8 77 69 17 9 74 66
Pacific 72 103 8 5 72 103 15 13 68 103
COUNTY TYPE                    
Large Metro 204 225 19 26 203 225 41 45 195 221
Small Metro 128 181 16 9 125 181 32 47 120 175
Nonmetro 97 66 10 12 97 65 22 9 93 63
Urbanized 76 33 7 1 76 33 7 3 75 32
Less Urbanized 31 56 7 12 31 55 6 8 30 52
Completely Rural 52 16 <1 * 52 17 19 4 48 16
POVERTY LEVEL1                    
Less Than 100% 111 106 9 12 110 106 26 40 107 98
100‑199% 110 195 12 15 109 195 29 34 105 191
200% or More 199 190 22 18 197 192 40 35 194 190
HEALTH INSURANCE2                    
Private 175 165 20 20 172 163 40 46 167 159
Medicaid/CHIP 145 142 18 22 142 140 34 38 136 134
Other3 143 218 4 * 143 218 15 7 142 218
No Coverage 69 74 2 2 69 74 13 22 67 71

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.98D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.09 0.10 0.10 0.12 0.09 0.11 0.16 0.17 0.10 0.12
GEOGRAPHIC DIVISION                    
Northeast 0.19 0.38 0.17 0.35 0.21 0.42 0.22 0.32 0.23 0.48
New England 0.29 0.95 0.22 0.13 0.31 1.03 0.32 1.15 0.35 1.18
Middle Atlantic 0.24 0.39 0.22 0.47 0.26 0.43 0.28 0.29 0.29 0.49
Midwest 0.17 0.15 0.20 0.25 0.19 0.16 0.35 0.45 0.21 0.17
East North Central 0.21 0.17 0.16 0.33 0.23 0.19 0.48 0.58 0.24 0.20
West North Central 0.35 0.25 0.52 0.36 0.38 0.28 0.38 0.68 0.44 0.30
South 0.15 0.14 0.20 0.20 0.16 0.15 0.31 0.32 0.19 0.17
South Atlantic 0.26 0.22 0.23 0.39 0.28 0.24 0.53 0.49 0.31 0.26
East South Central 0.19 0.26 0.12 0.07 0.21 0.28 0.51 0.47 0.23 0.32
West South Central 0.18 0.22 0.47 0.18 0.19 0.25 0.37 0.59 0.20 0.27
West 0.15 0.17 0.15 0.16 0.17 0.19 0.27 0.18 0.19 0.22
Mountain 0.33 0.30 0.22 0.38 0.37 0.33 0.60 0.30 0.41 0.37
Pacific 0.16 0.22 0.20 0.13 0.17 0.24 0.27 0.23 0.19 0.27
COUNTY TYPE                    
Large Metro 0.12 0.13 0.12 0.18 0.13 0.14 0.21 0.22 0.15 0.16
Small Metro 0.14 0.19 0.19 0.10 0.15 0.21 0.27 0.39 0.17 0.24
Nonmetro 0.28 0.19 0.36 0.44 0.30 0.20 0.52 0.23 0.34 0.23
Urbanized 0.55 0.26 0.71 0.14 0.59 0.28 0.38 0.22 0.69 0.32
Less Urbanized 0.26 0.40 0.62 0.99 0.28 0.43 0.41 0.46 0.31 0.47
Completely Rural 0.56 0.20 0.05 * 0.61 0.23 2.08 0.46 0.66 0.26
POVERTY LEVEL1                    
Less Than 100% 0.23 0.21 0.17 0.22 0.26 0.24 0.31 0.39 0.32 0.29
100‑199% 0.20 0.32 0.22 0.26 0.22 0.35 0.34 0.40 0.25 0.40
200% or More 0.11 0.10 0.14 0.13 0.11 0.11 0.21 0.20 0.13 0.12
HEALTH INSURANCE2                    
Private 0.10 0.09 0.14 0.14 0.11 0.10 0.20 0.22 0.12 0.11
Medicaid/CHIP 0.24 0.23 0.17 0.21 0.29 0.27 0.37 0.40 0.34 0.32
Other3 0.18 0.26 0.30 * 0.18 0.26 0.51 0.25 0.19 0.27
No Coverage 0.27 0.29 0.14 0.14 0.29 0.31 0.25 0.44 0.36 0.37

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.98P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3236   0.4910   0.3480   0.9293   0.3461  
GEOGRAPHIC DIVISION                    
Northeast 0.3162   0.6753   0.3376   0.3621   0.3847  
New England 0.2495   0.3325   0.2433   0.2246   0.3191  
Middle Atlantic 0.7171   0.5569   0.7649   0.8920   0.7465  
Midwest 0.2827   0.5072   0.2415   0.3088   0.1061  
East North Central 0.3665   0.1840   0.2797   0.5248   0.1544  
West North Central 0.5639   0.5749   0.6123   0.3089   0.4399  
South 0.1006   0.1495   0.1350   0.5031   0.1721  
South Atlantic 0.1855   0.9518   0.1791   0.4598   0.2317  
East South Central 0.7600   0.5824   0.7684   0.4158   0.9419  
West South Central 0.3368   0.0298   0.5538   0.8155   0.4645  
West 0.7085   0.8158   0.7151   0.2634   0.8656  
Mountain 0.1641   0.4451   0.1403   0.2169   0.2030  
Pacific 0.5150   0.3005   0.4681   0.7203   0.4251  
COUNTY TYPE                    
Large Metro 0.5376   0.9308   0.5185   0.7619   0.5468  
Small Metro 1.0000   0.1112   0.8996   0.4394   0.9396  
Nonmetro 0.0922   0.9247   0.0918   0.1518   0.1468  
Urbanized 0.1829   0.1905   0.2240   0.4858   0.2288  
Less Urbanized 0.5796   0.8311   0.6041   0.8132   0.6181  
Completely Rural 0.0110   *   0.0093   0.0713   0.0418  
POVERTY LEVEL1                    
Less Than 100% 0.4050   0.7546   0.3771   0.8193   0.3348  
100‑199% 0.7188   0.6548   0.6920   0.5191   0.7812  
200% or More 0.1909   0.3990   0.2160   0.3530   0.2845  
HEALTH INSURANCE2                    
Private 0.7976   0.3746   0.8696   0.6339   0.7603  
Medicaid/CHIP 0.1208   0.8347   0.1149   0.2834   0.1728  
Other3 0.8032   *   0.7855   0.1819   0.7253  
No Coverage 0.8837   0.8377   0.8897   0.1587   0.8192  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.99C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 147 155 13 12 146 154 32 37 143 150
GEOGRAPHIC DIVISION                    
Northeast 73 82 3 * 73 82 9 18 73 80
New England 8 24 2 * 8 24 1 17 8 15
Middle Atlantic 73 79 2 * 73 79 9 5 72 79
Midwest 61 49 8 11 61 48 18 9 58 47
East North Central 48 32 * 11 48 31 18 8 44 30
West North Central 40 33 8 4 39 32 4 4 39 32
South 89 111 8 5 88 111 22 30 86 107
South Atlantic 75 99 5 * 74 99 17 24 73 96
East South Central 22 18 <1 1 22 18 10 2 19 18
West South Central 43 54 6 5 42 54 9 18 41 51
West 65 47 4 1 65 47 13 8 64 46
Mountain 50 17 <1 1 50 17 5 1 50 17
Pacific 41 46 4 * 41 46 12 8 41 45
COUNTY TYPE                    
Large Metro 117 106 7 2 116 106 27 21 113 103
Small Metro 70 102 7 5 70 102 5 30 69 97
Nonmetro 58 44 8 11 58 43 17 2 55 43
Urbanized 33 23 * 1 32 23 4 1 32 22
Less Urbanized 16 37 5 11 16 35 5 1 15 35
Completely Rural 45 10 <1 * 45 11 14 * 42 11
POVERTY LEVEL1                    
Less Than 100% 62 68 4 6 63 68 23 28 59 62
100‑199% 60 70 5 11 59 69 13 21 58 66
200% or More 120 116 11 1 119 116 17 12 118 115
HEALTH INSURANCE2                    
Private 103 98 10 10 103 97 21 19 101 95
Medicaid/CHIP 82 80 7 7 82 80 23 29 79 74
Other3 79 124 * * 79 124 2 5 79 124
No Coverage 51 34 * 1 51 34 3 12 51 31

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.99D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.05 0.05 0.05 0.06 0.06 0.09 0.10 0.06 0.06
GEOGRAPHIC DIVISION                    
Northeast 0.15 0.16 0.08 * 0.16 0.17 0.15 0.30 0.18 0.19
New England 0.07 0.18 0.19 * 0.07 0.19 0.06 1.03 0.08 0.14
Middle Atlantic 0.20 0.21 0.08 * 0.22 0.22 0.20 0.12 0.25 0.26
Midwest 0.10 0.08 0.16 0.22 0.11 0.09 0.25 0.12 0.12 0.10
East North Central 0.12 0.08 * 0.29 0.13 0.08 0.36 0.15 0.14 0.09
West North Central 0.22 0.18 0.48 0.26 0.23 0.19 0.16 0.19 0.27 0.22
South 0.08 0.10 0.08 0.05 0.09 0.11 0.16 0.21 0.10 0.12
South Atlantic 0.13 0.16 0.10 * 0.14 0.18 0.25 0.33 0.15 0.20
East South Central 0.13 0.11 0.01 0.07 0.15 0.12 0.49 0.10 0.15 0.13
West South Central 0.12 0.15 0.17 0.13 0.13 0.17 0.19 0.38 0.15 0.18
West 0.10 0.07 0.06 0.01 0.11 0.08 0.15 0.09 0.12 0.09
Mountain 0.23 0.07 0.01 0.04 0.25 0.08 0.17 0.04 0.29 0.10
Pacific 0.09 0.10 0.09 * 0.10 0.11 0.22 0.14 0.11 0.12
COUNTY TYPE                    
Large Metro 0.07 0.06 0.04 0.01 0.08 0.07 0.14 0.10 0.09 0.08
Small Metro 0.08 0.11 0.09 0.06 0.09 0.12 0.04 0.26 0.10 0.14
Nonmetro 0.17 0.13 0.29 0.41 0.19 0.14 0.39 0.04 0.21 0.16
Urbanized 0.25 0.18 * 0.06 0.26 0.20 0.21 0.10 0.31 0.23
Less Urbanized 0.14 0.27 0.45 0.93 0.14 0.28 0.33 0.05 0.16 0.32
Completely Rural 0.52 0.13 0.05 * 0.57 0.16 1.62 * 0.62 0.18
POVERTY LEVEL1                    
Less Than 100% 0.13 0.14 0.07 0.11 0.15 0.16 0.27 0.29 0.18 0.18
100‑199% 0.11 0.12 0.09 0.18 0.12 0.13 0.15 0.25 0.14 0.14
200% or More 0.06 0.06 0.07 0.01 0.07 0.07 0.10 0.07 0.08 0.08
HEALTH INSURANCE2                    
Private 0.06 0.06 0.07 0.08 0.06 0.06 0.11 0.09 0.07 0.07
Medicaid/CHIP 0.14 0.13 0.07 0.07 0.17 0.16 0.26 0.31 0.20 0.18
Other3 0.10 0.15 * * 0.10 0.15 0.06 0.17 0.11 0.15
No Coverage 0.20 0.13 * 0.09 0.21 0.14 0.06 0.24 0.27 0.17

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.99P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1523   0.6536   0.1583   0.7551   0.1699  
GEOGRAPHIC DIVISION                    
Northeast 0.7412   *   0.7736   0.3167   0.6319  
New England 0.1623   *   0.1315   0.1998   0.3414  
Middle Atlantic 0.4971   *   0.5077   0.8625   0.5190  
Midwest 0.1316   0.5318   0.0995   0.3020   0.1543  
East North Central 0.2160   *   0.1318   0.2692   0.2283  
West North Central 0.3757   0.5549   0.4294   0.9259   0.4217  
South 0.5842   0.3664   0.6178   0.9572   0.5952  
South Atlantic 0.9696   *   0.9924   0.9742   0.9866  
East South Central 0.2028   0.4009   0.1889   0.0619   0.4941  
West South Central 0.5946   0.7223   0.6174   0.2681   0.3894  
West 0.3625   0.3912   0.3806   0.2806   0.4973  
Mountain 0.0812   0.3089   0.0778   0.1212   0.1043  
Pacific 0.7595   *   0.7144   0.5536   0.6110  
COUNTY TYPE                    
Large Metro 0.0977   0.1811   0.1061   0.2356   0.1666  
Small Metro 0.8143   0.5597   0.7859   0.0547   0.8299  
Nonmetro 0.3135   0.6729   0.2691   0.0438   0.4972  
Urbanized 0.8791   *   0.9870   0.3553   0.9267  
Less Urbanized 0.6841   0.4571   0.8422   0.1298   0.6857  
Completely Rural 0.0545   *   0.0482   *   0.1231  
POVERTY LEVEL1                    
Less Than 100% 0.4775   0.3703   0.4279   0.3176   0.6747  
100‑199% 0.8310   0.4730   0.9034   0.2339   0.8373  
200% or More 0.1061   0.0261   0.1366   0.5540   0.1542  
HEALTH INSURANCE2                    
Private 0.1669   0.6965   0.1756   0.2424   0.2555  
Medicaid/CHIP 0.2070   0.9887   0.1988   0.6185   0.2340  
Other3 0.3623   *   0.3622   0.1321   0.3922  
No Coverage 0.5897   *   0.5733   0.0214   0.2901  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.100C – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 763 759 46 56 757 756 100 116 747 746
GEOGRAPHIC DIVISION                    
Northeast 330 372 18 24 327 374 42 41 326 372
New England 170 198 7 3 169 198 27 39 166 191
Middle Atlantic 286 323 17 24 283 326 33 19 283 327
Midwest 282 301 23 24 282 296 41 54 280 287
East North Central 251 256 18 22 249 253 36 45 247 244
West North Central 143 150 15 9 142 148 21 30 138 146
South 504 465 32 33 499 465 66 84 491 450
South Atlantic 415 367 16 29 413 366 53 62 406 354
East South Central 164 165 11 4 164 165 20 21 159 165
West South Central 234 262 26 15 229 262 35 53 227 254
West 372 369 16 25 371 369 46 42 365 361
Mountain 210 190 9 18 208 189 30 24 203 186
Pacific 308 316 13 18 308 317 36 34 304 310
COUNTY TYPE                    
Large Metro 590 557 32 48 586 556 76 86 579 540
Small Metro 449 464 30 23 443 463 59 77 430 452
Nonmetro 225 273 16 17 222 271 32 26 215 269
Urbanized 140 194 9 3 138 194 16 16 133 193
Less Urbanized 145 165 14 15 141 163 19 18 138 160
Completely Rural 138 112 3 8 137 109 19 12 134 107
POVERTY LEVEL1                    
Less Than 100% 286 313 22 24 282 312 46 58 277 306
100‑199% 314 331 18 25 313 329 51 51 305 328
200% or More 616 577 37 39 613 577 73 83 603 568
HEALTH INSURANCE2                    
Private 578 562 34 39 574 560 77 96 566 554
Medicaid/CHIP 332 346 30 35 326 343 56 54 319 337
Other3 484 484 9 13 483 484 24 22 482 484
No Coverage 143 178 4 8 142 178 24 28 138 175

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.100D – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.22 0.23 0.18 0.22 0.24 0.25 0.27 0.31 0.27 0.28
GEOGRAPHIC DIVISION                    
Northeast 0.55 0.66 0.45 0.61 0.59 0.72 0.68 0.69 0.67 0.82
New England 1.05 1.39 0.76 0.26 1.13 1.51 1.41 2.23 1.28 1.70
Middle Atlantic 0.65 0.75 0.55 0.82 0.70 0.82 0.76 0.47 0.79 0.93
Midwest 0.42 0.43 0.43 0.43 0.46 0.46 0.56 0.66 0.53 0.53
East North Central 0.53 0.55 0.49 0.60 0.58 0.59 0.72 0.81 0.66 0.67
West North Central 0.68 0.63 0.84 0.50 0.75 0.69 0.87 1.16 0.85 0.78
South 0.37 0.36 0.31 0.32 0.40 0.40 0.45 0.57 0.46 0.45
South Atlantic 0.56 0.52 0.31 0.56 0.61 0.58 0.69 0.82 0.69 0.64
East South Central 0.82 0.94 0.70 0.28 0.91 1.03 0.89 0.96 1.05 1.21
West South Central 0.56 0.65 0.71 0.42 0.61 0.72 0.74 1.03 0.70 0.80
West 0.46 0.49 0.25 0.41 0.50 0.53 0.52 0.48 0.57 0.61
Mountain 0.76 0.77 0.43 0.86 0.82 0.85 1.01 0.82 0.94 0.97
Pacific 0.56 0.62 0.31 0.44 0.62 0.67 0.60 0.58 0.70 0.76
COUNTY TYPE                    
Large Metro 0.30 0.28 0.21 0.32 0.32 0.31 0.38 0.40 0.37 0.35
Small Metro 0.39 0.47 0.35 0.27 0.43 0.51 0.47 0.62 0.49 0.57
Nonmetro 0.53 0.68 0.55 0.61 0.57 0.73 0.72 0.65 0.64 0.83
Urbanized 0.86 1.32 0.91 0.27 0.90 1.44 0.76 1.01 1.03 1.65
Less Urbanized 0.88 0.96 1.18 1.26 0.94 1.03 1.28 1.03 1.07 1.18
Completely Rural 1.39 1.12 0.37 1.20 1.54 1.19 2.11 1.44 1.73 1.32
POVERTY LEVEL1                    
Less Than 100% 0.57 0.59 0.39 0.43 0.63 0.66 0.54 0.55 0.79 0.84
100‑199% 0.52 0.51 0.34 0.43 0.58 0.56 0.58 0.59 0.68 0.66
200% or More 0.28 0.28 0.25 0.27 0.30 0.30 0.38 0.46 0.33 0.33
HEALTH INSURANCE2                    
Private 0.27 0.29 0.23 0.27 0.29 0.32 0.38 0.44 0.33 0.36
Medicaid/CHIP 0.51 0.52 0.28 0.33 0.61 0.61 0.61 0.56 0.73 0.75
Other3 0.53 0.51 0.63 0.82 0.54 0.52 0.82 0.81 0.56 0.54
No Coverage 0.54 0.67 0.37 0.75 0.56 0.70 0.48 0.56 0.69 0.88

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.100P – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0019   0.8093   0.0013   0.1862   0.0028  
GEOGRAPHIC DIVISION                    
Northeast 0.6871   0.5653   0.6385   0.0182   0.8939  
New England 0.9675   0.0839   0.9309   0.5635   0.8431  
Middle Atlantic 0.6149   0.2828   0.5417   0.0046   0.7750  
Midwest 0.3635   0.8633   0.3502   0.3391   0.2688  
East North Central 0.4053   0.7271   0.3663   0.4486   0.2965  
West North Central 0.7092   0.3656   0.7620   0.5562   0.6807  
South 0.0003   0.5296   0.0003   0.5159   0.0004  
South Atlantic 0.0230   0.1163   0.0160   0.3008   0.0243  
East South Central 0.1328   0.0029   0.1756   0.7792   0.1952  
West South Central 0.0174   0.1293   0.0222   0.7400   0.0158  
West 0.5250   0.2503   0.4604   0.3653   0.5453  
Mountain 0.0484   0.2338   0.0356   0.2119   0.0548  
Pacific 0.6278   0.6426   0.6656   0.8690   0.6321  
COUNTY TYPE                    
Large Metro 0.0073   0.0640   0.0036   0.2316   0.0083  
Small Metro 0.0934   0.0316   0.1178   0.7662   0.1073  
Nonmetro 0.6328   0.6347   0.6412   0.3529   0.6529  
Urbanized 0.1971   0.0509   0.1560   0.3205   0.2385  
Less Urbanized 0.3998   0.8756   0.3950   0.0921   0.5513  
Completely Rural 0.0721   0.3103   0.0546   0.3226   0.0749  
POVERTY LEVEL1                    
Less Than 100% 0.4873   0.6453   0.4873   0.5390   0.6990  
100‑199% 0.0245   0.5802   0.0206   0.4659   0.0188  
200% or More 0.0301   0.7718   0.0228   0.4065   0.0290  
HEALTH INSURANCE2                    
Private 0.0077   0.9342   0.0063   0.5484   0.0108  
Medicaid/CHIP 0.1013   0.6430   0.0887   0.0260   0.1803  
Other3 0.0489   0.7834   0.0476   0.5228   0.0465  
No Coverage 0.3999   0.3285   0.4362   0.9369   0.4417  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.101C – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 223 256 23 29 220 256 54 60 211 250
GEOGRAPHIC DIVISION                    
Northeast 82 155 5 14 82 159 12 16 80 158
New England 38 54 2 1 38 54 4 19 37 51
Middle Atlantic 73 146 4 14 73 150 12 7 71 149
Midwest 95 81 11 12 95 80 20 33 90 72
East North Central 79 71 6 11 78 71 18 29 73 64
West North Central 57 39 9 5 56 39 9 16 54 34
South 156 153 19 21 152 151 43 44 147 144
South Atlantic 138 121 9 20 135 119 38 33 130 115
East South Central 30 44 2 <1 30 44 10 10 28 42
West South Central 65 85 17 6 61 84 17 29 57 78
West 88 117 6 8 88 116 21 16 83 115
Mountain 66 67 2 6 66 67 17 9 63 64
Pacific 59 97 6 5 58 97 13 13 54 97
COUNTY TYPE                    
Large Metro 187 182 16 25 185 183 38 41 178 178
Small Metro 117 173 14 8 114 173 32 45 108 168
Nonmetro 68 57 9 11 68 56 22 8 62 54
Urbanized 31 27 7 1 30 27 7 3 28 27
Less Urbanized 30 50 6 11 30 48 6 7 29 45
Completely Rural 51 16 <1 * 51 16 19 1 47 16
POVERTY LEVEL1                    
Less Than 100% 98 96 7 12 97 95 26 37 94 88
100‑199% 104 151 11 15 103 150 29 34 99 145
200% or More 170 183 19 17 168 185 36 32 165 182
HEALTH INSURANCE2                    
Private 155 160 18 19 153 158 37 43 148 154
Medicaid/CHIP 130 128 16 22 128 126 33 36 121 121
Other3 114 172 4 * 114 172 15 6 113 171
No Coverage 68 73 1 1 68 73 12 18 66 71

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.101D – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.08 0.09 0.09 0.11 0.08 0.09 0.15 0.17 0.09 0.11
GEOGRAPHIC DIVISION                    
Northeast 0.16 0.30 0.12 0.35 0.18 0.33 0.21 0.27 0.20 0.38
New England 0.28 0.40 0.22 0.13 0.30 0.44 0.24 1.15 0.34 0.48
Middle Atlantic 0.20 0.38 0.14 0.47 0.22 0.42 0.28 0.15 0.24 0.48
Midwest 0.16 0.13 0.20 0.23 0.17 0.15 0.28 0.43 0.19 0.15
East North Central 0.19 0.17 0.15 0.31 0.21 0.19 0.38 0.56 0.23 0.20
West North Central 0.30 0.21 0.51 0.29 0.33 0.22 0.37 0.66 0.38 0.23
South 0.14 0.13 0.18 0.20 0.15 0.14 0.31 0.31 0.17 0.16
South Atlantic 0.23 0.20 0.18 0.39 0.24 0.21 0.52 0.45 0.27 0.23
East South Central 0.18 0.25 0.12 0.03 0.20 0.28 0.50 0.47 0.22 0.32
West South Central 0.18 0.23 0.45 0.17 0.18 0.25 0.37 0.59 0.20 0.27
West 0.13 0.17 0.10 0.13 0.14 0.18 0.26 0.18 0.16 0.21
Mountain 0.29 0.29 0.10 0.29 0.31 0.32 0.60 0.30 0.35 0.36
Pacific 0.13 0.20 0.15 0.13 0.14 0.22 0.24 0.23 0.15 0.26
COUNTY TYPE                    
Large Metro 0.11 0.11 0.10 0.17 0.12 0.12 0.20 0.20 0.13 0.13
Small Metro 0.13 0.18 0.17 0.10 0.14 0.20 0.27 0.38 0.16 0.23
Nonmetro 0.19 0.17 0.33 0.40 0.21 0.18 0.52 0.20 0.22 0.20
Urbanized 0.23 0.21 0.67 0.14 0.24 0.23 0.37 0.22 0.26 0.26
Less Urbanized 0.25 0.35 0.56 0.94 0.27 0.38 0.41 0.43 0.30 0.41
Completely Rural 0.55 0.21 0.05 * 0.61 0.23 2.07 0.15 0.65 0.26
POVERTY LEVEL1                    
Less Than 100% 0.21 0.19 0.12 0.21 0.23 0.22 0.30 0.37 0.29 0.26
100‑199% 0.19 0.24 0.20 0.26 0.20 0.27 0.34 0.40 0.23 0.31
200% or More 0.09 0.10 0.13 0.12 0.10 0.11 0.20 0.18 0.11 0.12
HEALTH INSURANCE2                    
Private 0.09 0.09 0.12 0.14 0.09 0.10 0.18 0.21 0.10 0.11
Medicaid/CHIP 0.22 0.21 0.15 0.21 0.26 0.25 0.37 0.38 0.30 0.29
Other3 0.14 0.20 0.30 * 0.15 0.21 0.51 0.23 0.15 0.21
No Coverage 0.27 0.29 0.11 0.11 0.28 0.30 0.25 0.35 0.35 0.37

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.101P – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.5620   0.9125   0.5556   0.7673   0.5910  
GEOGRAPHIC DIVISION                    
Northeast 0.3875   0.2803   0.4516   0.4768   0.4976  
New England 0.5000   0.3325   0.4791   0.1552   0.7618  
Middle Atlantic 0.5140   0.2052   0.6025   0.3533   0.5395  
Midwest 0.3386   0.8049   0.3169   0.2224   0.1351  
East North Central 0.4326   0.3385   0.3596   0.3823   0.1936  
West North Central 0.6097   0.4312   0.6910   0.3367   0.4900  
South 0.1885   0.3368   0.2208   0.3045   0.3294  
South Atlantic 0.1532   0.7133   0.1325   0.2007   0.2299  
East South Central 0.9248   0.2518   0.9013   0.5693   0.7706  
West South Central 0.7709   0.0608   0.9880   0.8204   0.9430  
West 0.6889   0.8005   0.7083   0.3701   0.5780  
Mountain 0.4498   0.3564   0.4080   0.1923   0.5664  
Pacific 0.2567   0.6745   0.2478   0.9505   0.2428  
COUNTY TYPE                    
Large Metro 0.6970   0.5625   0.6338   0.7084   0.6783  
Small Metro 0.9304   0.3047   0.8685   0.5663   0.9887  
Nonmetro 0.1873   0.7616   0.1969   0.1228   0.3431  
Urbanized 0.5439   0.3295   0.6586   0.6440   0.6776  
Less Urbanized 0.6951   0.9411   0.7006   0.9448   0.6806  
Completely Rural 0.0154   *   0.0152   0.0619   0.0661  
POVERTY LEVEL1                    
Less Than 100% 0.6479   0.2911   0.5609   0.8472   0.6049  
100‑199% 0.9236   0.9044   0.9280   0.5352   0.8114  
200% or More 0.5717   0.5310   0.6055   0.3534   0.7341  
HEALTH INSURANCE2                    
Private 0.7230   0.6116   0.6832   0.5521   0.8051  
Medicaid/CHIP 0.1942   0.8321   0.1667   0.2834   0.2514  
Other3 0.9031   *   0.8800   0.1824   0.8008  
No Coverage 0.8598   0.7700   0.8654   0.4903   0.9886  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.102C – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 132 141 11 12 132 140 30 36 129 135
GEOGRAPHIC DIVISION                    
Northeast 55 79 3 * 55 79 9 18 54 77
New England 8 23 2 * 8 23 1 * 8 14
Middle Atlantic 54 75 2 * 54 75 9 5 53 75
Midwest 59 38 8 11 59 37 15 9 57 35
East North Central 46 32 * 10 46 31 15 7 43 30
West North Central 40 20 8 4 39 20 3 4 39 19
South 85 95 7 5 85 95 21 29 82 91
South Atlantic 73 85 5 * 73 85 17 23 71 82
East South Central 22 18 <1 <1 22 18 10 2 20 18
West South Central 38 49 5 5 37 49 9 18 36 46
West 63 46 <1 1 63 46 11 8 63 46
Mountain 48 17 <1 1 48 17 2 1 48 17
Pacific 41 45 <1 * 41 45 11 8 41 44
COUNTY TYPE                    
Large Metro 100 100 5 2 100 100 25 21 97 98
Small Metro 66 88 6 4 66 88 4 30 66 83
Nonmetro 58 36 8 11 57 34 17 2 55 34
Urbanized 33 23 * 1 32 23 4 1 32 22
Less Urbanized 16 27 5 11 15 24 5 1 14 24
Completely Rural 44 11 * * 44 11 * * 42 11
POVERTY LEVEL1                    
Less Than 100% 60 51 1 6 60 50 22 28 56 42
100‑199% 57 66 5 10 57 65 13 21 55 62
200% or More 106 108 10 1 106 108 14 11 105 108
HEALTH INSURANCE2                    
Private 88 94 10 10 88 93 18 19 86 91
Medicaid/CHIP 80 65 6 6 79 65 23 29 76 58
Other3 77 107 * * 77 107 <1 4 77 107
No Coverage 49 33 * * 49 33 2 11 49 31

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.102D – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.05 0.05 0.04 0.05 0.05 0.05 0.09 0.10 0.06 0.06
GEOGRAPHIC DIVISION                    
Northeast 0.11 0.15 0.08 * 0.12 0.17 0.15 0.30 0.13 0.18
New England 0.06 0.18 0.19 * 0.07 0.19 0.06 * 0.08 0.14
Middle Atlantic 0.15 0.20 0.08 * 0.16 0.22 0.20 0.12 0.18 0.25
Midwest 0.10 0.06 0.16 0.21 0.11 0.07 0.21 0.11 0.12 0.08
East North Central 0.11 0.08 * 0.28 0.12 0.08 0.30 0.14 0.14 0.09
West North Central 0.21 0.11 0.48 0.26 0.23 0.12 0.13 0.19 0.27 0.13
South 0.08 0.08 0.07 0.05 0.08 0.09 0.16 0.21 0.09 0.10
South Atlantic 0.12 0.14 0.09 * 0.13 0.15 0.25 0.33 0.15 0.17
East South Central 0.13 0.11 0.01 0.01 0.15 0.12 0.47 0.10 0.15 0.13
West South Central 0.10 0.14 0.13 0.13 0.12 0.15 0.19 0.38 0.13 0.17
West 0.09 0.07 0.01 0.01 0.10 0.07 0.14 0.09 0.12 0.09
Mountain 0.21 0.07 0.01 0.04 0.24 0.08 0.08 0.04 0.27 0.10
Pacific 0.09 0.10 0.01 * 0.10 0.11 0.20 0.14 0.11 0.12
COUNTY TYPE                    
Large Metro 0.06 0.06 0.04 0.01 0.07 0.07 0.13 0.10 0.07 0.07
Small Metro 0.08 0.10 0.07 0.05 0.08 0.11 0.04 0.26 0.10 0.12
Nonmetro 0.17 0.11 0.29 0.40 0.19 0.11 0.39 0.04 0.21 0.13
Urbanized 0.25 0.18 * 0.06 0.26 0.20 0.20 0.10 0.31 0.23
Less Urbanized 0.13 0.20 0.45 0.93 0.14 0.19 0.33 0.05 0.15 0.22
Completely Rural 0.52 0.14 * * 0.57 0.16 * * 0.62 0.18
POVERTY LEVEL1                    
Less Than 100% 0.13 0.10 0.01 0.10 0.15 0.12 0.27 0.29 0.17 0.13
100‑199% 0.10 0.11 0.09 0.18 0.11 0.12 0.15 0.24 0.13 0.13
200% or More 0.06 0.06 0.07 0.01 0.06 0.06 0.08 0.06 0.07 0.07
HEALTH INSURANCE2                    
Private 0.05 0.05 0.07 0.08 0.05 0.06 0.09 0.09 0.06 0.07
Medicaid/CHIP 0.13 0.11 0.06 0.06 0.16 0.13 0.26 0.31 0.19 0.14
Other3 0.10 0.13 * * 0.10 0.13 <0.01 0.15 0.10 0.13
No Coverage 0.20 0.13 * * 0.21 0.14 0.04 0.22 0.26 0.17

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.102P – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1257   0.8247   0.1263   0.9339   0.1108  
GEOGRAPHIC DIVISION                    
Northeast 0.9319   *   0.9724   0.3376   0.8079  
New England 0.2205   *   0.1812   *   0.4555  
Middle Atlantic 0.6671   *   0.6825   0.8625   0.6974  
Midwest 0.0737   0.7115   0.0574   0.5556   0.0698  
East North Central 0.2310   *   0.1609   0.3851   0.2309  
West North Central 0.1881   0.6008   0.2184   0.4348   0.1810  
South 0.3923   0.6308   0.4045   0.9463   0.3732  
South Atlantic 0.5833   *   0.6115   0.8921   0.6241  
East South Central 0.3459   0.8773   0.3428   0.1192   0.6682  
West South Central 0.7351   0.8582   0.7158   0.2736   0.4456  
West 0.5125   0.6719   0.5047   0.5958   0.5667  
Mountain 0.1416   0.3089   0.1361   0.1192   0.1580  
Pacific 0.7064   *   0.7074   0.8085   0.6630  
COUNTY TYPE                    
Large Metro 0.1841   0.3080   0.1929   0.4228   0.2520  
Small Metro 0.8362   0.8054   0.8460   0.0515   0.4448  
Nonmetro 0.2136   0.7876   0.1855   0.0676   0.3560  
Urbanized 0.9655   *   0.8420   0.5321   0.8116  
Less Urbanized 0.9144   0.4571   0.6775   0.1206   0.8867  
Completely Rural 0.0603   *   0.0601   *   0.1358  
POVERTY LEVEL1                    
Less Than 100% 0.2532   0.1653   0.2102   0.4563   0.3067  
100‑199% 0.7612   0.4858   0.8320   0.2094   0.8872  
200% or More 0.1143   0.0486   0.1432   0.8196   0.1478  
HEALTH INSURANCE2                    
Private 0.2912   0.8829   0.2932   0.6884   0.3249  
Medicaid/CHIP 0.1194   0.8505   0.1099   0.6527   0.1228  
Other3 0.7963   *   0.7964   0.0972   0.8398  
No Coverage 0.8202   *   0.8151   0.0256   0.4994  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.103C – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 536 555 52 43 532 554 67 78 529 548
GEOGRAPHIC DIVISION                    
Northeast 193 237 16 16 191 236 22 21 189 236
New England 118 146 7 7 117 145 12 2 116 145
Middle Atlantic 150 192 14 14 148 191 19 21 147 191
Midwest 190 214 25 17 188 210 34 30 185 206
East North Central 146 174 23 14 146 172 30 26 142 168
West North Central 119 115 12 10 117 111 15 16 116 109
South 360 356 35 32 360 353 44 56 360 350
South Atlantic 290 282 18 28 287 280 29 35 285 277
East South Central 126 137 6 9 126 137 8 23 126 134
West South Central 169 179 29 11 168 178 32 36 170 175
West 279 283 29 19 270 283 27 40 268 276
Mountain 137 132 8 18 136 131 18 25 135 127
Pacific 243 249 28 7 233 249 20 30 231 242
COUNTY TYPE                    
Large Metro 425 432 46 37 419 429 55 63 418 423
Small Metro 257 330 26 21 254 331 34 41 251 327
Nonmetro 173 147 7 11 172 146 16 20 169 144
Urbanized 126 96 6 4 125 96 9 12 124 95
Less Urbanized 104 80 4 8 102 77 11 13 99 76
Completely Rural 62 80 2 5 61 81 9 11 61 80
POVERTY LEVEL1                    
Less Than 100% 187 191 18 14 185 190 33 37 183 184
100‑199% 200 262 17 14 199 260 35 34 196 259
200% or More 440 431 46 37 434 429 45 59 431 425
HEALTH INSURANCE2                    
Private 416 391 44 31 409 389 48 62 405 384
Medicaid/CHIP 211 237 31 24 208 235 33 36 206 229
Other3 331 389 8 * 331 389 35 19 330 388
No Coverage 99 124 5 3 99 124 11 25 98 121

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.103D – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.17 0.17 0.20 0.16 0.19 0.19 0.18 0.21 0.22 0.22
GEOGRAPHIC DIVISION                    
Northeast 0.37 0.44 0.37 0.38 0.40 0.47 0.36 0.35 0.45 0.54
New England 0.76 0.99 0.70 0.65 0.82 1.07 0.72 0.16 0.94 1.23
Middle Atlantic 0.41 0.47 0.44 0.47 0.44 0.51 0.43 0.48 0.50 0.59
Midwest 0.30 0.33 0.47 0.31 0.32 0.36 0.46 0.38 0.37 0.41
East North Central 0.33 0.40 0.62 0.38 0.37 0.44 0.59 0.47 0.41 0.50
West North Central 0.58 0.54 0.64 0.55 0.63 0.58 0.65 0.68 0.72 0.67
South 0.30 0.29 0.33 0.30 0.33 0.32 0.32 0.38 0.38 0.37
South Atlantic 0.45 0.43 0.34 0.53 0.49 0.47 0.43 0.46 0.55 0.54
East South Central 0.68 0.82 0.38 0.58 0.76 0.91 0.36 1.10 0.88 1.03
West South Central 0.45 0.44 0.77 0.32 0.49 0.49 0.66 0.71 0.58 0.56
West 0.38 0.38 0.46 0.31 0.40 0.41 0.31 0.45 0.46 0.46
Mountain 0.57 0.55 0.37 0.82 0.63 0.59 0.58 0.83 0.73 0.68
Pacific 0.48 0.49 0.67 0.16 0.51 0.53 0.36 0.52 0.58 0.60
COUNTY TYPE                    
Large Metro 0.24 0.23 0.29 0.25 0.26 0.26 0.28 0.29 0.30 0.29
Small Metro 0.26 0.34 0.31 0.24 0.29 0.37 0.27 0.34 0.33 0.43
Nonmetro 0.48 0.40 0.26 0.37 0.52 0.44 0.40 0.52 0.59 0.50
Urbanized 0.85 0.74 0.55 0.45 0.91 0.81 0.47 0.73 1.06 0.93
Less Urbanized 0.81 0.50 0.37 0.68 0.88 0.54 0.75 0.78 0.97 0.62
Completely Rural 0.69 0.97 0.34 0.77 0.76 1.06 0.99 1.36 0.84 1.19
POVERTY LEVEL1                    
Less Than 100% 0.39 0.38 0.33 0.25 0.44 0.43 0.39 0.36 0.55 0.54
100‑199% 0.35 0.41 0.32 0.25 0.39 0.45 0.40 0.39 0.46 0.53
200% or More 0.22 0.22 0.30 0.26 0.23 0.24 0.24 0.33 0.26 0.26
HEALTH INSURANCE2                    
Private 0.22 0.21 0.29 0.22 0.24 0.23 0.24 0.29 0.27 0.26
Medicaid/CHIP 0.34 0.37 0.30 0.22 0.41 0.44 0.36 0.38 0.49 0.52
Other3 0.40 0.44 0.55 * 0.41 0.44 1.17 0.69 0.42 0.46
No Coverage 0.39 0.49 0.44 0.31 0.41 0.51 0.22 0.50 0.51 0.63

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.103P – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7674   0.0339   0.8962   0.4714   0.8410  
GEOGRAPHIC DIVISION                    
Northeast 0.2398   0.7330   0.2318   0.0995   0.1657  
New England 0.4907   0.9296   0.4905   0.0015   0.3537  
Middle Atlantic 0.3355   0.7367   0.3231   0.6890   0.2922  
Midwest 0.5057   0.3192   0.5658   0.3839   0.6724  
East North Central 0.8115   0.3334   0.8957   0.4332   0.9881  
West North Central 0.3945   0.7470   0.3957   0.6912   0.4295  
South 0.9623   0.3656   0.9864   0.0349   0.7897  
South Atlantic 0.7826   0.4114   0.8482   0.3535   0.9194  
East South Central 0.8091   0.7362   0.7859   0.0363   0.5847  
West South Central 0.7210   0.0180   0.9550   0.2465   0.7774  
West 0.3346   0.0690   0.4103   0.7453   0.3857  
Mountain 0.3860   0.4104   0.3335   0.8082   0.3567  
Pacific 0.5297   0.0058   0.6854   0.5275   0.6331  
COUNTY TYPE                    
Large Metro 0.8201   0.1603   0.9099   0.6504   0.9079  
Small Metro 0.6140   0.0215   0.4929   0.8995   0.5121  
Nonmetro 0.1724   0.3102   0.1483   0.2867   0.0974  
Urbanized 0.7556   0.3728   0.7977   0.0529   0.5623  
Less Urbanized 0.0551   0.1869   0.0405   0.6419   0.0423  
Completely Rural 0.9491   0.1616   0.9616   0.6478   0.9113  
POVERTY LEVEL1                    
Less Than 100% 0.1199   0.1056   0.1509   0.6310   0.2003  
100‑199% 0.8442   0.4852   0.8135   0.7490   0.8319  
200% or More 0.7412   0.1493   0.6549   0.1296   0.8002  
HEALTH INSURANCE2                    
Private 0.6052   0.0196   0.7535   0.1811   0.6611  
Medicaid/CHIP 0.2855   0.1680   0.3488   0.5004   0.3953  
Other3 0.4642   *   0.4501   0.1197   0.5121  
No Coverage 0.3978   0.9480   0.3998   0.2919   0.5062  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.104C – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 127 170 17 10 126 170 19 28 124 168
GEOGRAPHIC DIVISION                    
Northeast 56 136 6 * 56 136 5 11 55 136
New England 8 127 1 * 7 127 5 1 6 127
Middle Atlantic 55 49 5 * 55 49 1 11 55 48
Midwest 43 36 2 6 43 35 15 10 40 34
East North Central 27 19 1 4 27 19 15 9 23 17
West North Central 33 30 1 5 33 30 4 4 33 29
South 85 85 14 5 84 85 5 23 84 82
South Atlantic 78 79 8 1 78 79 4 17 78 77
East South Central 13 15 1 1 13 15 3 11 13 10
West South Central 31 28 11 5 29 27 <1 11 29 25
West 62 44 8 5 62 44 8 6 61 44
Mountain 44 16 4 5 44 16 4 1 44 16
Pacific 44 41 7 1 43 41 7 6 43 41
COUNTY TYPE                    
Large Metro 91 150 11 5 91 149 17 25 89 147
Small Metro 52 75 12 4 51 75 6 13 50 73
Nonmetro 71 35 4 7 71 34 4 5 71 34
Urbanized 70 19 3 1 70 19 3 2 69 19
Less Urbanized 10 29 3 6 9 28 <1 3 9 28
Completely Rural 9 6 <1 * 9 5 3 4 9 4
POVERTY LEVEL1                    
Less Than 100% 53 69 7 6 53 68 7 17 52 66
100‑199% 38 131 5 4 38 131 4 10 37 130
200% or More 109 82 15 7 108 81 17 19 106 79
HEALTH INSURANCE2                    
Private 85 81 11 7 84 81 16 19 82 79
Medicaid/CHIP 65 88 13 7 64 87 8 16 64 86
Other3 87 138 * * 87 138 3 3 87 138
No Coverage 19 18 1 2 19 18 4 14 18 12

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.104D – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.04 0.06 0.07 0.04 0.05 0.06 0.05 0.08 0.05 0.07
GEOGRAPHIC DIVISION                    
Northeast 0.11 0.27 0.13 * 0.12 0.30 0.08 0.19 0.14 0.34
New England 0.06 0.93 0.05 * 0.06 1.01 0.29 0.09 0.06 1.16
Middle Atlantic 0.15 0.14 0.18 * 0.17 0.15 0.03 0.25 0.19 0.17
Midwest 0.07 0.06 0.03 0.12 0.08 0.06 0.21 0.13 0.09 0.07
East North Central 0.07 0.05 0.03 0.11 0.07 0.05 0.30 0.17 0.07 0.05
West North Central 0.18 0.16 0.08 0.29 0.20 0.18 0.17 0.19 0.23 0.20
South 0.08 0.08 0.13 0.05 0.08 0.08 0.04 0.16 0.10 0.09
South Atlantic 0.13 0.13 0.15 0.02 0.14 0.14 0.07 0.24 0.16 0.16
East South Central 0.08 0.09 0.10 0.07 0.09 0.10 0.13 0.51 0.10 0.07
West South Central 0.09 0.08 0.32 0.14 0.09 0.08 0.01 0.23 0.11 0.09
West 0.09 0.06 0.13 0.08 0.10 0.07 0.10 0.07 0.11 0.08
Mountain 0.20 0.07 0.20 0.23 0.22 0.08 0.15 0.04 0.25 0.09
Pacific 0.09 0.09 0.17 0.03 0.10 0.10 0.13 0.10 0.12 0.11
COUNTY TYPE                    
Large Metro 0.06 0.09 0.07 0.04 0.06 0.10 0.09 0.12 0.07 0.11
Small Metro 0.06 0.08 0.15 0.05 0.06 0.09 0.05 0.11 0.07 0.10
Nonmetro 0.21 0.10 0.15 0.26 0.23 0.11 0.09 0.12 0.26 0.13
Urbanized 0.51 0.15 0.26 0.12 0.55 0.17 0.15 0.10 0.66 0.19
Less Urbanized 0.08 0.21 0.31 0.52 0.08 0.22 0.03 0.16 0.10 0.26
Completely Rural 0.11 0.08 0.05 * 0.12 0.08 0.31 0.43 0.13 0.07
POVERTY LEVEL1                    
Less Than 100% 0.11 0.14 0.12 0.10 0.13 0.16 0.09 0.17 0.16 0.20
100‑199% 0.07 0.21 0.10 0.07 0.08 0.24 0.04 0.12 0.09 0.28
200% or More 0.06 0.05 0.10 0.05 0.06 0.05 0.09 0.11 0.07 0.05
HEALTH INSURANCE2                    
Private 0.05 0.05 0.07 0.05 0.05 0.05 0.08 0.09 0.06 0.06
Medicaid/CHIP 0.11 0.14 0.13 0.07 0.13 0.17 0.09 0.17 0.16 0.21
Other3 0.11 0.17 * * 0.11 0.17 0.09 0.12 0.12 0.17
No Coverage 0.07 0.07 0.09 0.14 0.08 0.08 0.09 0.27 0.10 0.06

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.104P – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.8152   0.1060   0.7047   0.2443   0.8428  
GEOGRAPHIC DIVISION                    
Northeast 0.3665   *   0.3323   0.6279   0.3504  
New England 0.2222   *   0.2209   0.1763   0.2000  
Middle Atlantic 0.7882   *   0.8849   0.2530   0.7530  
Midwest 0.9596   0.1206   0.8884   0.8176   0.9422  
East North Central 0.9470   0.1870   0.9168   0.7766   0.9666  
West North Central 0.9901   0.3526   0.9221   0.9074   0.9095  
South 0.8897   0.0998   0.7346   0.0392   0.9516  
South Atlantic 0.5808   0.1539   0.5164   0.1578   0.6614  
East South Central 0.5688   0.7548   0.5855   0.4670   0.2416  
West South Central 0.4415   0.3108   0.6220   0.1483   0.3578  
West 0.1735   0.4134   0.2034   0.3126   0.2538  
Mountain 0.1072   0.8096   0.0973   0.4212   0.1128  
Pacific 0.6401   0.1785   0.7512   0.4648   0.8381  
COUNTY TYPE                    
Large Metro 0.7214   0.1047   0.6443   0.4349   0.7378  
Small Metro 0.6526   0.1362   0.5051   0.3045   0.6081  
Nonmetro 0.5008   0.4141   0.4460   0.8833   0.4339  
Urbanized 0.2591   0.3019   0.2774   0.6356   0.2808  
Less Urbanized 0.2960   0.3669   0.3909   0.3609   0.4348  
Completely Rural 0.7548   *   0.5323   0.9470   0.4687  
POVERTY LEVEL1                    
Less Than 100% 0.8087   0.6607   0.8388   0.3859   0.7159  
100‑199% 0.2742   0.4683   0.2573   0.4419   0.2858  
200% or More 0.5642   0.1469   0.6777   0.5458   0.5883  
HEALTH INSURANCE2                    
Private 0.8406   0.2635   0.7495   0.6403   0.8209  
Medicaid/CHIP 0.9876   0.2876   0.9009   0.6202   0.9670  
Other3 0.5842   *   0.5842   0.9646   0.5873  
No Coverage 0.7516   0.5076   0.7129   0.2798   0.2536  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.105C – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 61 78 6 5 61 78 12 6 60 78
GEOGRAPHIC DIVISION                    
Northeast 49 45 1 * 49 45 <1 2 49 45
New England 3 4 1 * 3 4 <1 1 3 4
Middle Atlantic 49 45 * * 49 45 * 2 49 45
Midwest 16 28 1 5 15 28 10 2 12 28
East North Central 14 10 * 3 14 10 10 2 10 9
West North Central 7 26 1 3 7 26 2 * 7 26
South 27 58 4 1 27 58 5 5 27 58
South Atlantic 16 52 1 * 16 52 4 5 16 52
East South Central 7 8 <1 1 7 8 3 * 6 8
West South Central 21 23 4 * 21 23 <1 1 21 23
West 17 10 4 * 17 10 6 1 16 10
Mountain 15 1 * * 15 1 4 1 14 1
Pacific 9 10 4 * 8 10 4 * 8 10
COUNTY TYPE                    
Large Metro 57 53 4 1 56 53 12 6 55 52
Small Metro 22 52 4 3 22 52 2 1 22 52
Nonmetro 7 27 1 3 7 27 3 <1 7 27
Urbanized 4 * 1 * 4 * 2 * 4 *
Less Urbanized 5 27 <1 * 5 27 <1 <1 5 27
Completely Rural 3 3 <1 * 3 * 2 * 2 *
POVERTY LEVEL1                    
Less Than 100% 21 47 4 3 20 47 6 1 19 47
100‑199% 17 39 1 3 17 39 3 2 17 39
200% or More 55 44 4 * 55 44 10 5 54 44
HEALTH INSURANCE2                    
Private 54 47 4 3 54 47 11 2 53 47
Medicaid/CHIP 24 61 4 5 23 60 4 1 23 60
Other3 18 62 * * 18 62 2 2 18 62
No Coverage 14 10 * 1 14 9 3 5 14 8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.105D – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.02 0.03 0.02 0.02 0.02 0.03 0.03 0.02 0.03 0.03
GEOGRAPHIC DIVISION                    
Northeast 0.10 0.09 0.01 * 0.11 0.10 0.01 0.04 0.12 0.11
New England 0.02 0.03 0.05 * 0.02 0.03 0.03 0.06 0.02 0.04
Middle Atlantic 0.14 0.12 * * 0.15 0.13 * 0.05 0.17 0.15
Midwest 0.03 0.05 0.01 0.09 0.03 0.05 0.13 0.03 0.03 0.06
East North Central 0.03 0.03 * 0.10 0.04 0.03 0.19 0.05 0.03 0.03
West North Central 0.04 0.14 0.04 0.17 0.04 0.15 0.10 * 0.05 0.18
South 0.02 0.05 0.04 0.01 0.03 0.06 0.03 0.03 0.03 0.06
South Atlantic 0.03 0.09 0.02 * 0.03 0.10 0.06 0.07 0.03 0.11
East South Central 0.04 0.05 0.01 0.07 0.05 0.05 0.13 * 0.05 0.06
West South Central 0.06 0.06 0.11 * 0.06 0.07 0.01 0.01 0.08 0.08
West 0.03 0.01 0.06 * 0.03 0.02 0.07 0.01 0.03 0.02
Mountain 0.07 <0.01 * * 0.07 <0.01 0.15 0.02 0.08 <0.01
Pacific 0.02 0.02 0.09 * 0.02 0.02 0.07 * 0.02 0.03
COUNTY TYPE                    
Large Metro 0.03 0.03 0.03 0.01 0.04 0.03 0.06 0.03 0.04 0.04
Small Metro 0.02 0.06 0.05 0.04 0.03 0.06 0.02 0.01 0.03 0.07
Nonmetro 0.02 0.08 0.03 0.12 0.02 0.09 0.06 <0.01 0.02 0.10
Urbanized 0.03 * 0.06 * 0.03 * 0.08 * 0.04 *
Less Urbanized 0.04 0.20 0.02 * 0.04 0.21 0.03 0.01 0.05 0.24
Completely Rural 0.04 0.04 0.05 * 0.04 * 0.26 * 0.03 *
POVERTY LEVEL1                    
Less Than 100% 0.04 0.10 0.07 0.06 0.05 0.11 0.07 0.01 0.06 0.14
100‑199% 0.03 0.06 0.02 0.06 0.03 0.07 0.04 0.03 0.04 0.08
200% or More 0.03 0.02 0.02 * 0.03 0.03 0.06 0.03 0.04 0.03
HEALTH INSURANCE2                    
Private 0.03 0.03 0.03 0.02 0.03 0.03 0.06 0.01 0.04 0.03
Medicaid/CHIP 0.04 0.10 0.04 0.04 0.05 0.12 0.04 0.01 0.06 0.15
Other3 0.02 0.07 * * 0.02 0.08 0.06 0.09 0.02 0.08
No Coverage 0.06 0.04 * 0.09 0.06 0.04 0.05 0.10 0.07 0.04

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.105P – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.6112   0.7776   0.5987   0.0939   0.4416  
GEOGRAPHIC DIVISION                    
Northeast 0.9415   *   0.9371   0.2943   0.9654  
New England 0.8156   *   0.7246   0.7102   0.7864  
Middle Atlantic 0.9552   *   0.9575   *   0.9801  
Midwest 0.6115   0.1420   0.7658   0.2986   0.5052  
East North Central 0.9600   *   0.8304   0.4830   0.8098  
West North Central 0.5694   0.4464   0.6273   *   0.5322  
South 0.4260   0.2806   0.3860   0.4398   0.3386  
South Atlantic 0.1637   *   0.1565   0.7692   0.1446  
East South Central 0.6268   0.4743   0.5740   *   0.8232  
West South Central 0.5174   *   0.5989   0.6812   0.5950  
West 0.2860   *   0.3688   0.0856   0.6682  
Mountain 0.2388   *   0.2390   0.3378   0.3450  
Pacific 0.7696   *   0.9822   *   0.6760  
COUNTY TYPE                    
Large Metro 0.6517   0.3821   0.6798   0.1785   0.8588  
Small Metro 0.2416   0.8896   0.2347   0.5113   0.2243  
Nonmetro 0.4766   0.5351   0.5207   0.1442   0.4327  
Urbanized *   *   *   *   *  
Less Urbanized 0.2955   *   0.2924   0.5531   0.2867  
Completely Rural 0.7773   *   *   *   *  
POVERTY LEVEL1                    
Less Than 100% 0.5416   0.7670   0.5208   0.0460   0.3520  
100‑199% 0.5883   0.3854   0.6391   0.3740   0.5855  
200% or More 0.9436   *   0.9840   0.5709   0.9416  
HEALTH INSURANCE2                    
Private 0.9085   0.8973   0.9125   0.0727   0.8470  
Medicaid/CHIP 0.4510   0.9434   0.4556   0.1206   0.4014  
Other3 0.0998   *   0.0998   0.7863   0.1020  
No Coverage 0.4603   *   0.4218   0.7329   0.3347  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.106C – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 653 674 43 50 651 673 95 104 639 660
GEOGRAPHIC DIVISION                    
Northeast 294 345 17 22 291 348 36 40 291 344
New England 170 181 7 2 169 180 23 39 167 173
Middle Atlantic 242 300 15 21 238 303 29 18 240 303
Midwest 252 278 21 19 253 277 39 48 249 268
East North Central 231 232 17 17 231 232 33 43 227 223
West North Central 115 140 12 10 115 137 21 22 110 137
South 438 391 31 29 436 389 64 73 428 377
South Atlantic 359 297 14 26 358 296 54 60 349 286
East South Central 134 163 9 4 134 164 17 17 129 161
West South Central 202 213 26 13 200 212 34 39 202 206
West 291 331 13 24 291 331 42 38 286 321
Mountain 153 157 4 17 153 157 26 21 150 154
Pacific 249 292 12 16 249 293 34 30 244 284
COUNTY TYPE                    
Large Metro 503 508 28 44 501 508 74 77 493 494
Small Metro 392 408 29 18 389 408 52 71 379 396
Nonmetro 189 232 14 17 187 229 32 21 179 225
Urbanized 124 156 4 2 123 156 15 15 118 153
Less Urbanized 114 134 13 16 110 131 19 10 106 129
Completely Rural 107 111 3 7 106 108 19 12 103 106
POVERTY LEVEL1                    
Less Than 100% 244 267 21 23 241 265 39 55 238 258
100‑199% 275 288 16 21 275 286 48 46 267 285
200% or More 531 527 32 34 531 528 69 75 523 519
HEALTH INSURANCE2                    
Private 480 500 30 38 480 498 74 85 468 491
Medicaid/CHIP 292 298 29 29 286 296 50 52 280 286
Other3 441 417 8 5 441 418 20 19 440 417
No Coverage 117 148 4 4 117 148 23 26 113 145

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.106D – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.20 0.20 0.17 0.19 0.22 0.22 0.26 0.28 0.25 0.25
GEOGRAPHIC DIVISION                    
Northeast 0.52 0.61 0.42 0.54 0.56 0.67 0.57 0.67 0.64 0.75
New England 1.08 1.25 0.73 0.23 1.17 1.35 1.20 2.22 1.33 1.52
Middle Atlantic 0.58 0.71 0.50 0.72 0.63 0.78 0.64 0.43 0.73 0.88
Midwest 0.37 0.41 0.38 0.36 0.41 0.45 0.53 0.60 0.46 0.51
East North Central 0.48 0.51 0.46 0.46 0.53 0.56 0.67 0.78 0.59 0.63
West North Central 0.56 0.64 0.66 0.55 0.63 0.70 0.84 0.88 0.71 0.80
South 0.34 0.30 0.30 0.28 0.38 0.34 0.44 0.50 0.43 0.38
South Atlantic 0.52 0.44 0.27 0.49 0.57 0.48 0.72 0.80 0.65 0.54
East South Central 0.71 0.94 0.57 0.29 0.78 1.04 0.78 0.76 0.88 1.20
West South Central 0.53 0.51 0.73 0.36 0.59 0.57 0.70 0.77 0.69 0.63
West 0.37 0.44 0.21 0.39 0.41 0.48 0.48 0.43 0.46 0.54
Mountain 0.59 0.66 0.21 0.81 0.65 0.72 0.89 0.72 0.75 0.83
Pacific 0.47 0.57 0.29 0.41 0.52 0.63 0.57 0.52 0.58 0.71
COUNTY TYPE                    
Large Metro 0.27 0.26 0.19 0.29 0.30 0.29 0.37 0.36 0.34 0.33
Small Metro 0.36 0.41 0.35 0.21 0.40 0.45 0.42 0.59 0.45 0.51
Nonmetro 0.46 0.60 0.48 0.61 0.50 0.65 0.72 0.55 0.56 0.73
Urbanized 0.77 1.14 0.35 0.22 0.82 1.24 0.70 0.97 0.94 1.39
Less Urbanized 0.72 0.81 1.18 1.28 0.77 0.87 1.28 0.64 0.88 0.99
Completely Rural 1.11 1.17 0.37 1.13 1.23 1.25 2.07 1.44 1.37 1.39
POVERTY LEVEL1                    
Less Than 100% 0.50 0.50 0.38 0.41 0.56 0.57 0.46 0.53 0.70 0.71
100‑199% 0.47 0.45 0.30 0.35 0.53 0.49 0.56 0.53 0.62 0.58
200% or More 0.25 0.25 0.22 0.23 0.27 0.28 0.37 0.41 0.30 0.30
HEALTH INSURANCE2                    
Private 0.24 0.26 0.20 0.26 0.26 0.28 0.36 0.39 0.29 0.32
Medicaid/CHIP 0.46 0.45 0.28 0.27 0.55 0.53 0.54 0.54 0.66 0.64
Other3 0.51 0.45 0.55 0.32 0.52 0.46 0.70 0.68 0.53 0.48
No Coverage 0.46 0.57 0.34 0.37 0.48 0.60 0.47 0.51 0.59 0.74

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.106P – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0108   0.6065   0.0080   0.2939   0.0134  
GEOGRAPHIC DIVISION                    
Northeast 0.8556   0.5844   0.8098   0.0781   0.9948  
New England 0.8964   0.1117   0.9308   0.9917   0.9276  
Middle Atlantic 0.8969   0.2985   0.8200   0.0062   0.9471  
Midwest 0.2828   0.9069   0.2646   0.3645   0.1964  
East North Central 0.2026   0.8856   0.1955   0.2740   0.1266  
West North Central 0.9327   0.6580   0.9782   0.9277   0.9508  
South 0.0027   0.5450   0.0029   0.5147   0.0039  
South Atlantic 0.0116   0.1420   0.0082   0.3087   0.0128  
East South Central 0.7627   0.0881   0.8143   0.6706   0.8667  
West South Central 0.0858   0.0857   0.1172   0.6029   0.0933  
West 0.7130   0.1288   0.6202   0.4200   0.7113  
Mountain 0.2088   0.0639   0.1527   0.3854   0.2006  
Pacific 0.7629   0.6737   0.7991   0.7189   0.7487  
COUNTY TYPE                    
Large Metro 0.0478   0.0881   0.0296   0.1831   0.0568  
Small Metro 0.1626   0.0620   0.1981   0.7177   0.1540  
Nonmetro 0.4383   0.7473   0.4089   0.2613   0.4432  
Urbanized 0.8600   0.3589   0.8283   0.4497   1.0000  
Less Urbanized 0.2934   0.9763   0.2810   0.0225   0.4674  
Completely Rural 0.5479   0.3486   0.4769   0.6029   0.5308  
POVERTY LEVEL1                    
Less Than 100% 0.2974   0.5989   0.3029   0.9102   0.3929  
100‑199% 0.1539   0.7581   0.1423   0.9072   0.1186  
200% or More 0.0774   0.3690   0.0580   0.2422   0.0809  
HEALTH INSURANCE2                    
Private 0.0563   0.1807   0.0394   0.3949   0.0652  
Medicaid/CHIP 0.0909   0.4015   0.0886   0.1957   0.1312  
Other3 0.0397   0.5383   0.0404   0.4352   0.0405  
No Coverage 0.7454   0.5820   0.7731   0.7791   0.8167  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.107C – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 208 248 20 29 207 248 51 57 198 242
GEOGRAPHIC DIVISION                    
Northeast 82 151 5 14 82 154 12 16 81 154
New England 36 30 2 1 36 30 4 19 36 26
Middle Atlantic 74 148 4 14 73 152 12 7 73 151
Midwest 91 72 8 13 91 70 20 32 86 63
East North Central 78 63 6 11 78 62 18 29 73 55
West North Central 51 33 6 6 51 32 9 12 49 30
South 139 160 17 21 137 157 42 41 131 152
South Atlantic 120 128 8 20 118 127 37 31 113 123
East South Central 30 41 2 <1 30 41 10 3 28 41
West South Central 60 81 15 7 58 80 17 27 54 76
West 87 94 6 8 87 94 19 16 84 93
Mountain 61 55 3 6 61 55 12 9 60 52
Pacific 62 79 5 5 62 78 14 13 59 78
COUNTY TYPE                    
Large Metro 160 165 13 25 160 166 38 38 153 162
Small Metro 110 177 15 8 107 177 27 44 103 172
Nonmetro 76 54 7 12 76 52 22 8 71 52
Urbanized 46 27 2 1 46 27 7 3 44 27
Less Urbanized 30 44 6 12 29 42 6 7 29 42
Completely Rural 51 16 <1 * 51 16 18 1 47 16
POVERTY LEVEL1                    
Less Than 100% 76 101 8 12 75 101 25 36 71 94
100‑199% 80 146 10 15 79 145 27 33 75 140
200% or More 167 172 16 18 167 174 35 29 165 171
HEALTH INSURANCE2                    
Private 143 145 14 20 142 142 35 39 138 139
Medicaid/CHIP 121 133 16 22 118 131 33 35 111 126
Other3 95 170 2 * 95 170 11 6 94 170
No Coverage 65 72 1 1 65 72 12 18 64 70

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.107D – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.07 0.08 0.08 0.11 0.08 0.09 0.14 0.16 0.09 0.10
GEOGRAPHIC DIVISION                    
Northeast 0.16 0.29 0.11 0.35 0.18 0.32 0.21 0.27 0.20 0.37
New England 0.27 0.23 0.22 0.13 0.29 0.25 0.24 1.15 0.33 0.25
Middle Atlantic 0.20 0.39 0.13 0.47 0.22 0.43 0.28 0.15 0.25 0.49
Midwest 0.15 0.12 0.15 0.24 0.17 0.13 0.28 0.42 0.18 0.13
East North Central 0.19 0.15 0.15 0.31 0.21 0.16 0.37 0.56 0.23 0.17
West North Central 0.27 0.17 0.35 0.36 0.30 0.19 0.37 0.51 0.34 0.21
South 0.12 0.14 0.17 0.20 0.13 0.15 0.30 0.29 0.15 0.17
South Atlantic 0.20 0.21 0.16 0.39 0.21 0.23 0.51 0.43 0.24 0.25
East South Central 0.18 0.24 0.12 0.03 0.20 0.27 0.50 0.15 0.22 0.31
West South Central 0.16 0.22 0.42 0.18 0.18 0.24 0.37 0.57 0.19 0.27
West 0.13 0.13 0.09 0.13 0.14 0.15 0.22 0.18 0.16 0.17
Mountain 0.27 0.24 0.13 0.29 0.30 0.27 0.44 0.30 0.34 0.30
Pacific 0.14 0.16 0.12 0.13 0.15 0.18 0.25 0.23 0.17 0.21
COUNTY TYPE                    
Large Metro 0.10 0.10 0.08 0.17 0.11 0.11 0.20 0.18 0.12 0.12
Small Metro 0.12 0.19 0.18 0.10 0.13 0.21 0.23 0.37 0.15 0.24
Nonmetro 0.22 0.16 0.23 0.43 0.24 0.17 0.51 0.20 0.26 0.19
Urbanized 0.33 0.22 0.18 0.14 0.36 0.24 0.37 0.22 0.41 0.27
Less Urbanized 0.24 0.31 0.56 0.98 0.26 0.33 0.41 0.43 0.30 0.37
Completely Rural 0.56 0.21 0.05 * 0.61 0.23 2.05 0.15 0.66 0.26
POVERTY LEVEL1                    
Less Than 100% 0.16 0.20 0.14 0.21 0.18 0.23 0.30 0.36 0.21 0.28
100‑199% 0.14 0.24 0.19 0.26 0.16 0.26 0.31 0.39 0.18 0.30
200% or More 0.09 0.09 0.11 0.13 0.10 0.10 0.19 0.16 0.11 0.11
HEALTH INSURANCE2                    
Private 0.08 0.08 0.09 0.14 0.09 0.09 0.17 0.19 0.10 0.10
Medicaid/CHIP 0.20 0.21 0.16 0.20 0.24 0.25 0.37 0.36 0.28 0.30
Other3 0.12 0.20 0.13 * 0.12 0.20 0.38 0.23 0.13 0.21
No Coverage 0.26 0.28 0.06 0.11 0.27 0.30 0.25 0.36 0.34 0.36

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.107P – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7689   0.6280   0.7141   0.6618   0.7855  
GEOGRAPHIC DIVISION                    
Northeast 0.1957   0.2412   0.2434   0.4375   0.2796  
New England 0.6327   0.3325   0.5986   0.1539   0.9515  
Middle Atlantic 0.2278   0.1736   0.2883   0.4015   0.2527  
Midwest 0.1773   0.3888   0.1403   0.2051   0.0406  
East North Central 0.2668   0.3720   0.2142   0.2659   0.0753  
West North Central 0.4785   0.8181   0.4541   0.5344   0.3453  
South 0.5634   0.5507   0.6039   0.1445   0.9062  
South Atlantic 0.7042   0.5493   0.6400   0.1727   0.9166  
East South Central 0.6717   0.2518   0.6959   0.0883   0.9843  
West South Central 0.7384   0.1050   0.9428   0.9337   0.9566  
West 0.7748   0.7711   0.7508   0.6117   0.8237  
Mountain 0.3747   0.6330   0.3498   0.3898   0.4267  
Pacific 0.7205   0.9585   0.7237   0.9692   0.7240  
COUNTY TYPE                    
Large Metro 0.9365   0.2919   0.8189   0.3490   0.9810  
Small Metro 0.7588   0.2771   0.6920   0.3501   0.8702  
Nonmetro 0.1166   0.6696   0.0983   0.1555   0.1742  
Urbanized 0.3310   0.6997   0.3406   0.6710   0.3397  
Less Urbanized 0.7358   0.7047   0.8010   0.9448   0.7888  
Completely Rural 0.0210   *   0.0206   0.0853   0.0749  
POVERTY LEVEL1                    
Less Than 100% 0.5677   0.4478   0.6338   0.7315   0.5159  
100‑199% 0.6072   0.9478   0.6129   0.4093   0.7455  
200% or More 0.2565   0.8412   0.2426   0.2083   0.3459  
HEALTH INSURANCE2                    
Private 0.8616   0.6000   0.8013   0.7253   0.7107  
Medicaid/CHIP 0.5287   0.9587   0.4983   0.1624   0.7550  
Other3 0.5512   *   0.5438   0.3843   0.5060  
No Coverage 0.7757   0.7056   0.7896   0.3889   0.9438  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.108C – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 1,237 1,302 120 126 1,217 1,273 183 197 1,160 1,248
GEOGRAPHIC DIVISION                    
Northeast 484 520 51 60 472 511 66 80 454 507
New England 205 207 30 20 196 202 26 36 192 198
Middle Atlantic 441 473 42 54 433 463 60 71 415 461
Midwest 484 523 47 50 474 510 75 91 454 493
East North Central 424 450 42 43 415 439 63 75 400 419
West North Central 245 274 22 26 238 267 39 53 229 264
South 847 836 80 85 833 817 125 120 794 799
South Atlantic 653 623 52 67 646 606 91 88 619 591
East South Central 248 276 26 21 245 273 32 33 244 271
West South Central 434 466 55 47 421 460 77 76 395 446
West 583 638 63 54 576 628 85 94 550 609
Mountain 331 289 34 34 324 282 51 70 310 281
Pacific 488 569 52 42 484 561 68 62 461 540
COUNTY TYPE                    
Large Metro 944 1,011 95 105 929 985 128 146 900 966
Small Metro 727 728 67 69 712 714 113 114 671 697
Nonmetro 447 471 55 35 434 460 63 56 403 443
Urbanized 301 260 48 18 288 255 43 33 269 243
Less Urbanized 282 285 21 25 274 274 36 38 257 263
Completely Rural 230 299 18 16 226 295 32 22 210 287
POVERTY LEVEL1                    
Less Than 100% 456 509 53 54 449 500 82 105 431 480
100‑199% 497 565 50 59 490 560 85 91 476 554
200% or More 922 999 94 95 906 977 116 123 882 960
HEALTH INSURANCE2                    
Private 862 922 90 86 849 904 132 142 824 890
Medicaid/CHIP 519 605 82 80 506 588 93 107 488 571
Other3 708 781 24 35 707 781 47 57 704 781
No Coverage 235 246 22 23 232 245 54 56 225 240

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.108D – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.32 0.35 0.42 0.44 0.34 0.38 0.44 0.45 0.39 0.43
GEOGRAPHIC DIVISION                    
Northeast 0.74 0.80 1.08 1.31 0.81 0.87 1.00 1.03 0.89 1.02
New England 1.25 1.19 2.67 1.81 1.30 1.31 1.56 1.76 1.45 1.54
Middle Atlantic 0.90 0.99 1.15 1.59 0.98 1.07 1.24 1.21 1.08 1.24
Midwest 0.59 0.64 0.81 0.82 0.64 0.68 0.86 0.95 0.72 0.77
East North Central 0.75 0.81 1.06 1.05 0.82 0.87 1.07 1.15 0.92 0.98
West North Central 1.02 0.99 1.17 1.31 1.11 1.07 1.41 1.76 1.25 1.24
South 0.55 0.58 0.69 0.75 0.60 0.63 0.73 0.76 0.68 0.71
South Atlantic 0.79 0.81 0.91 1.12 0.86 0.87 1.03 1.08 0.95 0.98
East South Central 1.31 1.29 1.50 1.33 1.47 1.42 1.38 1.31 1.71 1.63
West South Central 0.89 1.07 1.31 1.25 0.96 1.17 1.29 1.37 1.10 1.32
West 0.63 0.73 0.91 0.81 0.69 0.79 0.90 0.91 0.78 0.90
Mountain 1.04 1.00 1.36 1.53 1.12 1.07 1.44 1.98 1.24 1.26
Pacific 0.79 0.96 1.15 0.94 0.86 1.03 1.12 0.89 0.97 1.16
COUNTY TYPE                    
Large Metro 0.43 0.49 0.57 0.64 0.47 0.53 0.60 0.61 0.53 0.60
Small Metro 0.56 0.58 0.72 0.72 0.61 0.62 0.75 0.79 0.68 0.71
Nonmetro 0.85 0.95 1.52 1.12 0.93 1.01 1.21 1.13 1.01 1.13
Urbanized 1.46 1.50 2.95 1.54 1.62 1.62 1.70 1.54 1.82 1.83
Less Urbanized 1.45 1.31 1.90 1.89 1.55 1.37 1.89 1.97 1.70 1.54
Completely Rural 1.38 2.32 2.24 2.19 1.51 2.53 2.91 2.29 1.70 2.76
POVERTY LEVEL1                    
Less Than 100% 0.77 0.83 0.89 0.90 0.85 0.92 0.85 0.85 1.04 1.17
100‑199% 0.70 0.75 0.89 0.97 0.77 0.83 0.91 0.97 0.90 0.96
200% or More 0.39 0.45 0.57 0.60 0.42 0.48 0.58 0.63 0.46 0.53
HEALTH INSURANCE2                    
Private 0.38 0.45 0.56 0.55 0.41 0.48 0.57 0.58 0.46 0.55
Medicaid/CHIP 0.68 0.73 0.71 0.68 0.81 0.86 0.92 0.96 0.98 1.06
Other3 0.70 0.75 1.66 2.16 0.71 0.76 1.54 1.93 0.74 0.79
No Coverage 0.82 0.87 1.70 1.82 0.85 0.91 1.01 1.05 1.04 1.13

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.108P – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0271   0.0821   0.0357   0.3412   0.0555  
GEOGRAPHIC DIVISION                    
Northeast 0.1440   0.6552   0.1543   0.3851   0.1984  
New England 0.4985   0.1974   0.3882   0.2182   0.2790  
Middle Atlantic 0.0497   0.8352   0.0451   0.7138   0.0501  
Midwest 0.9572   0.7843   0.9547   0.0470   0.7614  
East North Central 0.4761   0.6480   0.5184   0.3993   0.5992  
West North Central 0.2645   0.1769   0.3200   0.0226   0.1392  
South 0.1184   0.3269   0.1304   0.0068   0.2949  
South Atlantic 0.8296   0.4434   0.9130   0.2577   0.7460  
East South Central 0.0547   0.0347   0.0839   0.0964   0.1390  
West South Central 0.0561   0.1546   0.0731   0.0201   0.1661  
West 0.1979   0.0940   0.2554   0.5498   0.2191  
Mountain 0.4289   0.5696   0.4579   0.5937   0.3946  
Pacific 0.2937   0.0905   0.3652   0.7443   0.3419  
COUNTY TYPE                    
Large Metro 0.0122   0.5718   0.0116   0.9450   0.0143  
Small Metro 0.8918   0.1118   0.9755   0.4180   0.8881  
Nonmetro 0.5623   0.1626   0.6669   0.1074   0.7601  
Urbanized 0.9948   0.0709   0.8029   0.7347   0.9708  
Less Urbanized 0.1769   0.8581   0.1663   0.1353   0.2433  
Completely Rural 0.6848   0.7722   0.7151   0.0468   0.4987  
POVERTY LEVEL1                    
Less Than 100% 0.4151   0.4943   0.4350   0.3641   0.7559  
100‑199% 0.1052   0.3780   0.1219   0.8678   0.0732  
200% or More 0.1008   0.1719   0.1164   0.3711   0.1413  
HEALTH INSURANCE2                    
Private 0.0895   0.2793   0.1004   0.5066   0.1536  
Medicaid/CHIP 0.4263   0.0292   0.6008   0.6936   0.6487  
Other3 0.3445   0.9707   0.3425   0.5915   0.3015  
No Coverage 0.8289   0.6756   0.7857   0.3329   0.9606  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.109C – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 328 344 39 49 324 340 84 72 307 329
GEOGRAPHIC DIVISION                    
Northeast 168 176 12 10 167 175 27 27 163 173
New England 117 35 6 3 117 34 9 6 116 36
Middle Atlantic 120 172 10 9 120 171 25 27 114 169
Midwest 124 122 17 17 122 120 25 32 117 114
East North Central 104 104 16 15 103 103 21 20 98 101
West North Central 63 61 7 8 62 61 12 25 60 53
South 208 206 29 41 204 200 66 49 192 194
South Atlantic 141 133 17 29 140 131 43 35 130 125
East South Central 85 91 5 12 85 91 11 17 84 87
West South Central 122 127 23 26 116 122 49 30 109 120
West 148 186 18 19 147 184 35 31 140 179
Mountain 85 92 13 14 84 90 23 15 79 91
Pacific 124 163 13 12 123 162 27 27 118 155
COUNTY TYPE                    
Large Metro 252 254 32 40 249 252 63 57 240 244
Small Metro 176 207 21 24 173 206 44 38 163 201
Nonmetro 120 117 12 13 118 115 31 20 113 111
Urbanized 77 58 7 5 76 58 19 11 73 53
Less Urbanized 74 88 9 11 72 86 13 13 70 85
Completely Rural 57 54 4 6 57 54 19 12 54 51
POVERTY LEVEL1                    
Less Than 100% 214 175 21 25 213 170 35 41 208 164
100‑199% 150 193 21 25 148 191 41 36 142 188
200% or More 206 231 27 31 203 229 54 44 192 225
HEALTH INSURANCE2                    
Private 212 227 26 36 211 224 60 52 200 218
Medicaid/CHIP 219 225 28 32 216 222 43 40 208 215
Other3 153 211 7 4 152 211 25 7 151 211
No Coverage 94 100 11 7 91 100 18 27 89 97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.109D – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.11 0.11 0.15 0.19 0.12 0.12 0.23 0.20 0.13 0.14
GEOGRAPHIC DIVISION                    
Northeast 0.33 0.34 0.28 0.24 0.35 0.37 0.44 0.43 0.40 0.42
New England 0.85 0.26 0.56 0.29 0.91 0.28 0.53 0.34 1.04 0.33
Middle Atlantic 0.32 0.45 0.33 0.30 0.35 0.49 0.58 0.58 0.38 0.56
Midwest 0.20 0.20 0.32 0.32 0.22 0.21 0.35 0.42 0.25 0.24
East North Central 0.25 0.25 0.43 0.41 0.27 0.27 0.43 0.39 0.30 0.30
West North Central 0.33 0.31 0.40 0.47 0.36 0.35 0.51 1.01 0.41 0.35
South 0.18 0.18 0.28 0.39 0.19 0.19 0.46 0.34 0.21 0.22
South Atlantic 0.23 0.22 0.33 0.56 0.25 0.24 0.58 0.47 0.27 0.26
East South Central 0.51 0.52 0.30 0.78 0.56 0.58 0.51 0.76 0.66 0.65
West South Central 0.33 0.34 0.62 0.72 0.35 0.37 1.01 0.61 0.39 0.43
West 0.21 0.26 0.30 0.31 0.23 0.28 0.42 0.35 0.26 0.32
Mountain 0.37 0.39 0.61 0.67 0.41 0.43 0.78 0.51 0.45 0.50
Pacific 0.27 0.34 0.32 0.31 0.29 0.37 0.49 0.47 0.33 0.41
COUNTY TYPE                    
Large Metro 0.15 0.15 0.21 0.27 0.16 0.16 0.32 0.27 0.18 0.18
Small Metro 0.19 0.22 0.25 0.30 0.21 0.24 0.36 0.32 0.23 0.27
Nonmetro 0.34 0.33 0.41 0.48 0.37 0.35 0.70 0.52 0.41 0.39
Urbanized 0.52 0.45 0.65 0.48 0.56 0.49 0.92 0.72 0.66 0.52
Less Urbanized 0.57 0.60 0.80 0.92 0.62 0.64 0.89 0.80 0.70 0.73
Completely Rural 0.64 0.68 0.56 0.96 0.71 0.73 2.10 1.44 0.77 0.77
POVERTY LEVEL1                    
Less Than 100% 0.44 0.34 0.37 0.43 0.49 0.38 0.41 0.40 0.61 0.47
100‑199% 0.26 0.30 0.39 0.44 0.29 0.33 0.47 0.42 0.33 0.39
200% or More 0.11 0.13 0.18 0.21 0.12 0.14 0.30 0.25 0.13 0.15
HEALTH INSURANCE2                    
Private 0.12 0.13 0.18 0.26 0.13 0.14 0.30 0.25 0.14 0.16
Medicaid/CHIP 0.36 0.34 0.27 0.30 0.43 0.41 0.47 0.41 0.51 0.49
Other3 0.19 0.25 0.49 0.29 0.20 0.25 0.89 0.26 0.20 0.26
No Coverage 0.36 0.39 0.86 0.64 0.37 0.41 0.35 0.53 0.46 0.50

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.109P – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.0910   0.8659   0.0810   0.0468   0.1894  
GEOGRAPHIC DIVISION                    
Northeast 0.3913   0.2188   0.4302   0.1131   0.5864  
New England 0.0634   0.3163   0.0701   0.0175   0.1072  
Middle Atlantic 0.9284   0.3808   0.8866   0.3320   0.7456  
Midwest 0.2631   0.7589   0.2335   0.1609   0.1100  
East North Central 0.4186   0.7935   0.3851   0.8951   0.3874  
West North Central 0.3954   0.8684   0.3770   0.0248   0.0851  
South 0.2854   0.6952   0.2430   0.0175   0.6131  
South Atlantic 0.6594   0.5761   0.5858   0.0103   0.8706  
East South Central 0.3720   0.0826   0.2779   0.9034   0.2859  
West South Central 0.5195   0.5318   0.5866   0.3405   0.8279  
West 0.7207   0.9356   0.7061   0.5831   0.7881  
Mountain 0.6803   0.7717   0.6443   0.2128   0.8551  
Pacific 0.8699   0.8338   0.8760   0.8285   0.8419  
COUNTY TYPE                    
Large Metro 0.1482   0.8202   0.1333   0.2858   0.2044  
Small Metro 0.9006   0.9815   0.8983   0.1262   0.8363  
Nonmetro 0.1195   0.9780   0.1155   0.2771   0.1645  
Urbanized 0.4706   0.3405   0.5270   0.3901   0.6302  
Less Urbanized 0.5775   0.8213   0.5901   0.8429   0.6111  
Completely Rural 0.0814   0.1856   0.0589   0.3822   0.0848  
POVERTY LEVEL1                    
Less Than 100% 0.0189   0.9542   0.0170   0.3122   0.0324  
100‑199% 0.6866   0.8725   0.6628   0.4243   0.7674  
200% or More 0.5506   0.9899   0.5392   0.0676   0.8380  
HEALTH INSURANCE2                    
Private 0.3737   0.4618   0.3116   0.0704   0.5628  
Medicaid/CHIP 0.1049   0.8574   0.0988   0.3371   0.1292  
Other3 0.7086   0.2518   0.6818   0.0296   0.5331  
No Coverage 0.9481   0.8341   0.9559   0.7732   0.8922  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.110C – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 193 180 19 25 192 178 39 36 188 173
GEOGRAPHIC DIVISION                    
Northeast 136 83 6 3 136 83 13 3 135 82
New England 116 17 1 <1 116 17 3 1 * 16
Middle Atlantic 73 81 6 3 72 81 12 2 71 81
Midwest 66 67 2 12 66 66 16 19 64 63
East North Central 54 61 2 11 54 60 15 10 51 59
West North Central 36 27 <1 4 36 28 3 16 37 23
South 86 106 16 21 85 102 31 30 80 97
South Atlantic 64 91 13 16 64 90 29 18 57 87
East South Central 32 31 2 5 32 30 2 12 32 28
West South Central 47 42 10 13 46 37 11 20 44 32
West 80 101 6 4 80 101 11 4 79 101
Mountain 41 68 3 1 41 68 7 1 41 68
Pacific 68 75 5 3 68 75 8 4 68 74
COUNTY TYPE                    
Large Metro 166 141 17 16 166 139 27 27 164 137
Small Metro 77 103 6 15 76 102 21 19 73 99
Nonmetro 58 36 4 11 58 34 18 11 54 33
Urbanized 43 19 3 2 43 19 6 1 42 19
Less Urbanized 28 25 3 10 28 23 2 1 27 23
Completely Rural 31 17 2 5 31 17 * * 28 13
POVERTY LEVEL1                    
Less Than 100% 154 109 10 11 154 108 18 17 153 107
100‑199% 69 92 11 11 68 91 22 29 65 86
200% or More 87 104 11 19 86 102 24 10 83 101
HEALTH INSURANCE2                    
Private 85 101 12 23 84 99 25 24 80 96
Medicaid/CHIP 159 124 11 10 158 123 26 14 156 122
Other3 78 79 6 4 77 79 7 2 77 79
No Coverage 45 71 7 1 44 71 7 21 44 67

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.110D – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.07 0.06 0.07 0.10 0.07 0.07 0.11 0.10 0.08 0.07
GEOGRAPHIC DIVISION                    
Northeast 0.27 0.17 0.15 0.08 0.30 0.18 0.22 0.04 0.34 0.21
New England 0.85 0.12 0.09 0.05 0.92 0.13 0.19 0.09 * 0.15
Middle Atlantic 0.20 0.23 0.21 0.10 0.22 0.25 0.29 0.05 0.24 0.29
Midwest 0.11 0.11 0.04 0.22 0.12 0.12 0.22 0.25 0.14 0.14
East North Central 0.13 0.15 0.06 0.30 0.15 0.16 0.31 0.20 0.16 0.18
West North Central 0.19 0.15 0.01 0.23 0.21 0.17 0.15 0.66 0.25 0.16
South 0.08 0.09 0.16 0.21 0.08 0.10 0.22 0.21 0.09 0.11
South Atlantic 0.11 0.15 0.25 0.31 0.11 0.16 0.41 0.25 0.12 0.18
East South Central 0.20 0.19 0.13 0.33 0.22 0.20 0.08 0.55 0.26 0.22
West South Central 0.13 0.11 0.26 0.37 0.14 0.11 0.24 0.41 0.16 0.11
West 0.12 0.14 0.10 0.06 0.13 0.16 0.13 0.05 0.15 0.18
Mountain 0.18 0.30 0.17 0.07 0.20 0.33 0.23 0.04 0.23 0.38
Pacific 0.15 0.16 0.13 0.08 0.16 0.17 0.15 0.07 0.18 0.20
COUNTY TYPE                    
Large Metro 0.10 0.08 0.11 0.11 0.11 0.09 0.14 0.13 0.12 0.10
Small Metro 0.08 0.11 0.08 0.18 0.09 0.12 0.18 0.16 0.10 0.14
Nonmetro 0.17 0.11 0.16 0.41 0.19 0.11 0.41 0.28 0.21 0.12
Urbanized 0.32 0.16 0.26 0.16 0.35 0.17 0.30 0.05 0.40 0.19
Less Urbanized 0.24 0.18 0.28 0.86 0.26 0.18 0.17 0.05 0.29 0.21
Completely Rural 0.38 0.22 0.31 0.81 0.41 0.22 * * 0.43 0.19
POVERTY LEVEL1                    
Less Than 100% 0.33 0.22 0.18 0.20 0.37 0.25 0.22 0.17 0.46 0.32
100‑199% 0.13 0.15 0.21 0.20 0.14 0.16 0.25 0.34 0.16 0.18
200% or More 0.05 0.06 0.07 0.13 0.05 0.06 0.13 0.06 0.05 0.07
HEALTH INSURANCE2                    
Private 0.05 0.06 0.08 0.16 0.05 0.06 0.13 0.12 0.06 0.07
Medicaid/CHIP 0.27 0.20 0.11 0.09 0.32 0.24 0.29 0.15 0.39 0.29
Other3 0.10 0.09 0.47 0.27 0.10 0.10 0.25 0.06 0.10 0.10
No Coverage 0.18 0.28 0.61 0.06 0.18 0.29 0.13 0.42 0.23 0.35

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.110P – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.7541   0.9886   0.7451   0.3543   0.8930  
GEOGRAPHIC DIVISION                    
Northeast 0.5574   0.2769   0.5865   0.0399   0.7098  
New England 0.3723   0.4137   0.3749   0.3134   *  
Middle Atlantic 0.9330   0.3283   0.8876   0.0648   0.7156  
Midwest 0.6575   0.0773   0.4992   0.3767   0.3428  
East North Central 0.7665   0.2153   0.6333   0.7723   0.6725  
West North Central 0.7049   0.0737   0.5955   0.0900   0.2277  
South 0.8667   0.9551   0.8728   0.6795   0.9768  
South Atlantic 0.4155   0.5680   0.3535   0.1400   0.1475  
East South Central 0.7451   0.1706   0.6212   0.1752   0.3894  
West South Central 0.1196   0.8712   0.0926   0.4843   0.0340  
West 0.5484   0.1112   0.4928   0.0242   0.3661  
Mountain 0.6927   0.2006   0.6490   0.0789   0.5392  
Pacific 0.6517   0.2754   0.6077   0.1302   0.5058  
COUNTY TYPE                    
Large Metro 0.9472   0.1314   0.8248   0.4321   0.7030  
Small Metro 0.4634   0.1686   0.5796   0.9792   0.5748  
Nonmetro 0.0064   0.2786   0.0030   0.3358   0.0049  
Urbanized 0.1245   0.4945   0.1362   0.0253   0.1998  
Less Urbanized 0.2293   0.3405   0.1317   0.3267   0.1503  
Completely Rural 0.0416   0.3074   0.0261   *   0.0175  
POVERTY LEVEL1                    
Less Than 100% 0.3471   0.6484   0.3599   0.1232   0.5239  
100‑199% 0.9777   0.4246   0.8893   0.3292   0.8607  
200% or More 0.7138   0.3929   0.8218   0.0785   0.5657  
HEALTH INSURANCE2                    
Private 0.3651   0.3564   0.4624   0.5693   0.3574  
Medicaid/CHIP 0.4224   0.8316   0.4170   0.0510   0.5998  
Other3 0.6660   0.2634   0.7225   0.0614   0.8105  
No Coverage 0.2890   0.1321   0.2345   0.1224   0.4242  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

NOTE: Does not include illegally made fentanyl (IMF).

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.111C – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 596 717 94 111 583 698 179 199 560 650
GEOGRAPHIC DIVISION                    
Northeast 252 297 41 38 241 293 66 91 234 268
New England 149 168 27 19 142 171 42 51 133 157
Middle Atlantic 204 239 31 33 195 234 52 77 192 212
Midwest 246 301 35 47 238 296 73 81 214 273
East North Central 202 252 30 43 194 244 56 72 176 223
West North Central 136 164 18 20 135 163 46 39 117 153
South 382 447 67 76 376 431 128 131 359 410
South Atlantic 296 326 46 53 286 316 95 109 265 292
East South Central 141 166 24 24 142 162 28 28 137 163
West South Central 211 285 44 50 208 274 81 80 210 241
West 317 357 44 54 309 346 82 83 296 315
Mountain 164 195 31 30 154 191 54 46 136 177
Pacific 270 308 31 46 267 297 62 72 262 269
COUNTY TYPE                    
Large Metro 474 569 74 84 462 557 134 149 445 506
Small Metro 340 418 57 66 327 405 112 127 302 371
Nonmetro 200 200 26 33 194 193 53 51 178 180
Urbanized 120 106 16 11 116 104 40 35 103 91
Less Urbanized 101 134 13 27 100 127 30 30 87 123
Completely Rural 129 115 16 16 124 113 18 18 120 108
POVERTY LEVEL1                    
Less Than 100% 254 295 30 41 250 292 83 103 232 268
100‑199% 209 301 33 49 203 296 73 83 187 285
200% or More 482 565 81 85 473 554 129 133 459 518
HEALTH INSURANCE2                    
Private 453 520 78 91 445 500 146 167 425 464
Medicaid/CHIP 278 340 50 54 270 334 71 84 260 317
Other3 238 307 24 28 237 306 44 46 232 303
No Coverage 141 208 14 21 141 206 42 40 131 203

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.111D – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.18 0.22 0.34 0.41 0.19 0.24 0.45 0.48 0.22 0.26
GEOGRAPHIC DIVISION                    
Northeast 0.43 0.58 0.96 0.95 0.46 0.61 1.04 1.42 0.52 0.65
New England 0.90 1.07 2.45 1.86 0.96 1.19 2.23 2.89 1.06 1.28
Middle Atlantic 0.49 0.65 0.97 1.10 0.51 0.68 1.15 1.59 0.59 0.72
Midwest 0.36 0.44 0.61 0.82 0.39 0.47 0.84 0.93 0.42 0.52
East North Central 0.43 0.55 0.78 1.11 0.47 0.58 0.95 1.19 0.51 0.63
West North Central 0.61 0.76 0.92 1.07 0.66 0.83 1.52 1.41 0.68 0.93
South 0.30 0.35 0.62 0.70 0.33 0.38 0.81 0.82 0.37 0.43
South Atlantic 0.44 0.49 0.83 0.97 0.47 0.52 1.14 1.22 0.50 0.58
East South Central 0.70 0.89 1.46 1.40 0.77 0.97 1.18 1.31 0.87 1.14
West South Central 0.56 0.65 1.17 1.35 0.61 0.70 1.56 1.47 0.74 0.75
West 0.42 0.44 0.65 0.83 0.46 0.48 0.92 0.86 0.51 0.52
Mountain 0.66 0.72 1.28 1.28 0.70 0.80 1.74 1.40 0.75 0.87
Pacific 0.53 0.58 0.71 1.08 0.58 0.62 1.06 1.11 0.65 0.66
COUNTY TYPE                    
Large Metro 0.25 0.30 0.46 0.54 0.27 0.32 0.62 0.64 0.30 0.35
Small Metro 0.31 0.41 0.61 0.75 0.33 0.45 0.79 0.89 0.37 0.49
Nonmetro 0.50 0.47 0.90 1.13 0.54 0.50 1.00 1.13 0.60 0.57
Urbanized 0.70 0.67 1.66 1.13 0.74 0.71 1.61 1.89 0.86 0.80
Less Urbanized 0.73 0.77 1.27 2.16 0.78 0.82 1.60 1.75 0.85 0.96
Completely Rural 1.28 1.17 1.92 2.29 1.38 1.28 1.79 1.97 1.54 1.40
POVERTY LEVEL1                    
Less Than 100% 0.51 0.54 0.54 0.70 0.57 0.61 0.89 0.85 0.67 0.73
100‑199% 0.36 0.47 0.59 0.85 0.39 0.51 0.81 0.91 0.43 0.58
200% or More 0.22 0.28 0.50 0.54 0.24 0.30 0.64 0.71 0.26 0.32
HEALTH INSURANCE2                    
Private 0.22 0.28 0.50 0.59 0.24 0.29 0.63 0.69 0.27 0.31
Medicaid/CHIP 0.44 0.50 0.48 0.51 0.51 0.59 0.73 0.85 0.61 0.70
Other3 0.30 0.36 1.68 1.73 0.30 0.36 1.43 1.62 0.31 0.37
No Coverage 0.55 0.76 1.14 1.72 0.58 0.79 0.84 0.80 0.68 0.99

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.111P – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.3895   0.6849   0.4254   0.8792   0.4009  
GEOGRAPHIC DIVISION                    
Northeast 0.9570   0.7528   0.9896   0.9099   0.9947  
New England 0.5325   0.3514   0.4399   0.8327   0.4565  
Middle Atlantic 0.6477   0.7776   0.5991   0.7787   0.6302  
Midwest 0.3865   0.0816   0.5571   0.7229   0.4752  
East North Central 0.3272   0.1743   0.4428   0.8454   0.4581  
West North Central 0.9450   0.2358   0.9203   0.3303   0.8648  
South 0.5746   0.7527   0.5321   0.9965   0.5344  
South Atlantic 0.4097   0.7281   0.3676   0.8197   0.3918  
East South Central 0.7288   0.9927   0.7288   0.7023   0.6709  
West South Central 0.7523   0.9083   0.7623   0.9096   0.7777  
West 0.7148   0.9123   0.7296   0.9240   0.7447  
Mountain 0.8803   0.2600   0.9677   0.3369   0.7346  
Pacific 0.6101   0.3567   0.7091   0.4034   0.8619  
COUNTY TYPE                    
Large Metro 0.3490   0.5929   0.3940   0.8411   0.3808  
Small Metro 0.6014   0.7321   0.5584   0.9910   0.5200  
Nonmetro 0.5144   0.5498   0.4381   0.9749   0.4641  
Urbanized 0.8619   0.1477   0.9436   0.3381   0.9008  
Less Urbanized 0.9006   0.1208   0.8451   0.2200   0.8992  
Completely Rural 0.3168   0.5498   0.2745   0.7647   0.2453  
POVERTY LEVEL1                    
Less Than 100% 0.8655   0.6664   0.8322   0.7557   0.7315  
100‑199% 0.0355   0.1209   0.0597   0.2177   0.0953  
200% or More 0.9520   0.9356   0.9398   0.6021   0.9502  
HEALTH INSURANCE2                    
Private 0.8240   0.2994   0.9712   0.8128   0.9724  
Medicaid/CHIP 0.9130   0.5897   0.9563   0.8407   0.9973  
Other3 0.1700   0.2634   0.2022   0.7379   0.2029  
No Coverage 0.0784   0.8954   0.0811   0.2462   0.0360  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.112C – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 342 425 41 36 341 423 94 124 327 386
GEOGRAPHIC DIVISION                    
Northeast 146 159 24 13 145 159 37 47 141 143
New England 84 69 * 8 82 71 20 14 78 69
Middle Atlantic 120 141 7 10 120 140 31 45 118 125
Midwest 124 152 12 12 123 151 40 48 117 140
East North Central 102 111 7 8 102 110 30 43 97 97
West North Central 76 104 9 9 75 104 27 21 69 99
South 223 264 24 27 222 262 62 73 208 242
South Atlantic 172 196 19 18 171 194 43 57 161 174
East South Central 60 100 5 4 60 100 19 12 57 99
West South Central 129 139 14 19 128 138 43 47 117 127
West 187 243 20 16 186 243 49 73 179 220
Mountain 102 136 13 7 101 136 34 31 93 128
Pacific 160 205 15 15 158 205 36 67 155 183
COUNTY TYPE                    
Large Metro 293 324 36 31 290 324 75 104 281 289
Small Metro 165 238 17 16 164 238 54 64 148 222
Nonmetro 120 124 10 8 119 124 34 29 111 119
Urbanized 72 66 7 3 72 66 27 23 62 61
Less Urbanized 50 101 7 6 49 100 19 11 43 100
Completely Rural 83 33 * 5 83 33 7 8 82 30
POVERTY LEVEL1                    
Less Than 100% 191 189 13 16 190 189 40 71 186 176
100‑199% 143 202 11 18 142 201 49 51 132 192
200% or More 246 286 37 26 247 285 71 81 234 266
HEALTH INSURANCE2                    
Private 229 256 36 28 228 255 76 102 218 223
Medicaid/CHIP 202 236 19 23 201 235 41 51 198 227
Other3 137 153 8 3 137 153 30 20 133 151
No Coverage 115 155 8 3 114 155 30 32 109 152

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.112D – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.11 0.14 0.16 0.14 0.12 0.15 0.26 0.32 0.14 0.16
GEOGRAPHIC DIVISION                    
Northeast 0.28 0.32 0.58 0.33 0.30 0.34 0.63 0.77 0.34 0.36
New England 0.57 0.49 * 0.79 0.60 0.54 1.19 0.83 0.66 0.61
Middle Atlantic 0.32 0.39 0.22 0.35 0.35 0.43 0.74 1.01 0.39 0.44
Midwest 0.20 0.24 0.22 0.22 0.21 0.27 0.54 0.59 0.24 0.29
East North Central 0.23 0.26 0.20 0.23 0.25 0.28 0.60 0.78 0.29 0.29
West North Central 0.39 0.54 0.53 0.49 0.43 0.60 1.05 0.85 0.47 0.67
South 0.20 0.22 0.24 0.26 0.21 0.24 0.42 0.49 0.23 0.26
South Atlantic 0.28 0.30 0.37 0.36 0.31 0.33 0.58 0.73 0.33 0.34
East South Central 0.33 0.56 0.29 0.27 0.37 0.61 0.86 0.55 0.41 0.71
West South Central 0.36 0.36 0.41 0.53 0.39 0.40 0.85 0.92 0.42 0.44
West 0.26 0.33 0.32 0.27 0.29 0.37 0.57 0.80 0.32 0.39
Mountain 0.42 0.56 0.60 0.34 0.47 0.62 1.13 0.97 0.51 0.69
Pacific 0.34 0.42 0.37 0.37 0.37 0.46 0.63 1.11 0.41 0.48
COUNTY TYPE                    
Large Metro 0.17 0.18 0.23 0.21 0.18 0.20 0.37 0.47 0.21 0.21
Small Metro 0.17 0.25 0.21 0.19 0.19 0.27 0.43 0.51 0.20 0.30
Nonmetro 0.33 0.34 0.36 0.31 0.36 0.37 0.72 0.70 0.40 0.41
Urbanized 0.50 0.47 0.72 0.31 0.53 0.51 1.22 1.39 0.57 0.57
Less Urbanized 0.39 0.68 0.65 0.51 0.43 0.74 1.21 0.71 0.45 0.85
Completely Rural 0.89 0.38 * 0.86 0.98 0.41 0.81 0.96 1.11 0.43
POVERTY LEVEL1                    
Less Than 100% 0.39 0.36 0.23 0.29 0.44 0.41 0.46 0.68 0.54 0.50
100‑199% 0.25 0.33 0.21 0.32 0.28 0.36 0.57 0.58 0.31 0.41
200% or More 0.13 0.15 0.25 0.19 0.14 0.17 0.38 0.45 0.15 0.17
HEALTH INSURANCE2                    
Private 0.12 0.14 0.24 0.20 0.14 0.15 0.36 0.46 0.15 0.16
Medicaid/CHIP 0.33 0.36 0.19 0.21 0.39 0.44 0.45 0.53 0.47 0.52
Other3 0.18 0.19 0.58 0.23 0.18 0.19 1.06 0.74 0.18 0.19
No Coverage 0.45 0.59 0.65 0.25 0.47 0.62 0.59 0.63 0.57 0.77

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.112P – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.4619   0.3865   0.4261   0.8959   0.3887  
GEOGRAPHIC DIVISION                    
Northeast 0.3667   0.4122   0.4129   0.5921   0.4697  
New England 0.2977   *   0.3955   0.4371   0.4955  
Middle Atlantic 0.6412   0.9032   0.6357   0.7989   0.6579  
Midwest 0.9118   0.3674   0.9895   0.6809   0.8881  
East North Central 0.4240   0.3334   0.4774   0.3922   0.6692  
West North Central 0.4583   0.7294   0.4312   0.0382   0.7878  
South 0.5111   0.9326   0.5150   0.6609   0.4217  
South Atlantic 0.2709   0.8183   0.2627   0.8454   0.2571  
East South Central 0.6923   0.6629   0.7031   0.2238   0.8848  
West South Central 0.9540   0.8170   0.9171   0.6669   0.9755  
West 0.2416   0.1453   0.1994   0.3492   0.2815  
Mountain 0.8419   0.1031   0.7327   0.5485   0.6020  
Pacific 0.2141   0.5082   0.1988   0.1464   0.3535  
COUNTY TYPE                    
Large Metro 0.8431   0.6500   0.8280   0.2576   0.8625  
Small Metro 0.1558   0.2037   0.1298   0.1311   0.0359  
Nonmetro 0.6213   0.7962   0.5997   0.3051   0.8093  
Urbanized 0.4479   0.4649   0.4003   0.8224   0.3468  
Less Urbanized 0.7942   0.8160   0.7807   0.0244   0.4506  
Completely Rural 0.0316   *   0.0218   0.6177   0.0178  
POVERTY LEVEL1                    
Less Than 100% 0.8095   0.5587   0.8648   0.4303   1.0000  
100‑199% 0.4018   0.4157   0.4478   0.8042   0.3579  
200% or More 0.8658   0.0935   0.7291   0.6366   0.6099  
HEALTH INSURANCE2                    
Private 0.8679   0.2206   0.7505   0.5870   0.9940  
Medicaid/CHIP 0.6587   0.4860   0.7473   0.6649   0.6722  
Other3 0.1207   0.1676   0.1070   0.4488   0.0724  
No Coverage 0.2891   0.4910   0.2814   0.5115   0.2089  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.113C – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 224 280 26 17 225 281 46 73 219 269
GEOGRAPHIC DIVISION                    
Northeast 102 97 22 3 99 97 21 32 96 92
New England 52 58 * 2 47 58 11 13 44 57
Middle Atlantic 88 75 3 3 88 75 18 29 86 72
Midwest 84 108 4 6 84 108 22 20 81 106
East North Central 69 82 4 3 69 82 16 18 66 80
West North Central 49 77 <1 5 49 77 14 9 47 76
South 152 156 12 14 152 155 28 46 147 149
South Atlantic 119 102 12 14 119 100 24 36 117 94
East South Central 36 39 1 1 36 39 3 8 36 38
West South Central 87 112 2 * 87 112 19 27 82 108
West 117 170 4 6 117 170 23 40 114 163
Mountain 67 96 4 5 67 96 13 17 62 94
Pacific 99 142 1 4 99 142 19 37 99 135
COUNTY TYPE                    
Large Metro 193 202 23 15 192 204 37 62 189 194
Small Metro 110 167 9 5 110 167 26 33 102 163
Nonmetro 80 74 3 5 80 74 16 19 77 71
Urbanized 52 54 3 2 51 54 11 18 48 51
Less Urbanized 37 45 1 3 37 45 12 7 34 44
Completely Rural 50 24 * * 50 23 1 1 50 23
POVERTY LEVEL1                    
Less Than 100% 133 139 6 5 133 139 20 43 131 131
100‑199% 95 135 2 4 95 135 26 26 91 133
200% or More 158 191 25 16 160 192 33 52 156 188
HEALTH INSURANCE2                    
Private 130 164 25 15 129 166 37 59 125 155
Medicaid/CHIP 151 181 7 8 151 180 27 33 148 177
Other3 73 124 <1 1 73 124 8 11 72 124
No Coverage 80 90 <1 1 80 90 12 18 78 88

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.113D – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.08 0.09 0.10 0.07 0.08 0.10 0.13 0.20 0.09 0.12
GEOGRAPHIC DIVISION                    
Northeast 0.20 0.19 0.54 0.08 0.22 0.21 0.36 0.53 0.24 0.23
New England 0.38 0.41 * 0.18 0.38 0.44 0.67 0.78 0.41 0.51
Middle Atlantic 0.24 0.21 0.10 0.09 0.26 0.23 0.42 0.66 0.29 0.25
Midwest 0.14 0.18 0.07 0.11 0.15 0.20 0.30 0.27 0.17 0.22
East North Central 0.16 0.20 0.11 0.08 0.18 0.22 0.33 0.35 0.20 0.25
West North Central 0.27 0.41 0.01 0.29 0.29 0.45 0.61 0.37 0.33 0.51
South 0.14 0.13 0.11 0.14 0.15 0.15 0.21 0.32 0.17 0.16
South Atlantic 0.20 0.16 0.22 0.28 0.22 0.17 0.35 0.50 0.25 0.19
East South Central 0.21 0.22 0.08 0.05 0.23 0.25 0.13 0.37 0.27 0.28
West South Central 0.24 0.30 0.06 * 0.27 0.34 0.41 0.55 0.30 0.39
West 0.17 0.24 0.07 0.11 0.19 0.26 0.27 0.45 0.21 0.30
Mountain 0.29 0.42 0.18 0.25 0.32 0.46 0.47 0.57 0.35 0.52
Pacific 0.21 0.30 0.03 0.10 0.24 0.33 0.34 0.62 0.27 0.36
COUNTY TYPE                    
Large Metro 0.12 0.12 0.15 0.11 0.13 0.13 0.19 0.30 0.14 0.14
Small Metro 0.12 0.18 0.11 0.07 0.13 0.20 0.22 0.28 0.14 0.23
Nonmetro 0.23 0.21 0.10 0.18 0.25 0.23 0.38 0.48 0.28 0.26
Urbanized 0.38 0.41 0.26 0.20 0.41 0.45 0.54 1.15 0.45 0.51
Less Urbanized 0.31 0.32 0.12 0.22 0.34 0.35 0.86 0.48 0.36 0.39
Completely Rural 0.57 0.29 * * 0.62 0.31 0.09 0.16 0.70 0.35
POVERTY LEVEL1                    
Less Than 100% 0.28 0.28 0.11 0.09 0.32 0.31 0.24 0.42 0.39 0.38
100‑199% 0.17 0.22 0.05 0.07 0.18 0.24 0.30 0.30 0.21 0.28
200% or More 0.08 0.10 0.16 0.11 0.09 0.11 0.19 0.29 0.10 0.12
HEALTH INSURANCE2                    
Private 0.07 0.09 0.17 0.11 0.08 0.10 0.19 0.28 0.09 0.11
Medicaid/CHIP 0.25 0.29 0.07 0.08 0.30 0.34 0.29 0.35 0.36 0.42
Other3 0.09 0.15 0.01 0.07 0.09 0.15 0.28 0.42 0.10 0.16
No Coverage 0.32 0.36 0.01 0.09 0.33 0.37 0.25 0.37 0.41 0.46

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.113P – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL 0.1563   0.4175   0.1460   0.1030   0.2721  
GEOGRAPHIC DIVISION                    
Northeast 0.2619   0.2630   0.3338   0.8792   0.2878  
New England 0.9289   *   0.8275   0.6317   0.9133  
Middle Atlantic 0.1958   0.6218   0.1983   0.9442   0.1848  
Midwest 0.6264   0.5803   0.6552   0.5744   0.5590  
East North Central 0.4183   0.5476   0.4077   0.7409   0.4446  
West North Central 0.8329   0.1784   0.7695   0.1465   0.9836  
South 0.9288   0.8169   0.9255   0.1267   0.7679  
South Atlantic 0.8373   0.9168   0.8328   0.2921   0.9305  
East South Central 0.2461   0.9648   0.2432   0.1128   0.1513  
West South Central 0.7343   *   0.7315   0.4780   0.8527  
West 0.0045   0.9870   0.0047   0.1172   0.0105  
Mountain 0.2713   0.7375   0.2630   0.3413   0.3269  
Pacific 0.0081   0.5981   0.0090   0.2082   0.0169  
COUNTY TYPE                    
Large Metro 0.6128   0.7489   0.6090   0.0725   0.9618  
Small Metro 0.0470   0.0528   0.0377   0.8721   0.0345  
Nonmetro 0.8101   0.4727   0.7738   0.8765   0.7327  
Urbanized 0.3829   0.7896   0.3711   0.3129   0.5376  
Less Urbanized 0.8558   0.7089   0.8385   0.2384   0.9190  
Completely Rural 0.1492   *   0.1250   0.7625   0.1236  
POVERTY LEVEL1                    
Less Than 100% 0.4677   0.6089   0.4657   0.1341   0.6273  
100‑199% 0.2429   0.5852   0.2530   0.8590   0.2628  
200% or More 0.5906   0.4449   0.5478   0.2722   0.7365  
HEALTH INSURANCE2                    
Private 0.1763   0.4375   0.1506   0.0642   0.4145  
Medicaid/CHIP 0.7649   0.9839   0.7970   0.8305   0.7653  
Other3 0.0184   0.3954   0.0187   0.4733   0.0216  
No Coverage 0.6405   0.3581   0.6563   0.3354   0.7921  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.114C – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 717 ‑‑ 77 ‑‑ 705 ‑‑ 196 ‑‑ 658
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 350 ‑‑ 24 ‑‑ 352 ‑‑ 66 ‑‑ 334
New England ‑‑ 160 ‑‑ 14 ‑‑ 158 ‑‑ 32 ‑‑ 153
Middle Atlantic ‑‑ 313 ‑‑ 19 ‑‑ 316 ‑‑ 61 ‑‑ 299
Midwest ‑‑ 255 ‑‑ 29 ‑‑ 250 ‑‑ 82 ‑‑ 228
East North Central ‑‑ 207 ‑‑ 24 ‑‑ 203 ‑‑ 73 ‑‑ 178
West North Central ‑‑ 144 ‑‑ 16 ‑‑ 142 ‑‑ 41 ‑‑ 133
South ‑‑ 408 ‑‑ 57 ‑‑ 394 ‑‑ 120 ‑‑ 364
South Atlantic ‑‑ 301 ‑‑ 38 ‑‑ 298 ‑‑ 95 ‑‑ 262
East South Central ‑‑ 141 ‑‑ 17 ‑‑ 140 ‑‑ 47 ‑‑ 131
West South Central ‑‑ 249 ‑‑ 39 ‑‑ 232 ‑‑ 64 ‑‑ 218
West ‑‑ 409 ‑‑ 39 ‑‑ 403 ‑‑ 111 ‑‑ 371
Mountain ‑‑ 235 ‑‑ 24 ‑‑ 232 ‑‑ 52 ‑‑ 216
Pacific ‑‑ 340 ‑‑ 31 ‑‑ 333 ‑‑ 98 ‑‑ 307
COUNTY TYPE                    
Large Metro ‑‑ 586 ‑‑ 63 ‑‑ 578 ‑‑ 165 ‑‑ 524
Small Metro ‑‑ 374 ‑‑ 41 ‑‑ 368 ‑‑ 103 ‑‑ 349
Nonmetro ‑‑ 198 ‑‑ 22 ‑‑ 194 ‑‑ 39 ‑‑ 184
Urbanized ‑‑ 104 ‑‑ 10 ‑‑ 101 ‑‑ 27 ‑‑ 93
Less Urbanized ‑‑ 159 ‑‑ 17 ‑‑ 155 ‑‑ 20 ‑‑ 150
Completely Rural ‑‑ 68 ‑‑ 9 ‑‑ 66 ‑‑ 16 ‑‑ 61
POVERTY LEVEL1                    
Less Than 100% ‑‑ 253 ‑‑ 40 ‑‑ 248 ‑‑ 103 ‑‑ 226
100‑199% ‑‑ 344 ‑‑ 40 ‑‑ 339 ‑‑ 82 ‑‑ 325
200% or More ‑‑ 528 ‑‑ 48 ‑‑ 527 ‑‑ 129 ‑‑ 500
HEALTH INSURANCE2                    
Private ‑‑ 485 ‑‑ 53 ‑‑ 480 ‑‑ 159 ‑‑ 449
Medicaid/CHIP ‑‑ 346 ‑‑ 55 ‑‑ 335 ‑‑ 86 ‑‑ 316
Other3 ‑‑ 349 ‑‑ 12 ‑‑ 349 ‑‑ 29 ‑‑ 349
No Coverage ‑‑ 207 ‑‑ 12 ‑‑ 207 ‑‑ 52 ‑‑ 196

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.114D – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.22 ‑‑ 0.29 ‑‑ 0.24 ‑‑ 0.48 ‑‑ 0.26
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 0.63 ‑‑ 0.60 ‑‑ 0.69 ‑‑ 0.97 ‑‑ 0.75
New England ‑‑ 1.09 ‑‑ 1.27 ‑‑ 1.17 ‑‑ 1.76 ‑‑ 1.32
Middle Atlantic ‑‑ 0.77 ‑‑ 0.66 ‑‑ 0.84 ‑‑ 1.25 ‑‑ 0.90
Midwest ‑‑ 0.37 ‑‑ 0.53 ‑‑ 0.40 ‑‑ 0.93 ‑‑ 0.44
East North Central ‑‑ 0.44 ‑‑ 0.66 ‑‑ 0.47 ‑‑ 1.19 ‑‑ 0.50
West North Central ‑‑ 0.68 ‑‑ 0.92 ‑‑ 0.75 ‑‑ 1.49 ‑‑ 0.82
South ‑‑ 0.32 ‑‑ 0.54 ‑‑ 0.34 ‑‑ 0.77 ‑‑ 0.37
South Atlantic ‑‑ 0.44 ‑‑ 0.69 ‑‑ 0.49 ‑‑ 1.09 ‑‑ 0.51
East South Central ‑‑ 0.75 ‑‑ 1.07 ‑‑ 0.83 ‑‑ 2.08 ‑‑ 0.91
West South Central ‑‑ 0.59 ‑‑ 1.11 ‑‑ 0.61 ‑‑ 1.27 ‑‑ 0.69
West ‑‑ 0.51 ‑‑ 0.61 ‑‑ 0.56 ‑‑ 1.15 ‑‑ 0.61
Mountain ‑‑ 0.92 ‑‑ 1.06 ‑‑ 1.01 ‑‑ 1.51 ‑‑ 1.13
Pacific ‑‑ 0.62 ‑‑ 0.73 ‑‑ 0.67 ‑‑ 1.54 ‑‑ 0.73
COUNTY TYPE                    
Large Metro ‑‑ 0.32 ‑‑ 0.42 ‑‑ 0.34 ‑‑ 0.71 ‑‑ 0.36
Small Metro ‑‑ 0.36 ‑‑ 0.49 ‑‑ 0.39 ‑‑ 0.72 ‑‑ 0.44
Nonmetro ‑‑ 0.50 ‑‑ 0.74 ‑‑ 0.54 ‑‑ 0.90 ‑‑ 0.59
Urbanized ‑‑ 0.67 ‑‑ 0.96 ‑‑ 0.72 ‑‑ 1.51 ‑‑ 0.81
Less Urbanized ‑‑ 0.95 ‑‑ 1.33 ‑‑ 1.03 ‑‑ 1.23 ‑‑ 1.15
Completely Rural ‑‑ 0.77 ‑‑ 1.42 ‑‑ 0.84 ‑‑ 1.97 ‑‑ 0.88
POVERTY LEVEL1                    
Less Than 100% ‑‑ 0.45 ‑‑ 0.69 ‑‑ 0.50 ‑‑ 0.84 ‑‑ 0.61
100‑199% ‑‑ 0.52 ‑‑ 0.68 ‑‑ 0.57 ‑‑ 0.89 ‑‑ 0.65
200% or More ‑‑ 0.27 ‑‑ 0.33 ‑‑ 0.29 ‑‑ 0.70 ‑‑ 0.31
HEALTH INSURANCE2                    
Private ‑‑ 0.26 ‑‑ 0.37 ‑‑ 0.28 ‑‑ 0.66 ‑‑ 0.30
Medicaid/CHIP ‑‑ 0.49 ‑‑ 0.50 ‑‑ 0.57 ‑‑ 0.85 ‑‑ 0.67
Other3 ‑‑ 0.40 ‑‑ 0.82 ‑‑ 0.41 ‑‑ 1.07 ‑‑ 0.42
No Coverage ‑‑ 0.78 ‑‑ 1.01 ‑‑ 0.81 ‑‑ 0.98 ‑‑ 0.97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.115C – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 408 ‑‑ 40 ‑‑ 409 ‑‑ 102 ‑‑ 395
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 159 ‑‑ 12 ‑‑ 158 ‑‑ 31 ‑‑ 156
New England ‑‑ 78 ‑‑ 3 ‑‑ 78 ‑‑ 22 ‑‑ 73
Middle Atlantic ‑‑ 143 ‑‑ 12 ‑‑ 142 ‑‑ 27 ‑‑ 141
Midwest ‑‑ 144 ‑‑ 16 ‑‑ 144 ‑‑ 44 ‑‑ 133
East North Central ‑‑ 110 ‑‑ 13 ‑‑ 110 ‑‑ 37 ‑‑ 102
West North Central ‑‑ 92 ‑‑ 9 ‑‑ 92 ‑‑ 24 ‑‑ 87
South ‑‑ 234 ‑‑ 33 ‑‑ 232 ‑‑ 67 ‑‑ 224
South Atlantic ‑‑ 173 ‑‑ 21 ‑‑ 172 ‑‑ 44 ‑‑ 167
East South Central ‑‑ 62 ‑‑ 6 ‑‑ 62 ‑‑ 40 ‑‑ 50
West South Central ‑‑ 144 ‑‑ 24 ‑‑ 144 ‑‑ 32 ‑‑ 138
West ‑‑ 247 ‑‑ 15 ‑‑ 246 ‑‑ 54 ‑‑ 238
Mountain ‑‑ 139 ‑‑ 7 ‑‑ 138 ‑‑ 26 ‑‑ 133
Pacific ‑‑ 209 ‑‑ 13 ‑‑ 208 ‑‑ 48 ‑‑ 202
COUNTY TYPE                    
Large Metro ‑‑ 315 ‑‑ 33 ‑‑ 314 ‑‑ 88 ‑‑ 298
Small Metro ‑‑ 234 ‑‑ 19 ‑‑ 233 ‑‑ 51 ‑‑ 229
Nonmetro ‑‑ 91 ‑‑ 15 ‑‑ 89 ‑‑ 23 ‑‑ 86
Urbanized ‑‑ 58 ‑‑ 3 ‑‑ 58 ‑‑ 18 ‑‑ 55
Less Urbanized ‑‑ 64 ‑‑ 12 ‑‑ 62 ‑‑ 9 ‑‑ 61
Completely Rural ‑‑ 30 ‑‑ 8 ‑‑ 29 ‑‑ * ‑‑ 26
POVERTY LEVEL1                    
Less Than 100% ‑‑ 177 ‑‑ 20 ‑‑ 176 ‑‑ 54 ‑‑ 169
100‑199% ‑‑ 176 ‑‑ 23 ‑‑ 175 ‑‑ 43 ‑‑ 168
200% or More ‑‑ 315 ‑‑ 26 ‑‑ 316 ‑‑ 75 ‑‑ 308
HEALTH INSURANCE2                    
Private ‑‑ 263 ‑‑ 28 ‑‑ 264 ‑‑ 84 ‑‑ 254
Medicaid/CHIP ‑‑ 226 ‑‑ 29 ‑‑ 223 ‑‑ 47 ‑‑ 219
Other3 ‑‑ 190 ‑‑ 4 ‑‑ 190 ‑‑ 20 ‑‑ 189
No Coverage ‑‑ 136 ‑‑ 8 ‑‑ 137 ‑‑ 32 ‑‑ 130

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.115D – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
TOTAL ‑‑ 0.13 ‑‑ 0.15 ‑‑ 0.15 ‑‑ 0.27 ‑‑ 0.17
GEOGRAPHIC DIVISION                    
Northeast ‑‑ 0.30 ‑‑ 0.29 ‑‑ 0.33 ‑‑ 0.52 ‑‑ 0.38
New England ‑‑ 0.56 ‑‑ 0.24 ‑‑ 0.60 ‑‑ 1.28 ‑‑ 0.66
Middle Atlantic ‑‑ 0.38 ‑‑ 0.39 ‑‑ 0.41 ‑‑ 0.65 ‑‑ 0.46
Midwest ‑‑ 0.23 ‑‑ 0.31 ‑‑ 0.26 ‑‑ 0.56 ‑‑ 0.28
East North Central ‑‑ 0.26 ‑‑ 0.37 ‑‑ 0.28 ‑‑ 0.67 ‑‑ 0.31
West North Central ‑‑ 0.48 ‑‑ 0.54 ‑‑ 0.54 ‑‑ 0.99 ‑‑ 0.59
South ‑‑ 0.19 ‑‑ 0.32 ‑‑ 0.21 ‑‑ 0.46 ‑‑ 0.24
South Atlantic ‑‑ 0.27 ‑‑ 0.41 ‑‑ 0.29 ‑‑ 0.58 ‑‑ 0.33
East South Central ‑‑ 0.36 ‑‑ 0.40 ‑‑ 0.40 ‑‑ 1.82 ‑‑ 0.37
West South Central ‑‑ 0.37 ‑‑ 0.67 ‑‑ 0.42 ‑‑ 0.65 ‑‑ 0.47
West ‑‑ 0.33 ‑‑ 0.24 ‑‑ 0.36 ‑‑ 0.59 ‑‑ 0.41
Mountain ‑‑ 0.58 ‑‑ 0.32 ‑‑ 0.63 ‑‑ 0.86 ‑‑ 0.71
Pacific ‑‑ 0.42 ‑‑ 0.32 ‑‑ 0.46 ‑‑ 0.78 ‑‑ 0.52
COUNTY TYPE                    
Large Metro ‑‑ 0.18 ‑‑ 0.22 ‑‑ 0.19 ‑‑ 0.41 ‑‑ 0.21
Small Metro ‑‑ 0.24 ‑‑ 0.24 ‑‑ 0.27 ‑‑ 0.41 ‑‑ 0.31
Nonmetro ‑‑ 0.25 ‑‑ 0.53 ‑‑ 0.27 ‑‑ 0.58 ‑‑ 0.31
Urbanized ‑‑ 0.44 ‑‑ 0.34 ‑‑ 0.47 ‑‑ 1.16 ‑‑ 0.55
Less Urbanized ‑‑ 0.45 ‑‑ 1.01 ‑‑ 0.48 ‑‑ 0.59 ‑‑ 0.54
Completely Rural ‑‑ 0.35 ‑‑ 1.31 ‑‑ 0.38 ‑‑ * ‑‑ 0.39
POVERTY LEVEL1                    
Less Than 100% ‑‑ 0.34 ‑‑ 0.35 ‑‑ 0.38 ‑‑ 0.50 ‑‑ 0.48
100‑199% ‑‑ 0.28 ‑‑ 0.40 ‑‑ 0.31 ‑‑ 0.50 ‑‑ 0.35
200% or More ‑‑ 0.17 ‑‑ 0.18 ‑‑ 0.18 ‑‑ 0.42 ‑‑ 0.20
HEALTH INSURANCE2                    
Private ‑‑ 0.15 ‑‑ 0.20 ‑‑ 0.16 ‑‑ 0.39 ‑‑ 0.18
Medicaid/CHIP ‑‑ 0.35 ‑‑ 0.27 ‑‑ 0.41 ‑‑ 0.49 ‑‑ 0.50
Other3 ‑‑ 0.23 ‑‑ 0.28 ‑‑ 0.23 ‑‑ 0.73 ‑‑ 0.24
No Coverage ‑‑ 0.53 ‑‑ 0.71 ‑‑ 0.55 ‑‑ 0.62 ‑‑ 0.66

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.

NOTE: Does not include illegally made fentanyl (IMF).

NOTE: Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.116C – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 236 263 97 148 89 129
GEOGRAPHIC DIVISION            
Northeast 105 132 60 65 56 55
New England 42 51 13 16 11 14
Middle Atlantic 101 123 59 62 55 53
Midwest 120 127 38 54 35 42
East North Central 80 119 19 54 13 42
West North Central 84 46 33 6 33 5
South 124 143 44 74 40 57
South Atlantic 81 104 25 68 24 50
East South Central 66 67 22 21 22 20
West South Central 69 67 29 20 23 18
West 124 119 48 96 46 93
Mountain 65 91 29 80 26 78
Pacific 106 77 36 53 36 51
COUNTY TYPE            
Large Metro 165 197 68 118 63 106
Small Metro 144 166 53 87 47 70
Nonmetro 91 59 40 24 39 23
Urbanized 41 40 36 16 36 16
Less Urbanized 79 40 15 15 15 15
Completely Rural 17 19 7 9 7 9
POVERTY LEVEL3            
Less Than 100% 141 156 69 99 66 85
100‑199% 101 142 51 100 48 93
200% or More 150 158 39 43 35 26
HEALTH INSURANCE4            
Private 135 157 35 67 27 46
Medicaid/CHIP 156 184 81 118 76 101
Other5 165 155 39 75 39 74
No Coverage 54 87 27 51 26 49

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.116D – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 0.08 0.09 0.03 0.05 0.03 0.04
GEOGRAPHIC DIVISION            
Northeast 0.21 0.26 0.12 0.13 0.11 0.11
New England 0.31 0.40 0.09 0.12 0.08 0.11
Middle Atlantic 0.27 0.33 0.16 0.17 0.15 0.15
Midwest 0.20 0.21 0.06 0.09 0.06 0.07
East North Central 0.20 0.29 0.05 0.13 0.03 0.10
West North Central 0.45 0.24 0.18 0.03 0.18 0.03
South 0.11 0.12 0.04 0.07 0.04 0.05
South Atlantic 0.14 0.17 0.04 0.11 0.04 0.08
East South Central 0.39 0.40 0.13 0.12 0.13 0.12
West South Central 0.19 0.18 0.08 0.05 0.06 0.05
West 0.17 0.17 0.07 0.14 0.07 0.13
Mountain 0.29 0.40 0.13 0.35 0.12 0.34
Pacific 0.22 0.16 0.08 0.12 0.08 0.11
COUNTY TYPE            
Large Metro 0.10 0.12 0.04 0.07 0.04 0.06
Small Metro 0.16 0.18 0.06 0.09 0.05 0.08
Nonmetro 0.26 0.17 0.12 0.07 0.12 0.07
Urbanized 0.30 0.33 0.27 0.13 0.27 0.13
Less Urbanized 0.63 0.28 0.13 0.11 0.12 0.11
Completely Rural 0.20 0.23 0.08 0.11 0.08 0.11
POVERTY LEVEL3            
Less Than 100% 0.30 0.31 0.15 0.20 0.14 0.17
100‑199% 0.18 0.23 0.09 0.16 0.09 0.15
200% or More 0.08 0.09 0.02 0.02 0.02 0.01
HEALTH INSURANCE4            
Private 0.08 0.09 0.02 0.04 0.02 0.03
Medicaid/CHIP 0.26 0.29 0.14 0.19 0.13 0.16
Other5 0.21 0.19 0.05 0.09 0.05 0.09
No Coverage 0.21 0.35 0.11 0.20 0.10 0.20

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.116P – Any Use and Misuse of Fentanyl in Past Year and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Geographic/Socioeconomic Characteristic Any Fentanyl Use1
(2024)
Any Fentanyl Use1
(2025)
Fentanyl Misuse2
(2024)
Fentanyl Misuse2
(2025)
IMF Use
(2024)
IMF Use
(2025)
TOTAL 0.9467   0.2933   0.5441  
GEOGRAPHIC DIVISION            
Northeast 0.4296   0.5847   0.7217  
New England 0.3980   0.2700   0.2039  
Middle Atlantic 0.6343   0.7680   0.9458  
Midwest 0.8484   0.8809   0.8549  
East North Central 0.2196   0.3496   0.4456  
West North Central 0.1386   0.1996   0.1940  
South 0.9482   0.9014   0.8288  
South Atlantic 0.1877   0.3179   0.5590  
East South Central 0.6239   0.4541   0.4561  
West South Central 0.1370   0.2687   0.3888  
West 0.4398   0.2760   0.3733  
Mountain 0.6808   0.4535   0.5042  
Pacific 0.5091   0.4071   0.5443  
COUNTY TYPE            
Large Metro 0.4902   0.1339   0.2073  
Small Metro 0.6551   0.7883   0.8186  
Nonmetro 0.5634   0.3221   0.3598  
Urbanized 0.3771   0.5161   0.5369  
Less Urbanized 0.1352   0.4673   0.5376  
Completely Rural 0.7020   0.7236   0.7121  
POVERTY LEVEL3            
Less Than 100% 0.4847   0.4745   0.8071  
100‑199% 0.5970   0.4896   0.5165  
200% or More 0.9217   0.8796   0.5565  
HEALTH INSURANCE4            
Private 0.5841   0.1296   0.2254  
Medicaid/CHIP 0.7165   0.7242   0.9673  
Other5 0.2509   0.3419   0.3859  
No Coverage 0.5462   0.9662   0.9510  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates that are used in these comparisons may differ from previously published estimates.

1 Includes the use of IMF or any use of prescription fentanyl in the past year.

2 Includes the use of IMF or the misuse of prescription fentanyl in the past year.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.117C – Modes of Marijuana Use in Past Year: Among Past Year Marijuana Users Aged 12 or Older; Modes of Marijuana Use in Past Month: Among Past Month Marijuana Users Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2024 and 2025
Mode of Marijuana Use1 Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
PAST YEAR                    
Smoking 1,021 1,068 96 109 1,005 1,054 295 354 909 942
Vaping 656 616 96 101 634 603 230 267 564 514
Dabbing waxes, shatter, or concentrates 314 367 42 40 310 361 138 157 268 305
Eating or drinking 764 818 67 69 753 814 223 237 700 756
Other 394 351 33 39 392 348 81 75 377 336
Applying Lotion, Cream, or Patches to Skin 311 268 21 17 310 269 64 53 296 261
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 181 198 18 16 180 197 45 41 176 188
Taking Pills 139 152 20 23 136 151 38 26 129 148
Some Other Way 88 100 14 26 87 97 18 27 85 93
PAST MONTH                    
Smoking 811 818 71 79 798 814 231 264 728 747
Vaping 503 506 73 74 492 499 175 203 454 434
Dabbing waxes, shatter, or concentrates 232 254 27 30 232 249 95 108 210 218
Eating or drinking 505 568 41 52 500 563 147 172 470 520
Other 246 252 14 25 245 251 55 52 231 244
Applying Lotion, Cream, or Patches to Skin 190 204 10 6 189 204 46 43 179 196
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 120 129 8 6 120 128 28 28 114 124
Taking Pills 88 94 9 21 87 93 23 17 84 92
Some Other Way 51 49 7 11 51 47 16 5 48 47

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents could indicate multiple modes of marijuana use; thus, these response categories are not mutually exclusive.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.117D – Modes of Marijuana Use in Past Year: Among Past Year Marijuana Users Aged 12 or Older; Modes of Marijuana Use in Past Month: Among Past Month Marijuana Users Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2024 and 2025
Mode of Marijuana Use1 Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
PAST YEAR                    
Smoking 0.67 0.69 1.84 2.01 0.70 0.72 0.81 0.93 0.82 0.87
Vaping 0.69 0.70 1.69 2.02 0.71 0.72 1.08 1.17 0.84 0.82
Dabbing waxes, shatter, or concentrates 0.45 0.52 1.44 1.56 0.46 0.53 0.95 1.04 0.51 0.58
Eating or drinking 0.71 0.80 1.93 2.32 0.73 0.83 1.07 1.24 0.88 0.99
Other 0.53 0.52 1.15 1.57 0.55 0.53 0.63 0.58 0.66 0.64
Applying Lotion, Cream, or Patches to Skin 0.44 0.42 0.76 0.75 0.46 0.43 0.51 0.43 0.55 0.53
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 0.27 0.30 0.66 0.69 0.29 0.31 0.36 0.33 0.35 0.38
Taking Pills 0.21 0.24 0.72 1.02 0.21 0.25 0.31 0.21 0.25 0.31
Some Other Way 0.14 0.16 0.50 1.11 0.14 0.16 0.15 0.22 0.17 0.20
PAST MONTH                    
Smoking 0.83 0.87 2.55 2.76 0.85 0.89 1.02 1.20 1.01 1.06
Vaping 0.80 0.84 2.43 2.63 0.83 0.86 1.26 1.44 0.99 0.98
Dabbing waxes, shatter, or concentrates 0.49 0.52 1.71 2.10 0.51 0.53 1.05 1.07 0.58 0.60
Eating or drinking 0.81 0.95 2.17 3.17 0.84 0.97 1.29 1.48 1.00 1.14
Other 0.52 0.53 0.91 1.80 0.54 0.55 0.63 0.60 0.63 0.65
Applying Lotion, Cream, or Patches to Skin 0.41 0.45 0.66 0.43 0.42 0.46 0.53 0.51 0.50 0.55
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 0.27 0.28 0.54 0.48 0.28 0.29 0.33 0.33 0.33 0.35
Taking Pills 0.19 0.21 0.56 1.56 0.20 0.22 0.27 0.20 0.24 0.26
Some Other Way 0.12 0.11 0.43 0.89 0.12 0.11 0.19 0.06 0.14 0.14

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents could indicate multiple modes of marijuana use; thus, these response categories are not mutually exclusive.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.117P – Modes of Marijuana Use in Past Year: Among Past Year Marijuana Users Aged 12 or Older; Modes of Marijuana Use in Past Month: Among Past Month Marijuana Users Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Mode of Marijuana Use1 Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
PAST YEAR                    
Smoking 0.3176   0.1004   0.4013   0.5705   0.3388  
Vaping 0.5406   0.4934   0.6298   0.5604   0.3825  
Dabbing waxes, shatter, or concentrates 0.5611   0.8985   0.5310   0.4330   0.3360  
Eating or drinking 0.6263   0.4054   0.6412   0.0558   0.8986  
Other 0.0016   0.6493   0.0016   0.0095   0.0088  
Applying Lotion, Cream, or Patches to Skin 0.0086   0.1340   0.0100   0.0089   0.0402  
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 0.5299   0.3912   0.5601   0.3070   0.7442  
Taking Pills 0.2359   0.8222   0.2217   0.0682   0.4123  
Some Other Way 0.8201   0.3857   0.9292   0.9091   0.9443  
PAST MONTH                    
Smoking 0.7805   0.2034   0.6951   0.7748   0.7368  
Vaping 0.4412   0.7135   0.5706   0.2257   0.3083  
Dabbing waxes, shatter, or concentrates 0.9903   0.6663   0.9827   0.8860   0.9703  
Eating or drinking 0.4161   0.0876   0.5499   0.8059   0.4775  
Other 0.1445   0.1828   0.1069   0.0543   0.2153  
Applying Lotion, Cream, or Patches to Skin 0.2752   0.0977   0.2867   0.1560   0.4397  
Putting Drops, Strips, Lozenges, or Sprays in Mouth or Under Tongue 0.6225   0.7034   0.6156   0.4828   0.7232  
Taking Pills 0.8391   0.1298   0.6404   0.5743   0.7245  
Some Other Way 0.8416   0.4318   0.7387   0.1106   0.9502  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents could indicate multiple modes of marijuana use; thus, these response categories are not mutually exclusive.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.118C – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 1,109 1,210 52 64 1,106 1,201 205 218 1,066 1,143
LSD 834 913 33 36 832 909 144 145 804 872
PCP 339 391 12 16 339 390 28 22 338 391
Peyote ‑‑ 357 ‑‑ 10 ‑‑ 357 ‑‑ 20 ‑‑ 356
Mescaline ‑‑ 408 ‑‑ 1 ‑‑ 408 ‑‑ 27 ‑‑ 407
Psilocybin 890 964 46 60 890 957 176 206 853 903
Ecstasy 616 667 24 33 617 665 109 118 598 634
Ketamine 298 333 19 20 297 334 57 79 297 307
DMT, AMT, or 5‑MeO‑DIPT/Foxy 241 250 13 20 242 248 47 66 234 237
Salvia divinorum 279 297 8 11 278 297 40 41 275 293
INHALANTS1 ‑‑ 727 ‑‑ 76 ‑‑ 718 ‑‑ 145 ‑‑ 688
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush2 ‑‑ 455 ‑‑ 18 ‑‑ 454 ‑‑ 99 ‑‑ 434
Correction Fluid, Degreaser, or Cleaning Fluid2 ‑‑ 109 ‑‑ 22 ‑‑ 106 ‑‑ 29 ‑‑ 104
Gasoline or Lighter Fluid2 ‑‑ 196 ‑‑ 35 ‑‑ 192 ‑‑ 27 ‑‑ 190
Glue, Shoe Polish, or Toluene2 ‑‑ 180 ‑‑ 37 ‑‑ 176 ‑‑ 36 ‑‑ 170
Halothane, Ether, or Other Anesthetics2 ‑‑ 113 ‑‑ 9 ‑‑ 111 ‑‑ 8 ‑‑ 111
Lacquer Thinner or Other Paint Solvents2 ‑‑ 121 ‑‑ 17 ‑‑ 121 ‑‑ 21 ‑‑ 119
Lighter Gases2 ‑‑ 79 ‑‑ 16 ‑‑ 77 ‑‑ 16 ‑‑ 76
Nitrous Oxide or Whippits2 ‑‑ 517 ‑‑ 29 ‑‑ 515 ‑‑ 97 ‑‑ 499
Felt‑Tip Pens or Felt‑Tip/Magic Markers2 ‑‑ 201 ‑‑ 63 ‑‑ 186 ‑‑ 51 ‑‑ 176
Spray Paints2 ‑‑ 155 ‑‑ 30 ‑‑ 152 ‑‑ 22 ‑‑ 150
Computer Cleaner/Air Duster2 ‑‑ 169 ‑‑ 16 ‑‑ 168 ‑‑ 40 ‑‑ 161
Other Aerosol Sprays2 ‑‑ 79 ‑‑ 14 ‑‑ 78 ‑‑ 15 ‑‑ 76
NEEDLE USE2,3 321 371 14 17 320 371 38 33 321 369
Heroin Needle Use2 221 264 1 <1 221 264 20 21 221 264
Cocaine Needle Use2 209 294 1 * 209 294 17 14 208 293
Methamphetamine Needle Use2 229 282 3 * 229 282 20 12 228 282
Illegally Made Fentanyl Needle Use2,3 101 82 12 14 100 81 20 4 98 81
HEROIN 333 370 10 4 333 369 27 39 331 368
Smoke Heroin2 203 243 9 * 203 243 25 34 201 238
Sniff or Snort Heroin2 306 295 10 <1 305 295 20 35 305 295

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

2 Respondents with unknown specific drug information were excluded from the respective analyses.

3 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.118D – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 0.31 0.32 0.20 0.24 0.34 0.35 0.51 0.52 0.37 0.39
LSD 0.25 0.27 0.13 0.14 0.28 0.29 0.39 0.38 0.30 0.32
PCP 0.11 0.13 0.05 0.06 0.13 0.14 0.08 0.06 0.14 0.16
Peyote ‑‑ 0.12 ‑‑ 0.04 ‑‑ 0.13 ‑‑ 0.05 ‑‑ 0.15
Mescaline ‑‑ 0.13 ‑‑ <0.01 ‑‑ 0.15 ‑‑ 0.07 ‑‑ 0.17
Psilocybin 0.26 0.28 0.18 0.23 0.28 0.30 0.45 0.50 0.31 0.33
Ecstasy 0.19 0.20 0.09 0.13 0.21 0.22 0.30 0.31 0.24 0.25
Ketamine 0.10 0.11 0.07 0.08 0.11 0.12 0.16 0.21 0.13 0.13
DMT, AMT, or 5‑MeO‑DIPT/Foxy 0.08 0.08 0.05 0.08 0.09 0.09 0.13 0.18 0.10 0.10
Salvia divinorum 0.09 0.10 0.03 0.04 0.10 0.11 0.11 0.11 0.12 0.12
INHALANTS1 ‑‑ 0.22 ‑‑ 0.29 ‑‑ 0.24 ‑‑ 0.38 ‑‑ 0.27
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush2 ‑‑ 0.15 ‑‑ 0.07 ‑‑ 0.16 ‑‑ 0.27 ‑‑ 0.18
Correction Fluid, Degreaser, or Cleaning Fluid2 ‑‑ 0.04 ‑‑ 0.09 ‑‑ 0.04 ‑‑ 0.08 ‑‑ 0.05
Gasoline or Lighter Fluid2 ‑‑ 0.07 ‑‑ 0.13 ‑‑ 0.07 ‑‑ 0.08 ‑‑ 0.08
Glue, Shoe Polish, or Toluene2 ‑‑ 0.06 ‑‑ 0.14 ‑‑ 0.07 ‑‑ 0.10 ‑‑ 0.07
Halothane, Ether, or Other Anesthetics2 ‑‑ 0.04 ‑‑ 0.03 ‑‑ 0.04 ‑‑ 0.02 ‑‑ 0.05
Lacquer Thinner or Other Paint Solvents2 ‑‑ 0.04 ‑‑ 0.07 ‑‑ 0.05 ‑‑ 0.06 ‑‑ 0.05
Lighter Gases2 ‑‑ 0.03 ‑‑ 0.06 ‑‑ 0.03 ‑‑ 0.04 ‑‑ 0.03
Nitrous Oxide or Whippits2 ‑‑ 0.16 ‑‑ 0.11 ‑‑ 0.18 ‑‑ 0.26 ‑‑ 0.20
Felt‑Tip Pens or Felt‑Tip/Magic Markers2 ‑‑ 0.07 ‑‑ 0.24 ‑‑ 0.07 ‑‑ 0.14 ‑‑ 0.08
Spray Paints2 ‑‑ 0.05 ‑‑ 0.12 ‑‑ 0.06 ‑‑ 0.06 ‑‑ 0.07
Computer Cleaner/Air Duster2 ‑‑ 0.06 ‑‑ 0.06 ‑‑ 0.06 ‑‑ 0.11 ‑‑ 0.07
Other Aerosol Sprays2 ‑‑ 0.03 ‑‑ 0.05 ‑‑ 0.03 ‑‑ 0.04 ‑‑ 0.03
NEEDLE USE2,3 0.11 0.12 0.05 0.07 0.12 0.14 0.11 0.09 0.14 0.16
Heroin Needle Use2 0.07 0.09 <0.01 <0.01 0.08 0.10 0.06 0.06 0.09 0.11
Cocaine Needle Use2 0.07 0.10 <0.01 * 0.08 0.11 0.05 0.04 0.09 0.13
Methamphetamine Needle Use2 0.08 0.10 0.01 * 0.09 0.10 0.06 0.03 0.10 0.12
Illegally Made Fentanyl Needle Use2,3 0.03 0.03 0.05 0.05 0.04 0.03 0.06 0.01 0.04 0.04
HEROIN 0.11 0.12 0.04 0.02 0.12 0.13 0.08 0.11 0.14 0.16
Smoke Heroin2 0.07 0.08 0.04 * 0.08 0.09 0.07 0.10 0.09 0.10
Sniff or Snort Heroin2 0.10 0.10 0.04 <0.01 0.11 0.11 0.06 0.10 0.13 0.13

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

2 Respondents with unknown specific drug information were excluded from the respective analyses.

3 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.118P – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 0.3578   0.9074   0.3108   0.0224   0.5809  
LSD 0.0593   0.5409   0.0518   0.1031   0.0909  
PCP 0.7164   0.7684   0.6853   0.1268   0.7910  
Peyote ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Mescaline ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Psilocybin 0.1826   0.7705   0.1637   0.3290   0.2187  
Ecstasy 0.8781   0.5719   0.9543   0.3237   0.7716  
Ketamine 0.8942   0.5429   0.8893   0.1170   0.8384  
DMT, AMT, or 5‑MeO‑DIPT/Foxy 0.9481   0.6107   1.0000   0.3225   0.8155  
Salvia divinorum 0.3553   0.5483   0.3261   0.4691   0.3950  
INHALANTS1 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Correction Fluid, Degreaser, or Cleaning Fluid2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Gasoline or Lighter Fluid2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Glue, Shoe Polish, or Toluene2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Halothane, Ether, or Other Anesthetics2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Lacquer Thinner or Other Paint Solvents2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Lighter Gases2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Nitrous Oxide or Whippits2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Felt‑Tip Pens or Felt‑Tip/Magic Markers2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Spray Paints2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Computer Cleaner/Air Duster2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Other Aerosol Sprays2 ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
NEEDLE USE2,3 0.7564   0.5073   0.7091   0.5004   0.7892  
Heroin Needle Use2 0.9478   0.0499   0.9635   0.5093   0.8955  
Cocaine Needle Use2 0.4556   *   0.4673   0.4236   0.4211  
Methamphetamine Needle Use2 0.2950   *   0.3014   0.2148   0.2527  
Illegally Made Fentanyl Needle Use2,3 0.0453   0.6959   0.0372   0.0117   0.0909  
HEROIN 0.7885   0.1465   0.7871   0.8992   0.8239  
Smoke Heroin2 0.8984   *   0.9190   0.9158   0.9478  
Sniff or Snort Heroin2 0.1371   0.0904   0.1399   0.9130   0.1449  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

2 Respondents with unknown specific drug information were excluded from the respective analyses.

3 The estimates that are used in these comparisons exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.119C – Specific Hallucinogen, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 409 386 43 49 406 383 120 145 389 344
LSD 139 136 24 26 140 133 47 70 130 111
PCP 27 32 1 16 27 28 10 13 25 25
Peyote ‑‑ 21 ‑‑ 2 ‑‑ 21 ‑‑ 7 ‑‑ 20
Mescaline ‑‑ 51 ‑‑ <1 ‑‑ 51 ‑‑ 19 ‑‑ 47
Psilocybin 344 324 37 41 341 325 109 118 323 296
Ecstasy 137 153 16 21 135 152 49 68 125 127
Ketamine 136 134 9 17 135 133 35 47 133 121
DMT, AMT, or 5‑MeO‑DIPT/Foxy 79 105 8 11 78 104 14 34 77 98
Salvia divinorum 24 27 8 6 22 26 4 15 22 21
NEEDLE USE1,2 126 122 12 10 126 121 29 19 122 119
Heroin Needle Use1 63 58 <1 * 63 58 7 <1 62 58
Cocaine Needle Use1 44 66 <1 * 44 66 6 1 44 66
Methamphetamine Needle Use1 90 107 3 * 89 107 12 2 89 107
Illegally Made Fentanyl Needle Use1,2 61 45 12 7 60 45 18 3 57 45
HEROIN 87 97 6 <1 86 97 14 2 86 97
Smoke Heroin1 89 59 4 * 88 59 13 2 87 59
Sniff or Snort Heroin1 57 81 6 * 56 81 9 5 57 81

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.119D – Specific Hallucinogen, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 0.13 0.13 0.16 0.19 0.15 0.14 0.33 0.37 0.16 0.14
LSD 0.05 0.05 0.09 0.10 0.05 0.05 0.13 0.19 0.06 0.05
PCP 0.01 0.01 <0.01 0.06 0.01 0.01 0.03 0.04 0.01 0.01
Peyote ‑‑ 0.01 ‑‑ 0.01 ‑‑ 0.01 ‑‑ 0.02 ‑‑ 0.01
Mescaline ‑‑ 0.02 ‑‑ <0.01 ‑‑ 0.02 ‑‑ 0.05 ‑‑ 0.02
Psilocybin 0.11 0.11 0.14 0.16 0.12 0.12 0.30 0.31 0.14 0.13
Ecstasy 0.05 0.05 0.06 0.08 0.05 0.06 0.14 0.19 0.05 0.05
Ketamine 0.05 0.05 0.04 0.07 0.05 0.05 0.10 0.13 0.06 0.05
DMT, AMT, or 5‑MeO‑DIPT/Foxy 0.03 0.04 0.03 0.04 0.03 0.04 0.04 0.09 0.03 0.04
Salvia divinorum 0.01 0.01 0.03 0.02 0.01 0.01 0.01 0.04 0.01 0.01
NEEDLE USE1,2 0.04 0.04 0.05 0.04 0.05 0.05 0.08 0.05 0.05 0.05
Heroin Needle Use1 0.02 0.02 <0.01 * 0.02 0.02 0.02 <0.01 0.03 0.03
Cocaine Needle Use1 0.02 0.02 <0.01 * 0.02 0.03 0.02 <0.01 0.02 0.03
Methamphetamine Needle Use1 0.03 0.04 0.01 * 0.03 0.04 0.03 0.01 0.04 0.05
Illegally Made Fentanyl Needle Use1,2 0.02 0.02 0.05 0.03 0.02 0.02 0.05 0.01 0.02 0.02
HEROIN 0.03 0.03 0.02 <0.01 0.03 0.04 0.04 0.01 0.04 0.04
Smoke Heroin1 0.03 0.02 0.02 * 0.03 0.02 0.04 <0.01 0.04 0.03
Sniff or Snort Heroin1 0.02 0.03 0.02 * 0.02 0.03 0.03 0.02 0.02 0.04

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.119P – Specific Hallucinogen, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 0.0108   0.5550   0.0118   0.1265   0.0281  
LSD 0.2287   0.6857   0.2555   0.7064   0.1356  
PCP 0.6543   0.0687   0.7985   0.5182   0.9920  
Peyote ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Mescaline ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Psilocybin 0.0016   0.4586   0.0020   0.0305   0.0101  
Ecstasy 0.7214   0.6137   0.6566   0.3013   0.3079  
Ketamine 0.8568   0.4746   0.7877   0.0417   0.3346  
DMT, AMT, or 5‑MeO‑DIPT/Foxy 0.0933   0.9577   0.0928   0.0013   0.4167  
Salvia divinorum 0.7343   0.6113   0.6147   0.3526   0.9292  
NEEDLE USE1,2 0.3636   0.8398   0.3458   0.0279   0.6132  
Heroin Needle Use1 0.6847   *   0.6808   0.0184   0.8384  
Cocaine Needle Use1 0.2285   *   0.2297   0.0592   0.1755  
Methamphetamine Needle Use1 0.8302   *   0.8208   0.0207   0.6609  
Illegally Made Fentanyl Needle Use1,2 0.2627   0.4693   0.3131   0.0379   0.6116  
HEROIN 0.8753   0.0990   0.8250   0.0014   0.5575  
Smoke Heroin1 0.4353   *   0.4555   0.0037   0.7037  
Sniff or Snort Heroin1 0.6135   *   0.5593   0.0822   0.4366  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 The estimates that are used in these comparisons exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.120C – Specific Hallucinogen, Needle, and Heroin Use in Past Month: Among People Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 181 191 28 23 179 192 51 71 170 176
LSD 59 53 7 9 58 52 15 21 57 48
PCP 22 16 <1 5 22 15 6 2 21 15
Peyote ‑‑ 5 ‑‑ * ‑‑ 5 ‑‑ 2 ‑‑ 5
Mescaline ‑‑ 6 ‑‑ * ‑‑ 6 ‑‑ 1 ‑‑ 6
Psilocybin 148 158 17 22 148 159 42 59 140 144
Ecstasy 69 63 5 12 69 63 23 20 65 59
Ketamine 69 69 2 14 69 67 17 23 67 62
DMT, AMT, or 5‑MeO‑DIPT/Foxy 34 43 <1 3 34 43 2 25 34 35
Salvia divinorum 20 11 1 1 19 11 1 1 19 11
NEEDLE USE1,2 93 78 12 7 92 77 21 3 90 77
Heroin Needle Use1 61 43 * * 61 43 2 <1 61 43
Cocaine Needle Use1 41 21 * * 41 21 4 1 41 21
Methamphetamine Needle Use1 47 67 * * 47 67 9 2 46 67
Illegally Made Fentanyl Needle Use1,2 58 35 12 7 57 34 17 2 54 35
HEROIN 68 88 1 <1 68 88 5 2 68 88
Smoke Heroin1 63 30 <1 * 63 30 4 <1 62 30
Sniff or Snort Heroin1 40 73 4 * 40 73 4 5 41 73

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.120D – Specific Hallucinogen, Needle, and Heroin Use in Past Month: Among People Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2024 and 2025
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 0.06 0.06 0.11 0.09 0.07 0.07 0.14 0.19 0.07 0.08
LSD 0.02 0.02 0.03 0.03 0.02 0.02 0.04 0.06 0.02 0.02
PCP 0.01 0.01 <0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.01
Peyote ‑‑ <0.01 ‑‑ * ‑‑ <0.01 ‑‑ <0.01 ‑‑ <0.01
Mescaline ‑‑ <0.01 ‑‑ * ‑‑ <0.01 ‑‑ <0.01 ‑‑ <0.01
Psilocybin 0.05 0.05 0.07 0.09 0.06 0.06 0.12 0.16 0.06 0.06
Ecstasy 0.02 0.02 0.02 0.05 0.03 0.02 0.07 0.06 0.03 0.03
Ketamine 0.02 0.02 0.01 0.06 0.03 0.03 0.05 0.06 0.03 0.03
DMT, AMT, or 5‑MeO‑DIPT/Foxy 0.01 0.01 <0.01 0.01 0.01 0.02 <0.01 0.07 0.01 0.02
Salvia divinorum 0.01 <0.01 <0.01 <0.01 0.01 <0.01 <0.01 <0.01 0.01 <0.01
NEEDLE USE1,2 0.03 0.03 0.05 0.03 0.03 0.03 0.06 0.01 0.04 0.03
Heroin Needle Use1 0.02 0.01 * * 0.02 0.02 0.01 <0.01 0.03 0.02
Cocaine Needle Use1 0.01 0.01 * * 0.02 0.01 0.01 <0.01 0.02 0.01
Methamphetamine Needle Use1 0.02 0.02 * * 0.02 0.03 0.03 <0.01 0.02 0.03
Illegally Made Fentanyl Needle Use1,2 0.02 0.01 0.05 0.03 0.02 0.01 0.05 0.01 0.02 0.02
HEROIN 0.02 0.03 <0.01 <0.01 0.03 0.03 0.01 0.01 0.03 0.04
Smoke Heroin1 0.02 0.01 <0.01 * 0.02 0.01 0.01 <0.01 0.03 0.01
Sniff or Snort Heroin1 0.01 0.03 0.02 * 0.02 0.03 0.01 0.01 0.02 0.03

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.120P – Specific Hallucinogen, Needle, and Heroin Use in Past Month: Among People Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2025 Versus 2024
Drug or Method of Administration Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
HALLUCINOGENS 0.7496   0.5933   0.7948   0.1382   0.4077  
LSD 0.7260   0.8231   0.7496   0.7486   0.8294  
PCP 0.8255   0.0990   0.5784   0.2977   0.7425  
Peyote ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Mescaline ‑‑   ‑‑   ‑‑   ‑‑   ‑‑  
Psilocybin 0.4979   0.6744   0.4567   0.2540   0.2183  
Ecstasy 0.5535   0.5129   0.4827   0.5005   0.6087  
Ketamine 0.8888   0.2680   0.7535   0.2426   0.4839  
DMT, AMT, or 5‑MeO‑DIPT/Foxy 0.2802   0.1760   0.3137   0.0829   0.8014  
Salvia divinorum 0.5305   0.6251   0.5074   0.7123   0.4869  
NEEDLE USE1,2 0.2340   0.6055   0.2524   0.0097   0.5001  
Heroin Needle Use1 0.6460   *   0.6427   0.1466   0.6765  
Cocaine Needle Use1 0.6805   *   0.6780   0.1277   0.7769  
Methamphetamine Needle Use1 0.4872   *   0.4926   0.1987   0.3921  
Illegally Made Fentanyl Needle Use1,2 0.0666   0.4693   0.0848   0.0706   0.1961  
HEROIN 0.1739   0.2573   0.1738   0.0534   0.1432  
Smoke Heroin1 0.6823   *   0.6812   0.0508   0.7721  
Sniff or Snort Heroin1 0.1967   *   0.1802   0.5541   0.1669  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown specific drug information were excluded from the respective analyses.

2 The estimates that are used in these comparisons exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See Chapter 2 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.121C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 1,236 1,300 321 341 0.47 0.51
Hydrocodone Products2 862 898 207 216 0.58 0.62
Oxycodone Products2 667 656 182 205 0.80 0.93
OxyContin® 416 398 148 114 1.57 1.27
Tramadol Products2 530 595 121 132 0.78 0.84
Codeine Products2 622 545 146 160 0.71 0.88
Morphine Products2 297 299 52 112 0.90 2.06
Prescription Fentanyl Products3 226 249 68 111 2.14 3.21
Buprenorphine Products2 233 239 98 99 2.48 2.49
Oxymorphone Products2 133 148 20 54 2.17 4.48
Demerol®2 152 136 11 43 1.27 *
Hydromorphone Products2 151 178 22 10 1.33 0.72
Methadone2 137 182 67 63 4.57 3.95

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.121D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.32 0.35 0.11 0.11 0.47 0.51
Hydrocodone Products2 0.25 0.27 0.07 0.07 0.58 0.62
Oxycodone Products2 0.21 0.20 0.06 0.07 0.80 0.93
OxyContin® 0.14 0.13 0.05 0.04 1.57 1.27
Tramadol Products2 0.17 0.19 0.04 0.05 0.78 0.84
Codeine Products2 0.19 0.17 0.05 0.05 0.71 0.88
Morphine Products2 0.10 0.10 0.02 0.04 0.90 2.06
Prescription Fentanyl Products3 0.08 0.08 0.02 0.04 2.14 3.21
Buprenorphine Products2 0.08 0.08 0.03 0.03 2.48 2.49
Oxymorphone Products2 0.05 0.05 0.01 0.02 2.17 4.48
Demerol®2 0.05 0.05 <0.01 0.01 1.27 *
Hydromorphone Products2 0.05 0.06 0.01 <0.01 1.33 0.72
Methadone2 0.05 0.06 0.02 0.02 4.57 3.95

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.121P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.0271   0.0992   0.3589  
Hydrocodone Products2 0.0524   0.0451   0.1572  
Oxycodone Products2 0.1425   0.9313   0.6930  
OxyContin® 0.7861   0.5253   0.5514  
Tramadol Products2 0.8568   0.4349   0.3853  
Codeine Products2 0.0029   0.6478   0.5358  
Morphine Products2 0.0601   0.1204   0.0432  
Prescription Fentanyl Products3 0.9258   0.2101   0.1673  
Buprenorphine Products2 0.9388   0.4464   0.3600  
Oxymorphone Products2 0.3437   0.1276   0.1951  
Demerol®2 0.3695   0.1599   *  
Hydromorphone Products2 0.2047   0.0081   0.0238  
Methadone2 0.4988   1.0000   0.7790  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.122C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 120 126 39 49 1.25 1.69
Hydrocodone Products2 57 60 21 25 2.89 3.48
Oxycodone Products2 56 59 24 24 3.24 3.63
OxyContin® 32 45 17 11 * 3.36
Tramadol Products2 39 42 16 9 4.36 3.41
Codeine Products2 79 83 28 34 1.79 2.24
Morphine Products2 28 40 5 20 * *
Prescription Fentanyl Products3 22 31 3 2 * 1.02
Buprenorphine Products2 19 28 12 4 * *
Oxymorphone Products2 10 22 4 3 * *
Demerol®2 7 13 3 <1 * *
Hydromorphone Products2 12 11 1 5 * *
Methadone2 8 13 4 2 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.122D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.42 0.44 0.15 0.19 1.25 1.69
Hydrocodone Products2 0.22 0.23 0.08 0.10 2.89 3.48
Oxycodone Products2 0.22 0.22 0.09 0.09 3.24 3.63
OxyContin® 0.12 0.17 0.06 0.04 * 3.36
Tramadol Products2 0.15 0.16 0.06 0.04 4.36 3.41
Codeine Products2 0.30 0.31 0.11 0.13 1.79 2.24
Morphine Products2 0.11 0.16 0.02 0.08 * *
Prescription Fentanyl Products3 0.09 0.12 0.01 0.01 * 1.02
Buprenorphine Products2 0.07 0.11 0.05 0.02 * *
Oxymorphone Products2 0.04 0.09 0.01 0.01 * *
Demerol®2 0.03 0.05 0.01 <0.01 * *
Hydromorphone Products2 0.05 0.04 <0.01 0.02 * *
Methadone2 0.03 0.05 0.01 0.01 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.122P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.0825   0.8057   0.3669  
Hydrocodone Products2 0.4085   0.8011   0.5974  
Oxycodone Products2 0.2964   0.3753   0.5725  
OxyContin® 0.4548   0.2771   *  
Tramadol Products2 0.4523   0.1846   0.2573  
Codeine Products2 0.3809   0.8133   0.9410  
Morphine Products2 0.1580   0.0462   *  
Prescription Fentanyl Products3 0.1265   0.5682   *  
Buprenorphine Products2 0.1746   0.2352   *  
Oxymorphone Products2 0.1749   0.6993   *  
Demerol®2 0.5115   0.3212   *  
Hydromorphone Products2 0.8391   0.4016   *  
Methadone2 0.7926   0.5941   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.123C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 1,215 1,271 317 337 0.49 0.53
Hydrocodone Products2 855 892 207 215 0.59 0.63
Oxycodone Products2 664 646 182 204 0.83 0.96
OxyContin® 415 393 147 114 1.61 1.31
Tramadol Products2 528 592 120 131 0.79 0.85
Codeine Products2 610 532 140 154 0.74 0.93
Morphine Products2 296 296 52 110 0.93 2.13
Prescription Fentanyl Products3 224 246 68 111 2.22 3.37
Buprenorphine Products2 233 233 97 99 2.51 2.57
Oxymorphone Products2 133 146 19 54 2.22 4.78
Demerol®2 152 136 11 43 1.23 *
Hydromorphone Products2 150 178 22 9 1.35 0.65
Methadone2 136 182 67 63 4.62 4.02

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.123D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.34 0.38 0.12 0.12 0.49 0.53
Hydrocodone Products2 0.27 0.29 0.08 0.08 0.59 0.63
Oxycodone Products2 0.23 0.22 0.07 0.08 0.83 0.96
OxyContin® 0.15 0.14 0.06 0.04 1.61 1.31
Tramadol Products2 0.19 0.21 0.05 0.05 0.79 0.85
Codeine Products2 0.21 0.19 0.05 0.06 0.74 0.93
Morphine Products2 0.11 0.11 0.02 0.04 0.93 2.13
Prescription Fentanyl Products3 0.08 0.09 0.03 0.04 2.22 3.37
Buprenorphine Products2 0.09 0.09 0.04 0.04 2.51 2.57
Oxymorphone Products2 0.05 0.06 0.01 0.02 2.22 4.78
Demerol®2 0.06 0.05 <0.01 0.02 1.23 *
Hydromorphone Products2 0.06 0.07 0.01 <0.01 1.35 0.65
Methadone2 0.05 0.07 0.03 0.02 4.62 4.02

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.123P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.0357   0.0869   0.2992  
Hydrocodone Products2 0.0506   0.0397   0.1411  
Oxycodone Products2 0.1550   0.9886   0.6351  
OxyContin® 0.7076   0.5974   0.6510  
Tramadol Products2 0.8417   0.5099   0.4546  
Codeine Products2 0.0036   0.6754   0.5378  
Morphine Products2 0.0380   0.2203   0.0853  
Prescription Fentanyl Products3 0.7754   0.2075   0.1415  
Buprenorphine Products2 0.9351   0.5030   0.4695  
Oxymorphone Products2 0.4363   0.1187   0.1626  
Demerol®2 0.3393   0.1389   *  
Hydromorphone Products2 0.2033   0.0042   0.0120  
Methadone2 0.5174   0.9838   0.8039  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.124C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 183 197 84 72 1.55 1.40
Hydrocodone Products2 118 116 47 47 1.97 2.29
Oxycodone Products2 88 103 42 37 2.41 2.17
OxyContin® 55 60 24 16 3.59 2.71
Tramadol Products2 69 77 36 23 3.95 3.10
Codeine Products2 93 116 52 42 2.81 2.43
Morphine Products2 57 50 7 8 1.34 1.98
Prescription Fentanyl Products3 33 39 15 16 5.51 5.17
Buprenorphine Products2 25 46 13 10 * 3.51
Oxymorphone Products2 20 28 7 4 * *
Demerol®2 8 14 3 7 * *
Hydromorphone Products2 20 22 3 4 * *
Methadone2 18 17 2 3 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.124D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.44 0.45 0.23 0.20 1.55 1.40
Hydrocodone Products2 0.32 0.31 0.13 0.13 1.97 2.29
Oxycodone Products2 0.25 0.27 0.12 0.10 2.41 2.17
OxyContin® 0.16 0.16 0.07 0.04 3.59 2.71
Tramadol Products2 0.19 0.21 0.10 0.06 3.95 3.10
Codeine Products2 0.24 0.29 0.15 0.12 2.81 2.43
Morphine Products2 0.16 0.14 0.02 0.02 1.34 1.98
Prescription Fentanyl Products3 0.09 0.11 0.04 0.04 5.51 5.17
Buprenorphine Products2 0.07 0.13 0.04 0.03 * 3.51
Oxymorphone Products2 0.06 0.08 0.02 0.01 * *
Demerol®2 0.02 0.04 0.01 0.02 * *
Hydromorphone Products2 0.06 0.06 0.01 0.01 * *
Methadone2 0.05 0.05 0.01 0.01 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.124P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.3566   0.0788   0.1148  
Hydrocodone Products2 0.0545   0.2755   0.6844  
Oxycodone Products2 0.9484   0.1035   0.0774  
OxyContin® 0.4327   0.1111   0.1734  
Tramadol Products2 0.6531   0.1216   0.1049  
Codeine Products2 0.6168   0.1040   0.1025  
Morphine Products2 0.0224   0.4104   0.9025  
Prescription Fentanyl Products3 0.5385   0.7973   0.5570  
Buprenorphine Products2 0.0298   0.3030   *  
Oxymorphone Products2 0.3454   0.6166   *  
Demerol®2 0.5143   0.5992   *  
Hydromorphone Products2 0.8870   0.8318   *  
Methadone2 0.8715   0.8182   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.125C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 1,158 1,246 301 327 0.51 0.56
Hydrocodone Products2 833 885 203 212 0.62 0.66
Oxycodone Products2 647 632 175 200 0.86 1.01
OxyContin® 410 386 145 112 1.73 1.39
Tramadol Products2 518 585 115 129 0.80 0.89
Codeine Products2 596 513 127 147 0.75 0.99
Morphine Products2 288 291 52 109 1.02 2.32
Prescription Fentanyl Products3 221 243 66 110 2.34 3.68
Buprenorphine Products2 232 234 96 98 2.61 2.77
Oxymorphone Products2 131 143 18 54 2.32 *
Demerol®2 152 135 10 42 1.19 *
Hydromorphone Products2 149 176 22 8 1.40 0.60
Methadone2 136 181 67 63 4.87 4.20

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.125D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Standard Errors of Percentages, 2024 and 2025
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.39 0.43 0.13 0.14 0.51 0.56
Hydrocodone Products2 0.31 0.33 0.09 0.09 0.62 0.66
Oxycodone Products2 0.26 0.25 0.08 0.09 0.86 1.01
OxyContin® 0.17 0.16 0.06 0.05 1.73 1.39
Tramadol Products2 0.21 0.24 0.05 0.06 0.80 0.89
Codeine Products2 0.24 0.21 0.06 0.06 0.75 0.99
Morphine Products2 0.12 0.12 0.02 0.05 1.02 2.32
Prescription Fentanyl Products3 0.10 0.11 0.03 0.05 2.34 3.68
Buprenorphine Products2 0.10 0.10 0.04 0.04 2.61 2.77
Oxymorphone Products2 0.06 0.06 0.01 0.02 2.32 *
Demerol®2 0.07 0.06 <0.01 0.02 1.19 *
Hydromorphone Products2 0.07 0.08 0.01 <0.01 1.40 0.60
Methadone2 0.06 0.08 0.03 0.03 4.87 4.20

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.125P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Prescription Opioid Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes
(2025)
PRESCRIPTION OPIOID1 0.0550   0.1835   0.4725  
Hydrocodone Products2 0.1037   0.0668   0.1691  
Oxycodone Products2 0.1635   0.7206   0.4282  
OxyContin® 0.8110   0.7807   0.8188  
Tramadol Products2 0.7566   0.7739   0.6939  
Codeine Products2 0.0045   0.9177   0.2864  
Morphine Products2 0.0954   0.1907   0.0840  
Prescription Fentanyl Products3 0.7088   0.1853   0.1159  
Buprenorphine Products2 0.6833   0.5918   0.6928  
Oxymorphone Products2 0.5307   0.1008   *  
Demerol®2 0.3173   0.1587   *  
Hydromorphone Products2 0.2115   0.0038   0.0096  
Methadone2 0.4959   0.9714   0.7940  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Includes the use or misuse of other prescription opioids not shown in this table.

2 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

3 Includes fentanyl products that are available by prescription in the United States. Does not include illegally made fentanyl (IMF).

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.126C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 523 615 213 221 0.88 0.91
Amphetamines or Methylphenidate Products1 448 544 191 219 0.97 1.09
Amphetamines1 407 501 180 203 1.07 1.17
Methylphenidate Products1 205 261 72 90 1.58 1.75
Anorectic (Weight‑Loss) Stimulants1 182 231 36 41 1.27 1.38
Provigil®1 76 79 23 22 * *
Any Other Prescription Stimulant1,2 187 182 79 12 * 0.49

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.126D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.16 0.19 0.07 0.07 0.88 0.91
Amphetamines or Methylphenidate Products1 0.14 0.17 0.06 0.07 0.97 1.09
Amphetamines1 0.13 0.16 0.06 0.07 1.07 1.17
Methylphenidate Products1 0.07 0.09 0.03 0.03 1.58 1.75
Anorectic (Weight‑Loss) Stimulants1 0.06 0.08 0.01 0.01 1.27 1.38
Provigil®1 0.03 0.03 0.01 0.01 * *
Any Other Prescription Stimulant1,2 0.06 0.06 0.03 <0.01 * 0.49

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.126P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.4397   0.9740   0.7140  
Amphetamines or Methylphenidate Products1 0.0869   0.6190   0.6764  
Amphetamines1 0.0794   0.6147   0.6103  
Methylphenidate Products1 0.0639   0.6507   0.8505  
Anorectic (Weight‑Loss) Stimulants1 0.6152   0.8516   0.7393  
Provigil®1 0.6348   0.6888   *  
Any Other Prescription Stimulant1,2 0.7221   0.2319   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.127C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 93 110 31 34 1.52 1.63
Amphetamines or Methylphenidate Products1 90 105 31 34 1.68 1.77
Amphetamines1 76 76 26 29 2.12 2.33
Methylphenidate Products1 64 81 21 17 2.60 2.01
Anorectic (Weight‑Loss) Stimulants1 20 26 11 3 * *
Provigil®1 5 2 * 1 * *
Any Other Prescription Stimulant1,2 35 42 2 * 0.65 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.127D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.34 0.41 0.12 0.13 1.52 1.63
Amphetamines or Methylphenidate Products1 0.33 0.39 0.12 0.13 1.68 1.77
Amphetamines1 0.29 0.29 0.10 0.12 2.12 2.33
Methylphenidate Products1 0.25 0.31 0.08 0.07 2.60 2.01
Anorectic (Weight‑Loss) Stimulants1 0.08 0.10 0.04 0.01 * *
Provigil®1 0.02 0.01 * 0.01 * *
Any Other Prescription Stimulant1,2 0.14 0.16 0.01 * 0.65 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.127P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.4879   0.7089   0.8750  
Amphetamines or Methylphenidate Products1 0.4444   0.8360   0.9518  
Amphetamines1 0.8410   0.9745   0.9601  
Methylphenidate Products1 0.4529   0.4975   0.3656  
Anorectic (Weight‑Loss) Stimulants1 0.5616   0.2995   *  
Provigil®1 0.2578   *   *  
Any Other Prescription Stimulant1,2 0.8296   *   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.128C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 509 594 211 217 0.94 0.98
Amphetamines or Methylphenidate Products1 433 524 188 215 1.04 1.19
Amphetamines1 394 488 179 201 1.15 1.26
Methylphenidate Products1 195 247 69 87 1.80 2.02
Anorectic (Weight‑Loss) Stimulants1 180 229 35 42 1.25 1.43
Provigil®1 76 79 23 22 * *
Any Other Prescription Stimulant1,2 182 178 79 12 * 0.56

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.128D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.17 0.21 0.08 0.08 0.94 0.98
Amphetamines or Methylphenidate Products1 0.15 0.18 0.07 0.08 1.04 1.19
Amphetamines1 0.14 0.17 0.07 0.07 1.15 1.26
Methylphenidate Products1 0.07 0.09 0.03 0.03 1.80 2.02
Anorectic (Weight‑Loss) Stimulants1 0.07 0.09 0.01 0.02 1.25 1.43
Provigil®1 0.03 0.03 0.01 0.01 * *
Any Other Prescription Stimulant1,2 0.07 0.07 0.03 <0.01 * 0.56

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.128P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.5085   0.9689   0.6888  
Amphetamines or Methylphenidate Products1 0.1062   0.6465   0.6579  
Amphetamines1 0.0792   0.6267   0.5847  
Methylphenidate Products1 0.0824   0.5221   1.0000  
Anorectic (Weight‑Loss) Stimulants1 0.6718   0.9822   0.9245  
Provigil®1 0.6671   0.7387   *  
Any Other Prescription Stimulant1,2 0.7588   0.2473   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.129C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 167 188 74 93 1.68 2.05
Amphetamines or Methylphenidate Products1 158 182 73 92 1.80 2.18
Amphetamines1 138 167 72 91 2.02 2.45
Methylphenidate Products1 76 86 26 26 2.45 2.47
Anorectic (Weight‑Loss) Stimulants1 25 30 9 11 * *
Provigil®1 21 10 1 <1 * *
Any Other Prescription Stimulant1,2 50 40 3 2 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.129D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.43 0.46 0.21 0.25 1.68 2.05
Amphetamines or Methylphenidate Products1 0.41 0.45 0.21 0.25 1.80 2.18
Amphetamines1 0.36 0.42 0.20 0.24 2.02 2.45
Methylphenidate Products1 0.22 0.23 0.08 0.07 2.45 2.47
Anorectic (Weight‑Loss) Stimulants1 0.07 0.08 0.03 0.03 * *
Provigil®1 0.06 0.03 <0.01 <0.01 * *
Any Other Prescription Stimulant1,2 0.14 0.11 0.01 0.01 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.129P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.9640   0.8142   0.7622  
Amphetamines or Methylphenidate Products1 0.5292   0.8875   0.5668  
Amphetamines1 0.2699   0.9493   0.4887  
Methylphenidate Products1 0.7872   0.3753   0.4084  
Anorectic (Weight‑Loss) Stimulants1 0.7338   0.4946   *  
Provigil®1 0.0855   0.2243   *  
Any Other Prescription Stimulant1,2 0.0228   0.8977   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.130C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 484 552 197 186 1.11 1.07
Amphetamines or Methylphenidate Products1 411 483 172 186 1.25 1.36
Amphetamines1 375 454 163 172 1.36 1.41
Methylphenidate Products1 170 233 63 83 2.32 2.57
Anorectic (Weight‑Loss) Stimulants1 178 230 34 40 1.29 1.47
Provigil®1 73 79 23 22 * *
Any Other Prescription Stimulant1,2 175 173 79 12 * 0.62

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.130D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Standard Errors of Percentages, 2024 and 2025
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.19 0.23 0.08 0.08 1.11 1.07
Amphetamines or Methylphenidate Products1 0.17 0.20 0.07 0.08 1.25 1.36
Amphetamines1 0.15 0.19 0.07 0.07 1.36 1.41
Methylphenidate Products1 0.07 0.10 0.03 0.04 2.32 2.57
Anorectic (Weight‑Loss) Stimulants1 0.08 0.10 0.01 0.02 1.29 1.47
Provigil®1 0.03 0.03 0.01 0.01 * *
Any Other Prescription Stimulant1,2 0.08 0.07 0.03 0.01 * 0.62

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.130P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Stimulant Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes
(2025)
PRESCRIPTION STIMULANT 0.5234   0.9895   0.7542  
Amphetamines or Methylphenidate Products1 0.1548   0.5958   0.8169  
Amphetamines1 0.1585   0.6396   0.7446  
Methylphenidate Products1 0.0512   0.3265   0.7740  
Anorectic (Weight‑Loss) Stimulants1 0.6920   0.8323   0.9124  
Provigil®1 0.9490   0.6999   *  
Any Other Prescription Stimulant1,2 0.7863   0.2494   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of stimulants containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.131C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 763 759 223 256 0.67 0.81
Benzodiazepine Tranquilizers1 637 656 205 243 0.84 1.02
Alprazolam Products1 445 463 150 218 1.15 1.63
Lorazepam Products1 327 355 73 96 1.10 1.44
Clonazepam Products1 297 292 116 127 1.92 2.28
Diazepam Products1 266 300 86 77 1.69 1.77
Muscle Relaxants1 340 329 85 65 1.09 1.02
Cyclobenzaprine1 316 304 84 60 1.17 1.06
Soma®1 102 132 11 22 1.71 2.92
Any Other Prescription Tranquilizer1,2 274 285 46 65 1.00 1.51

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.131D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.22 0.23 0.08 0.09 0.67 0.81
Benzodiazepine Tranquilizers1 0.20 0.20 0.07 0.08 0.84 1.02
Alprazolam Products1 0.15 0.15 0.05 0.07 1.15 1.63
Lorazepam Products1 0.11 0.12 0.03 0.03 1.10 1.44
Clonazepam Products1 0.10 0.10 0.04 0.04 1.92 2.28
Diazepam Products1 0.09 0.10 0.03 0.03 1.69 1.77
Muscle Relaxants1 0.11 0.11 0.03 0.02 1.09 1.02
Cyclobenzaprine1 0.11 0.10 0.03 0.02 1.17 1.06
Soma®1 0.04 0.05 <0.01 0.01 1.71 2.92
Any Other Prescription Tranquilizer1,2 0.09 0.10 0.02 0.02 1.00 1.51

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.131P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.0019   0.5620   0.6077  
Benzodiazepine Tranquilizers1 0.0167   0.7555   0.5327  
Alprazolam Products1 0.2295   0.4007   0.1525  
Lorazepam Products1 0.7003   0.7240   0.6150  
Clonazepam Products1 0.0811   0.4126   0.8543  
Diazepam Products1 0.1595   0.1399   0.3263  
Muscle Relaxants1 0.0112   0.2647   0.6810  
Cyclobenzaprine1 0.0035   0.1946   0.6000  
Soma®1 0.6129   0.2231   0.3467  
Any Other Prescription Tranquilizer1,2 0.4689   0.5941   0.5057  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.132C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 46 56 23 29 3.71 4.55
Benzodiazepine Tranquilizers1 39 49 20 29 4.81 6.01
Alprazolam Products1 32 41 18 26 6.02 *
Lorazepam Products1 20 18 13 11 * *
Clonazepam Products1 18 15 12 4 * *
Diazepam Products1 20 20 11 7 * *
Muscle Relaxants1 11 15 4 3 * *
Cyclobenzaprine1 10 15 4 3 * *
Soma®1 7 2 <1 * * *
Any Other Prescription Tranquilizer1,2 24 27 2 5 1.31 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.132D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.18 0.22 0.09 0.11 3.71 4.55
Benzodiazepine Tranquilizers1 0.15 0.19 0.08 0.11 4.81 6.01
Alprazolam Products1 0.12 0.16 0.07 0.10 6.02 *
Lorazepam Products1 0.08 0.07 0.05 0.04 * *
Clonazepam Products1 0.07 0.06 0.05 0.02 * *
Diazepam Products1 0.08 0.08 0.04 0.03 * *
Muscle Relaxants1 0.04 0.06 0.01 0.01 * *
Cyclobenzaprine1 0.04 0.06 0.01 0.01 * *
Soma®1 0.03 0.01 <0.01 * * *
Any Other Prescription Tranquilizer1,2 0.09 0.10 0.01 0.02 1.31 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.132P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.8093   0.9125   0.7803  
Benzodiazepine Tranquilizers1 0.4940   0.5412   0.7624  
Alprazolam Products1 0.5228   0.8202   *  
Lorazepam Products1 0.9499   0.8317   *  
Clonazepam Products1 0.4798   0.4270   *  
Diazepam Products1 0.6839   0.6056   *  
Muscle Relaxants1 0.7053   0.7936   *  
Cyclobenzaprine1 0.5623   0.8312   *  
Soma®1 0.2102   *   *  
Any Other Prescription Tranquilizer1,2 0.6642   0.4662   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.133C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 757 756 220 256 0.68 0.83
Benzodiazepine Tranquilizers1 635 655 204 243 0.84 1.03
Alprazolam Products1 442 460 149 215 1.17 1.65
Lorazepam Products1 325 356 72 95 1.10 1.44
Clonazepam Products1 296 291 115 127 1.93 2.30
Diazepam Products1 266 299 86 77 1.70 1.79
Muscle Relaxants1 340 328 85 65 1.09 1.02
Cyclobenzaprine1 316 303 84 60 1.18 1.06
Soma®1 102 132 11 22 1.74 2.93
Any Other Prescription Tranquilizer1,2 272 283 46 64 1.04 1.55

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.133D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.24 0.25 0.08 0.09 0.68 0.83
Benzodiazepine Tranquilizers1 0.21 0.22 0.08 0.09 0.84 1.03
Alprazolam Products1 0.16 0.16 0.06 0.08 1.17 1.65
Lorazepam Products1 0.12 0.13 0.03 0.04 1.10 1.44
Clonazepam Products1 0.11 0.11 0.04 0.05 1.93 2.30
Diazepam Products1 0.10 0.11 0.03 0.03 1.70 1.79
Muscle Relaxants1 0.12 0.12 0.03 0.02 1.09 1.02
Cyclobenzaprine1 0.12 0.11 0.03 0.02 1.18 1.06
Soma®1 0.04 0.05 <0.01 0.01 1.74 2.93
Any Other Prescription Tranquilizer1,2 0.10 0.10 0.02 0.02 1.04 1.55

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.133P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.0013   0.5556   0.6022  
Benzodiazepine Tranquilizers1 0.0121   0.6904   0.5750  
Alprazolam Products1 0.1916   0.4194   0.1524  
Lorazepam Products1 0.6741   0.7039   0.5890  
Clonazepam Products1 0.0822   0.4386   0.8872  
Diazepam Products1 0.1437   0.1524   0.3579  
Muscle Relaxants1 0.0095   0.2649   0.6902  
Cyclobenzaprine1 0.0028   0.1945   0.6081  
Soma®1 0.5806   0.2213   0.3552  
Any Other Prescription Tranquilizer1,2 0.4805   0.6300   0.5387  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.134C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 100 116 54 60 2.23 2.82
Benzodiazepine Tranquilizers1 93 102 51 57 2.59 3.29
Alprazolam Products1 75 88 49 50 3.53 4.18
Lorazepam Products1 44 40 12 16 2.93 4.41
Clonazepam Products1 40 40 20 24 4.86 *
Diazepam Products1 35 29 19 7 6.15 3.48
Muscle Relaxants1 27 36 16 12 * 4.37
Cyclobenzaprine1 26 34 16 11 * *
Soma®1 7 13 3 8 * *
Any Other Prescription Tranquilizer1,2 42 35 11 14 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.134D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.27 0.31 0.15 0.17 2.23 2.82
Benzodiazepine Tranquilizers1 0.26 0.28 0.14 0.16 2.59 3.29
Alprazolam Products1 0.21 0.24 0.14 0.14 3.53 4.18
Lorazepam Products1 0.13 0.11 0.04 0.04 2.93 4.41
Clonazepam Products1 0.11 0.11 0.06 0.07 4.86 *
Diazepam Products1 0.10 0.08 0.05 0.02 6.15 3.48
Muscle Relaxants1 0.08 0.10 0.05 0.03 * 4.37
Cyclobenzaprine1 0.07 0.09 0.05 0.03 * *
Soma®1 0.02 0.04 0.01 0.02 * *
Any Other Prescription Tranquilizer1,2 0.12 0.10 0.03 0.04 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.134P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.1862   0.7673   0.6570  
Benzodiazepine Tranquilizers1 0.2906   0.6922   0.8230  
Alprazolam Products1 0.9222   0.5662   0.4196  
Lorazepam Products1 0.1957   0.9719   0.4995  
Clonazepam Products1 0.1971   0.7394   *  
Diazepam Products1 0.0801   0.0121   0.0228  
Muscle Relaxants1 0.3807   0.3803   *  
Cyclobenzaprine1 0.7423   0.2316   *  
Soma®1 0.1281   0.6601   *  
Any Other Prescription Tranquilizer1,2 0.0132   0.9824   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.135C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 747 746 211 250 0.69 0.87
Benzodiazepine Tranquilizers1 624 642 195 237 0.87 1.09
Alprazolam Products1 436 454 139 211 1.19 1.78
Lorazepam Products1 322 353 71 94 1.15 1.49
Clonazepam Products1 292 291 114 125 2.03 2.40
Diazepam Products1 264 299 82 76 1.75 1.88
Muscle Relaxants1 337 326 83 63 1.11 1.03
Cyclobenzaprine1 313 301 82 60 1.19 1.10
Soma®1 101 132 11 20 1.71 2.90
Any Other Prescription Tranquilizer1,2 268 282 44 63 1.10 1.61

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.135D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Standard Errors of Percentages, 2024 and 2025
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.27 0.28 0.09 0.11 0.69 0.87
Benzodiazepine Tranquilizers1 0.24 0.25 0.09 0.10 0.87 1.09
Alprazolam Products1 0.18 0.18 0.06 0.09 1.19 1.78
Lorazepam Products1 0.14 0.15 0.03 0.04 1.15 1.49
Clonazepam Products1 0.13 0.12 0.05 0.05 2.03 2.40
Diazepam Products1 0.11 0.13 0.04 0.03 1.75 1.88
Muscle Relaxants1 0.14 0.14 0.04 0.03 1.11 1.03
Cyclobenzaprine1 0.13 0.13 0.04 0.03 1.19 1.10
Soma®1 0.04 0.06 <0.01 0.01 1.71 2.90
Any Other Prescription Tranquilizer1,2 0.11 0.12 0.02 0.03 1.10 1.61

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.135P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Tranquilizer Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes
(2025)
PRESCRIPTION TRANQUILIZER 0.0028   0.5910   0.6734  
Benzodiazepine Tranquilizers1 0.0200   0.7527   0.6116  
Alprazolam Products1 0.1892   0.3253   0.1161  
Lorazepam Products1 0.8161   0.7012   0.6323  
Clonazepam Products1 0.1234   0.4696   0.8488  
Diazepam Products1 0.2158   0.3164   0.5735  
Muscle Relaxants1 0.0079   0.3324   0.7938  
Cyclobenzaprine1 0.0026   0.2792   0.7449  
Soma®1 0.6683   0.2532   0.3688  
Any Other Prescription Tranquilizer1,2 0.7345   0.6254   0.5751  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of tranquilizers containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.136C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 536 555 127 170 0.88 1.19
Zolpidem Products1 350 373 109 96 1.69 1.49
Eszopiclone Products1 122 135 16 17 1.56 1.82
Zaleplon Products1 66 112 * 11 * 1.78
Benzodiazepine Sedatives1 156 166 39 59 2.34 3.62
Flurazepam1 15 38 3 31 * *
Temazepam Products1 115 124 37 35 * *
Triazolam Products1 107 115 12 48 1.62 *
Barbiturates1 84 107 15 14 2.95 2.45
Any Other Prescription Sedative1,2 335 364 33 33 0.53 0.58

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.136D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.17 0.17 0.04 0.06 0.88 1.19
Zolpidem Products1 0.12 0.12 0.04 0.03 1.69 1.49
Eszopiclone Products1 0.04 0.05 0.01 0.01 1.56 1.82
Zaleplon Products1 0.02 0.04 * <0.01 * 1.78
Benzodiazepine Sedatives1 0.05 0.06 0.01 0.02 2.34 3.62
Flurazepam1 0.01 0.01 <0.01 0.01 * *
Temazepam Products1 0.04 0.04 0.01 0.01 * *
Triazolam Products1 0.04 0.04 <0.01 0.02 1.62 *
Barbiturates1 0.03 0.04 0.01 <0.01 2.95 2.45
Any Other Prescription Sedative1,2 0.11 0.12 0.01 0.01 0.53 0.58

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.136P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.7674   0.8152   0.7525  
Zolpidem Products1 0.6279   0.4980   0.3865  
Eszopiclone Products1 0.9095   0.8763   0.8468  
Zaleplon Products1 0.0240   *   *  
Benzodiazepine Sedatives1 0.7014   0.3908   0.3174  
Flurazepam1 0.1405   0.2316   *  
Temazepam Products1 0.4008   0.8941   *  
Triazolam Products1 0.7130   0.2587   *  
Barbiturates1 0.6713   0.9797   0.8803  
Any Other Prescription Sedative1,2 0.5164   0.9148   0.9372  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.137C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 52 43 17 10 2.96 2.38
Zolpidem Products1 21 25 12 6 * *
Eszopiclone Products1 6 11 5 6 * *
Zaleplon Products1 7 6 * 4 * *
Benzodiazepine Sedatives1 17 14 10 6 * *
Flurazepam1 5 8 1 4 * *
Temazepam Products1 8 7 1 4 * *
Triazolam Products1 14 11 10 * * *
Barbiturates1 10 13 6 5 * *
Any Other Prescription Sedative1,2 50 33 13 3 * 0.97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.137D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.20 0.16 0.07 0.04 2.96 2.38
Zolpidem Products1 0.08 0.10 0.05 0.02 * *
Eszopiclone Products1 0.02 0.04 0.02 0.02 * *
Zaleplon Products1 0.03 0.03 * 0.01 * *
Benzodiazepine Sedatives1 0.07 0.05 0.04 0.02 * *
Flurazepam1 0.02 0.03 <0.01 0.01 * *
Temazepam Products1 0.03 0.03 <0.01 0.02 * *
Triazolam Products1 0.06 0.04 0.04 * * *
Barbiturates1 0.04 0.05 0.02 0.02 * *
Any Other Prescription Sedative1,2 0.19 0.13 0.05 0.01 * 0.97

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.137P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.0339   0.1060   0.3193  
Zolpidem Products1 0.6746   0.3200   *  
Eszopiclone Products1 0.3608   0.9857   *  
Zaleplon Products1 0.7617   *   *  
Benzodiazepine Sedatives1 0.8647   0.6842   *  
Flurazepam1 0.2390   0.1558   *  
Temazepam Products1 0.9502   0.5751   *  
Triazolam Products1 0.7346   *   *  
Barbiturates1 0.3795   0.7732   *  
Any Other Prescription Sedative1,2 0.0235   0.1135   *  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.138C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 532 554 126 170 0.91 1.23
Zolpidem Products1 350 372 109 96 1.70 1.51
Eszopiclone Products1 122 134 15 16 1.48 1.74
Zaleplon Products1 66 112 * 10 * 1.72
Benzodiazepine Sedatives1 154 164 37 59 2.34 3.74
Flurazepam1 14 37 3 31 * *
Temazepam Products1 114 124 37 34 * *
Triazolam Products1 106 113 6 48 0.83 *
Barbiturates1 84 105 14 13 * 2.49
Any Other Prescription Sedative1,2 329 360 30 33 0.52 0.60

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.138D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.19 0.19 0.05 0.06 0.91 1.23
Zolpidem Products1 0.13 0.14 0.04 0.04 1.70 1.51
Eszopiclone Products1 0.05 0.05 0.01 0.01 1.48 1.74
Zaleplon Products1 0.03 0.04 * <0.01 * 1.72
Benzodiazepine Sedatives1 0.06 0.06 0.01 0.02 2.34 3.74
Flurazepam1 0.01 0.01 <0.01 0.01 * *
Temazepam Products1 0.04 0.05 0.01 0.01 * *
Triazolam Products1 0.04 0.04 <0.01 0.02 0.83 *
Barbiturates1 0.03 0.04 0.01 <0.01 * 2.49
Any Other Prescription Sedative1,2 0.12 0.13 0.01 0.01 0.52 0.60

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.138P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.8962   0.7047   0.6694  
Zolpidem Products1 0.6272   0.5509   0.4380  
Eszopiclone Products1 0.8508   0.8693   0.8235  
Zaleplon Products1 0.0253   *   *  
Benzodiazepine Sedatives1 0.7033   0.3467   0.2790  
Flurazepam1 0.2138   0.3024   *  
Temazepam Products1 0.3970   0.9334   *  
Triazolam Products1 0.6835   0.1546   *  
Barbiturates1 0.7480   0.8744   *  
Any Other Prescription Sedative1,2 0.7018   0.7118   0.6220  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.139C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 67 78 19 28 2.20 2.82
Zolpidem Products1 24 36 10 14 5.30 *
Eszopiclone Products1 13 21 12 4 * *
Zaleplon Products1 19 13 * 1 * *
Benzodiazepine Sedatives1 22 22 6 4 * *
Flurazepam1 3 7 * * * *
Temazepam Products1 14 11 3 1 * *
Triazolam Products1 18 18 5 4 * *
Barbiturates1 11 14 2 7 * *
Any Other Prescription Sedative1,2 57 61 10 16 1.91 2.70

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.139D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.18 0.21 0.05 0.08 2.20 2.82
Zolpidem Products1 0.07 0.10 0.03 0.04 5.30 *
Eszopiclone Products1 0.04 0.06 0.03 0.01 * *
Zaleplon Products1 0.05 0.04 * <0.01 * *
Benzodiazepine Sedatives1 0.06 0.06 0.02 0.01 * *
Flurazepam1 0.01 0.02 * * * *
Temazepam Products1 0.04 0.03 0.01 <0.01 * *
Triazolam Products1 0.05 0.05 0.01 0.01 * *
Barbiturates1 0.03 0.04 0.01 0.02 * *
Any Other Prescription Sedative1,2 0.16 0.17 0.03 0.04 1.91 2.70

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.139P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.4714   0.2443   0.3191  
Zolpidem Products1 0.2162   0.6667   *  
Eszopiclone Products1 0.9367   0.3249   *  
Zaleplon Products1 0.8773   *   *  
Benzodiazepine Sedatives1 0.8427   0.5650   *  
Flurazepam1 0.2618   *   *  
Temazepam Products1 0.1618   0.6178   *  
Triazolam Products1 0.9807   0.7011   *  
Barbiturates1 0.5231   0.6080   *  
Any Other Prescription Sedative1,2 0.8434   0.2314   0.2185  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.140C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 529 548 124 168 0.95 1.30
Zolpidem Products1 351 372 108 95 1.75 1.55
Eszopiclone Products1 121 133 9 16 0.97 1.78
Zaleplon Products1 63 111 * 10 * *
Benzodiazepine Sedatives1 152 163 37 58 2.50 4.04
Flurazepam1 14 37 3 31 * *
Temazepam Products1 113 123 36 34 * *
Triazolam Products1 104 112 3 47 0.51 *
Barbiturates1 83 104 14 11 * *
Any Other Prescription Sedative1,2 325 354 28 29 0.53 0.59

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.140D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Standard Errors of Percentages, 2024 and 2025
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.22 0.22 0.05 0.07 0.95 1.30
Zolpidem Products1 0.15 0.16 0.05 0.04 1.75 1.55
Eszopiclone Products1 0.05 0.06 <0.01 0.01 0.97 1.78
Zaleplon Products1 0.03 0.05 * <0.01 * *
Benzodiazepine Sedatives1 0.07 0.07 0.02 0.03 2.50 4.04
Flurazepam1 0.01 0.02 <0.01 0.01 * *
Temazepam Products1 0.05 0.05 0.02 0.02 * *
Triazolam Products1 0.05 0.05 <0.01 0.02 0.51 *
Barbiturates1 0.04 0.05 0.01 <0.01 * *
Any Other Prescription Sedative1,2 0.14 0.15 0.01 0.01 0.53 0.59

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.140P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Sedative Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes
(2025)
PRESCRIPTION SEDATIVE 0.8410   0.8428   0.8003  
Zolpidem Products1 0.6819   0.5870   0.4888  
Eszopiclone Products1 0.8513   0.3948   0.3864  
Zaleplon Products1 0.0245   *   *  
Benzodiazepine Sedatives1 0.7296   0.3138   0.2535  
Flurazepam1 0.2976   0.3022   *  
Temazepam Products1 0.4909   0.9035   *  
Triazolam Products1 0.6796   0.1379   *  
Barbiturates1 0.8067   0.9781   *  
Any Other Prescription Sedative1,2 0.6812   0.8772   0.9644  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the use or misuse of sedatives containing other active ingredients.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.141C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 653 674 208 248 0.81 0.98
Benzodiazepine Tranquilizers1 637 656 205 243 0.84 1.02
Alprazolam Products1 445 463 150 218 1.15 1.63
Lorazepam Products1 327 355 73 96 1.10 1.44
Clonazepam Products1 297 292 116 127 1.92 2.28
Diazepam Products1 266 300 86 77 1.69 1.77
Benzodiazepine Sedatives1 156 166 39 59 2.34 3.62
Flurazepam1 15 38 3 31 * *
Temazepam Products1 115 124 37 35 * *
Triazolam Products1 107 115 12 48 1.62 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 4 8 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.141D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.20 0.20 0.07 0.08 0.81 0.98
Benzodiazepine Tranquilizers1 0.20 0.20 0.07 0.08 0.84 1.02
Alprazolam Products1 0.15 0.15 0.05 0.07 1.15 1.63
Lorazepam Products1 0.11 0.12 0.03 0.03 1.10 1.44
Clonazepam Products1 0.10 0.10 0.04 0.04 1.92 2.28
Diazepam Products1 0.09 0.10 0.03 0.03 1.69 1.77
Benzodiazepine Sedatives1 0.05 0.06 0.01 0.02 2.34 3.62
Flurazepam1 0.01 0.01 <0.01 0.01 * *
Temazepam Products1 0.04 0.04 0.01 0.01 * *
Triazolam Products1 0.04 0.04 <0.01 0.02 1.62 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.01 <0.01 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.141P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.0108   0.7689   0.4812  
Benzodiazepine Tranquilizers1 0.0167   0.7555   0.5327  
Alprazolam Products1 0.2295   0.4007   0.1525  
Lorazepam Products1 0.7003   0.7240   0.6150  
Clonazepam Products1 0.0811   0.4126   0.8543  
Diazepam Products1 0.1595   0.1399   0.3263  
Benzodiazepine Sedatives1 0.7014   0.3908   0.3174  
Flurazepam1 0.1405   0.2316   *  
Temazepam Products1 0.4008   0.8941   *  
Triazolam Products1 0.7130   0.2587   *  
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da   0.5923   da  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.142C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 43 50 20 29 4.37 5.47
Benzodiazepine Tranquilizers1 39 49 20 29 4.81 6.01
Alprazolam Products1 32 41 18 26 6.02 *
Lorazepam Products1 20 18 13 11 * *
Clonazepam Products1 18 15 12 4 * *
Diazepam Products1 20 20 11 7 * *
Benzodiazepine Sedatives1 17 14 10 6 * *
Flurazepam1 5 8 1 4 * *
Temazepam Products1 8 7 1 4 * *
Triazolam Products1 14 11 10 * * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 1 * da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.142D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.17 0.19 0.08 0.11 4.37 5.47
Benzodiazepine Tranquilizers1 0.15 0.19 0.08 0.11 4.81 6.01
Alprazolam Products1 0.12 0.16 0.07 0.10 6.02 *
Lorazepam Products1 0.08 0.07 0.05 0.04 * *
Clonazepam Products1 0.07 0.06 0.05 0.02 * *
Diazepam Products1 0.08 0.08 0.04 0.03 * *
Benzodiazepine Sedatives1 0.07 0.05 0.04 0.02 * *
Flurazepam1 0.02 0.03 <0.01 0.01 * *
Temazepam Products1 0.03 0.03 <0.01 0.02 * *
Triazolam Products1 0.06 0.04 0.04 * * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.01 * da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.142P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.6065   0.6280   0.7896  
Benzodiazepine Tranquilizers1 0.4940   0.5412   0.7624  
Alprazolam Products1 0.5228   0.8202   *  
Lorazepam Products1 0.9499   0.8317   *  
Clonazepam Products1 0.4798   0.4270   *  
Diazepam Products1 0.6839   0.6056   *  
Benzodiazepine Sedatives1 0.8647   0.6842   *  
Flurazepam1 0.2390   0.1558   *  
Temazepam Products1 0.9502   0.5751   *  
Triazolam Products1 0.7346   *   *  
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da   *   da  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.143C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 651 673 207 248 0.82 1.00
Benzodiazepine Tranquilizers1 635 655 204 243 0.84 1.03
Alprazolam Products1 442 460 149 215 1.17 1.65
Lorazepam Products1 325 356 72 95 1.10 1.44
Clonazepam Products1 296 291 115 127 1.93 2.30
Diazepam Products1 266 299 86 77 1.70 1.79
Benzodiazepine Sedatives1 154 164 37 59 2.34 3.74
Flurazepam1 14 37 3 31 * *
Temazepam Products1 114 124 37 34 * *
Triazolam Products1 106 113 6 48 0.83 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 4 8 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.143D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.22 0.22 0.08 0.09 0.82 1.00
Benzodiazepine Tranquilizers1 0.21 0.22 0.08 0.09 0.84 1.03
Alprazolam Products1 0.16 0.16 0.06 0.08 1.17 1.65
Lorazepam Products1 0.12 0.13 0.03 0.04 1.10 1.44
Clonazepam Products1 0.11 0.11 0.04 0.05 1.93 2.30
Diazepam Products1 0.10 0.11 0.03 0.03 1.70 1.79
Benzodiazepine Sedatives1 0.06 0.06 0.01 0.02 2.34 3.74
Flurazepam1 0.01 0.01 <0.01 0.01 * *
Temazepam Products1 0.04 0.05 0.01 0.01 * *
Triazolam Products1 0.04 0.04 <0.01 0.02 0.83 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.01 <0.01 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.143P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.0080   0.7141   0.5157  
Benzodiazepine Tranquilizers1 0.0121   0.6904   0.5750  
Alprazolam Products1 0.1916   0.4194   0.1524  
Lorazepam Products1 0.6741   0.7039   0.5890  
Clonazepam Products1 0.0822   0.4386   0.8872  
Diazepam Products1 0.1437   0.1524   0.3579  
Benzodiazepine Sedatives1 0.7033   0.3467   0.2790  
Flurazepam1 0.2138   0.3024   *  
Temazepam Products1 0.3970   0.9334   *  
Triazolam Products1 0.6835   0.1546   *  
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da   0.5336   da  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.144C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 95 104 51 57 2.53 3.17
Benzodiazepine Tranquilizers1 93 102 51 57 2.59 3.29
Alprazolam Products1 75 88 49 50 3.53 4.18
Lorazepam Products1 44 40 12 16 2.93 4.41
Clonazepam Products1 40 40 20 24 4.86 *
Diazepam Products1 35 29 19 7 6.15 3.48
Benzodiazepine Sedatives1 22 22 6 4 * *
Flurazepam1 3 7 * * * *
Temazepam Products1 14 11 3 1 * *
Triazolam Products1 18 18 5 4 * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 2 3 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.144D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.26 0.28 0.14 0.16 2.53 3.17
Benzodiazepine Tranquilizers1 0.26 0.28 0.14 0.16 2.59 3.29
Alprazolam Products1 0.21 0.24 0.14 0.14 3.53 4.18
Lorazepam Products1 0.13 0.11 0.04 0.04 2.93 4.41
Clonazepam Products1 0.11 0.11 0.06 0.07 4.86 *
Diazepam Products1 0.10 0.08 0.05 0.02 6.15 3.48
Benzodiazepine Sedatives1 0.06 0.06 0.02 0.01 * *
Flurazepam1 0.01 0.02 * * * *
Temazepam Products1 0.04 0.03 0.01 <0.01 * *
Triazolam Products1 0.05 0.05 0.01 0.01 * *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 0.01 0.01 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.144P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.2939   0.6618   0.8775  
Benzodiazepine Tranquilizers1 0.2906   0.6922   0.8230  
Alprazolam Products1 0.9222   0.5662   0.4196  
Lorazepam Products1 0.1957   0.9719   0.4995  
Clonazepam Products1 0.1971   0.7394   *  
Diazepam Products1 0.0801   0.0121   0.0228  
Benzodiazepine Sedatives1 0.8427   0.5650   *  
Flurazepam1 0.2618   *   *  
Temazepam Products1 0.1618   0.6178   *  
Triazolam Products1 0.9807   0.7011   *  
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da   0.9100   da  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.145C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 639 660 198 242 0.85 1.06
Benzodiazepine Tranquilizers1 624 642 195 237 0.87 1.09
Alprazolam Products1 436 454 139 211 1.19 1.78
Lorazepam Products1 322 353 71 94 1.15 1.49
Clonazepam Products1 292 291 114 125 2.03 2.40
Diazepam Products1 264 299 82 76 1.75 1.88
Benzodiazepine Sedatives1 152 163 37 58 2.50 4.04
Flurazepam1 14 37 3 31 * *
Temazepam Products1 113 123 36 34 * *
Triazolam Products1 104 112 3 47 0.51 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da 3 8 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 standard errors of numbers in thousands may differ from previously published estimates because of a change to the standard error estimation method. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.145D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Standard Errors of Percentages, 2024 and 2025
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.25 0.25 0.09 0.10 0.85 1.06
Benzodiazepine Tranquilizers1 0.24 0.25 0.09 0.10 0.87 1.09
Alprazolam Products1 0.18 0.18 0.06 0.09 1.19 1.78
Lorazepam Products1 0.14 0.15 0.03 0.04 1.15 1.49
Clonazepam Products1 0.13 0.12 0.05 0.05 2.03 2.40
Diazepam Products1 0.11 0.13 0.04 0.03 1.75 1.88
Benzodiazepine Sedatives1 0.07 0.07 0.02 0.03 2.50 4.04
Flurazepam1 0.01 0.02 <0.01 0.01 * *
Temazepam Products1 0.05 0.05 0.02 0.02 * *
Triazolam Products1 0.05 0.05 <0.01 0.02 0.51 *
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da da <0.01 <0.01 da da

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260501
Table 1.145P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2025 Versus 2024
Benzodiazepine Subtype Any Use in Past Year
(2024)
Any Use in Past Year
(2025)
Misuse in Past Year among Total Population
(2024)
Misuse in Past Year among Total Population
(2025)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2024)
Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes
(2025)
PRESCRIPTION BENZODIAZEPINE 0.0134   0.7855   0.5443  
Benzodiazepine Tranquilizers1 0.0200   0.7527   0.6116  
Alprazolam Products1 0.1892   0.3253   0.1161  
Lorazepam Products1 0.8161   0.7012   0.6323  
Clonazepam Products1 0.1234   0.4696   0.8488  
Diazepam Products1 0.2158   0.3164   0.5735  
Benzodiazepine Sedatives1 0.7296   0.3138   0.2535  
Flurazepam1 0.2976   0.3022   *  
Temazepam Products1 0.4909   0.9035   *  
Triazolam Products1 0.6796   0.1379   *  
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives1,2 da   0.5351   da  

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

1 Respondents with unknown prescription drug subtype information were excluded from the respective analyses.

2 Includes the misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.1A – Nicotine Product and Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Substance Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
Aged 12‑20
(2024)
Aged 12‑20
(2025)
Aged 21+
(2024)
Aged 21+
(2025)
LIFETIME                            
Nicotine Products 175,628 173,770 5,023 5,022 170,605 168,748 19,464 19,178 151,142 149,570 10,867 11,021 164,761 162,748
Tobacco Products 163,970 161,701 2,077 2,138 161,892 159,563 13,849 13,668 148,043 145,896 5,522 5,822 158,448 155,880
Cigarettes 147,571 144,921 1,612 1,720 145,958 143,201 11,780 11,493 134,178 131,708 4,535 4,743 143,035 140,178
Daily Cigarettes 80,874 79,492 208 129 80,666 79,363 2,969b 2,466 77,697 76,897 567 555 80,306 78,937
Smokeless Tobacco 37,799 37,393 422 436 37,378 36,957 3,701 3,604 33,676 33,353 1,260 1,334 36,540 36,058
Cigars 84,273 84,041 639 689 83,634 83,352 7,302 6,742 76,332 76,610 2,242 2,247 82,032 81,794
Pipe Tobacco 25,725 24,162 209 212 25,517 23,950 1,472 1,447 24,045 22,504 503 544 25,222 23,618
Nicotine Vaping 73,901 75,114 4,711 4,644 69,191 70,470 17,458 17,195 51,732 53,274 10,112 10,037 63,789 65,077
Alcohol 228,371 226,957 5,532 5,149 222,839 221,808 25,805 25,830 197,034 195,978 12,659 12,540 215,712 214,416
Binge Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Heavy Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
PAST YEAR                            
Nicotine Products1 78,041 79,084 3,352 3,137 74,688 75,947 13,625 13,576 61,064 62,371 7,452 7,397 70,588 71,686
Tobacco Products1 61,078 61,119 1,236 1,192 59,842 59,928 8,363 8,555 51,479 51,373 3,479 3,699 57,599 57,420
Cigarettes 47,125 46,373 802 877 46,323 45,496 6,201 6,461 40,122 39,034 2,557 2,789 44,568 43,584
Daily Cigarettes ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Smokeless Tobacco 9,261 10,000 282 253 8,980 9,747 1,949 2,028 7,031 7,719 828 854 8,433 9,147
Cigars 18,342 18,641 464 376 17,878 18,265 3,784a 3,252 14,094 15,013 1,458 1,249 16,884 17,392
Pipe Tobacco1 ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Nicotine Vaping 39,121 40,471 3,107 2,846 36,014 37,625 11,262 11,006 24,753 26,619 6,679 6,409 32,442 34,062
Alcohol 178,687 173,710 4,244a 3,762 174,444 169,948 23,361 23,077 151,083 146,871 10,413 10,036 168,275 163,673
Binge Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Heavy Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
PAST MONTH                            
Nicotine Products 63,677 64,245 1,719 1,753 61,958 62,491 10,100 10,059 51,858 52,432 4,510 4,765 59,167 59,480
Tobacco Products 48,028 46,921 488 513 47,540 46,408 5,021 5,094 42,519 41,314 1,671 1,945 46,358 44,976
Cigarettes 37,780 36,107 320 340 37,460 35,766 3,353 3,522 34,107 32,245 1,172 1,349 36,608 34,757
Daily Cigarettes 22,273a 19,909 12 6 22,261a 19,903 655b 436 21,606a 19,467 130 79 22,143a 19,831
Smokeless Tobacco 6,671 7,276 117 97 6,554 7,180 1,170 1,235 5,384 5,945 356 412 6,315 6,864
Cigars 9,447 9,833 135 135 9,312 9,698 1,697a 1,361 7,615 8,337 513 492 8,935 9,341
Pipe Tobacco 1,804 1,883 32 44 1,773 1,839 312 240 1,461 1,599 127 101 1,678 1,782
Nicotine Vaping 27,680 29,274 1,567 1,610 26,113 27,664 8,296 8,036 17,818a 19,627 4,029 4,175 23,652 25,098
Alcohol 134,330 129,088 1,725 1,514 132,605 127,574 16,589 16,691 116,016 110,883 5,139 5,392 129,191 123,696
Binge Alcohol Use 57,863 56,756 900 753 56,963 56,003 9,329 9,644 47,634 46,358 2,946 3,110 54,918 53,646
Heavy Alcohol Use2 14,541 14,534 98 81 14,443 14,453 2,098 2,270 12,344 12,183 576 701 13,965 13,833

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 estimates may differ from previously published estimates due to updates. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Information about past year use of pipe tobacco was not collected. Nicotine product use (including tobacco product use) in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use.

2 Heavy alcohol users are a subset of binge alcohol users.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.1B – Nicotine Product and Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Substance Aged 12+
(2024)
Aged 12+
(2025)
Aged 12‑17
(2024)
Aged 12‑17
(2025)
Aged 18+
(2024)
Aged 18+
(2025)
Aged 18‑25
(2024)
Aged 18‑25
(2025)
Aged 26+
(2024)
Aged 26+
(2025)
Aged 12‑20
(2024)
Aged 12‑20
(2025)
Aged 21+
(2024)
Aged 21+
(2025)
LIFETIME                            
Nicotine Products 60.9a 59.8 19.4 19.7 65.0a 63.7 55.7a 53.1 66.5 65.3 28.2 28.1 66.0a 64.8
Tobacco Products 56.9a 55.7 8.0 8.4 61.7a 60.2 39.6 37.9 65.1a 63.7 14.3 14.8 63.4a 62.0
Cigarettes 51.2a 49.9 6.2 6.8 55.6b 54.0 33.7 31.8 59.0a 57.5 11.8 12.1 57.3a 55.8
Daily Cigarettes 28.1 27.4 0.8 0.5 30.8 29.9 8.5b 6.8 34.2 33.6 1.5 1.4 32.2 31.4
Smokeless Tobacco 13.1 12.9 1.6 1.7 14.3 13.9 10.6 10.0 14.8 14.6 3.3 3.4 14.6 14.3
Cigars 29.2 28.9 2.5 2.7 31.9 31.4 20.9b 18.7 33.6 33.5 5.8 5.7 32.8 32.6
Pipe Tobacco 8.9a 8.3 0.8 0.8 9.7a 9.0 4.2 4.0 10.6 9.8 1.3 1.4 10.1a 9.4
Nicotine Vaping 25.6 25.9 18.2 18.2 26.4 26.6 50.0a 47.6 22.8 23.3 26.3 25.6 25.5 25.9
Alcohol 79.2a 78.1 21.3 20.2 85.0b 83.7 73.8a 71.6 86.7a 85.6 32.9 32.0 86.4a 85.3
Binge Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Heavy Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
PAST YEAR                            
Nicotine Products1 27.1 27.2 12.9 12.3 28.5 28.7 39.0 37.6 26.9 27.2 19.3 18.9 28.3 28.5
Tobacco Products1 21.2 21.0 4.8 4.7 22.8 22.6 23.9 23.7 22.6 22.4 9.0 9.4 23.1 22.9
Cigarettes 16.3 16.0 3.1 3.4 17.7 17.2 17.7 17.9 17.6 17.0 6.6 7.1 17.8 17.3
Daily Cigarettes ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Smokeless Tobacco 3.2 3.4 1.1 1.0 3.4 3.7 5.6 5.6 3.1 3.4 2.1 2.2 3.4 3.6
Cigars 6.4 6.4 1.8 1.5 6.8 6.9 10.8b 9.0 6.2 6.6 3.8 3.2 6.8 6.9
Pipe Tobacco1 ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Nicotine Vaping 13.6 13.9 12.0 11.2 13.7 14.2 32.2 30.5 10.9 11.6 17.3 16.3 13.0 13.6
Alcohol 62.0b 59.8 16.4a 14.8 66.5b 64.1 66.8b 63.9 66.5b 64.1 27.0 25.6 67.4b 65.1
Binge Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
Heavy Alcohol Use ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑ ‑‑
PAST MONTH                            
Nicotine Products 22.1 22.1 6.6 6.9 23.6 23.6 28.9 27.9 22.8 22.9 11.7 12.1 23.7 23.7
Tobacco Products 16.7 16.2 1.9 2.0 18.1 17.5 14.4 14.1 18.7 18.0 4.3 5.0 18.6 17.9
Cigarettes 13.1 12.4 1.2 1.3 14.3 13.5 9.6 9.8 15.0 14.1 3.0 3.4 14.7 13.8
Daily Cigarettes 7.7b 6.9 <0.1 <0.1 8.5b 7.5 1.9b 1.2 9.5a 8.5 0.3 0.2 8.9b 7.9
Smokeless Tobacco 2.3 2.5 0.5 0.4 2.5 2.7 3.3 3.4 2.4 2.6 0.9 1.0 2.5 2.7
Cigars 3.3 3.4 0.5 0.5 3.6 3.7 4.9b 3.8 3.3 3.6 1.3 1.3 3.6 3.7
Pipe Tobacco 0.6 0.6 0.1 0.2 0.7 0.7 0.9 0.7 0.6 0.7 0.3 0.3 0.7 0.7
Nicotine Vaping 9.6 10.1 6.0 6.3 10.0 10.4 23.7 22.3 7.8a 8.6 10.5 10.6 9.5 10.0
Alcohol 46.6b 44.4 6.6 5.9 50.6b 48.1 47.5 46.2 51.0b 48.4 13.3 13.7 51.7b 49.2
Binge Alcohol Use 20.1 19.5 3.5 3.0 21.7 21.1 26.7 26.7 21.0 20.2 7.6 7.9 22.0 21.3
Heavy Alcohol Use2 5.0 5.0 0.4 0.3 5.5 5.5 6.0 6.3 5.4 5.3 1.5 1.8 5.6 5.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 estimates may differ from previously published estimates due to updates. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Information about past year use of pipe tobacco was not collected. Nicotine product use (including tobacco product use) in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use.

2 Heavy alcohol users are a subset of binge alcohol users.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.2A – Nicotine Product Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 175,628 173,770 78,041 79,084 63,677 64,245
12‑20 10,867 11,021 7,452 7,397 4,510 4,765
21 or Older 164,761 162,748 70,588 71,686 59,167 59,480
12‑17 5,023 5,022 3,352 3,137 1,719 1,753
12‑13 628 690 394 397 173 194
14‑15 1,595 1,639 1,032 1,013 483 502
16‑17 2,799 2,693 1,926 1,726 1,063 1,057
18 or Older 170,605 168,748 74,688 75,947 61,958 62,491
18‑25 19,464 19,178 13,625 13,576 10,100 10,059
18‑20 5,844 6,000 4,100 4,261 2,791 3,011
21‑25 13,620 13,178 9,524 9,315 7,309 7,048
26 or Older 151,142 149,570 61,064 62,371 51,858 52,432
26‑49 70,422 69,105 36,533 36,409 30,244 29,944
26‑29 11,206 10,846 6,920 6,713 5,415 5,222
30‑34 15,222 15,046 8,300 8,148 6,802 6,353
35‑39 15,694 14,799 8,164 7,813 6,811 6,595
40‑44 15,238 14,647 7,081 7,053 6,057 5,972
45‑49 13,062 13,767 6,068 6,682 5,159 5,802
50 or Older 80,720 80,465 24,531 25,962 21,614 22,488
50‑54 12,826 11,405 5,424 5,337 4,681 4,674
55‑59 13,425 12,956 5,182 5,373 4,647 4,635
60‑64 15,325 15,331 5,790 6,191 5,011 5,420
65 or Older 39,144 40,773 8,135 9,061 7,274 7,759

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 estimates may differ from previously published estimates due to updates. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Information about past year use of pipe tobacco was not collected. Nicotine product use in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.2B – Nicotine Product Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 60.9a 59.8 27.1 27.2 22.1 22.1
12‑20 28.2 28.1 19.3 18.9 11.7 12.1
21 or Older 66.0a 64.8 28.3 28.5 23.7 23.7
12‑17 19.4 19.7 12.9 12.3 6.6 6.9
12‑13 7.8 8.8 4.9 5.1 2.1 2.5
14‑15 18.0 18.8 11.6 11.6 5.5 5.8
16‑17 31.1 30.3 21.4 19.4 11.8 11.9
18 or Older 65.0a 63.7 28.5 28.7 23.6 23.6
18‑25 55.7a 53.1 39.0 37.6 28.9 27.9
18‑20 46.5 43.5 32.6 30.9 22.2 21.8
21‑25 60.8 59.1 42.6 41.8 32.7 31.6
26 or Older 66.5 65.3 26.9 27.2 22.8 22.9
26‑49 66.6 65.6 34.5 34.6 28.6 28.4
26‑29 64.1 62.9 39.6 38.9 31.0 30.3
30‑34 64.7 64.2 35.3 34.8 28.9 27.1
35‑39 67.7 65.7 35.2 34.7 29.4 29.3
40‑44 68.0 66.8 31.6 32.2 27.0 27.2
45‑49 67.9 68.1 31.5 33.1 26.8 28.7
50 or Older 66.4 65.1 20.2 21.0 17.8 18.2
50‑54 65.1 63.1 27.5 29.5 23.8 25.9
55‑59 69.0 66.0 26.6 27.4 23.9 23.6
60‑64 68.1 67.6 25.7 27.3 22.3 23.9
65 or Older 65.4 64.5 13.6 14.3 12.2 12.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Some 2024 estimates may differ from previously published estimates due to updates. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Information about past year use of pipe tobacco was not collected. Nicotine product use in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.3A – Tobacco Product Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 163,970 161,701 61,078 61,119 48,028 46,921
12‑20 5,522 5,822 3,479 3,699 1,671 1,945
21 or Older 158,448 155,880 57,599 57,420 46,358 44,976
12‑17 2,077 2,138 1,236 1,192 488 513
12‑13 214 229 117 101 41 37
14‑15 620 629 325 340 135 137
16‑17 1,243 1,280 793 750 312 338
18 or Older 161,892 159,563 59,842 59,928 47,540 46,408
18‑25 13,849 13,668 8,363 8,555 5,021 5,094
18‑20 3,444 3,683 2,243 2,507 1,183 1,432
21‑25 10,405 9,984 6,120 6,048 3,838 3,662
26 or Older 148,043 145,896 51,479 51,373 42,519 41,314
26‑49 67,562 65,935 28,598 28,115 22,347 21,487
26‑29 9,916 9,394 4,592 4,561 3,141 3,096
30‑34 14,529 14,137 6,071 6,213 4,615 4,362
35‑39 15,269 14,459 6,555 6,017 5,227 4,716
40‑44 14,978 14,402 6,007 5,604 4,959 4,525
45‑49 12,868 13,543 5,373 5,720 4,404 4,788
50 or Older 80,482 79,960 22,881 23,258 20,173 19,827
50‑54 12,751 11,295 4,887 4,462 4,232 3,742
55‑59 13,394 12,727 4,808 4,613 4,316 3,939
60‑64 15,257 15,192 5,438 5,703 4,714 5,013
65 or Older 39,080 40,748 7,748 8,479 6,911 7,133

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.3B – Tobacco Product Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 56.9a 55.7 21.2 21.0 16.7 16.2
12‑20 14.3 14.8 9.0 9.4 4.3 5.0
21 or Older 63.4a 62.0 23.1 22.9 18.6 17.9
12‑17 8.0 8.4 4.8 4.7 1.9 2.0
12‑13 2.6 2.9 1.4 1.3 0.5 0.5
14‑15 7.0 7.2 3.7 3.9 1.5 1.6
16‑17 13.8 14.4 8.8 8.4 3.5 3.8
18 or Older 61.7a 60.2 22.8 22.6 18.1 17.5
18‑25 39.6 37.9 23.9 23.7 14.4 14.1
18‑20 27.4 26.7 17.9 18.2 9.4 10.4
21‑25 46.5 44.8 27.3 27.1 17.1 16.4
26 or Older 65.1a 63.7 22.6 22.4 18.7 18.0
26‑49 63.9 62.6 27.0 26.7 21.1 20.4
26‑29 56.8 54.5 26.3 26.5 18.0 18.0
30‑34 61.8 60.3 25.8 26.5 19.6 18.6
35‑39 65.9 64.2 28.3 26.7 22.6 20.9
40‑44 66.8 65.7 26.8 25.6 22.1 20.6
45‑49 66.9 67.0 27.9 28.3 22.9 23.7
50 or Older 66.2 64.7 18.8 18.8 16.6 16.0
50‑54 64.7 62.5 24.8 24.7 21.5 20.7
55‑59 68.8 64.8 24.7 23.5 22.2 20.1
60‑64 67.8 67.0 24.2 25.1 20.9 22.1
65 or Older 65.3 64.4 12.9 13.4 11.5 11.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.4A – Cigarette Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 147,571 144,921 47,125 46,373 37,780 36,107
12‑20 4,535 4,743 2,557 2,789 1,172 1,349
21 or Older 143,035 140,178 44,568 43,584 36,608 34,757
12‑17 1,612 1,720 802 877 320 340
12‑13 184 180 92 71 36 24
14‑15 494 481 242 250 99 86
16‑17 934 1,060 468 556 185 231
18 or Older 145,958 143,201 46,323 45,496 37,460 35,766
18‑25 11,780 11,493 6,201 6,461 3,353 3,522
18‑20 2,923 3,023 1,755 1,911 851 1,009
21‑25 8,857 8,470 4,446 4,550 2,501 2,512
26 or Older 134,178 131,708 40,122 39,034 34,107 32,245
26‑49 60,392 58,967 21,688 20,942 17,358 16,367
26‑29 8,433 8,114 3,222 3,189 2,208 2,077
30‑34 12,532 12,041 4,421 4,404 3,378 3,116
35‑39 13,796 13,053 5,166 4,702 4,185 3,819
40‑44 13,808 13,315 4,774 4,209 3,986 3,456
45‑49 11,823 12,443 4,106 4,438 3,601 3,900
50 or Older 73,786 72,741 18,434 18,093 16,750 15,877
50‑54 11,320 10,368 3,865 3,591 3,518 3,047
55‑59 12,031 11,649 3,749 3,617 3,505 3,288
60‑64 14,068 13,478 4,628 4,338 4,064 3,982
65 or Older 36,368 37,247 6,192 6,546 5,662 5,560

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.4B – Cigarette Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 51.2a 49.9 16.3 16.0 13.1 12.4
12‑20 11.8 12.1 6.6 7.1 3.0 3.4
21 or Older 57.3a 55.8 17.8 17.3 14.7 13.8
12‑17 6.2 6.8 3.1 3.4 1.2 1.3
12‑13 2.3 2.3 1.1 0.9 0.4 0.3
14‑15 5.6 5.5 2.7 2.9 1.1 1.0
16‑17 10.4 11.9 5.2 6.3 2.1 2.6
18 or Older 55.6b 54.0 17.7 17.2 14.3 13.5
18‑25 33.7 31.8 17.7 17.9 9.6 9.8
18‑20 23.3 21.9 14.0 13.9 6.8 7.3
21‑25 39.6 38.0 19.9 20.4 11.2 11.3
26 or Older 59.0a 57.5 17.6 17.0 15.0 14.1
26‑49 57.1 56.0 20.5 19.9 16.4 15.5
26‑29 48.3 47.1 18.4 18.5 12.6 12.0
30‑34 53.3 51.4 18.8 18.8 14.4 13.3
35‑39 59.6 57.9 22.3 20.9 18.1 17.0
40‑44 61.6 60.7 21.3 19.2 17.8 15.8
45‑49 61.4 61.6 21.3 22.0 18.7 19.3
50 or Older 60.7 58.8 15.2 14.6 13.8 12.8
50‑54 57.5 57.3 19.6 19.9 17.9 16.9
55‑59 61.8 59.3 19.3 18.4 18.0 16.8
60‑64 62.5 59.4 20.6 19.1 18.1 17.5
65 or Older 60.8 58.9 10.3 10.4 9.5 8.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.5A – Smokeless Tobacco Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 37,799 37,393 9,261 10,000 6,671 7,276
12‑20 1,260 1,334 828 854 356 412
21 or Older 36,540 36,058 8,433 9,147 6,315 6,864
12‑17 422 436 282 253 117 97
12‑13 28 46 23 21 12 6
14‑15 108 107 52 77 21 21
16‑17 285 283 206 155 84 70
18 or Older 37,378 36,957 8,980 9,747 6,554 7,180
18‑25 3,701 3,604 1,949 2,028 1,170 1,235
18‑20 838 899 546 601 239 315
21‑25 2,863 2,705 1,402 1,428 931 920
26 or Older 33,676 33,353 7,031 7,719 5,384 5,945
26‑49 17,393 18,130 4,629 5,195 3,357 3,758
26‑29 2,512 2,513 929 1,034 716 729
30‑34 3,719 4,306 1,178 1,320 812 981
35‑39 3,807 4,032 1,040 1,048 778 709
40‑44 3,588 3,991 757 978 540 772
45‑49 3,767 3,288 725 814 512 566
50 or Older 16,283 15,222 2,402 2,524 2,027 2,187
50‑54 3,370 2,804 619 688 530 585
55‑59 4,058 3,223 745b 324 660a 321
60‑64 3,320 3,776 294b 750 210a 568
65 or Older 5,534 5,419 745 762 626 714

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260430
Table 2.5B – Smokeless Tobacco Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Lifetime
(2024)
Lifetime
(2025)
Past Year
(2024)
Past Year
(2025)
Past Month
(2024)
Past Month
(2025)
TOTAL 13.1 12.9 3.2 3.4 2.3 2.5
12‑20 3.3 3.4 2.1 2.2 0.9 1.0
21 or Older 14.6 14.3 3.4 3.6 2.5 2.7
12‑17 1.6 1.7 1.1 1.0 0.5 0.4
12‑13 0.3 0.6 0.3 0.3 0.1 0.1
14‑15 1.2 1.2 0.6 0.9 0.2 0.2
16‑17 3.2 3.2 2.3 1.7 0.9 0.8
18 or Older 14.3 13.9 3.4 3.7 2.5 2.7
18‑25 10.6 10.0 5.6 5.6 3.3 3.4
18‑20 6.7 6.5 4.3 4.4 1.9 2.3
21‑25 12.8 12.1 6.3 6.4 4.2 4.1
26 or Older 14.8 14.6 3.1 3.4 2.4 2.6
26‑49 16.4 17.2 4.4 4.9 3.2 3.6
26‑29 14.4 14.6 5.3 6.0 4.1 4.2
30‑34 15.8a 18.4 5.0 5.6 3.5 4.2
35‑39 16.4 17.9 4.5 4.7 3.4 3.1
40‑44 16.0 18.2 3.4 4.5 2.4a 3.5
45‑49 19.6a 16.3 3.8 4.0 2.7 2.8
50 or Older 13.4 12.3 2.0 2.0 1.7 1.8
50‑54 17.1 15.5 3.1 3.8